data_6pri_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6pri _Structure_validation_residue.Date_analyzed 2019-09-13 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.802 0 CA-C-O 120.472 0.177 . . . . 75.3 111.451 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.429 ' HE1' ' HA ' ' A' ' 227' ' ' THR . 3.3 m-30 . . . . . 0 N--CA 1.483 1.209 0 C-N-CA 124.409 1.084 . . . . 74.34 112.33 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 . . . . . 0 C--O 1.244 0.805 0 N-CA-C 108.084 -1.08 . . . . 75.34 108.084 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -78.67 140.83 38.33 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 113.569 -1.651 . . . . 75.42 109.699 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 82.5 mt -136.66 140.66 42.9 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.901 0.48 . . . . 70.31 110.318 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -93.88 122.96 36.9 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.385 -0.825 . . . . 71.42 108.804 174.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -123.51 127.75 48.79 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 107.445 -1.316 . . . . 74.35 107.445 176.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 25.1 m -68.48 123.61 21.29 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.19 0.596 . . . . 75.24 110.452 -175.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 29.8 tp -108.36 111.62 23.63 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.604 -0.887 . . . . 75.21 108.604 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -81.97 126.17 31.64 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.404 -0.962 . . . . 73.51 108.404 174.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.489 HG12 HG11 ' A' ' 253' ' ' VAL . 6.4 p -142.68 130.3 11.2 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 108.305 -0.998 . . . . 74.21 108.305 178.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . 0.412 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 57.6 Cg_endo -73.85 155.57 48.56 Favored 'Trans proline' 0 C--N 1.363 1.307 0 C-N-CA 121.678 1.585 . . . . 61.04 110.666 172.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.81 -48.27 88.12 Favored Pre-proline 0 CA--C 1.56 1.35 0 C-N-CA 123.917 0.887 . . . . 61.22 113.08 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.449 ' O ' HG13 ' A' ' 206' ' ' VAL . 78.0 Cg_exo -52.57 -56.12 3.15 Favored 'Trans proline' 0 C--N 1.396 3.03 0 C-N-CA 122.453 2.102 . . . . 72.41 113.57 175.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 59.8 mt -65.09 -28.97 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 123.406 0.683 . . . . 75.3 111.077 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.54 -49.27 71.9 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.091 0.472 . . . . 73.53 111.052 177.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 65.9 t -73.98 -47.57 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 115.955 -0.566 . . . . 74.3 112.496 -173.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 202' ' ' PRO . 13.6 p -88.49 -22.2 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 O-C-N 122.233 -0.292 . . . . 71.23 111.34 -175.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 87.72 166.38 42.36 Favored Glycine 0 C--N 1.342 0.882 0 N-CA-C 111.533 -0.627 . . . . 51.3 111.533 -171.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 162.71 -128.15 1.82 Allowed Glycine 0 C--O 1.226 -0.359 0 N-CA-C 111.213 -0.755 . . . . 63.35 111.213 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -137.65 151.48 48.32 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 108.712 -0.847 . . . . 74.1 108.712 173.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 26.6 m -138.37 162.3 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.075 0.55 . . . . 73.14 110.109 172.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 -84.42 115.43 22.53 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.456 -0.793 . . . . 75.03 109.854 174.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -106.79 156.76 18.32 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.716 0.806 . . . . 73.13 109.594 173.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 43.2 tpp -93.08 125.53 37.72 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.883 0.473 . . . . 72.41 109.874 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 61.1 m -137.8 160.78 38.32 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.692 1.197 . . . . 75.11 108.044 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 92.5 mt -65.95 -20.85 66.35 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.143 0.577 . . . . 75.12 111.788 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -80.02 -17.49 52.67 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.004 0.922 . . . . 74.12 110.95 174.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 125.0 -156.78 19.07 Favored Glycine 0 C--N 1.343 0.95 0 N-CA-C 111.449 -0.66 . . . . 50.41 111.449 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.9 121.07 6.04 Favored 'Trans proline' 0 C--N 1.363 1.3 0 C-N-CA 122.382 2.055 . . . . 70.23 111.607 173.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 32.7 m -111.26 155.91 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.244 0.617 . . . . 75.34 109.837 177.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -94.14 113.85 25.87 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.19 -0.67 . . . . 73.03 109.19 175.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 92.2 t -97.26 117.56 42.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 108.647 -0.872 . . . . 74.54 108.647 175.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.25 100.35 0.79 Allowed 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.474 0.484 . . . . 74.23 109.956 176.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 91.4 t -72.75 131.72 83.93 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 123.495 0.718 . . . . 75.21 109.754 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.33 165.92 31.25 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.266 1.977 . . . . 72.23 110.979 171.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -67.4 174.58 7.05 Favored 'Trans proline' 0 CA--C 1.551 1.374 0 C-N-CA 121.688 1.592 . . . . 72.45 112.818 170.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 69.91 0.32 3.01 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 125.374 1.47 . . . . 75.31 113.514 173.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.429 ' HA ' ' HE1' ' A' ' 176' ' ' TYR . 47.4 m -62.24 126.83 28.69 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.119 0.968 . . . . 75.03 111.781 -170.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.413 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 57.9 tp60 -124.4 143.2 50.75 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.816 0.846 . . . . 72.25 111.03 -167.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.86 131.75 51.66 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.904 1.282 . . . . 73.53 111.813 -178.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 99.4 -18.04 56.94 Favored Glycine 0 N--CA 1.473 1.116 0 O-C-N 123.705 0.628 . . . . 73.52 112.951 177.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.413 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 80.5 mtt180 -83.12 135.87 34.66 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.074 -0.714 . . . . 75.43 109.074 174.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.2 mppt? -102.11 131.78 48.4 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.192 -0.67 . . . . 75.25 109.192 176.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 29.0 mt -77.46 97.78 5.09 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.88 -1.155 . . . . 74.01 107.88 174.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -74.17 103.91 4.77 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.151 0.581 . . . . 74.55 110.18 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 7.4 mt -102.23 91.09 4.14 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.054 -1.091 . . . . 72.34 108.054 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -66.6 129.44 39.85 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.843 -0.617 . . . . 73.24 112.221 -172.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 95.5 -16.66 60.81 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 115.639 -0.709 . . . . 70.41 113.113 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.547 ' HA ' ' HE2' ' A' ' 238' ' ' LYS . 11.3 mmpt? -81.57 -12.63 58.71 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.324 0.649 . . . . 73.55 112.06 -176.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -79.5 -172.68 43.58 Favored Glycine 0 CA--C 1.535 1.339 0 N-CA-C 112.106 -0.398 . . . . 72.13 112.106 168.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -86.31 153.06 56.19 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 123.005 0.522 . . . . 75.03 111.451 -174.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 48.0 Cg_endo . . . . . 0 C--N 1.382 2.312 0 C-N-CA 123.019 2.479 . . . . 73.21 112.708 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 77.9 mtt180 . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 110.079 -0.341 . . . . 75.24 110.079 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -84.35 173.0 49.58 Favored Glycine 0 C--N 1.349 1.257 0 N-CA-C 114.014 0.366 . . . . 71.42 114.014 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -106.83 134.11 50.47 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.62 1.168 . . . . 75.4 109.007 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 32.7 tp -98.91 106.69 18.98 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.892 -0.781 . . . . 71.45 108.892 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.462 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 72.6 m-85 -88.76 107.52 19.0 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.361 0.664 . . . . 74.33 109.68 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 43.3 mt -88.08 108.47 19.26 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 108.787 -0.82 . . . . 75.51 108.787 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.409 ' HA ' ' HG3' ' A' ' 232' ' ' LYS . 34.8 mt-10 -76.79 99.89 5.29 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.263 -0.88 . . . . 75.22 109.813 -171.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.489 HG11 HG12 ' A' ' 199' ' ' VAL . 95.0 t -61.69 106.48 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 123.228 0.611 . . . . 71.21 111.071 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -109.38 95.09 5.39 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.198 0.999 . . . . 73.23 108.521 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 21.8 mt -76.18 113.9 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 123.264 0.625 . . . . 74.41 109.453 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 23.8 p . . . . . 0 C--O 1.249 1.044 0 C-N-CA 124.664 1.186 . . . . 72.41 110.256 -178.748 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 111.462 0.171 . . . . 54.43 111.462 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.643 ' HB3' HH21 ' A' ' 226' ' ' ARG . 34.7 m-85 . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 108.909 -0.774 . . . . 74.32 108.909 166.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.565 ' HB2' ' HB2' ' A' ' 240' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 121.515 0.674 . . . . 75.22 110.407 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -75.48 143.08 42.77 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.349 1.06 . . . . 73.22 110.397 177.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 82.5 mt -121.13 146.96 46.21 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.721 0.409 . . . . 72.41 110.678 -171.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.48 ' HE2' ' HZ1' ' A' ' 232' ' ' LYS . 24.2 m-85 -93.76 149.71 21.01 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 109.438 -0.578 . . . . 71.05 109.438 171.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.447 ' HB1' HD21 ' A' ' 251' ' ' LEU . . . -144.54 127.99 16.94 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.589 0.755 . . . . 72.34 109.003 -177.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 38.5 m -71.31 117.8 13.31 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 122.943 0.497 . . . . 73.42 109.946 -176.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 41.5 tp -108.0 109.91 21.49 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.604 -0.887 . . . . 74.33 108.604 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -92.3 112.53 24.51 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.44 0.696 . . . . 65.34 109.156 175.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.417 ' HA ' HG11 ' A' ' 210' ' ' VAL . 7.0 p -130.24 128.99 22.82 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 124.305 1.042 . . . . 71.44 108.956 -178.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . 0.424 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 41.7 Cg_endo -70.26 155.11 65.02 Favored 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.004 1.803 . . . . 75.31 111.836 176.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -48.41 -46.49 68.95 Favored Pre-proline 0 CA--C 1.566 1.566 0 N-CA-C 114.79 1.404 . . . . 61.5 114.79 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.467 ' O ' HG11 ' A' ' 206' ' ' VAL . 25.7 Cg_endo -61.86 -52.69 2.7 Favored 'Trans proline' 0 C--N 1.393 2.921 0 CA-C-N 121.114 1.433 . . . . 64.53 112.888 176.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 50.7 mt -64.93 -24.61 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 123.574 0.749 . . . . 73.04 110.952 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 227' ' ' THR . . . -68.66 -55.1 12.58 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.578 0.751 . . . . 71.24 111.34 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 76.6 t -66.76 -51.5 55.25 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-N 115.858 -0.61 . . . . 75.42 112.121 -175.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.467 HG11 ' O ' ' A' ' 202' ' ' PRO . 11.5 p -87.69 -25.96 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 N-CA-C 111.913 0.338 . . . . 72.13 111.913 -174.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 92.29 153.4 29.92 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 111.641 -0.584 . . . . 74.12 111.641 -171.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 178.76 -128.89 1.31 Allowed Glycine 0 C--N 1.33 0.235 0 CA-C-O 119.551 -0.583 . . . . 72.21 111.944 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -139.56 141.39 37.22 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.059 0.944 . . . . 73.42 110.144 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.417 HG11 ' HA ' ' A' ' 199' ' ' VAL . 30.8 m -135.14 167.57 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.963 0.905 . . . . 71.23 109.425 169.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -93.47 111.42 23.08 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.102 -0.703 . . . . 75.03 109.102 173.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.48 145.25 29.85 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.844 0.458 . . . . 64.32 110.065 175.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 87.4 mtp -88.02 104.47 16.68 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.653 -0.869 . . . . 72.24 108.653 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 27.7 m -111.78 177.35 4.68 Favored 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 124.824 1.25 . . . . 72.35 108.315 -178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 82.6 mt -63.57 -19.32 64.72 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.461 0.704 . . . . 74.23 112.845 -177.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -87.48 6.48 33.88 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.375 0.67 . . . . 74.13 111.555 175.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 93.65 -153.32 21.21 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 119.406 -0.663 . . . . 71.23 111.641 -173.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -75.63 126.46 9.58 Favored 'Trans proline' 0 C--N 1.367 1.527 0 C-N-CA 122.339 2.026 . . . . 74.03 111.079 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.94 153.16 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 123.124 0.57 . . . . 72.11 111.217 -171.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -84.92 110.58 18.97 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.198 -0.667 . . . . 71.53 109.198 175.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 95.4 t -109.2 123.0 64.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 123.854 0.862 . . . . 73.43 110.18 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -77.37 101.24 6.26 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.512 0.725 . . . . 73.12 109.943 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 57.3 t -73.67 130.95 82.75 Favored Pre-proline 0 CA--C 1.561 1.38 0 C-N-CA 125.12 1.368 . . . . 64.21 110.142 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -85.09 171.25 9.26 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 123.205 2.603 . . . . 74.04 111.032 174.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.04 166.35 21.09 Favored 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 121.689 1.593 . . . . 73.22 112.639 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . 0.643 HH21 ' HB3' ' A' ' 176' ' ' TYR . 29.3 mtm180 71.72 11.59 6.35 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 125.636 1.574 . . . . 72.24 112.634 177.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.461 ' O ' ' HB2' ' A' ' 204' ' ' ALA . 94.1 m -65.54 91.62 0.13 Allowed 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 121.776 0.798 . . . . 73.23 110.16 -178.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.496 ' HA ' HD11 ' A' ' 255' ' ' ILE . 32.8 tt0 -107.75 144.3 35.08 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 114.771 -1.104 . . . . 74.24 110.396 -168.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -55.02 129.98 39.97 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.004 1.321 . . . . 74.43 111.986 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 88.93 -9.06 78.15 Favored Glycine 0 N--CA 1.475 1.251 0 CA-C-N 115.997 -0.547 . . . . 62.11 114.032 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -81.98 150.89 27.42 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.437 -0.579 . . . . 73.21 109.437 171.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.51 ' HG3' ' HA ' ' A' ' 252' ' ' GLU . 0.0 OUTLIER -129.85 141.81 50.77 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.796 0.808 . . . . 73.13 110.995 -176.047 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.411 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 14.9 mt -114.77 99.64 7.65 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 114.101 -1.409 . . . . 71.31 109.516 -162.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . 0.518 ' HG3' ' HB3' ' A' ' 248' ' ' ASP . 52.1 ttp180 -76.78 102.54 6.31 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 123.516 0.51 . . . . 71.1 110.405 -175.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 21.9 mt -99.12 95.35 7.05 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.153 0.981 . . . . 74.44 108.443 176.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -66.64 148.06 52.42 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.64 0.776 . . . . 65.21 111.765 -176.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 72.67 30.93 63.29 Favored Glycine 0 CA--C 1.529 0.932 0 O-C-N 123.706 0.629 . . . . 75.43 113.513 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -130.12 -17.47 3.45 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 113.346 0.869 . . . . 74.43 113.346 -176.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -77.55 -152.82 5.54 Favored Glycine 0 N--CA 1.484 1.842 0 CA-C-N 118.028 0.376 . . . . 72.12 113.505 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.565 ' HB2' ' HB2' ' A' ' 191' ' ' GLN . 15.0 m-85 -69.12 155.34 93.76 Favored Pre-proline 0 N--CA 1.488 1.436 0 CA-C-O 118.595 -0.717 . . . . 73.31 110.152 172.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo . . . . . 0 C--N 1.377 2.061 0 C-N-CA 123.024 2.482 . . . . 62.0 113.02 175.17 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 . . . . . 0 C--O 1.244 0.806 0 N-CA-C 109.512 -0.551 . . . . 73.25 109.512 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -89.25 -160.16 36.17 Favored Glycine 0 C--N 1.339 0.719 0 CA-C-N 115.291 -0.868 . . . . 72.54 111.89 172.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.518 ' HB3' ' HG3' ' A' ' 234' ' ' ARG . 3.4 m-20 -98.21 169.95 9.23 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.175 0.59 . . . . 74.35 109.61 -176.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 33.7 tp -139.67 106.19 5.33 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.62 -0.882 . . . . 75.12 108.62 174.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -88.7 113.38 24.2 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.197 0.599 . . . . 73.13 109.401 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.447 HD21 ' HB1' ' A' ' 195' ' ' ALA . 57.0 mt -85.14 112.74 20.96 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.364 -0.976 . . . . 73.05 108.364 175.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.51 ' HA ' ' HG3' ' A' ' 232' ' ' LYS . 13.8 tp10 -76.83 101.0 5.7 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.749 1.219 . . . . 71.23 108.088 -179.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.69 106.94 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.518 0.675 . . . . 73.23 110.476 -176.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -107.02 96.5 6.47 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 114.425 -1.261 . . . . 73.45 107.7 174.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.496 HD11 ' HA ' ' A' ' 228' ' ' GLN . 24.2 mt -76.13 123.54 32.52 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 N-CA-C 108.83 -0.804 . . . . 74.52 108.83 176.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 41.5 p . . . . . 0 CA--C 1.549 0.934 0 C-N-CA 124.785 1.234 . . . . 73.11 108.755 177.358 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 112.498 0.555 . . . . 75.34 112.498 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 . . . . . 0 CA--C 1.541 0.633 0 N-CA-C 108.02 -1.104 . . . . 74.23 108.02 169.556 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.62 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 72.8 mt-30 . . . . . 0 CA--C 1.55 0.972 0 CA-C-O 120.967 0.413 . . . . 72.15 111.849 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -73.98 143.1 45.77 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.579 1.152 . . . . 64.13 110.683 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 95.2 mt -139.16 149.78 44.85 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.255 1.022 . . . . 62.01 109.942 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -111.54 128.47 56.04 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.305 1.042 . . . . 74.24 108.245 168.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -125.29 128.41 48.19 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.901 -0.777 . . . . 71.13 108.901 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 73.6 m -67.49 131.93 46.62 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.355 0.662 . . . . 73.42 110.373 178.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 20.6 tp -121.36 112.52 18.67 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.888 0.875 . . . . 72.14 108.969 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -92.47 120.47 32.98 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 108.752 -0.833 . . . . 61.25 108.752 172.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 3.0 p -131.64 128.05 21.65 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.143 0.977 . . . . 75.02 108.432 -178.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -71.39 153.03 61.22 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 121.6 1.533 . . . . 75.52 111.395 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -47.1 -48.73 53.46 Favored Pre-proline 0 CA--C 1.565 1.545 0 O-C-N 124.495 1.122 . . . . 73.41 113.064 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.32 -55.42 3.65 Favored 'Trans proline' 0 C--N 1.407 3.611 0 C-N-CA 122.458 2.106 . . . . 74.13 113.291 175.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 57.4 mt -67.76 -27.01 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 123.558 0.743 . . . . 75.12 111.1 -175.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.17 -45.48 73.38 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.588 0.755 . . . . 74.33 110.857 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 81.0 t -71.63 -55.92 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 115.77 -0.65 . . . . 72.22 110.685 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 11.2 m -73.52 -28.58 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 O-C-N 123.816 0.698 . . . . 74.51 112.191 -172.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 77.77 84.01 0.54 Allowed Glycine 0 C--N 1.344 0.994 0 CA-C-N 116.013 -0.54 . . . . 73.23 112.371 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -115.28 -126.0 4.04 Favored Glycine 0 C--N 1.342 0.886 0 N-CA-C 112.14 -0.384 . . . . 61.53 112.14 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -137.56 147.96 45.54 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.654 1.182 . . . . 75.01 108.36 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 28.4 m -133.35 168.71 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 121.305 0.574 . . . . 74.11 110.703 173.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -77.37 135.47 38.35 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.967 -1.015 . . . . 74.31 108.87 169.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -138.17 158.26 44.65 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.756 0.423 . . . . 64.3 110.509 176.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 67.0 mtm -81.02 119.06 23.04 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.045 -0.979 . . . . 72.25 110.242 -176.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 89.4 m -135.42 151.68 50.67 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.186 0.994 . . . . 75.44 109.63 176.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 62.6 mt -57.41 -25.56 59.77 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.564 1.146 . . . . 75.45 112.808 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -86.43 -18.86 30.65 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.155 0.982 . . . . 72.24 111.585 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 135.07 -177.72 19.11 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.543 -0.623 . . . . 74.43 111.543 -175.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.66 120.83 7.17 Favored 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 122.404 2.069 . . . . 73.22 111.431 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.6 m -113.14 161.67 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 123.064 0.546 . . . . 73.3 111.484 -173.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -91.59 111.99 23.73 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.799 0.839 . . . . 64.4 109.482 174.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 54.4 t -109.88 126.22 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.023 0.929 . . . . 75.21 109.421 -176.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -77.36 100.94 6.11 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.353 0.661 . . . . 72.15 111.188 -173.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 59.9 t -77.29 134.81 66.48 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 124.93 1.292 . . . . 75.04 109.827 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.03 170.3 20.71 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.523 2.149 . . . . 74.33 111.349 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.68 165.73 31.91 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 121.228 1.285 . . . . 73.33 111.259 169.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 63.39 22.97 13.52 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.781 0.832 . . . . 72.14 112.299 175.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 93.9 m -68.83 105.7 2.43 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.816 0.846 . . . . 62.11 109.634 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.403 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 24.7 tt0 -105.51 141.45 36.97 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.259 1.024 . . . . 74.44 110.223 -171.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.74 136.89 58.2 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.474 1.11 . . . . 74.2 111.371 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 92.22 -9.22 76.7 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.499 -0.773 . . . . 75.42 113.435 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.403 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 97.8 mtt180 -84.86 144.22 28.55 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.995 0.518 . . . . 74.41 109.7 173.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.662 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.2 mppt? -110.66 129.47 55.81 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.508 0.723 . . . . 74.15 109.196 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.552 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 53.9 mt -95.03 101.35 13.1 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.831 0.852 . . . . 74.55 109.751 -173.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -72.35 105.29 4.03 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.333 0.653 . . . . 73.43 110.676 -176.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 17.8 mt -105.12 98.15 7.9 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.826 -1.176 . . . . 75.43 107.826 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -75.78 148.43 38.48 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 122.544 0.338 . . . . 74.12 111.349 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 72.03 33.68 62.29 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-N 115.757 -0.656 . . . . 75.32 113.272 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.13 -37.3 3.4 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.606 0.762 . . . . 73.22 111.338 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -68.72 -154.09 0.63 Allowed Glycine 0 C--N 1.355 1.631 0 N-CA-C 114.455 0.542 . . . . 74.31 114.455 -177.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.62 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 81.5 m-85 -66.66 144.71 98.74 Favored Pre-proline 0 N--CA 1.481 1.117 0 C-N-CA 122.81 0.444 . . . . 75.53 111.003 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo . . . . . 0 C--N 1.374 1.913 0 C-N-CA 122.678 2.252 . . . . 72.11 113.317 178.577 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 . . . . . 0 C--O 1.24 0.554 0 N-CA-C 108.623 -0.88 . . . . 73.15 108.623 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.8 -170.11 16.19 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-N 115.534 -0.757 . . . . 74.15 113.738 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -98.34 165.82 11.67 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.448 0.699 . . . . 75.23 109.291 -172.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 41.1 tp -141.58 105.24 4.7 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.515 -0.92 . . . . 75.32 108.515 175.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.662 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 33.0 m-85 -91.07 111.32 22.74 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.357 0.663 . . . . 74.42 109.899 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.552 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 48.5 mt -86.02 109.18 18.62 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.885 -0.783 . . . . 74.21 108.885 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -77.81 100.01 6.14 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.05 -0.977 . . . . 61.54 109.642 -173.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 48.6 t -57.84 111.45 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 O-C-N 123.963 0.789 . . . . 75.2 111.404 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 21.2 mmm-85 -115.48 98.93 7.01 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 106.818 -1.549 . . . . 73.43 106.818 171.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 36.5 mt -75.82 119.53 23.94 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 N-CA-C 109.45 -0.574 . . . . 75.22 109.45 -176.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 7.5 p . . . . . 0 C--O 1.261 1.689 0 C-N-CA 124.647 1.179 . . . . 73.5 108.867 -174.294 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 111.885 0.328 . . . . 74.11 111.885 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.498 ' CE2' HD23 ' A' ' 233' ' ' LEU . 37.7 m-85 . . . . . 0 N--CA 1.482 1.157 0 C-N-CA 123.246 0.618 . . . . 73.21 110.843 167.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 . . . . . 0 N--CA 1.479 0.994 0 CA-C-O 121.088 0.471 . . . . 74.42 110.844 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -77.27 149.02 35.43 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.522 -0.763 . . . . 71.35 109.899 175.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 95.6 mt -134.94 156.5 48.89 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.29 0.636 . . . . 74.05 110.55 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -108.86 124.51 50.75 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.663 -0.866 . . . . 75.03 108.663 169.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -124.07 130.09 51.97 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.117 0.967 . . . . 62.52 108.829 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 14.7 m -68.92 121.25 16.22 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.365 0.666 . . . . 75.3 110.102 -177.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 35.0 tp -106.35 110.47 22.71 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.629 -1.248 . . . . 72.2 107.629 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -89.2 116.65 27.6 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.485 -0.931 . . . . 74.43 108.485 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.7 p -137.69 132.82 17.58 Favored Pre-proline 0 CA--C 1.546 0.794 0 N-CA-C 108.972 -0.751 . . . . 73.31 108.972 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . 0.422 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 44.8 Cg_endo -75.13 156.47 42.42 Favored 'Trans proline' 0 C--N 1.366 1.472 0 C-N-CA 121.924 1.75 . . . . 71.23 111.27 170.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -52.6 -45.27 96.23 Favored Pre-proline 0 CA--C 1.554 1.118 0 N-CA-C 114.347 1.24 . . . . 71.4 114.347 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 24.6 Cg_endo -59.14 -50.79 7.88 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 121.658 1.572 . . . . 74.02 112.956 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 49.6 mt -65.94 -25.02 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.676 0.79 . . . . 74.32 111.077 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.95 -46.44 62.41 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 122.848 0.459 . . . . 73.22 111.275 177.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 87.7 t -64.46 -52.7 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 122.991 0.516 . . . . 75.43 111.442 -177.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 11.8 p -84.17 -34.32 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 112.04 0.385 . . . . 73.2 112.04 -174.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 84.49 89.3 0.82 Allowed Glycine 0 C--N 1.335 0.483 0 CA-C-N 116.561 -0.291 . . . . 71.24 112.507 -171.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -106.39 -135.13 7.93 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 111.05 -0.82 . . . . 74.51 111.05 172.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -128.97 144.26 51.13 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 108.783 -0.821 . . . . 63.1 108.783 174.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.445 HG11 ' HA ' ' A' ' 199' ' ' VAL . 33.7 m -134.11 162.07 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.116 0.566 . . . . 65.32 110.333 176.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 69.0 ttt-85 -74.44 135.53 42.33 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.112 0.565 . . . . 73.23 109.979 172.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -140.7 151.26 44.39 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.702 0.801 . . . . 73.21 109.565 177.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -80.63 122.34 26.96 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.962 -0.755 . . . . 74.22 108.962 176.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 95.9 m -131.84 164.35 26.26 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 107.909 -1.145 . . . . 74.23 107.909 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 73.0 mt -63.86 -11.31 26.44 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.296 0.639 . . . . 64.14 112.069 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -103.43 17.74 23.41 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.817 1.247 . . . . 75.44 110.886 176.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 87.12 -161.99 33.38 Favored Glycine 0 C--N 1.349 1.281 0 CA-C-O 119.463 -0.632 . . . . 72.2 113.182 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -74.04 121.94 7.28 Favored 'Trans proline' 0 C--N 1.372 1.805 0 C-N-CA 122.505 2.137 . . . . 73.32 111.715 177.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.91 158.92 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.882 0.873 . . . . 74.41 110.402 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -90.42 108.93 20.09 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.873 0.469 . . . . 64.34 109.814 173.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 25.1 t -97.49 129.69 47.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 108.819 -0.808 . . . . 74.52 108.819 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.02 100.44 2.99 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.267 0.627 . . . . 71.1 110.586 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 50.9 t -64.27 139.43 97.7 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 125.254 1.421 . . . . 73.25 109.94 178.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.37 168.64 24.24 Favored 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 122.684 2.256 . . . . 71.22 111.548 173.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -73.82 172.92 14.87 Favored 'Trans proline' 0 CA--C 1.55 1.319 0 C-N-CA 121.453 1.435 . . . . 75.45 110.716 164.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 44.8 mtt180 66.12 6.34 4.09 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 124.684 1.194 . . . . 73.34 112.722 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.435 ' HA ' ' CZ ' ' A' ' 176' ' ' TYR . 94.4 m -59.91 110.54 1.2 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.375 0.67 . . . . 74.54 110.823 -170.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.481 ' HB3' ' HD3' ' A' ' 231' ' ' ARG . 60.1 tt0 -117.47 134.44 54.85 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.974 1.31 . . . . 74.55 110.328 -164.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.6 128.23 35.6 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.369 1.068 . . . . 71.43 112.444 -173.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.41 -9.85 62.93 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-N 115.915 -0.584 . . . . 54.3 113.119 177.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.481 ' HD3' ' HB3' ' A' ' 228' ' ' GLN . 76.2 mtp180 -89.41 158.55 17.7 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.079 0.552 . . . . 71.33 110.728 176.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.424 ' HG3' ' HA ' ' A' ' 252' ' ' GLU . 0.0 OUTLIER -131.34 144.11 51.0 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.088 0.555 . . . . 75.11 110.734 -174.036 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.498 HD23 ' CE2' ' A' ' 176' ' ' TYR . 44.6 mt -117.46 102.27 9.07 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.723 -0.672 . . . . 72.12 110.726 -164.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . 0.4 ' HG3' ' HB3' ' A' ' 248' ' ' ASP . 51.1 ttp180 -79.78 113.92 18.3 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.833 0.853 . . . . 75.22 110.935 -173.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 43.0 mt -112.38 96.95 6.3 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.574 0.75 . . . . 74.55 109.304 177.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -62.86 140.84 58.83 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.859 -0.61 . . . . 75.1 111.379 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 81.17 25.36 55.37 Favored Glycine 0 C--N 1.339 0.741 0 O-C-N 124.259 0.975 . . . . 74.14 114.508 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.78 -28.25 6.02 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.152 0.581 . . . . 72.53 111.306 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -74.63 -169.66 23.2 Favored Glycine 0 CA--C 1.535 1.339 0 O-C-N 123.399 0.437 . . . . 61.03 112.848 173.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -65.43 143.33 98.68 Favored Pre-proline 0 N--CA 1.486 1.339 0 C-N-CA 123.693 0.797 . . . . 73.51 111.495 -175.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo . . . . . 0 C--N 1.379 2.137 0 C-N-CA 122.735 2.29 . . . . 74.33 112.076 175.083 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 57.6 mtt85 . . . . . 0 N--CA 1.484 1.228 0 N-CA-C 110.478 -0.193 . . . . 75.35 110.478 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -71.79 -173.11 17.9 Favored Glycine 0 C--N 1.344 1.021 0 O-C-N 123.545 0.528 . . . . 75.12 113.565 -176.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.4 ' HB3' ' HG3' ' A' ' 234' ' ' ARG . 3.3 m-20 -98.67 157.88 15.98 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.805 -0.813 . . . . 73.15 108.805 -176.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 32.9 tp -125.9 106.49 9.69 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.102 -1.073 . . . . 74.55 108.102 172.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -89.68 107.47 19.11 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.857 -0.794 . . . . 74.44 108.857 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 62.3 mt -87.77 106.71 18.25 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.453 -0.944 . . . . 75.04 108.453 176.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.424 ' HA ' ' HG3' ' A' ' 232' ' ' LYS . 22.7 mt-10 -79.07 105.9 10.73 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 114.894 -1.048 . . . . 74.13 110.153 -173.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 83.4 t -60.15 107.45 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.693 0 O-C-N 124.169 0.918 . . . . 75.3 111.48 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -115.27 93.92 4.5 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 107.91 -1.144 . . . . 74.23 107.91 173.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 54.5 mt -76.65 132.5 32.83 Favored 'Isoleucine or valine' 0 C--N 1.351 0.671 0 CA-C-N 115.464 -0.789 . . . . 72.32 109.93 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 32.4 p . . . . . 0 C--O 1.253 1.237 0 C-N-CA 124.671 1.188 . . . . 74.54 108.694 -179.165 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 120.436 0.16 . . . . 73.14 111.166 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.441 ' CZ ' ' HA ' ' A' ' 227' ' ' THR . 6.2 m-85 . . . . . 0 N--CA 1.483 1.209 0 C-N-CA 123.787 0.835 . . . . 75.13 111.323 169.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 121.509 0.671 . . . . 74.41 110.762 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -83.77 159.15 21.5 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.541 -1.209 . . . . 75.3 112.631 -169.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.5 mt -143.68 138.01 28.62 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.097 0.959 . . . . 72.43 109.614 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -93.04 125.72 37.77 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.483 -1.303 . . . . 72.23 107.483 164.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -124.24 133.06 53.61 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.369 -0.604 . . . . 74.44 109.369 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' THR . . . . . 0.551 HG21 ' HG3' ' A' ' 254' ' ' ARG . 42.9 m -65.94 122.16 16.72 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 124.038 0.836 . . . . 72.24 109.77 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 40.3 tp -109.28 108.8 19.52 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.018 -1.475 . . . . 75.31 107.018 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -95.7 103.09 14.95 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 122.098 0.951 . . . . 62.14 109.225 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 2.8 p -120.12 117.41 32.05 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-N 114.569 -1.196 . . . . 74.43 109.02 -174.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.9 154.59 73.33 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 122.136 1.891 . . . . 72.24 111.579 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -48.04 -45.25 63.24 Favored Pre-proline 0 CA--C 1.565 1.554 0 N-CA-C 114.713 1.375 . . . . 73.52 114.713 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.427 ' O ' HG23 ' A' ' 206' ' ' VAL . 26.1 Cg_endo -59.72 -50.85 7.03 Favored 'Trans proline' 0 C--N 1.399 3.187 0 C-N-CA 121.425 1.416 . . . . 71.15 112.227 176.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.7 mt -70.0 -23.24 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 123.672 0.789 . . . . 72.31 111.263 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.59 -51.06 46.63 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 122.923 0.489 . . . . 65.4 110.166 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 84.5 t -67.0 -48.69 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 CA-C-N 115.606 -0.725 . . . . 73.03 111.866 -177.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 202' ' ' PRO . 33.9 m -89.9 -23.04 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 113.313 0.857 . . . . 74.53 113.313 -174.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.78 149.69 24.37 Favored Glycine 0 N--CA 1.477 1.385 0 N-CA-C 112.15 -0.38 . . . . 72.11 112.15 -173.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 163.97 175.61 35.02 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 116.927 0.363 . . . . 55.31 112.282 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 221' ' ' VAL . 50.2 mtmt -82.12 135.66 35.27 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.872 0.469 . . . . 72.35 110.226 -177.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 199' ' ' VAL . 33.9 m -138.94 170.03 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 123.84 0.856 . . . . 65.41 110.686 176.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -68.55 130.58 43.26 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.532 -0.758 . . . . 74.44 111.067 175.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -135.68 118.14 15.8 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.768 -0.827 . . . . 74.43 108.768 168.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 55.8 mtt -73.0 105.93 4.67 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.211 0.605 . . . . 64.41 109.874 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 25.6 m -110.03 171.46 7.44 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.88 1.272 . . . . 73.14 108.61 -175.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 85.8 mt -57.45 -35.33 70.0 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.576 0.75 . . . . 73.51 112.212 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -79.4 -11.02 59.92 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.803 0.841 . . . . 70.42 112.464 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 125.08 -179.33 16.2 Favored Glycine 0 N--CA 1.47 0.956 0 N-CA-C 111.121 -0.791 . . . . 61.43 111.121 -174.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.64 129.41 21.07 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 122.5 2.134 . . . . 74.24 110.997 176.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.463 HG23 HG21 ' A' ' 221' ' ' VAL . 29.5 m -123.29 162.26 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.777 0.831 . . . . 74.41 110.61 -174.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -90.58 106.04 18.23 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.692 0.758 . . . . 71.33 109.7 174.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.463 HG21 HG23 ' A' ' 219' ' ' VAL . 94.8 t -101.71 121.72 53.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 115.214 -0.903 . . . . 72.43 109.569 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.02 99.69 3.38 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 123.489 0.715 . . . . 71.41 110.009 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 31.1 t -84.53 132.64 46.3 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 114.547 -1.206 . . . . 74.53 109.172 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.42 170.05 17.06 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.862 2.375 . . . . 74.14 111.23 171.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.27 -174.43 0.26 Allowed 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.536 2.157 . . . . 72.23 113.563 174.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 38.5 mtp85 62.39 19.5 11.16 Favored 'General case' 0 N--CA 1.502 2.172 0 C-N-CA 125.137 1.375 . . . . 74.31 112.172 172.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.441 ' HA ' ' CZ ' ' A' ' 176' ' ' TYR . 55.5 m -71.82 99.18 2.12 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.965 0.906 . . . . 73.43 111.088 -171.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -98.55 134.94 40.81 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.255 1.422 . . . . 75.44 110.1 -175.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.67 146.22 54.21 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.25 0.62 . . . . 73.22 111.217 -178.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 96.73 -26.74 20.81 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-N 115.182 -0.917 . . . . 64.11 112.78 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -69.85 154.28 42.17 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 117.2 0.5 . . . . 74.21 111.12 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -130.32 142.92 50.51 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 108.176 -1.046 . . . . 74.54 108.176 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.43 HD21 ' CE2' ' A' ' 176' ' ' TYR . 27.4 mt -120.38 105.82 11.26 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.781 -0.645 . . . . 73.23 110.101 -165.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -73.23 102.86 3.76 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.744 0.818 . . . . 74.11 110.463 -174.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 37.3 mt -112.49 92.88 4.18 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.097 -0.705 . . . . 74.43 109.097 177.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -69.59 144.26 53.07 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 122.293 0.237 . . . . 75.42 110.735 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 80.81 29.75 41.6 Favored Glycine 0 C--N 1.342 0.912 0 O-C-N 123.73 0.644 . . . . 30.34 113.432 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -123.33 -28.33 3.98 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 117.577 0.689 . . . . 73.14 112.11 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -72.02 -145.83 0.53 Allowed Glycine 0 N--CA 1.481 1.667 0 C-N-CA 123.111 0.386 . . . . 55.32 113.867 -177.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -76.65 149.5 80.97 Favored Pre-proline 0 N--CA 1.486 1.36 0 O-C-N 122.272 -0.546 . . . . 64.14 110.874 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo . . . . . 0 C--N 1.375 1.968 0 C-N-CA 122.746 2.297 . . . . 75.23 112.361 174.78 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 108.43 -0.952 . . . . 75.14 108.43 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.84 -175.75 46.91 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.982 -0.553 . . . . 73.32 113.885 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -100.54 127.2 46.98 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.404 0.621 . . . . 74.22 110.057 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 35.1 tp -99.95 110.91 23.23 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 107.845 -1.168 . . . . 74.43 107.845 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -86.03 108.2 18.14 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.474 -1.306 . . . . 74.22 107.474 174.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 27.1 mt -84.2 105.13 14.82 Favored 'General case' 0 C--N 1.34 0.189 0 N-CA-C 107.775 -1.194 . . . . 71.4 107.775 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -77.18 103.23 6.99 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.649 -1.614 . . . . 71.35 108.966 -177.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 63.7 t -59.65 115.61 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 123.72 0.808 . . . . 74.51 110.722 177.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.551 ' HG3' HG21 ' A' ' 196' ' ' THR . 54.5 mmm-85 -125.64 97.1 5.03 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.001 -1.481 . . . . 73.15 107.001 177.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 54.8 mt -76.71 119.31 24.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 CA-C-N 116.232 -0.44 . . . . 74.21 110.197 -174.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 44.2 p . . . . . 0 C--O 1.255 1.344 0 C-N-CA 124.425 1.09 . . . . 63.44 108.185 177.785 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 112.143 0.423 . . . . 72.52 112.143 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 . . . . . 0 N--CA 1.49 1.569 0 C-N-CA 124.682 1.193 . . . . 64.22 112.103 177.206 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.505 ' HB3' ' HB2' ' A' ' 240' ' ' PHE . 82.3 mm-40 . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 121.352 0.596 . . . . 74.03 110.186 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -91.55 142.35 27.73 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.485 -0.779 . . . . 72.45 110.657 -175.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 96.2 mt -133.52 153.64 51.48 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.583 0.753 . . . . 74.54 110.244 -178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -104.14 121.66 43.71 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 108.748 -0.834 . . . . 75.31 108.748 174.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -125.69 133.22 52.22 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.553 1.141 . . . . 74.31 109.117 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 39.3 m -65.51 139.38 58.48 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.473 0.709 . . . . 52.43 111.322 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.428 HD13 HD12 ' A' ' 251' ' ' LEU . 26.3 tp -115.17 122.57 46.45 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 123.837 0.855 . . . . 74.25 109.199 176.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -89.52 106.08 18.22 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.273 -0.64 . . . . 70.51 109.273 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.604 HG11 HG13 ' A' ' 253' ' ' VAL . 6.4 p -129.56 131.36 23.54 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 122.86 0.464 . . . . 72.42 110.042 178.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . 0.42 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 55.8 Cg_endo -74.46 157.64 44.86 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 121.943 1.762 . . . . 54.32 111.404 169.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.486 ' HA ' HG22 ' A' ' 255' ' ' ILE . . . -50.95 -48.97 83.23 Favored Pre-proline 0 CA--C 1.57 1.732 0 CA-C-O 117.949 -1.024 . . . . 60.53 113.652 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.468 ' O ' HG11 ' A' ' 206' ' ' VAL . 28.7 Cg_endo -60.91 -51.52 4.65 Favored 'Trans proline' 0 C--N 1.402 3.371 0 C-N-CA 121.529 1.486 . . . . 75.41 111.945 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.4 mt -62.83 -26.47 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 123.599 0.76 . . . . 73.23 111.32 -176.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.3 -52.99 33.81 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-O 120.953 0.406 . . . . 75.44 110.8 174.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 90.0 t -67.94 -43.99 85.39 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 N-CA-C 112.675 0.62 . . . . 75.44 112.675 -175.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.468 HG11 ' O ' ' A' ' 202' ' ' PRO . 11.0 p -99.92 -21.66 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 122.857 0.463 . . . . 72.21 112.183 -173.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.66 144.67 11.41 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 112.229 -0.348 . . . . 62.43 112.229 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -177.25 -140.35 3.63 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-O 119.224 -0.765 . . . . 74.44 111.898 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -116.94 143.34 45.82 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 118.005 0.902 . . . . 74.14 109.208 176.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 34.4 m -139.83 169.87 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 123.457 0.703 . . . . 73.42 111.352 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -90.12 114.12 26.0 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.12 0.568 . . . . 73.35 110.343 173.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.44 127.12 52.06 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.111 -1.07 . . . . 75.41 108.111 165.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 89.8 mmm -81.58 104.97 12.37 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.215 -0.661 . . . . 75.15 109.215 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 87.4 m -113.4 162.03 16.59 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.572 1.149 . . . . 73.14 109.76 -176.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 87.3 mt -58.0 -16.67 13.39 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.035 0.934 . . . . 73.35 112.986 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -103.7 29.25 5.89 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.037 0.935 . . . . 73.52 110.924 175.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 86.9 -165.38 36.31 Favored Glycine 0 C--N 1.348 1.231 0 CA-C-N 116.237 -0.438 . . . . 74.44 113.442 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -72.54 121.65 7.6 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.78 2.32 . . . . 75.41 111.395 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.4 m -121.15 147.8 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.821 0.849 . . . . 75.04 109.96 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 9.8 pt-20 -90.49 113.93 26.0 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.285 0.564 . . . . 72.43 110.949 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 63.9 t -102.83 132.2 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.283 0.633 . . . . 72.4 109.452 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -78.94 99.99 7.06 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 123.657 0.783 . . . . 72.34 109.765 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 74.5 t -80.03 134.02 56.93 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.317 1.047 . . . . 75.24 110.201 178.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.42 170.96 18.96 Favored 'Trans proline' 0 C--N 1.383 2.36 0 C-N-CA 122.939 2.426 . . . . 75.44 111.372 172.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -65.01 175.22 3.98 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 121.869 1.713 . . . . 74.2 113.47 172.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 72.31 5.33 5.26 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 125.248 1.419 . . . . 75.12 112.844 174.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 87.6 m -69.42 127.63 33.72 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.156 0.583 . . . . 75.51 110.913 -172.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -127.14 142.34 51.53 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.817 0.847 . . . . 75.42 110.809 -167.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . 0.423 ' HB3' ' HB ' ' A' ' 255' ' ' ILE . . . -65.05 132.37 49.03 Favored 'General case' 0 C--N 1.348 0.543 0 C-N-CA 124.108 0.963 . . . . 73.24 110.767 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.13 -14.7 63.46 Favored Glycine 0 N--CA 1.468 0.77 0 O-C-N 123.994 0.809 . . . . 75.31 112.223 -178.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 78.2 mtt-85 -84.12 142.31 30.47 Favored 'General case' 0 C--N 1.351 0.65 0 N-CA-C 109.233 -0.654 . . . . 73.22 109.233 173.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.58 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.0 mppt? -110.64 130.88 55.46 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.786 -0.82 . . . . 74.34 108.786 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 27.1 mt -84.18 99.4 10.5 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.193 -1.04 . . . . 64.45 108.193 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -72.97 102.0 3.36 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.069 0.548 . . . . 74.35 109.956 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 14.0 mt -105.1 95.34 5.77 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.977 -0.749 . . . . 75.44 108.977 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -62.64 145.26 55.01 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 120.827 0.346 . . . . 70.42 111.452 176.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 74.58 19.78 79.76 Favored Glycine 0 C--N 1.344 0.985 0 CA-C-N 115.096 -0.956 . . . . 73.23 113.644 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -122.16 -11.17 8.47 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.426 0.691 . . . . 64.43 112.115 -176.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -77.98 -169.36 33.88 Favored Glycine 0 C--N 1.343 0.971 0 N-CA-C 111.842 -0.503 . . . . 72.23 111.842 167.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.505 ' HB2' ' HB3' ' A' ' 191' ' ' GLN . 18.0 m-30 -72.57 155.75 90.77 Favored Pre-proline 0 N--CA 1.483 1.201 0 CA-C-N 116.855 0.327 . . . . 75.22 110.995 -179.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo . . . . . 0 C--N 1.378 2.087 0 C-N-CA 122.557 2.171 . . . . 72.42 112.987 175.522 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 42.8 mtt180 . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 108.598 -0.889 . . . . 74.22 108.598 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -83.25 -165.82 38.62 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 116.014 -0.539 . . . . 53.31 112.811 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.54 164.83 12.1 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.921 0.888 . . . . 74.23 109.516 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 33.7 tp -134.99 107.76 7.49 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 107.793 -1.188 . . . . 75.14 107.793 173.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.58 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 73.5 m-85 -88.92 111.16 21.77 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.466 0.706 . . . . 71.54 109.608 -178.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.428 HD12 HD13 ' A' ' 197' ' ' LEU . 63.9 mt -86.46 104.33 15.83 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 107.998 -1.112 . . . . 74.52 107.998 174.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -78.95 97.58 6.1 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.38 -0.97 . . . . 75.13 108.38 -173.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.604 HG13 HG11 ' A' ' 199' ' ' VAL . 81.8 t -57.91 109.63 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-N 114.256 -1.338 . . . . 72.21 112.084 -175.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -105.03 97.93 7.71 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 124.281 1.033 . . . . 74.42 108.756 172.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.486 HG22 ' HA ' ' A' ' 201' ' ' ALA . 32.9 mt -77.56 126.92 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 123.651 0.594 . . . . 74.45 109.623 177.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 9.5 p . . . . . 0 CA--C 1.556 1.199 0 C-N-CA 124.677 1.191 . . . . 71.15 109.006 -178.389 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.838 0 CA-C-O 120.327 0.108 . . . . 74.13 111.182 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.411 ' HE1' ' HA ' ' A' ' 227' ' ' THR . 2.7 m-85 . . . . . 0 N--CA 1.494 1.738 0 C-N-CA 125.035 1.334 . . . . 74.55 113.423 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 109.336 -0.616 . . . . 73.42 109.336 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -75.59 147.29 39.72 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 114.954 -1.021 . . . . 70.33 109.936 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 96.0 mt -129.09 166.6 18.96 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.492 0.717 . . . . 73.43 110.289 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -119.65 145.34 46.55 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.388 1.075 . . . . 73.22 108.809 173.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.15 158.03 43.84 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.291 1.036 . . . . 60.32 108.562 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 16.5 m -92.46 130.83 38.02 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 122.68 0.392 . . . . 70.52 109.943 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 57.1 tp -111.99 126.11 54.79 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.724 0.809 . . . . 74.44 109.684 176.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -93.57 125.43 38.17 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.219 0.608 . . . . 63.51 109.368 170.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 6.5 p -144.94 133.76 11.04 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 124.045 0.938 . . . . 74.02 108.65 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.91 157.81 38.85 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.075 1.85 . . . . 74.33 111.29 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.22 -48.29 92.84 Favored Pre-proline 0 CA--C 1.555 1.173 0 N-CA-C 113.309 0.855 . . . . 64.55 113.309 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.505 ' O ' HG11 ' A' ' 206' ' ' VAL . 52.4 Cg_exo -56.13 -56.12 2.36 Favored 'Trans proline' 0 C--N 1.395 2.995 0 C-N-CA 121.836 1.691 . . . . 72.44 113.028 176.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 57.7 mt -60.91 -30.22 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 C-N-CA 122.717 0.407 . . . . 71.45 110.829 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . 0.431 ' HB1' ' O ' ' A' ' 227' ' ' THR . . . -63.61 -53.55 49.87 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 122.927 0.491 . . . . 74.42 111.038 178.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 32.3 t -78.91 -42.4 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 116.154 -0.476 . . . . 71.14 112.175 -172.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.505 HG11 ' O ' ' A' ' 202' ' ' PRO . 9.9 p -90.02 -19.57 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 122.654 0.381 . . . . 73.44 111.395 -176.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.31 159.04 34.31 Favored Glycine 0 C--N 1.348 1.226 0 N-CA-C 111.986 -0.446 . . . . 72.34 111.986 -174.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.79 -138.68 5.39 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-O 119.603 -0.554 . . . . 75.1 112.352 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.551 ' HB2' ' HZ3' ' A' ' 209' ' ' LYS . 9.5 mtmp? -137.31 142.31 41.89 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.564 0.746 . . . . 72.01 109.312 177.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.77 162.04 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 122.846 0.458 . . . . 72.42 110.539 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -86.51 104.77 16.28 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.295 -1.002 . . . . 73.03 108.295 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -103.49 138.86 39.61 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.773 0.829 . . . . 61.21 110.199 -175.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 22.5 ptt? -72.54 118.46 15.49 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 121.438 0.637 . . . . 72.12 109.401 176.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 28.0 m -135.45 154.59 51.39 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.091 0.956 . . . . 72.52 109.061 -177.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 68.7 mt -63.19 -21.66 66.36 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.003 0.921 . . . . 74.3 112.789 -177.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -93.62 0.8 56.69 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.276 0.63 . . . . 73.53 111.353 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 117.97 167.98 14.3 Favored Glycine 0 C--N 1.345 1.069 0 CA-C-O 119.534 -0.592 . . . . 53.35 112.515 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.76 121.26 8.3 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.513 2.142 . . . . 62.41 111.174 176.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 27.7 m -127.7 160.04 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 123.804 0.842 . . . . 61.4 110.879 -171.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -86.68 103.95 15.63 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.062 0.545 . . . . 74.15 109.817 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 99.0 t -96.84 124.14 49.5 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 N-CA-C 108.672 -0.862 . . . . 74.4 108.672 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.04 98.7 2.58 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.069 0.548 . . . . 50.13 110.244 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 94.8 t -73.97 128.0 87.24 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.203 1.001 . . . . 64.1 109.737 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.16 170.34 14.76 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.601 2.201 . . . . 70.52 111.317 176.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.52 167.87 26.13 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 121.249 1.3 . . . . 73.25 111.489 168.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 48.2 mtt-85 65.63 23.04 11.69 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 124.622 1.169 . . . . 75.5 111.989 176.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.431 ' O ' ' HB1' ' A' ' 204' ' ' ALA . 30.0 m -75.15 93.53 2.81 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.771 0.796 . . . . 74.13 110.416 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -86.03 145.71 26.97 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.461 -1.245 . . . . 74.32 110.531 -178.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.3 138.42 58.52 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.114 0.966 . . . . 72.41 111.126 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 92.74 -14.83 64.05 Favored Glycine 0 N--CA 1.473 1.108 0 CA-C-N 116.206 -0.452 . . . . 75.24 113.034 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -75.71 145.11 41.15 Favored 'General case' 0 C--N 1.348 0.504 0 N-CA-C 109.457 -0.571 . . . . 71.25 109.457 173.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.583 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 0.2 OUTLIER -110.48 122.71 48.39 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.199 -0.667 . . . . 74.41 109.199 175.451 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 18.7 mt -76.19 103.07 6.05 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.447 -0.945 . . . . 72.23 108.447 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 21.4 ttm-85 -70.95 101.2 2.12 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 109.395 -0.595 . . . . 74.33 109.395 175.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 10.0 mt -104.27 103.13 12.83 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 108.011 -1.107 . . . . 72.24 108.011 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -80.85 142.7 33.39 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.735 0.414 . . . . 74.04 111.521 -170.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 84.99 21.15 56.32 Favored Glycine 0 C--N 1.346 1.111 0 CA-C-N 115.985 -0.552 . . . . 64.15 113.506 178.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.45 ' HE3' ' HA ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -113.27 -26.92 8.17 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.285 0.634 . . . . 71.34 112.534 -173.824 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -72.91 -134.74 0.21 Allowed Glycine 0 CA--C 1.539 1.553 0 N-CA-C 114.262 0.465 . . . . 73.45 114.262 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -93.56 137.73 23.22 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 123.266 0.626 . . . . 75.24 110.114 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 56.3 Cg_endo . . . . . 0 C--N 1.379 2.137 0 C-N-CA 122.751 2.3 . . . . 64.45 112.487 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.549 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 0.8 OUTLIER . . . . . 0 CA--C 1.544 0.743 0 N-CA-C 109.894 -0.41 . . . . 73.41 109.894 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -68.33 -173.27 7.67 Favored Glycine 0 N--CA 1.477 1.369 0 N-CA-C 114.362 0.505 . . . . 72.24 114.362 -173.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -95.97 168.81 10.4 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.456 -0.942 . . . . 74.11 108.456 178.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 238' ' ' LYS . 34.6 tp -141.49 108.81 5.53 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.493 -0.928 . . . . 75.52 108.493 178.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.583 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 81.1 m-85 -90.39 109.28 20.4 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.902 0.881 . . . . 75.34 110.032 -176.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 46.8 mt -88.0 107.14 18.58 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.153 -0.684 . . . . 75.2 109.153 174.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -80.25 101.09 8.67 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.69 1.196 . . . . 73.13 108.801 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 89.4 t -63.39 120.23 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 125.218 1.407 . . . . 72.34 112.733 -171.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -113.83 100.11 8.2 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.039 -1.097 . . . . 72.2 108.039 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 18.6 mt -75.88 120.11 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 122.962 0.505 . . . . 74.13 109.75 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 CA--C 1.554 1.129 0 C-N-CA 124.296 1.038 . . . . 75.22 108.895 -179.997 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 112.423 0.527 . . . . 63.32 112.423 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.46 ' CE2' ' HA ' ' A' ' 227' ' ' THR . 43.6 m-85 . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 109.268 -0.642 . . . . 73.4 109.268 173.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 111.153 0.057 . . . . 70.03 111.153 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.73 142.61 42.39 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.143 0.977 . . . . 51.05 109.11 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 88.9 mt -127.51 160.61 30.98 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.794 0.838 . . . . 63.5 110.326 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -129.99 119.92 23.95 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.274 -1.01 . . . . 73.25 108.274 173.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -126.66 132.9 51.09 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.666 1.186 . . . . 63.2 109.07 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 51.9 m -66.13 129.67 40.62 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.442 0.697 . . . . 74.5 110.369 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 41.5 tp -116.12 110.85 19.41 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 107.571 -1.27 . . . . 74.15 107.571 176.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -93.63 106.77 18.71 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.496 -0.927 . . . . 72.51 108.496 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 2.8 p -125.27 122.53 25.18 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 124.576 1.151 . . . . 63.43 109.02 -176.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . 0.409 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 72.2 Cg_endo -71.51 158.38 54.05 Favored 'Trans proline' 0 C--N 1.372 1.764 0 C-N-CA 122.301 2.0 . . . . 73.23 111.277 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.98 -45.05 80.93 Favored Pre-proline 0 CA--C 1.571 1.759 0 N-CA-C 114.195 1.183 . . . . 74.03 114.195 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 75.8 Cg_exo -53.69 -54.65 4.5 Favored 'Trans proline' 0 C--N 1.399 3.198 0 C-N-CA 122.225 1.95 . . . . 72.32 113.572 173.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 49.3 mt -71.44 -25.29 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 122.999 0.52 . . . . 54.21 110.66 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.88 -40.53 83.55 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.241 0.616 . . . . 74.52 111.007 177.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 97.7 t -78.58 -56.3 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 CA-C-N 116.63 -0.259 . . . . 75.31 111.595 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.3 p -92.49 -25.77 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 112.675 0.62 . . . . 73.54 112.675 -170.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 96.18 156.81 31.39 Favored Glycine 0 N--CA 1.478 1.47 0 O-C-N 122.476 -0.14 . . . . 74.14 113.097 -176.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 169.65 -131.17 2.2 Favored Glycine 0 C--N 1.346 1.105 0 N-CA-C 111.7 -0.56 . . . . 71.43 111.7 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -134.55 141.71 46.76 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.187 0.995 . . . . 74.21 108.973 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.473 HG11 ' HA ' ' A' ' 199' ' ' VAL . 19.4 m -131.61 167.13 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 122.903 0.481 . . . . 73.34 110.732 176.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -82.03 107.28 14.61 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.526 -0.916 . . . . 75.52 108.526 170.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.02 133.54 48.79 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.317 0.647 . . . . 65.24 109.652 175.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 22.9 mmt -81.01 104.12 11.3 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 109.374 -0.602 . . . . 75.42 109.374 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 30.7 m -112.72 163.15 14.92 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 124.528 1.131 . . . . 63.43 109.039 -177.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 84.6 mt -67.98 -17.03 64.31 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.517 0.727 . . . . 75.35 112.037 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -80.37 -19.68 45.81 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.022 0.929 . . . . 75.31 111.028 173.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 126.24 177.32 14.83 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 110.678 -0.969 . . . . 74.43 110.678 -172.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.87 121.24 7.91 Favored 'Trans proline' 0 CA--C 1.554 1.504 0 C-N-CA 121.981 1.787 . . . . 70.04 110.819 174.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.434 HG22 HG23 ' A' ' 221' ' ' VAL . 35.0 m -124.81 161.0 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 123.324 0.65 . . . . 74.32 111.043 -173.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -85.47 105.75 16.31 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.013 -0.736 . . . . 74.22 109.013 177.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.434 HG23 HG22 ' A' ' 219' ' ' VAL . 49.7 t -102.76 129.16 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.599 0.759 . . . . 64.21 110.394 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.23 100.56 3.74 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 123.42 0.688 . . . . 73.31 110.278 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' A' ' 224' ' ' PRO . 58.6 t -88.14 131.56 42.36 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 124.599 1.16 . . . . 72.2 109.389 178.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 223' ' ' VAL . 3.4 Cg_exo -78.88 174.21 12.52 Favored 'Trans proline' 0 C--N 1.377 2.026 0 C-N-CA 123.677 2.918 . . . . 72.04 111.199 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -62.54 176.9 1.44 Allowed 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 121.993 1.795 . . . . 64.41 112.758 166.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 69.27 5.56 5.19 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 124.506 1.123 . . . . 73.0 112.947 172.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.46 ' HA ' ' CE2' ' A' ' 176' ' ' TYR . 87.8 m -66.05 97.57 0.38 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.896 0.878 . . . . 64.44 111.204 -171.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -101.83 141.7 34.27 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.049 1.34 . . . . 65.5 111.086 -171.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.04 141.98 57.78 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.159 0.984 . . . . 75.43 112.517 -174.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.71 -20.14 29.46 Favored Glycine 0 C--N 1.351 1.364 0 O-C-N 123.833 0.708 . . . . 74.44 113.659 178.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -77.23 160.61 28.79 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.067 0.547 . . . . 75.14 110.632 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 12.6 mptt -127.55 143.64 51.16 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.317 0.579 . . . . 75.11 109.985 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 23.3 mt -106.27 99.54 9.12 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.769 -1.105 . . . . 74.12 109.136 -170.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 42.8 ttm105 -73.74 102.03 3.86 Favored 'General case' 0 C--O 1.24 0.569 0 O-C-N 124.567 1.167 . . . . 75.12 110.437 -174.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 30.2 mt -105.82 94.6 5.28 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.476 -0.935 . . . . 73.0 108.476 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -70.21 140.21 52.42 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 122.845 0.458 . . . . 75.44 111.002 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 81.46 17.65 70.64 Favored Glycine 0 CA--C 1.528 0.892 0 O-C-N 123.918 0.762 . . . . 41.12 113.202 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -122.07 -11.81 8.42 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.437 0.695 . . . . 75.21 112.295 -175.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -77.88 -161.82 17.29 Favored Glycine 0 N--CA 1.48 1.61 0 CA-C-O 119.804 -0.442 . . . . 73.22 112.74 171.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -71.5 149.94 93.66 Favored Pre-proline 0 N--CA 1.484 1.257 0 CA-C-N 117.911 0.856 . . . . 74.33 111.6 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo . . . . . 0 C--N 1.376 1.975 0 C-N-CA 122.909 2.406 . . . . 73.11 112.31 172.618 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 107.651 -1.24 . . . . 74.42 107.651 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -80.91 -158.07 18.46 Favored Glycine 0 C--N 1.34 0.8 0 O-C-N 123.435 0.46 . . . . 72.42 113.045 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -100.06 159.15 15.32 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.507 -0.553 . . . . 63.41 109.507 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 40.7 tp -126.68 108.37 11.03 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.51 -1.292 . . . . 75.53 107.51 172.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.521 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 15.0 m-85 -90.19 108.15 19.57 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.514 -0.921 . . . . 74.43 108.514 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 57.2 mt -87.2 105.53 17.27 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.982 -1.118 . . . . 72.11 107.982 174.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -78.74 112.3 15.73 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.503 -0.771 . . . . 70.33 109.842 -175.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 58.0 t -63.3 119.37 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 124.636 1.174 . . . . 75.23 111.726 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 49.7 mmm-85 -120.39 95.6 4.8 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 125.167 1.387 . . . . 72.51 107.495 173.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.51 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 49.8 mt -77.87 113.12 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 122.741 0.417 . . . . 75.4 110.509 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 75.0 p . . . . . 0 CA--C 1.559 1.299 0 C-N-CA 124.379 1.071 . . . . 72.04 108.714 177.625 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 113.718 1.007 . . . . 64.33 113.718 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.532 ' HH ' ' HA ' ' A' ' 227' ' ' THR . 21.6 m-85 . . . . . 0 N--CA 1.475 0.777 0 C-N-CA 123.021 0.529 . . . . 74.45 110.041 170.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 . . . . . 0 N--CA 1.477 0.88 0 CA-C-O 120.614 0.245 . . . . 75.43 111.018 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -76.48 155.92 33.43 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.452 0.701 . . . . 75.53 111.276 -176.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 93.7 mt -128.74 152.93 47.88 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.147 0.979 . . . . 72.12 109.19 176.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -108.25 149.12 29.02 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.864 0.866 . . . . 74.35 108.852 172.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -155.03 136.1 13.86 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.972 0.909 . . . . 73.51 108.763 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 28.1 m -78.01 128.48 33.93 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.115 0.566 . . . . 71.31 109.888 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 22.0 tp -108.27 117.41 34.08 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.438 -0.579 . . . . 74.21 109.438 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -82.47 105.77 13.8 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.431 -0.951 . . . . 53.42 108.431 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.478 HG13 HG12 ' A' ' 253' ' ' VAL . 2.7 p -136.5 122.7 13.69 Favored Pre-proline 0 CA--C 1.548 0.888 0 N-CA-C 109.507 -0.553 . . . . 65.42 109.507 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . 0.457 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 54.9 Cg_endo -72.11 160.65 46.86 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.194 1.93 . . . . 72.55 112.049 173.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.75 -51.72 63.4 Favored Pre-proline 0 CA--C 1.567 1.611 0 C-N-CA 124.46 1.104 . . . . 63.14 113.745 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 56.6 Cg_endo -65.62 -36.06 34.91 Favored 'Trans proline' 0 C--N 1.401 3.327 0 C-N-CA 121.624 1.549 . . . . 71.52 112.606 -176.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 23.0 mt -72.7 -31.7 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 122.766 0.426 . . . . 71.33 110.551 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.1 -42.15 89.69 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 122.691 0.397 . . . . 74.0 110.768 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 90.7 t -69.7 -53.02 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.096 0 C-N-CA 123.281 0.632 . . . . 75.02 111.695 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 28.0 m -79.58 -32.83 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 112.153 0.427 . . . . 73.13 112.153 -175.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.18 105.77 0.97 Allowed Glycine 0 C--N 1.343 0.934 0 CA-C-N 116.146 -0.479 . . . . 65.43 112.584 -173.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -148.46 -177.03 22.39 Favored Glycine 0 C--N 1.344 1.021 0 N-CA-C 112.074 -0.41 . . . . 73.13 112.074 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.623 ' HB3' ' HB2' ' A' ' 220' ' ' GLU . 50.2 mtmt -86.93 127.61 35.07 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 117.13 0.465 . . . . 75.11 110.497 -175.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 20.7 m -124.22 167.95 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 123.14 0.576 . . . . 75.1 111.555 -177.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -71.53 106.63 4.07 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 123.974 0.796 . . . . 73.44 110.232 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.83 115.76 30.86 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 107.95 -1.13 . . . . 64.12 107.95 166.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 63.3 mtt -72.97 104.93 4.25 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 109.255 -0.646 . . . . 75.34 109.255 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 38.1 m -110.99 162.23 15.06 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.715 1.206 . . . . 73.34 109.268 -173.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 96.4 mt -57.68 -23.25 50.51 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.967 0.907 . . . . 72.1 112.95 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -87.47 -20.83 26.03 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.26 0.624 . . . . 74.32 111.707 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 139.05 -171.93 23.39 Favored Glycine 0 C--N 1.345 1.036 0 CA-C-O 119.577 -0.568 . . . . 71.11 111.95 -176.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.6 117.79 4.66 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.21 1.94 . . . . 72.11 110.788 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.26 166.78 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.15 0.58 . . . . 71.44 109.687 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.623 ' HB2' ' HB3' ' A' ' 209' ' ' LYS . 8.5 pt-20 -107.52 105.12 14.86 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.721 0.772 . . . . 75.54 109.746 178.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 58.7 t -99.46 131.42 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.886 1.275 . . . . 75.53 109.841 -175.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.73 100.43 2.84 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.801 0.841 . . . . 62.11 110.553 -176.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 80.8 t -78.55 138.62 58.83 Favored Pre-proline 0 N--CA 1.478 0.973 0 C-N-CA 124.872 1.269 . . . . 72.31 109.321 175.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -75.11 168.83 23.9 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 122.51 2.14 . . . . 70.42 111.506 178.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -68.35 172.71 10.77 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 121.421 1.414 . . . . 65.23 111.424 168.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 63.85 17.12 10.32 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.888 0.875 . . . . 74.35 112.071 174.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.532 ' HA ' ' HH ' ' A' ' 176' ' ' TYR . 53.7 m -75.01 133.18 41.71 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.943 0.897 . . . . 73.11 110.153 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -139.35 143.13 37.63 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.201 0.6 . . . . 70.51 110.846 -164.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.19 127.73 33.27 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 124.323 1.049 . . . . 65.51 111.373 -177.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 103.58 -21.84 37.67 Favored Glycine 0 N--CA 1.473 1.134 0 CA-C-N 115.902 -0.59 . . . . 71.04 112.719 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -75.81 141.98 42.36 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.082 0.553 . . . . 74.41 110.024 176.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.48 ' HG3' ' HG2' ' A' ' 252' ' ' GLU . 0.0 OUTLIER -108.38 127.57 54.0 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.497 0.719 . . . . 75.01 109.746 178.306 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 56.6 mt -90.6 96.88 10.87 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.9 -1.148 . . . . 73.23 107.9 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 30.4 ttp-105 -87.15 105.25 17.06 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 124.233 1.013 . . . . 74.15 110.24 -172.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 31.2 mt -99.85 94.82 6.52 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.602 -0.888 . . . . 72.41 108.602 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm -67.55 140.97 56.99 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.52 0.328 . . . . 74.34 110.554 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.06 28.41 56.38 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-N 116.097 -0.501 . . . . 74.34 113.642 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.449 ' HA ' ' HE2' ' A' ' 238' ' ' LYS . 9.3 mmpt? -127.54 -14.95 5.15 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.843 0.857 . . . . 74.53 112.801 -178.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -78.2 -152.98 6.23 Favored Glycine 0 N--CA 1.476 1.366 0 C-N-CA 122.736 0.207 . . . . 65.52 113.162 174.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -73.58 147.94 87.44 Favored Pre-proline 0 N--CA 1.485 1.296 0 C-N-CA 123.022 0.529 . . . . 71.31 111.28 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo . . . . . 0 C--N 1.377 2.058 0 C-N-CA 122.94 2.427 . . . . 74.5 112.741 172.892 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 66.2 mtm-85 . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 109.701 -0.481 . . . . 75.33 109.701 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -74.97 -157.25 5.79 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 116.405 -0.362 . . . . 74.11 112.994 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -97.37 170.02 9.36 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.071 0.548 . . . . 64.2 110.173 -175.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 29.4 tp -136.35 105.63 6.03 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.746 -1.205 . . . . 73.03 107.746 172.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -89.66 107.07 18.87 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.752 -0.833 . . . . 75.21 108.752 -178.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 71.9 mt -89.53 104.28 16.85 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.559 -1.275 . . . . 75.41 107.559 173.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.48 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 12.8 mt-10 -78.29 105.56 9.61 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.508 -0.769 . . . . 71.12 108.962 -173.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.478 HG12 HG13 ' A' ' 199' ' ' VAL . 61.3 t -59.62 104.21 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.82 0 O-C-N 124.073 0.858 . . . . 75.3 111.545 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -103.46 97.66 7.68 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 107.785 -1.191 . . . . 72.24 107.785 173.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 12.5 mt -75.02 114.73 15.39 Favored 'Isoleucine or valine' 0 C--N 1.356 0.853 0 O-C-N 123.958 0.786 . . . . 71.15 108.941 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 12.5 p . . . . . 0 C--O 1.256 1.423 0 C-N-CA 125.537 1.535 . . . . 72.22 108.16 -177.033 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.794 0 CA-C-O 120.382 0.134 . . . . 70.43 111.324 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 . . . . . 0 N--CA 1.487 1.382 0 C-N-CA 125.143 1.377 . . . . 75.42 110.162 -174.173 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.502 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 80.8 mt-30 . . . . . 0 N--CA 1.483 1.198 0 CA-C-O 120.311 0.1 . . . . 72.32 111.136 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -89.97 135.2 33.79 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.371 -0.603 . . . . 54.34 109.371 174.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 95.9 mt -131.72 129.09 40.22 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.022 0.929 . . . . 74.44 110.282 -172.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -92.6 119.95 32.55 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.926 -0.768 . . . . 73.23 108.926 173.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -130.73 128.53 41.01 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.703 1.201 . . . . 71.44 109.043 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 88.5 m -69.2 131.11 44.41 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.588 0.755 . . . . 72.43 111.451 -177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 42.3 tp -110.13 116.35 31.37 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.532 1.133 . . . . 75.21 108.476 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -92.11 109.39 20.75 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.475 -0.935 . . . . 75.44 108.475 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 3.4 p -130.92 122.87 19.63 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 124.198 0.999 . . . . 75.13 108.911 -178.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . 0.416 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 38.0 Cg_endo -67.87 156.56 65.44 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.08 1.853 . . . . 74.14 112.109 177.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -48.28 -46.22 67.22 Favored Pre-proline 0 CA--C 1.565 1.552 0 N-CA-C 114.569 1.322 . . . . 52.55 114.569 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.484 ' O ' HG22 ' A' ' 206' ' ' VAL . 17.9 Cg_endo -58.12 -52.7 5.3 Favored 'Trans proline' 0 C--N 1.4 3.283 0 C-N-CA 121.874 1.716 . . . . 74.14 112.245 176.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.8 mt -65.93 -30.88 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.429 0.692 . . . . 73.21 111.446 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.67 -54.64 24.71 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.416 0.686 . . . . 74.22 111.026 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 63.5 t -71.68 -53.52 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-N 115.93 -0.577 . . . . 74.41 111.626 -174.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 202' ' ' PRO . 15.5 m -90.3 -25.02 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 112.805 0.669 . . . . 72.02 112.805 -172.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 100.76 142.8 13.25 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 117.796 0.271 . . . . 61.11 112.639 -176.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -175.19 -141.49 3.73 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 111.149 -0.781 . . . . 74.33 111.149 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -133.27 143.14 48.89 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 117.737 0.768 . . . . 75.35 109.19 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 33.2 m -128.95 169.4 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.647 0.779 . . . . 74.43 110.234 173.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -99.3 112.47 24.63 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.129 0.972 . . . . 75.52 108.513 171.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.58 144.65 30.06 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.8 0.84 . . . . 65.24 109.692 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 21.1 mmt -91.77 103.57 16.12 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 109.039 -0.726 . . . . 74.52 109.039 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 61.7 m -117.88 164.14 15.49 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.639 1.176 . . . . 75.4 108.916 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.0 mt -59.3 -20.0 50.86 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 123.344 0.657 . . . . 75.01 112.048 173.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -81.87 4.72 21.32 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.62 1.168 . . . . 73.21 111.982 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 97.97 -163.74 21.4 Favored Glycine 0 C--N 1.344 1.011 0 C-N-CA 123.488 0.566 . . . . 72.45 111.822 -175.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.16 118.39 5.37 Favored 'Trans proline' 0 C--N 1.365 1.404 0 C-N-CA 122.026 1.818 . . . . 73.52 109.907 172.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 28.7 m -118.13 153.2 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.039 0.536 . . . . 75.31 111.113 -172.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -95.41 111.76 23.59 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.54 0.736 . . . . 73.43 109.37 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 48.7 t -112.58 116.23 52.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 123.837 0.855 . . . . 75.03 109.17 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.57 101.25 2.44 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 109.099 -0.704 . . . . 75.52 109.099 174.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 63.9 t -77.55 121.64 84.66 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.955 0.902 . . . . 65.32 109.472 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.66 169.83 21.42 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.657 2.238 . . . . 61.33 110.936 173.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.96 176.53 2.97 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.633 2.222 . . . . 74.24 113.778 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 55.5 mtm180 70.94 12.05 7.06 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 125.45 1.5 . . . . 73.42 113.081 174.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 12.5 m -72.37 93.35 1.51 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.072 0.949 . . . . 75.42 110.765 -174.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -91.83 140.09 30.03 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.61 1.164 . . . . 63.23 111.007 -173.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -64.23 139.19 58.74 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.259 1.024 . . . . 73.21 111.646 -176.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 93.14 -23.37 29.85 Favored Glycine 0 C--N 1.343 0.934 0 CA-C-N 115.129 -0.941 . . . . 65.53 112.812 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -72.84 145.19 47.12 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 122.909 0.484 . . . . 74.22 110.265 176.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.478 ' HG3' ' HG2' ' A' ' 252' ' ' GLU . 2.6 mppt? -104.44 139.49 39.3 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.827 -1.175 . . . . 71.21 107.827 173.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 42.6 mt -92.24 99.47 12.25 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.221 -1.399 . . . . 72.5 107.221 175.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 46.0 ttm180 -73.04 100.98 3.13 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.117 0.484 . . . . 75.23 109.704 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 17.9 mt -102.21 88.12 3.23 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.136 -1.061 . . . . 75.42 108.136 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -68.38 129.94 41.41 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.07 -0.968 . . . . 74.13 110.519 -175.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 84.67 27.62 34.68 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 123.762 0.664 . . . . 75.04 113.452 -175.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -125.9 -6.86 6.69 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 123.278 0.631 . . . . 74.45 112.651 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -86.79 -155.28 27.11 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 112.363 -0.295 . . . . 75.0 112.363 175.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.502 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 12.8 m-85 -70.46 140.03 87.08 Favored Pre-proline 0 N--CA 1.481 1.116 0 CA-C-N 117.184 0.492 . . . . 74.4 110.358 177.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo . . . . . 0 C--N 1.377 2.046 0 C-N-CA 122.702 2.268 . . . . 72.24 111.854 174.553 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 28.4 mtm-85 . . . . . 0 CA--C 1.546 0.788 0 N-CA-C 109.085 -0.709 . . . . 74.43 109.085 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.25 -165.18 19.34 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 123.373 0.42 . . . . 74.03 113.696 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -100.3 128.56 46.35 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.095 0.558 . . . . 73.31 109.633 -174.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 28.8 tp -99.04 107.78 20.28 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 107.847 -1.168 . . . . 75.13 107.847 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.429 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 47.8 m-85 -88.04 107.86 18.94 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.761 0.824 . . . . 73.31 109.011 -178.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 41.1 mt -87.08 105.43 17.16 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.441 -0.948 . . . . 74.21 108.441 175.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.478 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 33.3 mt-10 -77.6 94.17 4.33 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.297 -0.865 . . . . 72.0 108.79 -173.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 99.7 t -53.57 112.35 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 124.433 1.093 . . . . 71.03 111.323 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -117.32 100.88 7.98 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 108.094 -1.076 . . . . 74.14 108.094 175.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.46 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 43.0 mt -75.68 107.12 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 O-C-N 124.023 0.827 . . . . 72.43 108.965 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 16.2 p . . . . . 0 C--O 1.26 1.621 0 C-N-CA 124.897 1.279 . . . . 71.12 108.3 -179.066 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 112.583 0.586 . . . . 65.34 112.583 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 . . . . . 0 C--O 1.237 0.421 0 N-CA-C 108.108 -1.071 . . . . 74.52 108.108 170.902 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.633 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 23.0 mp0 . . . . . 0 N--CA 1.473 0.706 0 CA-C-O 120.747 0.308 . . . . 73.15 110.863 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -76.68 132.29 39.28 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.888 -0.782 . . . . 71.33 108.888 172.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 91.4 mt -133.05 167.92 19.43 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.234 0.614 . . . . 72.13 110.519 -171.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -121.21 125.87 48.23 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 107.553 -1.277 . . . . 75.22 107.553 168.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -124.08 127.27 47.59 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.606 0.762 . . . . 73.24 109.15 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 43.4 m -67.49 118.46 10.83 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.81 0.844 . . . . 74.41 110.919 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 21.9 tp -109.47 110.78 21.99 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.531 -0.915 . . . . 74.44 108.531 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -88.24 127.25 35.45 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.206 -1.035 . . . . 75.13 108.206 174.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 3.0 p -141.85 127.59 10.84 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 124.298 1.039 . . . . 75.12 108.367 -176.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -69.5 155.25 67.31 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 121.543 1.495 . . . . 74.42 111.346 175.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.419 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -47.21 -50.65 46.43 Favored Pre-proline 0 CA--C 1.559 1.32 0 O-C-N 124.341 1.025 . . . . 72.45 113.657 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -60.72 -48.79 10.0 Favored 'Trans proline' 0 C--N 1.395 2.988 0 C-N-CA 121.933 1.755 . . . . 74.41 112.622 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 44.0 mt -66.56 -27.38 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.645 0.778 . . . . 75.32 111.384 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.33 -47.91 58.9 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.169 0.588 . . . . 74.41 111.194 176.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 201' ' ' ALA . 81.2 t -67.9 -48.91 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.329 0.651 . . . . 71.31 111.841 -176.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.9 p -83.95 -29.1 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 CA-C-N 116.44 -0.346 . . . . 72.33 110.895 -175.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.61 86.07 0.64 Allowed Glycine 0 C--N 1.349 1.265 0 N-CA-C 111.559 -0.616 . . . . 64.4 111.559 -174.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -111.29 -122.94 4.31 Favored Glycine 0 C--N 1.344 1.02 0 N-CA-C 111.953 -0.459 . . . . 63.23 111.953 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 221' ' ' VAL . 95.9 mttt -136.99 149.84 47.76 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.914 0.885 . . . . 73.1 109.601 176.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 23.3 m -136.3 162.84 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 123.247 0.619 . . . . 74.13 111.461 177.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -86.3 106.53 17.43 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.565 0.746 . . . . 74.15 109.171 174.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -109.8 151.55 26.84 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.036 0.534 . . . . 51.03 110.756 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 31.8 mmt -83.55 111.3 18.96 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 123.898 0.749 . . . . 74.22 108.979 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.436 HG22 ' H ' ' A' ' 215' ' ' LEU . 3.4 m -126.83 176.4 7.31 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 108.581 -0.896 . . . . 74.54 108.581 -177.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.436 ' H ' HG22 ' A' ' 214' ' ' THR . 73.8 mt -59.89 -40.88 90.21 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.587 0.755 . . . . 75.24 112.652 -175.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -81.1 -3.38 51.78 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.308 0.643 . . . . 74.42 112.012 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 110.49 -151.76 17.5 Favored Glycine 0 C--N 1.343 0.94 0 CA-C-O 119.544 -0.587 . . . . 74.42 112.251 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.63 126.99 17.06 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 122.627 2.218 . . . . 71.25 112.316 177.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 32.8 m -129.59 162.78 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.509 0.724 . . . . 72.4 110.058 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -95.42 105.55 17.53 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 121.584 0.707 . . . . 72.41 109.991 175.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 55.3 t -99.77 126.77 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.793 0.837 . . . . 74.32 109.838 -174.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -76.63 100.01 5.22 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 123.946 0.779 . . . . 64.44 110.893 -177.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 59.5 t -69.25 141.94 91.98 Favored Pre-proline 0 CA--C 1.56 1.363 0 C-N-CA 125.662 1.585 . . . . 74.02 110.492 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -76.88 163.12 31.61 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 122.313 2.008 . . . . 64.22 110.855 173.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.55 160.99 45.32 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 121.471 1.447 . . . . 63.53 111.207 172.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 69.24 14.24 8.6 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.762 1.225 . . . . 75.02 112.651 177.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 85.2 m -62.16 113.18 2.71 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.843 0.857 . . . . 74.24 110.438 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -112.92 141.2 47.03 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.916 0.886 . . . . 74.5 110.602 -168.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.52 144.02 57.33 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.778 0.831 . . . . 75.45 111.377 -177.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.03 -22.65 13.56 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.303 -0.862 . . . . 63.11 113.035 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -79.58 150.32 31.1 Favored 'General case' 0 C--N 1.351 0.657 0 N-CA-C 109.438 -0.578 . . . . 63.24 109.438 173.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.655 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.4 mppt? -114.53 142.87 45.84 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.041 0.536 . . . . 74.02 109.852 177.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 46.2 mt -100.09 99.42 10.14 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.683 -0.858 . . . . 73.54 108.683 -176.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 27.3 ttm-85 -75.06 113.97 13.0 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 123.479 0.487 . . . . 75.21 109.936 -176.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 46.0 mt -120.54 102.06 8.17 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.509 0.724 . . . . 72.44 109.237 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -67.62 140.12 56.87 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.879 0.472 . . . . 74.24 111.581 -176.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.4 ' HA2' ' HB2' ' A' ' 246' ' ' ARG . . . 84.32 9.83 81.17 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 115.788 -0.642 . . . . 61.53 114.302 178.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -104.65 -16.47 14.98 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 117.682 0.741 . . . . 74.24 111.8 -176.802 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -81.15 -161.69 27.19 Favored Glycine 0 CA--C 1.535 1.293 0 O-C-N 123.535 0.522 . . . . 45.14 112.86 173.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.633 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 27.8 m-85 -65.98 151.28 95.54 Favored Pre-proline 0 N--CA 1.487 1.395 0 C-N-CA 123.373 0.669 . . . . 75.42 111.657 -178.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.491 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 37.9 Cg_endo . . . . . 0 C--N 1.377 2.054 0 C-N-CA 122.885 2.39 . . . . 73.04 112.708 176.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.491 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 86.8 mtt180 . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 110.231 -0.285 . . . . 74.14 110.231 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.8 173.98 55.27 Favored Glycine 0 C--N 1.342 0.916 0 CA-C-N 115.94 -0.573 . . . . 60.22 112.969 177.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -103.44 130.95 50.89 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.742 0.817 . . . . 70.44 110.631 -175.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 53.5 tp -102.94 117.42 34.56 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 123.86 0.864 . . . . 62.55 109.118 -173.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.655 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 19.5 m-85 -89.12 111.74 22.56 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.473 -0.936 . . . . 75.13 108.473 177.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 60.0 mt -85.85 111.57 20.31 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.642 -0.873 . . . . 75.22 108.642 175.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.411 ' HA ' ' HG3' ' A' ' 232' ' ' LYS . 31.6 mt-10 -76.05 101.43 5.28 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.237 -0.892 . . . . 74.23 108.971 -175.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 44.9 t -61.58 111.39 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 O-C-N 123.577 0.548 . . . . 73.42 110.84 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -114.0 93.6 4.44 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 106.598 -1.63 . . . . 75.41 106.598 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 26.9 mt -76.25 118.07 21.96 Favored 'Isoleucine or valine' 0 C--N 1.349 0.586 0 N-CA-C 109.405 -0.591 . . . . 75.13 109.405 -177.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 19.6 p . . . . . 0 C--O 1.253 1.275 0 C-N-CA 125.232 1.413 . . . . 65.44 107.922 -176.751 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 112.108 0.41 . . . . 72.52 112.108 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.444 ' HE1' ' HA ' ' A' ' 227' ' ' THR . 12.3 m-30 . . . . . 0 N--CA 1.471 0.596 0 N-CA-C 109.597 -0.52 . . . . 75.1 109.597 173.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 CA--C 1.548 0.872 0 N-CA-C 112.154 0.427 . . . . 74.42 112.154 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -80.1 159.43 26.1 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.623 0.769 . . . . 72.43 110.934 174.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 49.2 mt -139.35 150.68 45.63 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.79 0.836 . . . . 74.12 109.832 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -107.49 122.21 46.17 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.973 -0.751 . . . . 73.41 108.973 173.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -129.41 137.13 50.74 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.438 0.695 . . . . 74.13 109.248 178.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 96.2 m -71.73 131.67 43.45 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.862 0.465 . . . . 72.41 110.815 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 53.8 tp -108.25 123.88 49.44 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.255 -1.017 . . . . 70.1 108.255 175.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -88.65 117.53 27.68 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 108.488 -0.93 . . . . 61.43 108.488 176.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 4.4 p -140.48 125.84 11.3 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 109.057 -0.72 . . . . 72.41 109.057 178.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.61 154.41 54.76 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 122.136 1.891 . . . . 74.52 111.749 175.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.68 -45.34 91.56 Favored Pre-proline 0 CA--C 1.562 1.427 0 N-CA-C 114.629 1.344 . . . . 73.32 114.629 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -56.24 -52.69 6.64 Favored 'Trans proline' 0 C--N 1.392 2.827 0 C-N-CA 121.914 1.743 . . . . 72.54 113.099 174.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 32.8 mt -67.02 -27.66 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.218 0.607 . . . . 75.52 111.167 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.31 -48.83 69.08 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-O 121.26 0.553 . . . . 44.5 110.839 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 71.1 t -69.21 -46.29 77.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-N 115.798 -0.637 . . . . 74.52 111.764 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 14.4 m -86.6 -29.87 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 112.287 0.477 . . . . 71.23 112.287 -172.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.89 116.39 0.54 Allowed Glycine 0 CA--C 1.531 1.053 0 O-C-N 123.322 0.389 . . . . 64.23 113.298 -173.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -165.11 -177.68 37.78 Favored Glycine 0 N--CA 1.473 1.108 0 N-CA-C 111.687 -0.565 . . . . 72.24 111.687 176.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.57 ' HZ1' ' HB2' ' A' ' 209' ' ' LYS . 9.7 mtmp? -80.86 136.01 36.01 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 118.113 0.957 . . . . 75.11 109.994 -176.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 27.6 m -124.91 168.56 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 123.644 0.778 . . . . 73.31 111.15 178.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 55.2 ttp85 -83.4 131.65 35.03 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.288 -0.869 . . . . 75.35 110.019 173.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -134.35 159.74 40.07 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.25 0.62 . . . . 63.12 110.457 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 15.9 tpt -88.0 123.4 32.67 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.13 0.572 . . . . 72.51 110.717 -177.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.403 HG23 ' H ' ' A' ' 216' ' ' GLU . 50.8 m -144.52 161.06 40.03 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.964 0.906 . . . . 70.35 108.652 178.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 68.2 mt -63.78 -19.15 64.77 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.8 0.84 . . . . 73.53 111.763 176.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.403 ' H ' HG23 ' A' ' 214' ' ' THR . 3.2 mp0 -93.51 15.06 16.88 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.828 1.251 . . . . 74.31 111.155 175.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 90.54 -164.85 30.71 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-O 119.746 -0.475 . . . . 73.2 113.297 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.31 118.93 5.92 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.575 2.184 . . . . 72.34 111.616 174.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.7 m -113.06 149.78 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 123.023 0.529 . . . . 70.52 110.882 -176.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -82.29 114.85 21.06 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.643 0.777 . . . . 74.41 110.227 177.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 98.4 t -109.16 116.36 51.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.96 0.904 . . . . 72.01 109.308 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.84 100.64 2.44 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.573 0.749 . . . . 72.43 110.563 -177.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 69.4 t -77.35 134.61 66.48 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 124.54 1.136 . . . . 74.25 110.273 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.88 171.54 17.8 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 122.958 2.439 . . . . 75.02 110.905 172.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -71.38 168.52 23.24 Favored 'Trans proline' 0 C--N 1.366 1.485 0 CA-C-N 120.614 1.255 . . . . 71.23 111.3 170.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 14.9 mtm180 66.92 20.21 10.54 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 124.042 0.937 . . . . 75.22 112.29 173.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.444 ' HA ' ' HE1' ' A' ' 176' ' ' TYR . 99.8 m -69.56 113.28 6.7 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.698 0.799 . . . . 73.51 111.011 -178.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -115.32 141.81 47.54 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.112 -0.949 . . . . 75.12 110.125 -169.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.45 133.81 54.57 Favored 'General case' 0 C--N 1.35 0.611 0 C-N-CA 123.58 0.752 . . . . 74.24 111.665 -176.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.71 -15.12 61.28 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-N 115.332 -0.849 . . . . 54.2 113.159 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -77.02 124.6 28.02 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.798 0.439 . . . . 72.41 110.143 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.4 mppt? -88.05 143.9 26.82 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.041 0.536 . . . . 75.1 110.022 173.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.441 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 33.9 mt -109.27 103.28 12.21 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.299 -0.864 . . . . 74.21 109.224 -173.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -69.91 103.48 2.24 Favored 'General case' 0 CA--C 1.551 1.006 0 O-C-N 124.096 0.872 . . . . 74.43 111.121 -176.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 32.4 mt -119.45 94.34 4.38 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.611 0.764 . . . . 72.13 110.223 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 248' ' ' ASP . 44.5 mtmt -71.26 154.62 41.5 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.703 0.401 . . . . 72.33 111.289 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 82.11 18.4 67.29 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-N 115.992 -0.549 . . . . 60.43 113.987 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.487 ' HA ' ' HE2' ' A' ' 238' ' ' LYS . 11.3 mmpt? -118.87 -41.34 2.78 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 123.461 0.704 . . . . 71.04 111.718 -177.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -71.91 -153.97 1.83 Allowed Glycine 0 N--CA 1.485 1.916 0 N-CA-C 114.625 0.61 . . . . 73.24 114.625 -176.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -64.05 136.9 96.94 Favored Pre-proline 0 N--CA 1.485 1.296 0 C-N-CA 123.517 0.727 . . . . 74.41 110.813 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.701 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 18.6 Cg_endo . . . . . 0 C--N 1.379 2.139 0 C-N-CA 123.204 2.603 . . . . 74.41 113.97 -174.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.701 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 28.8 mtm180 . . . . . 0 C--O 1.242 0.667 0 CA-C-O 121.102 0.477 . . . . 74.51 109.774 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -84.25 -158.73 28.4 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 114.922 -1.035 . . . . 74.52 113.565 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 236' ' ' LYS . 2.5 t0 -99.77 162.09 13.21 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.836 0.454 . . . . 54.43 109.95 -170.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 40.6 tp -141.98 108.78 5.4 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 108.271 -1.011 . . . . 62.03 108.271 173.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.487 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 78.4 m-85 -88.74 108.13 19.32 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 108.732 -0.84 . . . . 75.11 108.732 175.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.451 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 38.9 mt -86.92 114.98 24.01 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.704 -0.85 . . . . 74.34 108.704 177.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -78.26 102.92 7.88 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.781 0.832 . . . . 73.51 109.365 -178.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 84.7 t -56.0 111.97 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 O-C-N 123.771 0.669 . . . . 74.04 110.68 175.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -113.4 101.8 9.72 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.288 -1.004 . . . . 73.15 108.288 172.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 37.1 mt -76.34 103.7 3.93 Favored 'Isoleucine or valine' 0 C--N 1.35 0.621 0 O-C-N 124.206 0.941 . . . . 65.34 109.004 177.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 46.7 p . . . . . 0 C--O 1.254 1.326 0 CA-C-N 115.506 -0.77 . . . . 73.32 109.07 176.09 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.622 0 N-CA-C 108.789 -0.819 . . . . 74.55 108.789 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.551 ' HH ' ' HD2' ' A' ' 231' ' ' ARG . 24.2 m-85 . . . . . 0 N--CA 1.49 1.552 0 C-N-CA 124.543 1.137 . . . . 72.01 110.846 -164.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 108.786 -0.82 . . . . 72.54 108.786 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -75.83 130.4 38.51 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.656 1.583 . . . . 74.54 108.943 176.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.454 HD13 ' HA2' ' A' ' 239' ' ' GLY . 92.8 mt -135.67 163.91 29.07 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.861 0.864 . . . . 73.32 110.697 -175.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -121.52 153.5 37.9 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.252 1.021 . . . . 62.04 108.962 171.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.422 ' HB1' HD13 ' A' ' 249' ' ' LEU . . . -152.78 171.29 18.47 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.551 1.14 . . . . 64.34 109.366 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 25.0 m -106.8 131.68 53.64 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.489 0.716 . . . . 70.45 109.485 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.712 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 42.8 tp -109.02 113.84 27.06 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.594 0.758 . . . . 74.22 109.008 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -83.66 116.85 22.83 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 107.75 -1.204 . . . . 73.35 107.75 172.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.433 HG13 HG12 ' A' ' 253' ' ' VAL . 2.4 p -138.15 120.54 10.85 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 123.794 0.837 . . . . 73.13 109.281 -178.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.1 158.42 56.58 Favored 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 122.218 1.946 . . . . 73.24 112.311 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.38 -48.56 85.8 Favored Pre-proline 0 CA--C 1.565 1.545 0 C-N-CA 124.459 1.103 . . . . 74.13 113.87 -177.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.469 ' O ' HG13 ' A' ' 206' ' ' VAL . 53.7 Cg_exo -54.24 -54.38 4.77 Favored 'Trans proline' 0 C--N 1.401 3.296 0 C-N-CA 122.377 2.051 . . . . 72.51 112.687 175.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 58.1 mt -67.62 -27.98 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.267 0.627 . . . . 62.14 111.041 -176.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.59 -41.59 96.15 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.199 -0.455 . . . . 75.01 110.416 176.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 64.3 t -74.86 -57.57 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 CA-C-N 116.545 -0.298 . . . . 74.34 111.63 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 202' ' ' PRO . 12.4 p -93.14 -28.48 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 112.666 0.617 . . . . 74.13 112.666 -167.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 98.12 144.99 18.05 Favored Glycine 0 N--CA 1.477 1.388 0 C-N-CA 122.472 0.082 . . . . 71.34 113.183 -177.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 170.23 -167.76 40.84 Favored Glycine 0 N--CA 1.472 1.058 0 N-CA-C 110.664 -0.974 . . . . 74.13 110.664 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.542 ' HB2' ' HZ3' ' A' ' 209' ' ' LYS . 8.8 mtmp? -96.88 138.28 34.68 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 118.336 1.068 . . . . 73.13 110.939 175.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 15.4 m -119.85 170.19 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.448 1.099 . . . . 70.24 109.764 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -102.03 112.24 24.82 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 110.021 -0.363 . . . . 75.3 110.021 174.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -105.34 166.44 10.42 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.983 0.913 . . . . 64.44 109.817 171.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 91.3 mmm -101.96 132.81 47.55 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 120.911 0.386 . . . . 70.54 110.276 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 88.1 m -132.79 167.51 20.03 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.869 1.268 . . . . 63.43 108.547 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 82.6 mt -54.83 -38.78 67.83 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.991 0.917 . . . . 74.01 112.665 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -78.25 -15.6 58.63 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.063 0.545 . . . . 72.13 111.799 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 132.78 -164.27 24.07 Favored Glycine 0 C--N 1.344 1.027 0 O-C-N 123.617 0.573 . . . . 74.42 111.727 -177.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.47 128.72 12.16 Favored 'Trans proline' 0 CA--C 1.555 1.538 0 C-N-CA 122.79 2.327 . . . . 62.24 112.007 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.32 159.89 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.322 1.049 . . . . 72.31 110.015 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 37.7 mt-10 -84.83 147.47 26.8 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 122.78 0.432 . . . . 74.45 110.599 169.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 96.9 t -130.75 124.23 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.163 1.385 . . . . 65.0 108.46 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -77.59 99.28 5.69 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 108.937 -0.764 . . . . 73.35 108.937 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 88.2 t -96.2 123.33 55.34 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.504 1.122 . . . . 74.02 110.566 -175.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.0 164.2 36.42 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.739 2.292 . . . . 74.42 111.384 175.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.87 177.0 0.37 Allowed 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 122.714 2.276 . . . . 65.22 113.418 174.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 24.0 mtp180 66.03 20.63 11.27 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.35 1.06 . . . . 73.41 112.324 174.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -68.86 88.69 0.38 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.686 0.794 . . . . 62.41 110.473 -173.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 -86.28 131.3 34.25 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.894 1.278 . . . . 73.3 110.573 -172.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.99 120.29 8.82 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.407 1.083 . . . . 62.34 111.97 -175.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.0 -4.51 41.72 Favored Glycine 0 N--CA 1.473 1.148 0 O-C-N 123.835 0.71 . . . . 73.42 114.386 176.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.551 ' HD2' ' HH ' ' A' ' 176' ' ' TYR . 96.5 mtt180 -84.62 157.32 21.2 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 117.552 0.676 . . . . 72.25 109.977 173.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.701 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.5 mppt? -127.3 131.55 50.47 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.943 -0.762 . . . . 74.21 108.943 -172.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.464 HD23 ' CE2' ' A' ' 176' ' ' TYR . 20.4 mt -108.56 102.43 11.5 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.601 -0.727 . . . . 74.43 109.791 -166.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -70.48 103.69 2.54 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.117 1.367 . . . . 75.13 110.939 -173.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 26.6 mt -118.19 100.16 7.33 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 122.944 0.498 . . . . 73.43 112.045 -175.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -56.52 142.06 40.51 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.162 0.801 . . . . 71.24 113.162 169.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 100.09 -14.12 60.04 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-N 113.649 -1.614 . . . . 74.44 112.665 174.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -99.89 -20.04 16.34 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.918 0.487 . . . . 73.2 111.967 -171.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . 0.454 ' HA2' HD13 ' A' ' 193' ' ' LEU . . . -77.92 -162.26 18.5 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.496 0.498 . . . . 70.51 113.656 177.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -80.77 154.64 73.34 Favored Pre-proline 0 N--CA 1.487 1.407 0 C-N-CA 123.2 0.6 . . . . 61.12 111.022 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo . . . . . 0 C--N 1.383 2.344 0 C-N-CA 123.8 3.0 . . . . 75.34 114.302 177.704 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 30.2 mtm180 . . . . . 0 N--CA 1.476 0.831 0 N-CA-C 108.892 -0.781 . . . . 74.31 108.892 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -67.29 -156.84 0.63 Allowed Glycine 0 C--N 1.341 0.858 0 O-C-N 123.865 0.728 . . . . 75.45 114.835 -170.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -96.23 160.85 14.22 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.263 0.554 . . . . 74.13 110.406 -170.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.422 HD13 ' HB1' ' A' ' 195' ' ' ALA . 31.1 tp -137.52 114.68 10.86 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.3 -1.37 . . . . 62.23 107.3 175.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.701 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 1.9 m-85 -91.18 108.84 20.14 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.994 -0.743 . . . . 74.43 108.994 -177.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.712 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 43.2 mt -86.36 107.49 18.03 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.548 -0.538 . . . . 75.32 109.548 -178.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -82.95 108.48 16.31 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.027 -0.988 . . . . 74.24 110.183 -174.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.433 HG12 HG13 ' A' ' 199' ' ' VAL . 61.1 t -56.3 120.16 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 C-N-CA 125.337 1.455 . . . . 64.22 112.581 -173.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 53.4 mmt-85 -114.8 96.91 5.95 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.724 1.21 . . . . 74.11 108.001 170.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 53.8 mt -74.89 103.85 2.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.936 -1.135 . . . . 71.11 107.936 175.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 25.3 p . . . . . 0 CA--C 1.555 1.166 0 N-CA-C 108.727 -0.842 . . . . 72.42 108.727 174.497 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 112.897 0.703 . . . . 41.52 112.897 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.534 ' CZ ' ' HA ' ' A' ' 227' ' ' THR . 8.5 m-85 . . . . . 0 N--CA 1.482 1.174 0 C-N-CA 123.07 0.548 . . . . 74.44 111.109 169.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.662 ' HB3' ' HB2' ' A' ' 240' ' ' PHE . 85.9 mm-40 . . . . . 0 CA--C 1.555 1.17 0 CA-C-O 120.794 0.33 . . . . 75.41 111.654 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -75.67 154.09 36.76 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.086 0.954 . . . . 71.33 110.739 -178.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 87.9 mt -131.93 158.56 41.09 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.767 0.827 . . . . 65.21 110.051 -173.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -115.0 124.2 51.04 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.994 -1.113 . . . . 74.33 107.994 173.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -124.94 129.31 50.11 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.374 -0.973 . . . . 75.13 108.374 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 42.3 m -68.39 126.29 29.13 Favored 'General case' 0 C--O 1.242 0.708 0 O-C-N 123.517 0.511 . . . . 74.15 110.22 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.444 HD11 ' HB3' ' A' ' 212' ' ' ALA . 46.0 tp -106.84 109.95 21.98 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.034 -1.469 . . . . 73.0 107.034 177.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -92.17 118.04 30.45 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.242 -1.021 . . . . 54.4 108.242 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.434 HG21 HG12 ' A' ' 210' ' ' VAL . 5.7 p -137.85 131.71 17.02 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 123.335 0.654 . . . . 74.12 109.784 -176.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -76.34 157.81 37.09 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.241 1.961 . . . . 74.44 111.701 172.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -55.0 -46.23 99.7 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 124.415 1.086 . . . . 71.31 113.543 -176.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.439 ' O ' HG13 ' A' ' 206' ' ' VAL . 71.2 Cg_exo -53.56 -54.99 3.98 Favored 'Trans proline' 0 C--N 1.402 3.381 0 C-N-CA 122.272 1.981 . . . . 73.1 112.78 174.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 48.7 mt -69.84 -21.03 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.3 0.64 . . . . 75.51 110.756 -176.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.2 -48.52 56.77 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.851 0.46 . . . . 72.13 110.342 176.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.0 -55.69 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 CA-C-N 115.959 -0.564 . . . . 75.32 111.431 -177.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.439 HG13 ' O ' ' A' ' 202' ' ' PRO . 14.6 p -87.15 -32.21 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 N-CA-C 112.611 0.597 . . . . 75.23 112.611 -172.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 101.53 166.68 27.48 Favored Glycine 0 N--CA 1.477 1.374 0 N-CA-C 112.076 -0.41 . . . . 74.01 112.076 -173.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 163.43 -131.94 2.6 Favored Glycine 0 C--N 1.345 1.032 0 N-CA-C 111.456 -0.658 . . . . 64.14 111.456 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -137.86 139.05 39.69 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.655 1.182 . . . . 75.41 108.594 174.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.434 HG12 HG21 ' A' ' 199' ' ' VAL . 32.3 m -136.53 168.02 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 122.956 0.502 . . . . 71.0 110.563 178.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 29.3 ttm-85 -87.51 113.19 22.98 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.763 -0.653 . . . . 73.53 109.887 178.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.444 ' HB3' HD11 ' A' ' 197' ' ' LEU . . . -105.79 158.42 16.75 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.842 0.857 . . . . 73.21 110.238 173.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 36.8 tpp -93.26 110.68 22.2 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.923 -0.769 . . . . 74.43 108.923 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 60.5 m -126.0 163.88 22.05 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.308 1.043 . . . . 74.53 109.815 -175.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 95.6 mt -61.81 -17.25 55.49 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.968 0.907 . . . . 74.31 112.965 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -96.59 8.39 44.26 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.471 0.708 . . . . 65.4 111.485 177.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 102.42 -164.01 16.66 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-O 119.708 -0.495 . . . . 64.21 112.129 -176.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.36 118.12 5.07 Favored 'Trans proline' 0 C--N 1.367 1.537 0 C-N-CA 122.124 1.883 . . . . 75.23 110.906 175.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.7 m -118.42 157.29 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 123.478 0.711 . . . . 75.31 110.51 -175.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -90.56 108.83 20.05 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.148 -0.686 . . . . 61.52 109.148 173.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 94.3 t -97.8 129.06 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.091 0.956 . . . . 73.34 109.942 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.88 103.09 2.12 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.999 0.92 . . . . 65.25 110.142 176.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 97.2 t -89.97 125.96 58.93 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 124.088 0.955 . . . . 74.23 110.166 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -78.18 171.44 17.06 Favored 'Trans proline' 0 CA--C 1.561 1.846 0 C-N-CA 123.163 2.575 . . . . 65.32 111.617 173.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.21 174.25 8.33 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.095 1.863 . . . . 74.24 113.694 174.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 67.16 15.37 10.03 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 125.903 1.681 . . . . 75.43 112.505 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.534 ' HA ' ' CZ ' ' A' ' 176' ' ' TYR . 93.9 m -64.75 100.96 0.43 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.523 0.729 . . . . 73.34 110.139 -176.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -101.83 137.26 40.36 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 125.135 1.374 . . . . 75.25 110.323 -174.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.92 132.9 53.65 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.568 1.147 . . . . 62.24 110.993 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.03 -1.55 67.93 Favored Glycine 0 C--N 1.337 0.613 0 O-C-N 123.849 0.718 . . . . 63.5 113.281 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -86.86 151.2 23.54 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 109.605 -0.517 . . . . 75.45 109.605 170.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.505 ' HG3' ' HA ' ' A' ' 252' ' ' GLU . 3.8 mppt? -131.67 139.03 48.96 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.279 -1.008 . . . . 73.42 108.279 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 29.1 mt -118.05 109.24 16.2 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.287 0.635 . . . . 74.32 110.309 -161.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 45.1 ttm-85 -76.96 108.9 10.35 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 124.057 0.848 . . . . 73.21 110.16 -174.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 21.8 mt -107.03 89.79 3.11 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.591 -0.892 . . . . 71.53 108.591 176.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.497 ' HG2' ' HB3' ' A' ' 248' ' ' ASP . 10.6 mtmp? -67.1 136.08 54.61 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.416 -0.357 . . . . 71.13 111.147 -177.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 95.24 -0.83 64.16 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 115.319 -0.855 . . . . 63.42 113.456 -175.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.543 ' HA ' ' HE2' ' A' ' 238' ' ' LYS . 10.4 mmpt? -106.55 -9.26 16.67 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 113.277 0.844 . . . . 71.01 113.277 -175.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.11 179.53 50.93 Favored Glycine 0 N--CA 1.476 1.334 0 N-CA-C 111.571 -0.612 . . . . 62.4 111.571 167.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.662 ' HB2' ' HB3' ' A' ' 191' ' ' GLN . 33.3 m-85 -60.28 154.33 53.29 Favored Pre-proline 0 N--CA 1.489 1.477 0 C-N-CA 123.42 0.688 . . . . 73.22 111.812 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 C--N 1.376 2.008 0 C-N-CA 122.477 2.118 . . . . 62.44 112.83 177.775 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 . . . . . 0 C--O 1.242 0.671 0 CA-C-O 120.572 0.225 . . . . 75.42 110.659 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -69.48 -175.46 13.39 Favored Glycine 0 C--N 1.343 0.967 0 O-C-N 123.998 0.811 . . . . 53.14 112.155 175.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.497 ' HB3' ' HG2' ' A' ' 236' ' ' LYS . 1.4 p30 -104.05 171.29 7.43 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.855 0.462 . . . . 72.42 111.547 -178.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 32.9 tp -129.36 112.87 14.28 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 108.737 -0.838 . . . . 73.54 108.737 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -86.76 109.47 19.26 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.684 0.794 . . . . 74.24 109.28 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 44.5 mt -87.16 111.39 20.91 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 109.077 -0.712 . . . . 74.21 109.077 175.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.505 ' HA ' ' HG3' ' A' ' 232' ' ' LYS . 31.5 mt-10 -78.77 101.08 7.4 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.092 -0.958 . . . . 72.13 109.566 -177.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.8 t -59.51 110.03 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 O-C-N 123.765 0.666 . . . . 72.54 111.072 176.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -115.12 93.44 4.3 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.003 -1.11 . . . . 75.32 108.003 176.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.423 HD12 ' O ' ' A' ' 227' ' ' THR . 54.9 mt -77.17 125.65 37.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 N-CA-C 109.473 -0.565 . . . . 72.24 109.473 178.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 24.4 p . . . . . 0 C--O 1.25 1.127 0 C-N-CA 124.157 0.983 . . . . 74.31 109.632 179.775 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.048 0 N-CA-C 109.253 -0.647 . . . . 74.55 109.253 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.429 ' CZ ' ' HA ' ' A' ' 227' ' ' THR . 4.5 m-85 . . . . . 0 N--CA 1.487 1.408 0 C-N-CA 125.591 1.556 . . . . 72.1 111.974 -176.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.417 HE21 ' HA2' ' A' ' 247' ' ' GLY . 5.7 pm0 . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 122.582 1.182 . . . . 64.22 109.832 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -87.43 163.48 16.72 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 114.689 -1.141 . . . . 71.5 111.087 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 83.2 mt -140.66 172.04 13.26 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.196 0.998 . . . . 73.41 109.994 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -118.01 145.06 45.03 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.052 0.941 . . . . 71.24 109.516 174.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -146.08 140.17 26.55 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.021 0.928 . . . . 71.22 109.282 178.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.9 m -77.36 129.19 35.49 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.058 0.543 . . . . 65.14 109.711 178.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.526 HD11 HD12 ' A' ' 251' ' ' LEU . 54.0 tp -107.45 111.3 23.53 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.451 -1.314 . . . . 61.14 107.451 177.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -92.04 100.5 13.13 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 108.291 -1.003 . . . . 72.52 108.291 -178.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.473 HG22 HG11 ' A' ' 210' ' ' VAL . 2.9 p -124.28 131.49 24.2 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 124.013 0.925 . . . . 73.05 108.799 -178.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . 0.534 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 98.4 Cg_endo -80.68 163.9 21.01 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.513 2.142 . . . . 72.14 111.355 172.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.17 -48.46 85.32 Favored Pre-proline 0 CA--C 1.566 1.581 0 N-CA-C 114.045 1.128 . . . . 73.34 114.045 176.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.534 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 25.5 Cg_endo -58.8 -52.46 5.2 Favored 'Trans proline' 0 C--N 1.396 3.044 0 C-N-CA 122.002 1.801 . . . . 62.43 113.057 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.8 mt -70.77 -22.21 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.238 0 C-N-CA 123.081 0.552 . . . . 73.01 110.856 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.33 -44.2 72.15 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.771 0.429 . . . . 75.22 110.717 177.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 76.1 t -71.49 -57.17 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 C-N-CA 122.181 0.192 . . . . 75.15 110.975 -178.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 12.6 p -85.38 -25.99 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 112.208 0.447 . . . . 64.41 112.208 -170.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 99.89 -178.63 29.75 Favored Glycine 0 N--CA 1.475 1.273 0 N-CA-C 112.156 -0.378 . . . . 73.32 112.156 -172.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 139.6 -139.17 9.76 Favored Glycine 0 C--N 1.343 0.932 0 N-CA-C 111.764 -0.535 . . . . 64.53 111.764 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -133.86 146.35 50.52 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.524 0.73 . . . . 70.13 109.751 175.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.473 HG11 HG22 ' A' ' 199' ' ' VAL . 22.2 m -138.67 169.2 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 123.711 0.632 . . . . 75.0 112.02 -177.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 -73.22 133.07 43.88 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.424 -0.807 . . . . 73.22 110.27 172.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.4 ' HB2' HD12 ' A' ' 197' ' ' LEU . . . -144.13 148.99 35.81 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.468 -0.938 . . . . 70.24 108.468 168.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 64.8 mtp -89.03 130.72 35.45 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.459 -0.571 . . . . 72.02 109.459 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 42.3 m -143.2 172.93 12.07 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 125.228 1.411 . . . . 73.22 108.082 -175.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 77.0 mt -60.08 -21.35 61.35 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.27 0.628 . . . . 74.31 111.708 173.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -86.65 16.83 4.33 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.641 1.176 . . . . 74.53 111.674 174.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 76.34 -155.82 46.05 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-O 118.87 -0.961 . . . . 55.14 111.757 -175.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.85 119.73 6.62 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 121.954 1.77 . . . . 74.42 110.423 171.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.55 166.09 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.284 1.034 . . . . 75.42 109.978 -176.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -102.46 107.51 18.51 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.898 -0.779 . . . . 72.2 108.898 175.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 95.5 t -95.15 131.64 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.145 0.978 . . . . 63.31 109.639 -175.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.45 98.72 2.32 Favored 'General case' 0 C--N 1.351 0.659 0 O-C-N 124.055 0.847 . . . . 74.4 109.39 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 55.9 t -91.84 127.71 48.84 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 124.83 1.252 . . . . 74.23 110.022 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -73.2 170.25 20.31 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.692 2.262 . . . . 73.15 110.962 173.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.46 178.07 4.11 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 122.02 1.813 . . . . 75.22 111.789 170.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 50.2 mtp180 63.68 20.29 12.15 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 124.978 1.311 . . . . 74.33 112.222 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.436 ' O ' HD12 ' A' ' 255' ' ' ILE . 98.1 m -65.64 106.68 1.53 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.361 0.664 . . . . 62.42 110.278 -178.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -100.13 139.86 35.2 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.925 1.29 . . . . 73.45 110.285 -174.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -69.92 127.95 34.66 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.737 1.215 . . . . 74.24 111.542 -177.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.39 10.55 53.71 Favored Glycine 0 C--N 1.342 0.881 0 O-C-N 123.724 0.64 . . . . 70.31 113.126 178.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -91.47 158.28 16.57 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 117.176 0.488 . . . . 75.41 111.341 175.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.412 ' HB3' ' HD2' ' A' ' 250' ' ' TYR . 1.8 mppt? -130.07 117.65 20.32 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.84 1.256 . . . . 74.12 109.162 -177.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 12.9 mt -105.8 100.7 10.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.301 -0.863 . . . . 74.33 108.711 -165.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 46.2 ttm105 -69.98 102.45 2.01 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 124.544 1.153 . . . . 73.01 110.057 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 29.8 mt -111.69 99.78 8.44 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.727 0.811 . . . . 74.21 110.159 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -66.74 142.86 57.25 Favored 'General case' 0 C--O 1.246 0.887 0 C-N-CA 123.407 0.683 . . . . 71.55 110.489 178.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 87.03 13.35 66.54 Favored Glycine 0 CA--C 1.532 1.117 0 O-C-N 123.745 0.653 . . . . 60.11 113.021 -174.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -130.83 -25.38 2.31 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.338 0.655 . . . . 73.42 112.292 -175.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -75.07 -159.51 7.41 Favored Glycine 0 N--CA 1.476 1.306 0 CA-C-O 120.295 -0.169 . . . . 63.53 112.823 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -69.45 134.38 88.81 Favored Pre-proline 0 CA--C 1.554 1.105 0 CA-C-O 118.24 -0.886 . . . . 71.42 109.408 -174.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.523 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 78.0 Cg_exo . . . . . 0 C--N 1.386 2.524 0 C-N-CA 122.904 2.403 . . . . 71.32 111.838 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.523 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 59.2 mtt-85 . . . . . 0 C--O 1.241 0.655 0 N-CA-C 109.036 -0.728 . . . . 74.41 109.036 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.417 ' HA2' HE21 ' A' ' 191' ' ' GLN . . . -82.45 -158.04 22.93 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-N 115.449 -0.796 . . . . 55.5 112.471 177.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -114.55 132.54 56.29 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.767 0.827 . . . . 73.45 110.089 -176.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 41.6 tp -106.88 121.33 44.21 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 108.415 -0.958 . . . . 73.01 108.415 -176.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.412 ' HD2' ' HB3' ' A' ' 232' ' ' LYS . 8.7 m-85 -87.79 113.27 23.3 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.4 -0.963 . . . . 74.22 108.4 179.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.526 HD12 HD11 ' A' ' 197' ' ' LEU . 51.2 mt -86.48 107.77 18.23 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.175 -0.676 . . . . 73.51 109.175 176.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -76.02 97.67 4.09 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 107.683 -1.229 . . . . 63.51 107.683 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 91.5 t -62.82 108.87 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.777 0 C-N-CA 124.952 1.301 . . . . 70.14 110.927 -177.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -109.3 93.82 4.71 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.243 -1.021 . . . . 74.31 108.243 174.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.436 HD12 ' O ' ' A' ' 227' ' ' THR . 58.9 mt -75.4 131.79 34.37 Favored 'Isoleucine or valine' 0 C--N 1.351 0.631 0 N-CA-C 109.324 -0.621 . . . . 74.45 109.324 174.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 16.4 p . . . . . 0 CA--C 1.558 1.273 0 C-N-CA 125.496 1.518 . . . . 71.21 107.56 178.084 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.85 0 N-CA-C 110.617 -0.142 . . . . 61.34 110.617 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.508 ' CE2' HD21 ' A' ' 233' ' ' LEU . 49.1 m-85 . . . . . 0 N--CA 1.483 1.178 0 C-N-CA 124.43 1.092 . . . . 74.2 110.648 -172.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.628 ' HB3' ' HB2' ' A' ' 240' ' ' PHE . 25.2 mm-40 . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 121.468 0.651 . . . . 75.44 112.138 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -94.29 138.65 32.03 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 114.353 -1.294 . . . . 74.45 110.807 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 91.5 mt -122.93 166.95 14.22 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.872 0.869 . . . . 73.23 110.455 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -106.34 149.89 26.51 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 107.955 -1.128 . . . . 72.01 107.955 166.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.97 129.15 12.76 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.933 -0.765 . . . . 74.41 108.933 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.5 m -65.52 121.77 15.67 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.572 0.749 . . . . 75.33 110.425 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.435 HD11 HD13 ' A' ' 251' ' ' LEU . 57.0 tp -108.0 112.99 25.85 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.951 0.901 . . . . 75.24 109.164 -178.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -85.93 112.07 20.84 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.312 -0.996 . . . . 72.41 108.312 174.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 2.2 p -139.49 119.9 9.42 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 123.945 0.898 . . . . 74.1 108.971 -177.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . 0.428 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 44.3 Cg_endo -71.3 158.02 55.53 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 121.879 1.72 . . . . 71.13 111.171 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -52.1 -47.28 92.3 Favored Pre-proline 0 CA--C 1.567 1.611 0 C-N-CA 124.781 1.233 . . . . 71.45 113.606 -177.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 37.2 Cg_endo -63.07 -43.62 18.56 Favored 'Trans proline' 0 C--N 1.404 3.491 0 C-N-CA 121.478 1.452 . . . . 63.03 112.186 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 40.1 mt -71.12 -28.26 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 O-C-N 123.616 0.572 . . . . 74.34 110.361 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.57 -46.56 82.22 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.207 0.603 . . . . 65.1 110.509 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 67.5 t -67.82 -57.07 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 122.727 0.411 . . . . 74.33 111.513 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 17.2 m -78.9 -20.83 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 112.285 0.476 . . . . 74.12 112.285 -170.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 77.52 132.97 0.62 Allowed Glycine 0 C--N 1.345 1.07 0 N-CA-C 111.675 -0.57 . . . . 71.14 111.675 -171.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 175.87 -175.01 47.25 Favored Glycine 0 N--CA 1.468 0.828 0 CA-C-N 117.265 0.532 . . . . 73.2 112.269 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -79.03 143.6 35.48 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 122.849 0.46 . . . . 74.44 111.0 -178.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.402 HG22 HG12 ' A' ' 221' ' ' VAL . 19.9 m -139.45 169.44 16.99 Favored 'Isoleucine or valine' 0 C--O 1.253 1.263 0 O-C-N 124.338 1.024 . . . . 73.24 110.351 177.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -72.48 118.46 15.41 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.502 -1.226 . . . . 74.32 109.979 169.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -110.66 137.33 48.47 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.407 -0.59 . . . . 73.4 109.407 169.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 63.0 mtt -84.95 103.68 14.21 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.521 -0.918 . . . . 73.11 108.521 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 43.4 m -122.35 168.56 11.92 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.688 1.195 . . . . 70.0 109.015 -176.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 80.1 mt -54.69 -27.29 39.23 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.023 0.929 . . . . 74.04 111.73 174.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -90.95 15.82 10.69 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.507 1.123 . . . . 63.52 111.837 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 83.07 -149.74 26.82 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-O 119.273 -0.737 . . . . 74.22 112.174 -177.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.05 120.3 5.99 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.376 2.051 . . . . 65.41 111.377 177.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 22.6 m -119.24 167.44 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 123.2 0.6 . . . . 70.21 111.522 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -76.67 116.36 17.28 Favored 'General case' 0 C--N 1.348 0.526 0 C-N-CA 124.38 1.072 . . . . 73.13 108.822 175.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.402 HG12 HG22 ' A' ' 210' ' ' VAL . 1.1 t -124.78 115.19 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 108.613 -0.884 . . . . 73.43 108.613 174.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -81.39 99.01 8.47 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 115.76 -0.655 . . . . 62.11 109.401 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 56.1 t -80.32 130.26 66.2 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 123.609 0.764 . . . . 73.12 109.904 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.37 167.68 7.53 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.168 2.579 . . . . 72.25 112.27 171.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.25 -179.51 3.19 Favored 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 121.837 1.691 . . . . 75.2 112.913 174.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 48.2 mtt85 60.66 18.23 8.28 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 124.974 1.31 . . . . 74.41 112.298 173.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.488 ' HA ' ' OH ' ' A' ' 176' ' ' TYR . 96.6 m -68.3 103.45 1.6 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.025 0.93 . . . . 75.44 110.245 -174.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.466 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 47.4 tp60 -103.78 142.2 34.78 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.419 1.088 . . . . 73.33 110.285 -174.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.82 130.96 49.47 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.716 1.206 . . . . 74.23 111.583 -176.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 95.01 -10.34 70.1 Favored Glycine 0 C--N 1.347 1.142 0 O-C-N 123.711 0.632 . . . . 74.11 113.144 177.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.466 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 68.3 mtt-85 -78.52 155.45 29.75 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.038 0.535 . . . . 75.2 109.626 174.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.591 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.7 mppt? -130.18 118.1 20.9 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.994 -0.743 . . . . 71.23 108.994 -176.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.508 HD21 ' CE2' ' A' ' 176' ' ' TYR . 5.0 mt -89.66 103.91 16.51 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.091 -0.959 . . . . 74.44 109.035 -164.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 16.8 ttm-85 -69.42 102.11 1.7 Allowed 'General case' 0 CA--C 1.541 0.598 0 O-C-N 123.92 0.763 . . . . 74.24 109.712 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.404 ' HB3' ' HG3' ' A' ' 238' ' ' LYS . 14.3 mt -96.05 91.32 5.91 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.282 -1.007 . . . . 72.43 108.282 175.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -62.78 140.94 58.79 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.283 -0.636 . . . . 74.4 109.283 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 72.9 34.59 58.87 Favored Glycine 0 C--N 1.343 0.949 0 O-C-N 123.424 0.453 . . . . 53.51 113.737 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.576 ' HA ' ' HZ1' ' A' ' 238' ' ' LYS . 0.4 OUTLIER -128.01 -27.05 2.8 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.601 0.761 . . . . 74.25 112.124 179.262 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -74.88 -165.21 13.54 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 112.455 -0.258 . . . . 75.33 112.455 169.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.628 ' HB2' ' HB3' ' A' ' 191' ' ' GLN . 90.9 m-85 -75.72 150.57 84.22 Favored Pre-proline 0 N--CA 1.487 1.395 0 CA-C-N 117.216 0.508 . . . . 74.14 110.046 -176.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo . . . . . 0 C--N 1.375 1.939 0 C-N-CA 122.284 1.989 . . . . 75.21 112.659 177.704 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 48.8 mtm180 . . . . . 0 N--CA 1.473 0.679 0 N-CA-C 108.731 -0.841 . . . . 71.41 108.731 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -69.97 171.0 42.99 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 115.3 -0.864 . . . . 70.14 113.963 -177.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -110.71 136.28 50.03 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.919 0.888 . . . . 72.45 108.863 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 31.9 tp -105.29 108.11 19.46 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 107.717 -1.216 . . . . 73.13 107.717 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.591 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 19.3 m-85 -88.54 108.99 19.7 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.716 -0.846 . . . . 75.33 108.716 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.435 HD13 HD11 ' A' ' 197' ' ' LEU . 43.0 mt -86.85 107.07 18.16 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.856 -0.794 . . . . 64.33 108.856 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -78.05 102.76 7.6 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 114.657 -1.156 . . . . 72.41 109.55 -177.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 63.2 t -59.57 115.26 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.695 0 CA-C-N 114.388 -1.278 . . . . 75.33 112.053 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 20.7 mmt85 -112.66 93.99 4.7 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.294 -1.373 . . . . 72.33 107.294 171.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 22.9 mt -74.99 109.36 7.83 Favored 'Isoleucine or valine' 0 C--N 1.352 0.689 0 N-CA-C 109.018 -0.734 . . . . 73.44 109.018 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 25.6 p . . . . . 0 CA--C 1.558 1.277 0 C-N-CA 124.524 1.13 . . . . 73.42 108.428 177.173 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.688 0 N-CA-C 109.272 -0.64 . . . . 72.1 109.272 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.503 ' CE2' HD23 ' A' ' 233' ' ' LEU . 66.6 m-85 . . . . . 0 N--CA 1.488 1.43 0 C-N-CA 125.23 1.412 . . . . 63.33 112.067 -166.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 . . . . . 0 CA--C 1.555 1.166 0 CA-C-O 122.992 1.377 . . . . 63.22 109.745 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -88.7 166.84 13.8 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 113.693 -1.594 . . . . 75.13 110.362 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.6 mt -133.19 164.61 26.68 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.618 0.767 . . . . 64.14 110.785 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -114.85 154.87 27.85 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 114.526 -1.215 . . . . 74.22 108.357 168.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -160.66 150.88 17.91 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.656 0.782 . . . . 73.24 109.319 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 33.2 m -81.66 135.65 35.52 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.065 0.546 . . . . 73.2 110.18 177.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.573 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 42.1 tp -114.54 113.57 24.6 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.707 -1.22 . . . . 75.03 107.707 170.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -91.93 123.7 35.5 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 109.269 -0.641 . . . . 53.14 109.269 177.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 3.6 p -142.92 130.9 11.22 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.531 1.132 . . . . 75.22 108.487 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.21 156.26 37.63 Favored 'Trans proline' 0 C--N 1.37 1.683 0 C-N-CA 121.586 1.524 . . . . 73.43 110.999 170.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -54.62 -42.18 93.53 Favored Pre-proline 0 CA--C 1.565 1.528 0 CA-C-O 117.333 -1.318 . . . . 73.12 114.29 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.24 -51.23 9.04 Favored 'Trans proline' 0 C--N 1.4 3.282 0 CA-C-N 121.832 1.69 . . . . 71.52 112.144 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 46.0 mt -68.69 -26.45 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.813 0.845 . . . . 75.11 110.802 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 227' ' ' THR . . . -70.69 -50.96 30.9 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.51 0.724 . . . . 72.41 111.326 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 96.1 t -67.65 -50.14 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.612 0.765 . . . . 71.11 111.253 -176.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.7 p -75.97 -31.5 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 122.524 0.33 . . . . 74.02 110.793 -177.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 79.96 103.46 0.27 Allowed Glycine 0 C--N 1.347 1.177 0 N-CA-C 111.667 -0.573 . . . . 72.34 111.667 -173.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -131.75 -129.7 3.06 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 116.978 0.389 . . . . 75.54 112.35 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.584 ' HB2' ' HZ3' ' A' ' 209' ' ' LYS . 9.0 mtmp? -132.93 141.75 48.52 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.129 0.972 . . . . 75.44 108.393 178.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 17.2 m -130.67 165.96 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.21 0.604 . . . . 75.54 110.924 -178.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -82.11 120.42 25.29 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.133 -0.692 . . . . 75.14 109.133 168.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -118.21 136.67 53.5 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.557 0.743 . . . . 74.3 109.285 173.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 87.1 mtp -76.83 116.63 17.67 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.026 0.53 . . . . 73.34 109.578 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 33.6 m -127.21 170.35 12.52 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.431 1.093 . . . . 63.03 108.848 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 81.4 mt -57.82 -34.29 69.5 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.012 0.925 . . . . 73.33 111.963 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -84.56 2.16 42.55 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.676 0.79 . . . . 74.12 111.93 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 108.79 -161.8 13.09 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-O 119.648 -0.529 . . . . 74.22 112.567 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.2 119.66 6.61 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 122.189 1.926 . . . . 62.14 111.312 176.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 32.7 m -114.9 163.94 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 123.306 0.642 . . . . 74.41 109.979 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -103.61 110.0 21.9 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.242 0.544 . . . . 73.32 109.703 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 62.0 t -104.29 126.25 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.151 0.98 . . . . 75.42 109.207 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.1 99.81 2.87 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.103 0.561 . . . . 71.01 109.899 176.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 78.1 t -88.52 121.28 70.24 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 124.112 0.965 . . . . 75.3 109.724 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -60.76 169.02 6.14 Favored 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 123.987 3.124 . . . . 75.33 113.359 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.98 169.35 20.69 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 122.073 1.849 . . . . 73.14 113.629 178.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 65.53 22.02 11.79 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 125.554 1.541 . . . . 71.52 112.186 176.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.493 ' HA ' ' CZ ' ' A' ' 176' ' ' TYR . 94.8 m -66.39 104.55 1.25 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.029 0.932 . . . . 63.43 110.811 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -102.06 141.63 34.6 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.987 0.915 . . . . 73.41 110.935 -172.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -64.77 143.31 58.02 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.295 1.038 . . . . 75.21 111.576 -179.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.76 -9.17 75.14 Favored Glycine 0 N--CA 1.47 0.909 0 O-C-N 123.831 0.707 . . . . 70.34 112.939 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.407 HH11 ' HE1' ' A' ' 176' ' ' TYR . 89.3 mtt180 -78.15 154.14 31.46 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.237 0.615 . . . . 75.04 109.989 171.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -131.23 136.31 48.11 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.592 1.157 . . . . 71.24 108.437 -178.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.503 HD23 ' CE2' ' A' ' 176' ' ' TYR . 30.2 mt -110.12 103.16 11.84 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.875 -0.602 . . . . 73.22 109.912 -169.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -70.5 100.65 1.83 Allowed 'General case' 0 C--O 1.239 0.501 0 O-C-N 124.038 0.836 . . . . 73.43 109.203 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 12.4 mt -97.79 98.59 9.97 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.305 -1.368 . . . . 73.52 107.305 177.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 36.3 mtmt -76.88 141.74 40.45 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.298 -0.41 . . . . 75.42 110.331 -176.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.98 33.07 42.37 Favored Glycine 0 C--N 1.344 1.015 0 O-C-N 123.478 0.486 . . . . 73.05 113.278 -179.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -125.0 -33.95 2.85 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.74 0.816 . . . . 73.11 111.619 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -65.61 -159.81 0.6 Allowed Glycine 0 C--N 1.359 1.856 0 O-C-N 123.488 0.493 . . . . 74.2 113.491 176.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -71.72 146.17 90.58 Favored Pre-proline 0 CA--C 1.554 1.112 0 O-C-N 122.049 -0.677 . . . . 75.53 110.078 -177.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo . . . . . 0 C--N 1.378 2.101 0 C-N-CA 122.778 2.319 . . . . 73.41 112.925 175.458 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 31.6 mtt180 . . . . . 0 N--CA 1.477 0.917 0 CA-C-O 121.096 0.474 . . . . 74.53 110.778 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.29 -165.63 27.56 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 115.334 -0.848 . . . . 61.32 112.363 177.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -99.07 168.8 9.85 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.214 0.606 . . . . 74.45 110.13 -177.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 40.4 tp -142.48 107.81 5.01 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.943 -0.762 . . . . 70.11 108.943 174.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -89.33 108.2 19.49 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.907 0.483 . . . . 74.13 109.964 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 34.7 mt -87.62 107.97 18.85 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 109.311 -0.625 . . . . 72.31 109.311 174.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -78.66 103.5 8.65 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 109.075 -0.713 . . . . 75.54 109.075 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.8 t -56.8 112.99 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 124.548 1.139 . . . . 72.33 111.194 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -116.34 100.55 7.97 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.039 -1.097 . . . . 75.51 108.039 176.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 30.1 mt -79.38 126.92 39.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 123.285 0.634 . . . . 62.35 110.665 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 19.7 p . . . . . 0 CA--C 1.557 1.213 0 C-N-CA 124.714 1.205 . . . . 72.32 108.708 176.135 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 108.966 -0.753 . . . . 73.33 108.966 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.576 ' CE2' HD23 ' A' ' 233' ' ' LEU . 40.6 m-85 . . . . . 0 N--CA 1.486 1.33 0 C-N-CA 124.724 1.21 . . . . 75.43 109.337 -159.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 109.724 -0.473 . . . . 75.55 109.724 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -80.33 132.14 35.75 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.467 -0.788 . . . . 73.22 109.431 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 86.2 mt -136.94 175.11 9.92 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.838 0.855 . . . . 64.44 109.772 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -105.26 163.49 12.56 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.055 0.942 . . . . 73.21 110.205 178.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -165.33 129.7 2.4 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.771 1.228 . . . . 63.2 108.13 175.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' THR . . . . . 0.457 ' HA ' ' HB2' ' A' ' 252' ' ' GLU . 50.1 m -70.69 137.11 49.52 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 122.794 0.438 . . . . 75.23 111.163 -178.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 21.9 tp -122.46 112.44 18.05 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.182 -1.044 . . . . 73.32 108.182 175.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -91.23 128.43 37.05 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 108.913 -0.773 . . . . 65.05 108.913 175.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 3.3 p -139.6 124.87 11.64 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 123.799 0.84 . . . . 63.03 109.578 -177.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -67.5 153.51 76.31 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 121.467 1.444 . . . . 72.24 111.717 176.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.59 -45.17 85.24 Favored Pre-proline 0 CA--C 1.564 1.496 0 CA-C-O 117.648 -1.167 . . . . 53.33 113.887 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.437 ' O ' HG11 ' A' ' 206' ' ' VAL . 19.9 Cg_endo -59.36 -52.27 5.07 Favored 'Trans proline' 0 C--N 1.397 3.127 0 CA-C-N 121.426 1.545 . . . . 74.44 112.17 175.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 46.0 mt -63.8 -27.31 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 123.639 0.776 . . . . 75.42 110.896 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 227' ' ' THR . . . -70.86 -49.33 47.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.386 0.675 . . . . 72.51 111.169 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 84.7 t -67.84 -54.0 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 122.988 0.515 . . . . 73.21 110.96 -177.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.437 HG11 ' O ' ' A' ' 202' ' ' PRO . 11.1 p -74.34 -38.66 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 122.701 0.4 . . . . 70.11 111.345 -175.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.79 79.16 1.3 Allowed Glycine 0 C--N 1.343 0.955 0 N-CA-C 112.07 -0.412 . . . . 65.02 112.07 -172.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -99.33 -125.54 5.45 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-O 119.546 -0.586 . . . . 75.35 112.064 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.547 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 33.7 mtmm -138.18 150.18 46.54 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.101 0.961 . . . . 75.34 109.4 174.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 24.3 m -138.51 170.18 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 124.031 0.932 . . . . 75.44 110.946 177.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 19.3 ttm180 -96.76 115.72 27.91 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.798 0.839 . . . . 75.35 110.303 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -107.67 156.14 19.39 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 109.181 -0.674 . . . . 75.22 109.181 168.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 83.6 mtp -98.08 120.93 39.35 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.034 0.445 . . . . 64.0 110.063 177.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 5.5 m -111.26 174.41 5.88 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 125.083 1.353 . . . . 74.13 107.382 175.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 76.1 mt -59.44 -35.17 73.51 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 113.118 0.785 . . . . 74.34 113.118 -171.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -90.6 -19.11 24.07 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.207 0.603 . . . . 74.22 111.279 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 147.04 -158.88 27.87 Favored Glycine 0 C--N 1.353 1.502 0 CA-C-O 119.824 -0.431 . . . . 75.31 113.324 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.9 143.91 29.99 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.496 2.797 . . . . 72.14 113.498 -173.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 31.2 m -133.25 161.45 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.106 0.962 . . . . 73.01 110.084 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -95.57 110.92 22.94 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.747 0.819 . . . . 74.35 109.656 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 54.5 t -96.52 111.28 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.574 1.149 . . . . 72.14 108.159 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.547 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . . . -73.72 95.8 2.42 Favored 'General case' 0 C--N 1.349 0.568 0 N-CA-C 109.34 -0.615 . . . . 73.44 109.34 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 53.6 t -64.31 132.09 95.24 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 124.468 1.107 . . . . 72.42 110.279 -173.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.74 166.71 28.66 Favored 'Trans proline' 0 CA--C 1.559 1.729 0 C-N-CA 122.668 2.246 . . . . 74.33 112.213 170.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.29 167.03 28.12 Favored 'Trans proline' 0 C--N 1.372 1.798 0 C-N-CA 121.822 1.682 . . . . 74.04 112.057 173.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 65.37 19.18 11.57 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.718 1.207 . . . . 74.52 112.157 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.534 ' HA ' ' CZ ' ' A' ' 176' ' ' TYR . 79.1 m -66.87 101.19 0.8 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.187 0.595 . . . . 72.44 110.659 -176.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -101.96 143.09 32.26 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 125.605 1.562 . . . . 72.43 110.596 -174.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -68.87 145.04 54.05 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 123.927 0.891 . . . . 64.11 111.166 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.06 -12.73 68.71 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.247 -0.888 . . . . 52.4 112.446 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.521 HH11 ' HE1' ' A' ' 176' ' ' TYR . 87.6 mtt180 -85.13 154.67 21.87 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.329 0.652 . . . . 73.42 110.415 175.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.55 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.3 mppt? -130.29 139.48 50.73 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.25 -1.019 . . . . 74.1 108.25 -178.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.576 HD23 ' CE2' ' A' ' 176' ' ' TYR . 26.1 mt -110.77 100.63 9.35 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 122.9 0.48 . . . . 65.54 109.829 -172.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -71.12 101.86 2.36 Favored 'General case' 0 CA--C 1.552 1.038 0 O-C-N 124.003 0.814 . . . . 75.21 110.01 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 11.8 mt -106.45 107.77 18.95 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.303 0.641 . . . . 75.33 109.283 -175.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -61.15 150.6 33.73 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.507 0.558 . . . . 75.14 112.507 176.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.78 24.78 61.6 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.483 -0.781 . . . . 72.52 114.004 171.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -119.83 -44.26 2.53 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.18 0.592 . . . . 75.01 109.578 -176.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -77.53 -177.01 45.97 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-N 115.352 -0.84 . . . . 74.22 112.727 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -64.83 150.87 94.03 Favored Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 123.703 0.801 . . . . 75.32 112.512 -171.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.622 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 52.6 Cg_endo . . . . . 0 C--N 1.383 2.352 0 C-N-CA 122.642 2.228 . . . . 74.35 112.329 -177.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.622 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 14.1 mtm180 . . . . . 0 N--CA 1.473 0.697 0 CA-C-O 120.826 0.346 . . . . 72.24 110.076 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -93.3 175.66 36.39 Favored Glycine 0 C--N 1.339 0.747 0 CA-C-N 115.658 -0.701 . . . . 72.33 113.451 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -99.61 170.37 8.63 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.215 1.006 . . . . 65.32 109.619 -176.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 32.0 tp -141.88 118.88 11.25 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.292 -0.633 . . . . 74.12 109.292 172.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.55 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 13.9 m-85 -88.69 109.41 20.1 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.748 -0.834 . . . . 74.44 108.748 -178.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 30.2 mt -85.97 108.57 18.27 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.93 -0.767 . . . . 74.31 108.93 176.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.457 ' HB2' ' HA ' ' A' ' 196' ' ' THR . 30.4 mt-10 -77.31 97.16 4.78 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 114.421 -1.263 . . . . 75.13 109.405 -174.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 65.6 t -60.67 105.16 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 O-C-N 123.765 0.665 . . . . 64.34 110.752 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -116.02 102.22 9.45 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 106.988 -1.486 . . . . 74.44 106.988 174.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 51.3 mt -81.52 131.63 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 116.111 -0.495 . . . . 75.24 110.843 -174.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 21.3 p . . . . . 0 CA--C 1.563 1.452 0 C-N-CA 124.537 1.135 . . . . 74.14 108.422 177.267 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 111.023 0.009 . . . . 73.1 111.023 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.509 ' CE2' HD23 ' A' ' 233' ' ' LEU . 25.3 m-85 . . . . . 0 N--CA 1.491 1.589 0 C-N-CA 124.44 1.096 . . . . 74.3 110.15 -160.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 CA--C 1.541 0.63 0 CA-C-O 121.11 0.481 . . . . 72.42 109.809 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.43 131.64 41.25 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 114.563 -1.199 . . . . 71.4 110.204 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 96.4 mt -135.8 155.49 50.27 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.81 0.844 . . . . 73.04 110.239 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -116.4 145.34 43.32 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.091 0.957 . . . . 74.55 109.17 172.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -150.1 136.76 19.15 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.31 0.644 . . . . 65.3 109.504 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 86.6 m -69.19 138.77 54.34 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.216 0.606 . . . . 70.04 110.353 175.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.509 HD13 HD11 ' A' ' 251' ' ' LEU . 45.3 tp -120.14 112.45 19.11 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 107.657 -1.238 . . . . 75.04 107.657 174.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -95.68 117.0 29.67 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.743 -0.836 . . . . 60.13 108.743 -178.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.9 p -142.32 129.07 11.03 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.019 0.928 . . . . 72.14 109.364 -176.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . 0.411 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 46.2 Cg_endo -71.08 155.58 61.25 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 121.792 1.662 . . . . 64.34 111.791 175.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -48.63 -46.69 71.54 Favored Pre-proline 0 N--CA 1.487 1.402 0 N-CA-C 114.522 1.304 . . . . 73.53 114.522 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 19.7 Cg_endo -57.74 -55.13 2.59 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 121.418 1.412 . . . . 73.23 112.802 176.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 58.9 mt -65.2 -29.52 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 123.426 0.69 . . . . 54.23 111.277 -177.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.8 -53.22 28.79 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.052 0.541 . . . . 73.32 111.03 -178.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 89.9 t -67.39 -55.17 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 115.642 -0.708 . . . . 74.13 110.956 -176.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.4 HG11 ' O ' ' A' ' 202' ' ' PRO . 7.7 p -77.12 -22.89 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 N-CA-C 112.268 0.47 . . . . 73.4 112.268 -173.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.41 139.01 8.19 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-O 120.1 -0.278 . . . . 60.11 112.622 -177.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -171.83 -145.48 4.9 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 116.753 0.276 . . . . 43.41 113.116 -178.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.525 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 96.4 mttt -133.76 132.7 40.85 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.963 0.905 . . . . 71.21 109.131 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.435 HG21 HG23 ' A' ' 223' ' ' VAL . 34.9 m -131.88 164.94 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-O 121.135 0.493 . . . . 74.32 110.716 177.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -75.45 141.34 43.16 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.082 -0.963 . . . . 74.21 110.645 174.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -141.47 157.55 45.0 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.727 0.811 . . . . 72.23 110.045 173.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 55.4 ttp -81.91 129.65 34.83 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.151 0.58 . . . . 72.32 110.72 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 89.5 m -143.61 166.96 23.38 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 124.418 1.087 . . . . 73.42 108.251 176.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 96.4 mt -56.6 -27.9 59.16 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.751 0.82 . . . . 75.22 112.458 174.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.46 14.56 3.61 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.826 0.85 . . . . 74.33 111.663 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 85.2 -148.75 23.34 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 111.192 -0.763 . . . . 41.01 111.192 -175.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.66 129.19 13.32 Favored 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 122.412 2.075 . . . . 75.42 111.327 174.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.2 m -122.21 155.87 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.726 0.811 . . . . 65.43 109.78 178.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -97.24 104.76 16.81 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.896 -0.779 . . . . 75.32 108.896 176.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.6 t -96.41 130.56 44.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 124.04 0.936 . . . . 73.14 109.829 -176.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.525 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . . . -77.48 101.93 6.67 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.322 0.649 . . . . 74.12 110.191 178.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.435 HG23 HG21 ' A' ' 210' ' ' VAL . 50.2 t -91.43 126.0 56.02 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 124.303 1.041 . . . . 71.03 109.959 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.7 172.6 9.18 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 123.665 2.91 . . . . 75.23 112.452 178.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.63 -179.41 1.98 Allowed 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 121.853 1.702 . . . . 73.51 112.154 166.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 68.86 5.29 4.91 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 125.28 1.432 . . . . 74.42 112.473 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.458 ' HA ' ' CZ ' ' A' ' 176' ' ' TYR . 90.5 m -67.05 114.34 5.75 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.374 0.607 . . . . 73.33 110.933 -171.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.447 ' HA ' HD13 ' A' ' 255' ' ' ILE . 6.7 tp-100 -125.77 139.53 53.44 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 124.033 0.933 . . . . 62.43 110.464 -165.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . 0.418 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -61.39 134.24 56.7 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.999 0.92 . . . . 75.31 112.826 -171.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.85 -2.35 85.74 Favored Glycine 0 N--CA 1.474 1.203 0 CA-C-N 115.883 -0.599 . . . . 74.42 113.663 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -89.67 146.91 24.19 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.327 -0.62 . . . . 71.21 109.327 173.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -126.73 138.69 53.42 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.791 0.836 . . . . 73.33 108.97 -172.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.509 HD23 ' CE2' ' A' ' 176' ' ' TYR . 40.6 mt -113.53 109.02 17.97 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.073 -0.512 . . . . 72.42 111.008 -163.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -70.64 102.61 2.32 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 124.62 1.2 . . . . 73.54 109.806 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 33.0 mt -109.4 91.7 3.75 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.322 -0.622 . . . . 75.42 109.322 178.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.539 ' HG2' ' HB3' ' A' ' 248' ' ' ASP . 45.4 mtmt -70.13 143.53 52.32 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 122.851 0.46 . . . . 74.13 110.721 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.36 34.34 45.8 Favored Glycine 0 C--N 1.346 1.111 0 O-C-N 123.875 0.734 . . . . 72.34 112.067 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -131.26 -34.12 1.44 Allowed 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.005 0.922 . . . . 75.53 110.386 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -74.03 -163.24 9.05 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-N 116.304 -0.407 . . . . 74.13 113.581 175.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -71.26 149.52 94.2 Favored Pre-proline 0 N--CA 1.484 1.242 0 C-N-CA 122.835 0.454 . . . . 73.3 111.438 -176.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo . . . . . 0 C--N 1.377 2.031 0 C-N-CA 122.918 2.412 . . . . 73.41 112.512 173.422 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 . . . . . 0 C--O 1.244 0.811 0 N-CA-C 109.252 -0.648 . . . . 75.34 109.252 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.96 -164.95 22.02 Favored Glycine 0 C--N 1.341 0.84 0 O-C-N 123.775 0.672 . . . . 64.02 113.663 -177.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.539 ' HB3' ' HG2' ' A' ' 236' ' ' LYS . 1.2 p-10 -113.52 132.81 55.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.589 0.709 . . . . 75.11 111.957 -168.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 42.0 tp -98.57 117.83 33.88 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.014 -1.448 . . . . 71.52 108.502 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -88.5 109.7 20.26 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 122.848 0.459 . . . . 74.32 109.939 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.509 HD11 HD13 ' A' ' 197' ' ' LEU . 31.8 mt -86.96 106.12 17.59 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.174 -0.676 . . . . 74.04 109.174 175.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -78.16 105.34 9.32 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 115.635 -0.711 . . . . 74.4 109.411 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 65.2 t -56.44 118.04 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 123.762 0.825 . . . . 74.34 111.014 176.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -117.3 94.77 4.69 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 107.799 -1.186 . . . . 74.35 107.799 175.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.447 HD13 ' HA ' ' A' ' 228' ' ' GLN . 14.5 mt -76.03 123.96 33.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 O-C-N 124.006 0.816 . . . . 75.32 109.779 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 37.4 p . . . . . 0 CA--C 1.557 1.239 0 CA-C-O 117.489 -1.243 . . . . 71.54 108.167 174.543 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.864 0 CA-C-O 120.533 0.206 . . . . 74.12 111.383 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 . . . . . 0 N--CA 1.486 1.368 0 C-N-CA 125.043 1.337 . . . . 74.31 111.837 -164.915 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.213 0.53 . . . . 75.22 110.477 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -75.53 138.31 41.44 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.055 -0.975 . . . . 73.33 108.909 173.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.7 mt -129.49 168.98 15.55 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.154 0.582 . . . . 74.4 111.033 -172.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -120.49 141.91 49.77 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 124.637 1.175 . . . . 74.4 108.258 172.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -153.83 128.22 9.19 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.172 0.989 . . . . 73.35 108.36 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' THR . . . . . 0.437 ' HA ' ' HB2' ' A' ' 252' ' ' GLU . 92.9 m -72.87 135.06 45.07 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.084 0.553 . . . . 75.21 111.595 -175.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 40.5 tp -114.35 113.73 24.94 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.768 1.227 . . . . 73.24 108.343 178.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -89.25 116.43 27.47 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.09 -0.707 . . . . 71.33 109.09 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 7.0 p -136.38 133.26 19.24 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 108.283 -1.006 . . . . 75.12 108.283 -174.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . 0.488 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 72.2 Cg_endo -74.84 161.85 38.46 Favored 'Trans proline' 0 C--N 1.37 1.658 0 C-N-CA 121.899 1.732 . . . . 73.14 111.892 175.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.05 -51.66 59.92 Favored Pre-proline 0 CA--C 1.569 1.696 0 N-CA-C 113.893 1.071 . . . . 74.01 113.893 177.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 23.1 Cg_endo -60.5 -52.48 3.85 Favored 'Trans proline' 0 C--N 1.399 3.221 0 C-N-CA 122.068 1.845 . . . . 74.0 112.926 -178.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 61.0 mt -64.26 -28.63 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 123.476 0.71 . . . . 75.51 111.447 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.23 -48.51 75.53 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.937 0.398 . . . . 75.33 111.234 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 61.7 t -71.37 -52.41 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.192 0 CA-C-N 116.099 -0.501 . . . . 70.32 112.18 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 11.4 p -85.11 -31.73 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 112.395 0.517 . . . . 73.1 112.395 -172.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 100.39 149.94 24.11 Favored Glycine 0 N--CA 1.471 0.974 0 CA-C-N 116.45 -0.341 . . . . 62.22 112.372 -173.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 162.42 173.78 31.51 Favored Glycine 0 C--N 1.34 0.782 0 N-CA-C 111.788 -0.525 . . . . 72.42 111.788 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -81.15 134.79 35.7 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 116.993 0.396 . . . . 75.23 110.094 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 25.7 m -123.28 167.84 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.488 0.715 . . . . 71.51 110.48 173.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 -81.5 105.31 12.56 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.705 -1.134 . . . . 74.1 108.975 172.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.69 144.0 32.32 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.6 0.76 . . . . 72.54 109.43 175.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 41.4 ttm -86.91 115.66 24.46 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.192 0.52 . . . . 74.3 110.512 -177.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 9.2 m -116.15 162.57 17.24 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.626 1.17 . . . . 74.41 107.901 176.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 96.0 mt -56.8 -35.63 68.96 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.227 0.611 . . . . 75.21 112.349 -177.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -78.55 -20.06 51.48 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.047 0.539 . . . . 73.35 111.537 -177.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 142.13 -171.8 24.42 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 116.16 -0.473 . . . . 72.44 112.337 -176.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.52 129.07 14.24 Favored 'Trans proline' 0 C--N 1.365 1.441 0 C-N-CA 123.022 2.482 . . . . 73.41 111.463 177.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.73 159.93 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 123.723 0.809 . . . . 63.03 109.549 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -91.18 111.18 22.54 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.36 0.664 . . . . 71.3 109.661 174.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 93.2 t -107.58 120.99 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.24 1.016 . . . . 74.43 108.903 177.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.48 98.87 2.86 Favored 'General case' 0 C--N 1.348 0.509 0 C-N-CA 122.989 0.515 . . . . 75.43 109.959 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 62.2 t -78.03 136.15 62.18 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 124.534 1.134 . . . . 64.3 109.173 177.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -76.77 173.22 14.83 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.998 2.465 . . . . 74.13 111.201 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.49 179.52 1.24 Allowed 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 121.972 1.781 . . . . 74.44 112.197 166.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 27.8 mtt-85 71.23 0.05 3.28 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 125.184 1.394 . . . . 74.22 112.355 176.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 95.4 m -65.76 106.33 1.48 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.185 0.594 . . . . 63.53 110.712 -170.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.486 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 60.5 tp60 -115.1 141.45 47.99 Favored 'General case' 0 C--N 1.35 0.596 0 CA-C-N 115.054 -0.975 . . . . 72.12 110.329 -170.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.99 139.83 58.81 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.344 1.057 . . . . 74.13 111.513 -175.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 91.7 -27.21 10.13 Favored Glycine 0 C--N 1.344 0.978 0 O-C-N 123.836 0.71 . . . . 51.11 112.791 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.486 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 78.5 mtt180 -77.2 160.64 28.79 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.013 0.525 . . . . 72.01 110.413 176.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.464 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 2.8 mppt? -130.1 144.93 51.62 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.205 0.602 . . . . 74.13 109.653 -176.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.431 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 12.8 mt -97.9 104.44 16.47 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 115.738 -0.664 . . . . 74.24 109.269 -176.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 54.0 ttm-85 -71.51 105.74 3.72 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 123.873 0.733 . . . . 75.02 110.292 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 27.8 mt -112.26 94.59 5.0 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.18 0.592 . . . . 74.41 109.43 -178.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -65.74 143.81 57.29 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.32 0.248 . . . . 74.01 111.346 178.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 85.07 12.83 73.02 Favored Glycine 0 C--N 1.346 1.125 0 O-C-N 123.956 0.785 . . . . 60.22 113.707 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -110.78 -27.23 8.96 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 117.28 0.54 . . . . 75.23 110.539 -178.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -75.33 -167.69 21.93 Favored Glycine 0 C--N 1.352 1.469 0 O-C-N 123.473 0.483 . . . . 52.04 113.076 171.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.424 ' HA ' ' HD3' ' A' ' 241' ' ' PRO . 71.2 m-85 -70.44 144.37 91.64 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 123.414 0.685 . . . . 75.4 112.847 -171.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 240' ' ' PHE . 13.7 Cg_exo . . . . . 0 C--N 1.379 2.14 0 C-N-CA 123.443 2.762 . . . . 74.11 111.856 173.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 110.447 -0.205 . . . . 72.32 110.447 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.3 167.8 52.91 Favored Glycine 0 C--N 1.348 1.235 0 O-C-N 123.669 0.605 . . . . 55.21 113.877 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -112.67 133.08 54.87 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.38 1.072 . . . . 72.45 110.137 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 40.2 tp -99.24 122.42 42.39 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.339 1.055 . . . . 73.11 108.808 -174.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.464 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 3.8 m-85 -89.6 110.14 21.03 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.485 -0.932 . . . . 74.14 108.485 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.447 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 27.8 mt -86.86 104.99 16.73 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.646 -0.872 . . . . 74.44 108.646 173.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.437 ' HB2' ' HA ' ' A' ' 196' ' ' THR . 32.5 mt-10 -77.88 97.33 5.24 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.68 -1.146 . . . . 71.3 109.46 -171.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 59.0 t -58.95 114.93 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 114.94 -1.027 . . . . 73.24 111.459 -177.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -116.86 95.97 5.26 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.74 -1.208 . . . . 75.42 107.74 171.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.462 HD11 ' HA ' ' A' ' 228' ' ' GLN . 50.8 mt -75.53 126.88 36.79 Favored 'Isoleucine or valine' 0 C--N 1.35 0.594 0 CA-C-N 115.376 -0.829 . . . . 75.11 108.955 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 14.5 p . . . . . 0 C--O 1.252 1.192 0 C-N-CA 124.79 1.236 . . . . 74.44 108.159 177.995 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 121.042 0.449 . . . . 73.41 109.888 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 28.6 p -154.39 109.8 3.14 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.504 0.721 . . . . 64.33 109.499 -177.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -91.25 -178.02 5.03 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.457 0.703 . . . . 71.45 109.73 172.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 79.8 mt -68.59 102.44 1.48 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.307 -0.627 . . . . 72.24 109.307 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 4.1 tpm_? -62.98 117.17 6.06 Favored 'General case' 0 C--O 1.242 0.658 0 O-C-N 124.062 0.851 . . . . 73.34 110.756 -177.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.896 ' HA ' HD23 ' A' ' 235' ' ' LEU . 29.8 mt -86.5 97.02 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 121.356 0.598 . . . . 72.14 110.498 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -83.98 -2.95 57.56 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.907 -1.042 . . . . 75.45 111.344 176.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -83.11 171.67 13.48 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.625 0.77 . . . . 75.3 111.451 177.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.429 ' HE1' ' HA ' ' A' ' 227' ' ' THR . 3.3 m-30 67.65 22.5 9.02 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.409 1.084 . . . . 74.34 112.33 176.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -137.91 68.73 0.51 Allowed Glycine 0 C--N 1.339 0.739 0 N-CA-C 110.096 -1.202 . . . . 72.25 110.096 168.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -66.97 98.37 0.43 Allowed 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.705 2.27 . . . . 73.23 111.274 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 41.6 t60 -147.12 98.24 3.0 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.805 -0.634 . . . . 72.12 109.382 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -77.39 133.7 13.61 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 115.827 -0.624 . . . . 63.44 111.927 175.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 13.6 t -160.25 -171.56 3.24 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.579 0.752 . . . . 54.41 109.164 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -78.73 69.07 2.91 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-N 118.236 0.471 . . . . 72.41 113.222 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -147.59 166.19 28.72 Favored Glycine 0 N--CA 1.472 1.039 0 N-CA-C 111.362 -0.695 . . . . 61.1 111.362 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 37.7 m -78.79 83.96 4.89 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.381 0.673 . . . . 75.34 111.594 -175.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.606 ' HA2' ' HE2' ' A' ' 236' ' ' LYS . . . -106.26 -64.67 0.63 Allowed Glycine 0 C--N 1.337 0.623 0 N-CA-C 110.7 -0.96 . . . . 75.1 110.7 173.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 72.39 -175.48 43.15 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.487 -0.356 . . . . 75.11 112.312 -176.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 57.2 p -78.72 -13.45 59.81 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.359 0.663 . . . . 74.3 111.115 175.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 176.56 170.91 39.71 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 111.368 -0.693 . . . . 73.33 111.368 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -84.53 -173.5 49.86 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 122.809 0.242 . . . . 62.43 112.686 175.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 32.7 m -71.8 -80.35 0.06 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.173 0.589 . . . . 73.22 111.144 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 -106.5 74.26 1.01 Allowed 'General case' 0 C--O 1.244 0.805 0 N-CA-C 108.084 -1.08 . . . . 75.34 108.084 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -78.67 140.83 38.33 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 113.569 -1.651 . . . . 75.42 109.699 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 82.5 mt -136.66 140.66 42.9 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.901 0.48 . . . . 70.31 110.318 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -93.88 122.96 36.9 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.385 -0.825 . . . . 71.42 108.804 174.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -123.51 127.75 48.79 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 107.445 -1.316 . . . . 74.35 107.445 176.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 25.1 m -68.48 123.61 21.29 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.19 0.596 . . . . 75.24 110.452 -175.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 29.8 tp -108.36 111.62 23.63 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.604 -0.887 . . . . 75.21 108.604 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -81.97 126.17 31.64 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.404 -0.962 . . . . 73.51 108.404 174.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.489 HG12 HG11 ' A' ' 253' ' ' VAL . 6.4 p -142.68 130.3 11.2 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 108.305 -0.998 . . . . 74.21 108.305 178.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.412 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 57.6 Cg_endo -73.85 155.57 48.56 Favored 'Trans proline' 0 C--N 1.363 1.307 0 C-N-CA 121.678 1.585 . . . . 61.04 110.666 172.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.81 -48.27 88.12 Favored Pre-proline 0 CA--C 1.56 1.35 0 C-N-CA 123.917 0.887 . . . . 61.22 113.08 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.449 ' O ' HG13 ' A' ' 206' ' ' VAL . 78.0 Cg_exo -52.57 -56.12 3.15 Favored 'Trans proline' 0 C--N 1.396 3.03 0 C-N-CA 122.453 2.102 . . . . 72.41 113.57 175.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 59.8 mt -65.09 -28.97 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 123.406 0.683 . . . . 75.3 111.077 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.54 -49.27 71.9 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.091 0.472 . . . . 73.53 111.052 177.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 65.9 t -73.98 -47.57 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 115.955 -0.566 . . . . 74.3 112.496 -173.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 202' ' ' PRO . 13.6 p -88.49 -22.2 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 O-C-N 122.233 -0.292 . . . . 71.23 111.34 -175.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 87.72 166.38 42.36 Favored Glycine 0 C--N 1.342 0.882 0 N-CA-C 111.533 -0.627 . . . . 51.3 111.533 -171.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 162.71 -128.15 1.82 Allowed Glycine 0 C--O 1.226 -0.359 0 N-CA-C 111.213 -0.755 . . . . 63.35 111.213 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -137.65 151.48 48.32 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 108.712 -0.847 . . . . 74.1 108.712 173.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 26.6 m -138.37 162.3 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.075 0.55 . . . . 73.14 110.109 172.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 -84.42 115.43 22.53 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.456 -0.793 . . . . 75.03 109.854 174.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -106.79 156.76 18.32 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.716 0.806 . . . . 73.13 109.594 173.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 43.2 tpp -93.08 125.53 37.72 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.883 0.473 . . . . 72.41 109.874 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 61.1 m -137.8 160.78 38.32 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.692 1.197 . . . . 75.11 108.044 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 92.5 mt -65.95 -20.85 66.35 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.143 0.577 . . . . 75.12 111.788 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -80.02 -17.49 52.67 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.004 0.922 . . . . 74.12 110.95 174.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 125.0 -156.78 19.07 Favored Glycine 0 C--N 1.343 0.95 0 N-CA-C 111.449 -0.66 . . . . 50.41 111.449 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.9 121.07 6.04 Favored 'Trans proline' 0 C--N 1.363 1.3 0 C-N-CA 122.382 2.055 . . . . 70.23 111.607 173.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 32.7 m -111.26 155.91 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.244 0.617 . . . . 75.34 109.837 177.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -94.14 113.85 25.87 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.19 -0.67 . . . . 73.03 109.19 175.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 92.2 t -97.26 117.56 42.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 108.647 -0.872 . . . . 74.54 108.647 175.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.25 100.35 0.79 Allowed 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.474 0.484 . . . . 74.23 109.956 176.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 91.4 t -72.75 131.72 83.93 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 123.495 0.718 . . . . 75.21 109.754 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.33 165.92 31.25 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.266 1.977 . . . . 72.23 110.979 171.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -67.4 174.58 7.05 Favored 'Trans proline' 0 CA--C 1.551 1.374 0 C-N-CA 121.688 1.592 . . . . 72.45 112.818 170.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 69.91 0.32 3.01 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 125.374 1.47 . . . . 75.31 113.514 173.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.429 ' HA ' ' HE1' ' A' ' 176' ' ' TYR . 47.4 m -62.24 126.83 28.69 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.119 0.968 . . . . 75.03 111.781 -170.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.413 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 57.9 tp60 -124.4 143.2 50.75 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.816 0.846 . . . . 72.25 111.03 -167.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.86 131.75 51.66 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.904 1.282 . . . . 73.53 111.813 -178.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 99.4 -18.04 56.94 Favored Glycine 0 N--CA 1.473 1.116 0 O-C-N 123.705 0.628 . . . . 73.52 112.951 177.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.413 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 80.5 mtt180 -83.12 135.87 34.66 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.074 -0.714 . . . . 75.43 109.074 174.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.2 mppt? -102.11 131.78 48.4 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.192 -0.67 . . . . 75.25 109.192 176.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 29.0 mt -77.46 97.78 5.09 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.88 -1.155 . . . . 74.01 107.88 174.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -74.17 103.91 4.77 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.151 0.581 . . . . 74.55 110.18 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.896 HD23 ' HA ' ' A' ' 173' ' ' ILE . 7.4 mt -102.23 91.09 4.14 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.054 -1.091 . . . . 72.34 108.054 -177.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.606 ' HE2' ' HA2' ' A' ' 185' ' ' GLY . 26.0 mtpp -66.6 129.44 39.85 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.843 -0.617 . . . . 73.24 112.221 -172.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 95.5 -16.66 60.81 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 115.639 -0.709 . . . . 70.41 113.113 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.547 ' HA ' ' HE2' ' A' ' 238' ' ' LYS . 11.3 mmpt? -81.57 -12.63 58.71 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.324 0.649 . . . . 73.55 112.06 -176.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -79.5 -172.68 43.58 Favored Glycine 0 CA--C 1.535 1.339 0 N-CA-C 112.106 -0.398 . . . . 72.13 112.106 168.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -86.31 153.06 56.19 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 123.005 0.522 . . . . 75.03 111.451 -174.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 48.0 Cg_endo -66.17 154.89 72.35 Favored 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 123.019 2.479 . . . . 73.21 112.708 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -177.89 -155.75 14.86 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-O 119.061 -0.855 . . . . 60.12 112.904 -178.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -48.98 -53.97 6.17 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 124.551 3.501 . . . . 74.33 114.992 -175.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -83.82 -3.11 57.6 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.398 0.679 . . . . 64.23 112.324 -173.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 127.61 -93.88 0.39 Allowed Glycine 0 C--N 1.343 0.947 0 N-CA-C 111.043 -0.823 . . . . 72.02 111.043 -178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 77.9 mtt180 -127.44 159.29 34.94 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.926 0.89 . . . . 75.24 110.079 172.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -84.35 173.0 49.58 Favored Glycine 0 C--N 1.349 1.257 0 N-CA-C 114.014 0.366 . . . . 71.42 114.014 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -106.83 134.11 50.47 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.62 1.168 . . . . 75.4 109.007 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 32.7 tp -98.91 106.69 18.98 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.892 -0.781 . . . . 71.45 108.892 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.462 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 72.6 m-85 -88.76 107.52 19.0 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.361 0.664 . . . . 74.33 109.68 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 43.3 mt -88.08 108.47 19.26 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 108.787 -0.82 . . . . 75.51 108.787 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.409 ' HA ' ' HG3' ' A' ' 232' ' ' LYS . 34.8 mt-10 -76.79 99.89 5.29 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.263 -0.88 . . . . 75.22 109.813 -171.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.489 HG11 HG12 ' A' ' 199' ' ' VAL . 95.0 t -61.69 106.48 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 123.228 0.611 . . . . 71.21 111.071 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -109.38 95.09 5.39 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.198 0.999 . . . . 73.23 108.521 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 21.8 mt -76.18 113.9 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 123.264 0.625 . . . . 74.41 109.453 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 23.8 p . . . . . 0 C--O 1.249 1.044 0 C-N-CA 124.664 1.186 . . . . 72.41 110.256 -178.748 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' MET . . . . . 0.407 ' SD ' ' HA ' ' A' ' 219' ' ' VAL . 92.9 mtp . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.404 0.145 . . . . 72.41 110.789 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.5 m -62.14 105.29 0.57 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.748 1.219 . . . . 75.44 112.524 -173.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 56.68 20.61 5.17 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.29 1.436 . . . . 74.11 113.559 171.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 86.6 mt -85.32 76.52 10.12 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-O 122.109 0.957 . . . . 75.11 108.479 174.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 33.5 mtm105 -119.98 155.17 33.37 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 113.895 -1.502 . . . . 73.42 108.047 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.689 ' HB ' ' HD3' ' A' ' 224' ' ' PRO . 77.1 mt -87.32 -74.78 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 109.845 -0.428 . . . . 74.21 109.845 177.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . 55.93 19.36 3.55 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.124 0.97 . . . . 55.03 113.019 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.643 ' H ' HG23 ' A' ' 173' ' ' ILE . . . -87.04 12.19 11.94 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.837 0.855 . . . . 54.43 111.462 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.643 ' HB3' HH21 ' A' ' 226' ' ' ARG . 34.7 m-85 -92.76 65.94 4.29 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.909 -0.774 . . . . 74.32 108.909 166.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 145.74 162.35 9.65 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-N 114.485 -1.234 . . . . 61.43 111.233 -174.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -71.79 142.71 39.93 Favored 'Trans proline' 0 C--N 1.364 1.367 0 C-N-CA 122.905 2.403 . . . . 75.34 112.825 -173.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -79.65 -38.23 34.19 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.518 -0.549 . . . . 74.11 109.518 173.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 131.25 73.43 0.11 Allowed Glycine 0 C--N 1.344 0.983 0 CA-C-N 115.339 -0.846 . . . . 74.22 111.134 -175.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 56.9 p -61.32 92.3 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.328 1.051 . . . . 74.44 111.399 -176.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -161.75 -71.91 0.02 OUTLIER Glycine 0 C--N 1.34 0.801 0 N-CA-C 110.807 -0.917 . . . . 72.02 110.807 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -89.83 150.54 21.14 Favored Glycine 0 C--N 1.345 1.039 0 N-CA-C 111.002 -0.839 . . . . 75.2 111.002 174.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.417 ' HB2' ' HB2' ' A' ' 244' ' ' ALA . 90.7 p 49.81 89.28 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.276 1.43 . . . . 71.42 111.922 -175.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -95.23 -132.32 6.85 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 112.116 -0.394 . . . . 65.32 112.116 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -150.57 34.53 0.97 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 112.048 -0.421 . . . . 70.03 112.048 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 22.5 p -79.43 107.51 12.26 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 108.893 -0.781 . . . . 72.02 108.893 175.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.39 17.83 70.36 Favored Glycine 0 N--CA 1.473 1.13 0 N-CA-C 111.504 -0.638 . . . . 75.32 111.504 -166.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.402 ' HA2' HE22 ' A' ' 191' ' ' GLN . . . -91.76 67.39 2.15 Favored Glycine 0 C--N 1.348 1.198 0 N-CA-C 111.847 -0.501 . . . . 74.01 111.847 -177.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 16.3 m -110.95 16.18 21.36 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.574 0.75 . . . . 72.05 110.86 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.565 ' HB2' ' HB2' ' A' ' 240' ' ' PHE . 0.0 OUTLIER -112.7 13.55 19.87 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.585 1.154 . . . . 75.22 110.407 -172.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -75.48 143.08 42.77 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.349 1.06 . . . . 73.22 110.397 177.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 82.5 mt -121.13 146.96 46.21 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.721 0.409 . . . . 72.41 110.678 -171.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.48 ' HE2' ' HZ1' ' A' ' 232' ' ' LYS . 24.2 m-85 -93.76 149.71 21.01 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 109.438 -0.578 . . . . 71.05 109.438 171.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.447 ' HB1' HD21 ' A' ' 251' ' ' LEU . . . -144.54 127.99 16.94 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.589 0.755 . . . . 72.34 109.003 -177.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 38.5 m -71.31 117.8 13.31 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 122.943 0.497 . . . . 73.42 109.946 -176.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 41.5 tp -108.0 109.91 21.49 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.604 -0.887 . . . . 74.33 108.604 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -92.3 112.53 24.51 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.44 0.696 . . . . 65.34 109.156 175.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.417 ' HA ' HG11 ' A' ' 210' ' ' VAL . 7.0 p -130.24 128.99 22.82 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 124.305 1.042 . . . . 71.44 108.956 -178.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.424 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 41.7 Cg_endo -70.26 155.11 65.02 Favored 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.004 1.803 . . . . 75.31 111.836 176.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -48.41 -46.49 68.95 Favored Pre-proline 0 CA--C 1.566 1.566 0 N-CA-C 114.79 1.404 . . . . 61.5 114.79 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.467 ' O ' HG11 ' A' ' 206' ' ' VAL . 25.7 Cg_endo -61.86 -52.69 2.7 Favored 'Trans proline' 0 C--N 1.393 2.921 0 CA-C-N 121.114 1.433 . . . . 64.53 112.888 176.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 50.7 mt -64.93 -24.61 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 123.574 0.749 . . . . 73.04 110.952 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 227' ' ' THR . . . -68.66 -55.1 12.58 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.578 0.751 . . . . 71.24 111.34 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 76.6 t -66.76 -51.5 55.25 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-N 115.858 -0.61 . . . . 75.42 112.121 -175.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.467 HG11 ' O ' ' A' ' 202' ' ' PRO . 11.5 p -87.69 -25.96 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 N-CA-C 111.913 0.338 . . . . 72.13 111.913 -174.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 92.29 153.4 29.92 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 111.641 -0.584 . . . . 74.12 111.641 -171.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 178.76 -128.89 1.31 Allowed Glycine 0 C--N 1.33 0.235 0 CA-C-O 119.551 -0.583 . . . . 72.21 111.944 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -139.56 141.39 37.22 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.059 0.944 . . . . 73.42 110.144 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.417 HG11 ' HA ' ' A' ' 199' ' ' VAL . 30.8 m -135.14 167.57 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.963 0.905 . . . . 71.23 109.425 169.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -93.47 111.42 23.08 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.102 -0.703 . . . . 75.03 109.102 173.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.48 145.25 29.85 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.844 0.458 . . . . 64.32 110.065 175.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 87.4 mtp -88.02 104.47 16.68 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.653 -0.869 . . . . 72.24 108.653 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 27.7 m -111.78 177.35 4.68 Favored 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 124.824 1.25 . . . . 72.35 108.315 -178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 82.6 mt -63.57 -19.32 64.72 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.461 0.704 . . . . 74.23 112.845 -177.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -87.48 6.48 33.88 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.375 0.67 . . . . 74.13 111.555 175.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 93.65 -153.32 21.21 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 119.406 -0.663 . . . . 71.23 111.641 -173.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -75.63 126.46 9.58 Favored 'Trans proline' 0 C--N 1.367 1.527 0 C-N-CA 122.339 2.026 . . . . 74.03 111.079 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.407 ' HA ' ' SD ' ' A' ' 168' ' ' MET . 35.1 m -131.94 153.16 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 123.124 0.57 . . . . 72.11 111.217 -171.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -84.92 110.58 18.97 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.198 -0.667 . . . . 71.53 109.198 175.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 95.4 t -109.2 123.0 64.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 123.854 0.862 . . . . 73.43 110.18 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -77.37 101.24 6.26 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.512 0.725 . . . . 73.12 109.943 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.542 ' HA ' HD13 ' A' ' 173' ' ' ILE . 57.3 t -73.67 130.95 82.75 Favored Pre-proline 0 CA--C 1.561 1.38 0 C-N-CA 125.12 1.368 . . . . 64.21 110.142 177.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.689 ' HD3' ' HB ' ' A' ' 173' ' ' ILE . 63.8 Cg_endo -85.09 171.25 9.26 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 123.205 2.603 . . . . 74.04 111.032 174.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.04 166.35 21.09 Favored 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 121.689 1.593 . . . . 73.22 112.639 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.643 HH21 ' HB3' ' A' ' 176' ' ' TYR . 29.3 mtm180 71.72 11.59 6.35 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 125.636 1.574 . . . . 72.24 112.634 177.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.461 ' O ' ' HB2' ' A' ' 204' ' ' ALA . 94.1 m -65.54 91.62 0.13 Allowed 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 121.776 0.798 . . . . 73.23 110.16 -178.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.496 ' HA ' HD11 ' A' ' 255' ' ' ILE . 32.8 tt0 -107.75 144.3 35.08 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 114.771 -1.104 . . . . 74.24 110.396 -168.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -55.02 129.98 39.97 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.004 1.321 . . . . 74.43 111.986 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 88.93 -9.06 78.15 Favored Glycine 0 N--CA 1.475 1.251 0 CA-C-N 115.997 -0.547 . . . . 62.11 114.032 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -81.98 150.89 27.42 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.437 -0.579 . . . . 73.21 109.437 171.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.51 ' HG3' ' HA ' ' A' ' 252' ' ' GLU . 0.0 OUTLIER -129.85 141.81 50.77 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.796 0.808 . . . . 73.13 110.995 -176.047 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.624 HD11 HG21 ' A' ' 173' ' ' ILE . 14.9 mt -114.77 99.64 7.65 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 114.101 -1.409 . . . . 71.31 109.516 -162.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.518 ' HG3' ' HB3' ' A' ' 248' ' ' ASP . 52.1 ttp180 -76.78 102.54 6.31 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 123.516 0.51 . . . . 71.1 110.405 -175.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.496 HD22 HG22 ' A' ' 173' ' ' ILE . 21.9 mt -99.12 95.35 7.05 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.153 0.981 . . . . 74.44 108.443 176.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -66.64 148.06 52.42 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.64 0.776 . . . . 65.21 111.765 -176.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 72.67 30.93 63.29 Favored Glycine 0 CA--C 1.529 0.932 0 O-C-N 123.706 0.629 . . . . 75.43 113.513 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -130.12 -17.47 3.45 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 113.346 0.869 . . . . 74.43 113.346 -176.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -77.55 -152.82 5.54 Favored Glycine 0 N--CA 1.484 1.842 0 CA-C-N 118.028 0.376 . . . . 72.12 113.505 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.565 ' HB2' ' HB2' ' A' ' 191' ' ' GLN . 15.0 m-85 -69.12 155.34 93.76 Favored Pre-proline 0 N--CA 1.488 1.436 0 CA-C-O 118.595 -0.717 . . . . 73.31 110.152 172.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -50.49 129.41 26.35 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 123.024 2.482 . . . . 62.0 113.02 175.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -146.26 -163.84 10.59 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 119.389 -0.673 . . . . 73.24 112.961 -174.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -64.98 -31.18 56.34 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 123.521 2.814 . . . . 71.53 112.293 -177.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.417 ' HB2' ' HB2' ' A' ' 184' ' ' SER . . . -91.88 23.97 3.42 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.717 1.207 . . . . 74.35 110.793 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 89.58 -62.85 3.36 Favored Glycine 0 C--N 1.352 1.466 0 N-CA-C 110.413 -1.075 . . . . 64.25 110.413 -171.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -126.36 175.69 7.67 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 125.148 1.379 . . . . 73.25 109.512 169.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -89.25 -160.16 36.17 Favored Glycine 0 C--N 1.339 0.719 0 CA-C-N 115.291 -0.868 . . . . 72.54 111.89 172.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.518 ' HB3' ' HG3' ' A' ' 234' ' ' ARG . 3.4 m-20 -98.21 169.95 9.23 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.175 0.59 . . . . 74.35 109.61 -176.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 33.7 tp -139.67 106.19 5.33 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.62 -0.882 . . . . 75.12 108.62 174.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -88.7 113.38 24.2 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.197 0.599 . . . . 73.13 109.401 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.447 HD21 ' HB1' ' A' ' 195' ' ' ALA . 57.0 mt -85.14 112.74 20.96 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.364 -0.976 . . . . 73.05 108.364 175.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.51 ' HA ' ' HG3' ' A' ' 232' ' ' LYS . 13.8 tp10 -76.83 101.0 5.7 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.749 1.219 . . . . 71.23 108.088 -179.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.69 106.94 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.518 0.675 . . . . 73.23 110.476 -176.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -107.02 96.5 6.47 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 114.425 -1.261 . . . . 73.45 107.7 174.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.496 HD11 ' HA ' ' A' ' 228' ' ' GLN . 24.2 mt -76.13 123.54 32.52 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 N-CA-C 108.83 -0.804 . . . . 74.52 108.83 176.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 41.5 p . . . . . 0 CA--C 1.549 0.934 0 C-N-CA 124.785 1.234 . . . . 73.11 108.755 177.358 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 23.2 ptp . . . . . 0 N--CA 1.477 0.91 0 CA-C-O 120.935 0.398 . . . . 73.41 110.038 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 65.9 m -76.7 84.93 3.33 Favored 'General case' 0 C--N 1.35 0.601 0 CA-C-O 121.398 0.618 . . . . 65.34 109.965 176.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -109.57 86.5 2.3 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.952 0.901 . . . . 72.23 108.588 -177.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 5.4 mp -75.6 84.26 2.64 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.476 -0.784 . . . . 64.15 109.352 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -72.75 114.07 10.48 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 114.93 -1.032 . . . . 74.15 109.721 177.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.598 HG22 ' H ' ' A' ' 175' ' ' ALA . 73.3 mt -77.41 -83.91 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 109.509 -0.552 . . . . 72.03 109.509 176.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.464 ' HA ' ' HB3' ' A' ' 224' ' ' PRO . . . 48.31 26.63 1.14 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.429 1.092 . . . . 74.41 112.794 -176.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.598 ' H ' HG22 ' A' ' 173' ' ' ILE . . . -66.12 -17.36 64.66 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.325 1.05 . . . . 75.34 112.498 -167.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.18 92.72 0.78 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.02 -1.104 . . . . 74.23 108.02 169.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 150.6 -172.52 30.33 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-N 114.75 -1.113 . . . . 74.11 111.316 -174.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -87.48 39.91 0.6 Allowed 'Trans proline' 0 CA--C 1.552 1.377 0 C-N-CA 123.491 2.794 . . . . 74.51 112.64 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 30.2 m-70 -76.46 137.53 39.74 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.563 0.745 . . . . 73.25 111.324 -171.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 87.83 -75.95 2.03 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 115.232 -0.895 . . . . 70.02 111.665 -174.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 67.0 m -147.17 150.73 35.51 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.368 0.667 . . . . 61.25 110.517 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -114.86 42.61 1.88 Allowed Glycine 0 C--N 1.343 0.942 0 N-CA-C 110.918 -0.873 . . . . 74.4 110.918 175.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -90.3 141.77 16.07 Favored Glycine 0 C--N 1.346 1.103 0 N-CA-C 112.037 -0.425 . . . . 73.44 112.037 -177.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 41.8 m -76.98 107.57 9.42 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.412 0.685 . . . . 73.4 109.997 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 110.4 -145.66 17.25 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 115.845 -0.616 . . . . 63.22 111.696 -176.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -151.03 125.67 1.95 Allowed Glycine 0 C--N 1.346 1.114 0 N-CA-C 112.47 -0.252 . . . . 72.42 112.47 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 26.6 t -98.24 -178.31 4.0 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.516 0.726 . . . . 63.32 109.842 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 78.01 -91.51 1.11 Allowed Glycine 0 C--N 1.347 1.145 0 N-CA-C 111.011 -0.836 . . . . 73.15 111.011 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 77.73 127.9 0.4 Allowed Glycine 0 C--N 1.356 1.692 0 CA-C-O 119.54 -0.589 . . . . 54.44 112.621 177.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 40.5 m 75.2 -37.81 0.35 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 125.806 1.642 . . . . 72.34 111.253 -174.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.62 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 72.8 mt-30 -57.23 -22.73 43.11 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.686 1.195 . . . . 72.15 111.849 167.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -73.98 143.1 45.77 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.579 1.152 . . . . 64.13 110.683 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 95.2 mt -139.16 149.78 44.85 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.255 1.022 . . . . 62.01 109.942 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -111.54 128.47 56.04 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.305 1.042 . . . . 74.24 108.245 168.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -125.29 128.41 48.19 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.901 -0.777 . . . . 71.13 108.901 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 73.6 m -67.49 131.93 46.62 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.355 0.662 . . . . 73.42 110.373 178.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 20.6 tp -121.36 112.52 18.67 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.888 0.875 . . . . 72.14 108.969 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -92.47 120.47 32.98 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 108.752 -0.833 . . . . 61.25 108.752 172.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 3.0 p -131.64 128.05 21.65 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.143 0.977 . . . . 75.02 108.432 -178.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -71.39 153.03 61.22 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 121.6 1.533 . . . . 75.52 111.395 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -47.1 -48.73 53.46 Favored Pre-proline 0 CA--C 1.565 1.545 0 O-C-N 124.495 1.122 . . . . 73.41 113.064 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.32 -55.42 3.65 Favored 'Trans proline' 0 C--N 1.407 3.611 0 C-N-CA 122.458 2.106 . . . . 74.13 113.291 175.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 57.4 mt -67.76 -27.01 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 123.558 0.743 . . . . 75.12 111.1 -175.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.17 -45.48 73.38 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.588 0.755 . . . . 74.33 110.857 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 81.0 t -71.63 -55.92 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 115.77 -0.65 . . . . 72.22 110.685 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 11.2 m -73.52 -28.58 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 O-C-N 123.816 0.698 . . . . 74.51 112.191 -172.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 77.77 84.01 0.54 Allowed Glycine 0 C--N 1.344 0.994 0 CA-C-N 116.013 -0.54 . . . . 73.23 112.371 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -115.28 -126.0 4.04 Favored Glycine 0 C--N 1.342 0.886 0 N-CA-C 112.14 -0.384 . . . . 61.53 112.14 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -137.56 147.96 45.54 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.654 1.182 . . . . 75.01 108.36 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 28.4 m -133.35 168.71 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 121.305 0.574 . . . . 74.11 110.703 173.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -77.37 135.47 38.35 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.967 -1.015 . . . . 74.31 108.87 169.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -138.17 158.26 44.65 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.756 0.423 . . . . 64.3 110.509 176.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 67.0 mtm -81.02 119.06 23.04 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.045 -0.979 . . . . 72.25 110.242 -176.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 89.4 m -135.42 151.68 50.67 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.186 0.994 . . . . 75.44 109.63 176.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 62.6 mt -57.41 -25.56 59.77 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.564 1.146 . . . . 75.45 112.808 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -86.43 -18.86 30.65 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.155 0.982 . . . . 72.24 111.585 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 135.07 -177.72 19.11 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.543 -0.623 . . . . 74.43 111.543 -175.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.66 120.83 7.17 Favored 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 122.404 2.069 . . . . 73.22 111.431 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.6 m -113.14 161.67 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 123.064 0.546 . . . . 73.3 111.484 -173.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -91.59 111.99 23.73 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.799 0.839 . . . . 64.4 109.482 174.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 54.4 t -109.88 126.22 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.023 0.929 . . . . 75.21 109.421 -176.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -77.36 100.94 6.11 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.353 0.661 . . . . 72.15 111.188 -173.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.535 ' HA ' HD13 ' A' ' 173' ' ' ILE . 59.9 t -77.29 134.81 66.48 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 124.93 1.292 . . . . 75.04 109.827 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.559 ' HD3' ' HB ' ' A' ' 173' ' ' ILE . 87.6 Cg_endo -75.03 170.3 20.71 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.523 2.149 . . . . 74.33 111.349 176.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.68 165.73 31.91 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 121.228 1.285 . . . . 73.33 111.259 169.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 63.39 22.97 13.52 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.781 0.832 . . . . 72.14 112.299 175.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 93.9 m -68.83 105.7 2.43 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.816 0.846 . . . . 62.11 109.634 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.403 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 24.7 tt0 -105.51 141.45 36.97 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.259 1.024 . . . . 74.44 110.223 -171.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.74 136.89 58.2 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.474 1.11 . . . . 74.2 111.371 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 92.22 -9.22 76.7 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.499 -0.773 . . . . 75.42 113.435 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.403 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 97.8 mtt180 -84.86 144.22 28.55 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.995 0.518 . . . . 74.41 109.7 173.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.662 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.2 mppt? -110.66 129.47 55.81 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.508 0.723 . . . . 74.15 109.196 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.588 HD11 HG23 ' A' ' 173' ' ' ILE . 53.9 mt -95.03 101.35 13.1 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.831 0.852 . . . . 74.55 109.751 -173.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -72.35 105.29 4.03 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.333 0.653 . . . . 73.43 110.676 -176.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.445 HD23 HG21 ' A' ' 173' ' ' ILE . 17.8 mt -105.12 98.15 7.9 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.826 -1.176 . . . . 75.43 107.826 174.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -75.78 148.43 38.48 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 122.544 0.338 . . . . 74.12 111.349 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 72.03 33.68 62.29 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-N 115.757 -0.656 . . . . 75.32 113.272 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.13 -37.3 3.4 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.606 0.762 . . . . 73.22 111.338 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -68.72 -154.09 0.63 Allowed Glycine 0 C--N 1.355 1.631 0 N-CA-C 114.455 0.542 . . . . 74.31 114.455 -177.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.62 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 81.5 m-85 -66.66 144.71 98.74 Favored Pre-proline 0 N--CA 1.481 1.117 0 C-N-CA 122.81 0.444 . . . . 75.53 111.003 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.48 164.04 34.35 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.678 2.252 . . . . 72.11 113.317 178.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 172.75 -161.13 32.4 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 115.356 -0.838 . . . . 64.05 112.509 175.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -71.76 -10.54 26.61 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 123.125 2.55 . . . . 74.43 113.759 -177.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -99.72 19.33 16.12 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.638 0.775 . . . . 72.13 110.735 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 85.32 -100.8 2.47 Favored Glycine 0 C--N 1.347 1.168 0 N-CA-C 109.916 -1.274 . . . . 65.52 109.916 -171.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -127.42 159.85 33.24 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.623 -0.88 . . . . 73.15 108.623 165.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.8 -170.11 16.19 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-N 115.534 -0.757 . . . . 74.15 113.738 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -98.34 165.82 11.67 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.448 0.699 . . . . 75.23 109.291 -172.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 41.1 tp -141.58 105.24 4.7 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.515 -0.92 . . . . 75.32 108.515 175.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.662 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 33.0 m-85 -91.07 111.32 22.74 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.357 0.663 . . . . 74.42 109.899 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.552 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 48.5 mt -86.02 109.18 18.62 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.885 -0.783 . . . . 74.21 108.885 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -77.81 100.01 6.14 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.05 -0.977 . . . . 61.54 109.642 -173.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 48.6 t -57.84 111.45 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 O-C-N 123.963 0.789 . . . . 75.2 111.404 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 21.2 mmm-85 -115.48 98.93 7.01 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 106.818 -1.549 . . . . 73.43 106.818 171.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 36.5 mt -75.82 119.53 23.94 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 N-CA-C 109.45 -0.574 . . . . 75.22 109.45 -176.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 7.5 p . . . . . 0 C--O 1.261 1.689 0 C-N-CA 124.647 1.179 . . . . 73.5 108.867 -174.294 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 N--CA 1.483 1.21 0 N-CA-C 109.815 -0.439 . . . . 73.54 109.815 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 49.7 m -76.83 82.99 3.41 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.474 0.654 . . . . 75.14 109.778 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -144.84 118.57 9.23 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.104 -0.953 . . . . 74.3 108.542 -178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 91.1 mt -80.33 71.18 7.12 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.488 0.661 . . . . 75.45 109.505 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.579 ' HA ' ' HB1' ' A' ' 222' ' ' ALA . 79.9 ttt180 -79.32 102.34 8.57 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.433 -0.803 . . . . 72.55 109.164 -178.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.506 HD13 ' HA ' ' A' ' 223' ' ' VAL . 68.3 mt -59.06 -64.68 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.343 0.657 . . . . 75.14 109.872 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . 54.43 24.14 5.01 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.703 1.201 . . . . 71.42 113.397 175.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -80.09 -3.29 48.07 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.555 0.742 . . . . 74.11 111.885 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.498 ' CE2' HD23 ' A' ' 233' ' ' LEU . 37.7 m-85 -87.14 4.89 40.46 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.246 0.618 . . . . 73.21 110.843 167.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -137.21 176.72 20.33 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 110.92 -0.872 . . . . 51.34 110.92 171.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.88 83.9 0.53 Allowed 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.657 2.238 . . . . 73.1 111.538 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -145.71 146.11 31.13 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.633 -0.712 . . . . 75.12 110.268 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 156.46 -85.43 0.13 Allowed Glycine 0 C--N 1.343 0.954 0 N-CA-C 109.05 -1.62 . . . . 72.33 109.05 -176.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 48.7 p -170.24 -49.45 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.998 0.919 . . . . 72.32 108.906 176.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 160.8 -155.85 27.09 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.028 -0.987 . . . . 74.1 111.136 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -87.06 -10.54 71.56 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-O 120.003 -0.332 . . . . 42.22 112.595 175.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 51.8 m -68.49 101.35 1.24 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.51 0.724 . . . . 73.44 110.847 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 160.5 -157.51 28.92 Favored Glycine 0 C--O 1.241 0.577 0 CA-C-N 114.853 -1.067 . . . . 70.14 111.19 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -160.82 87.37 0.11 Allowed Glycine 0 C--O 1.239 0.435 0 N-CA-C 109.827 -1.309 . . . . 65.24 109.827 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 53.7 m -63.52 92.75 0.07 Allowed 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.514 0.726 . . . . 73.23 111.213 -178.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 149.74 -167.2 29.85 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 115.393 -0.822 . . . . 55.12 111.85 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 91.91 -90.51 1.51 Allowed Glycine 0 C--N 1.339 0.713 0 N-CA-C 111.723 -0.551 . . . . 73.42 111.723 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 26.5 p -170.47 -22.11 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.556 0.742 . . . . 74.21 111.951 -172.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -72.93 -28.34 62.38 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.635 0.774 . . . . 74.42 110.844 -176.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -77.27 149.02 35.43 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.522 -0.763 . . . . 71.35 109.899 175.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 95.6 mt -134.94 156.5 48.89 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.29 0.636 . . . . 74.05 110.55 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -108.86 124.51 50.75 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.663 -0.866 . . . . 75.03 108.663 169.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -124.07 130.09 51.97 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.117 0.967 . . . . 62.52 108.829 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 14.7 m -68.92 121.25 16.22 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.365 0.666 . . . . 75.3 110.102 -177.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 35.0 tp -106.35 110.47 22.71 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.629 -1.248 . . . . 72.2 107.629 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -89.2 116.65 27.6 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.485 -0.931 . . . . 74.43 108.485 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.7 p -137.69 132.82 17.58 Favored Pre-proline 0 CA--C 1.546 0.794 0 N-CA-C 108.972 -0.751 . . . . 73.31 108.972 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.422 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 44.8 Cg_endo -75.13 156.47 42.42 Favored 'Trans proline' 0 C--N 1.366 1.472 0 C-N-CA 121.924 1.75 . . . . 71.23 111.27 170.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -52.6 -45.27 96.23 Favored Pre-proline 0 CA--C 1.554 1.118 0 N-CA-C 114.347 1.24 . . . . 71.4 114.347 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 24.6 Cg_endo -59.14 -50.79 7.88 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 121.658 1.572 . . . . 74.02 112.956 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 49.6 mt -65.94 -25.02 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.676 0.79 . . . . 74.32 111.077 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.95 -46.44 62.41 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 122.848 0.459 . . . . 73.22 111.275 177.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 87.7 t -64.46 -52.7 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 122.991 0.516 . . . . 75.43 111.442 -177.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 11.8 p -84.17 -34.32 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 112.04 0.385 . . . . 73.2 112.04 -174.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 84.49 89.3 0.82 Allowed Glycine 0 C--N 1.335 0.483 0 CA-C-N 116.561 -0.291 . . . . 71.24 112.507 -171.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -106.39 -135.13 7.93 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 111.05 -0.82 . . . . 74.51 111.05 172.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -128.97 144.26 51.13 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 108.783 -0.821 . . . . 63.1 108.783 174.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.445 HG11 ' HA ' ' A' ' 199' ' ' VAL . 33.7 m -134.11 162.07 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.116 0.566 . . . . 65.32 110.333 176.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 69.0 ttt-85 -74.44 135.53 42.33 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.112 0.565 . . . . 73.23 109.979 172.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -140.7 151.26 44.39 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.702 0.801 . . . . 73.21 109.565 177.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -80.63 122.34 26.96 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.962 -0.755 . . . . 74.22 108.962 176.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 95.9 m -131.84 164.35 26.26 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 107.909 -1.145 . . . . 74.23 107.909 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 73.0 mt -63.86 -11.31 26.44 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.296 0.639 . . . . 64.14 112.069 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -103.43 17.74 23.41 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.817 1.247 . . . . 75.44 110.886 176.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 87.12 -161.99 33.38 Favored Glycine 0 C--N 1.349 1.281 0 CA-C-O 119.463 -0.632 . . . . 72.2 113.182 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -74.04 121.94 7.28 Favored 'Trans proline' 0 C--N 1.372 1.805 0 C-N-CA 122.505 2.137 . . . . 73.32 111.715 177.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.91 158.92 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.882 0.873 . . . . 74.41 110.402 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -90.42 108.93 20.09 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.873 0.469 . . . . 64.34 109.814 173.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 25.1 t -97.49 129.69 47.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 108.819 -0.808 . . . . 74.52 108.819 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.579 ' HB1' ' HA ' ' A' ' 172' ' ' ARG . . . -73.02 100.44 2.99 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.267 0.627 . . . . 71.1 110.586 -178.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.506 ' HA ' HD13 ' A' ' 173' ' ' ILE . 50.9 t -64.27 139.43 97.7 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 125.254 1.421 . . . . 73.25 109.94 178.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.446 ' HD3' HD13 ' A' ' 173' ' ' ILE . 6.3 Cg_exo -73.37 168.64 24.24 Favored 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 122.684 2.256 . . . . 71.22 111.548 173.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -73.82 172.92 14.87 Favored 'Trans proline' 0 CA--C 1.55 1.319 0 C-N-CA 121.453 1.435 . . . . 75.45 110.716 164.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 44.8 mtt180 66.12 6.34 4.09 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 124.684 1.194 . . . . 73.34 112.722 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.435 ' HA ' ' CZ ' ' A' ' 176' ' ' TYR . 94.4 m -59.91 110.54 1.2 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.375 0.67 . . . . 74.54 110.823 -170.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.481 ' HB3' ' HD3' ' A' ' 231' ' ' ARG . 60.1 tt0 -117.47 134.44 54.85 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.974 1.31 . . . . 74.55 110.328 -164.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.6 128.23 35.6 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.369 1.068 . . . . 71.43 112.444 -173.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.41 -9.85 62.93 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-N 115.915 -0.584 . . . . 54.3 113.119 177.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.481 ' HD3' ' HB3' ' A' ' 228' ' ' GLN . 76.2 mtp180 -89.41 158.55 17.7 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.079 0.552 . . . . 71.33 110.728 176.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.424 ' HG3' ' HA ' ' A' ' 252' ' ' GLU . 0.0 OUTLIER -131.34 144.11 51.0 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.088 0.555 . . . . 75.11 110.734 -174.036 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.498 HD23 ' CE2' ' A' ' 176' ' ' TYR . 44.6 mt -117.46 102.27 9.07 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.723 -0.672 . . . . 72.12 110.726 -164.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.4 ' HG3' ' HB3' ' A' ' 248' ' ' ASP . 51.1 ttp180 -79.78 113.92 18.3 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.833 0.853 . . . . 75.22 110.935 -173.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.502 HD22 HG21 ' A' ' 173' ' ' ILE . 43.0 mt -112.38 96.95 6.3 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.574 0.75 . . . . 74.55 109.304 177.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -62.86 140.84 58.83 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.859 -0.61 . . . . 75.1 111.379 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 81.17 25.36 55.37 Favored Glycine 0 C--N 1.339 0.741 0 O-C-N 124.259 0.975 . . . . 74.14 114.508 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.78 -28.25 6.02 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.152 0.581 . . . . 72.53 111.306 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -74.63 -169.66 23.2 Favored Glycine 0 CA--C 1.535 1.339 0 O-C-N 123.399 0.437 . . . . 61.03 112.848 173.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -65.43 143.33 98.68 Favored Pre-proline 0 N--CA 1.486 1.339 0 C-N-CA 123.693 0.797 . . . . 73.51 111.495 -175.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.5 128.74 30.59 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.735 2.29 . . . . 74.33 112.076 175.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.59 -179.06 16.02 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-O 119.739 -0.479 . . . . 75.43 112.748 -176.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.17 -44.86 42.58 Favored 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 123.78 2.987 . . . . 71.42 113.289 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -94.0 20.15 8.2 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.106 0.563 . . . . 64.41 111.608 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 102.66 -176.74 25.3 Favored Glycine 0 C--N 1.348 1.246 0 C-N-CA 123.451 0.548 . . . . 75.11 111.948 -176.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 57.6 mtt85 -63.35 148.89 47.14 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.048 0.539 . . . . 75.35 110.478 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -71.79 -173.11 17.9 Favored Glycine 0 C--N 1.344 1.021 0 O-C-N 123.545 0.528 . . . . 75.12 113.565 -176.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.4 ' HB3' ' HG3' ' A' ' 234' ' ' ARG . 3.3 m-20 -98.67 157.88 15.98 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.805 -0.813 . . . . 73.15 108.805 -176.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 32.9 tp -125.9 106.49 9.69 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.102 -1.073 . . . . 74.55 108.102 172.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -89.68 107.47 19.11 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.857 -0.794 . . . . 74.44 108.857 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 62.3 mt -87.77 106.71 18.25 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.453 -0.944 . . . . 75.04 108.453 176.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.424 ' HA ' ' HG3' ' A' ' 232' ' ' LYS . 22.7 mt-10 -79.07 105.9 10.73 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 114.894 -1.048 . . . . 74.13 110.153 -173.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 83.4 t -60.15 107.45 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.693 0 O-C-N 124.169 0.918 . . . . 75.3 111.48 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -115.27 93.92 4.5 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 107.91 -1.144 . . . . 74.23 107.91 173.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 54.5 mt -76.65 132.5 32.83 Favored 'Isoleucine or valine' 0 C--N 1.351 0.671 0 CA-C-N 115.464 -0.789 . . . . 72.32 109.93 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 32.4 p . . . . . 0 C--O 1.253 1.237 0 C-N-CA 124.671 1.188 . . . . 74.54 108.694 -179.165 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 54.0 ttm . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 109.255 -0.646 . . . . 72.23 109.255 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.5 m -70.11 110.42 5.13 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 115.344 -0.843 . . . . 73.04 110.325 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -79.24 -65.06 1.05 Allowed 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 109.451 -0.574 . . . . 71.0 109.451 172.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.6 mt -106.88 97.68 7.44 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.259 -0.645 . . . . 75.22 109.259 173.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -77.7 122.08 24.88 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 108.144 -1.058 . . . . 73.11 108.144 173.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.648 HG21 ' H ' ' A' ' 175' ' ' ALA . 63.8 mt -72.46 -75.49 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 109.793 -0.447 . . . . 64.32 109.793 177.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . 59.56 11.23 2.24 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 124.596 1.159 . . . . 75.13 113.659 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.648 ' H ' HG21 ' A' ' 173' ' ' ILE . . . -75.57 -14.1 60.38 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.79 0.836 . . . . 73.14 111.166 177.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.441 ' CZ ' ' HA ' ' A' ' 227' ' ' THR . 6.2 m-85 -66.1 -17.73 64.89 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.787 0.835 . . . . 75.13 111.323 169.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -131.17 179.76 16.76 Favored Glycine 0 C--N 1.346 1.098 0 N-CA-C 111.411 -0.675 . . . . 74.51 111.411 174.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -72.53 81.8 1.5 Allowed 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 122.397 2.065 . . . . 73.4 112.358 177.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -76.25 99.0 4.61 Favored 'General case' 0 C--N 1.351 0.672 0 CA-C-N 115.743 -0.662 . . . . 74.32 109.698 175.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 163.65 -164.28 36.22 Favored Glycine 0 C--O 1.243 0.659 0 CA-C-N 115.189 -0.914 . . . . 74.15 111.646 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 22.7 t -174.24 -178.93 1.52 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.226 1.01 . . . . 72.22 109.136 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 93.83 -72.9 1.2 Allowed Glycine 0 C--N 1.347 1.155 0 N-CA-C 111.43 -0.668 . . . . 52.32 111.43 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -178.53 -67.0 0.06 OUTLIER Glycine 0 C--N 1.343 0.936 0 N-CA-C 111.226 -0.75 . . . . 73.1 111.226 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 20.9 t -168.35 159.47 10.61 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.026 0.93 . . . . 64.22 109.754 176.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -116.99 -178.22 17.81 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 116.12 -0.491 . . . . 75.11 112.235 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -88.26 148.91 20.98 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-O 119.905 -0.386 . . . . 62.51 112.4 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 46.7 t -62.48 134.9 57.07 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.885 0.874 . . . . 72.31 111.157 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -170.21 98.68 0.14 Allowed Glycine 0 C--N 1.352 1.469 0 N-CA-C 111.994 -0.442 . . . . 52.51 111.994 -177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -138.34 92.66 0.2 Allowed Glycine 0 C--N 1.343 0.968 0 C-N-CA 123.146 0.403 . . . . 73.22 112.126 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 66.6 m -155.43 167.15 31.32 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.569 1.148 . . . . 63.54 109.532 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 60.96 26.02 15.98 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 124.365 1.066 . . . . 74.41 110.762 -174.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -83.77 159.15 21.5 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.541 -1.209 . . . . 75.3 112.631 -169.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.5 mt -143.68 138.01 28.62 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.097 0.959 . . . . 72.43 109.614 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -93.04 125.72 37.77 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.483 -1.303 . . . . 72.23 107.483 164.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -124.24 133.06 53.61 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.369 -0.604 . . . . 74.44 109.369 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' THR . . . . . 0.551 HG21 ' HG3' ' A' ' 254' ' ' ARG . 42.9 m -65.94 122.16 16.72 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 124.038 0.836 . . . . 72.24 109.77 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 40.3 tp -109.28 108.8 19.52 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.018 -1.475 . . . . 75.31 107.018 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -95.7 103.09 14.95 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 122.098 0.951 . . . . 62.14 109.225 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 2.8 p -120.12 117.41 32.05 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-N 114.569 -1.196 . . . . 74.43 109.02 -174.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.9 154.59 73.33 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 122.136 1.891 . . . . 72.24 111.579 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -48.04 -45.25 63.24 Favored Pre-proline 0 CA--C 1.565 1.554 0 N-CA-C 114.713 1.375 . . . . 73.52 114.713 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.427 ' O ' HG23 ' A' ' 206' ' ' VAL . 26.1 Cg_endo -59.72 -50.85 7.03 Favored 'Trans proline' 0 C--N 1.399 3.187 0 C-N-CA 121.425 1.416 . . . . 71.15 112.227 176.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.7 mt -70.0 -23.24 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 123.672 0.789 . . . . 72.31 111.263 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.59 -51.06 46.63 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 122.923 0.489 . . . . 65.4 110.166 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 84.5 t -67.0 -48.69 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 CA-C-N 115.606 -0.725 . . . . 73.03 111.866 -177.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 202' ' ' PRO . 33.9 m -89.9 -23.04 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 113.313 0.857 . . . . 74.53 113.313 -174.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.78 149.69 24.37 Favored Glycine 0 N--CA 1.477 1.385 0 N-CA-C 112.15 -0.38 . . . . 72.11 112.15 -173.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 163.97 175.61 35.02 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 116.927 0.363 . . . . 55.31 112.282 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 221' ' ' VAL . 50.2 mtmt -82.12 135.66 35.27 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.872 0.469 . . . . 72.35 110.226 -177.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 199' ' ' VAL . 33.9 m -138.94 170.03 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 123.84 0.856 . . . . 65.41 110.686 176.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -68.55 130.58 43.26 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.532 -0.758 . . . . 74.44 111.067 175.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -135.68 118.14 15.8 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.768 -0.827 . . . . 74.43 108.768 168.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 55.8 mtt -73.0 105.93 4.67 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.211 0.605 . . . . 64.41 109.874 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 25.6 m -110.03 171.46 7.44 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.88 1.272 . . . . 73.14 108.61 -175.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 85.8 mt -57.45 -35.33 70.0 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.576 0.75 . . . . 73.51 112.212 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -79.4 -11.02 59.92 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.803 0.841 . . . . 70.42 112.464 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 125.08 -179.33 16.2 Favored Glycine 0 N--CA 1.47 0.956 0 N-CA-C 111.121 -0.791 . . . . 61.43 111.121 -174.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.64 129.41 21.07 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 122.5 2.134 . . . . 74.24 110.997 176.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.463 HG23 HG21 ' A' ' 221' ' ' VAL . 29.5 m -123.29 162.26 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.777 0.831 . . . . 74.41 110.61 -174.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -90.58 106.04 18.23 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.692 0.758 . . . . 71.33 109.7 174.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.463 HG21 HG23 ' A' ' 219' ' ' VAL . 94.8 t -101.71 121.72 53.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 115.214 -0.903 . . . . 72.43 109.569 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.02 99.69 3.38 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 123.489 0.715 . . . . 71.41 110.009 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 31.1 t -84.53 132.64 46.3 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 114.547 -1.206 . . . . 74.53 109.172 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.411 ' HD3' ' HB ' ' A' ' 173' ' ' ILE . 60.3 Cg_endo -69.42 170.05 17.06 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.862 2.375 . . . . 74.14 111.23 171.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.27 -174.43 0.26 Allowed 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.536 2.157 . . . . 72.23 113.563 174.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 38.5 mtp85 62.39 19.5 11.16 Favored 'General case' 0 N--CA 1.502 2.172 0 C-N-CA 125.137 1.375 . . . . 74.31 112.172 172.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.441 ' HA ' ' CZ ' ' A' ' 176' ' ' TYR . 55.5 m -71.82 99.18 2.12 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.965 0.906 . . . . 73.43 111.088 -171.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -98.55 134.94 40.81 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.255 1.422 . . . . 75.44 110.1 -175.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.67 146.22 54.21 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.25 0.62 . . . . 73.22 111.217 -178.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 96.73 -26.74 20.81 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-N 115.182 -0.917 . . . . 64.11 112.78 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -69.85 154.28 42.17 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 117.2 0.5 . . . . 74.21 111.12 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -130.32 142.92 50.51 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 108.176 -1.046 . . . . 74.54 108.176 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.577 HD11 HG22 ' A' ' 173' ' ' ILE . 27.4 mt -120.38 105.82 11.26 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.781 -0.645 . . . . 73.23 110.101 -165.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -73.23 102.86 3.76 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.744 0.818 . . . . 74.11 110.463 -174.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.544 HD23 HG23 ' A' ' 173' ' ' ILE . 37.3 mt -112.49 92.88 4.18 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.097 -0.705 . . . . 74.43 109.097 177.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -69.59 144.26 53.07 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 122.293 0.237 . . . . 75.42 110.735 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 80.81 29.75 41.6 Favored Glycine 0 C--N 1.342 0.912 0 O-C-N 123.73 0.644 . . . . 30.34 113.432 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -123.33 -28.33 3.98 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 117.577 0.689 . . . . 73.14 112.11 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -72.02 -145.83 0.53 Allowed Glycine 0 N--CA 1.481 1.667 0 C-N-CA 123.111 0.386 . . . . 55.32 113.867 -177.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -76.65 149.5 80.97 Favored Pre-proline 0 N--CA 1.486 1.36 0 O-C-N 122.272 -0.546 . . . . 64.14 110.874 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -60.6 145.15 99.33 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.746 2.297 . . . . 75.23 112.361 174.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -167.25 -155.39 9.1 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 115.866 -0.606 . . . . 63.12 112.375 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -80.47 1.03 9.59 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 123.543 2.829 . . . . 65.15 113.336 -174.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -120.48 22.16 11.36 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.947 0.899 . . . . 72.23 110.352 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 91.6 -92.32 1.71 Allowed Glycine 0 C--N 1.348 1.244 0 N-CA-C 110.945 -0.862 . . . . 72.23 110.945 -174.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -126.12 169.43 12.81 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.43 -0.952 . . . . 75.14 108.43 167.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.84 -175.75 46.91 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.982 -0.553 . . . . 73.32 113.885 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -100.54 127.2 46.98 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.404 0.621 . . . . 74.22 110.057 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 35.1 tp -99.95 110.91 23.23 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 107.845 -1.168 . . . . 74.43 107.845 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -86.03 108.2 18.14 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.474 -1.306 . . . . 74.22 107.474 174.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 27.1 mt -84.2 105.13 14.82 Favored 'General case' 0 C--N 1.34 0.189 0 N-CA-C 107.775 -1.194 . . . . 71.4 107.775 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -77.18 103.23 6.99 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.649 -1.614 . . . . 71.35 108.966 -177.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 63.7 t -59.65 115.61 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 123.72 0.808 . . . . 74.51 110.722 177.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.551 ' HG3' HG21 ' A' ' 196' ' ' THR . 54.5 mmm-85 -125.64 97.1 5.03 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.001 -1.481 . . . . 73.15 107.001 177.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 54.8 mt -76.71 119.31 24.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 CA-C-N 116.232 -0.44 . . . . 74.21 110.197 -174.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 44.2 p . . . . . 0 C--O 1.255 1.344 0 C-N-CA 124.425 1.09 . . . . 63.44 108.185 177.785 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 24.9 mmt . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 109.696 -0.483 . . . . 73.32 109.696 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 15.2 m -69.45 -26.66 64.7 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.448 0.699 . . . . 71.51 112.207 -173.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.407 ' O ' ' HD3' ' A' ' 238' ' ' LYS . 79.7 mm-40 61.54 75.64 0.4 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.011 1.324 . . . . 72.42 111.923 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.9 mp -91.78 12.51 21.15 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.93 0.892 . . . . 74.41 110.557 175.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -63.21 124.2 20.6 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.929 0.891 . . . . 74.33 110.675 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.635 ' HA ' HD23 ' A' ' 235' ' ' LEU . 73.5 mt -78.53 105.99 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 115.583 -0.735 . . . . 71.42 110.678 -174.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -66.46 -28.92 68.97 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 114.749 -1.114 . . . . 74.31 111.119 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -74.79 170.48 15.8 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.959 0.904 . . . . 72.52 112.143 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 64.76 23.3 12.7 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.682 1.193 . . . . 64.22 112.103 177.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 174.15 145.48 5.24 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 118.791 -1.005 . . . . 73.15 110.727 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -65.41 97.54 0.31 Allowed 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.764 2.309 . . . . 74.32 111.424 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -75.1 -40.43 59.97 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.255 -0.884 . . . . 74.42 109.687 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 178.74 -171.44 43.62 Favored Glycine 0 C--N 1.34 0.773 0 CA-C-N 115.314 -0.857 . . . . 70.31 111.715 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 34.8 p -87.45 -7.42 57.67 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.486 0.714 . . . . 65.32 111.254 176.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 100.87 87.97 1.99 Allowed Glycine 0 C--N 1.347 1.179 0 N-CA-C 111.708 -0.557 . . . . 34.4 111.708 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -74.88 73.91 1.43 Allowed Glycine 0 C--N 1.35 1.319 0 N-CA-C 111.395 -0.682 . . . . 62.13 111.395 173.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 40.6 t -158.82 165.17 34.87 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.559 1.144 . . . . 62.35 109.454 -172.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 161.68 -107.21 0.3 Allowed Glycine 0 C--N 1.348 1.208 0 N-CA-C 111.908 -0.477 . . . . 74.33 111.908 177.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.01 -11.55 28.15 Favored Glycine 0 CA--C 1.54 1.632 0 CA-C-O 119.72 -0.489 . . . . 75.1 114.3 176.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 37.8 m 57.01 82.94 0.11 Allowed 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.879 1.272 . . . . 71.43 111.472 -173.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -165.92 -105.83 0.19 Allowed Glycine 0 C--N 1.342 0.912 0 N-CA-C 110.823 -0.911 . . . . 64.35 110.823 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -151.47 158.68 27.86 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 111.761 -0.535 . . . . 53.42 111.761 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 18.9 m -92.59 121.44 34.02 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.775 0.83 . . . . 65.2 108.987 174.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.505 ' HB3' ' HB2' ' A' ' 240' ' ' PHE . 82.3 mm-40 -82.54 56.96 3.5 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.233 0.613 . . . . 74.03 110.186 175.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -91.55 142.35 27.73 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.485 -0.779 . . . . 72.45 110.657 -175.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 96.2 mt -133.52 153.64 51.48 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.583 0.753 . . . . 74.54 110.244 -178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -104.14 121.66 43.71 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 108.748 -0.834 . . . . 75.31 108.748 174.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -125.69 133.22 52.22 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.553 1.141 . . . . 74.31 109.117 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 39.3 m -65.51 139.38 58.48 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.473 0.709 . . . . 52.43 111.322 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.428 HD13 HD12 ' A' ' 251' ' ' LEU . 26.3 tp -115.17 122.57 46.45 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 123.837 0.855 . . . . 74.25 109.199 176.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -89.52 106.08 18.22 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.273 -0.64 . . . . 70.51 109.273 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.604 HG11 HG13 ' A' ' 253' ' ' VAL . 6.4 p -129.56 131.36 23.54 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 122.86 0.464 . . . . 72.42 110.042 178.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.42 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 55.8 Cg_endo -74.46 157.64 44.86 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 121.943 1.762 . . . . 54.32 111.404 169.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.486 ' HA ' HG22 ' A' ' 255' ' ' ILE . . . -50.95 -48.97 83.23 Favored Pre-proline 0 CA--C 1.57 1.732 0 CA-C-O 117.949 -1.024 . . . . 60.53 113.652 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.468 ' O ' HG11 ' A' ' 206' ' ' VAL . 28.7 Cg_endo -60.91 -51.52 4.65 Favored 'Trans proline' 0 C--N 1.402 3.371 0 C-N-CA 121.529 1.486 . . . . 75.41 111.945 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.4 mt -62.83 -26.47 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 123.599 0.76 . . . . 73.23 111.32 -176.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.3 -52.99 33.81 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-O 120.953 0.406 . . . . 75.44 110.8 174.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 90.0 t -67.94 -43.99 85.39 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 N-CA-C 112.675 0.62 . . . . 75.44 112.675 -175.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.468 HG11 ' O ' ' A' ' 202' ' ' PRO . 11.0 p -99.92 -21.66 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 122.857 0.463 . . . . 72.21 112.183 -173.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.66 144.67 11.41 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 112.229 -0.348 . . . . 62.43 112.229 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -177.25 -140.35 3.63 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-O 119.224 -0.765 . . . . 74.44 111.898 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -116.94 143.34 45.82 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 118.005 0.902 . . . . 74.14 109.208 176.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 34.4 m -139.83 169.87 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 123.457 0.703 . . . . 73.42 111.352 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -90.12 114.12 26.0 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.12 0.568 . . . . 73.35 110.343 173.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.44 127.12 52.06 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.111 -1.07 . . . . 75.41 108.111 165.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 89.8 mmm -81.58 104.97 12.37 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.215 -0.661 . . . . 75.15 109.215 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 87.4 m -113.4 162.03 16.59 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.572 1.149 . . . . 73.14 109.76 -176.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 87.3 mt -58.0 -16.67 13.39 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.035 0.934 . . . . 73.35 112.986 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -103.7 29.25 5.89 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.037 0.935 . . . . 73.52 110.924 175.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 86.9 -165.38 36.31 Favored Glycine 0 C--N 1.348 1.231 0 CA-C-N 116.237 -0.438 . . . . 74.44 113.442 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -72.54 121.65 7.6 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.78 2.32 . . . . 75.41 111.395 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.4 m -121.15 147.8 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.821 0.849 . . . . 75.04 109.96 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 9.8 pt-20 -90.49 113.93 26.0 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.285 0.564 . . . . 72.43 110.949 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 63.9 t -102.83 132.2 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.283 0.633 . . . . 72.4 109.452 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -78.94 99.99 7.06 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 123.657 0.783 . . . . 72.34 109.765 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 74.5 t -80.03 134.02 56.93 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.317 1.047 . . . . 75.24 110.201 178.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.42 170.96 18.96 Favored 'Trans proline' 0 C--N 1.383 2.36 0 C-N-CA 122.939 2.426 . . . . 75.44 111.372 172.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -65.01 175.22 3.98 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 121.869 1.713 . . . . 74.2 113.47 172.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 72.31 5.33 5.26 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 125.248 1.419 . . . . 75.12 112.844 174.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 87.6 m -69.42 127.63 33.72 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.156 0.583 . . . . 75.51 110.913 -172.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -127.14 142.34 51.53 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.817 0.847 . . . . 75.42 110.809 -167.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . 0.423 ' HB3' ' HB ' ' A' ' 255' ' ' ILE . . . -65.05 132.37 49.03 Favored 'General case' 0 C--N 1.348 0.543 0 C-N-CA 124.108 0.963 . . . . 73.24 110.767 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.13 -14.7 63.46 Favored Glycine 0 N--CA 1.468 0.77 0 O-C-N 123.994 0.809 . . . . 75.31 112.223 -178.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 78.2 mtt-85 -84.12 142.31 30.47 Favored 'General case' 0 C--N 1.351 0.65 0 N-CA-C 109.233 -0.654 . . . . 73.22 109.233 173.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.58 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.0 mppt? -110.64 130.88 55.46 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.786 -0.82 . . . . 74.34 108.786 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.516 HD12 HD11 ' A' ' 173' ' ' ILE . 27.1 mt -84.18 99.4 10.5 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.193 -1.04 . . . . 64.45 108.193 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -72.97 102.0 3.36 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.069 0.548 . . . . 74.35 109.956 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.635 HD23 ' HA ' ' A' ' 173' ' ' ILE . 14.0 mt -105.1 95.34 5.77 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.977 -0.749 . . . . 75.44 108.977 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -62.64 145.26 55.01 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 120.827 0.346 . . . . 70.42 111.452 176.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 74.58 19.78 79.76 Favored Glycine 0 C--N 1.344 0.985 0 CA-C-N 115.096 -0.956 . . . . 73.23 113.644 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.407 ' HD3' ' O ' ' A' ' 170' ' ' GLN . 31.1 mmmt -122.16 -11.17 8.47 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.426 0.691 . . . . 64.43 112.115 -176.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -77.98 -169.36 33.88 Favored Glycine 0 C--N 1.343 0.971 0 N-CA-C 111.842 -0.503 . . . . 72.23 111.842 167.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.505 ' HB2' ' HB3' ' A' ' 191' ' ' GLN . 18.0 m-30 -72.57 155.75 90.77 Favored Pre-proline 0 N--CA 1.483 1.201 0 CA-C-N 116.855 0.327 . . . . 75.22 110.995 -179.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.26 155.13 70.45 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.557 2.171 . . . . 72.42 112.987 175.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -173.04 -168.23 34.01 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-N 115.384 -0.825 . . . . 64.02 111.929 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -60.94 -23.83 78.08 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.452 2.768 . . . . 73.0 112.661 174.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -87.27 20.14 2.91 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.131 0.972 . . . . 70.01 111.94 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 79.22 -94.36 1.36 Allowed Glycine 0 C--N 1.349 1.302 0 N-CA-C 110.321 -1.112 . . . . 51.25 110.321 -173.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 42.8 mtt180 -128.48 159.46 35.36 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.598 -0.889 . . . . 74.22 108.598 164.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -83.25 -165.82 38.62 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 116.014 -0.539 . . . . 53.31 112.811 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.54 164.83 12.1 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.921 0.888 . . . . 74.23 109.516 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 33.7 tp -134.99 107.76 7.49 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 107.793 -1.188 . . . . 75.14 107.793 173.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.58 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 73.5 m-85 -88.92 111.16 21.77 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.466 0.706 . . . . 71.54 109.608 -178.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.428 HD12 HD13 ' A' ' 197' ' ' LEU . 63.9 mt -86.46 104.33 15.83 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 107.998 -1.112 . . . . 74.52 107.998 174.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -78.95 97.58 6.1 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.38 -0.97 . . . . 75.13 108.38 -173.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.604 HG13 HG11 ' A' ' 199' ' ' VAL . 81.8 t -57.91 109.63 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-N 114.256 -1.338 . . . . 72.21 112.084 -175.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -105.03 97.93 7.71 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 124.281 1.033 . . . . 74.42 108.756 172.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.486 HG22 ' HA ' ' A' ' 201' ' ' ALA . 32.9 mt -77.56 126.92 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 123.651 0.594 . . . . 74.45 109.623 177.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 9.5 p . . . . . 0 CA--C 1.556 1.199 0 C-N-CA 124.677 1.191 . . . . 71.15 109.006 -178.389 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 121.17 0.509 . . . . 73.2 109.992 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 33.4 t -173.55 118.24 0.28 Allowed 'General case' 0 C--O 1.246 0.875 0 C-N-CA 124.844 1.258 . . . . 65.31 108.073 177.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -68.95 -58.66 3.82 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.271 -0.64 . . . . 74.22 109.271 175.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.569 HD11 HG23 ' A' ' 221' ' ' VAL . 3.2 pp -74.35 123.69 25.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.535 -0.757 . . . . 72.25 111.436 -176.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -143.81 150.18 38.14 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.718 1.207 . . . . 75.2 108.613 175.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.767 ' HA ' HD22 ' A' ' 235' ' ' LEU . 22.6 mt -92.61 106.43 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 120.993 0.425 . . . . 73.05 111.092 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -86.82 -21.37 26.49 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.25 1.02 . . . . 75.11 111.257 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -72.87 165.1 25.57 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.51 0.724 . . . . 74.13 111.182 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.411 ' HE1' ' HA ' ' A' ' 227' ' ' THR . 2.7 m-85 70.84 5.04 5.29 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 125.035 1.334 . . . . 74.55 113.423 176.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -163.09 55.0 0.29 Allowed Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.201 -0.777 . . . . 73.44 111.807 171.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -83.69 174.33 8.75 Favored 'Trans proline' 0 C--N 1.383 2.374 0 C-N-CA 122.082 1.855 . . . . 75.1 111.49 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -98.77 41.96 1.12 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.463 0.705 . . . . 72.51 109.763 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.65 -56.2 5.04 Favored Glycine 0 C--N 1.351 1.404 0 CA-C-N 115.382 -0.826 . . . . 62.23 112.642 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 21.9 t -162.04 -171.08 2.72 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.012 0.925 . . . . 64.33 109.376 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -170.06 -15.24 0.02 OUTLIER Glycine 0 CA--C 1.525 0.698 0 N-CA-C 112.038 -0.425 . . . . 73.32 112.038 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 158.58 -148.96 18.86 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 111.244 -0.742 . . . . 73.43 111.244 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 39.8 t -73.16 -28.61 62.33 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.64 0.776 . . . . 61.44 110.617 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 98.28 -26.92 21.72 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-N 116.214 -0.448 . . . . 62.45 112.45 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 78.63 4.28 87.57 Favored Glycine 0 C--N 1.354 1.572 0 C-N-CA 122.774 0.226 . . . . 65.34 113.276 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 50.4 p -92.1 123.41 35.43 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.188 0.995 . . . . 72.43 110.237 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -165.24 35.89 0.27 Allowed Glycine 0 C--N 1.342 0.89 0 CA-C-N 116.3 -0.409 . . . . 74.51 112.877 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 67.97 43.71 81.23 Favored Glycine 0 C--N 1.346 1.12 0 C-N-CA 123.529 0.585 . . . . 70.32 113.646 177.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 35.8 m -143.49 -76.34 0.25 Allowed 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 117.468 0.634 . . . . 73.53 110.737 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -72.68 -41.4 65.38 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 109.336 -0.616 . . . . 73.42 109.336 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -75.59 147.29 39.72 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 114.954 -1.021 . . . . 70.33 109.936 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 96.0 mt -129.09 166.6 18.96 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.492 0.717 . . . . 73.43 110.289 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -119.65 145.34 46.55 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.388 1.075 . . . . 73.22 108.809 173.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.15 158.03 43.84 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.291 1.036 . . . . 60.32 108.562 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 16.5 m -92.46 130.83 38.02 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 122.68 0.392 . . . . 70.52 109.943 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 57.1 tp -111.99 126.11 54.79 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.724 0.809 . . . . 74.44 109.684 176.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -93.57 125.43 38.17 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.219 0.608 . . . . 63.51 109.368 170.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 6.5 p -144.94 133.76 11.04 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 124.045 0.938 . . . . 74.02 108.65 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.91 157.81 38.85 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.075 1.85 . . . . 74.33 111.29 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.22 -48.29 92.84 Favored Pre-proline 0 CA--C 1.555 1.173 0 N-CA-C 113.309 0.855 . . . . 64.55 113.309 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.505 ' O ' HG11 ' A' ' 206' ' ' VAL . 52.4 Cg_exo -56.13 -56.12 2.36 Favored 'Trans proline' 0 C--N 1.395 2.995 0 C-N-CA 121.836 1.691 . . . . 72.44 113.028 176.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 57.7 mt -60.91 -30.22 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 C-N-CA 122.717 0.407 . . . . 71.45 110.829 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.431 ' HB1' ' O ' ' A' ' 227' ' ' THR . . . -63.61 -53.55 49.87 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 122.927 0.491 . . . . 74.42 111.038 178.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 32.3 t -78.91 -42.4 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 116.154 -0.476 . . . . 71.14 112.175 -172.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.505 HG11 ' O ' ' A' ' 202' ' ' PRO . 9.9 p -90.02 -19.57 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 122.654 0.381 . . . . 73.44 111.395 -176.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.31 159.04 34.31 Favored Glycine 0 C--N 1.348 1.226 0 N-CA-C 111.986 -0.446 . . . . 72.34 111.986 -174.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.79 -138.68 5.39 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-O 119.603 -0.554 . . . . 75.1 112.352 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.551 ' HB2' ' HZ3' ' A' ' 209' ' ' LYS . 9.5 mtmp? -137.31 142.31 41.89 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.564 0.746 . . . . 72.01 109.312 177.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.77 162.04 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 122.846 0.458 . . . . 72.42 110.539 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -86.51 104.77 16.28 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.295 -1.002 . . . . 73.03 108.295 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -103.49 138.86 39.61 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.773 0.829 . . . . 61.21 110.199 -175.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 22.5 ptt? -72.54 118.46 15.49 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 121.438 0.637 . . . . 72.12 109.401 176.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 28.0 m -135.45 154.59 51.39 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.091 0.956 . . . . 72.52 109.061 -177.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 68.7 mt -63.19 -21.66 66.36 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.003 0.921 . . . . 74.3 112.789 -177.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -93.62 0.8 56.69 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.276 0.63 . . . . 73.53 111.353 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 117.97 167.98 14.3 Favored Glycine 0 C--N 1.345 1.069 0 CA-C-O 119.534 -0.592 . . . . 53.35 112.515 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.76 121.26 8.3 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.513 2.142 . . . . 62.41 111.174 176.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.457 HG22 HD23 ' A' ' 171' ' ' LEU . 27.7 m -127.7 160.04 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 123.804 0.842 . . . . 61.4 110.879 -171.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -86.68 103.95 15.63 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.062 0.545 . . . . 74.15 109.817 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.569 HG23 HD11 ' A' ' 171' ' ' LEU . 99.0 t -96.84 124.14 49.5 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 N-CA-C 108.672 -0.862 . . . . 74.4 108.672 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.04 98.7 2.58 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.069 0.548 . . . . 50.13 110.244 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 94.8 t -73.97 128.0 87.24 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.203 1.001 . . . . 64.1 109.737 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.16 170.34 14.76 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.601 2.201 . . . . 70.52 111.317 176.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.52 167.87 26.13 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 121.249 1.3 . . . . 73.25 111.489 168.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 48.2 mtt-85 65.63 23.04 11.69 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 124.622 1.169 . . . . 75.5 111.989 176.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.431 ' O ' ' HB1' ' A' ' 204' ' ' ALA . 30.0 m -75.15 93.53 2.81 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.771 0.796 . . . . 74.13 110.416 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -86.03 145.71 26.97 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.461 -1.245 . . . . 74.32 110.531 -178.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.3 138.42 58.52 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.114 0.966 . . . . 72.41 111.126 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 92.74 -14.83 64.05 Favored Glycine 0 N--CA 1.473 1.108 0 CA-C-N 116.206 -0.452 . . . . 75.24 113.034 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -75.71 145.11 41.15 Favored 'General case' 0 C--N 1.348 0.504 0 N-CA-C 109.457 -0.571 . . . . 71.25 109.457 173.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.583 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 0.2 OUTLIER -110.48 122.71 48.39 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.199 -0.667 . . . . 74.41 109.199 175.451 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.446 HD12 HD11 ' A' ' 173' ' ' ILE . 18.7 mt -76.19 103.07 6.05 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.447 -0.945 . . . . 72.23 108.447 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 21.4 ttm-85 -70.95 101.2 2.12 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 109.395 -0.595 . . . . 74.33 109.395 175.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.767 HD22 ' HA ' ' A' ' 173' ' ' ILE . 10.0 mt -104.27 103.13 12.83 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 108.011 -1.107 . . . . 72.24 108.011 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -80.85 142.7 33.39 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.735 0.414 . . . . 74.04 111.521 -170.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 84.99 21.15 56.32 Favored Glycine 0 C--N 1.346 1.111 0 CA-C-N 115.985 -0.552 . . . . 64.15 113.506 178.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.45 ' HE3' ' HA ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -113.27 -26.92 8.17 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.285 0.634 . . . . 71.34 112.534 -173.824 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -72.91 -134.74 0.21 Allowed Glycine 0 CA--C 1.539 1.553 0 N-CA-C 114.262 0.465 . . . . 73.45 114.262 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -93.56 137.73 23.22 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 123.266 0.626 . . . . 75.24 110.114 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 56.3 Cg_endo -69.17 128.88 17.24 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.751 2.3 . . . . 64.45 112.487 -178.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -137.55 -175.93 14.14 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-O 119.504 -0.609 . . . . 74.23 112.512 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.66 -28.95 69.27 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 123.998 3.132 . . . . 74.45 113.155 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -94.43 14.88 19.23 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.44 0.696 . . . . 73.43 110.725 177.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 97.68 175.19 33.86 Favored Glycine 0 C--N 1.349 1.3 0 N-CA-C 111.537 -0.625 . . . . 73.1 111.537 -176.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.549 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 0.8 OUTLIER -61.24 145.77 50.09 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.618 0.767 . . . . 73.41 109.894 172.421 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -68.33 -173.27 7.67 Favored Glycine 0 N--CA 1.477 1.369 0 N-CA-C 114.362 0.505 . . . . 72.24 114.362 -173.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -95.97 168.81 10.4 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.456 -0.942 . . . . 74.11 108.456 178.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 238' ' ' LYS . 34.6 tp -141.49 108.81 5.53 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.493 -0.928 . . . . 75.52 108.493 178.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.583 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 81.1 m-85 -90.39 109.28 20.4 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.902 0.881 . . . . 75.34 110.032 -176.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 46.8 mt -88.0 107.14 18.58 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.153 -0.684 . . . . 75.2 109.153 174.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -80.25 101.09 8.67 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.69 1.196 . . . . 73.13 108.801 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 89.4 t -63.39 120.23 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 125.218 1.407 . . . . 72.34 112.733 -171.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -113.83 100.11 8.2 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.039 -1.097 . . . . 72.2 108.039 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 18.6 mt -75.88 120.11 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 122.962 0.505 . . . . 74.13 109.75 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 CA--C 1.554 1.129 0 C-N-CA 124.296 1.038 . . . . 75.22 108.895 -179.997 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 121.061 0.458 . . . . 71.53 111.183 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 41.1 m -73.47 10.24 1.11 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.765 0.826 . . . . 74.22 112.696 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -58.73 137.2 57.77 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.16 0.984 . . . . 75.01 111.525 173.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.405 ' O ' HG13 ' A' ' 221' ' ' VAL . 62.5 mt -82.61 80.85 8.62 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.648 0.779 . . . . 72.2 109.35 176.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 55.1 mtm180 -79.15 105.24 10.34 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 107.366 -1.346 . . . . 72.25 107.366 175.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.564 HG23 HD11 ' A' ' 233' ' ' LEU . 50.9 mt -76.79 108.63 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 O-C-N 123.24 0.338 . . . . 74.54 110.195 -175.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -100.98 14.84 30.64 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.86 0.864 . . . . 75.04 110.432 174.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -73.03 -43.83 61.56 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.967 0.907 . . . . 63.32 112.423 -171.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.46 ' CE2' ' HA ' ' A' ' 227' ' ' THR . 43.6 m-85 -83.21 100.23 10.45 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.268 -0.642 . . . . 73.4 109.268 173.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 91.67 59.25 1.36 Allowed Glycine 0 CA--C 1.533 1.174 0 CA-C-N 114.586 -1.188 . . . . 70.12 112.196 -173.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.78 135.96 11.73 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 122.213 1.942 . . . . 73.24 111.999 -177.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -76.2 -42.87 44.85 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.069 0.462 . . . . 72.43 110.413 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -128.46 173.72 19.06 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 115.712 -0.676 . . . . 74.31 112.473 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 38.3 t -153.1 162.65 41.07 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.214 1.006 . . . . 63.34 109.063 175.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 98.63 -179.32 31.67 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 116.497 -0.32 . . . . 75.31 113.661 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -142.4 -97.51 0.28 Allowed Glycine 0 C--N 1.343 0.926 0 N-CA-C 110.547 -1.021 . . . . 74.12 110.547 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 35.8 p -158.96 -61.49 0.07 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.576 0.75 . . . . 74.0 110.903 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 174.48 66.84 0.05 OUTLIER Glycine 0 C--N 1.344 1.005 0 N-CA-C 110.993 -0.843 . . . . 72.55 110.993 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -75.93 80.92 1.05 Allowed Glycine 0 C--N 1.352 1.421 0 N-CA-C 112.024 -0.43 . . . . 64.53 112.024 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.8 m -68.19 120.77 14.9 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 123.733 0.813 . . . . 74.04 110.414 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 69.31 26.31 74.69 Favored Glycine 0 C--N 1.347 1.187 0 O-C-N 123.709 0.63 . . . . 51.33 112.727 -174.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -62.44 107.95 1.85 Allowed Glycine 0 C--N 1.352 1.46 0 C-N-CA 123.157 0.408 . . . . 63.31 112.868 -176.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 19.7 m -129.65 19.23 5.67 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.14 0.976 . . . . 73.24 110.349 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -85.42 2.43 44.49 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.043 0.937 . . . . 70.03 111.153 -175.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.73 142.61 42.39 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.143 0.977 . . . . 51.05 109.11 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 88.9 mt -127.51 160.61 30.98 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.794 0.838 . . . . 63.5 110.326 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -129.99 119.92 23.95 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.274 -1.01 . . . . 73.25 108.274 173.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -126.66 132.9 51.09 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.666 1.186 . . . . 63.2 109.07 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 51.9 m -66.13 129.67 40.62 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.442 0.697 . . . . 74.5 110.369 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 41.5 tp -116.12 110.85 19.41 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 107.571 -1.27 . . . . 74.15 107.571 176.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -93.63 106.77 18.71 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.496 -0.927 . . . . 72.51 108.496 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 2.8 p -125.27 122.53 25.18 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 124.576 1.151 . . . . 63.43 109.02 -176.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.409 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 72.2 Cg_endo -71.51 158.38 54.05 Favored 'Trans proline' 0 C--N 1.372 1.764 0 C-N-CA 122.301 2.0 . . . . 73.23 111.277 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.98 -45.05 80.93 Favored Pre-proline 0 CA--C 1.571 1.759 0 N-CA-C 114.195 1.183 . . . . 74.03 114.195 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 75.8 Cg_exo -53.69 -54.65 4.5 Favored 'Trans proline' 0 C--N 1.399 3.198 0 C-N-CA 122.225 1.95 . . . . 72.32 113.572 173.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 49.3 mt -71.44 -25.29 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 122.999 0.52 . . . . 54.21 110.66 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.88 -40.53 83.55 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.241 0.616 . . . . 74.52 111.007 177.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 97.7 t -78.58 -56.3 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 CA-C-N 116.63 -0.259 . . . . 75.31 111.595 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.3 p -92.49 -25.77 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 112.675 0.62 . . . . 73.54 112.675 -170.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 96.18 156.81 31.39 Favored Glycine 0 N--CA 1.478 1.47 0 O-C-N 122.476 -0.14 . . . . 74.14 113.097 -176.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 169.65 -131.17 2.2 Favored Glycine 0 C--N 1.346 1.105 0 N-CA-C 111.7 -0.56 . . . . 71.43 111.7 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -134.55 141.71 46.76 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.187 0.995 . . . . 74.21 108.973 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.473 HG11 ' HA ' ' A' ' 199' ' ' VAL . 19.4 m -131.61 167.13 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 122.903 0.481 . . . . 73.34 110.732 176.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -82.03 107.28 14.61 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.526 -0.916 . . . . 75.52 108.526 170.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.02 133.54 48.79 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.317 0.647 . . . . 65.24 109.652 175.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 22.9 mmt -81.01 104.12 11.3 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 109.374 -0.602 . . . . 75.42 109.374 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 30.7 m -112.72 163.15 14.92 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 124.528 1.131 . . . . 63.43 109.039 -177.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 84.6 mt -67.98 -17.03 64.31 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.517 0.727 . . . . 75.35 112.037 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -80.37 -19.68 45.81 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.022 0.929 . . . . 75.31 111.028 173.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 126.24 177.32 14.83 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 110.678 -0.969 . . . . 74.43 110.678 -172.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.87 121.24 7.91 Favored 'Trans proline' 0 CA--C 1.554 1.504 0 C-N-CA 121.981 1.787 . . . . 70.04 110.819 174.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.434 HG22 HG23 ' A' ' 221' ' ' VAL . 35.0 m -124.81 161.0 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 123.324 0.65 . . . . 74.32 111.043 -173.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -85.47 105.75 16.31 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.013 -0.736 . . . . 74.22 109.013 177.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.434 HG23 HG22 ' A' ' 219' ' ' VAL . 49.7 t -102.76 129.16 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.599 0.759 . . . . 64.21 110.394 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.23 100.56 3.74 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 123.42 0.688 . . . . 73.31 110.278 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.481 ' HA ' HD13 ' A' ' 173' ' ' ILE . 58.6 t -88.14 131.56 42.36 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 124.599 1.16 . . . . 72.2 109.389 178.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 223' ' ' VAL . 3.4 Cg_exo -78.88 174.21 12.52 Favored 'Trans proline' 0 C--N 1.377 2.026 0 C-N-CA 123.677 2.918 . . . . 72.04 111.199 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -62.54 176.9 1.44 Allowed 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 121.993 1.795 . . . . 64.41 112.758 166.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 69.27 5.56 5.19 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 124.506 1.123 . . . . 73.0 112.947 172.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.46 ' HA ' ' CE2' ' A' ' 176' ' ' TYR . 87.8 m -66.05 97.57 0.38 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.896 0.878 . . . . 64.44 111.204 -171.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -101.83 141.7 34.27 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.049 1.34 . . . . 65.5 111.086 -171.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.04 141.98 57.78 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.159 0.984 . . . . 75.43 112.517 -174.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.71 -20.14 29.46 Favored Glycine 0 C--N 1.351 1.364 0 O-C-N 123.833 0.708 . . . . 74.44 113.659 178.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -77.23 160.61 28.79 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.067 0.547 . . . . 75.14 110.632 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 12.6 mptt -127.55 143.64 51.16 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.317 0.579 . . . . 75.11 109.985 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.564 HD11 HG23 ' A' ' 173' ' ' ILE . 23.3 mt -106.27 99.54 9.12 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.769 -1.105 . . . . 74.12 109.136 -170.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 42.8 ttm105 -73.74 102.03 3.86 Favored 'General case' 0 C--O 1.24 0.569 0 O-C-N 124.567 1.167 . . . . 75.12 110.437 -174.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.472 HD22 HG21 ' A' ' 173' ' ' ILE . 30.2 mt -105.82 94.6 5.28 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.476 -0.935 . . . . 73.0 108.476 177.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -70.21 140.21 52.42 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 122.845 0.458 . . . . 75.44 111.002 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 81.46 17.65 70.64 Favored Glycine 0 CA--C 1.528 0.892 0 O-C-N 123.918 0.762 . . . . 41.12 113.202 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -122.07 -11.81 8.42 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.437 0.695 . . . . 75.21 112.295 -175.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -77.88 -161.82 17.29 Favored Glycine 0 N--CA 1.48 1.61 0 CA-C-O 119.804 -0.442 . . . . 73.22 112.74 171.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -71.5 149.94 93.66 Favored Pre-proline 0 N--CA 1.484 1.257 0 CA-C-N 117.911 0.856 . . . . 74.33 111.6 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -64.07 140.74 73.53 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.909 2.406 . . . . 73.11 112.31 172.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -163.43 -164.38 18.4 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-O 119.251 -0.75 . . . . 71.41 111.714 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -65.5 -22.28 59.12 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 123.163 2.575 . . . . 71.12 112.879 -174.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -97.0 22.66 8.12 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.846 0.858 . . . . 74.43 111.527 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.46 -97.63 2.35 Favored Glycine 0 C--N 1.346 1.111 0 N-CA-C 110.793 -0.923 . . . . 31.25 110.793 -177.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -128.08 152.83 47.5 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 107.651 -1.24 . . . . 74.42 107.651 166.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -80.91 -158.07 18.46 Favored Glycine 0 C--N 1.34 0.8 0 O-C-N 123.435 0.46 . . . . 72.42 113.045 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -100.06 159.15 15.32 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.507 -0.553 . . . . 63.41 109.507 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 40.7 tp -126.68 108.37 11.03 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.51 -1.292 . . . . 75.53 107.51 172.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.521 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 15.0 m-85 -90.19 108.15 19.57 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.514 -0.921 . . . . 74.43 108.514 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 57.2 mt -87.2 105.53 17.27 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.982 -1.118 . . . . 72.11 107.982 174.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -78.74 112.3 15.73 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.503 -0.771 . . . . 70.33 109.842 -175.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 58.0 t -63.3 119.37 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 124.636 1.174 . . . . 75.23 111.726 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 49.7 mmm-85 -120.39 95.6 4.8 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 125.167 1.387 . . . . 72.51 107.495 173.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.51 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 49.8 mt -77.87 113.12 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 122.741 0.417 . . . . 75.4 110.509 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 75.0 p . . . . . 0 CA--C 1.559 1.299 0 C-N-CA 124.379 1.071 . . . . 72.04 108.714 177.625 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 52.8 ttm . . . . . 0 N--CA 1.473 0.699 0 CA-C-O 120.764 0.316 . . . . 65.02 110.285 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 67.1 m -137.21 120.3 16.64 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.612 -1.255 . . . . 71.12 107.612 173.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -83.74 77.55 9.85 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.548 0.739 . . . . 73.13 110.357 -175.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 10.1 mp -69.06 93.85 0.61 Allowed 'General case' 0 C--N 1.353 0.744 0 N-CA-C 109.093 -0.706 . . . . 74.2 109.093 173.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -79.8 120.18 23.71 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 107.568 -1.271 . . . . 75.31 107.568 168.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.584 ' HB ' ' HD3' ' A' ' 224' ' ' PRO . 76.3 mt -77.46 -78.05 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 122.795 0.438 . . . . 73.23 110.419 -177.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . 51.51 27.21 3.69 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.439 1.096 . . . . 65.21 113.272 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.557 ' H ' HG21 ' A' ' 173' ' ' ILE . . . -73.96 -1.15 18.6 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 113.718 1.007 . . . . 64.33 113.718 -169.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.532 ' HH ' ' HA ' ' A' ' 227' ' ' THR . 21.6 m-85 -78.53 -29.48 46.49 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.021 0.529 . . . . 74.45 110.041 170.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -93.08 158.67 24.0 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 119.03 -0.872 . . . . 63.45 111.271 167.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.4 106.64 0.6 Allowed 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 122.726 2.284 . . . . 72.33 111.985 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -138.09 151.7 48.07 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.786 0.834 . . . . 75.53 110.591 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 174.82 -168.9 41.73 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-N 115.582 -0.735 . . . . 73.41 112.067 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 34.6 t -82.45 -25.36 33.66 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.052 0.541 . . . . 75.41 110.119 173.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 153.61 -149.73 21.28 Favored Glycine 0 C--N 1.351 1.393 0 N-CA-C 111.445 -0.662 . . . . 74.24 111.445 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.456 ' HA3' ' HB3' ' A' ' 187' ' ' SER . . . 102.4 111.39 3.5 Favored Glycine 0 C--N 1.346 1.105 0 C-N-CA 122.954 0.311 . . . . 74.51 112.678 174.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 22.6 t -86.48 104.71 16.21 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 109.162 -0.681 . . . . 65.51 109.162 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 91.25 -62.59 2.81 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 116.419 -0.355 . . . . 74.31 112.231 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -128.48 153.13 19.45 Favored Glycine 0 C--N 1.347 1.144 0 N-CA-C 111.847 -0.501 . . . . 74.1 111.847 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.456 ' HB3' ' HA3' ' A' ' 183' ' ' GLY . 44.3 p -152.71 149.94 28.91 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.128 0.971 . . . . 74.43 109.835 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 75.56 -96.15 1.02 Allowed Glycine 0 CA--C 1.532 1.129 0 CA-C-O 119.909 -0.384 . . . . 64.44 113.119 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 123.27 59.19 0.19 Allowed Glycine 0 C--N 1.347 1.169 0 C-N-CA 123.479 0.562 . . . . 74.25 112.014 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 19.2 m 61.33 18.38 9.19 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.702 1.201 . . . . 71.43 111.928 -177.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -90.59 21.73 3.84 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.329 1.052 . . . . 75.43 111.018 -176.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -76.48 155.92 33.43 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.452 0.701 . . . . 75.53 111.276 -176.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 93.7 mt -128.74 152.93 47.88 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.147 0.979 . . . . 72.12 109.19 176.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -108.25 149.12 29.02 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.864 0.866 . . . . 74.35 108.852 172.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -155.03 136.1 13.86 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.972 0.909 . . . . 73.51 108.763 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 28.1 m -78.01 128.48 33.93 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.115 0.566 . . . . 71.31 109.888 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 22.0 tp -108.27 117.41 34.08 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.438 -0.579 . . . . 74.21 109.438 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -82.47 105.77 13.8 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.431 -0.951 . . . . 53.42 108.431 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.478 HG13 HG12 ' A' ' 253' ' ' VAL . 2.7 p -136.5 122.7 13.69 Favored Pre-proline 0 CA--C 1.548 0.888 0 N-CA-C 109.507 -0.553 . . . . 65.42 109.507 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.457 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 54.9 Cg_endo -72.11 160.65 46.86 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.194 1.93 . . . . 72.55 112.049 173.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.75 -51.72 63.4 Favored Pre-proline 0 CA--C 1.567 1.611 0 C-N-CA 124.46 1.104 . . . . 63.14 113.745 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 56.6 Cg_endo -65.62 -36.06 34.91 Favored 'Trans proline' 0 C--N 1.401 3.327 0 C-N-CA 121.624 1.549 . . . . 71.52 112.606 -176.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 23.0 mt -72.7 -31.7 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 122.766 0.426 . . . . 71.33 110.551 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.1 -42.15 89.69 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 122.691 0.397 . . . . 74.0 110.768 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 90.7 t -69.7 -53.02 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.096 0 C-N-CA 123.281 0.632 . . . . 75.02 111.695 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 28.0 m -79.58 -32.83 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 112.153 0.427 . . . . 73.13 112.153 -175.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.18 105.77 0.97 Allowed Glycine 0 C--N 1.343 0.934 0 CA-C-N 116.146 -0.479 . . . . 65.43 112.584 -173.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -148.46 -177.03 22.39 Favored Glycine 0 C--N 1.344 1.021 0 N-CA-C 112.074 -0.41 . . . . 73.13 112.074 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.623 ' HB3' ' HB2' ' A' ' 220' ' ' GLU . 50.2 mtmt -86.93 127.61 35.07 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 117.13 0.465 . . . . 75.11 110.497 -175.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 20.7 m -124.22 167.95 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 123.14 0.576 . . . . 75.1 111.555 -177.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -71.53 106.63 4.07 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 123.974 0.796 . . . . 73.44 110.232 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.83 115.76 30.86 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 107.95 -1.13 . . . . 64.12 107.95 166.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 63.3 mtt -72.97 104.93 4.25 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 109.255 -0.646 . . . . 75.34 109.255 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 38.1 m -110.99 162.23 15.06 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.715 1.206 . . . . 73.34 109.268 -173.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 96.4 mt -57.68 -23.25 50.51 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.967 0.907 . . . . 72.1 112.95 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -87.47 -20.83 26.03 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.26 0.624 . . . . 74.32 111.707 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 139.05 -171.93 23.39 Favored Glycine 0 C--N 1.345 1.036 0 CA-C-O 119.577 -0.568 . . . . 71.11 111.95 -176.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.6 117.79 4.66 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.21 1.94 . . . . 72.11 110.788 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.26 166.78 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.15 0.58 . . . . 71.44 109.687 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.623 ' HB2' ' HB3' ' A' ' 209' ' ' LYS . 8.5 pt-20 -107.52 105.12 14.86 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.721 0.772 . . . . 75.54 109.746 178.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 58.7 t -99.46 131.42 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.886 1.275 . . . . 75.53 109.841 -175.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.73 100.43 2.84 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.801 0.841 . . . . 62.11 110.553 -176.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.522 ' HA ' HD11 ' A' ' 173' ' ' ILE . 80.8 t -78.55 138.62 58.83 Favored Pre-proline 0 N--CA 1.478 0.973 0 C-N-CA 124.872 1.269 . . . . 72.31 109.321 175.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.584 ' HD3' ' HB ' ' A' ' 173' ' ' ILE . 88.1 Cg_endo -75.11 168.83 23.9 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 122.51 2.14 . . . . 70.42 111.506 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -68.35 172.71 10.77 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 121.421 1.414 . . . . 65.23 111.424 168.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 63.85 17.12 10.32 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.888 0.875 . . . . 74.35 112.071 174.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.532 ' HA ' ' HH ' ' A' ' 176' ' ' TYR . 53.7 m -75.01 133.18 41.71 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.943 0.897 . . . . 73.11 110.153 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -139.35 143.13 37.63 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.201 0.6 . . . . 70.51 110.846 -164.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.19 127.73 33.27 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 124.323 1.049 . . . . 65.51 111.373 -177.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 103.58 -21.84 37.67 Favored Glycine 0 N--CA 1.473 1.134 0 CA-C-N 115.902 -0.59 . . . . 71.04 112.719 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -75.81 141.98 42.36 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.082 0.553 . . . . 74.41 110.024 176.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.48 ' HG3' ' HG2' ' A' ' 252' ' ' GLU . 0.0 OUTLIER -108.38 127.57 54.0 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.497 0.719 . . . . 75.01 109.746 178.306 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.527 HD11 HG22 ' A' ' 173' ' ' ILE . 56.6 mt -90.6 96.88 10.87 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.9 -1.148 . . . . 73.23 107.9 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 30.4 ttp-105 -87.15 105.25 17.06 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 124.233 1.013 . . . . 74.15 110.24 -172.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.515 HD21 HG23 ' A' ' 173' ' ' ILE . 31.2 mt -99.85 94.82 6.52 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.602 -0.888 . . . . 72.41 108.602 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm -67.55 140.97 56.99 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.52 0.328 . . . . 74.34 110.554 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.06 28.41 56.38 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-N 116.097 -0.501 . . . . 74.34 113.642 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.449 ' HA ' ' HE2' ' A' ' 238' ' ' LYS . 9.3 mmpt? -127.54 -14.95 5.15 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.843 0.857 . . . . 74.53 112.801 -178.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -78.2 -152.98 6.23 Favored Glycine 0 N--CA 1.476 1.366 0 C-N-CA 122.736 0.207 . . . . 65.52 113.162 174.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -73.58 147.94 87.44 Favored Pre-proline 0 N--CA 1.485 1.296 0 C-N-CA 123.022 0.529 . . . . 71.31 111.28 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -59.81 143.36 99.63 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.94 2.427 . . . . 74.5 112.741 172.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -154.4 -170.33 20.12 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-O 119.391 -0.672 . . . . 73.32 112.913 -176.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.64 -40.22 67.05 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 123.411 2.741 . . . . 73.31 113.285 -174.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -103.97 22.02 15.34 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.477 0.711 . . . . 53.55 111.501 -177.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 104.7 -161.85 15.01 Favored Glycine 0 N--CA 1.473 1.139 0 CA-C-O 119.642 -0.532 . . . . 74.41 111.864 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 66.2 mtm-85 -75.71 146.4 40.16 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.365 0.582 . . . . 75.33 109.701 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -74.97 -157.25 5.79 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 116.405 -0.362 . . . . 74.11 112.994 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -97.37 170.02 9.36 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.071 0.548 . . . . 64.2 110.173 -175.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 29.4 tp -136.35 105.63 6.03 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.746 -1.205 . . . . 73.03 107.746 172.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -89.66 107.07 18.87 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.752 -0.833 . . . . 75.21 108.752 -178.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 71.9 mt -89.53 104.28 16.85 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.559 -1.275 . . . . 75.41 107.559 173.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.48 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 12.8 mt-10 -78.29 105.56 9.61 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.508 -0.769 . . . . 71.12 108.962 -173.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.478 HG12 HG13 ' A' ' 199' ' ' VAL . 61.3 t -59.62 104.21 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.82 0 O-C-N 124.073 0.858 . . . . 75.3 111.545 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -103.46 97.66 7.68 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 107.785 -1.191 . . . . 72.24 107.785 173.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 12.5 mt -75.02 114.73 15.39 Favored 'Isoleucine or valine' 0 C--N 1.356 0.853 0 O-C-N 123.958 0.786 . . . . 71.15 108.941 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 12.5 p . . . . . 0 C--O 1.256 1.423 0 C-N-CA 125.537 1.535 . . . . 72.22 108.16 -177.033 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 65.3 mtm . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 121.201 0.525 . . . . 73.42 110.98 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 23.2 t -153.74 117.6 4.74 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.943 -1.026 . . . . 71.42 108.282 175.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -59.06 -40.87 86.5 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 121.496 0.665 . . . . 72.41 109.912 176.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 85.4 mt -103.47 91.82 4.21 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.862 -1.063 . . . . 64.12 109.095 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 -64.92 110.32 2.4 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.86 -0.792 . . . . 74.31 108.86 177.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.566 ' HA ' HD23 ' A' ' 235' ' ' LEU . 65.4 mt -81.59 -81.16 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 119.034 -0.508 . . . . 74.11 111.102 -172.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . 52.49 28.48 6.0 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.971 0.908 . . . . 74.43 112.472 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.465 ' H ' HG21 ' A' ' 173' ' ' ILE . . . -81.56 -178.94 7.17 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.441 -0.799 . . . . 70.43 111.324 -177.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 68.64 33.35 3.88 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 125.143 1.377 . . . . 75.42 110.162 -174.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 175.57 179.4 46.07 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 114.569 -1.196 . . . . 72.51 111.23 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -64.94 109.42 1.29 Allowed 'Trans proline' 0 C--N 1.367 1.539 0 C-N-CA 122.458 2.105 . . . . 65.45 110.746 173.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 51.8 t60 -67.3 -44.05 80.16 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.719 0.408 . . . . 72.51 109.994 178.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 119.69 15.08 5.46 Favored Glycine 0 N--CA 1.476 1.356 0 CA-C-N 115.61 -0.723 . . . . 73.33 112.908 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 9.4 m -79.26 157.48 27.76 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.027 0.931 . . . . 73.22 111.728 -173.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -164.86 101.26 0.18 Allowed Glycine 0 C--N 1.352 1.439 0 N-CA-C 111.766 -0.534 . . . . 64.01 111.766 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 176.99 96.57 0.1 Allowed Glycine 0 C--N 1.346 1.105 0 N-CA-C 110.975 -0.85 . . . . 62.2 110.975 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 61.4 p -138.31 144.09 40.26 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.462 1.105 . . . . 63.2 109.868 -175.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 161.49 -84.83 0.11 Allowed Glycine 0 C--N 1.346 1.104 0 N-CA-C 111.134 -0.786 . . . . 64.3 111.134 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.553 ' HA3' ' HB2' ' A' ' 243' ' ' PRO . . . -90.8 82.95 1.3 Allowed Glycine 0 C--N 1.344 0.987 0 C-N-CA 122.884 0.278 . . . . 73.33 112.852 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 64.4 m -119.34 141.13 49.3 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.209 0.603 . . . . 73.32 110.673 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 167.6 172.97 35.28 Favored Glycine 0 CA--C 1.528 0.876 0 O-C-N 123.71 0.631 . . . . 43.43 111.968 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 83.09 -98.29 2.05 Favored Glycine 0 C--N 1.346 1.089 0 N-CA-C 112.042 -0.423 . . . . 75.25 112.042 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.5 m -152.54 35.88 0.51 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.992 0.917 . . . . 72.03 110.623 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.502 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 80.8 mt-30 -59.78 -43.74 94.25 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.792 0.437 . . . . 72.32 111.136 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -89.97 135.2 33.79 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.371 -0.603 . . . . 54.34 109.371 174.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 95.9 mt -131.72 129.09 40.22 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.022 0.929 . . . . 74.44 110.282 -172.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -92.6 119.95 32.55 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.926 -0.768 . . . . 73.23 108.926 173.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -130.73 128.53 41.01 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.703 1.201 . . . . 71.44 109.043 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 88.5 m -69.2 131.11 44.41 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.588 0.755 . . . . 72.43 111.451 -177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 42.3 tp -110.13 116.35 31.37 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.532 1.133 . . . . 75.21 108.476 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -92.11 109.39 20.75 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.475 -0.935 . . . . 75.44 108.475 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 3.4 p -130.92 122.87 19.63 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 124.198 0.999 . . . . 75.13 108.911 -178.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.416 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 38.0 Cg_endo -67.87 156.56 65.44 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.08 1.853 . . . . 74.14 112.109 177.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -48.28 -46.22 67.22 Favored Pre-proline 0 CA--C 1.565 1.552 0 N-CA-C 114.569 1.322 . . . . 52.55 114.569 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.484 ' O ' HG22 ' A' ' 206' ' ' VAL . 17.9 Cg_endo -58.12 -52.7 5.3 Favored 'Trans proline' 0 C--N 1.4 3.283 0 C-N-CA 121.874 1.716 . . . . 74.14 112.245 176.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.8 mt -65.93 -30.88 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.429 0.692 . . . . 73.21 111.446 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.67 -54.64 24.71 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.416 0.686 . . . . 74.22 111.026 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 63.5 t -71.68 -53.52 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-N 115.93 -0.577 . . . . 74.41 111.626 -174.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 202' ' ' PRO . 15.5 m -90.3 -25.02 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 112.805 0.669 . . . . 72.02 112.805 -172.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 100.76 142.8 13.25 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 117.796 0.271 . . . . 61.11 112.639 -176.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -175.19 -141.49 3.73 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 111.149 -0.781 . . . . 74.33 111.149 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -133.27 143.14 48.89 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 117.737 0.768 . . . . 75.35 109.19 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 33.2 m -128.95 169.4 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.647 0.779 . . . . 74.43 110.234 173.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -99.3 112.47 24.63 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.129 0.972 . . . . 75.52 108.513 171.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.58 144.65 30.06 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.8 0.84 . . . . 65.24 109.692 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 21.1 mmt -91.77 103.57 16.12 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 109.039 -0.726 . . . . 74.52 109.039 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 61.7 m -117.88 164.14 15.49 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.639 1.176 . . . . 75.4 108.916 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.0 mt -59.3 -20.0 50.86 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 123.344 0.657 . . . . 75.01 112.048 173.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -81.87 4.72 21.32 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.62 1.168 . . . . 73.21 111.982 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 97.97 -163.74 21.4 Favored Glycine 0 C--N 1.344 1.011 0 C-N-CA 123.488 0.566 . . . . 72.45 111.822 -175.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.16 118.39 5.37 Favored 'Trans proline' 0 C--N 1.365 1.404 0 C-N-CA 122.026 1.818 . . . . 73.52 109.907 172.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 28.7 m -118.13 153.2 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.039 0.536 . . . . 75.31 111.113 -172.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -95.41 111.76 23.59 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.54 0.736 . . . . 73.43 109.37 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 48.7 t -112.58 116.23 52.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 123.837 0.855 . . . . 75.03 109.17 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.57 101.25 2.44 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 109.099 -0.704 . . . . 75.52 109.099 174.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 63.9 t -77.55 121.64 84.66 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.955 0.902 . . . . 65.32 109.472 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.66 169.83 21.42 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.657 2.238 . . . . 61.33 110.936 173.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.96 176.53 2.97 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.633 2.222 . . . . 74.24 113.778 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 55.5 mtm180 70.94 12.05 7.06 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 125.45 1.5 . . . . 73.42 113.081 174.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 12.5 m -72.37 93.35 1.51 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.072 0.949 . . . . 75.42 110.765 -174.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -91.83 140.09 30.03 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.61 1.164 . . . . 63.23 111.007 -173.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -64.23 139.19 58.74 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.259 1.024 . . . . 73.21 111.646 -176.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 93.14 -23.37 29.85 Favored Glycine 0 C--N 1.343 0.934 0 CA-C-N 115.129 -0.941 . . . . 65.53 112.812 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -72.84 145.19 47.12 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 122.909 0.484 . . . . 74.22 110.265 176.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.478 ' HG3' ' HG2' ' A' ' 252' ' ' GLU . 2.6 mppt? -104.44 139.49 39.3 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.827 -1.175 . . . . 71.21 107.827 173.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 42.6 mt -92.24 99.47 12.25 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.221 -1.399 . . . . 72.5 107.221 175.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 46.0 ttm180 -73.04 100.98 3.13 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.117 0.484 . . . . 75.23 109.704 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.566 HD23 ' HA ' ' A' ' 173' ' ' ILE . 17.9 mt -102.21 88.12 3.23 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.136 -1.061 . . . . 75.42 108.136 -178.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -68.38 129.94 41.41 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.07 -0.968 . . . . 74.13 110.519 -175.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 84.67 27.62 34.68 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 123.762 0.664 . . . . 75.04 113.452 -175.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -125.9 -6.86 6.69 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 123.278 0.631 . . . . 74.45 112.651 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -86.79 -155.28 27.11 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 112.363 -0.295 . . . . 75.0 112.363 175.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.502 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 12.8 m-85 -70.46 140.03 87.08 Favored Pre-proline 0 N--CA 1.481 1.116 0 CA-C-N 117.184 0.492 . . . . 74.4 110.358 177.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -66.75 152.9 79.66 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.702 2.268 . . . . 72.24 111.854 174.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -160.71 -170.89 25.92 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 115.477 -0.783 . . . . 63.43 111.619 177.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.553 ' HB2' ' HA3' ' A' ' 186' ' ' GLY . 24.6 Cg_exo -61.89 -32.86 85.29 Favored 'Trans proline' 0 CA--C 1.556 1.58 0 C-N-CA 123.299 2.666 . . . . 71.5 112.749 177.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -87.0 3.71 44.84 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.271 0.629 . . . . 73.03 111.811 177.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 99.29 -167.93 21.7 Favored Glycine 0 C--N 1.342 0.88 0 N-CA-C 111.527 -0.629 . . . . 73.24 111.527 -174.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 28.4 mtm-85 -71.46 139.71 49.75 Favored 'General case' 0 CA--C 1.546 0.788 0 N-CA-C 109.085 -0.709 . . . . 74.43 109.085 174.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.25 -165.18 19.34 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 123.373 0.42 . . . . 74.03 113.696 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -100.3 128.56 46.35 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.095 0.558 . . . . 73.31 109.633 -174.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 28.8 tp -99.04 107.78 20.28 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 107.847 -1.168 . . . . 75.13 107.847 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.429 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 47.8 m-85 -88.04 107.86 18.94 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.761 0.824 . . . . 73.31 109.011 -178.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 41.1 mt -87.08 105.43 17.16 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.441 -0.948 . . . . 74.21 108.441 175.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.478 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 33.3 mt-10 -77.6 94.17 4.33 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.297 -0.865 . . . . 72.0 108.79 -173.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 99.7 t -53.57 112.35 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 124.433 1.093 . . . . 71.03 111.323 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -117.32 100.88 7.98 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 108.094 -1.076 . . . . 74.14 108.094 175.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.46 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 43.0 mt -75.68 107.12 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 O-C-N 124.023 0.827 . . . . 72.43 108.965 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 16.2 p . . . . . 0 C--O 1.26 1.621 0 C-N-CA 124.897 1.279 . . . . 71.12 108.3 -179.066 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 25.1 mmt . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 109.835 -0.432 . . . . 75.5 109.835 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.9 m -81.74 70.77 8.7 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-O 121.696 0.76 . . . . 61.52 111.236 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -87.87 55.26 3.4 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.257 1.023 . . . . 64.43 109.714 175.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.438 HD23 HG22 ' A' ' 221' ' ' VAL . 6.6 mp 53.15 59.21 4.58 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.193 -1.367 . . . . 75.24 110.648 -177.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.542 HH11 ' HB1' ' A' ' 222' ' ' ALA . 30.3 mmm180 -68.62 99.91 1.06 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.231 -1.349 . . . . 73.35 108.975 176.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.611 HG21 HD12 ' A' ' 233' ' ' LEU . 69.1 mt -59.68 -69.87 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 123.488 0.715 . . . . 65.32 110.355 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . 52.42 29.21 6.65 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.204 1.002 . . . . 73.15 113.037 177.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.449 ' H ' HG23 ' A' ' 173' ' ' ILE . . . -64.99 -32.29 73.94 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.257 1.023 . . . . 65.34 112.583 -173.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -74.71 87.99 2.22 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.108 -1.071 . . . . 74.52 108.108 170.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -173.12 153.96 19.41 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 115.509 -0.769 . . . . 73.33 112.135 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.2 -16.66 56.22 Favored 'Trans proline' 0 CA--C 1.557 1.633 0 C-N-CA 123.212 2.608 . . . . 75.41 113.079 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -80.82 11.55 3.84 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.837 0.855 . . . . 70.12 112.824 -176.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -64.81 -28.5 73.47 Favored Glycine 0 N--CA 1.477 1.399 0 N-CA-C 113.773 0.269 . . . . 63.51 113.773 173.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 29.2 m -84.19 140.75 31.51 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.344 0.657 . . . . 70.32 109.775 174.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 163.97 -26.73 0.21 Allowed Glycine 0 C--N 1.347 1.172 0 N-CA-C 112.346 -0.302 . . . . 70.05 112.346 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -71.82 155.93 52.26 Favored Glycine 0 C--N 1.352 1.443 0 CA-C-O 119.843 -0.421 . . . . 65.21 112.625 -178.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 20.3 m -60.49 -43.53 96.91 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.695 0.798 . . . . 73.42 112.248 -176.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -167.71 149.96 15.67 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 111.78 -0.528 . . . . 73.44 111.78 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -101.21 67.47 0.46 Allowed Glycine 0 C--N 1.348 1.196 0 N-CA-C 111.705 -0.558 . . . . 71.24 111.705 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 39.5 m -137.89 119.52 15.04 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.514 0.726 . . . . 71.24 109.374 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -153.64 -68.82 0.01 OUTLIER Glycine 0 C--N 1.343 0.948 0 N-CA-C 111.279 -0.728 . . . . 62.01 111.279 176.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 75.56 9.23 84.67 Favored Glycine 0 C--N 1.346 1.127 0 C-N-CA 122.927 0.298 . . . . 72.12 113.108 -173.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 61.4 m -154.92 -50.05 0.09 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.685 0.794 . . . . 73.01 109.916 -175.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.633 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 23.0 mp0 -69.99 -40.2 75.46 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.695 -0.684 . . . . 73.15 110.863 -176.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -76.68 132.29 39.28 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.888 -0.782 . . . . 71.33 108.888 172.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 91.4 mt -133.05 167.92 19.43 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.234 0.614 . . . . 72.13 110.519 -171.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -121.21 125.87 48.23 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 107.553 -1.277 . . . . 75.22 107.553 168.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -124.08 127.27 47.59 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.606 0.762 . . . . 73.24 109.15 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 43.4 m -67.49 118.46 10.83 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.81 0.844 . . . . 74.41 110.919 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 21.9 tp -109.47 110.78 21.99 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.531 -0.915 . . . . 74.44 108.531 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -88.24 127.25 35.45 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.206 -1.035 . . . . 75.13 108.206 174.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 3.0 p -141.85 127.59 10.84 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 124.298 1.039 . . . . 75.12 108.367 -176.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -69.5 155.25 67.31 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 121.543 1.495 . . . . 74.42 111.346 175.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.419 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -47.21 -50.65 46.43 Favored Pre-proline 0 CA--C 1.559 1.32 0 O-C-N 124.341 1.025 . . . . 72.45 113.657 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -60.72 -48.79 10.0 Favored 'Trans proline' 0 C--N 1.395 2.988 0 C-N-CA 121.933 1.755 . . . . 74.41 112.622 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 44.0 mt -66.56 -27.38 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.645 0.778 . . . . 75.32 111.384 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.33 -47.91 58.9 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.169 0.588 . . . . 74.41 111.194 176.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 201' ' ' ALA . 81.2 t -67.9 -48.91 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.329 0.651 . . . . 71.31 111.841 -176.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.9 p -83.95 -29.1 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 CA-C-N 116.44 -0.346 . . . . 72.33 110.895 -175.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.61 86.07 0.64 Allowed Glycine 0 C--N 1.349 1.265 0 N-CA-C 111.559 -0.616 . . . . 64.4 111.559 -174.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -111.29 -122.94 4.31 Favored Glycine 0 C--N 1.344 1.02 0 N-CA-C 111.953 -0.459 . . . . 63.23 111.953 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 221' ' ' VAL . 95.9 mttt -136.99 149.84 47.76 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.914 0.885 . . . . 73.1 109.601 176.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 23.3 m -136.3 162.84 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 123.247 0.619 . . . . 74.13 111.461 177.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -86.3 106.53 17.43 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.565 0.746 . . . . 74.15 109.171 174.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -109.8 151.55 26.84 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.036 0.534 . . . . 51.03 110.756 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 31.8 mmt -83.55 111.3 18.96 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 123.898 0.749 . . . . 74.22 108.979 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.436 HG22 ' H ' ' A' ' 215' ' ' LEU . 3.4 m -126.83 176.4 7.31 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 108.581 -0.896 . . . . 74.54 108.581 -177.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.436 ' H ' HG22 ' A' ' 214' ' ' THR . 73.8 mt -59.89 -40.88 90.21 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.587 0.755 . . . . 75.24 112.652 -175.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -81.1 -3.38 51.78 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.308 0.643 . . . . 74.42 112.012 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 110.49 -151.76 17.5 Favored Glycine 0 C--N 1.343 0.94 0 CA-C-O 119.544 -0.587 . . . . 74.42 112.251 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.63 126.99 17.06 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 122.627 2.218 . . . . 71.25 112.316 177.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 32.8 m -129.59 162.78 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.509 0.724 . . . . 72.4 110.058 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -95.42 105.55 17.53 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 121.584 0.707 . . . . 72.41 109.991 175.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.438 HG22 HD23 ' A' ' 171' ' ' LEU . 55.3 t -99.77 126.77 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.793 0.837 . . . . 74.32 109.838 -174.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.542 ' HB1' HH11 ' A' ' 172' ' ' ARG . . . -76.63 100.01 5.22 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 123.946 0.779 . . . . 64.44 110.893 -177.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.554 ' HA ' HD11 ' A' ' 173' ' ' ILE . 59.5 t -69.25 141.94 91.98 Favored Pre-proline 0 CA--C 1.56 1.363 0 C-N-CA 125.662 1.585 . . . . 74.02 110.492 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.606 ' HD3' ' HB ' ' A' ' 173' ' ' ILE . 90.0 Cg_endo -76.88 163.12 31.61 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 122.313 2.008 . . . . 64.22 110.855 173.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.55 160.99 45.32 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 121.471 1.447 . . . . 63.53 111.207 172.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 69.24 14.24 8.6 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.762 1.225 . . . . 75.02 112.651 177.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 85.2 m -62.16 113.18 2.71 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.843 0.857 . . . . 74.24 110.438 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -112.92 141.2 47.03 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.916 0.886 . . . . 74.5 110.602 -168.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.52 144.02 57.33 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.778 0.831 . . . . 75.45 111.377 -177.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.03 -22.65 13.56 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.303 -0.862 . . . . 63.11 113.035 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -79.58 150.32 31.1 Favored 'General case' 0 C--N 1.351 0.657 0 N-CA-C 109.438 -0.578 . . . . 63.24 109.438 173.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.655 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.4 mppt? -114.53 142.87 45.84 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.041 0.536 . . . . 74.02 109.852 177.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.611 HD12 HG21 ' A' ' 173' ' ' ILE . 46.2 mt -100.09 99.42 10.14 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.683 -0.858 . . . . 73.54 108.683 -176.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 27.3 ttm-85 -75.06 113.97 13.0 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 123.479 0.487 . . . . 75.21 109.936 -176.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.608 HD21 HG22 ' A' ' 173' ' ' ILE . 46.0 mt -120.54 102.06 8.17 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.509 0.724 . . . . 72.44 109.237 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -67.62 140.12 56.87 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.879 0.472 . . . . 74.24 111.581 -176.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.4 ' HA2' ' HB2' ' A' ' 246' ' ' ARG . . . 84.32 9.83 81.17 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 115.788 -0.642 . . . . 61.53 114.302 178.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -104.65 -16.47 14.98 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 117.682 0.741 . . . . 74.24 111.8 -176.802 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -81.15 -161.69 27.19 Favored Glycine 0 CA--C 1.535 1.293 0 O-C-N 123.535 0.522 . . . . 45.14 112.86 173.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.633 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 27.8 m-85 -65.98 151.28 95.54 Favored Pre-proline 0 N--CA 1.487 1.395 0 C-N-CA 123.373 0.669 . . . . 75.42 111.657 -178.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.491 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 37.9 Cg_endo -64.6 128.99 22.41 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.885 2.39 . . . . 73.04 112.708 176.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -98.32 -156.06 29.58 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 119.233 -0.759 . . . . 44.32 112.19 176.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -59.11 -61.32 0.25 Allowed 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 122.977 2.451 . . . . 73.43 112.497 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -122.22 -13.08 8.18 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.686 0.794 . . . . 64.22 111.941 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -142.15 146.39 17.35 Favored Glycine 0 C--N 1.344 0.984 0 N-CA-C 111.732 -0.547 . . . . 75.33 111.732 -178.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.491 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 86.8 mtt180 -74.87 162.72 28.38 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.597 0.759 . . . . 74.14 110.231 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.8 173.98 55.27 Favored Glycine 0 C--N 1.342 0.916 0 CA-C-N 115.94 -0.573 . . . . 60.22 112.969 177.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -103.44 130.95 50.89 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.742 0.817 . . . . 70.44 110.631 -175.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 53.5 tp -102.94 117.42 34.56 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 123.86 0.864 . . . . 62.55 109.118 -173.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.655 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 19.5 m-85 -89.12 111.74 22.56 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.473 -0.936 . . . . 75.13 108.473 177.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 60.0 mt -85.85 111.57 20.31 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.642 -0.873 . . . . 75.22 108.642 175.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.411 ' HA ' ' HG3' ' A' ' 232' ' ' LYS . 31.6 mt-10 -76.05 101.43 5.28 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.237 -0.892 . . . . 74.23 108.971 -175.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 44.9 t -61.58 111.39 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 O-C-N 123.577 0.548 . . . . 73.42 110.84 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -114.0 93.6 4.44 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 106.598 -1.63 . . . . 75.41 106.598 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 26.9 mt -76.25 118.07 21.96 Favored 'Isoleucine or valine' 0 C--N 1.349 0.586 0 N-CA-C 109.405 -0.591 . . . . 75.13 109.405 -177.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 19.6 p . . . . . 0 C--O 1.253 1.275 0 C-N-CA 125.232 1.413 . . . . 65.44 107.922 -176.751 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 28.5 mmt . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 110.473 -0.195 . . . . 75.22 110.473 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 32.9 m -95.8 -83.72 0.36 Allowed 'General case' 0 C--N 1.35 0.607 0 N-CA-C 108.379 -0.971 . . . . 70.02 108.379 167.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 58.03 18.99 5.56 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.582 1.153 . . . . 74.34 112.837 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 8.6 mp -61.24 87.3 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 123.196 0.598 . . . . 63.41 110.429 -176.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -78.94 135.32 36.92 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.272 0.629 . . . . 75.15 109.493 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.735 HD11 ' HA ' ' A' ' 223' ' ' VAL . 97.4 mt -84.8 -73.44 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-N 115.582 -0.735 . . . . 70.13 110.32 -176.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . 61.03 5.35 0.99 Allowed 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 113.925 1.083 . . . . 62.43 113.925 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.544 ' H ' HG22 ' A' ' 173' ' ' ILE . . . -70.56 -21.24 62.72 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.135 0.974 . . . . 72.52 112.108 -172.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.444 ' HE1' ' HA ' ' A' ' 227' ' ' THR . 12.3 m-30 -70.62 104.36 2.79 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.597 -0.52 . . . . 75.1 109.597 173.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 145.4 175.7 18.74 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.382 -1.087 . . . . 74.35 110.382 -176.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.3 -29.07 72.6 Favored 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 122.766 2.311 . . . . 75.2 112.867 175.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -143.74 129.36 19.18 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.544 0.738 . . . . 72.45 109.875 178.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -88.64 -91.51 1.11 Allowed Glycine 0 C--N 1.348 1.205 0 N-CA-C 110.543 -1.023 . . . . 53.45 110.543 172.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 36.7 t -86.23 123.61 31.69 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.705 -0.85 . . . . 71.54 108.705 171.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -94.14 31.9 6.32 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-O 119.694 -0.503 . . . . 71.2 113.901 -175.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -69.2 91.87 0.3 Allowed Glycine 0 C--N 1.351 1.395 0 N-CA-C 111.384 -0.687 . . . . 73.44 111.384 174.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 25.9 t -62.72 93.73 0.06 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.092 0.957 . . . . 65.11 111.362 -174.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.415 ' HA3' ' HB2' ' A' ' 244' ' ' ALA . . . -121.08 2.17 11.64 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 115.344 -0.844 . . . . 72.42 112.102 176.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 70.9 -85.28 0.38 Allowed Glycine 0 C--N 1.351 1.398 0 N-CA-C 111.885 -0.486 . . . . 73.15 111.885 -175.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.3 p -171.51 153.94 3.65 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.586 1.154 . . . . 74.31 109.528 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -111.78 -43.54 0.95 Allowed Glycine 0 C--N 1.344 1.0 0 N-CA-C 112.165 -0.374 . . . . 54.32 112.165 177.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 140.56 -131.47 5.01 Favored Glycine 0 C--N 1.354 1.545 0 C-N-CA 123.186 0.422 . . . . 73.12 112.238 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 27.5 m -81.92 25.32 0.57 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.949 0.9 . . . . 73.21 112.04 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -81.24 1.82 30.65 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.945 0.898 . . . . 74.42 112.154 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -80.1 159.43 26.1 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.623 0.769 . . . . 72.43 110.934 174.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 49.2 mt -139.35 150.68 45.63 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.79 0.836 . . . . 74.12 109.832 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -107.49 122.21 46.17 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.973 -0.751 . . . . 73.41 108.973 173.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -129.41 137.13 50.74 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.438 0.695 . . . . 74.13 109.248 178.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 96.2 m -71.73 131.67 43.45 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.862 0.465 . . . . 72.41 110.815 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 53.8 tp -108.25 123.88 49.44 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.255 -1.017 . . . . 70.1 108.255 175.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -88.65 117.53 27.68 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 108.488 -0.93 . . . . 61.43 108.488 176.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 4.4 p -140.48 125.84 11.3 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 109.057 -0.72 . . . . 72.41 109.057 178.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.61 154.41 54.76 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 122.136 1.891 . . . . 74.52 111.749 175.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.68 -45.34 91.56 Favored Pre-proline 0 CA--C 1.562 1.427 0 N-CA-C 114.629 1.344 . . . . 73.32 114.629 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -56.24 -52.69 6.64 Favored 'Trans proline' 0 C--N 1.392 2.827 0 C-N-CA 121.914 1.743 . . . . 72.54 113.099 174.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 32.8 mt -67.02 -27.66 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.218 0.607 . . . . 75.52 111.167 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.31 -48.83 69.08 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-O 121.26 0.553 . . . . 44.5 110.839 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 71.1 t -69.21 -46.29 77.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-N 115.798 -0.637 . . . . 74.52 111.764 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 14.4 m -86.6 -29.87 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 112.287 0.477 . . . . 71.23 112.287 -172.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.89 116.39 0.54 Allowed Glycine 0 CA--C 1.531 1.053 0 O-C-N 123.322 0.389 . . . . 64.23 113.298 -173.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -165.11 -177.68 37.78 Favored Glycine 0 N--CA 1.473 1.108 0 N-CA-C 111.687 -0.565 . . . . 72.24 111.687 176.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.57 ' HZ1' ' HB2' ' A' ' 209' ' ' LYS . 9.7 mtmp? -80.86 136.01 36.01 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 118.113 0.957 . . . . 75.11 109.994 -176.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 27.6 m -124.91 168.56 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 123.644 0.778 . . . . 73.31 111.15 178.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 55.2 ttp85 -83.4 131.65 35.03 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.288 -0.869 . . . . 75.35 110.019 173.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -134.35 159.74 40.07 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.25 0.62 . . . . 63.12 110.457 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 15.9 tpt -88.0 123.4 32.67 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.13 0.572 . . . . 72.51 110.717 -177.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.403 HG23 ' H ' ' A' ' 216' ' ' GLU . 50.8 m -144.52 161.06 40.03 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.964 0.906 . . . . 70.35 108.652 178.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 68.2 mt -63.78 -19.15 64.77 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.8 0.84 . . . . 73.53 111.763 176.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.403 ' H ' HG23 ' A' ' 214' ' ' THR . 3.2 mp0 -93.51 15.06 16.88 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.828 1.251 . . . . 74.31 111.155 175.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 90.54 -164.85 30.71 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-O 119.746 -0.475 . . . . 73.2 113.297 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.31 118.93 5.92 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.575 2.184 . . . . 72.34 111.616 174.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.7 m -113.06 149.78 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 123.023 0.529 . . . . 70.52 110.882 -176.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -82.29 114.85 21.06 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.643 0.777 . . . . 74.41 110.227 177.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 98.4 t -109.16 116.36 51.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.96 0.904 . . . . 72.01 109.308 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.84 100.64 2.44 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.573 0.749 . . . . 72.43 110.563 -177.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.735 ' HA ' HD11 ' A' ' 173' ' ' ILE . 69.4 t -77.35 134.61 66.48 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 124.54 1.136 . . . . 74.25 110.273 178.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.88 171.54 17.8 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 122.958 2.439 . . . . 75.02 110.905 172.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -71.38 168.52 23.24 Favored 'Trans proline' 0 C--N 1.366 1.485 0 CA-C-N 120.614 1.255 . . . . 71.23 111.3 170.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 14.9 mtm180 66.92 20.21 10.54 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 124.042 0.937 . . . . 75.22 112.29 173.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.444 ' HA ' ' HE1' ' A' ' 176' ' ' TYR . 99.8 m -69.56 113.28 6.7 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.698 0.799 . . . . 73.51 111.011 -178.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -115.32 141.81 47.54 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.112 -0.949 . . . . 75.12 110.125 -169.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.45 133.81 54.57 Favored 'General case' 0 C--N 1.35 0.611 0 C-N-CA 123.58 0.752 . . . . 74.24 111.665 -176.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.71 -15.12 61.28 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-N 115.332 -0.849 . . . . 54.2 113.159 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -77.02 124.6 28.02 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.798 0.439 . . . . 72.41 110.143 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.4 mppt? -88.05 143.9 26.82 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.041 0.536 . . . . 75.1 110.022 173.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.563 HD11 HD13 ' A' ' 173' ' ' ILE . 33.9 mt -109.27 103.28 12.21 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.299 -0.864 . . . . 74.21 109.224 -173.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -69.91 103.48 2.24 Favored 'General case' 0 CA--C 1.551 1.006 0 O-C-N 124.096 0.872 . . . . 74.43 111.121 -176.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 32.4 mt -119.45 94.34 4.38 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.611 0.764 . . . . 72.13 110.223 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 248' ' ' ASP . 44.5 mtmt -71.26 154.62 41.5 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.703 0.401 . . . . 72.33 111.289 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 82.11 18.4 67.29 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-N 115.992 -0.549 . . . . 60.43 113.987 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.487 ' HA ' ' HE2' ' A' ' 238' ' ' LYS . 11.3 mmpt? -118.87 -41.34 2.78 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 123.461 0.704 . . . . 71.04 111.718 -177.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -71.91 -153.97 1.83 Allowed Glycine 0 N--CA 1.485 1.916 0 N-CA-C 114.625 0.61 . . . . 73.24 114.625 -176.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -64.05 136.9 96.94 Favored Pre-proline 0 N--CA 1.485 1.296 0 C-N-CA 123.517 0.727 . . . . 74.41 110.813 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.701 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 18.6 Cg_endo -56.96 125.93 20.59 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 123.204 2.603 . . . . 74.41 113.97 -174.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -126.18 -169.84 12.88 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.505 -0.77 . . . . 62.32 113.311 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -69.25 -12.8 34.72 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 123.098 2.532 . . . . 70.11 112.611 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.415 ' HB2' ' HA3' ' A' ' 185' ' ' GLY . . . -102.42 23.3 12.04 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.491 1.116 . . . . 75.43 110.992 177.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 98.39 -87.62 0.83 Allowed Glycine 0 C--N 1.345 1.061 0 N-CA-C 110.473 -1.051 . . . . 63.14 110.473 -174.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.701 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 28.8 mtm180 -125.57 172.82 9.41 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 123.238 0.615 . . . . 74.51 109.774 172.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -84.25 -158.73 28.4 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 114.922 -1.035 . . . . 74.52 113.565 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 236' ' ' LYS . 2.5 t0 -99.77 162.09 13.21 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.836 0.454 . . . . 54.43 109.95 -170.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 40.6 tp -141.98 108.78 5.4 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 108.271 -1.011 . . . . 62.03 108.271 173.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.487 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 78.4 m-85 -88.74 108.13 19.32 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 108.732 -0.84 . . . . 75.11 108.732 175.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.451 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 38.9 mt -86.92 114.98 24.01 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.704 -0.85 . . . . 74.34 108.704 177.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -78.26 102.92 7.88 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.781 0.832 . . . . 73.51 109.365 -178.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 84.7 t -56.0 111.97 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 O-C-N 123.771 0.669 . . . . 74.04 110.68 175.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -113.4 101.8 9.72 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.288 -1.004 . . . . 73.15 108.288 172.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 37.1 mt -76.34 103.7 3.93 Favored 'Isoleucine or valine' 0 C--N 1.35 0.621 0 O-C-N 124.206 0.941 . . . . 65.34 109.004 177.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 46.7 p . . . . . 0 C--O 1.254 1.326 0 CA-C-N 115.506 -0.77 . . . . 73.32 109.07 176.09 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 87.9 mtp . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.72 0.295 . . . . 75.43 110.205 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 45.4 t -148.13 151.28 35.33 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 123.896 0.878 . . . . 74.15 108.962 176.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -67.05 -49.95 63.45 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 123.916 0.76 . . . . 63.13 109.179 174.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.452 ' HA ' ' HD2' ' A' ' 238' ' ' LYS . 6.5 mp -89.41 71.8 8.05 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.448 -0.945 . . . . 75.52 108.448 172.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.06 105.74 5.43 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 107.364 -1.347 . . . . 73.32 107.364 176.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.599 HD12 ' HA ' ' A' ' 223' ' ' VAL . 49.3 mt -72.85 100.12 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.207 0.527 . . . . 74.53 110.788 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -92.74 35.33 1.04 Allowed 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.144 -0.934 . . . . 70.02 109.625 171.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -121.71 177.7 5.15 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.713 1.205 . . . . 74.55 108.789 176.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.551 ' HH ' ' HD2' ' A' ' 231' ' ' ARG . 24.2 m-85 66.83 19.64 10.66 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.543 1.137 . . . . 72.01 110.846 -164.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -110.57 -132.59 6.23 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-O 119.155 -0.803 . . . . 63.31 111.866 -178.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -86.14 171.28 7.92 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 122.876 2.384 . . . . 75.54 113.315 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -127.38 123.49 36.33 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.322 1.049 . . . . 73.34 109.715 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 153.15 -32.78 0.79 Allowed Glycine 0 C--N 1.343 0.94 0 N-CA-C 111.71 -0.556 . . . . 44.23 111.71 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 22.9 p -67.36 102.68 1.13 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.508 0.723 . . . . 75.14 109.314 175.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 148.72 59.63 0.01 OUTLIER Glycine 0 C--N 1.338 0.656 0 N-CA-C 109.711 -1.356 . . . . 71.04 109.711 -173.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -129.26 -7.55 3.96 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.329 -0.436 . . . . 74.35 113.195 -178.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 95.6 p -73.92 152.62 40.1 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 117.182 0.491 . . . . 74.43 110.06 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -82.73 79.34 1.91 Allowed Glycine 0 CA--C 1.528 0.855 0 CA-C-O 119.81 -0.439 . . . . 64.41 112.677 -177.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -68.78 111.13 3.76 Favored Glycine 0 C--N 1.356 1.679 0 N-CA-C 111.741 -0.544 . . . . 74.21 111.741 176.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 48.0 m -125.04 102.46 7.52 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.7 0.8 . . . . 70.52 110.594 -177.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -163.02 -45.04 0.02 OUTLIER Glycine 0 C--N 1.338 0.693 0 N-CA-C 111.901 -0.479 . . . . 72.35 111.901 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 124.92 -132.02 7.97 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 111.365 -0.694 . . . . 74.42 111.365 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 67.5 m -88.52 68.79 8.83 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.369 0.668 . . . . 65.31 112.063 -175.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.59 -20.86 24.45 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 108.786 -0.82 . . . . 72.54 108.786 162.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -75.83 130.4 38.51 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.656 1.583 . . . . 74.54 108.943 176.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.454 HD13 ' HA2' ' A' ' 239' ' ' GLY . 92.8 mt -135.67 163.91 29.07 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.861 0.864 . . . . 73.32 110.697 -175.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -121.52 153.5 37.9 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.252 1.021 . . . . 62.04 108.962 171.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.422 ' HB1' HD13 ' A' ' 249' ' ' LEU . . . -152.78 171.29 18.47 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.551 1.14 . . . . 64.34 109.366 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 25.0 m -106.8 131.68 53.64 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.489 0.716 . . . . 70.45 109.485 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.712 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 42.8 tp -109.02 113.84 27.06 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.594 0.758 . . . . 74.22 109.008 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -83.66 116.85 22.83 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 107.75 -1.204 . . . . 73.35 107.75 172.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.433 HG13 HG12 ' A' ' 253' ' ' VAL . 2.4 p -138.15 120.54 10.85 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 123.794 0.837 . . . . 73.13 109.281 -178.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.1 158.42 56.58 Favored 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 122.218 1.946 . . . . 73.24 112.311 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.38 -48.56 85.8 Favored Pre-proline 0 CA--C 1.565 1.545 0 C-N-CA 124.459 1.103 . . . . 74.13 113.87 -177.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.469 ' O ' HG13 ' A' ' 206' ' ' VAL . 53.7 Cg_exo -54.24 -54.38 4.77 Favored 'Trans proline' 0 C--N 1.401 3.296 0 C-N-CA 122.377 2.051 . . . . 72.51 112.687 175.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 58.1 mt -67.62 -27.98 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.267 0.627 . . . . 62.14 111.041 -176.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.59 -41.59 96.15 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.199 -0.455 . . . . 75.01 110.416 176.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 64.3 t -74.86 -57.57 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 CA-C-N 116.545 -0.298 . . . . 74.34 111.63 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 202' ' ' PRO . 12.4 p -93.14 -28.48 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 112.666 0.617 . . . . 74.13 112.666 -167.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 98.12 144.99 18.05 Favored Glycine 0 N--CA 1.477 1.388 0 C-N-CA 122.472 0.082 . . . . 71.34 113.183 -177.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 170.23 -167.76 40.84 Favored Glycine 0 N--CA 1.472 1.058 0 N-CA-C 110.664 -0.974 . . . . 74.13 110.664 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.542 ' HB2' ' HZ3' ' A' ' 209' ' ' LYS . 8.8 mtmp? -96.88 138.28 34.68 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 118.336 1.068 . . . . 73.13 110.939 175.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 15.4 m -119.85 170.19 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.448 1.099 . . . . 70.24 109.764 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -102.03 112.24 24.82 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 110.021 -0.363 . . . . 75.3 110.021 174.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -105.34 166.44 10.42 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.983 0.913 . . . . 64.44 109.817 171.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 91.3 mmm -101.96 132.81 47.55 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 120.911 0.386 . . . . 70.54 110.276 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 88.1 m -132.79 167.51 20.03 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.869 1.268 . . . . 63.43 108.547 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 82.6 mt -54.83 -38.78 67.83 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.991 0.917 . . . . 74.01 112.665 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -78.25 -15.6 58.63 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.063 0.545 . . . . 72.13 111.799 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 132.78 -164.27 24.07 Favored Glycine 0 C--N 1.344 1.027 0 O-C-N 123.617 0.573 . . . . 74.42 111.727 -177.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.47 128.72 12.16 Favored 'Trans proline' 0 CA--C 1.555 1.538 0 C-N-CA 122.79 2.327 . . . . 62.24 112.007 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.32 159.89 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.322 1.049 . . . . 72.31 110.015 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 37.7 mt-10 -84.83 147.47 26.8 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 122.78 0.432 . . . . 74.45 110.599 169.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.424 HG21 ' HB2' ' A' ' 171' ' ' LEU . 96.9 t -130.75 124.23 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.163 1.385 . . . . 65.0 108.46 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -77.59 99.28 5.69 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 108.937 -0.764 . . . . 73.35 108.937 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.599 ' HA ' HD12 ' A' ' 173' ' ' ILE . 88.2 t -96.2 123.33 55.34 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.504 1.122 . . . . 74.02 110.566 -175.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.0 164.2 36.42 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.739 2.292 . . . . 74.42 111.384 175.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.87 177.0 0.37 Allowed 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 122.714 2.276 . . . . 65.22 113.418 174.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 24.0 mtp180 66.03 20.63 11.27 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.35 1.06 . . . . 73.41 112.324 174.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -68.86 88.69 0.38 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.686 0.794 . . . . 62.41 110.473 -173.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 -86.28 131.3 34.25 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.894 1.278 . . . . 73.3 110.573 -172.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.99 120.29 8.82 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.407 1.083 . . . . 62.34 111.97 -175.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.0 -4.51 41.72 Favored Glycine 0 N--CA 1.473 1.148 0 O-C-N 123.835 0.71 . . . . 73.42 114.386 176.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.551 ' HD2' ' HH ' ' A' ' 176' ' ' TYR . 96.5 mtt180 -84.62 157.32 21.2 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 117.552 0.676 . . . . 72.25 109.977 173.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.701 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.5 mppt? -127.3 131.55 50.47 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.943 -0.762 . . . . 74.21 108.943 -172.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.464 HD23 ' CE2' ' A' ' 176' ' ' TYR . 20.4 mt -108.56 102.43 11.5 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.601 -0.727 . . . . 74.43 109.791 -166.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -70.48 103.69 2.54 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.117 1.367 . . . . 75.13 110.939 -173.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.559 HD11 HG12 ' A' ' 173' ' ' ILE . 26.6 mt -118.19 100.16 7.33 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 122.944 0.498 . . . . 73.43 112.045 -175.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -56.52 142.06 40.51 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.162 0.801 . . . . 71.24 113.162 169.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 100.09 -14.12 60.04 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-N 113.649 -1.614 . . . . 74.44 112.665 174.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 171' ' ' LEU . 11.4 mmpt? -99.89 -20.04 16.34 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.918 0.487 . . . . 73.2 111.967 -171.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . 0.454 ' HA2' HD13 ' A' ' 193' ' ' LEU . . . -77.92 -162.26 18.5 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.496 0.498 . . . . 70.51 113.656 177.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -80.77 154.64 73.34 Favored Pre-proline 0 N--CA 1.487 1.407 0 C-N-CA 123.2 0.6 . . . . 61.12 111.022 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -48.35 130.81 21.86 Favored 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 123.8 3.0 . . . . 75.34 114.302 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -138.89 -177.4 15.36 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 119.732 -0.482 . . . . 72.15 112.917 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -64.94 -35.31 44.36 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 124.138 3.225 . . . . 74.34 113.863 -172.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -106.87 7.98 30.42 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.634 0.774 . . . . 75.34 111.006 -177.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 127.37 175.09 13.97 Favored Glycine 0 C--N 1.341 0.82 0 N-CA-C 111.229 -0.748 . . . . 62.43 111.229 -174.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 30.2 mtm180 -59.03 129.14 40.72 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.892 -0.781 . . . . 74.31 108.892 175.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -67.29 -156.84 0.63 Allowed Glycine 0 C--N 1.341 0.858 0 O-C-N 123.865 0.728 . . . . 75.45 114.835 -170.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -96.23 160.85 14.22 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.263 0.554 . . . . 74.13 110.406 -170.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.422 HD13 ' HB1' ' A' ' 195' ' ' ALA . 31.1 tp -137.52 114.68 10.86 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.3 -1.37 . . . . 62.23 107.3 175.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.701 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 1.9 m-85 -91.18 108.84 20.14 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.994 -0.743 . . . . 74.43 108.994 -177.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.712 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 43.2 mt -86.36 107.49 18.03 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.548 -0.538 . . . . 75.32 109.548 -178.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -82.95 108.48 16.31 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.027 -0.988 . . . . 74.24 110.183 -174.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.433 HG12 HG13 ' A' ' 199' ' ' VAL . 61.1 t -56.3 120.16 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 C-N-CA 125.337 1.455 . . . . 64.22 112.581 -173.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 53.4 mmt-85 -114.8 96.91 5.95 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.724 1.21 . . . . 74.11 108.001 170.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 53.8 mt -74.89 103.85 2.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.936 -1.135 . . . . 71.11 107.936 175.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 25.3 p . . . . . 0 CA--C 1.555 1.166 0 N-CA-C 108.727 -0.842 . . . . 72.42 108.727 174.497 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 22.9 ptp . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 112.368 0.507 . . . . 74.12 112.368 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 49.5 m -63.99 132.45 50.68 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 123.036 0.534 . . . . 74.31 111.278 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -81.05 134.69 35.71 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.042 0.537 . . . . 75.42 109.599 176.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 6.3 mp -80.89 101.32 9.36 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.504 -0.925 . . . . 74.44 108.504 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.489 ' HA ' ' HB1' ' A' ' 222' ' ' ALA . 45.8 mtm180 -87.82 144.19 26.73 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 110.068 -0.345 . . . . 74.2 110.068 177.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.635 HG23 ' H ' ' A' ' 175' ' ' ALA . 75.8 mt -87.62 -74.1 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 115.558 -0.746 . . . . 62.2 110.189 177.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . 66.25 -7.75 0.39 Allowed 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 125.346 1.459 . . . . 70.21 113.382 -176.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.635 ' H ' HG23 ' A' ' 173' ' ' ILE . . . -70.54 -3.69 19.3 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.53 1.132 . . . . 41.52 112.897 -174.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.534 ' CZ ' ' HA ' ' A' ' 227' ' ' THR . 8.5 m-85 -84.99 7.69 20.39 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.07 0.548 . . . . 74.44 111.109 169.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -132.19 -172.13 12.97 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-O 119.404 -0.664 . . . . 72.22 112.682 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -57.98 -50.78 9.29 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 123.513 2.809 . . . . 63.54 112.359 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -83.64 111.31 19.01 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.515 -0.766 . . . . 74.32 109.723 175.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -85.72 -99.54 0.73 Allowed Glycine 0 C--N 1.341 0.84 0 N-CA-C 110.423 -1.071 . . . . 55.14 110.423 169.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.2 t -139.8 154.14 47.29 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 108.455 -0.943 . . . . 74.44 108.455 171.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -80.68 -147.66 5.26 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 123.531 0.519 . . . . 75.25 113.657 -173.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 175.23 -173.24 46.12 Favored Glycine 0 C--N 1.342 0.873 0 N-CA-C 112.018 -0.433 . . . . 75.32 112.018 -178.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 20.7 m -77.8 -17.1 57.84 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.71 0.804 . . . . 72.22 111.515 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 113.22 -6.69 25.08 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-O 119.431 -0.649 . . . . 74.24 114.102 172.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.427 ' HA3' ' HB1' ' A' ' 244' ' ' ALA . . . -112.91 141.6 16.96 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-N 117.6 0.7 . . . . 61.25 111.673 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 26.4 t -85.84 82.23 8.25 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.019 -0.734 . . . . 72.14 109.019 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -163.14 67.73 0.23 Allowed Glycine 0 C--N 1.343 0.968 0 CA-C-N 115.398 -0.819 . . . . 72.35 111.314 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -130.99 60.09 0.68 Allowed Glycine 0 C--N 1.341 0.834 0 CA-C-N 114.897 -0.652 . . . . 70.02 112.253 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 31.2 m -68.09 -4.42 13.54 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.934 0.894 . . . . 71.42 112.09 174.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.662 ' HB3' ' HB2' ' A' ' 240' ' ' PHE . 85.9 mm-40 -81.41 26.27 0.47 Allowed 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.527 1.131 . . . . 75.41 111.654 172.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -75.67 154.09 36.76 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.086 0.954 . . . . 71.33 110.739 -178.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 87.9 mt -131.93 158.56 41.09 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.767 0.827 . . . . 65.21 110.051 -173.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -115.0 124.2 51.04 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.994 -1.113 . . . . 74.33 107.994 173.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -124.94 129.31 50.11 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.374 -0.973 . . . . 75.13 108.374 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 42.3 m -68.39 126.29 29.13 Favored 'General case' 0 C--O 1.242 0.708 0 O-C-N 123.517 0.511 . . . . 74.15 110.22 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.444 HD11 ' HB3' ' A' ' 212' ' ' ALA . 46.0 tp -106.84 109.95 21.98 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.034 -1.469 . . . . 73.0 107.034 177.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -92.17 118.04 30.45 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.242 -1.021 . . . . 54.4 108.242 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.434 HG21 HG12 ' A' ' 210' ' ' VAL . 5.7 p -137.85 131.71 17.02 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 123.335 0.654 . . . . 74.12 109.784 -176.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -76.34 157.81 37.09 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.241 1.961 . . . . 74.44 111.701 172.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -55.0 -46.23 99.7 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 124.415 1.086 . . . . 71.31 113.543 -176.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.439 ' O ' HG13 ' A' ' 206' ' ' VAL . 71.2 Cg_exo -53.56 -54.99 3.98 Favored 'Trans proline' 0 C--N 1.402 3.381 0 C-N-CA 122.272 1.981 . . . . 73.1 112.78 174.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 48.7 mt -69.84 -21.03 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.3 0.64 . . . . 75.51 110.756 -176.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.2 -48.52 56.77 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.851 0.46 . . . . 72.13 110.342 176.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.0 -55.69 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 CA-C-N 115.959 -0.564 . . . . 75.32 111.431 -177.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.439 HG13 ' O ' ' A' ' 202' ' ' PRO . 14.6 p -87.15 -32.21 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 N-CA-C 112.611 0.597 . . . . 75.23 112.611 -172.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 101.53 166.68 27.48 Favored Glycine 0 N--CA 1.477 1.374 0 N-CA-C 112.076 -0.41 . . . . 74.01 112.076 -173.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 163.43 -131.94 2.6 Favored Glycine 0 C--N 1.345 1.032 0 N-CA-C 111.456 -0.658 . . . . 64.14 111.456 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -137.86 139.05 39.69 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.655 1.182 . . . . 75.41 108.594 174.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.434 HG12 HG21 ' A' ' 199' ' ' VAL . 32.3 m -136.53 168.02 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 122.956 0.502 . . . . 71.0 110.563 178.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 29.3 ttm-85 -87.51 113.19 22.98 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.763 -0.653 . . . . 73.53 109.887 178.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.444 ' HB3' HD11 ' A' ' 197' ' ' LEU . . . -105.79 158.42 16.75 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.842 0.857 . . . . 73.21 110.238 173.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 36.8 tpp -93.26 110.68 22.2 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.923 -0.769 . . . . 74.43 108.923 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 60.5 m -126.0 163.88 22.05 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.308 1.043 . . . . 74.53 109.815 -175.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 95.6 mt -61.81 -17.25 55.49 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.968 0.907 . . . . 74.31 112.965 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -96.59 8.39 44.26 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.471 0.708 . . . . 65.4 111.485 177.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 102.42 -164.01 16.66 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-O 119.708 -0.495 . . . . 64.21 112.129 -176.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.36 118.12 5.07 Favored 'Trans proline' 0 C--N 1.367 1.537 0 C-N-CA 122.124 1.883 . . . . 75.23 110.906 175.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.7 m -118.42 157.29 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 123.478 0.711 . . . . 75.31 110.51 -175.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -90.56 108.83 20.05 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.148 -0.686 . . . . 61.52 109.148 173.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 94.3 t -97.8 129.06 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.091 0.956 . . . . 73.34 109.942 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.489 ' HB1' ' HA ' ' A' ' 172' ' ' ARG . . . -69.88 103.09 2.12 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.999 0.92 . . . . 65.25 110.142 176.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.522 ' HA ' HD12 ' A' ' 173' ' ' ILE . 97.2 t -89.97 125.96 58.93 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 124.088 0.955 . . . . 74.23 110.166 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -78.18 171.44 17.06 Favored 'Trans proline' 0 CA--C 1.561 1.846 0 C-N-CA 123.163 2.575 . . . . 65.32 111.617 173.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.21 174.25 8.33 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.095 1.863 . . . . 74.24 113.694 174.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 67.16 15.37 10.03 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 125.903 1.681 . . . . 75.43 112.505 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.534 ' HA ' ' CZ ' ' A' ' 176' ' ' TYR . 93.9 m -64.75 100.96 0.43 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.523 0.729 . . . . 73.34 110.139 -176.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -101.83 137.26 40.36 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 125.135 1.374 . . . . 75.25 110.323 -174.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.92 132.9 53.65 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.568 1.147 . . . . 62.24 110.993 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.03 -1.55 67.93 Favored Glycine 0 C--N 1.337 0.613 0 O-C-N 123.849 0.718 . . . . 63.5 113.281 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -86.86 151.2 23.54 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 109.605 -0.517 . . . . 75.45 109.605 170.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.505 ' HG3' ' HA ' ' A' ' 252' ' ' GLU . 3.8 mppt? -131.67 139.03 48.96 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.279 -1.008 . . . . 73.42 108.279 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.563 HD11 HG21 ' A' ' 173' ' ' ILE . 29.1 mt -118.05 109.24 16.2 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.287 0.635 . . . . 74.32 110.309 -161.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 45.1 ttm-85 -76.96 108.9 10.35 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 124.057 0.848 . . . . 73.21 110.16 -174.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.43 HD22 HG22 ' A' ' 173' ' ' ILE . 21.8 mt -107.03 89.79 3.11 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.591 -0.892 . . . . 71.53 108.591 176.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.497 ' HG2' ' HB3' ' A' ' 248' ' ' ASP . 10.6 mtmp? -67.1 136.08 54.61 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.416 -0.357 . . . . 71.13 111.147 -177.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 95.24 -0.83 64.16 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 115.319 -0.855 . . . . 63.42 113.456 -175.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.543 ' HA ' ' HE2' ' A' ' 238' ' ' LYS . 10.4 mmpt? -106.55 -9.26 16.67 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 113.277 0.844 . . . . 71.01 113.277 -175.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.11 179.53 50.93 Favored Glycine 0 N--CA 1.476 1.334 0 N-CA-C 111.571 -0.612 . . . . 62.4 111.571 167.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.662 ' HB2' ' HB3' ' A' ' 191' ' ' GLN . 33.3 m-85 -60.28 154.33 53.29 Favored Pre-proline 0 N--CA 1.489 1.477 0 C-N-CA 123.42 0.688 . . . . 73.22 111.812 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.79 129.36 24.54 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.477 2.118 . . . . 62.44 112.83 177.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -119.33 -175.22 15.96 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-O 119.451 -0.638 . . . . 63.41 112.256 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -60.13 -46.57 18.26 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 123.462 2.775 . . . . 71.22 112.974 -177.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.427 ' HB1' ' HA3' ' A' ' 186' ' ' GLY . . . -98.6 22.34 10.03 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.362 0.665 . . . . 53.12 111.031 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 111.44 178.56 20.24 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 115.625 -0.716 . . . . 75.12 112.449 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -63.11 142.58 58.33 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.673 0.789 . . . . 75.42 110.659 -177.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -69.48 -175.46 13.39 Favored Glycine 0 C--N 1.343 0.967 0 O-C-N 123.998 0.811 . . . . 53.14 112.155 175.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.497 ' HB3' ' HG2' ' A' ' 236' ' ' LYS . 1.4 p30 -104.05 171.29 7.43 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.855 0.462 . . . . 72.42 111.547 -178.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 32.9 tp -129.36 112.87 14.28 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 108.737 -0.838 . . . . 73.54 108.737 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -86.76 109.47 19.26 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.684 0.794 . . . . 74.24 109.28 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 44.5 mt -87.16 111.39 20.91 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 109.077 -0.712 . . . . 74.21 109.077 175.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.505 ' HA ' ' HG3' ' A' ' 232' ' ' LYS . 31.5 mt-10 -78.77 101.08 7.4 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.092 -0.958 . . . . 72.13 109.566 -177.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.8 t -59.51 110.03 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 O-C-N 123.765 0.666 . . . . 72.54 111.072 176.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -115.12 93.44 4.3 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.003 -1.11 . . . . 75.32 108.003 176.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.423 HD12 ' O ' ' A' ' 227' ' ' THR . 54.9 mt -77.17 125.65 37.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 N-CA-C 109.473 -0.565 . . . . 72.24 109.473 178.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 24.4 p . . . . . 0 C--O 1.25 1.127 0 C-N-CA 124.157 0.983 . . . . 74.31 109.632 179.775 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' MET . . . . . 0.468 ' SD ' ' N ' ' A' ' 168' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 109.143 -0.688 . . . . 75.41 109.143 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.9 t -72.34 91.99 1.38 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 109.583 -0.525 . . . . 72.43 109.583 -177.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -74.26 155.72 37.97 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.284 -0.871 . . . . 72.23 109.482 177.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.409 ' HG ' ' HD2' ' A' ' 238' ' ' LYS . 2.2 tt -66.58 102.66 0.93 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 108.008 -1.108 . . . . 73.02 108.008 178.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -117.89 146.19 44.1 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.064 0.946 . . . . 73.43 109.273 -177.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.665 HD13 ' HA ' ' A' ' 223' ' ' VAL . 73.7 mt -87.54 96.2 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-O 121.222 0.534 . . . . 73.52 110.487 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -87.45 63.42 7.66 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 108.538 -0.912 . . . . 45.43 108.538 171.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -156.0 -168.39 2.75 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.584 1.154 . . . . 74.55 109.253 -175.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.429 ' CZ ' ' HA ' ' A' ' 227' ' ' THR . 4.5 m-85 77.79 -63.09 0.35 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 125.591 1.556 . . . . 72.1 111.974 -176.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -100.16 100.43 2.18 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 118.511 -1.161 . . . . 72.3 111.871 -176.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.63 -9.98 25.89 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 123.006 2.47 . . . . 71.34 113.125 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -77.36 87.33 3.75 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 109.096 -0.705 . . . . 72.31 109.096 176.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 177.05 134.42 1.99 Allowed Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.384 -0.825 . . . . 61.23 111.433 -178.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 13.6 t -80.26 167.85 19.78 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.209 0.604 . . . . 74.44 110.453 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 89.26 18.78 52.36 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-N 116.235 -0.439 . . . . 72.13 112.799 -173.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -92.26 54.68 2.83 Favored Glycine 0 C--N 1.353 1.502 0 C-N-CA 123.652 0.644 . . . . 40.04 112.315 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.6 t -86.74 164.81 16.5 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.634 0.774 . . . . 73.4 110.092 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 179.63 -170.9 42.47 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.325 -0.71 . . . . 74.54 111.325 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 145.17 45.44 0.04 OUTLIER Glycine 0 N--CA 1.473 1.149 0 N-CA-C 110.818 -0.913 . . . . 71.12 110.818 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 33.4 t -78.77 116.05 18.86 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.873 0.869 . . . . 45.31 109.777 -177.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -78.56 73.49 2.23 Favored Glycine 0 CA--C 1.533 1.162 0 N-CA-C 111.712 -0.555 . . . . 75.41 111.712 176.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 131.67 162.67 10.57 Favored Glycine 0 C--N 1.343 0.97 0 N-CA-C 110.817 -0.913 . . . . 75.5 110.817 -176.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 50.2 m -110.46 90.27 3.27 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.079 0.951 . . . . 72.22 109.729 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.613 ' HG3' ' HA3' ' A' ' 242' ' ' GLY . 5.7 pm0 -98.04 39.68 1.22 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.582 1.182 . . . . 64.22 109.832 176.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -87.43 163.48 16.72 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 114.689 -1.141 . . . . 71.5 111.087 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 83.2 mt -140.66 172.04 13.26 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.196 0.998 . . . . 73.41 109.994 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -118.01 145.06 45.03 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.052 0.941 . . . . 71.24 109.516 174.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -146.08 140.17 26.55 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.021 0.928 . . . . 71.22 109.282 178.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.9 m -77.36 129.19 35.49 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.058 0.543 . . . . 65.14 109.711 178.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.526 HD11 HD12 ' A' ' 251' ' ' LEU . 54.0 tp -107.45 111.3 23.53 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.451 -1.314 . . . . 61.14 107.451 177.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -92.04 100.5 13.13 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 108.291 -1.003 . . . . 72.52 108.291 -178.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.473 HG22 HG11 ' A' ' 210' ' ' VAL . 2.9 p -124.28 131.49 24.2 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 124.013 0.925 . . . . 73.05 108.799 -178.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.534 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 98.4 Cg_endo -80.68 163.9 21.01 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.513 2.142 . . . . 72.14 111.355 172.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.17 -48.46 85.32 Favored Pre-proline 0 CA--C 1.566 1.581 0 N-CA-C 114.045 1.128 . . . . 73.34 114.045 176.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.534 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 25.5 Cg_endo -58.8 -52.46 5.2 Favored 'Trans proline' 0 C--N 1.396 3.044 0 C-N-CA 122.002 1.801 . . . . 62.43 113.057 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.8 mt -70.77 -22.21 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.238 0 C-N-CA 123.081 0.552 . . . . 73.01 110.856 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.33 -44.2 72.15 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.771 0.429 . . . . 75.22 110.717 177.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 76.1 t -71.49 -57.17 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 C-N-CA 122.181 0.192 . . . . 75.15 110.975 -178.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 12.6 p -85.38 -25.99 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 112.208 0.447 . . . . 64.41 112.208 -170.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 99.89 -178.63 29.75 Favored Glycine 0 N--CA 1.475 1.273 0 N-CA-C 112.156 -0.378 . . . . 73.32 112.156 -172.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 139.6 -139.17 9.76 Favored Glycine 0 C--N 1.343 0.932 0 N-CA-C 111.764 -0.535 . . . . 64.53 111.764 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -133.86 146.35 50.52 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.524 0.73 . . . . 70.13 109.751 175.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.473 HG11 HG22 ' A' ' 199' ' ' VAL . 22.2 m -138.67 169.2 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 123.711 0.632 . . . . 75.0 112.02 -177.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 -73.22 133.07 43.88 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.424 -0.807 . . . . 73.22 110.27 172.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.4 ' HB2' HD12 ' A' ' 197' ' ' LEU . . . -144.13 148.99 35.81 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.468 -0.938 . . . . 70.24 108.468 168.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 64.8 mtp -89.03 130.72 35.45 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.459 -0.571 . . . . 72.02 109.459 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 42.3 m -143.2 172.93 12.07 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 125.228 1.411 . . . . 73.22 108.082 -175.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 77.0 mt -60.08 -21.35 61.35 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.27 0.628 . . . . 74.31 111.708 173.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -86.65 16.83 4.33 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.641 1.176 . . . . 74.53 111.674 174.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 76.34 -155.82 46.05 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-O 118.87 -0.961 . . . . 55.14 111.757 -175.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.85 119.73 6.62 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 121.954 1.77 . . . . 74.42 110.423 171.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.55 166.09 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.284 1.034 . . . . 75.42 109.978 -176.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -102.46 107.51 18.51 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.898 -0.779 . . . . 72.2 108.898 175.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 95.5 t -95.15 131.64 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.145 0.978 . . . . 63.31 109.639 -175.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.45 98.72 2.32 Favored 'General case' 0 C--N 1.351 0.659 0 O-C-N 124.055 0.847 . . . . 74.4 109.39 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.665 ' HA ' HD13 ' A' ' 173' ' ' ILE . 55.9 t -91.84 127.71 48.84 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 124.83 1.252 . . . . 74.23 110.022 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.452 ' HD3' ' HB ' ' A' ' 173' ' ' ILE . 92.4 Cg_endo -73.2 170.25 20.31 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.692 2.262 . . . . 73.15 110.962 173.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.46 178.07 4.11 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 122.02 1.813 . . . . 75.22 111.789 170.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 50.2 mtp180 63.68 20.29 12.15 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 124.978 1.311 . . . . 74.33 112.222 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.436 ' O ' HD12 ' A' ' 255' ' ' ILE . 98.1 m -65.64 106.68 1.53 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.361 0.664 . . . . 62.42 110.278 -178.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -100.13 139.86 35.2 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.925 1.29 . . . . 73.45 110.285 -174.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -69.92 127.95 34.66 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.737 1.215 . . . . 74.24 111.542 -177.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.39 10.55 53.71 Favored Glycine 0 C--N 1.342 0.881 0 O-C-N 123.724 0.64 . . . . 70.31 113.126 178.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -91.47 158.28 16.57 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 117.176 0.488 . . . . 75.41 111.341 175.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.412 ' HB3' ' HD2' ' A' ' 250' ' ' TYR . 1.8 mppt? -130.07 117.65 20.32 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.84 1.256 . . . . 74.12 109.162 -177.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 12.9 mt -105.8 100.7 10.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.301 -0.863 . . . . 74.33 108.711 -165.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 46.2 ttm105 -69.98 102.45 2.01 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 124.544 1.153 . . . . 73.01 110.057 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.461 HD21 HG23 ' A' ' 173' ' ' ILE . 29.8 mt -111.69 99.78 8.44 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.727 0.811 . . . . 74.21 110.159 -176.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -66.74 142.86 57.25 Favored 'General case' 0 C--O 1.246 0.887 0 C-N-CA 123.407 0.683 . . . . 71.55 110.489 178.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 87.03 13.35 66.54 Favored Glycine 0 CA--C 1.532 1.117 0 O-C-N 123.745 0.653 . . . . 60.11 113.021 -174.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.409 ' HD2' ' HG ' ' A' ' 171' ' ' LEU . 41.9 mmtm -130.83 -25.38 2.31 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.338 0.655 . . . . 73.42 112.292 -175.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -75.07 -159.51 7.41 Favored Glycine 0 N--CA 1.476 1.306 0 CA-C-O 120.295 -0.169 . . . . 63.53 112.823 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -69.45 134.38 88.81 Favored Pre-proline 0 CA--C 1.554 1.105 0 CA-C-O 118.24 -0.886 . . . . 71.42 109.408 -174.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.523 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 78.0 Cg_exo -51.69 128.35 25.95 Favored 'Trans proline' 0 C--N 1.386 2.524 0 C-N-CA 122.904 2.403 . . . . 71.32 111.838 179.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.613 ' HA3' ' HG3' ' A' ' 191' ' ' GLN . . . -152.82 -162.44 10.96 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 119.558 -0.579 . . . . 52.23 113.069 -172.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.28 -16.1 50.49 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 123.578 2.852 . . . . 73.41 112.868 -177.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -94.96 19.96 9.59 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.088 0.955 . . . . 70.35 111.156 176.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 85.1 -73.75 2.58 Favored Glycine 0 C--N 1.352 1.462 0 N-CA-C 109.39 -1.484 . . . . 73.24 109.39 -170.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.523 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 59.2 mtt-85 -126.11 161.33 27.89 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.744 1.218 . . . . 74.41 109.036 166.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.417 ' HA2' HE21 ' A' ' 191' ' ' GLN . . . -82.45 -158.04 22.93 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-N 115.449 -0.796 . . . . 55.5 112.471 177.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -114.55 132.54 56.29 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.767 0.827 . . . . 73.45 110.089 -176.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 41.6 tp -106.88 121.33 44.21 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 108.415 -0.958 . . . . 73.01 108.415 -176.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.412 ' HD2' ' HB3' ' A' ' 232' ' ' LYS . 8.7 m-85 -87.79 113.27 23.3 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.4 -0.963 . . . . 74.22 108.4 179.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.526 HD12 HD11 ' A' ' 197' ' ' LEU . 51.2 mt -86.48 107.77 18.23 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.175 -0.676 . . . . 73.51 109.175 176.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -76.02 97.67 4.09 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 107.683 -1.229 . . . . 63.51 107.683 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 91.5 t -62.82 108.87 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.777 0 C-N-CA 124.952 1.301 . . . . 70.14 110.927 -177.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -109.3 93.82 4.71 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.243 -1.021 . . . . 74.31 108.243 174.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.436 HD12 ' O ' ' A' ' 227' ' ' THR . 58.9 mt -75.4 131.79 34.37 Favored 'Isoleucine or valine' 0 C--N 1.351 0.631 0 N-CA-C 109.324 -0.621 . . . . 74.45 109.324 174.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 16.4 p . . . . . 0 CA--C 1.558 1.273 0 C-N-CA 125.496 1.518 . . . . 71.21 107.56 178.084 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 15.8 tpt . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 109.402 -0.592 . . . . 72.32 109.402 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 40.3 m -148.15 112.74 5.34 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.098 0.959 . . . . 75.13 109.497 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -131.51 147.71 52.56 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.713 0.805 . . . . 75.32 110.346 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 6.6 mp -79.33 95.5 5.73 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.072 0.949 . . . . 72.13 109.526 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -74.46 88.08 2.1 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.771 0.828 . . . . 74.2 110.525 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.438 HG23 HD23 ' A' ' 235' ' ' LEU . 29.1 mt -76.66 131.31 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 115.111 -0.949 . . . . 74.44 111.243 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -137.56 93.42 2.8 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.117 0.967 . . . . 71.43 108.631 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -132.54 179.05 6.37 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.226 1.01 . . . . 61.34 110.617 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.508 ' CE2' HD21 ' A' ' 233' ' ' LEU . 49.1 m-85 59.42 36.78 23.26 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.43 1.092 . . . . 74.2 110.648 -172.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 147.68 154.28 6.2 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 114.947 -1.024 . . . . 65.45 111.115 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.45 166.36 28.7 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 122.766 2.31 . . . . 71.44 112.574 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -154.0 -54.5 0.1 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.716 0.406 . . . . 74.14 110.996 -177.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 155.07 125.86 0.98 Allowed Glycine 0 C--N 1.35 1.353 0 CA-C-O 119.667 -0.518 . . . . 71.55 113.959 177.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.485 ' HB3' ' HE3' ' A' ' 236' ' ' LYS . 33.5 t 178.54 114.35 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 126.023 1.729 . . . . 74.42 108.029 168.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 174.53 45.72 0.05 OUTLIER Glycine 0 C--N 1.341 0.854 0 C-N-CA 121.559 -0.353 . . . . 72.13 112.627 177.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -158.11 59.17 0.34 Allowed Glycine 0 C--N 1.343 0.951 0 N-CA-C 111.624 -0.591 . . . . 45.32 111.624 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 44.7 m -148.95 156.76 42.75 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.329 1.052 . . . . 72.05 109.439 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -96.03 -174.83 36.31 Favored Glycine 0 N--CA 1.472 1.04 0 O-C-N 123.441 0.463 . . . . 73.31 112.513 175.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 160.35 -157.44 28.81 Favored Glycine 0 N--CA 1.47 0.966 0 N-CA-C 112.211 -0.356 . . . . 70.51 112.211 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 54.8 m -140.16 101.75 4.22 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.274 0.63 . . . . 75.24 110.276 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 151.37 -157.54 27.26 Favored Glycine 0 C--N 1.343 0.93 0 N-CA-C 111.685 -0.566 . . . . 73.15 111.685 177.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.418 ' H ' ' NE2' ' A' ' 191' ' ' GLN . . . -96.67 -112.51 2.88 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 111.558 -0.617 . . . . 71.52 111.558 174.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 7.0 p -81.83 -38.79 24.94 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.997 0.919 . . . . 71.35 109.958 175.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.628 ' HB3' ' HB2' ' A' ' 240' ' ' PHE . 25.2 mm-40 65.96 35.08 6.68 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.723 1.209 . . . . 75.44 112.138 173.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -94.29 138.65 32.03 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 114.353 -1.294 . . . . 74.45 110.807 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 91.5 mt -122.93 166.95 14.22 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.872 0.869 . . . . 73.23 110.455 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -106.34 149.89 26.51 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 107.955 -1.128 . . . . 72.01 107.955 166.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.97 129.15 12.76 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.933 -0.765 . . . . 74.41 108.933 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.5 m -65.52 121.77 15.67 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.572 0.749 . . . . 75.33 110.425 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.435 HD11 HD13 ' A' ' 251' ' ' LEU . 57.0 tp -108.0 112.99 25.85 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.951 0.901 . . . . 75.24 109.164 -178.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -85.93 112.07 20.84 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.312 -0.996 . . . . 72.41 108.312 174.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 2.2 p -139.49 119.9 9.42 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 123.945 0.898 . . . . 74.1 108.971 -177.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.428 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 44.3 Cg_endo -71.3 158.02 55.53 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 121.879 1.72 . . . . 71.13 111.171 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -52.1 -47.28 92.3 Favored Pre-proline 0 CA--C 1.567 1.611 0 C-N-CA 124.781 1.233 . . . . 71.45 113.606 -177.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 37.2 Cg_endo -63.07 -43.62 18.56 Favored 'Trans proline' 0 C--N 1.404 3.491 0 C-N-CA 121.478 1.452 . . . . 63.03 112.186 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 40.1 mt -71.12 -28.26 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 O-C-N 123.616 0.572 . . . . 74.34 110.361 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.57 -46.56 82.22 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.207 0.603 . . . . 65.1 110.509 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 67.5 t -67.82 -57.07 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 122.727 0.411 . . . . 74.33 111.513 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 17.2 m -78.9 -20.83 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 112.285 0.476 . . . . 74.12 112.285 -170.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 77.52 132.97 0.62 Allowed Glycine 0 C--N 1.345 1.07 0 N-CA-C 111.675 -0.57 . . . . 71.14 111.675 -171.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 175.87 -175.01 47.25 Favored Glycine 0 N--CA 1.468 0.828 0 CA-C-N 117.265 0.532 . . . . 73.2 112.269 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -79.03 143.6 35.48 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 122.849 0.46 . . . . 74.44 111.0 -178.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.402 HG22 HG12 ' A' ' 221' ' ' VAL . 19.9 m -139.45 169.44 16.99 Favored 'Isoleucine or valine' 0 C--O 1.253 1.263 0 O-C-N 124.338 1.024 . . . . 73.24 110.351 177.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -72.48 118.46 15.41 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.502 -1.226 . . . . 74.32 109.979 169.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -110.66 137.33 48.47 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.407 -0.59 . . . . 73.4 109.407 169.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 63.0 mtt -84.95 103.68 14.21 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.521 -0.918 . . . . 73.11 108.521 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 43.4 m -122.35 168.56 11.92 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.688 1.195 . . . . 70.0 109.015 -176.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 80.1 mt -54.69 -27.29 39.23 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.023 0.929 . . . . 74.04 111.73 174.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -90.95 15.82 10.69 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.507 1.123 . . . . 63.52 111.837 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 83.07 -149.74 26.82 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-O 119.273 -0.737 . . . . 74.22 112.174 -177.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.05 120.3 5.99 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.376 2.051 . . . . 65.41 111.377 177.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 22.6 m -119.24 167.44 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 123.2 0.6 . . . . 70.21 111.522 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -76.67 116.36 17.28 Favored 'General case' 0 C--N 1.348 0.526 0 C-N-CA 124.38 1.072 . . . . 73.13 108.822 175.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.402 HG12 HG22 ' A' ' 210' ' ' VAL . 1.1 t -124.78 115.19 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 108.613 -0.884 . . . . 73.43 108.613 174.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -81.39 99.01 8.47 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 115.76 -0.655 . . . . 62.11 109.401 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 56.1 t -80.32 130.26 66.2 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 123.609 0.764 . . . . 73.12 109.904 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.37 167.68 7.53 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.168 2.579 . . . . 72.25 112.27 171.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.25 -179.51 3.19 Favored 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 121.837 1.691 . . . . 75.2 112.913 174.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 48.2 mtt85 60.66 18.23 8.28 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 124.974 1.31 . . . . 74.41 112.298 173.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.488 ' HA ' ' OH ' ' A' ' 176' ' ' TYR . 96.6 m -68.3 103.45 1.6 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.025 0.93 . . . . 75.44 110.245 -174.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.466 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 47.4 tp60 -103.78 142.2 34.78 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.419 1.088 . . . . 73.33 110.285 -174.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.82 130.96 49.47 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.716 1.206 . . . . 74.23 111.583 -176.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 95.01 -10.34 70.1 Favored Glycine 0 C--N 1.347 1.142 0 O-C-N 123.711 0.632 . . . . 74.11 113.144 177.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.466 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 68.3 mtt-85 -78.52 155.45 29.75 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.038 0.535 . . . . 75.2 109.626 174.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.591 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.7 mppt? -130.18 118.1 20.9 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.994 -0.743 . . . . 71.23 108.994 -176.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.508 HD21 ' CE2' ' A' ' 176' ' ' TYR . 5.0 mt -89.66 103.91 16.51 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.091 -0.959 . . . . 74.44 109.035 -164.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 16.8 ttm-85 -69.42 102.11 1.7 Allowed 'General case' 0 CA--C 1.541 0.598 0 O-C-N 123.92 0.763 . . . . 74.24 109.712 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.438 HD23 HG23 ' A' ' 173' ' ' ILE . 14.3 mt -96.05 91.32 5.91 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.282 -1.007 . . . . 72.43 108.282 175.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.485 ' HE3' ' HB3' ' A' ' 181' ' ' SER . 6.0 mtmt -62.78 140.94 58.79 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.283 -0.636 . . . . 74.4 109.283 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 72.9 34.59 58.87 Favored Glycine 0 C--N 1.343 0.949 0 O-C-N 123.424 0.453 . . . . 53.51 113.737 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.576 ' HA ' ' HZ1' ' A' ' 238' ' ' LYS . 0.4 OUTLIER -128.01 -27.05 2.8 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.601 0.761 . . . . 74.25 112.124 179.262 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -74.88 -165.21 13.54 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 112.455 -0.258 . . . . 75.33 112.455 169.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.628 ' HB2' ' HB3' ' A' ' 191' ' ' GLN . 90.9 m-85 -75.72 150.57 84.22 Favored Pre-proline 0 N--CA 1.487 1.395 0 CA-C-N 117.216 0.508 . . . . 74.14 110.046 -176.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -64.81 157.64 55.2 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 122.284 1.989 . . . . 75.21 112.659 177.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -163.02 175.0 39.4 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 115.557 -0.747 . . . . 73.31 111.585 -176.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.71 -11.63 29.88 Favored 'Trans proline' 0 C--N 1.366 1.475 0 C-N-CA 122.952 2.435 . . . . 72.35 113.021 -177.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -104.16 14.83 29.69 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.892 0.877 . . . . 75.14 111.337 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 119.45 -124.39 5.96 Favored Glycine 0 C--N 1.348 1.223 0 N-CA-C 110.973 -0.851 . . . . 61.45 110.973 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 48.8 mtm180 -126.55 162.56 25.38 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.731 -0.841 . . . . 71.41 108.731 169.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -69.97 171.0 42.99 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 115.3 -0.864 . . . . 70.14 113.963 -177.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -110.71 136.28 50.03 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.919 0.888 . . . . 72.45 108.863 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 31.9 tp -105.29 108.11 19.46 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 107.717 -1.216 . . . . 73.13 107.717 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.591 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 19.3 m-85 -88.54 108.99 19.7 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.716 -0.846 . . . . 75.33 108.716 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.435 HD13 HD11 ' A' ' 197' ' ' LEU . 43.0 mt -86.85 107.07 18.16 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.856 -0.794 . . . . 64.33 108.856 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -78.05 102.76 7.6 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 114.657 -1.156 . . . . 72.41 109.55 -177.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 63.2 t -59.57 115.26 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.695 0 CA-C-N 114.388 -1.278 . . . . 75.33 112.053 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 20.7 mmt85 -112.66 93.99 4.7 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.294 -1.373 . . . . 72.33 107.294 171.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 22.9 mt -74.99 109.36 7.83 Favored 'Isoleucine or valine' 0 C--N 1.352 0.689 0 N-CA-C 109.018 -0.734 . . . . 73.44 109.018 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 25.6 p . . . . . 0 CA--C 1.558 1.277 0 C-N-CA 124.524 1.13 . . . . 73.42 108.428 177.173 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 22.3 mmt . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 109.54 -0.541 . . . . 75.32 109.54 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.7 m -74.98 102.68 4.89 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 109.42 -0.585 . . . . 70.51 109.42 174.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -68.69 -18.92 64.34 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.037 0.535 . . . . 75.41 112.311 -177.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.5 HD11 HG22 ' A' ' 221' ' ' VAL . 86.9 mt 58.9 44.31 16.79 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.326 1.05 . . . . 75.31 110.748 174.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 27.5 tpt180 -59.11 115.96 3.52 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 114.435 -1.257 . . . . 74.01 110.888 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.664 ' HA ' HD23 ' A' ' 235' ' ' LEU . 57.5 mt -77.78 108.29 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 114.768 -1.106 . . . . 75.25 108.618 171.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -84.07 40.08 0.74 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.891 0.876 . . . . 74.02 110.78 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -153.83 163.67 39.65 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.896 1.278 . . . . 72.1 109.272 -174.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.503 ' CE2' HD23 ' A' ' 233' ' ' LEU . 66.6 m-85 63.42 15.42 8.73 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.23 1.412 . . . . 63.33 112.067 -166.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -162.9 177.09 39.09 Favored Glycine 0 C--N 1.344 0.994 0 C-N-CA 123.397 0.522 . . . . 71.45 111.818 -177.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.09 123.24 13.04 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 123.374 2.716 . . . . 74.04 111.986 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -129.81 115.62 17.53 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.865 0.866 . . . . 70.43 108.904 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.8 165.23 54.74 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 116.293 -0.412 . . . . 70.01 112.262 178.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 39.9 m -70.89 -35.31 72.28 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.349 0.66 . . . . 74.3 111.748 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 91.08 -56.98 3.26 Favored Glycine 0 C--N 1.342 0.877 0 N-CA-C 111.564 -0.615 . . . . 63.1 111.564 -176.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 135.72 -161.69 24.82 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 111.538 -0.625 . . . . 73.34 111.538 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 22.8 t -93.51 -165.69 1.38 Allowed 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 123.719 0.807 . . . . 74.3 109.732 175.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 147.12 -22.32 1.58 Allowed Glycine 0 C--N 1.351 1.389 0 O-C-N 122.209 -0.307 . . . . 74.21 113.057 176.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -175.37 80.03 0.07 OUTLIER Glycine 0 C--N 1.342 0.869 0 N-CA-C 111.609 -0.596 . . . . 50.42 111.609 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 40.9 m -67.18 147.9 52.48 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.279 1.031 . . . . 73.03 111.845 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 99.73 68.01 0.87 Allowed Glycine 0 C--N 1.346 1.106 0 CA-C-N 116.128 -0.487 . . . . 62.01 111.886 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 70.17 -168.56 47.69 Favored Glycine 0 C--N 1.352 1.448 0 N-CA-C 113.623 0.209 . . . . 64.22 113.623 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 52.5 p -155.51 164.27 38.9 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.24 0.616 . . . . 73.04 110.615 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -88.7 53.39 2.69 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-O 122.992 1.377 . . . . 63.22 109.745 176.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -88.7 166.84 13.8 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 113.693 -1.594 . . . . 75.13 110.362 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.6 mt -133.19 164.61 26.68 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.618 0.767 . . . . 64.14 110.785 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -114.85 154.87 27.85 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 114.526 -1.215 . . . . 74.22 108.357 168.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -160.66 150.88 17.91 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.656 0.782 . . . . 73.24 109.319 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 33.2 m -81.66 135.65 35.52 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.065 0.546 . . . . 73.2 110.18 177.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.573 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 42.1 tp -114.54 113.57 24.6 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.707 -1.22 . . . . 75.03 107.707 170.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -91.93 123.7 35.5 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 109.269 -0.641 . . . . 53.14 109.269 177.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 3.6 p -142.92 130.9 11.22 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.531 1.132 . . . . 75.22 108.487 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.21 156.26 37.63 Favored 'Trans proline' 0 C--N 1.37 1.683 0 C-N-CA 121.586 1.524 . . . . 73.43 110.999 170.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -54.62 -42.18 93.53 Favored Pre-proline 0 CA--C 1.565 1.528 0 CA-C-O 117.333 -1.318 . . . . 73.12 114.29 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.24 -51.23 9.04 Favored 'Trans proline' 0 C--N 1.4 3.282 0 CA-C-N 121.832 1.69 . . . . 71.52 112.144 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 46.0 mt -68.69 -26.45 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.813 0.845 . . . . 75.11 110.802 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 227' ' ' THR . . . -70.69 -50.96 30.9 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.51 0.724 . . . . 72.41 111.326 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 96.1 t -67.65 -50.14 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.612 0.765 . . . . 71.11 111.253 -176.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.7 p -75.97 -31.5 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 122.524 0.33 . . . . 74.02 110.793 -177.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 79.96 103.46 0.27 Allowed Glycine 0 C--N 1.347 1.177 0 N-CA-C 111.667 -0.573 . . . . 72.34 111.667 -173.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -131.75 -129.7 3.06 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 116.978 0.389 . . . . 75.54 112.35 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.584 ' HB2' ' HZ3' ' A' ' 209' ' ' LYS . 9.0 mtmp? -132.93 141.75 48.52 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.129 0.972 . . . . 75.44 108.393 178.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 17.2 m -130.67 165.96 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.21 0.604 . . . . 75.54 110.924 -178.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -82.11 120.42 25.29 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.133 -0.692 . . . . 75.14 109.133 168.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -118.21 136.67 53.5 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.557 0.743 . . . . 74.3 109.285 173.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 87.1 mtp -76.83 116.63 17.67 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.026 0.53 . . . . 73.34 109.578 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 33.6 m -127.21 170.35 12.52 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.431 1.093 . . . . 63.03 108.848 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 81.4 mt -57.82 -34.29 69.5 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.012 0.925 . . . . 73.33 111.963 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -84.56 2.16 42.55 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.676 0.79 . . . . 74.12 111.93 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 108.79 -161.8 13.09 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-O 119.648 -0.529 . . . . 74.22 112.567 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.2 119.66 6.61 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 122.189 1.926 . . . . 62.14 111.312 176.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 32.7 m -114.9 163.94 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 123.306 0.642 . . . . 74.41 109.979 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -103.61 110.0 21.9 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.242 0.544 . . . . 73.32 109.703 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.5 HG22 HD11 ' A' ' 171' ' ' LEU . 62.0 t -104.29 126.25 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.151 0.98 . . . . 75.42 109.207 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.1 99.81 2.87 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.103 0.561 . . . . 71.01 109.899 176.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 78.1 t -88.52 121.28 70.24 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 124.112 0.965 . . . . 75.3 109.724 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -60.76 169.02 6.14 Favored 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 123.987 3.124 . . . . 75.33 113.359 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.98 169.35 20.69 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 122.073 1.849 . . . . 73.14 113.629 178.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 65.53 22.02 11.79 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 125.554 1.541 . . . . 71.52 112.186 176.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.493 ' HA ' ' CZ ' ' A' ' 176' ' ' TYR . 94.8 m -66.39 104.55 1.25 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.029 0.932 . . . . 63.43 110.811 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -102.06 141.63 34.6 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.987 0.915 . . . . 73.41 110.935 -172.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -64.77 143.31 58.02 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.295 1.038 . . . . 75.21 111.576 -179.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.76 -9.17 75.14 Favored Glycine 0 N--CA 1.47 0.909 0 O-C-N 123.831 0.707 . . . . 70.34 112.939 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.407 HH11 ' HE1' ' A' ' 176' ' ' TYR . 89.3 mtt180 -78.15 154.14 31.46 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.237 0.615 . . . . 75.04 109.989 171.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -131.23 136.31 48.11 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.592 1.157 . . . . 71.24 108.437 -178.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.503 HD23 ' CE2' ' A' ' 176' ' ' TYR . 30.2 mt -110.12 103.16 11.84 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.875 -0.602 . . . . 73.22 109.912 -169.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -70.5 100.65 1.83 Allowed 'General case' 0 C--O 1.239 0.501 0 O-C-N 124.038 0.836 . . . . 73.43 109.203 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.664 HD23 ' HA ' ' A' ' 173' ' ' ILE . 12.4 mt -97.79 98.59 9.97 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.305 -1.368 . . . . 73.52 107.305 177.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 36.3 mtmt -76.88 141.74 40.45 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.298 -0.41 . . . . 75.42 110.331 -176.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.98 33.07 42.37 Favored Glycine 0 C--N 1.344 1.015 0 O-C-N 123.478 0.486 . . . . 73.05 113.278 -179.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -125.0 -33.95 2.85 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.74 0.816 . . . . 73.11 111.619 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -65.61 -159.81 0.6 Allowed Glycine 0 C--N 1.359 1.856 0 O-C-N 123.488 0.493 . . . . 74.2 113.491 176.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -71.72 146.17 90.58 Favored Pre-proline 0 CA--C 1.554 1.112 0 O-C-N 122.049 -0.677 . . . . 75.53 110.078 -177.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -59.24 155.59 39.53 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.778 2.319 . . . . 73.41 112.925 175.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -164.33 -173.66 33.23 Favored Glycine 0 CA--C 1.539 1.551 0 CA-C-O 119.782 -0.454 . . . . 64.33 113.248 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.55 -34.66 96.81 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.869 3.046 . . . . 72.31 113.574 -178.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -100.81 22.04 12.66 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.956 0.902 . . . . 60.53 111.108 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 91.52 -163.72 28.81 Favored Glycine 0 C--N 1.347 1.164 0 N-CA-C 111.472 -0.651 . . . . 64.11 111.472 -173.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 31.6 mtt180 -69.57 156.36 39.04 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.096 0.474 . . . . 74.53 110.778 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.29 -165.63 27.56 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 115.334 -0.848 . . . . 61.32 112.363 177.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -99.07 168.8 9.85 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.214 0.606 . . . . 74.45 110.13 -177.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 40.4 tp -142.48 107.81 5.01 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.943 -0.762 . . . . 70.11 108.943 174.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -89.33 108.2 19.49 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.907 0.483 . . . . 74.13 109.964 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 34.7 mt -87.62 107.97 18.85 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 109.311 -0.625 . . . . 72.31 109.311 174.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -78.66 103.5 8.65 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 109.075 -0.713 . . . . 75.54 109.075 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.8 t -56.8 112.99 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 124.548 1.139 . . . . 72.33 111.194 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -116.34 100.55 7.97 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.039 -1.097 . . . . 75.51 108.039 176.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 30.1 mt -79.38 126.92 39.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 123.285 0.634 . . . . 62.35 110.665 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 19.7 p . . . . . 0 CA--C 1.557 1.213 0 C-N-CA 124.714 1.205 . . . . 72.32 108.708 176.135 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 53.1 tpp . . . . . 0 N--CA 1.473 0.692 0 N-CA-C 109.472 -0.566 . . . . 75.22 109.472 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 28.5 p -152.52 121.2 6.46 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.244 0.618 . . . . 75.41 110.534 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -65.89 142.25 57.97 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.394 0.678 . . . . 74.31 109.7 174.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.55 ' HA ' ' HE2' ' A' ' 238' ' ' LYS . 58.1 mt -80.46 81.36 6.73 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.372 0.606 . . . . 72.02 110.254 -173.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -70.56 127.95 34.47 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 114.682 -1.144 . . . . 73.53 109.933 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.539 HG23 ' H ' ' A' ' 175' ' ' ALA . 41.5 mt -76.13 -70.87 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 122.607 0.363 . . . . 72.34 110.2 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . 60.14 33.76 21.15 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.078 0.951 . . . . 65.41 111.384 -177.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.539 ' H ' HG23 ' A' ' 173' ' ' ILE . . . -130.03 161.6 30.6 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.682 1.193 . . . . 73.33 108.966 175.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.576 ' CE2' HD23 ' A' ' 233' ' ' LEU . 40.6 m-85 66.54 -68.44 0.14 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.724 1.21 . . . . 75.43 109.337 -159.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -96.77 95.35 1.73 Allowed Glycine 0 CA--C 1.533 1.179 0 N-CA-C 109.819 -1.312 . . . . 72.12 109.819 165.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -84.23 173.17 9.04 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.465 2.11 . . . . 73.42 112.519 -175.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -138.14 -175.29 4.05 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.452 0.701 . . . . 71.54 110.6 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.65 125.93 40.69 Favored Glycine 0 C--N 1.356 1.694 0 O-C-N 123.775 0.672 . . . . 70.12 113.058 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 53.8 m -118.53 133.75 55.63 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.381 1.072 . . . . 64.54 110.584 -172.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -137.73 16.83 3.5 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 115.59 -0.732 . . . . 71.31 111.846 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -90.0 44.31 2.98 Favored Glycine 0 C--N 1.349 1.278 0 C-N-CA 122.879 0.276 . . . . 73.25 112.689 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 49.5 m -88.38 114.83 25.4 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.308 0.643 . . . . 71.31 109.539 177.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -148.19 150.54 22.75 Favored Glycine 0 C--N 1.337 0.635 0 N-CA-C 111.564 -0.615 . . . . 71.13 111.564 -178.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -98.15 -170.12 32.12 Favored Glycine 0 N--CA 1.469 0.893 0 CA-C-O 119.807 -0.441 . . . . 73.24 112.471 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 17.3 m 59.79 91.43 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.586 1.155 . . . . 71.22 111.985 176.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -67.88 88.09 0.18 Allowed Glycine 0 C--N 1.35 1.337 0 CA-C-N 115.945 -0.57 . . . . 72.33 112.831 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -105.5 34.73 5.55 Favored Glycine 0 C--N 1.342 0.892 0 C-N-CA 123.584 0.611 . . . . 63.34 112.314 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 21.5 m 65.07 35.19 8.18 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.734 1.214 . . . . 71.41 112.279 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -65.74 -65.93 0.61 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.111 0.565 . . . . 75.55 109.724 175.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -80.33 132.14 35.75 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.467 -0.788 . . . . 73.22 109.431 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 86.2 mt -136.94 175.11 9.92 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.838 0.855 . . . . 64.44 109.772 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -105.26 163.49 12.56 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.055 0.942 . . . . 73.21 110.205 178.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -165.33 129.7 2.4 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.771 1.228 . . . . 63.2 108.13 175.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' THR . . . . . 0.457 ' HA ' ' HB2' ' A' ' 252' ' ' GLU . 50.1 m -70.69 137.11 49.52 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 122.794 0.438 . . . . 75.23 111.163 -178.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 21.9 tp -122.46 112.44 18.05 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.182 -1.044 . . . . 73.32 108.182 175.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -91.23 128.43 37.05 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 108.913 -0.773 . . . . 65.05 108.913 175.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 3.3 p -139.6 124.87 11.64 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 123.799 0.84 . . . . 63.03 109.578 -177.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -67.5 153.51 76.31 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 121.467 1.444 . . . . 72.24 111.717 176.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.59 -45.17 85.24 Favored Pre-proline 0 CA--C 1.564 1.496 0 CA-C-O 117.648 -1.167 . . . . 53.33 113.887 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.437 ' O ' HG11 ' A' ' 206' ' ' VAL . 19.9 Cg_endo -59.36 -52.27 5.07 Favored 'Trans proline' 0 C--N 1.397 3.127 0 CA-C-N 121.426 1.545 . . . . 74.44 112.17 175.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 46.0 mt -63.8 -27.31 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 123.639 0.776 . . . . 75.42 110.896 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 227' ' ' THR . . . -70.86 -49.33 47.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.386 0.675 . . . . 72.51 111.169 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 84.7 t -67.84 -54.0 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 122.988 0.515 . . . . 73.21 110.96 -177.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.437 HG11 ' O ' ' A' ' 202' ' ' PRO . 11.1 p -74.34 -38.66 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 122.701 0.4 . . . . 70.11 111.345 -175.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.79 79.16 1.3 Allowed Glycine 0 C--N 1.343 0.955 0 N-CA-C 112.07 -0.412 . . . . 65.02 112.07 -172.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -99.33 -125.54 5.45 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-O 119.546 -0.586 . . . . 75.35 112.064 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.547 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 33.7 mtmm -138.18 150.18 46.54 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.101 0.961 . . . . 75.34 109.4 174.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 24.3 m -138.51 170.18 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 124.031 0.932 . . . . 75.44 110.946 177.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 19.3 ttm180 -96.76 115.72 27.91 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.798 0.839 . . . . 75.35 110.303 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -107.67 156.14 19.39 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 109.181 -0.674 . . . . 75.22 109.181 168.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 83.6 mtp -98.08 120.93 39.35 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.034 0.445 . . . . 64.0 110.063 177.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 5.5 m -111.26 174.41 5.88 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 125.083 1.353 . . . . 74.13 107.382 175.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 76.1 mt -59.44 -35.17 73.51 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 113.118 0.785 . . . . 74.34 113.118 -171.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -90.6 -19.11 24.07 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.207 0.603 . . . . 74.22 111.279 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 147.04 -158.88 27.87 Favored Glycine 0 C--N 1.353 1.502 0 CA-C-O 119.824 -0.431 . . . . 75.31 113.324 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.9 143.91 29.99 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.496 2.797 . . . . 72.14 113.498 -173.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 31.2 m -133.25 161.45 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.106 0.962 . . . . 73.01 110.084 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -95.57 110.92 22.94 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.747 0.819 . . . . 74.35 109.656 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 54.5 t -96.52 111.28 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.574 1.149 . . . . 72.14 108.159 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.547 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . . . -73.72 95.8 2.42 Favored 'General case' 0 C--N 1.349 0.568 0 N-CA-C 109.34 -0.615 . . . . 73.44 109.34 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 53.6 t -64.31 132.09 95.24 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 124.468 1.107 . . . . 72.42 110.279 -173.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.74 166.71 28.66 Favored 'Trans proline' 0 CA--C 1.559 1.729 0 C-N-CA 122.668 2.246 . . . . 74.33 112.213 170.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.29 167.03 28.12 Favored 'Trans proline' 0 C--N 1.372 1.798 0 C-N-CA 121.822 1.682 . . . . 74.04 112.057 173.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 65.37 19.18 11.57 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.718 1.207 . . . . 74.52 112.157 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.534 ' HA ' ' CZ ' ' A' ' 176' ' ' TYR . 79.1 m -66.87 101.19 0.8 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.187 0.595 . . . . 72.44 110.659 -176.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -101.96 143.09 32.26 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 125.605 1.562 . . . . 72.43 110.596 -174.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -68.87 145.04 54.05 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 123.927 0.891 . . . . 64.11 111.166 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.06 -12.73 68.71 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.247 -0.888 . . . . 52.4 112.446 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.521 HH11 ' HE1' ' A' ' 176' ' ' TYR . 87.6 mtt180 -85.13 154.67 21.87 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.329 0.652 . . . . 73.42 110.415 175.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.55 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.3 mppt? -130.29 139.48 50.73 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.25 -1.019 . . . . 74.1 108.25 -178.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.576 HD23 ' CE2' ' A' ' 176' ' ' TYR . 26.1 mt -110.77 100.63 9.35 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 122.9 0.48 . . . . 65.54 109.829 -172.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -71.12 101.86 2.36 Favored 'General case' 0 CA--C 1.552 1.038 0 O-C-N 124.003 0.814 . . . . 75.21 110.01 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 11.8 mt -106.45 107.77 18.95 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.303 0.641 . . . . 75.33 109.283 -175.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -61.15 150.6 33.73 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.507 0.558 . . . . 75.14 112.507 176.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.78 24.78 61.6 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.483 -0.781 . . . . 72.52 114.004 171.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.55 ' HE2' ' HA ' ' A' ' 171' ' ' LEU . 11.1 mmtp -119.83 -44.26 2.53 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.18 0.592 . . . . 75.01 109.578 -176.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -77.53 -177.01 45.97 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-N 115.352 -0.84 . . . . 74.22 112.727 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -64.83 150.87 94.03 Favored Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 123.703 0.801 . . . . 75.32 112.512 -171.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.622 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 52.6 Cg_endo -66.09 151.96 82.45 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 122.642 2.228 . . . . 74.35 112.329 -177.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -168.22 -156.07 9.97 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 119.413 -0.659 . . . . 44.12 113.214 -177.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.56 -30.41 61.09 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 123.545 2.83 . . . . 70.14 112.345 -176.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -85.76 16.19 4.2 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.268 1.027 . . . . 65.22 111.509 178.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 87.63 -74.01 2.28 Favored Glycine 0 C--N 1.35 1.319 0 N-CA-C 110.94 -0.864 . . . . 65.44 110.94 -175.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.622 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 14.1 mtm180 -128.42 169.21 14.56 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.3 1.04 . . . . 72.24 110.076 174.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -93.3 175.66 36.39 Favored Glycine 0 C--N 1.339 0.747 0 CA-C-N 115.658 -0.701 . . . . 72.33 113.451 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -99.61 170.37 8.63 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.215 1.006 . . . . 65.32 109.619 -176.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 32.0 tp -141.88 118.88 11.25 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.292 -0.633 . . . . 74.12 109.292 172.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.55 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 13.9 m-85 -88.69 109.41 20.1 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.748 -0.834 . . . . 74.44 108.748 -178.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 30.2 mt -85.97 108.57 18.27 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.93 -0.767 . . . . 74.31 108.93 176.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.457 ' HB2' ' HA ' ' A' ' 196' ' ' THR . 30.4 mt-10 -77.31 97.16 4.78 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 114.421 -1.263 . . . . 75.13 109.405 -174.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 65.6 t -60.67 105.16 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 O-C-N 123.765 0.665 . . . . 64.34 110.752 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -116.02 102.22 9.45 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 106.988 -1.486 . . . . 74.44 106.988 174.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 51.3 mt -81.52 131.63 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 116.111 -0.495 . . . . 75.24 110.843 -174.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 21.3 p . . . . . 0 CA--C 1.563 1.452 0 C-N-CA 124.537 1.135 . . . . 74.14 108.422 177.267 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 N--CA 1.484 1.266 0 N-CA-C 110.556 -0.164 . . . . 70.31 110.556 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 33.5 t -153.02 105.38 2.92 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.156 -0.683 . . . . 72.22 109.156 176.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -104.27 155.58 18.62 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.26 0.624 . . . . 75.15 111.234 -177.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.412 HD13 HG23 ' A' ' 219' ' ' VAL . 86.2 mt -97.63 27.21 4.47 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.374 1.07 . . . . 74.21 110.626 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -45.66 148.0 0.81 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 126.678 1.991 . . . . 75.41 114.487 178.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.579 HG22 HD22 ' A' ' 235' ' ' LEU . 75.9 mt -93.44 107.93 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.996 0.918 . . . . 73.04 110.152 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -84.1 -5.71 59.28 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.387 0.675 . . . . 70.41 110.76 173.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -76.38 -179.52 5.2 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.821 0.849 . . . . 73.1 111.023 177.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.509 ' CE2' HD23 ' A' ' 233' ' ' LEU . 25.3 m-85 64.35 37.98 8.1 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.44 1.096 . . . . 74.3 110.15 -160.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -157.63 71.46 0.25 Allowed Glycine 0 CA--C 1.534 1.279 0 CA-C-N 114.064 -1.425 . . . . 75.14 111.34 175.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -60.43 -5.44 4.24 Favored 'Trans proline' 0 C--N 1.389 2.661 0 C-N-CA 123.703 2.935 . . . . 71.42 114.979 175.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -62.43 84.01 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.399 0.68 . . . . 74.22 111.183 170.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -163.68 108.47 0.34 Allowed Glycine 0 C--N 1.339 0.749 0 CA-C-N 116.011 -0.541 . . . . 65.43 112.678 -173.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 50.0 m -109.06 33.09 4.45 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.202 1.001 . . . . 73.05 109.71 176.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -151.94 167.43 31.11 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.745 -0.661 . . . . 74.3 113.013 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 79.21 8.4 87.84 Favored Glycine 0 C--N 1.352 1.444 0 CA-C-O 119.462 -0.632 . . . . 51.43 114.272 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.3 p -69.65 90.2 0.56 Allowed 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 117.683 0.741 . . . . 73.11 111.48 -174.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -174.75 162.23 32.14 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 114.958 -1.019 . . . . 71.13 110.677 179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 70.45 62.8 3.5 Favored Glycine 0 C--N 1.35 1.328 0 CA-C-N 117.63 0.715 . . . . 72.34 112.866 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 26.9 m -126.29 119.98 28.77 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.846 0.859 . . . . 74.43 110.115 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 103.91 155.33 23.9 Favored Glycine 0 C--N 1.351 1.396 0 C-N-CA 123.356 0.503 . . . . 73.51 112.853 -179.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 100.52 -177.42 28.28 Favored Glycine 0 C--N 1.349 1.281 0 C-N-CA 123.051 0.358 . . . . 73.12 112.553 178.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 23.4 t -69.44 -11.62 60.97 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.817 0.847 . . . . 74.1 112.155 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -63.01 -36.2 82.75 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.335 1.054 . . . . 72.42 109.809 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.43 131.64 41.25 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 114.563 -1.199 . . . . 71.4 110.204 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 96.4 mt -135.8 155.49 50.27 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.81 0.844 . . . . 73.04 110.239 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -116.4 145.34 43.32 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.091 0.957 . . . . 74.55 109.17 172.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -150.1 136.76 19.15 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.31 0.644 . . . . 65.3 109.504 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 86.6 m -69.19 138.77 54.34 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.216 0.606 . . . . 70.04 110.353 175.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.509 HD13 HD11 ' A' ' 251' ' ' LEU . 45.3 tp -120.14 112.45 19.11 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 107.657 -1.238 . . . . 75.04 107.657 174.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -95.68 117.0 29.67 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.743 -0.836 . . . . 60.13 108.743 -178.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.9 p -142.32 129.07 11.03 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.019 0.928 . . . . 72.14 109.364 -176.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.411 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 46.2 Cg_endo -71.08 155.58 61.25 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 121.792 1.662 . . . . 64.34 111.791 175.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -48.63 -46.69 71.54 Favored Pre-proline 0 N--CA 1.487 1.402 0 N-CA-C 114.522 1.304 . . . . 73.53 114.522 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 19.7 Cg_endo -57.74 -55.13 2.59 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 121.418 1.412 . . . . 73.23 112.802 176.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 58.9 mt -65.2 -29.52 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 123.426 0.69 . . . . 54.23 111.277 -177.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.8 -53.22 28.79 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.052 0.541 . . . . 73.32 111.03 -178.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 89.9 t -67.39 -55.17 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 115.642 -0.708 . . . . 74.13 110.956 -176.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.4 HG11 ' O ' ' A' ' 202' ' ' PRO . 7.7 p -77.12 -22.89 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 N-CA-C 112.268 0.47 . . . . 73.4 112.268 -173.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.41 139.01 8.19 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-O 120.1 -0.278 . . . . 60.11 112.622 -177.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -171.83 -145.48 4.9 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 116.753 0.276 . . . . 43.41 113.116 -178.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.525 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 96.4 mttt -133.76 132.7 40.85 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.963 0.905 . . . . 71.21 109.131 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.435 HG21 HG23 ' A' ' 223' ' ' VAL . 34.9 m -131.88 164.94 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-O 121.135 0.493 . . . . 74.32 110.716 177.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -75.45 141.34 43.16 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.082 -0.963 . . . . 74.21 110.645 174.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -141.47 157.55 45.0 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.727 0.811 . . . . 72.23 110.045 173.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 55.4 ttp -81.91 129.65 34.83 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.151 0.58 . . . . 72.32 110.72 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 89.5 m -143.61 166.96 23.38 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 124.418 1.087 . . . . 73.42 108.251 176.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 96.4 mt -56.6 -27.9 59.16 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.751 0.82 . . . . 75.22 112.458 174.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.46 14.56 3.61 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.826 0.85 . . . . 74.33 111.663 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 85.2 -148.75 23.34 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 111.192 -0.763 . . . . 41.01 111.192 -175.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.66 129.19 13.32 Favored 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 122.412 2.075 . . . . 75.42 111.327 174.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.412 HG23 HD13 ' A' ' 171' ' ' LEU . 29.2 m -122.21 155.87 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.726 0.811 . . . . 65.43 109.78 178.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -97.24 104.76 16.81 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.896 -0.779 . . . . 75.32 108.896 176.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.6 t -96.41 130.56 44.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 124.04 0.936 . . . . 73.14 109.829 -176.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.525 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . . . -77.48 101.93 6.67 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.322 0.649 . . . . 74.12 110.191 178.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.454 ' HA ' HD12 ' A' ' 173' ' ' ILE . 50.2 t -91.43 126.0 56.02 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 124.303 1.041 . . . . 71.03 109.959 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.415 ' HD3' ' HB ' ' A' ' 173' ' ' ILE . 57.2 Cg_endo -66.7 172.6 9.18 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 123.665 2.91 . . . . 75.23 112.452 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.63 -179.41 1.98 Allowed 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 121.853 1.702 . . . . 73.51 112.154 166.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 68.86 5.29 4.91 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 125.28 1.432 . . . . 74.42 112.473 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.458 ' HA ' ' CZ ' ' A' ' 176' ' ' TYR . 90.5 m -67.05 114.34 5.75 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.374 0.607 . . . . 73.33 110.933 -171.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.447 ' HA ' HD13 ' A' ' 255' ' ' ILE . 6.7 tp-100 -125.77 139.53 53.44 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 124.033 0.933 . . . . 62.43 110.464 -165.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . 0.418 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -61.39 134.24 56.7 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.999 0.92 . . . . 75.31 112.826 -171.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.85 -2.35 85.74 Favored Glycine 0 N--CA 1.474 1.203 0 CA-C-N 115.883 -0.599 . . . . 74.42 113.663 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -89.67 146.91 24.19 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.327 -0.62 . . . . 71.21 109.327 173.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -126.73 138.69 53.42 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.791 0.836 . . . . 73.33 108.97 -172.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.509 HD23 ' CE2' ' A' ' 176' ' ' TYR . 40.6 mt -113.53 109.02 17.97 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.073 -0.512 . . . . 72.42 111.008 -163.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -70.64 102.61 2.32 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 124.62 1.2 . . . . 73.54 109.806 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.579 HD22 HG22 ' A' ' 173' ' ' ILE . 33.0 mt -109.4 91.7 3.75 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.322 -0.622 . . . . 75.42 109.322 178.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.539 ' HG2' ' HB3' ' A' ' 248' ' ' ASP . 45.4 mtmt -70.13 143.53 52.32 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 122.851 0.46 . . . . 74.13 110.721 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.36 34.34 45.8 Favored Glycine 0 C--N 1.346 1.111 0 O-C-N 123.875 0.734 . . . . 72.34 112.067 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -131.26 -34.12 1.44 Allowed 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.005 0.922 . . . . 75.53 110.386 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -74.03 -163.24 9.05 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-N 116.304 -0.407 . . . . 74.13 113.581 175.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -71.26 149.52 94.2 Favored Pre-proline 0 N--CA 1.484 1.242 0 C-N-CA 122.835 0.454 . . . . 73.3 111.438 -176.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -67.83 161.32 44.46 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.918 2.412 . . . . 73.41 112.512 173.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -170.36 -173.26 37.52 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 115.739 -0.664 . . . . 73.2 112.188 177.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.25 -2.63 12.36 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 123.388 2.725 . . . . 74.2 113.133 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -118.44 21.17 12.76 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.269 1.028 . . . . 64.01 110.558 174.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 86.41 -167.07 38.76 Favored Glycine 0 C--N 1.345 1.043 0 CA-C-N 115.982 -0.554 . . . . 55.11 112.506 -175.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -79.85 132.95 36.23 Favored 'General case' 0 C--O 1.244 0.811 0 N-CA-C 109.252 -0.648 . . . . 75.34 109.252 175.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.96 -164.95 22.02 Favored Glycine 0 C--N 1.341 0.84 0 O-C-N 123.775 0.672 . . . . 64.02 113.663 -177.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.539 ' HB3' ' HG2' ' A' ' 236' ' ' LYS . 1.2 p-10 -113.52 132.81 55.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.589 0.709 . . . . 75.11 111.957 -168.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 42.0 tp -98.57 117.83 33.88 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.014 -1.448 . . . . 71.52 108.502 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -88.5 109.7 20.26 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 122.848 0.459 . . . . 74.32 109.939 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.509 HD11 HD13 ' A' ' 197' ' ' LEU . 31.8 mt -86.96 106.12 17.59 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.174 -0.676 . . . . 74.04 109.174 175.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -78.16 105.34 9.32 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 115.635 -0.711 . . . . 74.4 109.411 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 65.2 t -56.44 118.04 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 123.762 0.825 . . . . 74.34 111.014 176.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -117.3 94.77 4.69 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 107.799 -1.186 . . . . 74.35 107.799 175.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.447 HD13 ' HA ' ' A' ' 228' ' ' GLN . 14.5 mt -76.03 123.96 33.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 O-C-N 124.006 0.816 . . . . 75.32 109.779 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 37.4 p . . . . . 0 CA--C 1.557 1.239 0 CA-C-O 117.489 -1.243 . . . . 71.54 108.167 174.543 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 23.0 mmt . . . . . 0 N--CA 1.473 0.676 0 N-CA-C 109.847 -0.427 . . . . 73.51 109.847 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.7 t -162.84 -167.53 1.55 Allowed 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 124.804 1.242 . . . . 60.12 108.234 -178.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -157.08 150.25 23.9 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.519 0.728 . . . . 72.03 109.248 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 6.0 mp -71.56 87.87 0.92 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.367 0.667 . . . . 65.14 109.287 176.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -94.63 139.64 30.94 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.847 0.859 . . . . 72.1 109.653 177.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.41 ' HA ' HD21 ' A' ' 235' ' ' LEU . 26.4 mm -82.99 110.7 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 122.788 0.435 . . . . 75.31 110.205 178.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -94.25 12.21 27.58 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.751 0.82 . . . . 62.02 110.729 172.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -103.85 178.84 4.44 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.36 1.064 . . . . 74.12 111.383 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 59.18 29.46 19.02 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.043 1.337 . . . . 74.31 111.837 -164.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -86.2 152.41 25.57 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 115.244 -0.889 . . . . 61.24 111.224 169.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.92 -9.48 12.08 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 123.683 2.922 . . . . 74.55 113.876 177.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -128.32 141.56 51.4 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.988 0.915 . . . . 74.21 108.686 171.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -86.24 -106.79 0.77 Allowed Glycine 0 C--N 1.347 1.146 0 N-CA-C 111.167 -0.773 . . . . 73.44 111.167 173.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.8 m -155.32 172.84 17.53 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.183 0.993 . . . . 44.52 109.476 174.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -166.19 74.39 0.15 Allowed Glycine 0 C--N 1.34 0.798 0 N-CA-C 111.39 -0.684 . . . . 73.23 111.39 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -124.29 45.18 1.2 Allowed Glycine 0 C--N 1.346 1.116 0 C-N-CA 123.301 0.477 . . . . 74.12 112.364 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 40.1 t -71.49 98.16 1.79 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.334 0.654 . . . . 74.32 109.769 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 134.3 -7.35 4.68 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-O 119.656 -0.524 . . . . 63.12 112.886 -177.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -78.47 -87.16 0.47 Allowed Glycine 0 C--N 1.352 1.455 0 CA-C-N 116.731 0.265 . . . . 73.5 112.684 178.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.526 ' HB3' ' NE2' ' A' ' 191' ' ' GLN . 75.6 m -150.85 79.64 1.32 Allowed 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.033 0.933 . . . . 61.12 109.63 -179.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -91.36 -116.28 2.02 Favored Glycine 0 C--N 1.341 0.849 0 CA-C-N 115.244 -0.889 . . . . 63.52 111.814 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 76.24 -76.55 1.45 Allowed Glycine 0 C--N 1.348 1.242 0 C-N-CA 123.4 0.524 . . . . 75.41 112.529 176.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 23.9 t -162.61 12.89 0.07 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.573 0.749 . . . . 75.22 111.246 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.526 ' NE2' ' HB3' ' A' ' 187' ' ' SER . 78.3 mt-30 -63.78 -36.66 84.62 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.213 0.53 . . . . 75.22 110.477 177.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -75.53 138.31 41.44 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.055 -0.975 . . . . 73.33 108.909 173.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.7 mt -129.49 168.98 15.55 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.154 0.582 . . . . 74.4 111.033 -172.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -120.49 141.91 49.77 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 124.637 1.175 . . . . 74.4 108.258 172.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -153.83 128.22 9.19 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.172 0.989 . . . . 73.35 108.36 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' THR . . . . . 0.437 ' HA ' ' HB2' ' A' ' 252' ' ' GLU . 92.9 m -72.87 135.06 45.07 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.084 0.553 . . . . 75.21 111.595 -175.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 40.5 tp -114.35 113.73 24.94 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.768 1.227 . . . . 73.24 108.343 178.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -89.25 116.43 27.47 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.09 -0.707 . . . . 71.33 109.09 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 7.0 p -136.38 133.26 19.24 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 108.283 -1.006 . . . . 75.12 108.283 -174.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.488 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 72.2 Cg_endo -74.84 161.85 38.46 Favored 'Trans proline' 0 C--N 1.37 1.658 0 C-N-CA 121.899 1.732 . . . . 73.14 111.892 175.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.05 -51.66 59.92 Favored Pre-proline 0 CA--C 1.569 1.696 0 N-CA-C 113.893 1.071 . . . . 74.01 113.893 177.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 23.1 Cg_endo -60.5 -52.48 3.85 Favored 'Trans proline' 0 C--N 1.399 3.221 0 C-N-CA 122.068 1.845 . . . . 74.0 112.926 -178.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 61.0 mt -64.26 -28.63 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 123.476 0.71 . . . . 75.51 111.447 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.23 -48.51 75.53 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.937 0.398 . . . . 75.33 111.234 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 61.7 t -71.37 -52.41 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.192 0 CA-C-N 116.099 -0.501 . . . . 70.32 112.18 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 11.4 p -85.11 -31.73 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 112.395 0.517 . . . . 73.1 112.395 -172.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 100.39 149.94 24.11 Favored Glycine 0 N--CA 1.471 0.974 0 CA-C-N 116.45 -0.341 . . . . 62.22 112.372 -173.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 162.42 173.78 31.51 Favored Glycine 0 C--N 1.34 0.782 0 N-CA-C 111.788 -0.525 . . . . 72.42 111.788 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -81.15 134.79 35.7 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 116.993 0.396 . . . . 75.23 110.094 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 25.7 m -123.28 167.84 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.488 0.715 . . . . 71.51 110.48 173.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 -81.5 105.31 12.56 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.705 -1.134 . . . . 74.1 108.975 172.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.69 144.0 32.32 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.6 0.76 . . . . 72.54 109.43 175.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 41.4 ttm -86.91 115.66 24.46 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.192 0.52 . . . . 74.3 110.512 -177.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 9.2 m -116.15 162.57 17.24 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.626 1.17 . . . . 74.41 107.901 176.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 96.0 mt -56.8 -35.63 68.96 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.227 0.611 . . . . 75.21 112.349 -177.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -78.55 -20.06 51.48 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.047 0.539 . . . . 73.35 111.537 -177.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 142.13 -171.8 24.42 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 116.16 -0.473 . . . . 72.44 112.337 -176.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.52 129.07 14.24 Favored 'Trans proline' 0 C--N 1.365 1.441 0 C-N-CA 123.022 2.482 . . . . 73.41 111.463 177.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.73 159.93 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 123.723 0.809 . . . . 63.03 109.549 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -91.18 111.18 22.54 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.36 0.664 . . . . 71.3 109.661 174.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 93.2 t -107.58 120.99 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.24 1.016 . . . . 74.43 108.903 177.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.48 98.87 2.86 Favored 'General case' 0 C--N 1.348 0.509 0 C-N-CA 122.989 0.515 . . . . 75.43 109.959 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 62.2 t -78.03 136.15 62.18 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 124.534 1.134 . . . . 64.3 109.173 177.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -76.77 173.22 14.83 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.998 2.465 . . . . 74.13 111.201 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.49 179.52 1.24 Allowed 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 121.972 1.781 . . . . 74.44 112.197 166.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 27.8 mtt-85 71.23 0.05 3.28 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 125.184 1.394 . . . . 74.22 112.355 176.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 95.4 m -65.76 106.33 1.48 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.185 0.594 . . . . 63.53 110.712 -170.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.486 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 60.5 tp60 -115.1 141.45 47.99 Favored 'General case' 0 C--N 1.35 0.596 0 CA-C-N 115.054 -0.975 . . . . 72.12 110.329 -170.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.99 139.83 58.81 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.344 1.057 . . . . 74.13 111.513 -175.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 91.7 -27.21 10.13 Favored Glycine 0 C--N 1.344 0.978 0 O-C-N 123.836 0.71 . . . . 51.11 112.791 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.486 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 78.5 mtt180 -77.2 160.64 28.79 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.013 0.525 . . . . 72.01 110.413 176.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.464 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 2.8 mppt? -130.1 144.93 51.62 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.205 0.602 . . . . 74.13 109.653 -176.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.431 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 12.8 mt -97.9 104.44 16.47 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 115.738 -0.664 . . . . 74.24 109.269 -176.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 54.0 ttm-85 -71.51 105.74 3.72 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 123.873 0.733 . . . . 75.02 110.292 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.41 HD21 ' HA ' ' A' ' 173' ' ' ILE . 27.8 mt -112.26 94.59 5.0 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.18 0.592 . . . . 74.41 109.43 -178.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -65.74 143.81 57.29 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.32 0.248 . . . . 74.01 111.346 178.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 85.07 12.83 73.02 Favored Glycine 0 C--N 1.346 1.125 0 O-C-N 123.956 0.785 . . . . 60.22 113.707 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -110.78 -27.23 8.96 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 117.28 0.54 . . . . 75.23 110.539 -178.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -75.33 -167.69 21.93 Favored Glycine 0 C--N 1.352 1.469 0 O-C-N 123.473 0.483 . . . . 52.04 113.076 171.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.424 ' HA ' ' HD3' ' A' ' 241' ' ' PRO . 71.2 m-85 -70.44 144.37 91.64 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 123.414 0.685 . . . . 75.4 112.847 -171.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 240' ' ' PHE . 13.7 Cg_exo -72.18 132.59 19.77 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 123.443 2.762 . . . . 74.11 111.856 173.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.442 ' HA3' HE22 ' A' ' 191' ' ' GLN . . . -140.91 -174.69 14.2 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 119.775 -0.459 . . . . 71.32 113.695 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -52.01 -53.64 6.63 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 124.501 3.467 . . . . 72.41 114.751 -173.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -94.27 -24.57 17.39 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.674 0.79 . . . . 75.12 112.017 -173.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 175.67 -164.91 35.39 Favored Glycine 0 C--N 1.347 1.155 0 C-N-CA 121.836 -0.221 . . . . 63.42 112.773 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 -107.53 150.71 26.52 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.909 0.884 . . . . 72.32 110.447 -177.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.3 167.8 52.91 Favored Glycine 0 C--N 1.348 1.235 0 O-C-N 123.669 0.605 . . . . 55.21 113.877 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -112.67 133.08 54.87 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.38 1.072 . . . . 72.45 110.137 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 40.2 tp -99.24 122.42 42.39 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.339 1.055 . . . . 73.11 108.808 -174.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.464 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 3.8 m-85 -89.6 110.14 21.03 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.485 -0.932 . . . . 74.14 108.485 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.447 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 27.8 mt -86.86 104.99 16.73 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.646 -0.872 . . . . 74.44 108.646 173.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.437 ' HB2' ' HA ' ' A' ' 196' ' ' THR . 32.5 mt-10 -77.88 97.33 5.24 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.68 -1.146 . . . . 71.3 109.46 -171.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 59.0 t -58.95 114.93 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 114.94 -1.027 . . . . 73.24 111.459 -177.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -116.86 95.97 5.26 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.74 -1.208 . . . . 75.42 107.74 171.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.462 HD11 ' HA ' ' A' ' 228' ' ' GLN . 50.8 mt -75.53 126.88 36.79 Favored 'Isoleucine or valine' 0 C--N 1.35 0.594 0 CA-C-N 115.376 -0.829 . . . . 75.11 108.955 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 14.5 p . . . . . 0 C--O 1.252 1.192 0 C-N-CA 124.79 1.236 . . . . 74.44 108.159 177.995 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.802 0 CA-C-O 120.472 0.177 . . . . 75.299999999999997 111.451 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.4 ' HE1' ' HA ' ' A' ' 227' ' ' THR . 3.3 m-30 . . . . . 0 N--CA 1.483 1.209 0 C-N-CA 124.409 1.084 . . . . 74.340000000000003 112.33 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 . . . . . 0 C--O 1.244 0.805 0 N-CA-C 108.084 -1.08 . . . . 54.210000000000001 108.084 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -78.67 140.83 38.33 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 113.569 -1.651 . . . . 75.420000000000002 109.699 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 82.5 mt -136.66 140.66 42.9 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.901 0.48 . . . . 63.420000000000002 110.318 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -93.88 122.96 36.9 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.385 -0.825 . . . . 64.310000000000002 108.804 174.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -123.51 127.75 48.79 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 107.445 -1.316 . . . . 62.25 107.445 176.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' THR . . . . . 0.402 ' HA ' ' HB2' ' A' ' 252' ' ' GLU . 25.1 m -68.48 123.61 21.29 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.19 0.596 . . . . 63.310000000000002 110.452 -175.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 29.8 tp -108.36 111.62 23.63 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.604 -0.887 . . . . 75.209999999999994 108.604 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -81.97 126.17 31.64 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.404 -0.962 . . . . 73.510000000000005 108.404 174.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.484 HG11 HG13 ' A' ' 253' ' ' VAL . 6.4 p -142.68 130.3 11.2 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 108.305 -0.998 . . . . 25.199999999999999 108.305 178.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' PRO . . . . . 0.41 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 57.6 Cg_endo -73.85 155.57 48.56 Favored 'Trans proline' 0 C--N 1.363 1.307 0 C-N-CA 121.678 1.585 . . . . 61.039999999999999 110.666 172.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.81 -48.27 88.12 Favored Pre-proline 0 CA--C 1.56 1.35 0 C-N-CA 123.917 0.887 . . . . 60.439999999999998 113.08 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.468 ' O ' HG12 ' A' ' 206' ' ' VAL . 78.0 Cg_exo -52.57 -56.12 3.15 Favored 'Trans proline' 0 C--N 1.396 3.03 0 C-N-CA 122.453 2.102 . . . . 64.019999999999996 113.57 175.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 59.8 mt -65.09 -28.97 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 123.406 0.683 . . . . 75.299999999999997 111.077 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.54 -49.27 71.9 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.091 0.472 . . . . 54.140000000000001 111.052 177.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 65.9 t -73.98 -47.57 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 115.955 -0.566 . . . . 74.299999999999997 112.496 -173.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 202' ' ' PRO . 13.6 p -88.49 -22.2 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 O-C-N 122.233 -0.292 . . . . 61.439999999999998 111.34 -175.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 87.72 166.38 42.36 Favored Glycine 0 C--N 1.342 0.882 0 N-CA-C 111.533 -0.627 . . . . 51.299999999999997 111.533 -171.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 162.71 -128.15 1.82 Allowed Glycine 0 C--O 1.226 -0.359 0 N-CA-C 111.213 -0.755 . . . . 63.350000000000001 111.213 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.404 ' HD2' ' HB3' ' A' ' 220' ' ' GLU . 48.6 mtmt -137.65 151.48 48.32 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 108.712 -0.847 . . . . 73.109999999999999 108.712 173.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 26.6 m -138.37 162.3 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.075 0.55 . . . . 73.140000000000001 110.109 172.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 -84.42 115.43 22.53 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.456 -0.793 . . . . 75.030000000000001 109.854 174.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -106.79 156.76 18.32 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.716 0.806 . . . . 71.540000000000006 109.594 173.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 43.2 tpp -93.08 125.53 37.72 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.883 0.473 . . . . 65.319999999999993 109.874 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.442 HG22 ' H ' ' A' ' 216' ' ' GLU . 61.1 m -137.8 160.78 38.32 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.692 1.197 . . . . 75.109999999999999 108.044 -178.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 92.5 mt -65.95 -20.85 66.35 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.143 0.577 . . . . 64.099999999999994 111.788 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.442 ' H ' HG22 ' A' ' 214' ' ' THR . 13.5 mm-40 -80.02 -17.49 52.67 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.004 0.922 . . . . 74.120000000000005 110.95 174.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 125.0 -156.78 19.07 Favored Glycine 0 C--N 1.343 0.95 0 N-CA-C 111.449 -0.66 . . . . 32.439999999999998 111.449 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.9 121.07 6.04 Favored 'Trans proline' 0 C--N 1.363 1.3 0 C-N-CA 122.382 2.055 . . . . 70.230000000000004 111.607 173.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 32.7 m -111.26 155.91 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.244 0.617 . . . . 75.340000000000003 109.837 177.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.404 ' HB3' ' HD2' ' A' ' 209' ' ' LYS . 49.8 mt-10 -94.14 113.85 25.87 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.19 -0.67 . . . . 73.030000000000001 109.19 175.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 92.2 t -97.26 117.56 42.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 108.647 -0.872 . . . . 74.540000000000006 108.647 175.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.25 100.35 0.79 Allowed 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.474 0.484 . . . . 74.230000000000004 109.956 176.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 91.4 t -72.75 131.72 83.93 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 123.495 0.718 . . . . 75.209999999999994 109.754 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.33 165.92 31.25 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.266 1.977 . . . . 72.230000000000004 110.979 171.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -67.4 174.58 7.05 Favored 'Trans proline' 0 CA--C 1.551 1.374 0 C-N-CA 121.688 1.592 . . . . 65.409999999999997 112.818 170.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 69.91 0.32 3.01 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 125.374 1.47 . . . . 75.310000000000002 113.514 173.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.454 HG22 HG11 ' A' ' 253' ' ' VAL . 47.4 m -62.24 126.83 28.69 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.119 0.968 . . . . 75.030000000000001 111.781 -170.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.415 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 57.9 tp60 -124.4 143.2 50.75 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.816 0.846 . . . . 72.25 111.03 -167.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.86 131.75 51.66 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.904 1.282 . . . . 71.510000000000005 111.813 -178.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 99.4 -18.04 56.94 Favored Glycine 0 N--CA 1.473 1.116 0 O-C-N 123.705 0.628 . . . . 52.219999999999999 112.951 177.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.415 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 80.5 mtt180 -83.12 135.87 34.66 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.074 -0.714 . . . . 64.439999999999998 109.074 174.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.2 mppt? -102.11 131.78 48.4 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.192 -0.67 . . . . 71.430000000000007 109.192 176.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.509 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 29.0 mt -77.46 97.78 5.09 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.88 -1.155 . . . . 74.010000000000005 107.88 174.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -74.17 103.91 4.77 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.151 0.581 . . . . 74.549999999999997 110.18 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 7.4 mt -102.23 91.09 4.14 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.054 -1.091 . . . . 72.340000000000003 108.054 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -66.6 129.44 39.85 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.843 -0.617 . . . . 71.430000000000007 112.221 -172.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 95.5 -16.66 60.81 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 115.639 -0.709 . . . . 64.030000000000001 113.113 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.542 ' HA ' ' HE2' ' A' ' 238' ' ' LYS . 11.3 mmpt? -81.57 -12.63 58.71 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.324 0.649 . . . . 73.549999999999997 112.06 -176.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -79.5 -172.68 43.58 Favored Glycine 0 CA--C 1.535 1.339 0 N-CA-C 112.106 -0.398 . . . . 72.129999999999995 112.106 168.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -86.31 153.06 56.19 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 123.005 0.522 . . . . 75.030000000000001 111.451 -174.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.46 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 48.0 Cg_endo . . . . . 0 C--N 1.382 2.312 0 C-N-CA 123.019 2.479 . . . . 72.219999999999999 112.708 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 77.9 mtt180 . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 110.079 -0.341 . . . . 75.239999999999995 110.079 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -84.35 173.0 49.58 Favored Glycine 0 C--N 1.349 1.257 0 N-CA-C 114.014 0.366 . . . . 71.420000000000002 114.014 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -106.83 134.11 50.47 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.62 1.168 . . . . 75.400000000000006 109.007 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 32.7 tp -98.91 106.69 18.98 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.892 -0.781 . . . . 63.32 108.892 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.458 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 72.6 m-85 -88.76 107.52 19.0 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.361 0.664 . . . . 74.329999999999998 109.68 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.509 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 43.3 mt -88.08 108.47 19.26 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 108.787 -0.82 . . . . 75.120000000000005 108.787 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.402 ' HB2' ' HA ' ' A' ' 196' ' ' THR . 34.8 mt-10 -76.79 99.89 5.29 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.263 -0.88 . . . . 62.020000000000003 109.813 -171.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.484 HG13 HG11 ' A' ' 199' ' ' VAL . 95.0 t -61.69 106.48 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 123.228 0.611 . . . . 54.25 111.071 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -109.38 95.09 5.39 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.198 0.999 . . . . 73.230000000000004 108.521 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 21.8 mt -76.18 113.9 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 123.264 0.625 . . . . 72.430000000000007 109.453 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 23.8 p . . . . . 0 C--O 1.249 1.044 0 C-N-CA 124.664 1.186 . . . . 72.409999999999997 110.256 -178.748 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 111.462 0.171 . . . . 54.43 111.462 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.675 ' HB3' HH21 ' A' ' 226' ' ' ARG . 34.7 m-85 . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 108.909 -0.774 . . . . 53.539999999999999 108.909 166.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.571 ' HB2' ' HB2' ' A' ' 240' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 121.515 0.674 . . . . 75.219999999999999 110.407 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -75.48 143.08 42.77 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.349 1.06 . . . . 73.219999999999999 110.397 177.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 82.5 mt -121.13 146.96 46.21 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.721 0.409 . . . . 72.409999999999997 110.678 -171.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -93.76 149.71 21.01 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 109.438 -0.578 . . . . 71.049999999999997 109.438 171.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.461 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -144.54 127.99 16.94 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.589 0.755 . . . . 72.340000000000003 109.003 -177.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 38.5 m -71.31 117.8 13.31 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 122.943 0.497 . . . . 43.509999999999998 109.946 -176.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 41.5 tp -108.0 109.91 21.49 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.604 -0.887 . . . . 53.0 108.604 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -92.3 112.53 24.51 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.44 0.696 . . . . 65.340000000000003 109.156 175.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.409 ' HA ' HG11 ' A' ' 210' ' ' VAL . 7.0 p -130.24 128.99 22.82 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 124.305 1.042 . . . . 53.350000000000001 108.956 -178.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' PRO . . . . . 0.406 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 41.7 Cg_endo -70.26 155.11 65.02 Favored 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.004 1.803 . . . . 75.310000000000002 111.836 176.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -48.41 -46.49 68.95 Favored Pre-proline 0 CA--C 1.566 1.566 0 N-CA-C 114.79 1.404 . . . . 61.5 114.79 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.48 ' O ' HG12 ' A' ' 206' ' ' VAL . 25.7 Cg_endo -61.86 -52.69 2.7 Favored 'Trans proline' 0 C--N 1.393 2.921 0 CA-C-N 121.114 1.433 . . . . 64.530000000000001 112.888 176.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 50.7 mt -64.93 -24.61 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 123.574 0.749 . . . . 73.040000000000006 110.952 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.47 ' HB1' ' O ' ' A' ' 227' ' ' THR . . . -68.66 -55.1 12.58 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.578 0.751 . . . . 71.239999999999995 111.34 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 76.6 t -66.76 -51.5 55.25 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-N 115.858 -0.61 . . . . 72.230000000000004 112.121 -175.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 202' ' ' PRO . 11.5 p -87.69 -25.96 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 N-CA-C 111.913 0.338 . . . . 60.310000000000002 111.913 -174.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 92.29 153.4 29.92 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 111.641 -0.584 . . . . 74.120000000000005 111.641 -171.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 178.76 -128.89 1.31 Allowed Glycine 0 C--N 1.33 0.235 0 CA-C-O 119.551 -0.583 . . . . 72.209999999999994 111.944 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -139.56 141.39 37.22 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.059 0.944 . . . . 73.420000000000002 110.144 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.409 HG11 ' HA ' ' A' ' 199' ' ' VAL . 30.8 m -135.14 167.57 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.963 0.905 . . . . 71.230000000000004 109.425 169.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -93.47 111.42 23.08 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.102 -0.703 . . . . 75.030000000000001 109.102 173.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.48 145.25 29.85 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.844 0.458 . . . . 64.319999999999993 110.065 175.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 87.4 mtp -88.02 104.47 16.68 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.653 -0.869 . . . . 72.239999999999995 108.653 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 215' ' ' LEU . 27.7 m -111.78 177.35 4.68 Favored 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 124.824 1.25 . . . . 70.310000000000002 108.315 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.414 ' H ' HG22 ' A' ' 214' ' ' THR . 82.6 mt -63.57 -19.32 64.72 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.461 0.704 . . . . 71.310000000000002 112.845 -177.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -87.48 6.48 33.88 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.375 0.67 . . . . 74.109999999999999 111.555 175.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 93.65 -153.32 21.21 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 119.406 -0.663 . . . . 61.299999999999997 111.641 -173.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -75.63 126.46 9.58 Favored 'Trans proline' 0 C--N 1.367 1.527 0 C-N-CA 122.339 2.026 . . . . 72.439999999999998 111.079 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.94 153.16 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 123.124 0.57 . . . . 54.450000000000003 111.217 -171.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -84.92 110.58 18.97 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.198 -0.667 . . . . 71.349999999999994 109.198 175.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 95.4 t -109.2 123.0 64.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 123.854 0.862 . . . . 70.299999999999997 110.18 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -77.37 101.24 6.26 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.512 0.725 . . . . 73.120000000000005 109.943 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 57.3 t -73.67 130.95 82.75 Favored Pre-proline 0 CA--C 1.561 1.38 0 C-N-CA 125.12 1.368 . . . . 63.520000000000003 110.142 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -85.09 171.25 9.26 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 123.205 2.603 . . . . 74.040000000000006 111.032 174.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.04 166.35 21.09 Favored 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 121.689 1.593 . . . . 73.219999999999999 112.639 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ARG . . . . . 0.675 HH21 ' HB3' ' A' ' 176' ' ' TYR . 29.3 mtm180 71.72 11.59 6.35 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 125.636 1.574 . . . . 71.109999999999999 112.634 177.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.47 ' O ' ' HB1' ' A' ' 204' ' ' ALA . 94.1 m -65.54 91.62 0.13 Allowed 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 121.776 0.798 . . . . 73.230000000000004 110.16 -178.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.508 ' HA ' HD11 ' A' ' 255' ' ' ILE . 32.8 tt0 -107.75 144.3 35.08 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 114.771 -1.104 . . . . 74.239999999999995 110.396 -168.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -55.02 129.98 39.97 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.004 1.321 . . . . 74.430000000000007 111.986 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 88.93 -9.06 78.15 Favored Glycine 0 N--CA 1.475 1.251 0 CA-C-N 115.997 -0.547 . . . . 62.109999999999999 114.032 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -81.98 150.89 27.42 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.437 -0.579 . . . . 73.010000000000005 109.437 171.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.509 ' HG3' ' HA ' ' A' ' 252' ' ' GLU . 0.0 OUTLIER -129.85 141.81 50.77 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.796 0.808 . . . . 73.129999999999995 110.995 -176.047 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 14.9 mt -114.77 99.64 7.65 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 114.101 -1.409 . . . . 71.310000000000002 109.516 -162.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ARG . . . . . 0.543 ' HG3' ' HB3' ' A' ' 248' ' ' ASP . 52.1 ttp180 -76.78 102.54 6.31 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 123.516 0.51 . . . . 71.099999999999994 110.405 -175.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 21.9 mt -99.12 95.35 7.05 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.153 0.981 . . . . 74.439999999999998 108.443 176.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -66.64 148.06 52.42 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.64 0.776 . . . . 53.219999999999999 111.765 -176.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 72.67 30.93 63.29 Favored Glycine 0 CA--C 1.529 0.932 0 O-C-N 123.706 0.629 . . . . 75.430000000000007 113.513 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -130.12 -17.47 3.45 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 113.346 0.869 . . . . 74.430000000000007 113.346 -176.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -77.55 -152.82 5.54 Favored Glycine 0 N--CA 1.484 1.842 0 CA-C-N 118.028 0.376 . . . . 61.039999999999999 113.505 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.571 ' HB2' ' HB2' ' A' ' 191' ' ' GLN . 15.0 m-85 -69.12 155.34 93.76 Favored Pre-proline 0 N--CA 1.488 1.436 0 CA-C-O 118.595 -0.717 . . . . 73.310000000000002 110.152 172.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo . . . . . 0 C--N 1.377 2.061 0 C-N-CA 123.024 2.482 . . . . 52.530000000000001 113.02 175.17 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 . . . . . 0 C--O 1.244 0.806 0 N-CA-C 109.512 -0.551 . . . . 73.25 109.512 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -89.25 -160.16 36.17 Favored Glycine 0 C--N 1.339 0.719 0 CA-C-N 115.291 -0.868 . . . . 72.349999999999994 111.89 172.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.543 ' HB3' ' HG3' ' A' ' 234' ' ' ARG . 3.4 m-20 -98.21 169.95 9.23 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.175 0.59 . . . . 74.349999999999994 109.61 -176.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 33.7 tp -139.67 106.19 5.33 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.62 -0.882 . . . . 64.219999999999999 108.62 174.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -88.7 113.38 24.2 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.197 0.599 . . . . 73.129999999999995 109.401 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.461 HD23 ' HB3' ' A' ' 195' ' ' ALA . 57.0 mt -85.14 112.74 20.96 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.364 -0.976 . . . . 73.049999999999997 108.364 175.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.509 ' HA ' ' HG3' ' A' ' 232' ' ' LYS . 13.8 tp10 -76.83 101.0 5.7 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.749 1.219 . . . . 70.25 108.088 -179.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.69 106.94 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.518 0.675 . . . . 63.149999999999999 110.476 -176.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -107.02 96.5 6.47 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 114.425 -1.261 . . . . 70.430000000000007 107.7 174.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.508 HD11 ' HA ' ' A' ' 228' ' ' GLN . 24.2 mt -76.13 123.54 32.52 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 N-CA-C 108.83 -0.804 . . . . 73.140000000000001 108.83 176.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 41.5 p . . . . . 0 CA--C 1.549 0.934 0 C-N-CA 124.785 1.234 . . . . 73.109999999999999 108.755 177.358 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 112.498 0.555 . . . . 64.430000000000007 112.498 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 . . . . . 0 CA--C 1.541 0.633 0 N-CA-C 108.02 -1.104 . . . . 73.530000000000001 108.02 169.556 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.631 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 72.8 mt-30 . . . . . 0 CA--C 1.55 0.972 0 CA-C-O 120.967 0.413 . . . . 70.430000000000007 111.849 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -73.98 143.1 45.77 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.579 1.152 . . . . 54.130000000000003 110.683 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 95.2 mt -139.16 149.78 44.85 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.255 1.022 . . . . 62.009999999999998 109.942 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -111.54 128.47 56.04 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.305 1.042 . . . . 74.239999999999995 108.245 168.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -125.29 128.41 48.19 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.901 -0.777 . . . . 65.409999999999997 108.901 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 73.6 m -67.49 131.93 46.62 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.355 0.662 . . . . 65.219999999999999 110.373 178.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 20.6 tp -121.36 112.52 18.67 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.888 0.875 . . . . 72.140000000000001 108.969 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -92.47 120.47 32.98 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 108.752 -0.833 . . . . 61.240000000000002 108.752 172.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 3.0 p -131.64 128.05 21.65 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.143 0.977 . . . . 75.019999999999996 108.432 -178.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -71.39 153.03 61.22 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 121.6 1.533 . . . . 75.519999999999996 111.395 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -47.1 -48.73 53.46 Favored Pre-proline 0 CA--C 1.565 1.545 0 O-C-N 124.495 1.122 . . . . 73.409999999999997 113.064 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.32 -55.42 3.65 Favored 'Trans proline' 0 C--N 1.407 3.611 0 C-N-CA 122.458 2.106 . . . . 72.319999999999993 113.291 175.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 57.4 mt -67.76 -27.01 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 123.558 0.743 . . . . 75.120000000000005 111.1 -175.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.17 -45.48 73.38 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.588 0.755 . . . . 73.340000000000003 110.857 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 81.0 t -71.63 -55.92 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 115.77 -0.65 . . . . 54.43 110.685 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 11.2 m -73.52 -28.58 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 O-C-N 123.816 0.698 . . . . 74.299999999999997 112.191 -172.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 77.77 84.01 0.54 Allowed Glycine 0 C--N 1.344 0.994 0 CA-C-N 116.013 -0.54 . . . . 73.230000000000004 112.371 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -115.28 -126.0 4.04 Favored Glycine 0 C--N 1.342 0.886 0 N-CA-C 112.14 -0.384 . . . . 44.310000000000002 112.14 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -137.56 147.96 45.54 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.654 1.182 . . . . 75.010000000000005 108.36 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 28.4 m -133.35 168.71 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 121.305 0.574 . . . . 54.329999999999998 110.703 173.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -77.37 135.47 38.35 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.967 -1.015 . . . . 74.310000000000002 108.87 169.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -138.17 158.26 44.65 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.756 0.423 . . . . 64.299999999999997 110.509 176.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 67.0 mtm -81.02 119.06 23.04 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.045 -0.979 . . . . 71.200000000000003 110.242 -176.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.432 HG22 ' H ' ' A' ' 216' ' ' GLU . 89.4 m -135.42 151.68 50.67 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.186 0.994 . . . . 42.240000000000002 109.63 176.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 62.6 mt -57.41 -25.56 59.77 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.564 1.146 . . . . 75.450000000000003 112.808 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.432 ' H ' HG22 ' A' ' 214' ' ' THR . 34.0 mt-10 -86.43 -18.86 30.65 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.155 0.982 . . . . 72.239999999999995 111.585 -178.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 135.07 -177.72 19.11 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.543 -0.623 . . . . 62.210000000000001 111.543 -175.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.66 120.83 7.17 Favored 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 122.404 2.069 . . . . 73.219999999999999 111.431 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.6 m -113.14 161.67 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 123.064 0.546 . . . . 73.299999999999997 111.484 -173.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -91.59 111.99 23.73 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.799 0.839 . . . . 64.400000000000006 109.482 174.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 54.4 t -109.88 126.22 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.023 0.929 . . . . 75.209999999999994 109.421 -176.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -77.36 100.94 6.11 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.353 0.661 . . . . 24.329999999999998 111.188 -173.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 59.9 t -77.29 134.81 66.48 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 124.93 1.292 . . . . 74.299999999999997 109.827 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.03 170.3 20.71 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.523 2.149 . . . . 74.329999999999998 111.349 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.68 165.73 31.91 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 121.228 1.285 . . . . 73.329999999999998 111.259 169.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 63.39 22.97 13.52 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.781 0.832 . . . . 72.140000000000001 112.299 175.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 93.9 m -68.83 105.7 2.43 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.816 0.846 . . . . 42.240000000000002 109.634 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -105.51 141.45 36.97 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.259 1.024 . . . . 64.230000000000004 110.223 -171.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.74 136.89 58.2 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.474 1.11 . . . . 73.540000000000006 111.371 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 92.22 -9.22 76.7 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.499 -0.773 . . . . 75.420000000000002 113.435 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -84.86 144.22 28.55 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.995 0.518 . . . . 73.129999999999995 109.7 173.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.654 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.2 mppt? -110.66 129.47 55.81 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.508 0.723 . . . . 74.150000000000006 109.196 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.554 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 53.9 mt -95.03 101.35 13.1 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.831 0.852 . . . . 64.109999999999999 109.751 -173.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -72.35 105.29 4.03 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.333 0.653 . . . . 72.409999999999997 110.676 -176.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 17.8 mt -105.12 98.15 7.9 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.826 -1.176 . . . . 72.230000000000004 107.826 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -75.78 148.43 38.48 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 122.544 0.338 . . . . 74.099999999999994 111.349 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 72.03 33.68 62.29 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-N 115.757 -0.656 . . . . 75.319999999999993 113.272 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.13 -37.3 3.4 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.606 0.762 . . . . 71.239999999999995 111.338 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -68.72 -154.09 0.63 Allowed Glycine 0 C--N 1.355 1.631 0 N-CA-C 114.455 0.542 . . . . 72.439999999999998 114.455 -177.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.631 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 81.5 m-85 -66.66 144.71 98.74 Favored Pre-proline 0 N--CA 1.481 1.117 0 C-N-CA 122.81 0.444 . . . . 75.530000000000001 111.003 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo . . . . . 0 C--N 1.374 1.913 0 C-N-CA 122.678 2.252 . . . . 72.109999999999999 113.317 178.577 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 . . . . . 0 C--O 1.24 0.554 0 N-CA-C 108.623 -0.88 . . . . 73.129999999999995 108.623 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.8 -170.11 16.19 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-N 115.534 -0.757 . . . . 74.150000000000006 113.738 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -98.34 165.82 11.67 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.448 0.699 . . . . 71.209999999999994 109.291 -172.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 41.1 tp -141.58 105.24 4.7 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.515 -0.92 . . . . 72.120000000000005 108.515 175.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.654 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 33.0 m-85 -91.07 111.32 22.74 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.357 0.663 . . . . 74.420000000000002 109.899 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.554 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 48.5 mt -86.02 109.18 18.62 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.885 -0.783 . . . . 72.310000000000002 108.885 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -77.81 100.01 6.14 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.05 -0.977 . . . . 61.539999999999999 109.642 -173.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 48.6 t -57.84 111.45 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 O-C-N 123.963 0.789 . . . . 73.439999999999998 111.404 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 21.2 mmm-85 -115.48 98.93 7.01 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 106.818 -1.549 . . . . 65.400000000000006 106.818 171.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 36.5 mt -75.82 119.53 23.94 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 N-CA-C 109.45 -0.574 . . . . 75.219999999999999 109.45 -176.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 7.5 p . . . . . 0 C--O 1.261 1.689 0 C-N-CA 124.647 1.179 . . . . 73.049999999999997 108.867 -174.294 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 111.885 0.328 . . . . 74.109999999999999 111.885 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.582 ' CE2' HD21 ' A' ' 233' ' ' LEU . 37.7 m-85 . . . . . 0 N--CA 1.482 1.157 0 C-N-CA 123.246 0.618 . . . . 73.209999999999994 110.843 167.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 . . . . . 0 N--CA 1.479 0.994 0 CA-C-O 121.088 0.471 . . . . 74.420000000000002 110.844 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -77.27 149.02 35.43 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.522 -0.763 . . . . 71.349999999999994 109.899 175.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 95.6 mt -134.94 156.5 48.89 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.29 0.636 . . . . 63.420000000000002 110.55 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -108.86 124.51 50.75 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.663 -0.866 . . . . 73.549999999999997 108.663 169.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -124.07 130.09 51.97 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.117 0.967 . . . . 62.520000000000003 108.829 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 14.7 m -68.92 121.25 16.22 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.365 0.666 . . . . 71.209999999999994 110.102 -177.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.426 HD22 ' HB3' ' A' ' 251' ' ' LEU . 35.0 tp -106.35 110.47 22.71 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.629 -1.248 . . . . 63.509999999999998 107.629 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -89.2 116.65 27.6 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.485 -0.931 . . . . 74.430000000000007 108.485 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.7 p -137.69 132.82 17.58 Favored Pre-proline 0 CA--C 1.546 0.794 0 N-CA-C 108.972 -0.751 . . . . 73.310000000000002 108.972 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -75.13 156.47 42.42 Favored 'Trans proline' 0 C--N 1.366 1.472 0 C-N-CA 121.924 1.75 . . . . 71.230000000000004 111.27 170.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.412 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -52.6 -45.27 96.23 Favored Pre-proline 0 CA--C 1.554 1.118 0 N-CA-C 114.347 1.24 . . . . 42.219999999999999 114.347 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.406 ' O ' HG12 ' A' ' 206' ' ' VAL . 24.6 Cg_endo -59.14 -50.79 7.88 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 121.658 1.572 . . . . 74.019999999999996 112.956 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 49.6 mt -65.94 -25.02 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.676 0.79 . . . . 74.319999999999993 111.077 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.95 -46.44 62.41 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 122.848 0.459 . . . . 73.219999999999999 111.275 177.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 201' ' ' ALA . 87.7 t -64.46 -52.7 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 122.991 0.516 . . . . 72.129999999999995 111.442 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 202' ' ' PRO . 11.8 p -84.17 -34.32 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 112.04 0.385 . . . . 73.200000000000003 112.04 -174.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 84.49 89.3 0.82 Allowed Glycine 0 C--N 1.335 0.483 0 CA-C-N 116.561 -0.291 . . . . 43.030000000000001 112.507 -171.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -106.39 -135.13 7.93 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 111.05 -0.82 . . . . 61.409999999999997 111.05 172.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -128.97 144.26 51.13 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 108.783 -0.821 . . . . 52.039999999999999 108.783 174.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.44 HG11 ' HA ' ' A' ' 199' ' ' VAL . 33.7 m -134.11 162.07 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.116 0.566 . . . . 64.329999999999998 110.333 176.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 69.0 ttt-85 -74.44 135.53 42.33 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.112 0.565 . . . . 73.109999999999999 109.979 172.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -140.7 151.26 44.39 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.702 0.801 . . . . 73.209999999999994 109.565 177.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -80.63 122.34 26.96 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.962 -0.755 . . . . 74.219999999999999 108.962 176.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.416 HG22 ' H ' ' A' ' 216' ' ' GLU . 95.9 m -131.84 164.35 26.26 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 107.909 -1.145 . . . . 74.230000000000004 107.909 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 73.0 mt -63.86 -11.31 26.44 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.296 0.639 . . . . 54.109999999999999 112.069 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.416 ' H ' HG22 ' A' ' 214' ' ' THR . 40.9 mt-10 -103.43 17.74 23.41 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.817 1.247 . . . . 75.439999999999998 110.886 176.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 87.12 -161.99 33.38 Favored Glycine 0 C--N 1.349 1.281 0 CA-C-O 119.463 -0.632 . . . . 72.200000000000003 113.182 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -74.04 121.94 7.28 Favored 'Trans proline' 0 C--N 1.372 1.805 0 C-N-CA 122.505 2.137 . . . . 73.319999999999993 111.715 177.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.91 158.92 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.882 0.873 . . . . 65.310000000000002 110.402 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -90.42 108.93 20.09 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.873 0.469 . . . . 63.210000000000001 109.814 173.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 25.1 t -97.49 129.69 47.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 108.819 -0.808 . . . . 74.519999999999996 108.819 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.02 100.44 2.99 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.267 0.627 . . . . 64.010000000000005 110.586 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 50.9 t -64.27 139.43 97.7 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 125.254 1.421 . . . . 73.25 109.94 178.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.37 168.64 24.24 Favored 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 122.684 2.256 . . . . 71.219999999999999 111.548 173.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -73.82 172.92 14.87 Favored 'Trans proline' 0 CA--C 1.55 1.319 0 C-N-CA 121.453 1.435 . . . . 75.450000000000003 110.716 164.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 44.8 mtt180 66.12 6.34 4.09 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 124.684 1.194 . . . . 65.329999999999998 112.722 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.447 ' O ' HD11 ' A' ' 255' ' ' ILE . 94.4 m -59.91 110.54 1.2 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.375 0.67 . . . . 74.540000000000006 110.823 -170.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.494 ' HB3' ' HD3' ' A' ' 231' ' ' ARG . 60.1 tt0 -117.47 134.44 54.85 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.974 1.31 . . . . 74.549999999999997 110.328 -164.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.6 128.23 35.6 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.369 1.068 . . . . 71.430000000000007 112.444 -173.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.41 -9.85 62.93 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-N 115.915 -0.584 . . . . 54.299999999999997 113.119 177.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.494 ' HD3' ' HB3' ' A' ' 228' ' ' GLN . 76.2 mtp180 -89.41 158.55 17.7 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.079 0.552 . . . . 70.439999999999998 110.728 176.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.428 ' HG3' ' HA ' ' A' ' 252' ' ' GLU . 0.0 OUTLIER -131.34 144.11 51.0 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.088 0.555 . . . . 54.130000000000003 110.734 -174.036 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.582 HD21 ' CE2' ' A' ' 176' ' ' TYR . 44.6 mt -117.46 102.27 9.07 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.723 -0.672 . . . . 62.009999999999998 110.726 -164.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ARG . . . . . 0.419 ' HG3' ' HB3' ' A' ' 248' ' ' ASP . 51.1 ttp180 -79.78 113.92 18.3 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.833 0.853 . . . . 74.409999999999997 110.935 -173.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 43.0 mt -112.38 96.95 6.3 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.574 0.75 . . . . 74.549999999999997 109.304 177.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -62.86 140.84 58.83 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.859 -0.61 . . . . 75.099999999999994 111.379 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 81.17 25.36 55.37 Favored Glycine 0 C--N 1.339 0.741 0 O-C-N 124.259 0.975 . . . . 74.140000000000001 114.508 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.78 -28.25 6.02 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.152 0.581 . . . . 72.230000000000004 111.306 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -74.63 -169.66 23.2 Favored Glycine 0 CA--C 1.535 1.339 0 O-C-N 123.399 0.437 . . . . 51.299999999999997 112.848 173.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -65.43 143.33 98.68 Favored Pre-proline 0 N--CA 1.486 1.339 0 C-N-CA 123.693 0.797 . . . . 71.409999999999997 111.495 -175.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo . . . . . 0 C--N 1.379 2.137 0 C-N-CA 122.735 2.29 . . . . 72.109999999999999 112.076 175.083 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 57.6 mtt85 . . . . . 0 N--CA 1.484 1.228 0 N-CA-C 110.478 -0.193 . . . . 63.030000000000001 110.478 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -71.79 -173.11 17.9 Favored Glycine 0 C--N 1.344 1.021 0 O-C-N 123.545 0.528 . . . . 75.120000000000005 113.565 -176.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.419 ' HB3' ' HG3' ' A' ' 234' ' ' ARG . 3.3 m-20 -98.67 157.88 15.98 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.805 -0.813 . . . . 73.150000000000006 108.805 -176.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 32.9 tp -125.9 106.49 9.69 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.102 -1.073 . . . . 74.549999999999997 108.102 172.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -89.68 107.47 19.11 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.857 -0.794 . . . . 72.340000000000003 108.857 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.426 ' HB3' HD22 ' A' ' 197' ' ' LEU . 62.3 mt -87.77 106.71 18.25 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.453 -0.944 . . . . 75.040000000000006 108.453 176.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.428 ' HA ' ' HG3' ' A' ' 232' ' ' LYS . 22.7 mt-10 -79.07 105.9 10.73 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 114.894 -1.048 . . . . 73.129999999999995 110.153 -173.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 83.4 t -60.15 107.45 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.693 0 O-C-N 124.169 0.918 . . . . 75.299999999999997 111.48 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -115.27 93.92 4.5 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 107.91 -1.144 . . . . 73.310000000000002 107.91 173.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.464 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 54.5 mt -76.65 132.5 32.83 Favored 'Isoleucine or valine' 0 C--N 1.351 0.671 0 CA-C-N 115.464 -0.789 . . . . 54.530000000000001 109.93 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 32.4 p . . . . . 0 C--O 1.253 1.237 0 C-N-CA 124.671 1.188 . . . . 72.420000000000002 108.694 -179.165 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 120.436 0.16 . . . . 73.140000000000001 111.166 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.461 ' CE2' HD21 ' A' ' 233' ' ' LEU . 6.2 m-85 . . . . . 0 N--CA 1.483 1.209 0 C-N-CA 123.787 0.835 . . . . 75.129999999999995 111.323 169.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 121.509 0.671 . . . . 74.409999999999997 110.762 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -83.77 159.15 21.5 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.541 -1.209 . . . . 75.299999999999997 112.631 -169.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.5 mt -143.68 138.01 28.62 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.097 0.959 . . . . 72.430000000000007 109.614 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -93.04 125.72 37.77 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.483 -1.303 . . . . 72.230000000000004 107.483 164.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -124.24 133.06 53.61 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.369 -0.604 . . . . 74.439999999999998 109.369 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' THR . . . . . 0.589 HG23 ' HG3' ' A' ' 254' ' ' ARG . 42.9 m -65.94 122.16 16.72 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 124.038 0.836 . . . . 63.32 109.77 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 40.3 tp -109.28 108.8 19.52 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.018 -1.475 . . . . 71.209999999999994 107.018 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -95.7 103.09 14.95 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 122.098 0.951 . . . . 62.140000000000001 109.225 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 2.8 p -120.12 117.41 32.05 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-N 114.569 -1.196 . . . . 73.030000000000001 109.02 -174.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.9 154.59 73.33 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 122.136 1.891 . . . . 72.239999999999995 111.579 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -48.04 -45.25 63.24 Favored Pre-proline 0 CA--C 1.565 1.554 0 N-CA-C 114.713 1.375 . . . . 34.340000000000003 114.713 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.438 ' O ' HG22 ' A' ' 206' ' ' VAL . 26.1 Cg_endo -59.72 -50.85 7.03 Favored 'Trans proline' 0 C--N 1.399 3.187 0 C-N-CA 121.425 1.416 . . . . 71.150000000000006 112.227 176.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.7 mt -70.0 -23.24 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 123.672 0.789 . . . . 65.329999999999998 111.263 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.59 -51.06 46.63 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 122.923 0.489 . . . . 65.400000000000006 110.166 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 84.5 t -67.0 -48.69 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 CA-C-N 115.606 -0.725 . . . . 71.209999999999994 111.866 -177.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 202' ' ' PRO . 33.9 m -89.9 -23.04 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 113.313 0.857 . . . . 74.530000000000001 113.313 -174.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.78 149.69 24.37 Favored Glycine 0 N--CA 1.477 1.385 0 N-CA-C 112.15 -0.38 . . . . 72.109999999999999 112.15 -173.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 163.97 175.61 35.02 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 116.927 0.363 . . . . 55.310000000000002 112.282 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 221' ' ' VAL . 50.2 mtmt -82.12 135.66 35.27 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.872 0.469 . . . . 72.349999999999994 110.226 -177.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.465 HG11 ' HA ' ' A' ' 199' ' ' VAL . 33.9 m -138.94 170.03 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 123.84 0.856 . . . . 65.329999999999998 110.686 176.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -68.55 130.58 43.26 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.532 -0.758 . . . . 65.409999999999997 111.067 175.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -135.68 118.14 15.8 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.768 -0.827 . . . . 74.239999999999995 108.768 168.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 55.8 mtt -73.0 105.93 4.67 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.211 0.605 . . . . 64.409999999999997 109.874 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 25.6 m -110.03 171.46 7.44 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.88 1.272 . . . . 53.210000000000001 108.61 -175.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 85.8 mt -57.45 -35.33 70.0 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.576 0.75 . . . . 63.119999999999997 112.212 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -79.4 -11.02 59.92 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.803 0.841 . . . . 70.420000000000002 112.464 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 125.08 -179.33 16.2 Favored Glycine 0 N--CA 1.47 0.956 0 N-CA-C 111.121 -0.791 . . . . 61.43 111.121 -174.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.64 129.41 21.07 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 122.5 2.134 . . . . 74.239999999999995 110.997 176.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.474 HG23 HG23 ' A' ' 221' ' ' VAL . 29.5 m -123.29 162.26 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.777 0.831 . . . . 74.409999999999997 110.61 -174.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -90.58 106.04 18.23 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.692 0.758 . . . . 71.329999999999998 109.7 174.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.474 HG23 HG23 ' A' ' 219' ' ' VAL . 94.8 t -101.71 121.72 53.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 115.214 -0.903 . . . . 65.030000000000001 109.569 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.02 99.69 3.38 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 123.489 0.715 . . . . 52.539999999999999 110.009 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 31.1 t -84.53 132.64 46.3 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 114.547 -1.206 . . . . 74.530000000000001 109.172 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.42 170.05 17.06 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.862 2.375 . . . . 74.140000000000001 111.23 171.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.27 -174.43 0.26 Allowed 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.536 2.157 . . . . 62.32 113.563 174.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 38.5 mtp85 62.39 19.5 11.16 Favored 'General case' 0 N--CA 1.502 2.172 0 C-N-CA 125.137 1.375 . . . . 74.310000000000002 112.172 172.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.448 ' HA ' ' CZ ' ' A' ' 176' ' ' TYR . 55.5 m -71.82 99.18 2.12 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.965 0.906 . . . . 73.430000000000007 111.088 -171.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -98.55 134.94 40.81 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.255 1.422 . . . . 75.439999999999998 110.1 -175.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.67 146.22 54.21 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.25 0.62 . . . . 53.200000000000003 111.217 -178.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 96.73 -26.74 20.81 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-N 115.182 -0.917 . . . . 64.109999999999999 112.78 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -69.85 154.28 42.17 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 117.2 0.5 . . . . 74.209999999999994 111.12 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -130.32 142.92 50.51 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 108.176 -1.046 . . . . 71.510000000000005 108.176 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.461 HD21 ' CE2' ' A' ' 176' ' ' TYR . 27.4 mt -120.38 105.82 11.26 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.781 -0.645 . . . . 71.200000000000003 110.101 -165.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -73.23 102.86 3.76 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.744 0.818 . . . . 74.109999999999999 110.463 -174.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 37.3 mt -112.49 92.88 4.18 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.097 -0.705 . . . . 74.430000000000007 109.097 177.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.41 ' HG2' ' HB3' ' A' ' 248' ' ' ASP . 47.0 mtmt -69.59 144.26 53.07 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 122.293 0.237 . . . . 75.230000000000004 110.735 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 80.81 29.75 41.6 Favored Glycine 0 C--N 1.342 0.912 0 O-C-N 123.73 0.644 . . . . 30.34 113.432 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 249' ' ' LEU . 72.0 mmtt -123.33 -28.33 3.98 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 117.577 0.689 . . . . 73.140000000000001 112.11 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -72.02 -145.83 0.53 Allowed Glycine 0 N--CA 1.481 1.667 0 C-N-CA 123.111 0.386 . . . . 51.219999999999999 113.867 -177.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -76.65 149.5 80.97 Favored Pre-proline 0 N--CA 1.486 1.36 0 O-C-N 122.272 -0.546 . . . . 63.340000000000003 110.874 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo . . . . . 0 C--N 1.375 1.968 0 C-N-CA 122.746 2.297 . . . . 75.230000000000004 112.361 174.78 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 108.43 -0.952 . . . . 71.049999999999997 108.43 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.84 -175.75 46.91 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.982 -0.553 . . . . 73.319999999999993 113.885 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.41 ' HB3' ' HG2' ' A' ' 236' ' ' LYS . 3.6 p-10 -100.54 127.2 46.98 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.404 0.621 . . . . 74.219999999999999 110.057 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 238' ' ' LYS . 35.1 tp -99.95 110.91 23.23 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 107.845 -1.168 . . . . 70.209999999999994 107.845 -178.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -86.03 108.2 18.14 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.474 -1.306 . . . . 73.340000000000003 107.474 174.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 27.1 mt -84.2 105.13 14.82 Favored 'General case' 0 C--N 1.34 0.189 0 N-CA-C 107.775 -1.194 . . . . 63.020000000000003 107.775 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -77.18 103.23 6.99 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.649 -1.614 . . . . 61.420000000000002 108.966 -177.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 63.7 t -59.65 115.61 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 123.72 0.808 . . . . 72.519999999999996 110.722 177.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.589 ' HG3' HG23 ' A' ' 196' ' ' THR . 54.5 mmm-85 -125.64 97.1 5.03 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.001 -1.481 . . . . 73.150000000000006 107.001 177.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 54.8 mt -76.71 119.31 24.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 CA-C-N 116.232 -0.44 . . . . 72.349999999999994 110.197 -174.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 44.2 p . . . . . 0 C--O 1.255 1.344 0 C-N-CA 124.425 1.09 . . . . 63.439999999999998 108.185 177.785 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 112.143 0.423 . . . . 71.549999999999997 112.143 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 . . . . . 0 N--CA 1.49 1.569 0 C-N-CA 124.682 1.193 . . . . 61.310000000000002 112.103 177.206 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.517 ' HB3' ' HB2' ' A' ' 240' ' ' PHE . 82.3 mm-40 . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 121.352 0.596 . . . . 62.450000000000003 110.186 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -91.55 142.35 27.73 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.485 -0.779 . . . . 72.450000000000003 110.657 -175.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 96.2 mt -133.52 153.64 51.48 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.583 0.753 . . . . 63.539999999999999 110.244 -178.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -104.14 121.66 43.71 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 108.748 -0.834 . . . . 75.310000000000002 108.748 174.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -125.69 133.22 52.22 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.553 1.141 . . . . 74.310000000000002 109.117 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 39.3 m -65.51 139.38 58.48 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.473 0.709 . . . . 52.43 111.322 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.487 HD13 HD13 ' A' ' 251' ' ' LEU . 26.3 tp -115.17 122.57 46.45 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 123.837 0.855 . . . . 74.25 109.199 176.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -89.52 106.08 18.22 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.273 -0.64 . . . . 70.510000000000005 109.273 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.618 HG11 HG13 ' A' ' 253' ' ' VAL . 6.4 p -129.56 131.36 23.54 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 122.86 0.464 . . . . 72.420000000000002 110.042 178.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' PRO . . . . . 0.414 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 55.8 Cg_endo -74.46 157.64 44.86 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 121.943 1.762 . . . . 43.310000000000002 111.404 169.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.448 ' HA ' HG23 ' A' ' 255' ' ' ILE . . . -50.95 -48.97 83.23 Favored Pre-proline 0 CA--C 1.57 1.732 0 CA-C-O 117.949 -1.024 . . . . 53.219999999999999 113.652 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.479 ' O ' HG12 ' A' ' 206' ' ' VAL . 28.7 Cg_endo -60.91 -51.52 4.65 Favored 'Trans proline' 0 C--N 1.402 3.371 0 C-N-CA 121.529 1.486 . . . . 75.409999999999997 111.945 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.4 mt -62.83 -26.47 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 123.599 0.76 . . . . 65.430000000000007 111.32 -176.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.3 -52.99 33.81 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-O 120.953 0.406 . . . . 73.200000000000003 110.8 174.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 90.0 t -67.94 -43.99 85.39 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 N-CA-C 112.675 0.62 . . . . 75.439999999999998 112.675 -175.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 202' ' ' PRO . 11.0 p -99.92 -21.66 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 122.857 0.463 . . . . 72.209999999999994 112.183 -173.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.66 144.67 11.41 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 112.229 -0.348 . . . . 62.43 112.229 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -177.25 -140.35 3.63 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-O 119.224 -0.765 . . . . 74.439999999999998 111.898 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -116.94 143.34 45.82 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 118.005 0.902 . . . . 73.239999999999995 109.208 176.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 34.4 m -139.83 169.87 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 123.457 0.703 . . . . 61.450000000000003 111.352 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -90.12 114.12 26.0 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.12 0.568 . . . . 72.299999999999997 110.343 173.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.44 127.12 52.06 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.111 -1.07 . . . . 72.239999999999995 108.111 165.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 89.8 mmm -81.58 104.97 12.37 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.215 -0.661 . . . . 60.039999999999999 109.215 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 87.4 m -113.4 162.03 16.59 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.572 1.149 . . . . 73.140000000000001 109.76 -176.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 87.3 mt -58.0 -16.67 13.39 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.035 0.934 . . . . 70.530000000000001 112.986 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -103.7 29.25 5.89 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.037 0.935 . . . . 73.519999999999996 110.924 175.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 86.9 -165.38 36.31 Favored Glycine 0 C--N 1.348 1.231 0 CA-C-N 116.237 -0.438 . . . . 74.439999999999998 113.442 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -72.54 121.65 7.6 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.78 2.32 . . . . 55.100000000000001 111.395 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.4 m -121.15 147.8 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.821 0.849 . . . . 73.209999999999994 109.96 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 9.8 pt-20 -90.49 113.93 26.0 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.285 0.564 . . . . 72.430000000000007 110.949 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 63.9 t -102.83 132.2 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.283 0.633 . . . . 71.540000000000006 109.452 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -78.94 99.99 7.06 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 123.657 0.783 . . . . 65.549999999999997 109.765 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 74.5 t -80.03 134.02 56.93 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.317 1.047 . . . . 55.240000000000002 110.201 178.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.42 170.96 18.96 Favored 'Trans proline' 0 C--N 1.383 2.36 0 C-N-CA 122.939 2.426 . . . . 72.239999999999995 111.372 172.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -65.01 175.22 3.98 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 121.869 1.713 . . . . 72.140000000000001 113.47 172.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 72.31 5.33 5.26 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 125.248 1.419 . . . . 71.040000000000006 112.844 174.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 87.6 m -69.42 127.63 33.72 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.156 0.583 . . . . 75.510000000000005 110.913 -172.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -127.14 142.34 51.53 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.817 0.847 . . . . 71.519999999999996 110.809 -167.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.421 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -65.05 132.37 49.03 Favored 'General case' 0 C--N 1.348 0.543 0 C-N-CA 124.108 0.963 . . . . 73.239999999999995 110.767 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.13 -14.7 63.46 Favored Glycine 0 N--CA 1.468 0.77 0 O-C-N 123.994 0.809 . . . . 75.310000000000002 112.223 -178.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 78.2 mtt-85 -84.12 142.31 30.47 Favored 'General case' 0 C--N 1.351 0.65 0 N-CA-C 109.233 -0.654 . . . . 73.219999999999999 109.233 173.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.58 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.0 mppt? -110.64 130.88 55.46 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.786 -0.82 . . . . 74.340000000000003 108.786 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.406 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 27.1 mt -84.18 99.4 10.5 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.193 -1.04 . . . . 64.319999999999993 108.193 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -72.97 102.0 3.36 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.069 0.548 . . . . 74.109999999999999 109.956 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 14.0 mt -105.1 95.34 5.77 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.977 -0.749 . . . . 75.439999999999998 108.977 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -62.64 145.26 55.01 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 120.827 0.346 . . . . 63.240000000000002 111.452 176.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 74.58 19.78 79.76 Favored Glycine 0 C--N 1.344 0.985 0 CA-C-N 115.096 -0.956 . . . . 73.230000000000004 113.644 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -122.16 -11.17 8.47 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.426 0.691 . . . . 63.43 112.115 -176.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -77.98 -169.36 33.88 Favored Glycine 0 C--N 1.343 0.971 0 N-CA-C 111.842 -0.503 . . . . 40.420000000000002 111.842 167.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.517 ' HB2' ' HB3' ' A' ' 191' ' ' GLN . 18.0 m-30 -72.57 155.75 90.77 Favored Pre-proline 0 N--CA 1.483 1.201 0 CA-C-N 116.855 0.327 . . . . 71.129999999999995 110.995 -179.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo . . . . . 0 C--N 1.378 2.087 0 C-N-CA 122.557 2.171 . . . . 72.420000000000002 112.987 175.522 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 42.8 mtt180 . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 108.598 -0.889 . . . . 61.130000000000003 108.598 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -83.25 -165.82 38.62 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 116.014 -0.539 . . . . 53.310000000000002 112.811 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.54 164.83 12.1 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.921 0.888 . . . . 74.230000000000004 109.516 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 33.7 tp -134.99 107.76 7.49 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 107.793 -1.188 . . . . 72.420000000000002 107.793 173.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.58 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 73.5 m-85 -88.92 111.16 21.77 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.466 0.706 . . . . 60.130000000000003 109.608 -178.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.487 HD13 HD13 ' A' ' 197' ' ' LEU . 63.9 mt -86.46 104.33 15.83 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 107.998 -1.112 . . . . 74.519999999999996 107.998 174.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -78.95 97.58 6.1 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.38 -0.97 . . . . 75.129999999999995 108.38 -173.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.618 HG13 HG11 ' A' ' 199' ' ' VAL . 81.8 t -57.91 109.63 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-N 114.256 -1.338 . . . . 63.219999999999999 112.084 -175.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -105.03 97.93 7.71 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 124.281 1.033 . . . . 74.420000000000002 108.756 172.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.448 HG23 ' HA ' ' A' ' 201' ' ' ALA . 32.9 mt -77.56 126.92 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 123.651 0.594 . . . . 74.450000000000003 109.623 177.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 9.5 p . . . . . 0 CA--C 1.556 1.199 0 C-N-CA 124.677 1.191 . . . . 71.150000000000006 109.006 -178.389 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.838 0 CA-C-O 120.327 0.108 . . . . 74.129999999999995 111.182 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.42 ' HE1' ' HA ' ' A' ' 227' ' ' THR . 2.7 m-85 . . . . . 0 N--CA 1.494 1.738 0 C-N-CA 125.035 1.334 . . . . 74.549999999999997 113.423 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 109.336 -0.616 . . . . 73.420000000000002 109.336 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -75.59 147.29 39.72 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 114.954 -1.021 . . . . 64.420000000000002 109.936 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 96.0 mt -129.09 166.6 18.96 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.492 0.717 . . . . 73.430000000000007 110.289 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -119.65 145.34 46.55 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.388 1.075 . . . . 72.120000000000005 108.809 173.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.15 158.03 43.84 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.291 1.036 . . . . 53.539999999999999 108.562 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 16.5 m -92.46 130.83 38.02 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 122.68 0.392 . . . . 70.519999999999996 109.943 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 57.1 tp -111.99 126.11 54.79 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.724 0.809 . . . . 74.439999999999998 109.684 176.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -93.57 125.43 38.17 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.219 0.608 . . . . 63.509999999999998 109.368 170.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 6.5 p -144.94 133.76 11.04 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 124.045 0.938 . . . . 72.129999999999995 108.65 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.91 157.81 38.85 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.075 1.85 . . . . 74.329999999999998 111.29 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.22 -48.29 92.84 Favored Pre-proline 0 CA--C 1.555 1.173 0 N-CA-C 113.309 0.855 . . . . 51.219999999999999 113.309 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.528 ' O ' HG12 ' A' ' 206' ' ' VAL . 52.4 Cg_exo -56.13 -56.12 2.36 Favored 'Trans proline' 0 C--N 1.395 2.995 0 C-N-CA 121.836 1.691 . . . . 51.420000000000002 113.028 176.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 57.7 mt -60.91 -30.22 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 C-N-CA 122.717 0.407 . . . . 64.430000000000007 110.829 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.449 ' HB1' ' O ' ' A' ' 227' ' ' THR . . . -63.61 -53.55 49.87 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 122.927 0.491 . . . . 53.009999999999998 111.038 178.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 32.3 t -78.91 -42.4 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 116.154 -0.476 . . . . 42.450000000000003 112.175 -172.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 202' ' ' PRO . 9.9 p -90.02 -19.57 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 122.654 0.381 . . . . 73.439999999999998 111.395 -176.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.31 159.04 34.31 Favored Glycine 0 C--N 1.348 1.226 0 N-CA-C 111.986 -0.446 . . . . 72.299999999999997 111.986 -174.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.79 -138.68 5.39 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-O 119.603 -0.554 . . . . 75.099999999999994 112.352 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -137.31 142.31 41.89 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.564 0.746 . . . . 64.420000000000002 109.312 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.77 162.04 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 122.846 0.458 . . . . 72.420000000000002 110.539 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -86.51 104.77 16.28 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.295 -1.002 . . . . 53.439999999999998 108.295 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -103.49 138.86 39.61 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.773 0.829 . . . . 61.210000000000001 110.199 -175.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 22.5 ptt? -72.54 118.46 15.49 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 121.438 0.637 . . . . 72.120000000000005 109.401 176.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 28.0 m -135.45 154.59 51.39 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.091 0.956 . . . . 72.519999999999996 109.061 -177.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 68.7 mt -63.19 -21.66 66.36 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.003 0.921 . . . . 74.299999999999997 112.789 -177.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -93.62 0.8 56.69 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.276 0.63 . . . . 73.530000000000001 111.353 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 117.97 167.98 14.3 Favored Glycine 0 C--N 1.345 1.069 0 CA-C-O 119.534 -0.592 . . . . 53.350000000000001 112.515 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.76 121.26 8.3 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.513 2.142 . . . . 62.409999999999997 111.174 176.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 27.7 m -127.7 160.04 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 123.804 0.842 . . . . 61.399999999999999 110.879 -171.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -86.68 103.95 15.63 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.062 0.545 . . . . 74.150000000000006 109.817 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 99.0 t -96.84 124.14 49.5 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 N-CA-C 108.672 -0.862 . . . . 74.400000000000006 108.672 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.04 98.7 2.58 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.069 0.548 . . . . 43.140000000000001 110.244 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 94.8 t -73.97 128.0 87.24 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.203 1.001 . . . . 63.420000000000002 109.737 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.16 170.34 14.76 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.601 2.201 . . . . 70.519999999999996 111.317 176.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.52 167.87 26.13 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 121.249 1.3 . . . . 73.25 111.489 168.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 48.2 mtt-85 65.63 23.04 11.69 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 124.622 1.169 . . . . 75.5 111.989 176.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.449 ' O ' ' HB1' ' A' ' 204' ' ' ALA . 30.0 m -75.15 93.53 2.81 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.771 0.796 . . . . 74.129999999999995 110.416 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -86.03 145.71 26.97 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.461 -1.245 . . . . 74.319999999999993 110.531 -178.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.3 138.42 58.52 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.114 0.966 . . . . 72.409999999999997 111.126 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 92.74 -14.83 64.05 Favored Glycine 0 N--CA 1.473 1.108 0 CA-C-N 116.206 -0.452 . . . . 75.239999999999995 113.034 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -75.71 145.11 41.15 Favored 'General case' 0 C--N 1.348 0.504 0 N-CA-C 109.457 -0.571 . . . . 62.409999999999997 109.457 173.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.579 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 0.2 OUTLIER -110.48 122.71 48.39 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.199 -0.667 . . . . 74.409999999999997 109.199 175.451 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 18.7 mt -76.19 103.07 6.05 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.447 -0.945 . . . . 72.230000000000004 108.447 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 21.4 ttm-85 -70.95 101.2 2.12 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 109.395 -0.595 . . . . 74.329999999999998 109.395 175.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 10.0 mt -104.27 103.13 12.83 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 108.011 -1.107 . . . . 62.149999999999999 108.011 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -80.85 142.7 33.39 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.735 0.414 . . . . 74.040000000000006 111.521 -170.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 84.99 21.15 56.32 Favored Glycine 0 C--N 1.346 1.111 0 CA-C-N 115.985 -0.552 . . . . 51.420000000000002 113.506 178.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -113.27 -26.92 8.17 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.285 0.634 . . . . 63.509999999999998 112.534 -173.824 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -72.91 -134.74 0.21 Allowed Glycine 0 CA--C 1.539 1.553 0 N-CA-C 114.262 0.465 . . . . 73.450000000000003 114.262 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -93.56 137.73 23.22 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 123.266 0.626 . . . . 72.420000000000002 110.114 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 56.3 Cg_endo . . . . . 0 C--N 1.379 2.137 0 C-N-CA 122.751 2.3 . . . . 52.340000000000003 112.487 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.524 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 0.8 OUTLIER . . . . . 0 CA--C 1.544 0.743 0 N-CA-C 109.894 -0.41 . . . . 73.409999999999997 109.894 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -68.33 -173.27 7.67 Favored Glycine 0 N--CA 1.477 1.369 0 N-CA-C 114.362 0.505 . . . . 71.340000000000003 114.362 -173.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -95.97 168.81 10.4 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.456 -0.942 . . . . 74.109999999999999 108.456 178.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 238' ' ' LYS . 34.6 tp -141.49 108.81 5.53 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.493 -0.928 . . . . 75.519999999999996 108.493 178.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.579 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 81.1 m-85 -90.39 109.28 20.4 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.902 0.881 . . . . 75.340000000000003 110.032 -176.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.505 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 46.8 mt -88.0 107.14 18.58 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.153 -0.684 . . . . 74.230000000000004 109.153 174.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -80.25 101.09 8.67 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.69 1.196 . . . . 73.129999999999995 108.801 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 89.4 t -63.39 120.23 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 125.218 1.407 . . . . 51.299999999999997 112.733 -171.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -113.83 100.11 8.2 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.039 -1.097 . . . . 72.200000000000003 108.039 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 18.6 mt -75.88 120.11 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 122.962 0.505 . . . . 73.329999999999998 109.75 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 CA--C 1.554 1.129 0 C-N-CA 124.296 1.038 . . . . 75.140000000000001 108.895 -179.997 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 112.423 0.527 . . . . 41.43 112.423 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.453 ' CE2' ' HA ' ' A' ' 227' ' ' THR . 43.6 m-85 . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 109.268 -0.642 . . . . 73.400000000000006 109.268 173.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 111.153 0.057 . . . . 35.32 111.153 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.73 142.61 42.39 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.143 0.977 . . . . 51.049999999999997 109.11 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 88.9 mt -127.51 160.61 30.98 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.794 0.838 . . . . 63.5 110.326 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -129.99 119.92 23.95 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.274 -1.01 . . . . 73.25 108.274 173.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -126.66 132.9 51.09 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.666 1.186 . . . . 60.450000000000003 109.07 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 51.9 m -66.13 129.67 40.62 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.442 0.697 . . . . 74.5 110.369 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 41.5 tp -116.12 110.85 19.41 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 107.571 -1.27 . . . . 74.150000000000006 107.571 176.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -93.63 106.77 18.71 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.496 -0.927 . . . . 42.340000000000003 108.496 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 2.8 p -125.27 122.53 25.18 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 124.576 1.151 . . . . 53.520000000000003 109.02 -176.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' PRO . . . . . 0.405 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 72.2 Cg_endo -71.51 158.38 54.05 Favored 'Trans proline' 0 C--N 1.372 1.764 0 C-N-CA 122.301 2.0 . . . . 62.240000000000002 111.277 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.98 -45.05 80.93 Favored Pre-proline 0 CA--C 1.571 1.759 0 N-CA-C 114.195 1.183 . . . . 74.030000000000001 114.195 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 75.8 Cg_exo -53.69 -54.65 4.5 Favored 'Trans proline' 0 C--N 1.399 3.198 0 C-N-CA 122.225 1.95 . . . . 72.319999999999993 113.572 173.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 49.3 mt -71.44 -25.29 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 122.999 0.52 . . . . 15.140000000000001 110.66 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.88 -40.53 83.55 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.241 0.616 . . . . 74.519999999999996 111.007 177.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 97.7 t -78.58 -56.3 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 CA-C-N 116.63 -0.259 . . . . 73.120000000000005 111.595 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.3 p -92.49 -25.77 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 112.675 0.62 . . . . 62.420000000000002 112.675 -170.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 96.18 156.81 31.39 Favored Glycine 0 N--CA 1.478 1.47 0 O-C-N 122.476 -0.14 . . . . 74.140000000000001 113.097 -176.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 169.65 -131.17 2.2 Favored Glycine 0 C--N 1.346 1.105 0 N-CA-C 111.7 -0.56 . . . . 50.450000000000003 111.7 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -134.55 141.71 46.76 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.187 0.995 . . . . 70.109999999999999 108.973 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.465 HG11 ' HA ' ' A' ' 199' ' ' VAL . 19.4 m -131.61 167.13 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 122.903 0.481 . . . . 73.340000000000003 110.732 176.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -82.03 107.28 14.61 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.526 -0.916 . . . . 75.519999999999996 108.526 170.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.02 133.54 48.79 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.317 0.647 . . . . 65.239999999999995 109.652 175.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 22.9 mmt -81.01 104.12 11.3 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 109.374 -0.602 . . . . 75.420000000000002 109.374 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 30.7 m -112.72 163.15 14.92 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 124.528 1.131 . . . . 63.43 109.039 -177.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 84.6 mt -67.98 -17.03 64.31 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.517 0.727 . . . . 75.349999999999994 112.037 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -80.37 -19.68 45.81 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.022 0.929 . . . . 75.040000000000006 111.028 173.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 126.24 177.32 14.83 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 110.678 -0.969 . . . . 74.430000000000007 110.678 -172.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.87 121.24 7.91 Favored 'Trans proline' 0 CA--C 1.554 1.504 0 C-N-CA 121.981 1.787 . . . . 70.040000000000006 110.819 174.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.45 HG23 HG23 ' A' ' 221' ' ' VAL . 35.0 m -124.81 161.0 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 123.324 0.65 . . . . 73.129999999999995 111.043 -173.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -85.47 105.75 16.31 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.013 -0.736 . . . . 74.219999999999999 109.013 177.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.45 HG23 HG23 ' A' ' 219' ' ' VAL . 49.7 t -102.76 129.16 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.599 0.759 . . . . 64.209999999999994 110.394 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.23 100.56 3.74 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 123.42 0.688 . . . . 73.310000000000002 110.278 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.434 ' HA ' ' HD3' ' A' ' 224' ' ' PRO . 58.6 t -88.14 131.56 42.36 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 124.599 1.16 . . . . 61.32 109.389 178.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 223' ' ' VAL . 3.4 Cg_exo -78.88 174.21 12.52 Favored 'Trans proline' 0 C--N 1.377 2.026 0 C-N-CA 123.677 2.918 . . . . 65.239999999999995 111.199 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -62.54 176.9 1.44 Allowed 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 121.993 1.795 . . . . 62.109999999999999 112.758 166.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 69.27 5.56 5.19 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 124.506 1.123 . . . . 70.200000000000003 112.947 172.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.453 ' HA ' ' CE2' ' A' ' 176' ' ' TYR . 87.8 m -66.05 97.57 0.38 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.896 0.878 . . . . 64.439999999999998 111.204 -171.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 63.3 tp60 -101.83 141.7 34.27 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.049 1.34 . . . . 65.5 111.086 -171.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.04 141.98 57.78 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.159 0.984 . . . . 74.239999999999995 112.517 -174.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.71 -20.14 29.46 Favored Glycine 0 C--N 1.351 1.364 0 O-C-N 123.833 0.708 . . . . 74.439999999999998 113.659 178.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -77.23 160.61 28.79 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.067 0.547 . . . . 75.140000000000001 110.632 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 12.6 mptt -127.55 143.64 51.16 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.317 0.579 . . . . 63.420000000000002 109.985 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.453 HD21 ' CE2' ' A' ' 176' ' ' TYR . 23.3 mt -106.27 99.54 9.12 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.769 -1.105 . . . . 65.299999999999997 109.136 -170.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 42.8 ttm105 -73.74 102.03 3.86 Favored 'General case' 0 C--O 1.24 0.569 0 O-C-N 124.567 1.167 . . . . 74.549999999999997 110.437 -174.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 30.2 mt -105.82 94.6 5.28 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.476 -0.935 . . . . 44.140000000000001 108.476 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -70.21 140.21 52.42 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 122.845 0.458 . . . . 75.439999999999998 111.002 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 81.46 17.65 70.64 Favored Glycine 0 CA--C 1.528 0.892 0 O-C-N 123.918 0.762 . . . . 40.140000000000001 113.202 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -122.07 -11.81 8.42 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.437 0.695 . . . . 54.32 112.295 -175.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -77.88 -161.82 17.29 Favored Glycine 0 N--CA 1.48 1.61 0 CA-C-O 119.804 -0.442 . . . . 73.219999999999999 112.74 171.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -71.5 149.94 93.66 Favored Pre-proline 0 N--CA 1.484 1.257 0 CA-C-N 117.911 0.856 . . . . 63.439999999999998 111.6 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo . . . . . 0 C--N 1.376 1.975 0 C-N-CA 122.909 2.406 . . . . 72.329999999999998 112.31 172.618 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 107.651 -1.24 . . . . 64.209999999999994 107.651 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -80.91 -158.07 18.46 Favored Glycine 0 C--N 1.34 0.8 0 O-C-N 123.435 0.46 . . . . 72.420000000000002 113.045 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -100.06 159.15 15.32 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.507 -0.553 . . . . 63.409999999999997 109.507 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 40.7 tp -126.68 108.37 11.03 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.51 -1.292 . . . . 75.319999999999993 107.51 172.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.511 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 15.0 m-85 -90.19 108.15 19.57 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.514 -0.921 . . . . 74.430000000000007 108.514 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 57.2 mt -87.2 105.53 17.27 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.982 -1.118 . . . . 72.109999999999999 107.982 174.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -78.74 112.3 15.73 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.503 -0.771 . . . . 70.329999999999998 109.842 -175.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 58.0 t -63.3 119.37 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 124.636 1.174 . . . . 75.230000000000004 111.726 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 49.7 mmm-85 -120.39 95.6 4.8 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 125.167 1.387 . . . . 72.510000000000005 107.495 173.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 49.8 mt -77.87 113.12 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 122.741 0.417 . . . . 74.239999999999995 110.509 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 75.0 p . . . . . 0 CA--C 1.559 1.299 0 C-N-CA 124.379 1.071 . . . . 72.040000000000006 108.714 177.625 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 113.718 1.007 . . . . 64.329999999999998 113.718 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 . . . . . 0 N--CA 1.475 0.777 0 C-N-CA 123.021 0.529 . . . . 73.439999999999998 110.041 170.649 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 . . . . . 0 N--CA 1.477 0.88 0 CA-C-O 120.614 0.245 . . . . 75.430000000000007 111.018 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -76.48 155.92 33.43 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.452 0.701 . . . . 75.530000000000001 111.276 -176.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 93.7 mt -128.74 152.93 47.88 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.147 0.979 . . . . 72.120000000000005 109.19 176.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -108.25 149.12 29.02 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.864 0.866 . . . . 74.349999999999994 108.852 172.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -155.03 136.1 13.86 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.972 0.909 . . . . 73.319999999999993 108.763 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 28.1 m -78.01 128.48 33.93 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.115 0.566 . . . . 55.32 109.888 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 22.0 tp -108.27 117.41 34.08 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.438 -0.579 . . . . 51.219999999999999 109.438 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -82.47 105.77 13.8 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.431 -0.951 . . . . 53.420000000000002 108.431 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.502 HG11 HG13 ' A' ' 253' ' ' VAL . 2.7 p -136.5 122.7 13.69 Favored Pre-proline 0 CA--C 1.548 0.888 0 N-CA-C 109.507 -0.553 . . . . 65.109999999999999 109.507 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' PRO . . . . . 0.449 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 54.9 Cg_endo -72.11 160.65 46.86 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.194 1.93 . . . . 71.510000000000005 112.049 173.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.75 -51.72 63.4 Favored Pre-proline 0 CA--C 1.567 1.611 0 C-N-CA 124.46 1.104 . . . . 63.140000000000001 113.745 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 56.6 Cg_endo -65.62 -36.06 34.91 Favored 'Trans proline' 0 C--N 1.401 3.327 0 C-N-CA 121.624 1.549 . . . . 60.219999999999999 112.606 -176.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 23.0 mt -72.7 -31.7 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 122.766 0.426 . . . . 71.150000000000006 110.551 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.1 -42.15 89.69 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 122.691 0.397 . . . . 74.0 110.768 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 90.7 t -69.7 -53.02 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.096 0 C-N-CA 123.281 0.632 . . . . 73.150000000000006 111.695 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 28.0 m -79.58 -32.83 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 112.153 0.427 . . . . 51.530000000000001 112.153 -175.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.18 105.77 0.97 Allowed Glycine 0 C--N 1.343 0.934 0 CA-C-N 116.146 -0.479 . . . . 65.430000000000007 112.584 -173.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -148.46 -177.03 22.39 Favored Glycine 0 C--N 1.344 1.021 0 N-CA-C 112.074 -0.41 . . . . 51.350000000000001 112.074 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.645 ' HB3' ' HB2' ' A' ' 220' ' ' GLU . 50.2 mtmt -86.93 127.61 35.07 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 117.13 0.465 . . . . 75.109999999999999 110.497 -175.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 20.7 m -124.22 167.95 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 123.14 0.576 . . . . 63.530000000000001 111.555 -177.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -71.53 106.63 4.07 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 123.974 0.796 . . . . 62.420000000000002 110.232 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.83 115.76 30.86 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 107.95 -1.13 . . . . 53.130000000000003 107.95 166.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 63.3 mtt -72.97 104.93 4.25 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 109.255 -0.646 . . . . 63.210000000000001 109.255 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 38.1 m -110.99 162.23 15.06 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.715 1.206 . . . . 73.340000000000003 109.268 -173.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 96.4 mt -57.68 -23.25 50.51 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.967 0.907 . . . . 61.310000000000002 112.95 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -87.47 -20.83 26.03 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.26 0.624 . . . . 72.549999999999997 111.707 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 139.05 -171.93 23.39 Favored Glycine 0 C--N 1.345 1.036 0 CA-C-O 119.577 -0.568 . . . . 71.109999999999999 111.95 -176.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.6 117.79 4.66 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.21 1.94 . . . . 72.109999999999999 110.788 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.403 HG23 HG23 ' A' ' 221' ' ' VAL . 32.8 m -116.26 166.78 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.15 0.58 . . . . 71.439999999999998 109.687 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.645 ' HB2' ' HB3' ' A' ' 209' ' ' LYS . 8.5 pt-20 -107.52 105.12 14.86 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.721 0.772 . . . . 75.540000000000006 109.746 178.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.403 HG23 HG23 ' A' ' 219' ' ' VAL . 58.7 t -99.46 131.42 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.886 1.275 . . . . 75.530000000000001 109.841 -175.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.73 100.43 2.84 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.801 0.841 . . . . 43.539999999999999 110.553 -176.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 80.8 t -78.55 138.62 58.83 Favored Pre-proline 0 N--CA 1.478 0.973 0 C-N-CA 124.872 1.269 . . . . 72.310000000000002 109.321 175.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -75.11 168.83 23.9 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 122.51 2.14 . . . . 65.329999999999998 111.506 178.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -68.35 172.71 10.77 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 121.421 1.414 . . . . 63.329999999999998 111.424 168.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 63.85 17.12 10.32 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.888 0.875 . . . . 73.540000000000006 112.071 174.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 53.7 m -75.01 133.18 41.71 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.943 0.897 . . . . 72.400000000000006 110.153 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -139.35 143.13 37.63 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.201 0.6 . . . . 51.329999999999998 110.846 -164.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.19 127.73 33.27 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 124.323 1.049 . . . . 65.510000000000005 111.373 -177.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 103.58 -21.84 37.67 Favored Glycine 0 N--CA 1.473 1.134 0 CA-C-N 115.902 -0.59 . . . . 71.040000000000006 112.719 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -75.81 141.98 42.36 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.082 0.553 . . . . 74.409999999999997 110.024 176.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.497 ' HG3' ' HG2' ' A' ' 252' ' ' GLU . 0.0 OUTLIER -108.38 127.57 54.0 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.497 0.719 . . . . 73.400000000000006 109.746 178.306 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 56.6 mt -90.6 96.88 10.87 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.9 -1.148 . . . . 73.230000000000004 107.9 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 30.4 ttp-105 -87.15 105.25 17.06 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 124.233 1.013 . . . . 74.150000000000006 110.24 -172.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 31.2 mt -99.85 94.82 6.52 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.602 -0.888 . . . . 72.409999999999997 108.602 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm -67.55 140.97 56.99 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.52 0.328 . . . . 74.340000000000003 110.554 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.06 28.41 56.38 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-N 116.097 -0.501 . . . . 74.030000000000001 113.642 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.451 ' HA ' ' HE2' ' A' ' 238' ' ' LYS . 9.3 mmpt? -127.54 -14.95 5.15 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.843 0.857 . . . . 74.530000000000001 112.801 -178.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -78.2 -152.98 6.23 Favored Glycine 0 N--CA 1.476 1.366 0 C-N-CA 122.736 0.207 . . . . 65.519999999999996 113.162 174.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -73.58 147.94 87.44 Favored Pre-proline 0 N--CA 1.485 1.296 0 C-N-CA 123.022 0.529 . . . . 71.310000000000002 111.28 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo . . . . . 0 C--N 1.377 2.058 0 C-N-CA 122.94 2.427 . . . . 72.299999999999997 112.741 172.892 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 66.2 mtm-85 . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 109.701 -0.481 . . . . 75.329999999999998 109.701 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -74.97 -157.25 5.79 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 116.405 -0.362 . . . . 74.109999999999999 112.994 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -97.37 170.02 9.36 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.071 0.548 . . . . 61.310000000000002 110.173 -175.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 29.4 tp -136.35 105.63 6.03 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.746 -1.205 . . . . 73.030000000000001 107.746 172.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -89.66 107.07 18.87 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.752 -0.833 . . . . 75.209999999999994 108.752 -178.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 71.9 mt -89.53 104.28 16.85 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.559 -1.275 . . . . 74.329999999999998 107.559 173.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.497 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 12.8 mt-10 -78.29 105.56 9.61 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.508 -0.769 . . . . 63.240000000000002 108.962 -173.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.502 HG13 HG11 ' A' ' 199' ' ' VAL . 61.3 t -59.62 104.21 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.82 0 O-C-N 124.073 0.858 . . . . 42.020000000000003 111.545 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -103.46 97.66 7.68 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 107.785 -1.191 . . . . 72.239999999999995 107.785 173.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 12.5 mt -75.02 114.73 15.39 Favored 'Isoleucine or valine' 0 C--N 1.356 0.853 0 O-C-N 123.958 0.786 . . . . 71.150000000000006 108.941 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 12.5 p . . . . . 0 C--O 1.256 1.423 0 C-N-CA 125.537 1.535 . . . . 72.150000000000006 108.16 -177.033 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.794 0 CA-C-O 120.382 0.134 . . . . 54.210000000000001 111.324 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 . . . . . 0 N--CA 1.487 1.382 0 C-N-CA 125.143 1.377 . . . . 75.239999999999995 110.162 -174.173 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.505 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 80.8 mt-30 . . . . . 0 N--CA 1.483 1.198 0 CA-C-O 120.311 0.1 . . . . 72.219999999999999 111.136 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -89.97 135.2 33.79 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.371 -0.603 . . . . 54.340000000000003 109.371 174.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 95.9 mt -131.72 129.09 40.22 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.022 0.929 . . . . 64.329999999999998 110.282 -172.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -92.6 119.95 32.55 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.926 -0.768 . . . . 73.230000000000004 108.926 173.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -130.73 128.53 41.01 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.703 1.201 . . . . 61.229999999999997 109.043 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 88.5 m -69.2 131.11 44.41 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.588 0.755 . . . . 71.150000000000006 111.451 -177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 42.3 tp -110.13 116.35 31.37 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.532 1.133 . . . . 75.209999999999994 108.476 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -92.11 109.39 20.75 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.475 -0.935 . . . . 74.319999999999993 108.475 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 3.4 p -130.92 122.87 19.63 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 124.198 0.999 . . . . 73.430000000000007 108.911 -178.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.87 156.56 65.44 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.08 1.853 . . . . 73.049999999999997 112.109 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -48.28 -46.22 67.22 Favored Pre-proline 0 CA--C 1.565 1.552 0 N-CA-C 114.569 1.322 . . . . 52.549999999999997 114.569 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.5 ' O ' HG22 ' A' ' 206' ' ' VAL . 17.9 Cg_endo -58.12 -52.7 5.3 Favored 'Trans proline' 0 C--N 1.4 3.283 0 C-N-CA 121.874 1.716 . . . . 74.140000000000001 112.245 176.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.8 mt -65.93 -30.88 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.429 0.692 . . . . 73.209999999999994 111.446 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.67 -54.64 24.71 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.416 0.686 . . . . 54.109999999999999 111.026 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 63.5 t -71.68 -53.52 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-N 115.93 -0.577 . . . . 71.120000000000005 111.626 -174.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 202' ' ' PRO . 15.5 m -90.3 -25.02 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 112.805 0.669 . . . . 53.520000000000003 112.805 -172.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 100.76 142.8 13.25 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 117.796 0.271 . . . . 54.299999999999997 112.639 -176.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -175.19 -141.49 3.73 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 111.149 -0.781 . . . . 74.329999999999998 111.149 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -133.27 143.14 48.89 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 117.737 0.768 . . . . 64.140000000000001 109.19 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 33.2 m -128.95 169.4 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.647 0.779 . . . . 74.430000000000007 110.234 173.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -99.3 112.47 24.63 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.129 0.972 . . . . 75.519999999999996 108.513 171.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.58 144.65 30.06 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.8 0.84 . . . . 65.239999999999995 109.692 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 21.1 mmt -91.77 103.57 16.12 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 109.039 -0.726 . . . . 74.519999999999996 109.039 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 61.7 m -117.88 164.14 15.49 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.639 1.176 . . . . 75.400000000000006 108.916 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.0 mt -59.3 -20.0 50.86 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 123.344 0.657 . . . . 75.010000000000005 112.048 173.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -81.87 4.72 21.32 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.62 1.168 . . . . 73.209999999999994 111.982 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 97.97 -163.74 21.4 Favored Glycine 0 C--N 1.344 1.011 0 C-N-CA 123.488 0.566 . . . . 72.450000000000003 111.822 -175.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.16 118.39 5.37 Favored 'Trans proline' 0 C--N 1.365 1.404 0 C-N-CA 122.026 1.818 . . . . 73.519999999999996 109.907 172.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 28.7 m -118.13 153.2 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.039 0.536 . . . . 72.140000000000001 111.113 -172.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -95.41 111.76 23.59 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.54 0.736 . . . . 73.430000000000007 109.37 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 48.7 t -112.58 116.23 52.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 123.837 0.855 . . . . 62.149999999999999 109.17 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.57 101.25 2.44 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 109.099 -0.704 . . . . 75.519999999999996 109.099 174.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 63.9 t -77.55 121.64 84.66 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.955 0.902 . . . . 62.299999999999997 109.472 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.66 169.83 21.42 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.657 2.238 . . . . 45.32 110.936 173.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.96 176.53 2.97 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.633 2.222 . . . . 74.239999999999995 113.778 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 55.5 mtm180 70.94 12.05 7.06 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 125.45 1.5 . . . . 72.510000000000005 113.081 174.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 12.5 m -72.37 93.35 1.51 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.072 0.949 . . . . 75.420000000000002 110.765 -174.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -91.83 140.09 30.03 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.61 1.164 . . . . 60.329999999999998 111.007 -173.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -64.23 139.19 58.74 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.259 1.024 . . . . 71.439999999999998 111.646 -176.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 93.14 -23.37 29.85 Favored Glycine 0 C--N 1.343 0.934 0 CA-C-N 115.129 -0.941 . . . . 35.100000000000001 112.812 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -72.84 145.19 47.12 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 122.909 0.484 . . . . 74.219999999999999 110.265 176.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.489 ' HG3' ' HG2' ' A' ' 252' ' ' GLU . 2.6 mppt? -104.44 139.49 39.3 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.827 -1.175 . . . . 71.209999999999994 107.827 173.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 42.6 mt -92.24 99.47 12.25 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.221 -1.399 . . . . 72.5 107.221 175.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 46.0 ttm180 -73.04 100.98 3.13 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.117 0.484 . . . . 70.109999999999999 109.704 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 17.9 mt -102.21 88.12 3.23 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.136 -1.061 . . . . 73.400000000000006 108.136 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -68.38 129.94 41.41 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.07 -0.968 . . . . 63.420000000000002 110.519 -175.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 84.67 27.62 34.68 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 123.762 0.664 . . . . 73.439999999999998 113.452 -175.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -125.9 -6.86 6.69 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 123.278 0.631 . . . . 73.340000000000003 112.651 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -86.79 -155.28 27.11 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 112.363 -0.295 . . . . 50.200000000000003 112.363 175.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.505 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 12.8 m-85 -70.46 140.03 87.08 Favored Pre-proline 0 N--CA 1.481 1.116 0 CA-C-N 117.184 0.492 . . . . 74.400000000000006 110.358 177.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo . . . . . 0 C--N 1.377 2.046 0 C-N-CA 122.702 2.268 . . . . 70.239999999999995 111.854 174.553 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 28.4 mtm-85 . . . . . 0 CA--C 1.546 0.788 0 N-CA-C 109.085 -0.709 . . . . 74.239999999999995 109.085 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.25 -165.18 19.34 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 123.373 0.42 . . . . 74.030000000000001 113.696 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -100.3 128.56 46.35 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.095 0.558 . . . . 73.310000000000002 109.633 -174.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 28.8 tp -99.04 107.78 20.28 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 107.847 -1.168 . . . . 73.230000000000004 107.847 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.428 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 47.8 m-85 -88.04 107.86 18.94 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.761 0.824 . . . . 73.310000000000002 109.011 -178.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 41.1 mt -87.08 105.43 17.16 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.441 -0.948 . . . . 74.209999999999994 108.441 175.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.489 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 33.3 mt-10 -77.6 94.17 4.33 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.297 -0.865 . . . . 63.219999999999999 108.79 -173.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 99.7 t -53.57 112.35 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 124.433 1.093 . . . . 64.209999999999994 111.323 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -117.32 100.88 7.98 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 108.094 -1.076 . . . . 73.299999999999997 108.094 175.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 43.0 mt -75.68 107.12 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 O-C-N 124.023 0.827 . . . . 61.210000000000001 108.965 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 16.2 p . . . . . 0 C--O 1.26 1.621 0 C-N-CA 124.897 1.279 . . . . 71.120000000000005 108.3 -179.066 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 112.583 0.586 . . . . 50.200000000000003 112.583 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 . . . . . 0 C--O 1.237 0.421 0 N-CA-C 108.108 -1.071 . . . . 74.519999999999996 108.108 170.902 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.669 HE21 ' N ' ' A' ' 191' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.706 0 CA-C-O 120.747 0.308 . . . . 54.210000000000001 110.863 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -76.68 132.29 39.28 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.888 -0.782 . . . . 60.109999999999999 108.888 172.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 91.4 mt -133.05 167.92 19.43 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.234 0.614 . . . . 72.129999999999995 110.519 -171.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -121.21 125.87 48.23 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 107.553 -1.277 . . . . 75.219999999999999 107.553 168.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -124.08 127.27 47.59 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.606 0.762 . . . . 33.340000000000003 109.15 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 43.4 m -67.49 118.46 10.83 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.81 0.844 . . . . 64.140000000000001 110.919 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 21.9 tp -109.47 110.78 21.99 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.531 -0.915 . . . . 71.420000000000002 108.531 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -88.24 127.25 35.45 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.206 -1.035 . . . . 75.129999999999995 108.206 174.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 3.0 p -141.85 127.59 10.84 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 124.298 1.039 . . . . 75.120000000000005 108.367 -176.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -69.5 155.25 67.31 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 121.543 1.495 . . . . 74.420000000000002 111.346 175.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.446 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -47.21 -50.65 46.43 Favored Pre-proline 0 CA--C 1.559 1.32 0 O-C-N 124.341 1.025 . . . . 64.219999999999999 113.657 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.411 ' O ' HG12 ' A' ' 206' ' ' VAL . 30.5 Cg_endo -60.72 -48.79 10.0 Favored 'Trans proline' 0 C--N 1.395 2.988 0 C-N-CA 121.933 1.755 . . . . 74.409999999999997 112.622 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 44.0 mt -66.56 -27.38 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.645 0.778 . . . . 73.209999999999994 111.384 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.33 -47.91 58.9 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.169 0.588 . . . . 74.409999999999997 111.194 176.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 201' ' ' ALA . 81.2 t -67.9 -48.91 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.329 0.651 . . . . 65.120000000000005 111.841 -176.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 202' ' ' PRO . 7.9 p -83.95 -29.1 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 CA-C-N 116.44 -0.346 . . . . 72.329999999999998 110.895 -175.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.61 86.07 0.64 Allowed Glycine 0 C--N 1.349 1.265 0 N-CA-C 111.559 -0.616 . . . . 64.349999999999994 111.559 -174.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -111.29 -122.94 4.31 Favored Glycine 0 C--N 1.344 1.02 0 N-CA-C 111.953 -0.459 . . . . 63.229999999999997 111.953 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 221' ' ' VAL . 95.9 mttt -136.99 149.84 47.76 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.914 0.885 . . . . 73.099999999999994 109.601 176.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 23.3 m -136.3 162.84 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 123.247 0.619 . . . . 71.430000000000007 111.461 177.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -86.3 106.53 17.43 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.565 0.746 . . . . 74.150000000000006 109.171 174.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -109.8 151.55 26.84 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.036 0.534 . . . . 51.030000000000001 110.756 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 31.8 mmt -83.55 111.3 18.96 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 123.898 0.749 . . . . 72.239999999999995 108.979 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 215' ' ' LEU . 3.4 m -126.83 176.4 7.31 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 108.581 -0.896 . . . . 73.319999999999993 108.581 -177.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.428 ' H ' HG22 ' A' ' 214' ' ' THR . 73.8 mt -59.89 -40.88 90.21 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.587 0.755 . . . . 75.239999999999995 112.652 -175.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -81.1 -3.38 51.78 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.308 0.643 . . . . 65.400000000000006 112.012 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 110.49 -151.76 17.5 Favored Glycine 0 C--N 1.343 0.94 0 CA-C-O 119.544 -0.587 . . . . 74.420000000000002 112.251 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.63 126.99 17.06 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 122.627 2.218 . . . . 65.349999999999994 112.316 177.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 32.8 m -129.59 162.78 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.509 0.724 . . . . 53.43 110.058 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -95.42 105.55 17.53 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 121.584 0.707 . . . . 72.409999999999997 109.991 175.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 55.3 t -99.77 126.77 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.793 0.837 . . . . 71.099999999999994 109.838 -174.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -76.63 100.01 5.22 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 123.946 0.779 . . . . 64.439999999999998 110.893 -177.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 59.5 t -69.25 141.94 91.98 Favored Pre-proline 0 CA--C 1.56 1.363 0 C-N-CA 125.662 1.585 . . . . 72.439999999999998 110.492 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -76.88 163.12 31.61 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 122.313 2.008 . . . . 60.109999999999999 110.855 173.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.55 160.99 45.32 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 121.471 1.447 . . . . 63.020000000000003 111.207 172.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 69.24 14.24 8.6 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.762 1.225 . . . . 52.420000000000002 112.651 177.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 85.2 m -62.16 113.18 2.71 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.843 0.857 . . . . 53.130000000000003 110.438 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -112.92 141.2 47.03 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.916 0.886 . . . . 74.219999999999999 110.602 -168.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.52 144.02 57.33 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.778 0.831 . . . . 75.450000000000003 111.377 -177.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.03 -22.65 13.56 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.303 -0.862 . . . . 44.130000000000003 113.035 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -79.58 150.32 31.1 Favored 'General case' 0 C--N 1.351 0.657 0 N-CA-C 109.438 -0.578 . . . . 61.140000000000001 109.438 173.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.662 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.4 mppt? -114.53 142.87 45.84 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.041 0.536 . . . . 62.420000000000002 109.852 177.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.489 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 46.2 mt -100.09 99.42 10.14 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.683 -0.858 . . . . 51.119999999999997 108.683 -176.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 27.3 ttm-85 -75.06 113.97 13.0 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 123.479 0.487 . . . . 74.120000000000005 109.936 -176.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 46.0 mt -120.54 102.06 8.17 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.509 0.724 . . . . 65.099999999999994 109.237 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -67.62 140.12 56.87 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.879 0.472 . . . . 74.239999999999995 111.581 -176.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.431 ' HA2' ' HB2' ' A' ' 246' ' ' ARG . . . 84.32 9.83 81.17 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 115.788 -0.642 . . . . 61.530000000000001 114.302 178.272 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -104.65 -16.47 14.98 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 117.682 0.741 . . . . 61.399999999999999 111.8 -176.802 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -81.15 -161.69 27.19 Favored Glycine 0 CA--C 1.535 1.293 0 O-C-N 123.535 0.522 . . . . 45.140000000000001 112.86 173.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.645 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 27.8 m-85 -65.98 151.28 95.54 Favored Pre-proline 0 N--CA 1.487 1.395 0 C-N-CA 123.373 0.669 . . . . 75.420000000000002 111.657 -178.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.458 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 37.9 Cg_endo . . . . . 0 C--N 1.377 2.054 0 C-N-CA 122.885 2.39 . . . . 64.0 112.708 176.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.458 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 86.8 mtt180 . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 110.231 -0.285 . . . . 74.140000000000001 110.231 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.8 173.98 55.27 Favored Glycine 0 C--N 1.342 0.916 0 CA-C-N 115.94 -0.573 . . . . 60.219999999999999 112.969 177.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -103.44 130.95 50.89 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.742 0.817 . . . . 62.399999999999999 110.631 -175.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 53.5 tp -102.94 117.42 34.56 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 123.86 0.864 . . . . 62.549999999999997 109.118 -173.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.662 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 19.5 m-85 -89.12 111.74 22.56 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.473 -0.936 . . . . 75.129999999999995 108.473 177.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.489 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 60.0 mt -85.85 111.57 20.31 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.642 -0.873 . . . . 55.049999999999997 108.642 175.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.405 ' HA ' ' HG3' ' A' ' 232' ' ' LYS . 31.6 mt-10 -76.05 101.43 5.28 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.237 -0.892 . . . . 74.230000000000004 108.971 -175.061 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 44.9 t -61.58 111.39 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 O-C-N 123.577 0.548 . . . . 63.210000000000001 110.84 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -114.0 93.6 4.44 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 106.598 -1.63 . . . . 75.409999999999997 106.598 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 26.9 mt -76.25 118.07 21.96 Favored 'Isoleucine or valine' 0 C--N 1.349 0.586 0 N-CA-C 109.405 -0.591 . . . . 53.420000000000002 109.405 -177.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 19.6 p . . . . . 0 C--O 1.253 1.275 0 C-N-CA 125.232 1.413 . . . . 65.439999999999998 107.922 -176.751 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 112.108 0.41 . . . . 62.420000000000002 112.108 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.412 ' HE1' ' HA ' ' A' ' 227' ' ' THR . 12.3 m-30 . . . . . 0 N--CA 1.471 0.596 0 N-CA-C 109.597 -0.52 . . . . 75.099999999999994 109.597 173.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 CA--C 1.548 0.872 0 N-CA-C 112.154 0.427 . . . . 63.43 112.154 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -80.1 159.43 26.1 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.623 0.769 . . . . 72.430000000000007 110.934 174.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 49.2 mt -139.35 150.68 45.63 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.79 0.836 . . . . 62.219999999999999 109.832 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -107.49 122.21 46.17 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.973 -0.751 . . . . 73.409999999999997 108.973 173.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -129.41 137.13 50.74 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.438 0.695 . . . . 74.129999999999995 109.248 178.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 96.2 m -71.73 131.67 43.45 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.862 0.465 . . . . 65.340000000000003 110.815 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.459 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 53.8 tp -108.25 123.88 49.44 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.255 -1.017 . . . . 61.130000000000003 108.255 175.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -88.65 117.53 27.68 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 108.488 -0.93 . . . . 61.420000000000002 108.488 176.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 4.4 p -140.48 125.84 11.3 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 109.057 -0.72 . . . . 72.409999999999997 109.057 178.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.61 154.41 54.76 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 122.136 1.891 . . . . 62.240000000000002 111.749 175.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.68 -45.34 91.56 Favored Pre-proline 0 CA--C 1.562 1.427 0 N-CA-C 114.629 1.344 . . . . 73.319999999999993 114.629 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -56.24 -52.69 6.64 Favored 'Trans proline' 0 C--N 1.392 2.827 0 C-N-CA 121.914 1.743 . . . . 55.420000000000002 113.099 174.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 32.8 mt -67.02 -27.66 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.218 0.607 . . . . 74.420000000000002 111.167 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.31 -48.83 69.08 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-O 121.26 0.553 . . . . 43.229999999999997 110.839 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 71.1 t -69.21 -46.29 77.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-N 115.798 -0.637 . . . . 71.129999999999995 111.764 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 14.4 m -86.6 -29.87 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 112.287 0.477 . . . . 61.219999999999999 112.287 -172.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.89 116.39 0.54 Allowed Glycine 0 CA--C 1.531 1.053 0 O-C-N 123.322 0.389 . . . . 64.230000000000004 113.298 -173.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -165.11 -177.68 37.78 Favored Glycine 0 N--CA 1.473 1.108 0 N-CA-C 111.687 -0.565 . . . . 72.239999999999995 111.687 176.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -80.86 136.01 36.01 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 118.113 0.957 . . . . 72.209999999999994 109.994 -176.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 27.6 m -124.91 168.56 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 123.644 0.778 . . . . 72.209999999999994 111.15 178.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 55.2 ttp85 -83.4 131.65 35.03 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.288 -0.869 . . . . 75.349999999999994 110.019 173.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -134.35 159.74 40.07 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.25 0.62 . . . . 63.119999999999997 110.457 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 15.9 tpt -88.0 123.4 32.67 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.13 0.572 . . . . 63.109999999999999 110.717 -177.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.434 HG22 ' H ' ' A' ' 216' ' ' GLU . 50.8 m -144.52 161.06 40.03 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.964 0.906 . . . . 64.140000000000001 108.652 178.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 68.2 mt -63.78 -19.15 64.77 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.8 0.84 . . . . 65.430000000000007 111.763 176.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.434 ' H ' HG22 ' A' ' 214' ' ' THR . 3.2 mp0 -93.51 15.06 16.88 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.828 1.251 . . . . 72.019999999999996 111.155 175.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 90.54 -164.85 30.71 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-O 119.746 -0.475 . . . . 73.019999999999996 113.297 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.31 118.93 5.92 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.575 2.184 . . . . 51.43 111.616 174.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.7 m -113.06 149.78 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 123.023 0.529 . . . . 70.519999999999996 110.882 -176.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -82.29 114.85 21.06 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.643 0.777 . . . . 74.409999999999997 110.227 177.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 98.4 t -109.16 116.36 51.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.96 0.904 . . . . 72.010000000000005 109.308 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.84 100.64 2.44 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.573 0.749 . . . . 72.430000000000007 110.563 -177.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 69.4 t -77.35 134.61 66.48 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 124.54 1.136 . . . . 74.25 110.273 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.88 171.54 17.8 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 122.958 2.439 . . . . 73.319999999999993 110.905 172.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -71.38 168.52 23.24 Favored 'Trans proline' 0 C--N 1.366 1.485 0 CA-C-N 120.614 1.255 . . . . 64.0 111.3 170.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 14.9 mtm180 66.92 20.21 10.54 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 124.042 0.937 . . . . 75.219999999999999 112.29 173.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.412 ' HA ' ' HE1' ' A' ' 176' ' ' TYR . 99.8 m -69.56 113.28 6.7 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.698 0.799 . . . . 73.510000000000005 111.011 -178.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -115.32 141.81 47.54 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.112 -0.949 . . . . 72.140000000000001 110.125 -169.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.45 133.81 54.57 Favored 'General case' 0 C--N 1.35 0.611 0 C-N-CA 123.58 0.752 . . . . 71.519999999999996 111.665 -176.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.71 -15.12 61.28 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-N 115.332 -0.849 . . . . 54.200000000000003 113.159 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -77.02 124.6 28.02 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.798 0.439 . . . . 71.329999999999998 110.143 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.4 mppt? -88.05 143.9 26.82 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.041 0.536 . . . . 75.099999999999994 110.022 173.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 33.9 mt -109.27 103.28 12.21 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.299 -0.864 . . . . 64.310000000000002 109.224 -173.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -69.91 103.48 2.24 Favored 'General case' 0 CA--C 1.551 1.006 0 O-C-N 124.096 0.872 . . . . 74.430000000000007 111.121 -176.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 32.4 mt -119.45 94.34 4.38 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.611 0.764 . . . . 64.409999999999997 110.223 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -71.26 154.62 41.5 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.703 0.401 . . . . 61.219999999999999 111.289 178.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 82.11 18.4 67.29 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-N 115.992 -0.549 . . . . 53.509999999999998 113.987 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.477 ' HA ' ' HE2' ' A' ' 238' ' ' LYS . 11.3 mmpt? -118.87 -41.34 2.78 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 123.461 0.704 . . . . 60.409999999999997 111.718 -177.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -71.91 -153.97 1.83 Allowed Glycine 0 N--CA 1.485 1.916 0 N-CA-C 114.625 0.61 . . . . 73.239999999999995 114.625 -176.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -64.05 136.9 96.94 Favored Pre-proline 0 N--CA 1.485 1.296 0 C-N-CA 123.517 0.727 . . . . 74.409999999999997 110.813 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.765 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 18.6 Cg_endo . . . . . 0 C--N 1.379 2.139 0 C-N-CA 123.204 2.603 . . . . 74.409999999999997 113.97 -174.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.765 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 28.8 mtm180 . . . . . 0 C--O 1.242 0.667 0 CA-C-O 121.102 0.477 . . . . 54.5 109.774 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -84.25 -158.73 28.4 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 114.922 -1.035 . . . . 74.519999999999996 113.565 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -99.77 162.09 13.21 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.836 0.454 . . . . 51.240000000000002 109.95 -170.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 40.6 tp -141.98 108.78 5.4 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 108.271 -1.011 . . . . 53.039999999999999 108.271 173.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.476 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 78.4 m-85 -88.74 108.13 19.32 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 108.732 -0.84 . . . . 73.010000000000005 108.732 175.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 38.9 mt -86.92 114.98 24.01 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.704 -0.85 . . . . 74.340000000000003 108.704 177.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -78.26 102.92 7.88 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.781 0.832 . . . . 63.450000000000003 109.365 -178.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 84.7 t -56.0 111.97 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 O-C-N 123.771 0.669 . . . . 74.040000000000006 110.68 175.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -113.4 101.8 9.72 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.288 -1.004 . . . . 71.400000000000006 108.288 172.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 37.1 mt -76.34 103.7 3.93 Favored 'Isoleucine or valine' 0 C--N 1.35 0.621 0 O-C-N 124.206 0.941 . . . . 65.340000000000003 109.004 177.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 46.7 p . . . . . 0 C--O 1.254 1.326 0 CA-C-N 115.506 -0.77 . . . . 73.319999999999993 109.07 176.09 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.622 0 N-CA-C 108.789 -0.819 . . . . 43.299999999999997 108.789 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.498 ' CE2' HD21 ' A' ' 233' ' ' LEU . 24.2 m-85 . . . . . 0 N--CA 1.49 1.552 0 C-N-CA 124.543 1.137 . . . . 61.350000000000001 110.846 -164.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 108.786 -0.82 . . . . 61.539999999999999 108.786 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -75.83 130.4 38.51 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.656 1.583 . . . . 74.540000000000006 108.943 176.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.467 HD12 ' HA2' ' A' ' 239' ' ' GLY . 92.8 mt -135.67 163.91 29.07 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.861 0.864 . . . . 63.520000000000003 110.697 -175.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -121.52 153.5 37.9 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.252 1.021 . . . . 41.119999999999997 108.962 171.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.444 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -152.78 171.29 18.47 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.551 1.14 . . . . 62.200000000000003 109.366 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 25.0 m -106.8 131.68 53.64 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.489 0.716 . . . . 52.409999999999997 109.485 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.722 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 42.8 tp -109.02 113.84 27.06 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.594 0.758 . . . . 71.219999999999999 109.008 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -83.66 116.85 22.83 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 107.75 -1.204 . . . . 64.409999999999997 107.75 172.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.455 HG11 HG13 ' A' ' 253' ' ' VAL . 2.4 p -138.15 120.54 10.85 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 123.794 0.837 . . . . 73.129999999999995 109.281 -178.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.1 158.42 56.58 Favored 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 122.218 1.946 . . . . 73.239999999999995 112.311 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.402 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -51.38 -48.56 85.8 Favored Pre-proline 0 CA--C 1.565 1.545 0 C-N-CA 124.459 1.103 . . . . 74.129999999999995 113.87 -177.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.474 ' O ' HG12 ' A' ' 206' ' ' VAL . 53.7 Cg_exo -54.24 -54.38 4.77 Favored 'Trans proline' 0 C--N 1.401 3.296 0 C-N-CA 122.377 2.051 . . . . 72.510000000000005 112.687 175.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 58.1 mt -67.62 -27.98 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.267 0.627 . . . . 51.009999999999998 111.041 -176.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.59 -41.59 96.15 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.199 -0.455 . . . . 52.409999999999997 110.416 176.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 201' ' ' ALA . 64.3 t -74.86 -57.57 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 CA-C-N 116.545 -0.298 . . . . 70.219999999999999 111.63 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 202' ' ' PRO . 12.4 p -93.14 -28.48 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 112.666 0.617 . . . . 74.129999999999995 112.666 -167.112 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 98.12 144.99 18.05 Favored Glycine 0 N--CA 1.477 1.388 0 C-N-CA 122.472 0.082 . . . . 71.340000000000003 113.183 -177.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 170.23 -167.76 40.84 Favored Glycine 0 N--CA 1.472 1.058 0 N-CA-C 110.664 -0.974 . . . . 74.129999999999995 110.664 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -96.88 138.28 34.68 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 118.336 1.068 . . . . 54.420000000000002 110.939 175.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 15.4 m -119.85 170.19 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.448 1.099 . . . . 63.119999999999997 109.764 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -102.03 112.24 24.82 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 110.021 -0.363 . . . . 74.230000000000004 110.021 174.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -105.34 166.44 10.42 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.983 0.913 . . . . 64.439999999999998 109.817 171.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 91.3 mmm -101.96 132.81 47.55 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 120.911 0.386 . . . . 62.420000000000002 110.276 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 88.1 m -132.79 167.51 20.03 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.869 1.268 . . . . 63.43 108.547 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 82.6 mt -54.83 -38.78 67.83 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.991 0.917 . . . . 63.32 112.665 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -78.25 -15.6 58.63 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.063 0.545 . . . . 65.230000000000004 111.799 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 132.78 -164.27 24.07 Favored Glycine 0 C--N 1.344 1.027 0 O-C-N 123.617 0.573 . . . . 71.540000000000006 111.727 -177.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.47 128.72 12.16 Favored 'Trans proline' 0 CA--C 1.555 1.538 0 C-N-CA 122.79 2.327 . . . . 53.140000000000001 112.007 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.32 159.89 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.322 1.049 . . . . 72.310000000000002 110.015 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 37.7 mt-10 -84.83 147.47 26.8 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 122.78 0.432 . . . . 74.450000000000003 110.599 169.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 96.9 t -130.75 124.23 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.163 1.385 . . . . 65.0 108.46 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -77.59 99.28 5.69 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 108.937 -0.764 . . . . 73.349999999999994 108.937 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 88.2 t -96.2 123.33 55.34 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.504 1.122 . . . . 74.019999999999996 110.566 -175.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.0 164.2 36.42 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.739 2.292 . . . . 70.349999999999994 111.384 175.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.87 177.0 0.37 Allowed 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 122.714 2.276 . . . . 65.219999999999999 113.418 174.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 24.0 mtp180 66.03 20.63 11.27 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.35 1.06 . . . . 63.329999999999998 112.324 174.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -68.86 88.69 0.38 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.686 0.794 . . . . 62.409999999999997 110.473 -173.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 -86.28 131.3 34.25 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.894 1.278 . . . . 73.030000000000001 110.573 -172.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.99 120.29 8.82 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.407 1.083 . . . . 62.340000000000003 111.97 -175.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.0 -4.51 41.72 Favored Glycine 0 N--CA 1.473 1.148 0 O-C-N 123.835 0.71 . . . . 73.420000000000002 114.386 176.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -84.62 157.32 21.2 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 117.552 0.676 . . . . 62.219999999999999 109.977 173.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.706 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.5 mppt? -127.3 131.55 50.47 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.943 -0.762 . . . . 74.209999999999994 108.943 -172.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.498 HD21 ' CE2' ' A' ' 176' ' ' TYR . 20.4 mt -108.56 102.43 11.5 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.601 -0.727 . . . . 72.450000000000003 109.791 -166.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -70.48 103.69 2.54 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.117 1.367 . . . . 75.129999999999995 110.939 -173.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 26.6 mt -118.19 100.16 7.33 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 122.944 0.498 . . . . 73.109999999999999 112.045 -175.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -56.52 142.06 40.51 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.162 0.801 . . . . 71.239999999999995 113.162 169.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 100.09 -14.12 60.04 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-N 113.649 -1.614 . . . . 74.439999999999998 112.665 174.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -99.89 -20.04 16.34 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.918 0.487 . . . . 70.219999999999999 111.967 -171.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' GLY . . . . . 0.467 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -77.92 -162.26 18.5 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.496 0.498 . . . . 70.510000000000005 113.656 177.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -80.77 154.64 73.34 Favored Pre-proline 0 N--CA 1.487 1.407 0 C-N-CA 123.2 0.6 . . . . 60.229999999999997 111.022 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo . . . . . 0 C--N 1.383 2.344 0 C-N-CA 123.8 3.0 . . . . 74.329999999999998 114.302 177.704 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 30.2 mtm180 . . . . . 0 N--CA 1.476 0.831 0 N-CA-C 108.892 -0.781 . . . . 74.310000000000002 108.892 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -67.29 -156.84 0.63 Allowed Glycine 0 C--N 1.341 0.858 0 O-C-N 123.865 0.728 . . . . 75.450000000000003 114.835 -170.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -96.23 160.85 14.22 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.263 0.554 . . . . 74.129999999999995 110.406 -170.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.444 HD11 ' HB2' ' A' ' 195' ' ' ALA . 31.1 tp -137.52 114.68 10.86 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.3 -1.37 . . . . 60.340000000000003 107.3 175.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.706 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 1.9 m-85 -91.18 108.84 20.14 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.994 -0.743 . . . . 74.430000000000007 108.994 -177.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.722 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 43.2 mt -86.36 107.49 18.03 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.548 -0.538 . . . . 75.319999999999993 109.548 -178.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -82.95 108.48 16.31 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.027 -0.988 . . . . 62.340000000000003 110.183 -174.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.455 HG13 HG11 ' A' ' 199' ' ' VAL . 61.1 t -56.3 120.16 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 C-N-CA 125.337 1.455 . . . . 63.409999999999997 112.581 -173.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 53.4 mmt-85 -114.8 96.91 5.95 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.724 1.21 . . . . 74.109999999999999 108.001 170.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 53.8 mt -74.89 103.85 2.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.936 -1.135 . . . . 63.329999999999998 107.936 175.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 25.3 p . . . . . 0 CA--C 1.555 1.166 0 N-CA-C 108.727 -0.842 . . . . 61.329999999999998 108.727 174.497 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 112.897 0.703 . . . . 41.520000000000003 112.897 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.539 ' CZ ' ' HA ' ' A' ' 227' ' ' THR . 8.5 m-85 . . . . . 0 N--CA 1.482 1.174 0 C-N-CA 123.07 0.548 . . . . 74.439999999999998 111.109 169.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.672 ' HB3' ' HB2' ' A' ' 240' ' ' PHE . 85.9 mm-40 . . . . . 0 CA--C 1.555 1.17 0 CA-C-O 120.794 0.33 . . . . 72.409999999999997 111.654 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -75.67 154.09 36.76 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.086 0.954 . . . . 55.130000000000003 110.739 -178.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 87.9 mt -131.93 158.56 41.09 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.767 0.827 . . . . 54.100000000000001 110.051 -173.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -115.0 124.2 51.04 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.994 -1.113 . . . . 74.329999999999998 107.994 173.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -124.94 129.31 50.11 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.374 -0.973 . . . . 74.439999999999998 108.374 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 42.3 m -68.39 126.29 29.13 Favored 'General case' 0 C--O 1.242 0.708 0 O-C-N 123.517 0.511 . . . . 70.040000000000006 110.22 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.484 HD12 ' HB2' ' A' ' 212' ' ' ALA . 46.0 tp -106.84 109.95 21.98 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.034 -1.469 . . . . 71.540000000000006 107.034 177.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -92.17 118.04 30.45 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.242 -1.021 . . . . 54.399999999999999 108.242 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.461 HG23 HG11 ' A' ' 210' ' ' VAL . 5.7 p -137.85 131.71 17.02 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 123.335 0.654 . . . . 74.120000000000005 109.784 -176.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -76.34 157.81 37.09 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.241 1.961 . . . . 73.299999999999997 111.701 172.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -55.0 -46.23 99.7 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 124.415 1.086 . . . . 71.310000000000002 113.543 -176.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.448 ' O ' HG12 ' A' ' 206' ' ' VAL . 71.2 Cg_exo -53.56 -54.99 3.98 Favored 'Trans proline' 0 C--N 1.402 3.381 0 C-N-CA 122.272 1.981 . . . . 73.099999999999994 112.78 174.213 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 48.7 mt -69.84 -21.03 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.3 0.64 . . . . 64.5 110.756 -176.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.2 -48.52 56.77 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.851 0.46 . . . . 65.129999999999995 110.342 176.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.0 -55.69 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 CA-C-N 115.959 -0.564 . . . . 63.299999999999997 111.431 -177.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 202' ' ' PRO . 14.6 p -87.15 -32.21 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 N-CA-C 112.611 0.597 . . . . 64.120000000000005 112.611 -172.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 101.53 166.68 27.48 Favored Glycine 0 N--CA 1.477 1.374 0 N-CA-C 112.076 -0.41 . . . . 74.010000000000005 112.076 -173.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 163.43 -131.94 2.6 Favored Glycine 0 C--N 1.345 1.032 0 N-CA-C 111.456 -0.658 . . . . 52.310000000000002 111.456 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -137.86 139.05 39.69 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.655 1.182 . . . . 72.120000000000005 108.594 174.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.461 HG11 HG23 ' A' ' 199' ' ' VAL . 32.3 m -136.53 168.02 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 122.956 0.502 . . . . 71.0 110.563 178.116 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 29.3 ttm-85 -87.51 113.19 22.98 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.763 -0.653 . . . . 70.239999999999995 109.887 178.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.484 ' HB2' HD12 ' A' ' 197' ' ' LEU . . . -105.79 158.42 16.75 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.842 0.857 . . . . 40.329999999999998 110.238 173.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 36.8 tpp -93.26 110.68 22.2 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.923 -0.769 . . . . 64.0 108.923 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 60.5 m -126.0 163.88 22.05 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.308 1.043 . . . . 64.239999999999995 109.815 -175.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 95.6 mt -61.81 -17.25 55.49 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.968 0.907 . . . . 62.310000000000002 112.965 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -96.59 8.39 44.26 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.471 0.708 . . . . 65.400000000000006 111.485 177.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 102.42 -164.01 16.66 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-O 119.708 -0.495 . . . . 61.299999999999997 112.129 -176.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.36 118.12 5.07 Favored 'Trans proline' 0 C--N 1.367 1.537 0 C-N-CA 122.124 1.883 . . . . 75.230000000000004 110.906 175.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.7 m -118.42 157.29 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 123.478 0.711 . . . . 73.049999999999997 110.51 -175.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -90.56 108.83 20.05 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.148 -0.686 . . . . 60.119999999999997 109.148 173.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 94.3 t -97.8 129.06 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.091 0.956 . . . . 73.340000000000003 109.942 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.88 103.09 2.12 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.999 0.92 . . . . 65.25 110.142 176.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 97.2 t -89.97 125.96 58.93 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 124.088 0.955 . . . . 74.230000000000004 110.166 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -78.18 171.44 17.06 Favored 'Trans proline' 0 CA--C 1.561 1.846 0 C-N-CA 123.163 2.575 . . . . 61.140000000000001 111.617 173.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.21 174.25 8.33 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.095 1.863 . . . . 72.319999999999993 113.694 174.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 67.16 15.37 10.03 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 125.903 1.681 . . . . 64.349999999999994 112.505 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.539 ' HA ' ' CZ ' ' A' ' 176' ' ' TYR . 93.9 m -64.75 100.96 0.43 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.523 0.729 . . . . 73.340000000000003 110.139 -176.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -101.83 137.26 40.36 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 125.135 1.374 . . . . 75.25 110.323 -174.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.92 132.9 53.65 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.568 1.147 . . . . 54.43 110.993 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.03 -1.55 67.93 Favored Glycine 0 C--N 1.337 0.613 0 O-C-N 123.849 0.718 . . . . 61.140000000000001 113.281 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -86.86 151.2 23.54 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 109.605 -0.517 . . . . 74.230000000000004 109.605 170.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.501 ' HG3' ' HA ' ' A' ' 252' ' ' GLU . 3.8 mppt? -131.67 139.03 48.96 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.279 -1.008 . . . . 73.340000000000003 108.279 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.43 HD21 ' CE2' ' A' ' 176' ' ' TYR . 29.1 mt -118.05 109.24 16.2 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.287 0.635 . . . . 74.319999999999993 110.309 -161.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 45.1 ttm-85 -76.96 108.9 10.35 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 124.057 0.848 . . . . 73.209999999999994 110.16 -174.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 21.8 mt -107.03 89.79 3.11 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.591 -0.892 . . . . 70.209999999999994 108.591 176.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.517 ' HG2' ' HB3' ' A' ' 248' ' ' ASP . 10.6 mtmp? -67.1 136.08 54.61 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.416 -0.357 . . . . 71.129999999999995 111.147 -177.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 95.24 -0.83 64.16 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 115.319 -0.855 . . . . 54.130000000000003 113.456 -175.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.53 ' HA ' ' HE2' ' A' ' 238' ' ' LYS . 10.4 mmpt? -106.55 -9.26 16.67 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 113.277 0.844 . . . . 71.010000000000005 113.277 -175.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.11 179.53 50.93 Favored Glycine 0 N--CA 1.476 1.334 0 N-CA-C 111.571 -0.612 . . . . 62.399999999999999 111.571 167.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.672 ' HB2' ' HB3' ' A' ' 191' ' ' GLN . 33.3 m-85 -60.28 154.33 53.29 Favored Pre-proline 0 N--CA 1.489 1.477 0 C-N-CA 123.42 0.688 . . . . 73.219999999999999 111.812 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 36.6 Cg_endo . . . . . 0 C--N 1.376 2.008 0 C-N-CA 122.477 2.118 . . . . 62.439999999999998 112.83 177.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.423 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 82.2 mtt180 . . . . . 0 C--O 1.242 0.671 0 CA-C-O 120.572 0.225 . . . . 75.420000000000002 110.659 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -69.48 -175.46 13.39 Favored Glycine 0 C--N 1.343 0.967 0 O-C-N 123.998 0.811 . . . . 53.140000000000001 112.155 175.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.517 ' HB3' ' HG2' ' A' ' 236' ' ' LYS . 1.4 p30 -104.05 171.29 7.43 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.855 0.462 . . . . 72.010000000000005 111.547 -178.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 32.9 tp -129.36 112.87 14.28 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 108.737 -0.838 . . . . 73.540000000000006 108.737 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -86.76 109.47 19.26 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.684 0.794 . . . . 54.43 109.28 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 44.5 mt -87.16 111.39 20.91 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 109.077 -0.712 . . . . 74.209999999999994 109.077 175.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.501 ' HA ' ' HG3' ' A' ' 232' ' ' LYS . 31.5 mt-10 -78.77 101.08 7.4 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.092 -0.958 . . . . 72.129999999999995 109.566 -177.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.8 t -59.51 110.03 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 O-C-N 123.765 0.666 . . . . 72.25 111.072 176.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -115.12 93.44 4.3 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.003 -1.11 . . . . 74.439999999999998 108.003 176.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.492 HD11 ' O ' ' A' ' 227' ' ' THR . 54.9 mt -77.17 125.65 37.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 N-CA-C 109.473 -0.565 . . . . 72.239999999999995 109.473 178.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 24.4 p . . . . . 0 C--O 1.25 1.127 0 C-N-CA 124.157 0.983 . . . . 73.299999999999997 109.632 179.775 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.048 0 N-CA-C 109.253 -0.647 . . . . 74.549999999999997 109.253 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.431 ' CZ ' ' HA ' ' A' ' 227' ' ' THR . 4.5 m-85 . . . . . 0 N--CA 1.487 1.408 0 C-N-CA 125.591 1.556 . . . . 70.040000000000006 111.974 -176.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 122.582 1.182 . . . . 64.219999999999999 109.832 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -87.43 163.48 16.72 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 114.689 -1.141 . . . . 71.5 111.087 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 83.2 mt -140.66 172.04 13.26 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.196 0.998 . . . . 73.409999999999997 109.994 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -118.01 145.06 45.03 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.052 0.941 . . . . 71.239999999999995 109.516 174.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -146.08 140.17 26.55 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.021 0.928 . . . . 70.200000000000003 109.282 178.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.9 m -77.36 129.19 35.49 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.058 0.543 . . . . 43.509999999999998 109.711 178.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.559 HD13 HD13 ' A' ' 251' ' ' LEU . 54.0 tp -107.45 111.3 23.53 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.451 -1.314 . . . . 54.539999999999999 107.451 177.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -92.04 100.5 13.13 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 108.291 -1.003 . . . . 72.519999999999996 108.291 -178.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.502 HG23 HG11 ' A' ' 210' ' ' VAL . 2.9 p -124.28 131.49 24.2 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 124.013 0.925 . . . . 73.049999999999997 108.799 -178.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' PRO . . . . . 0.513 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 98.4 Cg_endo -80.68 163.9 21.01 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.513 2.142 . . . . 70.219999999999999 111.355 172.066 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.17 -48.46 85.32 Favored Pre-proline 0 CA--C 1.566 1.581 0 N-CA-C 114.045 1.128 . . . . 72.510000000000005 114.045 176.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.513 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 25.5 Cg_endo -58.8 -52.46 5.2 Favored 'Trans proline' 0 C--N 1.396 3.044 0 C-N-CA 122.002 1.801 . . . . 62.43 113.057 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.8 mt -70.77 -22.21 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.238 0 C-N-CA 123.081 0.552 . . . . 55.420000000000002 110.856 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.33 -44.2 72.15 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.771 0.429 . . . . 64.040000000000006 110.717 177.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 76.1 t -71.49 -57.17 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 C-N-CA 122.181 0.192 . . . . 73.049999999999997 110.975 -178.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 202' ' ' PRO . 12.6 p -85.38 -25.99 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 112.208 0.447 . . . . 64.409999999999997 112.208 -170.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 99.89 -178.63 29.75 Favored Glycine 0 N--CA 1.475 1.273 0 N-CA-C 112.156 -0.378 . . . . 52.350000000000001 112.156 -172.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 139.6 -139.17 9.76 Favored Glycine 0 C--N 1.343 0.932 0 N-CA-C 111.764 -0.535 . . . . 63.5 111.764 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -133.86 146.35 50.52 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.524 0.73 . . . . 60.399999999999999 109.751 175.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.502 HG11 HG23 ' A' ' 199' ' ' VAL . 22.2 m -138.67 169.2 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 123.711 0.632 . . . . 75.0 112.02 -177.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 -73.22 133.07 43.88 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.424 -0.807 . . . . 73.219999999999999 110.27 172.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.437 ' HB2' HD12 ' A' ' 197' ' ' LEU . . . -144.13 148.99 35.81 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.468 -0.938 . . . . 61.439999999999998 108.468 168.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 64.8 mtp -89.03 130.72 35.45 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.459 -0.571 . . . . 72.019999999999996 109.459 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 42.3 m -143.2 172.93 12.07 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 125.228 1.411 . . . . 73.0 108.082 -175.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 77.0 mt -60.08 -21.35 61.35 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.27 0.628 . . . . 65.530000000000001 111.708 173.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -86.65 16.83 4.33 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.641 1.176 . . . . 71.319999999999993 111.674 174.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 76.34 -155.82 46.05 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-O 118.87 -0.961 . . . . 55.140000000000001 111.757 -175.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.85 119.73 6.62 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 121.954 1.77 . . . . 74.420000000000002 110.423 171.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.55 166.09 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.284 1.034 . . . . 75.420000000000002 109.978 -176.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -102.46 107.51 18.51 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.898 -0.779 . . . . 54.039999999999999 108.898 175.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 95.5 t -95.15 131.64 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.145 0.978 . . . . 63.310000000000002 109.639 -175.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.45 98.72 2.32 Favored 'General case' 0 C--N 1.351 0.659 0 O-C-N 124.055 0.847 . . . . 74.400000000000006 109.39 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 55.9 t -91.84 127.71 48.84 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 124.83 1.252 . . . . 74.230000000000004 110.022 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -73.2 170.25 20.31 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.692 2.262 . . . . 73.150000000000006 110.962 173.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.46 178.07 4.11 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 122.02 1.813 . . . . 75.219999999999999 111.789 170.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 50.2 mtp180 63.68 20.29 12.15 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 124.978 1.311 . . . . 61.119999999999997 112.222 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.493 ' O ' HD11 ' A' ' 255' ' ' ILE . 98.1 m -65.64 106.68 1.53 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.361 0.664 . . . . 62.420000000000002 110.278 -178.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -100.13 139.86 35.2 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.925 1.29 . . . . 73.439999999999998 110.285 -174.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -69.92 127.95 34.66 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.737 1.215 . . . . 72.209999999999994 111.542 -177.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.39 10.55 53.71 Favored Glycine 0 C--N 1.342 0.881 0 O-C-N 123.724 0.64 . . . . 62.32 113.126 178.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -91.47 158.28 16.57 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 117.176 0.488 . . . . 75.409999999999997 111.341 175.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.402 ' HB3' ' HD2' ' A' ' 250' ' ' TYR . 1.8 mppt? -130.07 117.65 20.32 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.84 1.256 . . . . 74.120000000000005 109.162 -177.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 12.9 mt -105.8 100.7 10.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.301 -0.863 . . . . 55.5 108.711 -165.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 46.2 ttm105 -69.98 102.45 2.01 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 124.544 1.153 . . . . 73.010000000000005 110.057 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 29.8 mt -111.69 99.78 8.44 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.727 0.811 . . . . 61.5 110.159 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -66.74 142.86 57.25 Favored 'General case' 0 C--O 1.246 0.887 0 C-N-CA 123.407 0.683 . . . . 71.549999999999997 110.489 178.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 87.03 13.35 66.54 Favored Glycine 0 CA--C 1.532 1.117 0 O-C-N 123.745 0.653 . . . . 53.210000000000001 113.021 -174.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -130.83 -25.38 2.31 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.338 0.655 . . . . 73.420000000000002 112.292 -175.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -75.07 -159.51 7.41 Favored Glycine 0 N--CA 1.476 1.306 0 CA-C-O 120.295 -0.169 . . . . 63.530000000000001 112.823 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -69.45 134.38 88.81 Favored Pre-proline 0 CA--C 1.554 1.105 0 CA-C-O 118.24 -0.886 . . . . 71.420000000000002 109.408 -174.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.578 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 78.0 Cg_exo . . . . . 0 C--N 1.386 2.524 0 C-N-CA 122.904 2.403 . . . . 64.109999999999999 111.838 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.578 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 59.2 mtt-85 . . . . . 0 C--O 1.241 0.655 0 N-CA-C 109.036 -0.728 . . . . 71.430000000000007 109.036 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -82.45 -158.04 22.93 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-N 115.449 -0.796 . . . . 55.5 112.471 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -114.55 132.54 56.29 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.767 0.827 . . . . 73.450000000000003 110.089 -176.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 41.6 tp -106.88 121.33 44.21 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 108.415 -0.958 . . . . 71.420000000000002 108.415 -176.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.402 ' HD2' ' HB3' ' A' ' 232' ' ' LYS . 8.7 m-85 -87.79 113.27 23.3 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.4 -0.963 . . . . 53.520000000000003 108.4 179.05 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.559 HD13 HD13 ' A' ' 197' ' ' LEU . 51.2 mt -86.48 107.77 18.23 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.175 -0.676 . . . . 72.25 109.175 176.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.434 ' HG3' ' HD3' ' A' ' 254' ' ' ARG . 8.4 tp10 -76.02 97.67 4.09 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 107.683 -1.229 . . . . 60.310000000000002 107.683 177.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 91.5 t -62.82 108.87 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.777 0 C-N-CA 124.952 1.301 . . . . 63.009999999999998 110.927 -177.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.434 ' HD3' ' HG3' ' A' ' 252' ' ' GLU . 22.1 mmm180 -109.3 93.82 4.71 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.243 -1.021 . . . . 53.350000000000001 108.243 174.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.493 HD11 ' O ' ' A' ' 227' ' ' THR . 58.9 mt -75.4 131.79 34.37 Favored 'Isoleucine or valine' 0 C--N 1.351 0.631 0 N-CA-C 109.324 -0.621 . . . . 74.450000000000003 109.324 174.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 16.4 p . . . . . 0 CA--C 1.558 1.273 0 C-N-CA 125.496 1.518 . . . . 60.119999999999997 107.56 178.084 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.85 0 N-CA-C 110.617 -0.142 . . . . 61.340000000000003 110.617 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.628 ' CE2' HD22 ' A' ' 233' ' ' LEU . 49.1 m-85 . . . . . 0 N--CA 1.483 1.178 0 C-N-CA 124.43 1.092 . . . . 65.530000000000001 110.648 -172.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.64 ' HB3' ' HB2' ' A' ' 240' ' ' PHE . 25.2 mm-40 . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 121.468 0.651 . . . . 75.439999999999998 112.138 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -94.29 138.65 32.03 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 114.353 -1.294 . . . . 74.450000000000003 110.807 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 91.5 mt -122.93 166.95 14.22 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.872 0.869 . . . . 61.310000000000002 110.455 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -106.34 149.89 26.51 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 107.955 -1.128 . . . . 62.140000000000001 107.955 166.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.97 129.15 12.76 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.933 -0.765 . . . . 71.129999999999995 108.933 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.5 m -65.52 121.77 15.67 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.572 0.749 . . . . 75.329999999999998 110.425 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.479 HD22 ' HB3' ' A' ' 251' ' ' LEU . 57.0 tp -108.0 112.99 25.85 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.951 0.901 . . . . 75.239999999999995 109.164 -178.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -85.93 112.07 20.84 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.312 -0.996 . . . . 72.409999999999997 108.312 174.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 2.2 p -139.49 119.9 9.42 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 123.945 0.898 . . . . 73.5 108.971 -177.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' PRO . . . . . 0.425 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 44.3 Cg_endo -71.3 158.02 55.53 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 121.879 1.72 . . . . 70.420000000000002 111.171 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -52.1 -47.28 92.3 Favored Pre-proline 0 CA--C 1.567 1.611 0 C-N-CA 124.781 1.233 . . . . 65.019999999999996 113.606 -177.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 37.2 Cg_endo -63.07 -43.62 18.56 Favored 'Trans proline' 0 C--N 1.404 3.491 0 C-N-CA 121.478 1.452 . . . . 63.030000000000001 112.186 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 40.1 mt -71.12 -28.26 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 O-C-N 123.616 0.572 . . . . 74.340000000000003 110.361 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.57 -46.56 82.22 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.207 0.603 . . . . 63.140000000000001 110.509 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 67.5 t -67.82 -57.07 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 122.727 0.411 . . . . 73.099999999999994 111.513 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 17.2 m -78.9 -20.83 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 112.285 0.476 . . . . 64.239999999999995 112.285 -170.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 77.52 132.97 0.62 Allowed Glycine 0 C--N 1.345 1.07 0 N-CA-C 111.675 -0.57 . . . . 71.140000000000001 111.675 -171.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 175.87 -175.01 47.25 Favored Glycine 0 N--CA 1.468 0.828 0 CA-C-N 117.265 0.532 . . . . 73.200000000000003 112.269 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -79.03 143.6 35.48 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 122.849 0.46 . . . . 72.519999999999996 111.0 -178.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 19.9 m -139.45 169.44 16.99 Favored 'Isoleucine or valine' 0 C--O 1.253 1.263 0 O-C-N 124.338 1.024 . . . . 65.239999999999995 110.351 177.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -72.48 118.46 15.41 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.502 -1.226 . . . . 74.319999999999993 109.979 169.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -110.66 137.33 48.47 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.407 -0.59 . . . . 32.049999999999997 109.407 169.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 63.0 mtt -84.95 103.68 14.21 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.521 -0.918 . . . . 73.109999999999999 108.521 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 43.4 m -122.35 168.56 11.92 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.688 1.195 . . . . 64.310000000000002 109.015 -176.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 80.1 mt -54.69 -27.29 39.23 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.023 0.929 . . . . 54.32 111.73 174.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -90.95 15.82 10.69 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.507 1.123 . . . . 51.420000000000002 111.837 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 83.07 -149.74 26.82 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-O 119.273 -0.737 . . . . 44.539999999999999 112.174 -177.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.05 120.3 5.99 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.376 2.051 . . . . 64.140000000000001 111.377 177.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 22.6 m -119.24 167.44 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 123.2 0.6 . . . . 70.209999999999994 111.522 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -76.67 116.36 17.28 Favored 'General case' 0 C--N 1.348 0.526 0 C-N-CA 124.38 1.072 . . . . 73.129999999999995 108.822 175.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 1.1 t -124.78 115.19 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 108.613 -0.884 . . . . 64.040000000000006 108.613 174.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -81.39 99.01 8.47 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 115.76 -0.655 . . . . 62.109999999999999 109.401 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 56.1 t -80.32 130.26 66.2 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 123.609 0.764 . . . . 60.210000000000001 109.904 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.37 167.68 7.53 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.168 2.579 . . . . 53.030000000000001 112.27 171.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.25 -179.51 3.19 Favored 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 121.837 1.691 . . . . 75.200000000000003 112.913 174.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 48.2 mtt85 60.66 18.23 8.28 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 124.974 1.31 . . . . 72.25 112.298 173.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.497 ' HA ' ' OH ' ' A' ' 176' ' ' TYR . 96.6 m -68.3 103.45 1.6 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.025 0.93 . . . . 71.299999999999997 110.245 -174.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.452 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 47.4 tp60 -103.78 142.2 34.78 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.419 1.088 . . . . 73.329999999999998 110.285 -174.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.82 130.96 49.47 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.716 1.206 . . . . 41.109999999999999 111.583 -176.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 95.01 -10.34 70.1 Favored Glycine 0 C--N 1.347 1.142 0 O-C-N 123.711 0.632 . . . . 72.430000000000007 113.144 177.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.452 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 68.3 mtt-85 -78.52 155.45 29.75 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.038 0.535 . . . . 75.200000000000003 109.626 174.018 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.585 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.7 mppt? -130.18 118.1 20.9 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.994 -0.743 . . . . 51.109999999999999 108.994 -176.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.628 HD22 ' CE2' ' A' ' 176' ' ' TYR . 5.0 mt -89.66 103.91 16.51 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.091 -0.959 . . . . 74.439999999999998 109.035 -164.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 16.8 ttm-85 -69.42 102.11 1.7 Allowed 'General case' 0 CA--C 1.541 0.598 0 O-C-N 123.92 0.763 . . . . 74.239999999999995 109.712 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.414 ' HB3' ' HG3' ' A' ' 238' ' ' LYS . 14.3 mt -96.05 91.32 5.91 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.282 -1.007 . . . . 61.109999999999999 108.282 175.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -62.78 140.94 58.79 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.283 -0.636 . . . . 74.400000000000006 109.283 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 72.9 34.59 58.87 Favored Glycine 0 C--N 1.343 0.949 0 O-C-N 123.424 0.453 . . . . 53.509999999999998 113.737 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.432 ' HA ' ' NZ ' ' A' ' 238' ' ' LYS . 0.4 OUTLIER -128.01 -27.05 2.8 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.601 0.761 . . . . 73.319999999999993 112.124 179.262 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -74.88 -165.21 13.54 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 112.455 -0.258 . . . . 75.329999999999998 112.455 169.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.64 ' HB2' ' HB3' ' A' ' 191' ' ' GLN . 90.9 m-85 -75.72 150.57 84.22 Favored Pre-proline 0 N--CA 1.487 1.395 0 CA-C-N 117.216 0.508 . . . . 73.439999999999998 110.046 -176.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo . . . . . 0 C--N 1.375 1.939 0 C-N-CA 122.284 1.989 . . . . 70.450000000000003 112.659 177.704 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 48.8 mtm180 . . . . . 0 N--CA 1.473 0.679 0 N-CA-C 108.731 -0.841 . . . . 52.340000000000003 108.731 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -69.97 171.0 42.99 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 115.3 -0.864 . . . . 33.420000000000002 113.963 -177.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -110.71 136.28 50.03 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.919 0.888 . . . . 72.450000000000003 108.863 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 31.9 tp -105.29 108.11 19.46 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 107.717 -1.216 . . . . 73.129999999999995 107.717 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.585 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 19.3 m-85 -88.54 108.99 19.7 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.716 -0.846 . . . . 75.239999999999995 108.716 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.479 ' HB3' HD22 ' A' ' 197' ' ' LEU . 43.0 mt -86.85 107.07 18.16 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.856 -0.794 . . . . 64.329999999999998 108.856 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -78.05 102.76 7.6 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 114.657 -1.156 . . . . 72.409999999999997 109.55 -177.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 63.2 t -59.57 115.26 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.695 0 CA-C-N 114.388 -1.278 . . . . 72.109999999999999 112.053 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 20.7 mmt85 -112.66 93.99 4.7 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.294 -1.373 . . . . 72.010000000000005 107.294 171.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 22.9 mt -74.99 109.36 7.83 Favored 'Isoleucine or valine' 0 C--N 1.352 0.689 0 N-CA-C 109.018 -0.734 . . . . 73.439999999999998 109.018 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 25.6 p . . . . . 0 CA--C 1.558 1.277 0 C-N-CA 124.524 1.13 . . . . 73.420000000000002 108.428 177.173 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.688 0 N-CA-C 109.272 -0.64 . . . . 72.099999999999994 109.272 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.592 ' CE2' HD21 ' A' ' 233' ' ' LEU . 66.6 m-85 . . . . . 0 N--CA 1.488 1.43 0 C-N-CA 125.23 1.412 . . . . 62.420000000000002 112.067 -166.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 . . . . . 0 CA--C 1.555 1.166 0 CA-C-O 122.992 1.377 . . . . 53.420000000000002 109.745 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -88.7 166.84 13.8 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 113.693 -1.594 . . . . 64.340000000000003 110.362 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.6 mt -133.19 164.61 26.68 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.618 0.767 . . . . 53.149999999999999 110.785 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -114.85 154.87 27.85 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 114.526 -1.215 . . . . 74.219999999999999 108.357 168.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -160.66 150.88 17.91 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.656 0.782 . . . . 72.310000000000002 109.319 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 33.2 m -81.66 135.65 35.52 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.065 0.546 . . . . 61.539999999999999 110.18 177.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.578 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 42.1 tp -114.54 113.57 24.6 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.707 -1.22 . . . . 71.439999999999998 107.707 170.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -91.93 123.7 35.5 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 109.269 -0.641 . . . . 52.229999999999997 109.269 177.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 3.6 p -142.92 130.9 11.22 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.531 1.132 . . . . 75.219999999999999 108.487 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.21 156.26 37.63 Favored 'Trans proline' 0 C--N 1.37 1.683 0 C-N-CA 121.586 1.524 . . . . 73.430000000000007 110.999 170.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -54.62 -42.18 93.53 Favored Pre-proline 0 CA--C 1.565 1.528 0 CA-C-O 117.333 -1.318 . . . . 73.019999999999996 114.29 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.24 -51.23 9.04 Favored 'Trans proline' 0 C--N 1.4 3.282 0 CA-C-N 121.832 1.69 . . . . 44.219999999999999 112.144 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 46.0 mt -68.69 -26.45 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.813 0.845 . . . . 74.150000000000006 110.802 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.468 ' HB1' ' O ' ' A' ' 227' ' ' THR . . . -70.69 -50.96 30.9 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.51 0.724 . . . . 72.409999999999997 111.326 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 96.1 t -67.65 -50.14 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.612 0.765 . . . . 65.109999999999999 111.253 -176.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.7 p -75.97 -31.5 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 122.524 0.33 . . . . 74.019999999999996 110.793 -177.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 79.96 103.46 0.27 Allowed Glycine 0 C--N 1.347 1.177 0 N-CA-C 111.667 -0.573 . . . . 72.340000000000003 111.667 -173.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -131.75 -129.7 3.06 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 116.978 0.389 . . . . 55.009999999999998 112.35 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -132.93 141.75 48.52 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.129 0.972 . . . . 75.439999999999998 108.393 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 17.2 m -130.67 165.96 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.21 0.604 . . . . 71.120000000000005 110.924 -178.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -82.11 120.42 25.29 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.133 -0.692 . . . . 74.299999999999997 109.133 168.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -118.21 136.67 53.5 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.557 0.743 . . . . 41.32 109.285 173.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 87.1 mtp -76.83 116.63 17.67 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.026 0.53 . . . . 73.340000000000003 109.578 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 33.6 m -127.21 170.35 12.52 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.431 1.093 . . . . 63.030000000000001 108.848 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 81.4 mt -57.82 -34.29 69.5 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.012 0.925 . . . . 71.409999999999997 111.963 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -84.56 2.16 42.55 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.676 0.79 . . . . 74.120000000000005 111.93 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 108.79 -161.8 13.09 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-O 119.648 -0.529 . . . . 74.219999999999999 112.567 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.2 119.66 6.61 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 122.189 1.926 . . . . 62.140000000000001 111.312 176.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 32.7 m -114.9 163.94 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 123.306 0.642 . . . . 74.140000000000001 109.979 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -103.61 110.0 21.9 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.242 0.544 . . . . 72.340000000000003 109.703 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 62.0 t -104.29 126.25 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.151 0.98 . . . . 72.540000000000006 109.207 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.1 99.81 2.87 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.103 0.561 . . . . 70.140000000000001 109.899 176.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 78.1 t -88.52 121.28 70.24 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 124.112 0.965 . . . . 71.450000000000003 109.724 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -60.76 169.02 6.14 Favored 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 123.987 3.124 . . . . 63.119999999999997 113.359 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.98 169.35 20.69 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 122.073 1.849 . . . . 62.109999999999999 113.629 178.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 65.53 22.02 11.79 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 125.554 1.541 . . . . 71.519999999999996 112.186 176.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.503 ' HA ' ' CZ ' ' A' ' 176' ' ' TYR . 94.8 m -66.39 104.55 1.25 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.029 0.932 . . . . 63.43 110.811 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -102.06 141.63 34.6 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.987 0.915 . . . . 63.240000000000002 110.935 -172.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.4 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -64.77 143.31 58.02 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.295 1.038 . . . . 75.209999999999994 111.576 -179.021 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.76 -9.17 75.14 Favored Glycine 0 N--CA 1.47 0.909 0 O-C-N 123.831 0.707 . . . . 70.340000000000003 112.939 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.42 HH11 ' HE1' ' A' ' 176' ' ' TYR . 89.3 mtt180 -78.15 154.14 31.46 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.237 0.615 . . . . 70.5 109.989 171.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -131.23 136.31 48.11 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.592 1.157 . . . . 71.239999999999995 108.437 -178.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.592 HD21 ' CE2' ' A' ' 176' ' ' TYR . 30.2 mt -110.12 103.16 11.84 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.875 -0.602 . . . . 61.130000000000003 109.912 -169.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -70.5 100.65 1.83 Allowed 'General case' 0 C--O 1.239 0.501 0 O-C-N 124.038 0.836 . . . . 73.430000000000007 109.203 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 12.4 mt -97.79 98.59 9.97 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.305 -1.368 . . . . 63.530000000000001 107.305 177.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 36.3 mtmt -76.88 141.74 40.45 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.298 -0.41 . . . . 75.420000000000002 110.331 -176.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.98 33.07 42.37 Favored Glycine 0 C--N 1.344 1.015 0 O-C-N 123.478 0.486 . . . . 71.549999999999997 113.278 -179.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -125.0 -33.95 2.85 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.74 0.816 . . . . 73.109999999999999 111.619 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -65.61 -159.81 0.6 Allowed Glycine 0 C--N 1.359 1.856 0 O-C-N 123.488 0.493 . . . . 53.420000000000002 113.491 176.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -71.72 146.17 90.58 Favored Pre-proline 0 CA--C 1.554 1.112 0 O-C-N 122.049 -0.677 . . . . 75.530000000000001 110.078 -177.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 20.7 Cg_endo . . . . . 0 C--N 1.378 2.101 0 C-N-CA 122.778 2.319 . . . . 72.140000000000001 112.925 175.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 31.6 mtt180 . . . . . 0 N--CA 1.477 0.917 0 CA-C-O 121.096 0.474 . . . . 63.439999999999998 110.778 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.29 -165.63 27.56 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 115.334 -0.848 . . . . 55.509999999999998 112.363 177.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -99.07 168.8 9.85 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.214 0.606 . . . . 74.450000000000003 110.13 -177.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 40.4 tp -142.48 107.81 5.01 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.943 -0.762 . . . . 62.25 108.943 174.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -89.33 108.2 19.49 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.907 0.483 . . . . 72.340000000000003 109.964 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.578 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 34.7 mt -87.62 107.97 18.85 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 109.311 -0.625 . . . . 72.109999999999999 109.311 174.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -78.66 103.5 8.65 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 109.075 -0.713 . . . . 75.540000000000006 109.075 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.8 t -56.8 112.99 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 124.548 1.139 . . . . 72.329999999999998 111.194 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -116.34 100.55 7.97 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.039 -1.097 . . . . 74.420000000000002 108.039 176.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 30.1 mt -79.38 126.92 39.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 123.285 0.634 . . . . 54.43 110.665 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 19.7 p . . . . . 0 CA--C 1.557 1.213 0 C-N-CA 124.714 1.205 . . . . 64.540000000000006 108.708 176.135 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 108.966 -0.753 . . . . 73.329999999999998 108.966 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.673 ' CE2' HD21 ' A' ' 233' ' ' LEU . 40.6 m-85 . . . . . 0 N--CA 1.486 1.33 0 C-N-CA 124.724 1.21 . . . . 75.430000000000007 109.337 -159.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 109.724 -0.473 . . . . 75.549999999999997 109.724 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -80.33 132.14 35.75 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.467 -0.788 . . . . 73.219999999999999 109.431 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 86.2 mt -136.94 175.11 9.92 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.838 0.855 . . . . 64.409999999999997 109.772 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -105.26 163.49 12.56 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.055 0.942 . . . . 73.209999999999994 110.205 178.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -165.33 129.7 2.4 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.771 1.228 . . . . 60.109999999999999 108.13 175.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' THR . . . . . 0.446 ' HA ' ' HB2' ' A' ' 252' ' ' GLU . 50.1 m -70.69 137.11 49.52 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 122.794 0.438 . . . . 54.340000000000003 111.163 -178.071 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 21.9 tp -122.46 112.44 18.05 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.182 -1.044 . . . . 62.340000000000003 108.182 175.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -91.23 128.43 37.05 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 108.913 -0.773 . . . . 65.049999999999997 108.913 175.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 3.3 p -139.6 124.87 11.64 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 123.799 0.84 . . . . 61.439999999999998 109.578 -177.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -67.5 153.51 76.31 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 121.467 1.444 . . . . 44.329999999999998 111.717 176.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.59 -45.17 85.24 Favored Pre-proline 0 CA--C 1.564 1.496 0 CA-C-O 117.648 -1.167 . . . . 53.329999999999998 113.887 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.457 ' O ' HG12 ' A' ' 206' ' ' VAL . 19.9 Cg_endo -59.36 -52.27 5.07 Favored 'Trans proline' 0 C--N 1.397 3.127 0 CA-C-N 121.426 1.545 . . . . 62.310000000000002 112.17 175.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 46.0 mt -63.8 -27.31 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 123.639 0.776 . . . . 75.420000000000002 110.896 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' A' ' 227' ' ' THR . . . -70.86 -49.33 47.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.386 0.675 . . . . 72.510000000000005 111.169 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 84.7 t -67.84 -54.0 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 122.988 0.515 . . . . 73.209999999999994 110.96 -177.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.457 HG12 ' O ' ' A' ' 202' ' ' PRO . 11.1 p -74.34 -38.66 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 122.701 0.4 . . . . 60.32 111.345 -175.495 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.79 79.16 1.3 Allowed Glycine 0 C--N 1.343 0.955 0 N-CA-C 112.07 -0.412 . . . . 65.019999999999996 112.07 -172.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -99.33 -125.54 5.45 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-O 119.546 -0.586 . . . . 64.219999999999999 112.064 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.54 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 33.7 mtmm -138.18 150.18 46.54 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.101 0.961 . . . . 63.210000000000001 109.4 174.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 24.3 m -138.51 170.18 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 124.031 0.932 . . . . 75.439999999999998 110.946 177.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 19.3 ttm180 -96.76 115.72 27.91 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.798 0.839 . . . . 62.109999999999999 110.303 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -107.67 156.14 19.39 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 109.181 -0.674 . . . . 41.310000000000002 109.181 168.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 83.6 mtp -98.08 120.93 39.35 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.034 0.445 . . . . 61.130000000000003 110.063 177.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 215' ' ' LEU . 5.5 m -111.26 174.41 5.88 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 125.083 1.353 . . . . 70.230000000000004 107.382 175.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.42 ' H ' HG22 ' A' ' 214' ' ' THR . 76.1 mt -59.44 -35.17 73.51 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 113.118 0.785 . . . . 74.340000000000003 113.118 -171.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -90.6 -19.11 24.07 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.207 0.603 . . . . 74.219999999999999 111.279 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 147.04 -158.88 27.87 Favored Glycine 0 C--N 1.353 1.502 0 CA-C-O 119.824 -0.431 . . . . 65.340000000000003 113.324 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.9 143.91 29.99 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.496 2.797 . . . . 70.219999999999999 113.498 -173.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 31.2 m -133.25 161.45 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.106 0.962 . . . . 71.329999999999998 110.084 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -95.57 110.92 22.94 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.747 0.819 . . . . 74.349999999999994 109.656 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 54.5 t -96.52 111.28 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.574 1.149 . . . . 72.049999999999997 108.159 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.54 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . . . -73.72 95.8 2.42 Favored 'General case' 0 C--N 1.349 0.568 0 N-CA-C 109.34 -0.615 . . . . 73.439999999999998 109.34 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 53.6 t -64.31 132.09 95.24 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 124.468 1.107 . . . . 72.420000000000002 110.279 -173.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.74 166.71 28.66 Favored 'Trans proline' 0 CA--C 1.559 1.729 0 C-N-CA 122.668 2.246 . . . . 74.329999999999998 112.213 170.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.29 167.03 28.12 Favored 'Trans proline' 0 C--N 1.372 1.798 0 C-N-CA 121.822 1.682 . . . . 74.040000000000006 112.057 173.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 65.37 19.18 11.57 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.718 1.207 . . . . 73.450000000000003 112.157 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.544 ' HA ' ' CZ ' ' A' ' 176' ' ' TYR . 79.1 m -66.87 101.19 0.8 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.187 0.595 . . . . 42.329999999999998 110.659 -176.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -101.96 143.09 32.26 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 125.605 1.562 . . . . 71.019999999999996 110.596 -174.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -68.87 145.04 54.05 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 123.927 0.891 . . . . 64.099999999999994 111.166 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.06 -12.73 68.71 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.247 -0.888 . . . . 41.340000000000003 112.446 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.543 HH11 ' HE1' ' A' ' 176' ' ' TYR . 87.6 mtt180 -85.13 154.67 21.87 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.329 0.652 . . . . 72.349999999999994 110.415 175.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.552 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.3 mppt? -130.29 139.48 50.73 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.25 -1.019 . . . . 74.099999999999994 108.25 -178.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.673 HD21 ' CE2' ' A' ' 176' ' ' TYR . 26.1 mt -110.77 100.63 9.35 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 122.9 0.48 . . . . 61.240000000000002 109.829 -172.01 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -71.12 101.86 2.36 Favored 'General case' 0 CA--C 1.552 1.038 0 O-C-N 124.003 0.814 . . . . 75.209999999999994 110.01 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 11.8 mt -106.45 107.77 18.95 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.303 0.641 . . . . 64.0 109.283 -175.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -61.15 150.6 33.73 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.507 0.558 . . . . 70.549999999999997 112.507 176.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.78 24.78 61.6 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.483 -0.781 . . . . 72.519999999999996 114.004 171.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 249' ' ' LEU . 11.1 mmtp -119.83 -44.26 2.53 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.18 0.592 . . . . 72.310000000000002 109.578 -176.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -77.53 -177.01 45.97 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-N 115.352 -0.84 . . . . 74.219999999999999 112.727 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -64.83 150.87 94.03 Favored Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 123.703 0.801 . . . . 75.319999999999993 112.512 -171.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.645 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 52.6 Cg_endo . . . . . 0 C--N 1.383 2.352 0 C-N-CA 122.642 2.228 . . . . 74.349999999999994 112.329 -177.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.645 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 14.1 mtm180 . . . . . 0 N--CA 1.473 0.697 0 CA-C-O 120.826 0.346 . . . . 72.239999999999995 110.076 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -93.3 175.66 36.39 Favored Glycine 0 C--N 1.339 0.747 0 CA-C-N 115.658 -0.701 . . . . 61.100000000000001 113.451 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -99.61 170.37 8.63 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.215 1.006 . . . . 65.319999999999993 109.619 -176.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 238' ' ' LYS . 32.0 tp -141.88 118.88 11.25 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.292 -0.633 . . . . 74.120000000000005 109.292 172.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.552 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 13.9 m-85 -88.69 109.41 20.1 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.748 -0.834 . . . . 74.439999999999998 108.748 -178.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 30.2 mt -85.97 108.57 18.27 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.93 -0.767 . . . . 74.310000000000002 108.93 176.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 196' ' ' THR . 30.4 mt-10 -77.31 97.16 4.78 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 114.421 -1.263 . . . . 75.129999999999995 109.405 -174.107 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 65.6 t -60.67 105.16 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 O-C-N 123.765 0.665 . . . . 64.340000000000003 110.752 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -116.02 102.22 9.45 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 106.988 -1.486 . . . . 74.120000000000005 106.988 174.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.525 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 51.3 mt -81.52 131.63 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 116.111 -0.495 . . . . 75.239999999999995 110.843 -174.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 21.3 p . . . . . 0 CA--C 1.563 1.452 0 C-N-CA 124.537 1.135 . . . . 73.340000000000003 108.422 177.267 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 111.023 0.009 . . . . 31.41 111.023 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.567 ' CE2' HD21 ' A' ' 233' ' ' LEU . 25.3 m-85 . . . . . 0 N--CA 1.491 1.589 0 C-N-CA 124.44 1.096 . . . . 74.299999999999997 110.15 -160.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 CA--C 1.541 0.63 0 CA-C-O 121.11 0.481 . . . . 71.140000000000001 109.809 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.43 131.64 41.25 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 114.563 -1.199 . . . . 71.400000000000006 110.204 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 96.4 mt -135.8 155.49 50.27 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.81 0.844 . . . . 73.040000000000006 110.239 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -116.4 145.34 43.32 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.091 0.957 . . . . 62.030000000000001 109.17 172.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -150.1 136.76 19.15 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.31 0.644 . . . . 65.299999999999997 109.504 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 86.6 m -69.19 138.77 54.34 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.216 0.606 . . . . 64.549999999999997 110.353 175.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.523 HD13 HD13 ' A' ' 251' ' ' LEU . 45.3 tp -120.14 112.45 19.11 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 107.657 -1.238 . . . . 71.150000000000006 107.657 174.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -95.68 117.0 29.67 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.743 -0.836 . . . . 54.409999999999997 108.743 -178.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.9 p -142.32 129.07 11.03 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.019 0.928 . . . . 72.040000000000006 109.364 -176.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.08 155.58 61.25 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 121.792 1.662 . . . . 41.420000000000002 111.791 175.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -48.63 -46.69 71.54 Favored Pre-proline 0 N--CA 1.487 1.402 0 N-CA-C 114.522 1.304 . . . . 64.510000000000005 114.522 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.441 ' O ' HG12 ' A' ' 206' ' ' VAL . 19.7 Cg_endo -57.74 -55.13 2.59 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 121.418 1.412 . . . . 73.230000000000004 112.802 176.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 58.9 mt -65.2 -29.52 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 123.426 0.69 . . . . 43.200000000000003 111.277 -177.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.8 -53.22 28.79 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.052 0.541 . . . . 61.240000000000002 111.03 -178.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 89.9 t -67.39 -55.17 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 115.642 -0.708 . . . . 71.319999999999993 110.956 -176.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.441 HG12 ' O ' ' A' ' 202' ' ' PRO . 7.7 p -77.12 -22.89 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 N-CA-C 112.268 0.47 . . . . 73.400000000000006 112.268 -173.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.41 139.01 8.19 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-O 120.1 -0.278 . . . . 43.039999999999999 112.622 -177.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -171.83 -145.48 4.9 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 116.753 0.276 . . . . 42.119999999999997 113.116 -178.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.515 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 96.4 mttt -133.76 132.7 40.85 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.963 0.905 . . . . 71.140000000000001 109.131 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.413 HG22 HG21 ' A' ' 223' ' ' VAL . 34.9 m -131.88 164.94 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-O 121.135 0.493 . . . . 61.409999999999997 110.716 177.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -75.45 141.34 43.16 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.082 -0.963 . . . . 64.519999999999996 110.645 174.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -141.47 157.55 45.0 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.727 0.811 . . . . 52.549999999999997 110.045 173.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 55.4 ttp -81.91 129.65 34.83 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.151 0.58 . . . . 72.319999999999993 110.72 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 89.5 m -143.61 166.96 23.38 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 124.418 1.087 . . . . 73.420000000000002 108.251 176.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 96.4 mt -56.6 -27.9 59.16 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.751 0.82 . . . . 75.219999999999999 112.458 174.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.46 14.56 3.61 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.826 0.85 . . . . 62.520000000000003 111.663 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 85.2 -148.75 23.34 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 111.192 -0.763 . . . . 41.009999999999998 111.192 -175.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.66 129.19 13.32 Favored 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 122.412 2.075 . . . . 62.049999999999997 111.327 174.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.2 m -122.21 155.87 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.726 0.811 . . . . 63.0 109.78 178.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -97.24 104.76 16.81 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.896 -0.779 . . . . 75.319999999999993 108.896 176.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.6 t -96.41 130.56 44.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 124.04 0.936 . . . . 73.140000000000001 109.829 -176.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.515 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . . . -77.48 101.93 6.67 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.322 0.649 . . . . 65.349999999999994 110.191 178.104 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.413 HG21 HG22 ' A' ' 210' ' ' VAL . 50.2 t -91.43 126.0 56.02 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 124.303 1.041 . . . . 64.409999999999997 109.959 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.7 172.6 9.18 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 123.665 2.91 . . . . 74.200000000000003 112.452 178.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.63 -179.41 1.98 Allowed 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 121.853 1.702 . . . . 73.510000000000005 112.154 166.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 68.86 5.29 4.91 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 125.28 1.432 . . . . 74.420000000000002 112.473 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.451 ' HA ' ' CZ ' ' A' ' 176' ' ' TYR . 90.5 m -67.05 114.34 5.75 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.374 0.607 . . . . 72.450000000000003 110.933 -171.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.429 ' HA ' HD11 ' A' ' 255' ' ' ILE . 6.7 tp-100 -125.77 139.53 53.44 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 124.033 0.933 . . . . 51.130000000000003 110.464 -165.269 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.426 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -61.39 134.24 56.7 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.999 0.92 . . . . 75.310000000000002 112.826 -171.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.85 -2.35 85.74 Favored Glycine 0 N--CA 1.474 1.203 0 CA-C-N 115.883 -0.599 . . . . 64.010000000000005 113.663 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -89.67 146.91 24.19 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.327 -0.62 . . . . 51.439999999999998 109.327 173.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -126.73 138.69 53.42 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.791 0.836 . . . . 73.329999999999998 108.97 -172.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.567 HD21 ' CE2' ' A' ' 176' ' ' TYR . 40.6 mt -113.53 109.02 17.97 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.073 -0.512 . . . . 62.100000000000001 111.008 -163.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -70.64 102.61 2.32 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 124.62 1.2 . . . . 73.540000000000006 109.806 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 33.0 mt -109.4 91.7 3.75 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.322 -0.622 . . . . 63.350000000000001 109.322 178.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.556 ' HG2' ' HB3' ' A' ' 248' ' ' ASP . 45.4 mtmt -70.13 143.53 52.32 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 122.851 0.46 . . . . 63.119999999999997 110.721 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.36 34.34 45.8 Favored Glycine 0 C--N 1.346 1.111 0 O-C-N 123.875 0.734 . . . . 72.340000000000003 112.067 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -131.26 -34.12 1.44 Allowed 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.005 0.922 . . . . 74.030000000000001 110.386 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -74.03 -163.24 9.05 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-N 116.304 -0.407 . . . . 42.32 113.581 175.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -71.26 149.52 94.2 Favored Pre-proline 0 N--CA 1.484 1.242 0 C-N-CA 122.835 0.454 . . . . 73.299999999999997 111.438 -176.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo . . . . . 0 C--N 1.377 2.031 0 C-N-CA 122.918 2.412 . . . . 73.409999999999997 112.512 173.422 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 . . . . . 0 C--O 1.244 0.811 0 N-CA-C 109.252 -0.648 . . . . 74.010000000000005 109.252 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.96 -164.95 22.02 Favored Glycine 0 C--N 1.341 0.84 0 O-C-N 123.775 0.672 . . . . 52.399999999999999 113.663 -177.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.556 ' HB3' ' HG2' ' A' ' 236' ' ' LYS . 1.2 p-10 -113.52 132.81 55.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.589 0.709 . . . . 73.0 111.957 -168.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 42.0 tp -98.57 117.83 33.88 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.014 -1.448 . . . . 70.549999999999997 108.502 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -88.5 109.7 20.26 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 122.848 0.459 . . . . 74.319999999999993 109.939 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.523 HD13 HD13 ' A' ' 197' ' ' LEU . 31.8 mt -86.96 106.12 17.59 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.174 -0.676 . . . . 73.200000000000003 109.174 175.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -78.16 105.34 9.32 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 115.635 -0.711 . . . . 74.400000000000006 109.411 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 65.2 t -56.44 118.04 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 123.762 0.825 . . . . 74.340000000000003 111.014 176.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -117.3 94.77 4.69 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 107.799 -1.186 . . . . 74.340000000000003 107.799 175.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.429 HD11 ' HA ' ' A' ' 228' ' ' GLN . 14.5 mt -76.03 123.96 33.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 O-C-N 124.006 0.816 . . . . 75.319999999999993 109.779 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 37.4 p . . . . . 0 CA--C 1.557 1.239 0 CA-C-O 117.489 -1.243 . . . . 71.540000000000006 108.167 174.543 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.864 0 CA-C-O 120.533 0.206 . . . . 74.120000000000005 111.383 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 . . . . . 0 N--CA 1.486 1.368 0 C-N-CA 125.043 1.337 . . . . 74.310000000000002 111.837 -164.915 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.213 0.53 . . . . 75.219999999999999 110.477 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -75.53 138.31 41.44 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.055 -0.975 . . . . 73.329999999999998 108.909 173.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.7 mt -129.49 168.98 15.55 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.154 0.582 . . . . 73.420000000000002 111.033 -172.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -120.49 141.91 49.77 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 124.637 1.175 . . . . 74.400000000000006 108.258 172.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -153.83 128.22 9.19 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.172 0.989 . . . . 73.349999999999994 108.36 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' THR . . . . . 0.415 ' HA ' ' HB2' ' A' ' 252' ' ' GLU . 92.9 m -72.87 135.06 45.07 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.084 0.553 . . . . 73.150000000000006 111.595 -175.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 40.5 tp -114.35 113.73 24.94 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.768 1.227 . . . . 73.239999999999995 108.343 178.061 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -89.25 116.43 27.47 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.09 -0.707 . . . . 53.299999999999997 109.09 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 7.0 p -136.38 133.26 19.24 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 108.283 -1.006 . . . . 72.340000000000003 108.283 -174.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' PRO . . . . . 0.479 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 72.2 Cg_endo -74.84 161.85 38.46 Favored 'Trans proline' 0 C--N 1.37 1.658 0 C-N-CA 121.899 1.732 . . . . 64.319999999999993 111.892 175.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.05 -51.66 59.92 Favored Pre-proline 0 CA--C 1.569 1.696 0 N-CA-C 113.893 1.071 . . . . 74.010000000000005 113.893 177.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 23.1 Cg_endo -60.5 -52.48 3.85 Favored 'Trans proline' 0 C--N 1.399 3.221 0 C-N-CA 122.068 1.845 . . . . 74.0 112.926 -178.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 61.0 mt -64.26 -28.63 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 123.476 0.71 . . . . 75.430000000000007 111.447 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.23 -48.51 75.53 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.937 0.398 . . . . 75.329999999999998 111.234 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 61.7 t -71.37 -52.41 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.192 0 CA-C-N 116.099 -0.501 . . . . 70.319999999999993 112.18 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 202' ' ' PRO . 11.4 p -85.11 -31.73 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 112.395 0.517 . . . . 63.399999999999999 112.395 -172.1 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 100.39 149.94 24.11 Favored Glycine 0 N--CA 1.471 0.974 0 CA-C-N 116.45 -0.341 . . . . 62.219999999999999 112.372 -173.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 162.42 173.78 31.51 Favored Glycine 0 C--N 1.34 0.782 0 N-CA-C 111.788 -0.525 . . . . 72.420000000000002 111.788 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -81.15 134.79 35.7 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 116.993 0.396 . . . . 75.230000000000004 110.094 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 25.7 m -123.28 167.84 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.488 0.715 . . . . 62.130000000000003 110.48 173.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 -81.5 105.31 12.56 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.705 -1.134 . . . . 70.439999999999998 108.975 172.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.69 144.0 32.32 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.6 0.76 . . . . 72.329999999999998 109.43 175.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 41.4 ttm -86.91 115.66 24.46 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.192 0.52 . . . . 74.299999999999997 110.512 -177.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 9.2 m -116.15 162.57 17.24 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.626 1.17 . . . . 72.030000000000001 107.901 176.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 96.0 mt -56.8 -35.63 68.96 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.227 0.611 . . . . 75.209999999999994 112.349 -177.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -78.55 -20.06 51.48 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.047 0.539 . . . . 73.349999999999994 111.537 -177.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 142.13 -171.8 24.42 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 116.16 -0.473 . . . . 60.509999999999998 112.337 -176.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.52 129.07 14.24 Favored 'Trans proline' 0 C--N 1.365 1.441 0 C-N-CA 123.022 2.482 . . . . 73.409999999999997 111.463 177.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.73 159.93 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 123.723 0.809 . . . . 54.100000000000001 109.549 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -91.18 111.18 22.54 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.36 0.664 . . . . 71.299999999999997 109.661 174.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 93.2 t -107.58 120.99 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.24 1.016 . . . . 74.129999999999995 108.903 177.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.48 98.87 2.86 Favored 'General case' 0 C--N 1.348 0.509 0 C-N-CA 122.989 0.515 . . . . 72.519999999999996 109.959 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 62.2 t -78.03 136.15 62.18 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 124.534 1.134 . . . . 64.299999999999997 109.173 177.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -76.77 173.22 14.83 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.998 2.465 . . . . 74.129999999999995 111.201 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.49 179.52 1.24 Allowed 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 121.972 1.781 . . . . 74.439999999999998 112.197 166.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 27.8 mtt-85 71.23 0.05 3.28 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 125.184 1.394 . . . . 71.430000000000007 112.355 176.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 95.4 m -65.76 106.33 1.48 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.185 0.594 . . . . 54.530000000000001 110.712 -170.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.483 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 60.5 tp60 -115.1 141.45 47.99 Favored 'General case' 0 C--N 1.35 0.596 0 CA-C-N 115.054 -0.975 . . . . 72.109999999999999 110.329 -170.001 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.99 139.83 58.81 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.344 1.057 . . . . 54.119999999999997 111.513 -175.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 91.7 -27.21 10.13 Favored Glycine 0 C--N 1.344 0.978 0 O-C-N 123.836 0.71 . . . . 42.219999999999999 112.791 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.483 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 78.5 mtt180 -77.2 160.64 28.79 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.013 0.525 . . . . 72.010000000000005 110.413 176.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 2.8 mppt? -130.1 144.93 51.62 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.205 0.602 . . . . 71.439999999999998 109.653 -176.233 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.429 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 12.8 mt -97.9 104.44 16.47 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 115.738 -0.664 . . . . 74.239999999999995 109.269 -176.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 54.0 ttm-85 -71.51 105.74 3.72 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 123.873 0.733 . . . . 75.019999999999996 110.292 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 27.8 mt -112.26 94.59 5.0 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.18 0.592 . . . . 74.409999999999997 109.43 -178.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -65.74 143.81 57.29 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.32 0.248 . . . . 73.430000000000007 111.346 178.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 85.07 12.83 73.02 Favored Glycine 0 C--N 1.346 1.125 0 O-C-N 123.956 0.785 . . . . 53.340000000000003 113.707 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -110.78 -27.23 8.96 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 117.28 0.54 . . . . 74.129999999999995 110.539 -178.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -75.33 -167.69 21.93 Favored Glycine 0 C--N 1.352 1.469 0 O-C-N 123.473 0.483 . . . . 24.0 113.076 171.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 241' ' ' PRO . 71.2 m-85 -70.44 144.37 91.64 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 123.414 0.685 . . . . 75.400000000000006 112.847 -171.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 240' ' ' PHE . 13.7 Cg_exo . . . . . 0 C--N 1.379 2.14 0 C-N-CA 123.443 2.762 . . . . 72.140000000000001 111.856 173.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 110.447 -0.205 . . . . 53.520000000000003 110.447 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.3 167.8 52.91 Favored Glycine 0 C--N 1.348 1.235 0 O-C-N 123.669 0.605 . . . . 22.420000000000002 113.877 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -112.67 133.08 54.87 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.38 1.072 . . . . 72.450000000000003 110.137 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 40.2 tp -99.24 122.42 42.39 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.339 1.055 . . . . 73.109999999999999 108.808 -174.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.474 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 3.8 m-85 -89.6 110.14 21.03 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.485 -0.932 . . . . 72.219999999999999 108.485 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.447 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 27.8 mt -86.86 104.99 16.73 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.646 -0.872 . . . . 74.439999999999998 108.646 173.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.415 ' HB2' ' HA ' ' A' ' 196' ' ' THR . 32.5 mt-10 -77.88 97.33 5.24 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.68 -1.146 . . . . 71.299999999999997 109.46 -171.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 59.0 t -58.95 114.93 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 114.94 -1.027 . . . . 73.239999999999995 111.459 -177.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -116.86 95.97 5.26 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.74 -1.208 . . . . 75.420000000000002 107.74 171.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.466 HD11 ' HA ' ' A' ' 228' ' ' GLN . 50.8 mt -75.53 126.88 36.79 Favored 'Isoleucine or valine' 0 C--N 1.35 0.594 0 CA-C-N 115.376 -0.829 . . . . 75.109999999999999 108.955 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 14.5 p . . . . . 0 C--O 1.252 1.192 0 C-N-CA 124.79 1.236 . . . . 74.439999999999998 108.159 177.995 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 121.042 0.449 . . . . 73.409999999999997 109.888 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 28.6 p -154.39 109.8 3.14 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.504 0.721 . . . . 64.329999999999998 109.499 -177.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -91.25 -178.02 5.03 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.457 0.703 . . . . 65.219999999999999 109.73 172.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 79.8 mt -68.59 102.44 1.48 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.307 -0.627 . . . . 72.239999999999995 109.307 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 4.1 tpm_? -62.98 117.17 6.06 Favored 'General case' 0 C--O 1.242 0.658 0 O-C-N 124.062 0.851 . . . . 65.519999999999996 110.756 -177.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.918 ' HA ' HD22 ' A' ' 235' ' ' LEU . 29.8 mt -86.5 97.02 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 121.356 0.598 . . . . 63.109999999999999 110.498 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -83.98 -2.95 57.56 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.907 -1.042 . . . . 75.450000000000003 111.344 176.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -83.11 171.67 13.48 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.625 0.77 . . . . 75.299999999999997 111.451 177.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.4 ' HE1' ' HA ' ' A' ' 227' ' ' THR . 3.3 m-30 67.65 22.5 9.02 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.409 1.084 . . . . 74.340000000000003 112.33 176.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -137.91 68.73 0.51 Allowed Glycine 0 C--N 1.339 0.739 0 N-CA-C 110.096 -1.202 . . . . 72.25 110.096 168.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -66.97 98.37 0.43 Allowed 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.705 2.27 . . . . 72.340000000000003 111.274 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 41.6 t60 -147.12 98.24 3.0 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.805 -0.634 . . . . 72.120000000000005 109.382 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -77.39 133.7 13.61 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 115.827 -0.624 . . . . 63.439999999999998 111.927 175.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 13.6 t -160.25 -171.56 3.24 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.579 0.752 . . . . 54.149999999999999 109.164 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -78.73 69.07 2.91 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-N 118.236 0.471 . . . . 72.409999999999997 113.222 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -147.59 166.19 28.72 Favored Glycine 0 N--CA 1.472 1.039 0 N-CA-C 111.362 -0.695 . . . . 61.100000000000001 111.362 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 37.7 m -78.79 83.96 4.89 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.381 0.673 . . . . 75.340000000000003 111.594 -175.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.612 ' HA2' ' HE2' ' A' ' 236' ' ' LYS . . . -106.26 -64.67 0.63 Allowed Glycine 0 C--N 1.337 0.623 0 N-CA-C 110.7 -0.96 . . . . 75.099999999999994 110.7 173.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 72.39 -175.48 43.15 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.487 -0.356 . . . . 72.439999999999998 112.312 -176.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 57.2 p -78.72 -13.45 59.81 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.359 0.663 . . . . 61.409999999999997 111.115 175.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 176.56 170.91 39.71 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 111.368 -0.693 . . . . 44.420000000000002 111.368 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -84.53 -173.5 49.86 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 122.809 0.242 . . . . 54.25 112.686 175.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 32.7 m -71.8 -80.35 0.06 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.173 0.589 . . . . 72.430000000000007 111.144 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 -106.5 74.26 1.01 Allowed 'General case' 0 C--O 1.244 0.805 0 N-CA-C 108.084 -1.08 . . . . 54.210000000000001 108.084 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -78.67 140.83 38.33 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 113.569 -1.651 . . . . 75.420000000000002 109.699 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 82.5 mt -136.66 140.66 42.9 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.901 0.48 . . . . 63.420000000000002 110.318 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -93.88 122.96 36.9 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.385 -0.825 . . . . 64.310000000000002 108.804 174.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -123.51 127.75 48.79 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 107.445 -1.316 . . . . 62.25 107.445 176.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' THR . . . . . 0.402 ' HA ' ' HB2' ' A' ' 252' ' ' GLU . 25.1 m -68.48 123.61 21.29 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.19 0.596 . . . . 63.310000000000002 110.452 -175.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 29.8 tp -108.36 111.62 23.63 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.604 -0.887 . . . . 75.209999999999994 108.604 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -81.97 126.17 31.64 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.404 -0.962 . . . . 73.510000000000005 108.404 174.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.484 HG11 HG13 ' A' ' 253' ' ' VAL . 6.4 p -142.68 130.3 11.2 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 108.305 -0.998 . . . . 25.199999999999999 108.305 178.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.41 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 57.6 Cg_endo -73.85 155.57 48.56 Favored 'Trans proline' 0 C--N 1.363 1.307 0 C-N-CA 121.678 1.585 . . . . 61.039999999999999 110.666 172.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.81 -48.27 88.12 Favored Pre-proline 0 CA--C 1.56 1.35 0 C-N-CA 123.917 0.887 . . . . 60.439999999999998 113.08 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.468 ' O ' HG12 ' A' ' 206' ' ' VAL . 78.0 Cg_exo -52.57 -56.12 3.15 Favored 'Trans proline' 0 C--N 1.396 3.03 0 C-N-CA 122.453 2.102 . . . . 64.019999999999996 113.57 175.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 59.8 mt -65.09 -28.97 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 123.406 0.683 . . . . 75.299999999999997 111.077 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.54 -49.27 71.9 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.091 0.472 . . . . 54.140000000000001 111.052 177.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 65.9 t -73.98 -47.57 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 115.955 -0.566 . . . . 74.299999999999997 112.496 -173.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 202' ' ' PRO . 13.6 p -88.49 -22.2 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 O-C-N 122.233 -0.292 . . . . 61.439999999999998 111.34 -175.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 87.72 166.38 42.36 Favored Glycine 0 C--N 1.342 0.882 0 N-CA-C 111.533 -0.627 . . . . 51.299999999999997 111.533 -171.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 162.71 -128.15 1.82 Allowed Glycine 0 C--O 1.226 -0.359 0 N-CA-C 111.213 -0.755 . . . . 63.350000000000001 111.213 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.404 ' HD2' ' HB3' ' A' ' 220' ' ' GLU . 48.6 mtmt -137.65 151.48 48.32 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 108.712 -0.847 . . . . 73.109999999999999 108.712 173.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 26.6 m -138.37 162.3 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.075 0.55 . . . . 73.140000000000001 110.109 172.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 -84.42 115.43 22.53 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.456 -0.793 . . . . 75.030000000000001 109.854 174.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -106.79 156.76 18.32 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.716 0.806 . . . . 71.540000000000006 109.594 173.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 43.2 tpp -93.08 125.53 37.72 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.883 0.473 . . . . 65.319999999999993 109.874 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.442 HG22 ' H ' ' A' ' 216' ' ' GLU . 61.1 m -137.8 160.78 38.32 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.692 1.197 . . . . 75.109999999999999 108.044 -178.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 92.5 mt -65.95 -20.85 66.35 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.143 0.577 . . . . 64.099999999999994 111.788 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.442 ' H ' HG22 ' A' ' 214' ' ' THR . 13.5 mm-40 -80.02 -17.49 52.67 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.004 0.922 . . . . 74.120000000000005 110.95 174.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 125.0 -156.78 19.07 Favored Glycine 0 C--N 1.343 0.95 0 N-CA-C 111.449 -0.66 . . . . 32.439999999999998 111.449 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.9 121.07 6.04 Favored 'Trans proline' 0 C--N 1.363 1.3 0 C-N-CA 122.382 2.055 . . . . 70.230000000000004 111.607 173.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 32.7 m -111.26 155.91 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.244 0.617 . . . . 75.340000000000003 109.837 177.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.404 ' HB3' ' HD2' ' A' ' 209' ' ' LYS . 49.8 mt-10 -94.14 113.85 25.87 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.19 -0.67 . . . . 73.030000000000001 109.19 175.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 92.2 t -97.26 117.56 42.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 108.647 -0.872 . . . . 74.540000000000006 108.647 175.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.25 100.35 0.79 Allowed 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.474 0.484 . . . . 74.230000000000004 109.956 176.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 91.4 t -72.75 131.72 83.93 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 123.495 0.718 . . . . 75.209999999999994 109.754 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.33 165.92 31.25 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.266 1.977 . . . . 72.230000000000004 110.979 171.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -67.4 174.58 7.05 Favored 'Trans proline' 0 CA--C 1.551 1.374 0 C-N-CA 121.688 1.592 . . . . 65.409999999999997 112.818 170.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 69.91 0.32 3.01 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 125.374 1.47 . . . . 75.310000000000002 113.514 173.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.454 HG22 HG11 ' A' ' 253' ' ' VAL . 47.4 m -62.24 126.83 28.69 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.119 0.968 . . . . 75.030000000000001 111.781 -170.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.415 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 57.9 tp60 -124.4 143.2 50.75 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.816 0.846 . . . . 72.25 111.03 -167.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.86 131.75 51.66 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.904 1.282 . . . . 71.510000000000005 111.813 -178.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 99.4 -18.04 56.94 Favored Glycine 0 N--CA 1.473 1.116 0 O-C-N 123.705 0.628 . . . . 52.219999999999999 112.951 177.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.415 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 80.5 mtt180 -83.12 135.87 34.66 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.074 -0.714 . . . . 64.439999999999998 109.074 174.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.2 mppt? -102.11 131.78 48.4 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.192 -0.67 . . . . 71.430000000000007 109.192 176.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.509 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 29.0 mt -77.46 97.78 5.09 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.88 -1.155 . . . . 74.010000000000005 107.88 174.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -74.17 103.91 4.77 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.151 0.581 . . . . 74.549999999999997 110.18 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.918 HD22 ' HA ' ' A' ' 173' ' ' ILE . 7.4 mt -102.23 91.09 4.14 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.054 -1.091 . . . . 72.340000000000003 108.054 -177.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.612 ' HE2' ' HA2' ' A' ' 185' ' ' GLY . 26.0 mtpp -66.6 129.44 39.85 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.843 -0.617 . . . . 71.430000000000007 112.221 -172.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 95.5 -16.66 60.81 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 115.639 -0.709 . . . . 64.030000000000001 113.113 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.542 ' HA ' ' HE2' ' A' ' 238' ' ' LYS . 11.3 mmpt? -81.57 -12.63 58.71 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.324 0.649 . . . . 73.549999999999997 112.06 -176.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -79.5 -172.68 43.58 Favored Glycine 0 CA--C 1.535 1.339 0 N-CA-C 112.106 -0.398 . . . . 72.129999999999995 112.106 168.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -86.31 153.06 56.19 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 123.005 0.522 . . . . 75.030000000000001 111.451 -174.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.46 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 48.0 Cg_endo -66.17 154.89 72.35 Favored 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 123.019 2.479 . . . . 72.219999999999999 112.708 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -177.89 -155.75 14.86 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-O 119.061 -0.855 . . . . 44.310000000000002 112.904 -178.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -48.98 -53.97 6.17 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 124.551 3.501 . . . . 71.010000000000005 114.992 -175.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -83.82 -3.11 57.6 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.398 0.679 . . . . 63.119999999999997 112.324 -173.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 127.61 -93.88 0.39 Allowed Glycine 0 C--N 1.343 0.947 0 N-CA-C 111.043 -0.823 . . . . 72.019999999999996 111.043 -178.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 77.9 mtt180 -127.44 159.29 34.94 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.926 0.89 . . . . 75.239999999999995 110.079 172.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -84.35 173.0 49.58 Favored Glycine 0 C--N 1.349 1.257 0 N-CA-C 114.014 0.366 . . . . 71.420000000000002 114.014 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -106.83 134.11 50.47 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.62 1.168 . . . . 75.400000000000006 109.007 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 32.7 tp -98.91 106.69 18.98 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.892 -0.781 . . . . 63.32 108.892 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.458 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 72.6 m-85 -88.76 107.52 19.0 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.361 0.664 . . . . 74.329999999999998 109.68 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.509 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 43.3 mt -88.08 108.47 19.26 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 108.787 -0.82 . . . . 75.120000000000005 108.787 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.402 ' HB2' ' HA ' ' A' ' 196' ' ' THR . 34.8 mt-10 -76.79 99.89 5.29 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.263 -0.88 . . . . 62.020000000000003 109.813 -171.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.484 HG13 HG11 ' A' ' 199' ' ' VAL . 95.0 t -61.69 106.48 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 123.228 0.611 . . . . 54.25 111.071 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -109.38 95.09 5.39 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.198 0.999 . . . . 73.230000000000004 108.521 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 21.8 mt -76.18 113.9 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 123.264 0.625 . . . . 72.430000000000007 109.453 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 23.8 p . . . . . 0 C--O 1.249 1.044 0 C-N-CA 124.664 1.186 . . . . 72.409999999999997 110.256 -178.748 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 92.9 mtp . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.404 0.145 . . . . 71.209999999999994 110.789 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.5 m -62.14 105.29 0.57 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.748 1.219 . . . . 75.439999999999998 112.524 -173.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 56.68 20.61 5.17 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.29 1.436 . . . . 74.109999999999999 113.559 171.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 86.6 mt -85.32 76.52 10.12 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-O 122.109 0.957 . . . . 75.109999999999999 108.479 174.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 33.5 mtm105 -119.98 155.17 33.37 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 113.895 -1.502 . . . . 73.420000000000002 108.047 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.724 HG22 ' H ' ' A' ' 175' ' ' ALA . 77.1 mt -87.32 -74.78 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 109.845 -0.428 . . . . 64.530000000000001 109.845 177.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . 55.93 19.36 3.55 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.124 0.97 . . . . 55.030000000000001 113.019 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.724 ' H ' HG22 ' A' ' 173' ' ' ILE . . . -87.04 12.19 11.94 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.837 0.855 . . . . 54.43 111.462 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.675 ' HB3' HH21 ' A' ' 226' ' ' ARG . 34.7 m-85 -92.76 65.94 4.29 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.909 -0.774 . . . . 53.539999999999999 108.909 166.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 145.74 162.35 9.65 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-N 114.485 -1.234 . . . . 51.420000000000002 111.233 -174.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -71.79 142.71 39.93 Favored 'Trans proline' 0 C--N 1.364 1.367 0 C-N-CA 122.905 2.403 . . . . 73.049999999999997 112.825 -173.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -79.65 -38.23 34.19 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.518 -0.549 . . . . 72.420000000000002 109.518 173.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 131.25 73.43 0.11 Allowed Glycine 0 C--N 1.344 0.983 0 CA-C-N 115.339 -0.846 . . . . 71.519999999999996 111.134 -175.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 56.9 p -61.32 92.3 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.328 1.051 . . . . 55.109999999999999 111.399 -176.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -161.75 -71.91 0.02 OUTLIER Glycine 0 C--N 1.34 0.801 0 N-CA-C 110.807 -0.917 . . . . 72.019999999999996 110.807 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -89.83 150.54 21.14 Favored Glycine 0 C--N 1.345 1.039 0 N-CA-C 111.002 -0.839 . . . . 75.200000000000003 111.002 174.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.419 ' HB2' ' HB1' ' A' ' 244' ' ' ALA . 90.7 p 49.81 89.28 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.276 1.43 . . . . 42.030000000000001 111.922 -175.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -95.23 -132.32 6.85 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 112.116 -0.394 . . . . 60.130000000000003 112.116 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -150.57 34.53 0.97 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 112.048 -0.421 . . . . 70.030000000000001 112.048 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 22.5 p -79.43 107.51 12.26 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 108.893 -0.781 . . . . 64.409999999999997 108.893 175.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.39 17.83 70.36 Favored Glycine 0 N--CA 1.473 1.13 0 N-CA-C 111.504 -0.638 . . . . 43.229999999999997 111.504 -166.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.441 ' HA2' HE22 ' A' ' 191' ' ' GLN . . . -91.76 67.39 2.15 Favored Glycine 0 C--N 1.348 1.198 0 N-CA-C 111.847 -0.501 . . . . 74.010000000000005 111.847 -177.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 16.3 m -110.95 16.18 21.36 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.574 0.75 . . . . 54.140000000000001 110.86 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.571 ' HB2' ' HB2' ' A' ' 240' ' ' PHE . 0.0 OUTLIER -112.7 13.55 19.87 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.585 1.154 . . . . 75.219999999999999 110.407 -172.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -75.48 143.08 42.77 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.349 1.06 . . . . 73.219999999999999 110.397 177.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 82.5 mt -121.13 146.96 46.21 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.721 0.409 . . . . 72.409999999999997 110.678 -171.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -93.76 149.71 21.01 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 109.438 -0.578 . . . . 71.049999999999997 109.438 171.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.461 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -144.54 127.99 16.94 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.589 0.755 . . . . 72.340000000000003 109.003 -177.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 38.5 m -71.31 117.8 13.31 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 122.943 0.497 . . . . 43.509999999999998 109.946 -176.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 41.5 tp -108.0 109.91 21.49 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.604 -0.887 . . . . 53.0 108.604 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -92.3 112.53 24.51 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.44 0.696 . . . . 65.340000000000003 109.156 175.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.409 ' HA ' HG11 ' A' ' 210' ' ' VAL . 7.0 p -130.24 128.99 22.82 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 124.305 1.042 . . . . 53.350000000000001 108.956 -178.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.406 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 41.7 Cg_endo -70.26 155.11 65.02 Favored 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.004 1.803 . . . . 75.310000000000002 111.836 176.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -48.41 -46.49 68.95 Favored Pre-proline 0 CA--C 1.566 1.566 0 N-CA-C 114.79 1.404 . . . . 61.5 114.79 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.48 ' O ' HG12 ' A' ' 206' ' ' VAL . 25.7 Cg_endo -61.86 -52.69 2.7 Favored 'Trans proline' 0 C--N 1.393 2.921 0 CA-C-N 121.114 1.433 . . . . 64.530000000000001 112.888 176.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 50.7 mt -64.93 -24.61 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 123.574 0.749 . . . . 73.040000000000006 110.952 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.47 ' HB1' ' O ' ' A' ' 227' ' ' THR . . . -68.66 -55.1 12.58 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.578 0.751 . . . . 71.239999999999995 111.34 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 76.6 t -66.76 -51.5 55.25 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-N 115.858 -0.61 . . . . 72.230000000000004 112.121 -175.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 202' ' ' PRO . 11.5 p -87.69 -25.96 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 N-CA-C 111.913 0.338 . . . . 60.310000000000002 111.913 -174.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 92.29 153.4 29.92 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 111.641 -0.584 . . . . 74.120000000000005 111.641 -171.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 178.76 -128.89 1.31 Allowed Glycine 0 C--N 1.33 0.235 0 CA-C-O 119.551 -0.583 . . . . 72.209999999999994 111.944 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -139.56 141.39 37.22 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.059 0.944 . . . . 73.420000000000002 110.144 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.409 HG11 ' HA ' ' A' ' 199' ' ' VAL . 30.8 m -135.14 167.57 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.963 0.905 . . . . 71.230000000000004 109.425 169.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -93.47 111.42 23.08 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.102 -0.703 . . . . 75.030000000000001 109.102 173.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.48 145.25 29.85 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.844 0.458 . . . . 64.319999999999993 110.065 175.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 87.4 mtp -88.02 104.47 16.68 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.653 -0.869 . . . . 72.239999999999995 108.653 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 215' ' ' LEU . 27.7 m -111.78 177.35 4.68 Favored 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 124.824 1.25 . . . . 70.310000000000002 108.315 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.414 ' H ' HG22 ' A' ' 214' ' ' THR . 82.6 mt -63.57 -19.32 64.72 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.461 0.704 . . . . 71.310000000000002 112.845 -177.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -87.48 6.48 33.88 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.375 0.67 . . . . 74.109999999999999 111.555 175.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 93.65 -153.32 21.21 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 119.406 -0.663 . . . . 61.299999999999997 111.641 -173.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -75.63 126.46 9.58 Favored 'Trans proline' 0 C--N 1.367 1.527 0 C-N-CA 122.339 2.026 . . . . 72.439999999999998 111.079 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.94 153.16 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 123.124 0.57 . . . . 54.450000000000003 111.217 -171.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -84.92 110.58 18.97 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.198 -0.667 . . . . 71.349999999999994 109.198 175.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 95.4 t -109.2 123.0 64.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 123.854 0.862 . . . . 70.299999999999997 110.18 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -77.37 101.24 6.26 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.512 0.725 . . . . 73.120000000000005 109.943 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.57 ' HA ' HD12 ' A' ' 173' ' ' ILE . 57.3 t -73.67 130.95 82.75 Favored Pre-proline 0 CA--C 1.561 1.38 0 C-N-CA 125.12 1.368 . . . . 63.520000000000003 110.142 177.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.709 ' HD3' ' HB ' ' A' ' 173' ' ' ILE . 63.8 Cg_endo -85.09 171.25 9.26 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 123.205 2.603 . . . . 74.040000000000006 111.032 174.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.04 166.35 21.09 Favored 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 121.689 1.593 . . . . 73.219999999999999 112.639 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.675 HH21 ' HB3' ' A' ' 176' ' ' TYR . 29.3 mtm180 71.72 11.59 6.35 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 125.636 1.574 . . . . 71.109999999999999 112.634 177.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.47 ' O ' ' HB1' ' A' ' 204' ' ' ALA . 94.1 m -65.54 91.62 0.13 Allowed 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 121.776 0.798 . . . . 73.230000000000004 110.16 -178.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.508 ' HA ' HD11 ' A' ' 255' ' ' ILE . 32.8 tt0 -107.75 144.3 35.08 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 114.771 -1.104 . . . . 74.239999999999995 110.396 -168.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -55.02 129.98 39.97 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.004 1.321 . . . . 74.430000000000007 111.986 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 88.93 -9.06 78.15 Favored Glycine 0 N--CA 1.475 1.251 0 CA-C-N 115.997 -0.547 . . . . 62.109999999999999 114.032 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -81.98 150.89 27.42 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.437 -0.579 . . . . 73.010000000000005 109.437 171.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.509 ' HG3' ' HA ' ' A' ' 252' ' ' GLU . 0.0 OUTLIER -129.85 141.81 50.77 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.796 0.808 . . . . 73.129999999999995 110.995 -176.047 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.659 HD13 HG21 ' A' ' 173' ' ' ILE . 14.9 mt -114.77 99.64 7.65 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 114.101 -1.409 . . . . 71.310000000000002 109.516 -162.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.543 ' HG3' ' HB3' ' A' ' 248' ' ' ASP . 52.1 ttp180 -76.78 102.54 6.31 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 123.516 0.51 . . . . 71.099999999999994 110.405 -175.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.53 HD21 HG23 ' A' ' 173' ' ' ILE . 21.9 mt -99.12 95.35 7.05 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.153 0.981 . . . . 74.439999999999998 108.443 176.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -66.64 148.06 52.42 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.64 0.776 . . . . 53.219999999999999 111.765 -176.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 72.67 30.93 63.29 Favored Glycine 0 CA--C 1.529 0.932 0 O-C-N 123.706 0.629 . . . . 75.430000000000007 113.513 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -130.12 -17.47 3.45 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 113.346 0.869 . . . . 74.430000000000007 113.346 -176.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -77.55 -152.82 5.54 Favored Glycine 0 N--CA 1.484 1.842 0 CA-C-N 118.028 0.376 . . . . 61.039999999999999 113.505 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.571 ' HB2' ' HB2' ' A' ' 191' ' ' GLN . 15.0 m-85 -69.12 155.34 93.76 Favored Pre-proline 0 N--CA 1.488 1.436 0 CA-C-O 118.595 -0.717 . . . . 73.310000000000002 110.152 172.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -50.49 129.41 26.35 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 123.024 2.482 . . . . 52.530000000000001 113.02 175.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -146.26 -163.84 10.59 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 119.389 -0.673 . . . . 73.239999999999995 112.961 -174.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -64.98 -31.18 56.34 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 123.521 2.814 . . . . 71.299999999999997 112.293 -177.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.419 ' HB1' ' HB2' ' A' ' 184' ' ' SER . . . -91.88 23.97 3.42 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.717 1.207 . . . . 74.349999999999994 110.793 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 89.58 -62.85 3.36 Favored Glycine 0 C--N 1.352 1.466 0 N-CA-C 110.413 -1.075 . . . . 64.25 110.413 -171.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -126.36 175.69 7.67 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 125.148 1.379 . . . . 73.25 109.512 169.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -89.25 -160.16 36.17 Favored Glycine 0 C--N 1.339 0.719 0 CA-C-N 115.291 -0.868 . . . . 72.349999999999994 111.89 172.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.543 ' HB3' ' HG3' ' A' ' 234' ' ' ARG . 3.4 m-20 -98.21 169.95 9.23 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.175 0.59 . . . . 74.349999999999994 109.61 -176.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 33.7 tp -139.67 106.19 5.33 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.62 -0.882 . . . . 64.219999999999999 108.62 174.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -88.7 113.38 24.2 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.197 0.599 . . . . 73.129999999999995 109.401 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.461 HD23 ' HB3' ' A' ' 195' ' ' ALA . 57.0 mt -85.14 112.74 20.96 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.364 -0.976 . . . . 73.049999999999997 108.364 175.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.509 ' HA ' ' HG3' ' A' ' 232' ' ' LYS . 13.8 tp10 -76.83 101.0 5.7 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.749 1.219 . . . . 70.25 108.088 -179.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.69 106.94 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.518 0.675 . . . . 63.149999999999999 110.476 -176.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -107.02 96.5 6.47 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 114.425 -1.261 . . . . 70.430000000000007 107.7 174.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.508 HD11 ' HA ' ' A' ' 228' ' ' GLN . 24.2 mt -76.13 123.54 32.52 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 N-CA-C 108.83 -0.804 . . . . 73.140000000000001 108.83 176.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 41.5 p . . . . . 0 CA--C 1.549 0.934 0 C-N-CA 124.785 1.234 . . . . 73.109999999999999 108.755 177.358 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 23.2 ptp . . . . . 0 N--CA 1.477 0.91 0 CA-C-O 120.935 0.398 . . . . 73.409999999999997 110.038 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 65.9 m -76.7 84.93 3.33 Favored 'General case' 0 C--N 1.35 0.601 0 CA-C-O 121.398 0.618 . . . . 65.340000000000003 109.965 176.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -109.57 86.5 2.3 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.952 0.901 . . . . 72.230000000000004 108.588 -177.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 5.4 mp -75.6 84.26 2.64 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.476 -0.784 . . . . 54.240000000000002 109.352 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -72.75 114.07 10.48 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 114.93 -1.032 . . . . 74.150000000000006 109.721 177.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.636 HG22 ' H ' ' A' ' 175' ' ' ALA . 73.3 mt -77.41 -83.91 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 109.509 -0.552 . . . . 63.009999999999998 109.509 176.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.468 ' HA ' ' HB3' ' A' ' 224' ' ' PRO . . . 48.31 26.63 1.14 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.429 1.092 . . . . 70.129999999999995 112.794 -176.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.636 ' H ' HG22 ' A' ' 173' ' ' ILE . . . -66.12 -17.36 64.66 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.325 1.05 . . . . 64.430000000000007 112.498 -167.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.18 92.72 0.78 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.02 -1.104 . . . . 73.530000000000001 108.02 169.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 150.6 -172.52 30.33 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-N 114.75 -1.113 . . . . 74.109999999999999 111.316 -174.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -87.48 39.91 0.6 Allowed 'Trans proline' 0 CA--C 1.552 1.377 0 C-N-CA 123.491 2.794 . . . . 74.510000000000005 112.64 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 30.2 m-70 -76.46 137.53 39.74 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.563 0.745 . . . . 73.25 111.324 -171.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 87.83 -75.95 2.03 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 115.232 -0.895 . . . . 70.019999999999996 111.665 -174.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 67.0 m -147.17 150.73 35.51 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.368 0.667 . . . . 35.210000000000001 110.517 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -114.86 42.61 1.88 Allowed Glycine 0 C--N 1.343 0.942 0 N-CA-C 110.918 -0.873 . . . . 74.400000000000006 110.918 175.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -90.3 141.77 16.07 Favored Glycine 0 C--N 1.346 1.103 0 N-CA-C 112.037 -0.425 . . . . 73.439999999999998 112.037 -177.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 41.8 m -76.98 107.57 9.42 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.412 0.685 . . . . 71.329999999999998 109.997 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 110.4 -145.66 17.25 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 115.845 -0.616 . . . . 63.219999999999999 111.696 -176.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -151.03 125.67 1.95 Allowed Glycine 0 C--N 1.346 1.114 0 N-CA-C 112.47 -0.252 . . . . 72.420000000000002 112.47 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 26.6 t -98.24 -178.31 4.0 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.516 0.726 . . . . 53.149999999999999 109.842 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 78.01 -91.51 1.11 Allowed Glycine 0 C--N 1.347 1.145 0 N-CA-C 111.011 -0.836 . . . . 73.150000000000006 111.011 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 77.73 127.9 0.4 Allowed Glycine 0 C--N 1.356 1.692 0 CA-C-O 119.54 -0.589 . . . . 52.539999999999999 112.621 177.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 40.5 m 75.2 -37.81 0.35 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 125.806 1.642 . . . . 72.329999999999998 111.253 -174.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.631 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 22.9 mt-30 -57.23 -22.73 43.11 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.686 1.195 . . . . 70.430000000000007 111.849 167.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -73.98 143.1 45.77 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.579 1.152 . . . . 54.130000000000003 110.683 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 95.2 mt -139.16 149.78 44.85 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.255 1.022 . . . . 62.009999999999998 109.942 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -111.54 128.47 56.04 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.305 1.042 . . . . 74.239999999999995 108.245 168.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -125.29 128.41 48.19 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.901 -0.777 . . . . 65.409999999999997 108.901 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 73.6 m -67.49 131.93 46.62 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.355 0.662 . . . . 65.219999999999999 110.373 178.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 20.6 tp -121.36 112.52 18.67 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.888 0.875 . . . . 72.140000000000001 108.969 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -92.47 120.47 32.98 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 108.752 -0.833 . . . . 61.240000000000002 108.752 172.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 3.0 p -131.64 128.05 21.65 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.143 0.977 . . . . 75.019999999999996 108.432 -178.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -71.39 153.03 61.22 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 121.6 1.533 . . . . 75.519999999999996 111.395 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -47.1 -48.73 53.46 Favored Pre-proline 0 CA--C 1.565 1.545 0 O-C-N 124.495 1.122 . . . . 73.409999999999997 113.064 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.32 -55.42 3.65 Favored 'Trans proline' 0 C--N 1.407 3.611 0 C-N-CA 122.458 2.106 . . . . 72.319999999999993 113.291 175.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 57.4 mt -67.76 -27.01 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 123.558 0.743 . . . . 75.120000000000005 111.1 -175.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.17 -45.48 73.38 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.588 0.755 . . . . 73.340000000000003 110.857 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 81.0 t -71.63 -55.92 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 115.77 -0.65 . . . . 54.43 110.685 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 11.2 m -73.52 -28.58 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 O-C-N 123.816 0.698 . . . . 74.299999999999997 112.191 -172.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 77.77 84.01 0.54 Allowed Glycine 0 C--N 1.344 0.994 0 CA-C-N 116.013 -0.54 . . . . 73.230000000000004 112.371 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -115.28 -126.0 4.04 Favored Glycine 0 C--N 1.342 0.886 0 N-CA-C 112.14 -0.384 . . . . 44.310000000000002 112.14 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -137.56 147.96 45.54 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.654 1.182 . . . . 75.010000000000005 108.36 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 28.4 m -133.35 168.71 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 121.305 0.574 . . . . 54.329999999999998 110.703 173.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -77.37 135.47 38.35 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.967 -1.015 . . . . 74.310000000000002 108.87 169.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -138.17 158.26 44.65 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.756 0.423 . . . . 64.299999999999997 110.509 176.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 67.0 mtm -81.02 119.06 23.04 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.045 -0.979 . . . . 71.200000000000003 110.242 -176.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.432 HG22 ' H ' ' A' ' 216' ' ' GLU . 89.4 m -135.42 151.68 50.67 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.186 0.994 . . . . 42.240000000000002 109.63 176.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 62.6 mt -57.41 -25.56 59.77 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.564 1.146 . . . . 75.450000000000003 112.808 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.432 ' H ' HG22 ' A' ' 214' ' ' THR . 34.0 mt-10 -86.43 -18.86 30.65 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.155 0.982 . . . . 72.239999999999995 111.585 -178.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 135.07 -177.72 19.11 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.543 -0.623 . . . . 62.210000000000001 111.543 -175.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.66 120.83 7.17 Favored 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 122.404 2.069 . . . . 73.219999999999999 111.431 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.6 m -113.14 161.67 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 123.064 0.546 . . . . 73.299999999999997 111.484 -173.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -91.59 111.99 23.73 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.799 0.839 . . . . 64.400000000000006 109.482 174.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 54.4 t -109.88 126.22 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.023 0.929 . . . . 75.209999999999994 109.421 -176.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -77.36 100.94 6.11 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.353 0.661 . . . . 24.329999999999998 111.188 -173.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.528 ' HA ' HD12 ' A' ' 173' ' ' ILE . 59.9 t -77.29 134.81 66.48 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 124.93 1.292 . . . . 74.299999999999997 109.827 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.566 ' HD3' ' HB ' ' A' ' 173' ' ' ILE . 87.6 Cg_endo -75.03 170.3 20.71 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.523 2.149 . . . . 74.329999999999998 111.349 176.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.68 165.73 31.91 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 121.228 1.285 . . . . 73.329999999999998 111.259 169.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 63.39 22.97 13.52 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.781 0.832 . . . . 72.140000000000001 112.299 175.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 93.9 m -68.83 105.7 2.43 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.816 0.846 . . . . 42.240000000000002 109.634 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -105.51 141.45 36.97 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.259 1.024 . . . . 64.230000000000004 110.223 -171.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.74 136.89 58.2 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.474 1.11 . . . . 73.540000000000006 111.371 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 92.22 -9.22 76.7 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.499 -0.773 . . . . 75.420000000000002 113.435 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -84.86 144.22 28.55 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.995 0.518 . . . . 73.129999999999995 109.7 173.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.654 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.2 mppt? -110.66 129.47 55.81 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.508 0.723 . . . . 74.150000000000006 109.196 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.617 HD13 HG21 ' A' ' 173' ' ' ILE . 53.9 mt -95.03 101.35 13.1 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.831 0.852 . . . . 64.109999999999999 109.751 -173.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -72.35 105.29 4.03 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.333 0.653 . . . . 72.409999999999997 110.676 -176.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.484 HD21 HG23 ' A' ' 173' ' ' ILE . 17.8 mt -105.12 98.15 7.9 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.826 -1.176 . . . . 72.230000000000004 107.826 174.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -75.78 148.43 38.48 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 122.544 0.338 . . . . 74.099999999999994 111.349 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 72.03 33.68 62.29 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-N 115.757 -0.656 . . . . 75.319999999999993 113.272 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.13 -37.3 3.4 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.606 0.762 . . . . 71.239999999999995 111.338 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -68.72 -154.09 0.63 Allowed Glycine 0 C--N 1.355 1.631 0 N-CA-C 114.455 0.542 . . . . 72.439999999999998 114.455 -177.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.631 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 81.5 m-85 -66.66 144.71 98.74 Favored Pre-proline 0 N--CA 1.481 1.117 0 C-N-CA 122.81 0.444 . . . . 75.530000000000001 111.003 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.48 164.04 34.35 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.678 2.252 . . . . 72.109999999999999 113.317 178.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 172.75 -161.13 32.4 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 115.356 -0.838 . . . . 51.219999999999999 112.509 175.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -71.76 -10.54 26.61 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 123.125 2.55 . . . . 63.420000000000002 113.759 -177.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -99.72 19.33 16.12 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.638 0.775 . . . . 72.129999999999995 110.735 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 85.32 -100.8 2.47 Favored Glycine 0 C--N 1.347 1.168 0 N-CA-C 109.916 -1.274 . . . . 32.450000000000003 109.916 -171.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -127.42 159.85 33.24 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.623 -0.88 . . . . 73.129999999999995 108.623 165.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.8 -170.11 16.19 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-N 115.534 -0.757 . . . . 74.150000000000006 113.738 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -98.34 165.82 11.67 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.448 0.699 . . . . 71.209999999999994 109.291 -172.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 41.1 tp -141.58 105.24 4.7 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.515 -0.92 . . . . 72.120000000000005 108.515 175.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.654 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 33.0 m-85 -91.07 111.32 22.74 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.357 0.663 . . . . 74.420000000000002 109.899 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.554 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 48.5 mt -86.02 109.18 18.62 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.885 -0.783 . . . . 72.310000000000002 108.885 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -77.81 100.01 6.14 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.05 -0.977 . . . . 61.539999999999999 109.642 -173.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 48.6 t -57.84 111.45 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 O-C-N 123.963 0.789 . . . . 73.439999999999998 111.404 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 21.2 mmm-85 -115.48 98.93 7.01 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 106.818 -1.549 . . . . 65.400000000000006 106.818 171.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 36.5 mt -75.82 119.53 23.94 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 N-CA-C 109.45 -0.574 . . . . 75.219999999999999 109.45 -176.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 7.5 p . . . . . 0 C--O 1.261 1.689 0 C-N-CA 124.647 1.179 . . . . 73.049999999999997 108.867 -174.294 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 N--CA 1.483 1.21 0 N-CA-C 109.815 -0.439 . . . . 70.25 109.815 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 49.7 m -76.83 82.99 3.41 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.474 0.654 . . . . 75.140000000000001 109.778 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -144.84 118.57 9.23 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.104 -0.953 . . . . 74.299999999999997 108.542 -178.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 91.1 mt -80.33 71.18 7.12 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.488 0.661 . . . . 75.450000000000003 109.505 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.562 ' HA ' ' HB3' ' A' ' 222' ' ' ALA . 79.9 ttt180 -79.32 102.34 8.57 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.433 -0.803 . . . . 72.549999999999997 109.164 -178.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.599 HG23 HD21 ' A' ' 235' ' ' LEU . 68.3 mt -59.06 -64.68 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.343 0.657 . . . . 75.140000000000001 109.872 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . 54.43 24.14 5.01 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.703 1.201 . . . . 71.420000000000002 113.397 175.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.41 ' H ' HG22 ' A' ' 173' ' ' ILE . . . -80.09 -3.29 48.07 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.555 0.742 . . . . 74.109999999999999 111.885 -176.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.582 ' CE2' HD21 ' A' ' 233' ' ' LEU . 37.7 m-85 -87.14 4.89 40.46 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.246 0.618 . . . . 73.209999999999994 110.843 167.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -137.21 176.72 20.33 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 110.92 -0.872 . . . . 51.340000000000003 110.92 171.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.88 83.9 0.53 Allowed 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.657 2.238 . . . . 73.099999999999994 111.538 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -145.71 146.11 31.13 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.633 -0.712 . . . . 75.120000000000005 110.268 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 156.46 -85.43 0.13 Allowed Glycine 0 C--N 1.343 0.954 0 N-CA-C 109.05 -1.62 . . . . 72.329999999999998 109.05 -176.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 48.7 p -170.24 -49.45 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.998 0.919 . . . . 72.140000000000001 108.906 176.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 160.8 -155.85 27.09 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.028 -0.987 . . . . 51.240000000000002 111.136 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -87.06 -10.54 71.56 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-O 120.003 -0.332 . . . . 42.219999999999999 112.595 175.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 51.8 m -68.49 101.35 1.24 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.51 0.724 . . . . 73.439999999999998 110.847 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 160.5 -157.51 28.92 Favored Glycine 0 C--O 1.241 0.577 0 CA-C-N 114.853 -1.067 . . . . 63.039999999999999 111.19 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -160.82 87.37 0.11 Allowed Glycine 0 C--O 1.239 0.435 0 N-CA-C 109.827 -1.309 . . . . 65.239999999999995 109.827 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 53.7 m -63.52 92.75 0.07 Allowed 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.514 0.726 . . . . 73.230000000000004 111.213 -178.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 149.74 -167.2 29.85 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 115.393 -0.822 . . . . 55.119999999999997 111.85 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 91.91 -90.51 1.51 Allowed Glycine 0 C--N 1.339 0.713 0 N-CA-C 111.723 -0.551 . . . . 73.420000000000002 111.723 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 26.5 p -170.47 -22.11 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.556 0.742 . . . . 74.120000000000005 111.951 -172.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -72.93 -28.34 62.38 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.635 0.774 . . . . 74.420000000000002 110.844 -176.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -77.27 149.02 35.43 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.522 -0.763 . . . . 71.349999999999994 109.899 175.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 95.6 mt -134.94 156.5 48.89 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.29 0.636 . . . . 63.420000000000002 110.55 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -108.86 124.51 50.75 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.663 -0.866 . . . . 73.549999999999997 108.663 169.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -124.07 130.09 51.97 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.117 0.967 . . . . 62.520000000000003 108.829 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 14.7 m -68.92 121.25 16.22 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.365 0.666 . . . . 71.209999999999994 110.102 -177.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.426 HD22 ' HB3' ' A' ' 251' ' ' LEU . 35.0 tp -106.35 110.47 22.71 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.629 -1.248 . . . . 63.509999999999998 107.629 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -89.2 116.65 27.6 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.485 -0.931 . . . . 74.430000000000007 108.485 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.7 p -137.69 132.82 17.58 Favored Pre-proline 0 CA--C 1.546 0.794 0 N-CA-C 108.972 -0.751 . . . . 73.310000000000002 108.972 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -75.13 156.47 42.42 Favored 'Trans proline' 0 C--N 1.366 1.472 0 C-N-CA 121.924 1.75 . . . . 71.230000000000004 111.27 170.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.412 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -52.6 -45.27 96.23 Favored Pre-proline 0 CA--C 1.554 1.118 0 N-CA-C 114.347 1.24 . . . . 42.219999999999999 114.347 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.406 ' O ' HG12 ' A' ' 206' ' ' VAL . 24.6 Cg_endo -59.14 -50.79 7.88 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 121.658 1.572 . . . . 74.019999999999996 112.956 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 49.6 mt -65.94 -25.02 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.676 0.79 . . . . 74.319999999999993 111.077 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.95 -46.44 62.41 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 122.848 0.459 . . . . 73.219999999999999 111.275 177.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 201' ' ' ALA . 87.7 t -64.46 -52.7 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 122.991 0.516 . . . . 72.129999999999995 111.442 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 202' ' ' PRO . 11.8 p -84.17 -34.32 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 112.04 0.385 . . . . 73.200000000000003 112.04 -174.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 84.49 89.3 0.82 Allowed Glycine 0 C--N 1.335 0.483 0 CA-C-N 116.561 -0.291 . . . . 43.030000000000001 112.507 -171.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -106.39 -135.13 7.93 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 111.05 -0.82 . . . . 61.409999999999997 111.05 172.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -128.97 144.26 51.13 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 108.783 -0.821 . . . . 52.039999999999999 108.783 174.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.44 HG11 ' HA ' ' A' ' 199' ' ' VAL . 33.7 m -134.11 162.07 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.116 0.566 . . . . 64.329999999999998 110.333 176.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 69.0 ttt-85 -74.44 135.53 42.33 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.112 0.565 . . . . 73.109999999999999 109.979 172.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -140.7 151.26 44.39 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.702 0.801 . . . . 73.209999999999994 109.565 177.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -80.63 122.34 26.96 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.962 -0.755 . . . . 74.219999999999999 108.962 176.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.416 HG22 ' H ' ' A' ' 216' ' ' GLU . 95.9 m -131.84 164.35 26.26 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 107.909 -1.145 . . . . 74.230000000000004 107.909 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 73.0 mt -63.86 -11.31 26.44 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.296 0.639 . . . . 54.109999999999999 112.069 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.416 ' H ' HG22 ' A' ' 214' ' ' THR . 40.9 mt-10 -103.43 17.74 23.41 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.817 1.247 . . . . 75.439999999999998 110.886 176.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 87.12 -161.99 33.38 Favored Glycine 0 C--N 1.349 1.281 0 CA-C-O 119.463 -0.632 . . . . 72.200000000000003 113.182 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -74.04 121.94 7.28 Favored 'Trans proline' 0 C--N 1.372 1.805 0 C-N-CA 122.505 2.137 . . . . 73.319999999999993 111.715 177.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.91 158.92 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.882 0.873 . . . . 65.310000000000002 110.402 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -90.42 108.93 20.09 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.873 0.469 . . . . 63.210000000000001 109.814 173.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 25.1 t -97.49 129.69 47.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 108.819 -0.808 . . . . 74.519999999999996 108.819 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.562 ' HB3' ' HA ' ' A' ' 172' ' ' ARG . . . -73.02 100.44 2.99 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.267 0.627 . . . . 64.010000000000005 110.586 -178.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.529 ' HA ' HD12 ' A' ' 173' ' ' ILE . 50.9 t -64.27 139.43 97.7 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 125.254 1.421 . . . . 73.25 109.94 178.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.454 ' HD3' HD12 ' A' ' 173' ' ' ILE . 6.3 Cg_exo -73.37 168.64 24.24 Favored 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 122.684 2.256 . . . . 71.219999999999999 111.548 173.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -73.82 172.92 14.87 Favored 'Trans proline' 0 CA--C 1.55 1.319 0 C-N-CA 121.453 1.435 . . . . 75.450000000000003 110.716 164.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 44.8 mtt180 66.12 6.34 4.09 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 124.684 1.194 . . . . 65.329999999999998 112.722 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.447 ' O ' HD11 ' A' ' 255' ' ' ILE . 94.4 m -59.91 110.54 1.2 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.375 0.67 . . . . 74.540000000000006 110.823 -170.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.494 ' HB3' ' HD3' ' A' ' 231' ' ' ARG . 60.1 tt0 -117.47 134.44 54.85 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.974 1.31 . . . . 74.549999999999997 110.328 -164.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.6 128.23 35.6 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.369 1.068 . . . . 71.430000000000007 112.444 -173.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.41 -9.85 62.93 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-N 115.915 -0.584 . . . . 54.299999999999997 113.119 177.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.494 ' HD3' ' HB3' ' A' ' 228' ' ' GLN . 76.2 mtp180 -89.41 158.55 17.7 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.079 0.552 . . . . 70.439999999999998 110.728 176.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.428 ' HG3' ' HA ' ' A' ' 252' ' ' GLU . 0.0 OUTLIER -131.34 144.11 51.0 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.088 0.555 . . . . 54.130000000000003 110.734 -174.036 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.582 HD21 ' CE2' ' A' ' 176' ' ' TYR . 44.6 mt -117.46 102.27 9.07 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.723 -0.672 . . . . 62.009999999999998 110.726 -164.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.419 ' HG3' ' HB3' ' A' ' 248' ' ' ASP . 51.1 ttp180 -79.78 113.92 18.3 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.833 0.853 . . . . 74.409999999999997 110.935 -173.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.599 HD21 HG23 ' A' ' 173' ' ' ILE . 43.0 mt -112.38 96.95 6.3 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.574 0.75 . . . . 74.549999999999997 109.304 177.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -62.86 140.84 58.83 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.859 -0.61 . . . . 75.099999999999994 111.379 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 81.17 25.36 55.37 Favored Glycine 0 C--N 1.339 0.741 0 O-C-N 124.259 0.975 . . . . 74.140000000000001 114.508 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.78 -28.25 6.02 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.152 0.581 . . . . 72.230000000000004 111.306 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -74.63 -169.66 23.2 Favored Glycine 0 CA--C 1.535 1.339 0 O-C-N 123.399 0.437 . . . . 51.299999999999997 112.848 173.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -65.43 143.33 98.68 Favored Pre-proline 0 N--CA 1.486 1.339 0 C-N-CA 123.693 0.797 . . . . 71.409999999999997 111.495 -175.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.5 128.74 30.59 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.735 2.29 . . . . 72.109999999999999 112.076 175.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.59 -179.06 16.02 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-O 119.739 -0.479 . . . . 54.299999999999997 112.748 -176.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.17 -44.86 42.58 Favored 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 123.78 2.987 . . . . 62.25 113.289 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -94.0 20.15 8.2 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.106 0.563 . . . . 63.420000000000002 111.608 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 102.66 -176.74 25.3 Favored Glycine 0 C--N 1.348 1.246 0 C-N-CA 123.451 0.548 . . . . 75.109999999999999 111.948 -176.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 57.6 mtt85 -63.35 148.89 47.14 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.048 0.539 . . . . 63.030000000000001 110.478 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -71.79 -173.11 17.9 Favored Glycine 0 C--N 1.344 1.021 0 O-C-N 123.545 0.528 . . . . 75.120000000000005 113.565 -176.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.419 ' HB3' ' HG3' ' A' ' 234' ' ' ARG . 3.3 m-20 -98.67 157.88 15.98 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.805 -0.813 . . . . 73.150000000000006 108.805 -176.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 32.9 tp -125.9 106.49 9.69 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.102 -1.073 . . . . 74.549999999999997 108.102 172.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -89.68 107.47 19.11 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.857 -0.794 . . . . 72.340000000000003 108.857 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.426 ' HB3' HD22 ' A' ' 197' ' ' LEU . 62.3 mt -87.77 106.71 18.25 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.453 -0.944 . . . . 75.040000000000006 108.453 176.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.428 ' HA ' ' HG3' ' A' ' 232' ' ' LYS . 22.7 mt-10 -79.07 105.9 10.73 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 114.894 -1.048 . . . . 73.129999999999995 110.153 -173.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 83.4 t -60.15 107.45 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.693 0 O-C-N 124.169 0.918 . . . . 75.299999999999997 111.48 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -115.27 93.92 4.5 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 107.91 -1.144 . . . . 73.310000000000002 107.91 173.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.464 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 54.5 mt -76.65 132.5 32.83 Favored 'Isoleucine or valine' 0 C--N 1.351 0.671 0 CA-C-N 115.464 -0.789 . . . . 54.530000000000001 109.93 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 32.4 p . . . . . 0 C--O 1.253 1.237 0 C-N-CA 124.671 1.188 . . . . 72.420000000000002 108.694 -179.165 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 54.0 ttm . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 109.255 -0.646 . . . . 72.230000000000004 109.255 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.5 m -70.11 110.42 5.13 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 115.344 -0.843 . . . . 73.040000000000006 110.325 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -79.24 -65.06 1.05 Allowed 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 109.451 -0.574 . . . . 61.340000000000003 109.451 172.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.6 mt -106.88 97.68 7.44 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.259 -0.645 . . . . 73.329999999999998 109.259 173.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -77.7 122.08 24.88 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 108.144 -1.058 . . . . 73.109999999999999 108.144 173.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.686 HG22 ' H ' ' A' ' 175' ' ' ALA . 63.8 mt -72.46 -75.49 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 109.793 -0.447 . . . . 64.319999999999993 109.793 177.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . 59.56 11.23 2.24 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 124.596 1.159 . . . . 71.310000000000002 113.659 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.686 ' H ' HG22 ' A' ' 173' ' ' ILE . . . -75.57 -14.1 60.38 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.79 0.836 . . . . 73.140000000000001 111.166 177.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.461 ' CE2' HD21 ' A' ' 233' ' ' LEU . 6.2 m-85 -66.1 -17.73 64.89 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.787 0.835 . . . . 75.129999999999995 111.323 169.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -131.17 179.76 16.76 Favored Glycine 0 C--N 1.346 1.098 0 N-CA-C 111.411 -0.675 . . . . 74.319999999999993 111.411 174.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -72.53 81.8 1.5 Allowed 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 122.397 2.065 . . . . 63.399999999999999 112.358 177.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -76.25 99.0 4.61 Favored 'General case' 0 C--N 1.351 0.672 0 CA-C-N 115.743 -0.662 . . . . 74.319999999999993 109.698 175.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 163.65 -164.28 36.22 Favored Glycine 0 C--O 1.243 0.659 0 CA-C-N 115.189 -0.914 . . . . 43.329999999999998 111.646 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 22.7 t -174.24 -178.93 1.52 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.226 1.01 . . . . 72.219999999999999 109.136 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 93.83 -72.9 1.2 Allowed Glycine 0 C--N 1.347 1.155 0 N-CA-C 111.43 -0.668 . . . . 40.130000000000003 111.43 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -178.53 -67.0 0.06 OUTLIER Glycine 0 C--N 1.343 0.936 0 N-CA-C 111.226 -0.75 . . . . 45.310000000000002 111.226 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 20.9 t -168.35 159.47 10.61 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.026 0.93 . . . . 64.219999999999999 109.754 176.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -116.99 -178.22 17.81 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 116.12 -0.491 . . . . 75.109999999999999 112.235 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -88.26 148.91 20.98 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-O 119.905 -0.386 . . . . 62.509999999999998 112.4 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 46.7 t -62.48 134.9 57.07 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.885 0.874 . . . . 63.210000000000001 111.157 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -170.21 98.68 0.14 Allowed Glycine 0 C--N 1.352 1.469 0 N-CA-C 111.994 -0.442 . . . . 43.130000000000003 111.994 -177.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -138.34 92.66 0.2 Allowed Glycine 0 C--N 1.343 0.968 0 C-N-CA 123.146 0.403 . . . . 73.219999999999999 112.126 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 66.6 m -155.43 167.15 31.32 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.569 1.148 . . . . 63.539999999999999 109.532 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 60.96 26.02 15.98 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 124.365 1.066 . . . . 74.409999999999997 110.762 -174.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -83.77 159.15 21.5 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.541 -1.209 . . . . 75.299999999999997 112.631 -169.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.5 mt -143.68 138.01 28.62 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.097 0.959 . . . . 72.430000000000007 109.614 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -93.04 125.72 37.77 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.483 -1.303 . . . . 72.230000000000004 107.483 164.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -124.24 133.06 53.61 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.369 -0.604 . . . . 74.439999999999998 109.369 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' THR . . . . . 0.589 HG23 ' HG3' ' A' ' 254' ' ' ARG . 42.9 m -65.94 122.16 16.72 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 124.038 0.836 . . . . 63.32 109.77 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 40.3 tp -109.28 108.8 19.52 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.018 -1.475 . . . . 71.209999999999994 107.018 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -95.7 103.09 14.95 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 122.098 0.951 . . . . 62.140000000000001 109.225 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 2.8 p -120.12 117.41 32.05 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-N 114.569 -1.196 . . . . 73.030000000000001 109.02 -174.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.9 154.59 73.33 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 122.136 1.891 . . . . 72.239999999999995 111.579 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -48.04 -45.25 63.24 Favored Pre-proline 0 CA--C 1.565 1.554 0 N-CA-C 114.713 1.375 . . . . 34.340000000000003 114.713 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.438 ' O ' HG22 ' A' ' 206' ' ' VAL . 26.1 Cg_endo -59.72 -50.85 7.03 Favored 'Trans proline' 0 C--N 1.399 3.187 0 C-N-CA 121.425 1.416 . . . . 71.150000000000006 112.227 176.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.7 mt -70.0 -23.24 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 123.672 0.789 . . . . 65.329999999999998 111.263 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.59 -51.06 46.63 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 122.923 0.489 . . . . 65.400000000000006 110.166 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 84.5 t -67.0 -48.69 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 CA-C-N 115.606 -0.725 . . . . 71.209999999999994 111.866 -177.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 202' ' ' PRO . 33.9 m -89.9 -23.04 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 113.313 0.857 . . . . 74.530000000000001 113.313 -174.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.78 149.69 24.37 Favored Glycine 0 N--CA 1.477 1.385 0 N-CA-C 112.15 -0.38 . . . . 72.109999999999999 112.15 -173.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 163.97 175.61 35.02 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 116.927 0.363 . . . . 55.310000000000002 112.282 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 221' ' ' VAL . 50.2 mtmt -82.12 135.66 35.27 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.872 0.469 . . . . 72.349999999999994 110.226 -177.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.465 HG11 ' HA ' ' A' ' 199' ' ' VAL . 33.9 m -138.94 170.03 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 123.84 0.856 . . . . 65.329999999999998 110.686 176.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -68.55 130.58 43.26 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.532 -0.758 . . . . 65.409999999999997 111.067 175.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -135.68 118.14 15.8 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.768 -0.827 . . . . 74.239999999999995 108.768 168.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 55.8 mtt -73.0 105.93 4.67 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.211 0.605 . . . . 64.409999999999997 109.874 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 25.6 m -110.03 171.46 7.44 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.88 1.272 . . . . 53.210000000000001 108.61 -175.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 85.8 mt -57.45 -35.33 70.0 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.576 0.75 . . . . 63.119999999999997 112.212 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -79.4 -11.02 59.92 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.803 0.841 . . . . 70.420000000000002 112.464 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 125.08 -179.33 16.2 Favored Glycine 0 N--CA 1.47 0.956 0 N-CA-C 111.121 -0.791 . . . . 61.43 111.121 -174.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.64 129.41 21.07 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 122.5 2.134 . . . . 74.239999999999995 110.997 176.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.474 HG23 HG23 ' A' ' 221' ' ' VAL . 29.5 m -123.29 162.26 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.777 0.831 . . . . 74.409999999999997 110.61 -174.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -90.58 106.04 18.23 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.692 0.758 . . . . 71.329999999999998 109.7 174.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.474 HG23 HG23 ' A' ' 219' ' ' VAL . 94.8 t -101.71 121.72 53.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 115.214 -0.903 . . . . 65.030000000000001 109.569 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.02 99.69 3.38 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 123.489 0.715 . . . . 52.539999999999999 110.009 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.401 ' HA ' HD12 ' A' ' 173' ' ' ILE . 31.1 t -84.53 132.64 46.3 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 114.547 -1.206 . . . . 74.530000000000001 109.172 178.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.443 ' HD3' ' HB ' ' A' ' 173' ' ' ILE . 60.3 Cg_endo -69.42 170.05 17.06 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.862 2.375 . . . . 74.140000000000001 111.23 171.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.27 -174.43 0.26 Allowed 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.536 2.157 . . . . 62.32 113.563 174.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 38.5 mtp85 62.39 19.5 11.16 Favored 'General case' 0 N--CA 1.502 2.172 0 C-N-CA 125.137 1.375 . . . . 74.310000000000002 112.172 172.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.448 ' HA ' ' CZ ' ' A' ' 176' ' ' TYR . 55.5 m -71.82 99.18 2.12 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.965 0.906 . . . . 73.430000000000007 111.088 -171.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -98.55 134.94 40.81 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.255 1.422 . . . . 75.439999999999998 110.1 -175.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.67 146.22 54.21 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.25 0.62 . . . . 53.200000000000003 111.217 -178.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 96.73 -26.74 20.81 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-N 115.182 -0.917 . . . . 64.109999999999999 112.78 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -69.85 154.28 42.17 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 117.2 0.5 . . . . 74.209999999999994 111.12 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -130.32 142.92 50.51 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 108.176 -1.046 . . . . 71.510000000000005 108.176 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.63 HD13 HG21 ' A' ' 173' ' ' ILE . 27.4 mt -120.38 105.82 11.26 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.781 -0.645 . . . . 71.200000000000003 110.101 -165.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -73.23 102.86 3.76 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.744 0.818 . . . . 74.109999999999999 110.463 -174.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.602 HD21 HG23 ' A' ' 173' ' ' ILE . 37.3 mt -112.49 92.88 4.18 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.097 -0.705 . . . . 74.430000000000007 109.097 177.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.41 ' HG2' ' HB3' ' A' ' 248' ' ' ASP . 47.0 mtmt -69.59 144.26 53.07 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 122.293 0.237 . . . . 75.230000000000004 110.735 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 80.81 29.75 41.6 Favored Glycine 0 C--N 1.342 0.912 0 O-C-N 123.73 0.644 . . . . 30.34 113.432 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 249' ' ' LEU . 72.0 mmtt -123.33 -28.33 3.98 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 117.577 0.689 . . . . 73.140000000000001 112.11 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -72.02 -145.83 0.53 Allowed Glycine 0 N--CA 1.481 1.667 0 C-N-CA 123.111 0.386 . . . . 51.219999999999999 113.867 -177.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -76.65 149.5 80.97 Favored Pre-proline 0 N--CA 1.486 1.36 0 O-C-N 122.272 -0.546 . . . . 63.340000000000003 110.874 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -60.6 145.15 99.33 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.746 2.297 . . . . 75.230000000000004 112.361 174.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -167.25 -155.39 9.1 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 115.866 -0.606 . . . . 62.530000000000001 112.375 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -80.47 1.03 9.59 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 123.543 2.829 . . . . 51.140000000000001 113.336 -174.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -120.48 22.16 11.36 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.947 0.899 . . . . 72.230000000000004 110.352 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 91.6 -92.32 1.71 Allowed Glycine 0 C--N 1.348 1.244 0 N-CA-C 110.945 -0.862 . . . . 54.100000000000001 110.945 -174.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -126.12 169.43 12.81 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.43 -0.952 . . . . 71.049999999999997 108.43 167.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.84 -175.75 46.91 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.982 -0.553 . . . . 73.319999999999993 113.885 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.41 ' HB3' ' HG2' ' A' ' 236' ' ' LYS . 3.6 p-10 -100.54 127.2 46.98 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.404 0.621 . . . . 74.219999999999999 110.057 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 238' ' ' LYS . 35.1 tp -99.95 110.91 23.23 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 107.845 -1.168 . . . . 70.209999999999994 107.845 -178.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -86.03 108.2 18.14 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.474 -1.306 . . . . 73.340000000000003 107.474 174.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 27.1 mt -84.2 105.13 14.82 Favored 'General case' 0 C--N 1.34 0.189 0 N-CA-C 107.775 -1.194 . . . . 63.020000000000003 107.775 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -77.18 103.23 6.99 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.649 -1.614 . . . . 61.420000000000002 108.966 -177.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 63.7 t -59.65 115.61 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 123.72 0.808 . . . . 72.519999999999996 110.722 177.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.589 ' HG3' HG23 ' A' ' 196' ' ' THR . 54.5 mmm-85 -125.64 97.1 5.03 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.001 -1.481 . . . . 73.150000000000006 107.001 177.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 54.8 mt -76.71 119.31 24.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 CA-C-N 116.232 -0.44 . . . . 72.349999999999994 110.197 -174.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 44.2 p . . . . . 0 C--O 1.255 1.344 0 C-N-CA 124.425 1.09 . . . . 63.439999999999998 108.185 177.785 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 24.9 mmt . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 109.696 -0.483 . . . . 71.530000000000001 109.696 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 15.2 m -69.45 -26.66 64.7 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.448 0.699 . . . . 71.510000000000005 112.207 -173.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.406 ' O ' ' HD3' ' A' ' 238' ' ' LYS . 79.7 mm-40 61.54 75.64 0.4 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.011 1.324 . . . . 63.119999999999997 111.923 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.9 mp -91.78 12.51 21.15 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.93 0.892 . . . . 70.439999999999998 110.557 175.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -63.21 124.2 20.6 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.929 0.891 . . . . 74.329999999999998 110.675 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.688 ' HA ' HD22 ' A' ' 235' ' ' LEU . 73.5 mt -78.53 105.99 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 115.583 -0.735 . . . . 71.420000000000002 110.678 -174.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -66.46 -28.92 68.97 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 114.749 -1.114 . . . . 74.310000000000002 111.119 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -74.79 170.48 15.8 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.959 0.904 . . . . 71.549999999999997 112.143 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 64.76 23.3 12.7 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.682 1.193 . . . . 61.310000000000002 112.103 177.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 174.15 145.48 5.24 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 118.791 -1.005 . . . . 70.5 110.727 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -65.41 97.54 0.31 Allowed 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.764 2.309 . . . . 74.319999999999993 111.424 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -75.1 -40.43 59.97 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.255 -0.884 . . . . 73.340000000000003 109.687 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 178.74 -171.44 43.62 Favored Glycine 0 C--N 1.34 0.773 0 CA-C-N 115.314 -0.857 . . . . 70.310000000000002 111.715 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 34.8 p -87.45 -7.42 57.67 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.486 0.714 . . . . 61.200000000000003 111.254 176.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 100.87 87.97 1.99 Allowed Glycine 0 C--N 1.347 1.179 0 N-CA-C 111.708 -0.557 . . . . 34.399999999999999 111.708 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -74.88 73.91 1.43 Allowed Glycine 0 C--N 1.35 1.319 0 N-CA-C 111.395 -0.682 . . . . 62.130000000000003 111.395 173.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 40.6 t -158.82 165.17 34.87 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.559 1.144 . . . . 62.350000000000001 109.454 -172.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 161.68 -107.21 0.3 Allowed Glycine 0 C--N 1.348 1.208 0 N-CA-C 111.908 -0.477 . . . . 74.329999999999998 111.908 177.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.01 -11.55 28.15 Favored Glycine 0 CA--C 1.54 1.632 0 CA-C-O 119.72 -0.489 . . . . 75.099999999999994 114.3 176.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 37.8 m 57.01 82.94 0.11 Allowed 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.879 1.272 . . . . 71.430000000000007 111.472 -173.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -165.92 -105.83 0.19 Allowed Glycine 0 C--N 1.342 0.912 0 N-CA-C 110.823 -0.911 . . . . 64.349999999999994 110.823 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -151.47 158.68 27.86 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 111.761 -0.535 . . . . 53.420000000000002 111.761 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 18.9 m -92.59 121.44 34.02 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.775 0.83 . . . . 65.200000000000003 108.987 174.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.517 ' HB3' ' HB2' ' A' ' 240' ' ' PHE . 82.3 mm-40 -82.54 56.96 3.5 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.233 0.613 . . . . 62.450000000000003 110.186 175.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -91.55 142.35 27.73 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.485 -0.779 . . . . 72.450000000000003 110.657 -175.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 96.2 mt -133.52 153.64 51.48 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.583 0.753 . . . . 63.539999999999999 110.244 -178.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -104.14 121.66 43.71 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 108.748 -0.834 . . . . 75.310000000000002 108.748 174.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -125.69 133.22 52.22 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.553 1.141 . . . . 74.310000000000002 109.117 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 39.3 m -65.51 139.38 58.48 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.473 0.709 . . . . 52.43 111.322 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.487 HD13 HD13 ' A' ' 251' ' ' LEU . 26.3 tp -115.17 122.57 46.45 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 123.837 0.855 . . . . 74.25 109.199 176.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -89.52 106.08 18.22 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.273 -0.64 . . . . 70.510000000000005 109.273 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.618 HG11 HG13 ' A' ' 253' ' ' VAL . 6.4 p -129.56 131.36 23.54 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 122.86 0.464 . . . . 72.420000000000002 110.042 178.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.414 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 55.8 Cg_endo -74.46 157.64 44.86 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 121.943 1.762 . . . . 43.310000000000002 111.404 169.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.448 ' HA ' HG23 ' A' ' 255' ' ' ILE . . . -50.95 -48.97 83.23 Favored Pre-proline 0 CA--C 1.57 1.732 0 CA-C-O 117.949 -1.024 . . . . 53.219999999999999 113.652 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.479 ' O ' HG12 ' A' ' 206' ' ' VAL . 28.7 Cg_endo -60.91 -51.52 4.65 Favored 'Trans proline' 0 C--N 1.402 3.371 0 C-N-CA 121.529 1.486 . . . . 75.409999999999997 111.945 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.4 mt -62.83 -26.47 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 123.599 0.76 . . . . 65.430000000000007 111.32 -176.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.3 -52.99 33.81 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-O 120.953 0.406 . . . . 73.200000000000003 110.8 174.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 90.0 t -67.94 -43.99 85.39 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 N-CA-C 112.675 0.62 . . . . 75.439999999999998 112.675 -175.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 202' ' ' PRO . 11.0 p -99.92 -21.66 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 122.857 0.463 . . . . 72.209999999999994 112.183 -173.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.66 144.67 11.41 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 112.229 -0.348 . . . . 62.43 112.229 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -177.25 -140.35 3.63 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-O 119.224 -0.765 . . . . 74.439999999999998 111.898 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -116.94 143.34 45.82 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 118.005 0.902 . . . . 73.239999999999995 109.208 176.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 34.4 m -139.83 169.87 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 123.457 0.703 . . . . 61.450000000000003 111.352 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -90.12 114.12 26.0 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.12 0.568 . . . . 72.299999999999997 110.343 173.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.44 127.12 52.06 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.111 -1.07 . . . . 72.239999999999995 108.111 165.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 89.8 mmm -81.58 104.97 12.37 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.215 -0.661 . . . . 60.039999999999999 109.215 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 87.4 m -113.4 162.03 16.59 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.572 1.149 . . . . 73.140000000000001 109.76 -176.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 87.3 mt -58.0 -16.67 13.39 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.035 0.934 . . . . 70.530000000000001 112.986 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -103.7 29.25 5.89 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.037 0.935 . . . . 73.519999999999996 110.924 175.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 86.9 -165.38 36.31 Favored Glycine 0 C--N 1.348 1.231 0 CA-C-N 116.237 -0.438 . . . . 74.439999999999998 113.442 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -72.54 121.65 7.6 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.78 2.32 . . . . 55.100000000000001 111.395 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.4 m -121.15 147.8 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.821 0.849 . . . . 73.209999999999994 109.96 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 9.8 pt-20 -90.49 113.93 26.0 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.285 0.564 . . . . 72.430000000000007 110.949 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 63.9 t -102.83 132.2 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.283 0.633 . . . . 71.540000000000006 109.452 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -78.94 99.99 7.06 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 123.657 0.783 . . . . 65.549999999999997 109.765 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 74.5 t -80.03 134.02 56.93 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.317 1.047 . . . . 55.240000000000002 110.201 178.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.42 170.96 18.96 Favored 'Trans proline' 0 C--N 1.383 2.36 0 C-N-CA 122.939 2.426 . . . . 72.239999999999995 111.372 172.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -65.01 175.22 3.98 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 121.869 1.713 . . . . 72.140000000000001 113.47 172.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 72.31 5.33 5.26 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 125.248 1.419 . . . . 71.040000000000006 112.844 174.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 87.6 m -69.42 127.63 33.72 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.156 0.583 . . . . 75.510000000000005 110.913 -172.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -127.14 142.34 51.53 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.817 0.847 . . . . 71.519999999999996 110.809 -167.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.421 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -65.05 132.37 49.03 Favored 'General case' 0 C--N 1.348 0.543 0 C-N-CA 124.108 0.963 . . . . 73.239999999999995 110.767 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.13 -14.7 63.46 Favored Glycine 0 N--CA 1.468 0.77 0 O-C-N 123.994 0.809 . . . . 75.310000000000002 112.223 -178.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 78.2 mtt-85 -84.12 142.31 30.47 Favored 'General case' 0 C--N 1.351 0.65 0 N-CA-C 109.233 -0.654 . . . . 73.219999999999999 109.233 173.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.58 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.0 mppt? -110.64 130.88 55.46 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.786 -0.82 . . . . 74.340000000000003 108.786 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.577 HD13 HD13 ' A' ' 173' ' ' ILE . 27.1 mt -84.18 99.4 10.5 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.193 -1.04 . . . . 64.319999999999993 108.193 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -72.97 102.0 3.36 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.069 0.548 . . . . 74.109999999999999 109.956 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.688 HD22 ' HA ' ' A' ' 173' ' ' ILE . 14.0 mt -105.1 95.34 5.77 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.977 -0.749 . . . . 75.439999999999998 108.977 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -62.64 145.26 55.01 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 120.827 0.346 . . . . 63.240000000000002 111.452 176.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 74.58 19.78 79.76 Favored Glycine 0 C--N 1.344 0.985 0 CA-C-N 115.096 -0.956 . . . . 73.230000000000004 113.644 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.406 ' HD3' ' O ' ' A' ' 170' ' ' GLN . 31.1 mmmt -122.16 -11.17 8.47 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.426 0.691 . . . . 63.43 112.115 -176.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -77.98 -169.36 33.88 Favored Glycine 0 C--N 1.343 0.971 0 N-CA-C 111.842 -0.503 . . . . 40.420000000000002 111.842 167.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.517 ' HB2' ' HB3' ' A' ' 191' ' ' GLN . 18.0 m-30 -72.57 155.75 90.77 Favored Pre-proline 0 N--CA 1.483 1.201 0 CA-C-N 116.855 0.327 . . . . 71.129999999999995 110.995 -179.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.26 155.13 70.45 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.557 2.171 . . . . 72.420000000000002 112.987 175.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -173.04 -168.23 34.01 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-N 115.384 -0.825 . . . . 62.049999999999997 111.929 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -60.94 -23.83 78.08 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.452 2.768 . . . . 73.0 112.661 174.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -87.27 20.14 2.91 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.131 0.972 . . . . 63.020000000000003 111.94 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 79.22 -94.36 1.36 Allowed Glycine 0 C--N 1.349 1.302 0 N-CA-C 110.321 -1.112 . . . . 51.25 110.321 -173.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 42.8 mtt180 -128.48 159.46 35.36 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.598 -0.889 . . . . 61.130000000000003 108.598 164.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -83.25 -165.82 38.62 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 116.014 -0.539 . . . . 53.310000000000002 112.811 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.54 164.83 12.1 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.921 0.888 . . . . 74.230000000000004 109.516 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 33.7 tp -134.99 107.76 7.49 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 107.793 -1.188 . . . . 72.420000000000002 107.793 173.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.58 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 73.5 m-85 -88.92 111.16 21.77 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.466 0.706 . . . . 60.130000000000003 109.608 -178.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.487 HD13 HD13 ' A' ' 197' ' ' LEU . 63.9 mt -86.46 104.33 15.83 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 107.998 -1.112 . . . . 74.519999999999996 107.998 174.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -78.95 97.58 6.1 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.38 -0.97 . . . . 75.129999999999995 108.38 -173.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.618 HG13 HG11 ' A' ' 199' ' ' VAL . 81.8 t -57.91 109.63 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-N 114.256 -1.338 . . . . 63.219999999999999 112.084 -175.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -105.03 97.93 7.71 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 124.281 1.033 . . . . 74.420000000000002 108.756 172.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.448 HG23 ' HA ' ' A' ' 201' ' ' ALA . 32.9 mt -77.56 126.92 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 123.651 0.594 . . . . 74.450000000000003 109.623 177.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 9.5 p . . . . . 0 CA--C 1.556 1.199 0 C-N-CA 124.677 1.191 . . . . 71.150000000000006 109.006 -178.389 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 121.17 0.509 . . . . 62.549999999999997 109.992 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 33.4 t -173.55 118.24 0.28 Allowed 'General case' 0 C--O 1.246 0.875 0 C-N-CA 124.844 1.258 . . . . 65.310000000000002 108.073 177.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -68.95 -58.66 3.82 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.271 -0.64 . . . . 63.200000000000003 109.271 175.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.564 HD13 HG22 ' A' ' 221' ' ' VAL . 3.2 pp -74.35 123.69 25.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.535 -0.757 . . . . 72.25 111.436 -176.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -143.81 150.18 38.14 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.718 1.207 . . . . 65.439999999999998 108.613 175.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.854 ' HA ' HD22 ' A' ' 235' ' ' LEU . 22.6 mt -92.61 106.43 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 120.993 0.425 . . . . 63.539999999999999 111.092 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -86.82 -21.37 26.49 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.25 1.02 . . . . 71.409999999999997 111.257 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -72.87 165.1 25.57 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.51 0.724 . . . . 74.129999999999995 111.182 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.42 ' HE1' ' HA ' ' A' ' 227' ' ' THR . 2.7 m-85 70.84 5.04 5.29 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 125.035 1.334 . . . . 74.549999999999997 113.423 176.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -163.09 55.0 0.29 Allowed Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.201 -0.777 . . . . 73.439999999999998 111.807 171.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -83.69 174.33 8.75 Favored 'Trans proline' 0 C--N 1.383 2.374 0 C-N-CA 122.082 1.855 . . . . 75.099999999999994 111.49 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -98.77 41.96 1.12 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.463 0.705 . . . . 62.420000000000002 109.763 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.65 -56.2 5.04 Favored Glycine 0 C--N 1.351 1.404 0 CA-C-N 115.382 -0.826 . . . . 62.229999999999997 112.642 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 21.9 t -162.04 -171.08 2.72 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.012 0.925 . . . . 64.329999999999998 109.376 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -170.06 -15.24 0.02 OUTLIER Glycine 0 CA--C 1.525 0.698 0 N-CA-C 112.038 -0.425 . . . . 73.319999999999993 112.038 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 158.58 -148.96 18.86 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 111.244 -0.742 . . . . 54.130000000000003 111.244 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 39.8 t -73.16 -28.61 62.33 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.64 0.776 . . . . 54.119999999999997 110.617 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 98.28 -26.92 21.72 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-N 116.214 -0.448 . . . . 62.100000000000001 112.45 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 78.63 4.28 87.57 Favored Glycine 0 C--N 1.354 1.572 0 C-N-CA 122.774 0.226 . . . . 63.409999999999997 113.276 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 50.4 p -92.1 123.41 35.43 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.188 0.995 . . . . 71.340000000000003 110.237 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -165.24 35.89 0.27 Allowed Glycine 0 C--N 1.342 0.89 0 CA-C-N 116.3 -0.409 . . . . 74.510000000000005 112.877 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 67.97 43.71 81.23 Favored Glycine 0 C--N 1.346 1.12 0 C-N-CA 123.529 0.585 . . . . 44.299999999999997 113.646 177.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 35.8 m -143.49 -76.34 0.25 Allowed 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 117.468 0.634 . . . . 73.530000000000001 110.737 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -72.68 -41.4 65.38 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 109.336 -0.616 . . . . 73.420000000000002 109.336 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -75.59 147.29 39.72 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 114.954 -1.021 . . . . 64.420000000000002 109.936 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 96.0 mt -129.09 166.6 18.96 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.492 0.717 . . . . 73.430000000000007 110.289 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -119.65 145.34 46.55 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.388 1.075 . . . . 72.120000000000005 108.809 173.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.15 158.03 43.84 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.291 1.036 . . . . 53.539999999999999 108.562 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 16.5 m -92.46 130.83 38.02 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 122.68 0.392 . . . . 70.519999999999996 109.943 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 57.1 tp -111.99 126.11 54.79 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.724 0.809 . . . . 74.439999999999998 109.684 176.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -93.57 125.43 38.17 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.219 0.608 . . . . 63.509999999999998 109.368 170.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 6.5 p -144.94 133.76 11.04 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 124.045 0.938 . . . . 72.129999999999995 108.65 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.91 157.81 38.85 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.075 1.85 . . . . 74.329999999999998 111.29 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.22 -48.29 92.84 Favored Pre-proline 0 CA--C 1.555 1.173 0 N-CA-C 113.309 0.855 . . . . 51.219999999999999 113.309 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.528 ' O ' HG12 ' A' ' 206' ' ' VAL . 52.4 Cg_exo -56.13 -56.12 2.36 Favored 'Trans proline' 0 C--N 1.395 2.995 0 C-N-CA 121.836 1.691 . . . . 51.420000000000002 113.028 176.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 57.7 mt -60.91 -30.22 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 C-N-CA 122.717 0.407 . . . . 64.430000000000007 110.829 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.449 ' HB1' ' O ' ' A' ' 227' ' ' THR . . . -63.61 -53.55 49.87 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 122.927 0.491 . . . . 53.009999999999998 111.038 178.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 32.3 t -78.91 -42.4 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 116.154 -0.476 . . . . 42.450000000000003 112.175 -172.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 202' ' ' PRO . 9.9 p -90.02 -19.57 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 122.654 0.381 . . . . 73.439999999999998 111.395 -176.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.31 159.04 34.31 Favored Glycine 0 C--N 1.348 1.226 0 N-CA-C 111.986 -0.446 . . . . 72.299999999999997 111.986 -174.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.79 -138.68 5.39 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-O 119.603 -0.554 . . . . 75.099999999999994 112.352 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -137.31 142.31 41.89 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.564 0.746 . . . . 64.420000000000002 109.312 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.77 162.04 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 122.846 0.458 . . . . 72.420000000000002 110.539 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -86.51 104.77 16.28 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.295 -1.002 . . . . 53.439999999999998 108.295 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -103.49 138.86 39.61 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.773 0.829 . . . . 61.210000000000001 110.199 -175.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 22.5 ptt? -72.54 118.46 15.49 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 121.438 0.637 . . . . 72.120000000000005 109.401 176.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 28.0 m -135.45 154.59 51.39 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.091 0.956 . . . . 72.519999999999996 109.061 -177.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 68.7 mt -63.19 -21.66 66.36 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.003 0.921 . . . . 74.299999999999997 112.789 -177.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -93.62 0.8 56.69 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.276 0.63 . . . . 73.530000000000001 111.353 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 117.97 167.98 14.3 Favored Glycine 0 C--N 1.345 1.069 0 CA-C-O 119.534 -0.592 . . . . 53.350000000000001 112.515 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.76 121.26 8.3 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.513 2.142 . . . . 62.409999999999997 111.174 176.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.533 HG21 HD21 ' A' ' 171' ' ' LEU . 27.7 m -127.7 160.04 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 123.804 0.842 . . . . 61.399999999999999 110.879 -171.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -86.68 103.95 15.63 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.062 0.545 . . . . 74.150000000000006 109.817 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.564 HG22 HD13 ' A' ' 171' ' ' LEU . 99.0 t -96.84 124.14 49.5 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 N-CA-C 108.672 -0.862 . . . . 74.400000000000006 108.672 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.04 98.7 2.58 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.069 0.548 . . . . 43.140000000000001 110.244 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 94.8 t -73.97 128.0 87.24 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.203 1.001 . . . . 63.420000000000002 109.737 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.16 170.34 14.76 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.601 2.201 . . . . 70.519999999999996 111.317 176.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.52 167.87 26.13 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 121.249 1.3 . . . . 73.25 111.489 168.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 48.2 mtt-85 65.63 23.04 11.69 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 124.622 1.169 . . . . 75.5 111.989 176.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.449 ' O ' ' HB1' ' A' ' 204' ' ' ALA . 30.0 m -75.15 93.53 2.81 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.771 0.796 . . . . 74.129999999999995 110.416 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -86.03 145.71 26.97 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.461 -1.245 . . . . 74.319999999999993 110.531 -178.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.3 138.42 58.52 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.114 0.966 . . . . 72.409999999999997 111.126 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 92.74 -14.83 64.05 Favored Glycine 0 N--CA 1.473 1.108 0 CA-C-N 116.206 -0.452 . . . . 75.239999999999995 113.034 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -75.71 145.11 41.15 Favored 'General case' 0 C--N 1.348 0.504 0 N-CA-C 109.457 -0.571 . . . . 62.409999999999997 109.457 173.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.579 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 0.2 OUTLIER -110.48 122.71 48.39 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.199 -0.667 . . . . 74.409999999999997 109.199 175.451 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.445 HD13 HD13 ' A' ' 173' ' ' ILE . 18.7 mt -76.19 103.07 6.05 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.447 -0.945 . . . . 72.230000000000004 108.447 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 21.4 ttm-85 -70.95 101.2 2.12 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 109.395 -0.595 . . . . 74.329999999999998 109.395 175.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.854 HD22 ' HA ' ' A' ' 173' ' ' ILE . 10.0 mt -104.27 103.13 12.83 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 108.011 -1.107 . . . . 62.149999999999999 108.011 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -80.85 142.7 33.39 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.735 0.414 . . . . 74.040000000000006 111.521 -170.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 84.99 21.15 56.32 Favored Glycine 0 C--N 1.346 1.111 0 CA-C-N 115.985 -0.552 . . . . 51.420000000000002 113.506 178.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -113.27 -26.92 8.17 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.285 0.634 . . . . 63.509999999999998 112.534 -173.824 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -72.91 -134.74 0.21 Allowed Glycine 0 CA--C 1.539 1.553 0 N-CA-C 114.262 0.465 . . . . 73.450000000000003 114.262 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -93.56 137.73 23.22 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 123.266 0.626 . . . . 72.420000000000002 110.114 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 56.3 Cg_endo -69.17 128.88 17.24 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.751 2.3 . . . . 52.340000000000003 112.487 -178.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -137.55 -175.93 14.14 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-O 119.504 -0.609 . . . . 74.230000000000004 112.512 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.66 -28.95 69.27 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 123.998 3.132 . . . . 74.450000000000003 113.155 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -94.43 14.88 19.23 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.44 0.696 . . . . 71.340000000000003 110.725 177.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 97.68 175.19 33.86 Favored Glycine 0 C--N 1.349 1.3 0 N-CA-C 111.537 -0.625 . . . . 73.099999999999994 111.537 -176.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.524 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 0.8 OUTLIER -61.24 145.77 50.09 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.618 0.767 . . . . 73.409999999999997 109.894 172.421 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -68.33 -173.27 7.67 Favored Glycine 0 N--CA 1.477 1.369 0 N-CA-C 114.362 0.505 . . . . 71.340000000000003 114.362 -173.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -95.97 168.81 10.4 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.456 -0.942 . . . . 74.109999999999999 108.456 178.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 238' ' ' LYS . 34.6 tp -141.49 108.81 5.53 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.493 -0.928 . . . . 75.519999999999996 108.493 178.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.579 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 81.1 m-85 -90.39 109.28 20.4 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.902 0.881 . . . . 75.340000000000003 110.032 -176.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.505 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 46.8 mt -88.0 107.14 18.58 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.153 -0.684 . . . . 74.230000000000004 109.153 174.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -80.25 101.09 8.67 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.69 1.196 . . . . 73.129999999999995 108.801 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 89.4 t -63.39 120.23 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 125.218 1.407 . . . . 51.299999999999997 112.733 -171.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -113.83 100.11 8.2 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.039 -1.097 . . . . 72.200000000000003 108.039 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 18.6 mt -75.88 120.11 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 122.962 0.505 . . . . 73.329999999999998 109.75 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 CA--C 1.554 1.129 0 C-N-CA 124.296 1.038 . . . . 75.140000000000001 108.895 -179.997 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 121.061 0.458 . . . . 35.109999999999999 111.183 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 41.1 m -73.47 10.24 1.11 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.765 0.826 . . . . 64.120000000000005 112.696 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -58.73 137.2 57.77 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.16 0.984 . . . . 74.239999999999995 111.525 173.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.412 ' O ' HG13 ' A' ' 221' ' ' VAL . 62.5 mt -82.61 80.85 8.62 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.648 0.779 . . . . 63.240000000000002 109.35 176.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 55.1 mtm180 -79.15 105.24 10.34 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 107.366 -1.346 . . . . 63.109999999999999 107.366 175.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.621 HG21 HD13 ' A' ' 233' ' ' LEU . 50.9 mt -76.79 108.63 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 O-C-N 123.24 0.338 . . . . 74.540000000000006 110.195 -175.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -100.98 14.84 30.64 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.86 0.864 . . . . 75.040000000000006 110.432 174.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -73.03 -43.83 61.56 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.967 0.907 . . . . 41.43 112.423 -171.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.453 ' CE2' ' HA ' ' A' ' 227' ' ' THR . 43.6 m-85 -83.21 100.23 10.45 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.268 -0.642 . . . . 73.400000000000006 109.268 173.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 91.67 59.25 1.36 Allowed Glycine 0 CA--C 1.533 1.174 0 CA-C-N 114.586 -1.188 . . . . 70.120000000000005 112.196 -173.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.78 135.96 11.73 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 122.213 1.942 . . . . 63.399999999999999 111.999 -177.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -76.2 -42.87 44.85 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.069 0.462 . . . . 72.430000000000007 110.413 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -128.46 173.72 19.06 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 115.712 -0.676 . . . . 74.310000000000002 112.473 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 38.3 t -153.1 162.65 41.07 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.214 1.006 . . . . 42.049999999999997 109.063 175.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 98.63 -179.32 31.67 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 116.497 -0.32 . . . . 73.310000000000002 113.661 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -142.4 -97.51 0.28 Allowed Glycine 0 C--N 1.343 0.926 0 N-CA-C 110.547 -1.021 . . . . 74.120000000000005 110.547 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 35.8 p -158.96 -61.49 0.07 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.576 0.75 . . . . 64.310000000000002 110.903 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 174.48 66.84 0.05 OUTLIER Glycine 0 C--N 1.344 1.005 0 N-CA-C 110.993 -0.843 . . . . 72.549999999999997 110.993 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -75.93 80.92 1.05 Allowed Glycine 0 C--N 1.352 1.421 0 N-CA-C 112.024 -0.43 . . . . 34.130000000000003 112.024 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.8 m -68.19 120.77 14.9 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 123.733 0.813 . . . . 71.420000000000002 110.414 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 69.31 26.31 74.69 Favored Glycine 0 C--N 1.347 1.187 0 O-C-N 123.709 0.63 . . . . 51.329999999999998 112.727 -174.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -62.44 107.95 1.85 Allowed Glycine 0 C--N 1.352 1.46 0 C-N-CA 123.157 0.408 . . . . 63.310000000000002 112.868 -176.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 19.7 m -129.65 19.23 5.67 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.14 0.976 . . . . 73.239999999999995 110.349 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -85.42 2.43 44.49 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.043 0.937 . . . . 35.32 111.153 -175.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.73 142.61 42.39 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.143 0.977 . . . . 51.049999999999997 109.11 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 88.9 mt -127.51 160.61 30.98 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.794 0.838 . . . . 63.5 110.326 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -129.99 119.92 23.95 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.274 -1.01 . . . . 73.25 108.274 173.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -126.66 132.9 51.09 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.666 1.186 . . . . 60.450000000000003 109.07 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 51.9 m -66.13 129.67 40.62 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.442 0.697 . . . . 74.5 110.369 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 41.5 tp -116.12 110.85 19.41 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 107.571 -1.27 . . . . 74.150000000000006 107.571 176.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -93.63 106.77 18.71 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.496 -0.927 . . . . 42.340000000000003 108.496 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 2.8 p -125.27 122.53 25.18 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 124.576 1.151 . . . . 53.520000000000003 109.02 -176.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.405 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 72.2 Cg_endo -71.51 158.38 54.05 Favored 'Trans proline' 0 C--N 1.372 1.764 0 C-N-CA 122.301 2.0 . . . . 62.240000000000002 111.277 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.98 -45.05 80.93 Favored Pre-proline 0 CA--C 1.571 1.759 0 N-CA-C 114.195 1.183 . . . . 74.030000000000001 114.195 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 75.8 Cg_exo -53.69 -54.65 4.5 Favored 'Trans proline' 0 C--N 1.399 3.198 0 C-N-CA 122.225 1.95 . . . . 72.319999999999993 113.572 173.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 49.3 mt -71.44 -25.29 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 122.999 0.52 . . . . 15.140000000000001 110.66 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.88 -40.53 83.55 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.241 0.616 . . . . 74.519999999999996 111.007 177.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 97.7 t -78.58 -56.3 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 CA-C-N 116.63 -0.259 . . . . 73.120000000000005 111.595 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.3 p -92.49 -25.77 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 112.675 0.62 . . . . 62.420000000000002 112.675 -170.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 96.18 156.81 31.39 Favored Glycine 0 N--CA 1.478 1.47 0 O-C-N 122.476 -0.14 . . . . 74.140000000000001 113.097 -176.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 169.65 -131.17 2.2 Favored Glycine 0 C--N 1.346 1.105 0 N-CA-C 111.7 -0.56 . . . . 50.450000000000003 111.7 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -134.55 141.71 46.76 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.187 0.995 . . . . 70.109999999999999 108.973 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.465 HG11 ' HA ' ' A' ' 199' ' ' VAL . 19.4 m -131.61 167.13 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 122.903 0.481 . . . . 73.340000000000003 110.732 176.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -82.03 107.28 14.61 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.526 -0.916 . . . . 75.519999999999996 108.526 170.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.02 133.54 48.79 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.317 0.647 . . . . 65.239999999999995 109.652 175.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 22.9 mmt -81.01 104.12 11.3 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 109.374 -0.602 . . . . 75.420000000000002 109.374 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 30.7 m -112.72 163.15 14.92 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 124.528 1.131 . . . . 63.43 109.039 -177.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 84.6 mt -67.98 -17.03 64.31 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.517 0.727 . . . . 75.349999999999994 112.037 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -80.37 -19.68 45.81 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.022 0.929 . . . . 75.040000000000006 111.028 173.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 126.24 177.32 14.83 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 110.678 -0.969 . . . . 74.430000000000007 110.678 -172.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.87 121.24 7.91 Favored 'Trans proline' 0 CA--C 1.554 1.504 0 C-N-CA 121.981 1.787 . . . . 70.040000000000006 110.819 174.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.45 HG23 HG23 ' A' ' 221' ' ' VAL . 35.0 m -124.81 161.0 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 123.324 0.65 . . . . 73.129999999999995 111.043 -173.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -85.47 105.75 16.31 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.013 -0.736 . . . . 74.219999999999999 109.013 177.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.45 HG23 HG23 ' A' ' 219' ' ' VAL . 49.7 t -102.76 129.16 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.599 0.759 . . . . 64.209999999999994 110.394 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.23 100.56 3.74 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 123.42 0.688 . . . . 73.310000000000002 110.278 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.478 ' HA ' HD12 ' A' ' 173' ' ' ILE . 58.6 t -88.14 131.56 42.36 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 124.599 1.16 . . . . 61.32 109.389 178.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 223' ' ' VAL . 3.4 Cg_exo -78.88 174.21 12.52 Favored 'Trans proline' 0 C--N 1.377 2.026 0 C-N-CA 123.677 2.918 . . . . 65.239999999999995 111.199 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -62.54 176.9 1.44 Allowed 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 121.993 1.795 . . . . 62.109999999999999 112.758 166.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 69.27 5.56 5.19 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 124.506 1.123 . . . . 70.200000000000003 112.947 172.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.453 ' HA ' ' CE2' ' A' ' 176' ' ' TYR . 87.8 m -66.05 97.57 0.38 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.896 0.878 . . . . 64.439999999999998 111.204 -171.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 63.3 tp60 -101.83 141.7 34.27 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.049 1.34 . . . . 65.5 111.086 -171.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.04 141.98 57.78 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.159 0.984 . . . . 74.239999999999995 112.517 -174.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.71 -20.14 29.46 Favored Glycine 0 C--N 1.351 1.364 0 O-C-N 123.833 0.708 . . . . 74.439999999999998 113.659 178.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -77.23 160.61 28.79 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.067 0.547 . . . . 75.140000000000001 110.632 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 12.6 mptt -127.55 143.64 51.16 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.317 0.579 . . . . 63.420000000000002 109.985 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.621 HD13 HG21 ' A' ' 173' ' ' ILE . 23.3 mt -106.27 99.54 9.12 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.769 -1.105 . . . . 65.299999999999997 109.136 -170.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 42.8 ttm105 -73.74 102.03 3.86 Favored 'General case' 0 C--O 1.24 0.569 0 O-C-N 124.567 1.167 . . . . 74.549999999999997 110.437 -174.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.502 HD21 HG23 ' A' ' 173' ' ' ILE . 30.2 mt -105.82 94.6 5.28 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.476 -0.935 . . . . 44.140000000000001 108.476 177.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -70.21 140.21 52.42 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 122.845 0.458 . . . . 75.439999999999998 111.002 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 81.46 17.65 70.64 Favored Glycine 0 CA--C 1.528 0.892 0 O-C-N 123.918 0.762 . . . . 40.140000000000001 113.202 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -122.07 -11.81 8.42 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.437 0.695 . . . . 54.32 112.295 -175.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -77.88 -161.82 17.29 Favored Glycine 0 N--CA 1.48 1.61 0 CA-C-O 119.804 -0.442 . . . . 73.219999999999999 112.74 171.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -71.5 149.94 93.66 Favored Pre-proline 0 N--CA 1.484 1.257 0 CA-C-N 117.911 0.856 . . . . 63.439999999999998 111.6 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -64.07 140.74 73.53 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.909 2.406 . . . . 72.329999999999998 112.31 172.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -163.43 -164.38 18.4 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-O 119.251 -0.75 . . . . 71.409999999999997 111.714 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -65.5 -22.28 59.12 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 123.163 2.575 . . . . 71.120000000000005 112.879 -174.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -97.0 22.66 8.12 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.846 0.858 . . . . 74.430000000000007 111.527 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.46 -97.63 2.35 Favored Glycine 0 C--N 1.346 1.111 0 N-CA-C 110.793 -0.923 . . . . 31.25 110.793 -177.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -128.08 152.83 47.5 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 107.651 -1.24 . . . . 64.209999999999994 107.651 166.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -80.91 -158.07 18.46 Favored Glycine 0 C--N 1.34 0.8 0 O-C-N 123.435 0.46 . . . . 72.420000000000002 113.045 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -100.06 159.15 15.32 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.507 -0.553 . . . . 63.409999999999997 109.507 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 40.7 tp -126.68 108.37 11.03 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.51 -1.292 . . . . 75.319999999999993 107.51 172.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.511 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 15.0 m-85 -90.19 108.15 19.57 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.514 -0.921 . . . . 74.430000000000007 108.514 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 57.2 mt -87.2 105.53 17.27 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.982 -1.118 . . . . 72.109999999999999 107.982 174.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -78.74 112.3 15.73 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.503 -0.771 . . . . 70.329999999999998 109.842 -175.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 58.0 t -63.3 119.37 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 124.636 1.174 . . . . 75.230000000000004 111.726 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 49.7 mmm-85 -120.39 95.6 4.8 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 125.167 1.387 . . . . 72.510000000000005 107.495 173.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 49.8 mt -77.87 113.12 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 122.741 0.417 . . . . 74.239999999999995 110.509 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 75.0 p . . . . . 0 CA--C 1.559 1.299 0 C-N-CA 124.379 1.071 . . . . 72.040000000000006 108.714 177.625 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 52.8 ttm . . . . . 0 N--CA 1.473 0.699 0 CA-C-O 120.764 0.316 . . . . 65.019999999999996 110.285 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 67.1 m -137.21 120.3 16.64 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.612 -1.255 . . . . 71.120000000000005 107.612 173.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -83.74 77.55 9.85 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.548 0.739 . . . . 61.329999999999998 110.357 -175.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 10.1 mp -69.06 93.85 0.61 Allowed 'General case' 0 C--N 1.353 0.744 0 N-CA-C 109.093 -0.706 . . . . 74.200000000000003 109.093 173.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -79.8 120.18 23.71 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 107.568 -1.271 . . . . 75.310000000000002 107.568 168.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.611 ' HB ' ' HD3' ' A' ' 224' ' ' PRO . 76.3 mt -77.46 -78.05 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 122.795 0.438 . . . . 73.230000000000004 110.419 -177.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . 51.51 27.21 3.69 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.439 1.096 . . . . 65.209999999999994 113.272 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.576 ' H ' HG22 ' A' ' 173' ' ' ILE . . . -73.96 -1.15 18.6 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 113.718 1.007 . . . . 64.329999999999998 113.718 -169.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -78.53 -29.48 46.49 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.021 0.529 . . . . 73.439999999999998 110.041 170.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -93.08 158.67 24.0 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 119.03 -0.872 . . . . 21.34 111.271 167.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.4 106.64 0.6 Allowed 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 122.726 2.284 . . . . 72.329999999999998 111.985 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -138.09 151.7 48.07 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.786 0.834 . . . . 72.420000000000002 110.591 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 174.82 -168.9 41.73 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-N 115.582 -0.735 . . . . 73.409999999999997 112.067 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 34.6 t -82.45 -25.36 33.66 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.052 0.541 . . . . 75.409999999999997 110.119 173.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 153.61 -149.73 21.28 Favored Glycine 0 C--N 1.351 1.393 0 N-CA-C 111.445 -0.662 . . . . 74.239999999999995 111.445 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.473 ' HA3' ' HB3' ' A' ' 187' ' ' SER . . . 102.4 111.39 3.5 Favored Glycine 0 C--N 1.346 1.105 0 C-N-CA 122.954 0.311 . . . . 74.510000000000005 112.678 174.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 22.6 t -86.48 104.71 16.21 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 109.162 -0.681 . . . . 65.510000000000005 109.162 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 91.25 -62.59 2.81 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 116.419 -0.355 . . . . 74.310000000000002 112.231 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -128.48 153.13 19.45 Favored Glycine 0 C--N 1.347 1.144 0 N-CA-C 111.847 -0.501 . . . . 74.099999999999994 111.847 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.473 ' HB3' ' HA3' ' A' ' 183' ' ' GLY . 44.3 p -152.71 149.94 28.91 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.128 0.971 . . . . 74.430000000000007 109.835 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 75.56 -96.15 1.02 Allowed Glycine 0 CA--C 1.532 1.129 0 CA-C-O 119.909 -0.384 . . . . 52.030000000000001 113.119 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 123.27 59.19 0.19 Allowed Glycine 0 C--N 1.347 1.169 0 C-N-CA 123.479 0.562 . . . . 74.25 112.014 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 19.2 m 61.33 18.38 9.19 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.702 1.201 . . . . 64.150000000000006 111.928 -177.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -90.59 21.73 3.84 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.329 1.052 . . . . 75.430000000000007 111.018 -176.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -76.48 155.92 33.43 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.452 0.701 . . . . 75.530000000000001 111.276 -176.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 93.7 mt -128.74 152.93 47.88 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.147 0.979 . . . . 72.120000000000005 109.19 176.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -108.25 149.12 29.02 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.864 0.866 . . . . 74.349999999999994 108.852 172.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -155.03 136.1 13.86 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.972 0.909 . . . . 73.319999999999993 108.763 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 28.1 m -78.01 128.48 33.93 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.115 0.566 . . . . 55.32 109.888 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 22.0 tp -108.27 117.41 34.08 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.438 -0.579 . . . . 51.219999999999999 109.438 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -82.47 105.77 13.8 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.431 -0.951 . . . . 53.420000000000002 108.431 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.502 HG11 HG13 ' A' ' 253' ' ' VAL . 2.7 p -136.5 122.7 13.69 Favored Pre-proline 0 CA--C 1.548 0.888 0 N-CA-C 109.507 -0.553 . . . . 65.109999999999999 109.507 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.449 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 54.9 Cg_endo -72.11 160.65 46.86 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.194 1.93 . . . . 71.510000000000005 112.049 173.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.75 -51.72 63.4 Favored Pre-proline 0 CA--C 1.567 1.611 0 C-N-CA 124.46 1.104 . . . . 63.140000000000001 113.745 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 56.6 Cg_endo -65.62 -36.06 34.91 Favored 'Trans proline' 0 C--N 1.401 3.327 0 C-N-CA 121.624 1.549 . . . . 60.219999999999999 112.606 -176.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 23.0 mt -72.7 -31.7 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 122.766 0.426 . . . . 71.150000000000006 110.551 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.1 -42.15 89.69 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 122.691 0.397 . . . . 74.0 110.768 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 90.7 t -69.7 -53.02 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.096 0 C-N-CA 123.281 0.632 . . . . 73.150000000000006 111.695 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 28.0 m -79.58 -32.83 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 112.153 0.427 . . . . 51.530000000000001 112.153 -175.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.18 105.77 0.97 Allowed Glycine 0 C--N 1.343 0.934 0 CA-C-N 116.146 -0.479 . . . . 65.430000000000007 112.584 -173.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -148.46 -177.03 22.39 Favored Glycine 0 C--N 1.344 1.021 0 N-CA-C 112.074 -0.41 . . . . 51.350000000000001 112.074 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.645 ' HB3' ' HB2' ' A' ' 220' ' ' GLU . 50.2 mtmt -86.93 127.61 35.07 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 117.13 0.465 . . . . 75.109999999999999 110.497 -175.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 20.7 m -124.22 167.95 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 123.14 0.576 . . . . 63.530000000000001 111.555 -177.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -71.53 106.63 4.07 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 123.974 0.796 . . . . 62.420000000000002 110.232 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.83 115.76 30.86 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 107.95 -1.13 . . . . 53.130000000000003 107.95 166.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 63.3 mtt -72.97 104.93 4.25 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 109.255 -0.646 . . . . 63.210000000000001 109.255 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 38.1 m -110.99 162.23 15.06 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.715 1.206 . . . . 73.340000000000003 109.268 -173.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 96.4 mt -57.68 -23.25 50.51 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.967 0.907 . . . . 61.310000000000002 112.95 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -87.47 -20.83 26.03 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.26 0.624 . . . . 72.549999999999997 111.707 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 139.05 -171.93 23.39 Favored Glycine 0 C--N 1.345 1.036 0 CA-C-O 119.577 -0.568 . . . . 71.109999999999999 111.95 -176.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.6 117.79 4.66 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.21 1.94 . . . . 72.109999999999999 110.788 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.403 HG23 HG23 ' A' ' 221' ' ' VAL . 32.8 m -116.26 166.78 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.15 0.58 . . . . 71.439999999999998 109.687 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.645 ' HB2' ' HB3' ' A' ' 209' ' ' LYS . 8.5 pt-20 -107.52 105.12 14.86 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.721 0.772 . . . . 75.540000000000006 109.746 178.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.403 HG23 HG23 ' A' ' 219' ' ' VAL . 58.7 t -99.46 131.42 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.886 1.275 . . . . 75.530000000000001 109.841 -175.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.73 100.43 2.84 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.801 0.841 . . . . 43.539999999999999 110.553 -176.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.518 ' HA ' HD12 ' A' ' 173' ' ' ILE . 80.8 t -78.55 138.62 58.83 Favored Pre-proline 0 N--CA 1.478 0.973 0 C-N-CA 124.872 1.269 . . . . 72.310000000000002 109.321 175.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.611 ' HD3' ' HB ' ' A' ' 173' ' ' ILE . 88.1 Cg_endo -75.11 168.83 23.9 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 122.51 2.14 . . . . 65.329999999999998 111.506 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -68.35 172.71 10.77 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 121.421 1.414 . . . . 63.329999999999998 111.424 168.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 63.85 17.12 10.32 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.888 0.875 . . . . 73.540000000000006 112.071 174.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 53.7 m -75.01 133.18 41.71 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.943 0.897 . . . . 72.400000000000006 110.153 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -139.35 143.13 37.63 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.201 0.6 . . . . 51.329999999999998 110.846 -164.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.19 127.73 33.27 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 124.323 1.049 . . . . 65.510000000000005 111.373 -177.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 103.58 -21.84 37.67 Favored Glycine 0 N--CA 1.473 1.134 0 CA-C-N 115.902 -0.59 . . . . 71.040000000000006 112.719 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -75.81 141.98 42.36 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.082 0.553 . . . . 74.409999999999997 110.024 176.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.497 ' HG3' ' HG2' ' A' ' 252' ' ' GLU . 0.0 OUTLIER -108.38 127.57 54.0 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.497 0.719 . . . . 73.400000000000006 109.746 178.306 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.568 HD13 HG21 ' A' ' 173' ' ' ILE . 56.6 mt -90.6 96.88 10.87 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.9 -1.148 . . . . 73.230000000000004 107.9 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 30.4 ttp-105 -87.15 105.25 17.06 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 124.233 1.013 . . . . 74.150000000000006 110.24 -172.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.555 HD21 HG23 ' A' ' 173' ' ' ILE . 31.2 mt -99.85 94.82 6.52 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.602 -0.888 . . . . 72.409999999999997 108.602 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm -67.55 140.97 56.99 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.52 0.328 . . . . 74.340000000000003 110.554 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.06 28.41 56.38 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-N 116.097 -0.501 . . . . 74.030000000000001 113.642 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.451 ' HA ' ' HE2' ' A' ' 238' ' ' LYS . 9.3 mmpt? -127.54 -14.95 5.15 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.843 0.857 . . . . 74.530000000000001 112.801 -178.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -78.2 -152.98 6.23 Favored Glycine 0 N--CA 1.476 1.366 0 C-N-CA 122.736 0.207 . . . . 65.519999999999996 113.162 174.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -73.58 147.94 87.44 Favored Pre-proline 0 N--CA 1.485 1.296 0 C-N-CA 123.022 0.529 . . . . 71.310000000000002 111.28 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -59.81 143.36 99.63 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.94 2.427 . . . . 72.299999999999997 112.741 172.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -154.4 -170.33 20.12 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-O 119.391 -0.672 . . . . 64.400000000000006 112.913 -176.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.64 -40.22 67.05 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 123.411 2.741 . . . . 73.310000000000002 113.285 -174.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -103.97 22.02 15.34 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.477 0.711 . . . . 51.549999999999997 111.501 -177.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 104.7 -161.85 15.01 Favored Glycine 0 N--CA 1.473 1.139 0 CA-C-O 119.642 -0.532 . . . . 24.32 111.864 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 66.2 mtm-85 -75.71 146.4 40.16 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.365 0.582 . . . . 75.329999999999998 109.701 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -74.97 -157.25 5.79 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 116.405 -0.362 . . . . 74.109999999999999 112.994 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -97.37 170.02 9.36 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.071 0.548 . . . . 61.310000000000002 110.173 -175.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 29.4 tp -136.35 105.63 6.03 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.746 -1.205 . . . . 73.030000000000001 107.746 172.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -89.66 107.07 18.87 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.752 -0.833 . . . . 75.209999999999994 108.752 -178.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 71.9 mt -89.53 104.28 16.85 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.559 -1.275 . . . . 74.329999999999998 107.559 173.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.497 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 12.8 mt-10 -78.29 105.56 9.61 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.508 -0.769 . . . . 63.240000000000002 108.962 -173.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.502 HG13 HG11 ' A' ' 199' ' ' VAL . 61.3 t -59.62 104.21 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.82 0 O-C-N 124.073 0.858 . . . . 42.020000000000003 111.545 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -103.46 97.66 7.68 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 107.785 -1.191 . . . . 72.239999999999995 107.785 173.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 12.5 mt -75.02 114.73 15.39 Favored 'Isoleucine or valine' 0 C--N 1.356 0.853 0 O-C-N 123.958 0.786 . . . . 71.150000000000006 108.941 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 12.5 p . . . . . 0 C--O 1.256 1.423 0 C-N-CA 125.537 1.535 . . . . 72.150000000000006 108.16 -177.033 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 65.3 mtm . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 121.201 0.525 . . . . 63.240000000000002 110.98 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 23.2 t -153.74 117.6 4.74 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.943 -1.026 . . . . 71.420000000000002 108.282 175.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -59.06 -40.87 86.5 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 121.496 0.665 . . . . 54.020000000000003 109.912 176.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 85.4 mt -103.47 91.82 4.21 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.862 -1.063 . . . . 54.130000000000003 109.095 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 -64.92 110.32 2.4 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.86 -0.792 . . . . 72.010000000000005 108.86 177.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.591 ' HA ' HD22 ' A' ' 235' ' ' LEU . 65.4 mt -81.59 -81.16 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 119.034 -0.508 . . . . 74.109999999999999 111.102 -172.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . 52.49 28.48 6.0 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.971 0.908 . . . . 74.430000000000007 112.472 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.522 ' H ' HG22 ' A' ' 173' ' ' ILE . . . -81.56 -178.94 7.17 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.441 -0.799 . . . . 54.210000000000001 111.324 -177.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 68.64 33.35 3.88 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 125.143 1.377 . . . . 75.239999999999995 110.162 -174.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 175.57 179.4 46.07 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 114.569 -1.196 . . . . 72.510000000000005 111.23 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -64.94 109.42 1.29 Allowed 'Trans proline' 0 C--N 1.367 1.539 0 C-N-CA 122.458 2.105 . . . . 62.310000000000002 110.746 173.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 51.8 t60 -67.3 -44.05 80.16 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.719 0.408 . . . . 64.030000000000001 109.994 178.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 119.69 15.08 5.46 Favored Glycine 0 N--CA 1.476 1.356 0 CA-C-N 115.61 -0.723 . . . . 73.329999999999998 112.908 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 9.4 m -79.26 157.48 27.76 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.027 0.931 . . . . 73.219999999999999 111.728 -173.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -164.86 101.26 0.18 Allowed Glycine 0 C--N 1.352 1.439 0 N-CA-C 111.766 -0.534 . . . . 64.010000000000005 111.766 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 176.99 96.57 0.1 Allowed Glycine 0 C--N 1.346 1.105 0 N-CA-C 110.975 -0.85 . . . . 62.200000000000003 110.975 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 61.4 p -138.31 144.09 40.26 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.462 1.105 . . . . 43.420000000000002 109.868 -175.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 161.49 -84.83 0.11 Allowed Glycine 0 C--N 1.346 1.104 0 N-CA-C 111.134 -0.786 . . . . 60.299999999999997 111.134 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.549 ' HA3' ' HB2' ' A' ' 243' ' ' PRO . . . -90.8 82.95 1.3 Allowed Glycine 0 C--N 1.344 0.987 0 C-N-CA 122.884 0.278 . . . . 73.329999999999998 112.852 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 64.4 m -119.34 141.13 49.3 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.209 0.603 . . . . 73.319999999999993 110.673 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 167.6 172.97 35.28 Favored Glycine 0 CA--C 1.528 0.876 0 O-C-N 123.71 0.631 . . . . 40.240000000000002 111.968 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 83.09 -98.29 2.05 Favored Glycine 0 C--N 1.346 1.089 0 N-CA-C 112.042 -0.423 . . . . 74.150000000000006 112.042 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.5 m -152.54 35.88 0.51 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.992 0.917 . . . . 53.240000000000002 110.623 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.505 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 80.8 mt-30 -59.78 -43.74 94.25 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.792 0.437 . . . . 72.219999999999999 111.136 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -89.97 135.2 33.79 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.371 -0.603 . . . . 54.340000000000003 109.371 174.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 95.9 mt -131.72 129.09 40.22 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.022 0.929 . . . . 64.329999999999998 110.282 -172.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -92.6 119.95 32.55 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.926 -0.768 . . . . 73.230000000000004 108.926 173.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -130.73 128.53 41.01 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.703 1.201 . . . . 61.229999999999997 109.043 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 88.5 m -69.2 131.11 44.41 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.588 0.755 . . . . 71.150000000000006 111.451 -177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 42.3 tp -110.13 116.35 31.37 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.532 1.133 . . . . 75.209999999999994 108.476 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -92.11 109.39 20.75 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.475 -0.935 . . . . 74.319999999999993 108.475 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 3.4 p -130.92 122.87 19.63 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 124.198 0.999 . . . . 73.430000000000007 108.911 -178.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.87 156.56 65.44 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.08 1.853 . . . . 73.049999999999997 112.109 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -48.28 -46.22 67.22 Favored Pre-proline 0 CA--C 1.565 1.552 0 N-CA-C 114.569 1.322 . . . . 52.549999999999997 114.569 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.5 ' O ' HG22 ' A' ' 206' ' ' VAL . 17.9 Cg_endo -58.12 -52.7 5.3 Favored 'Trans proline' 0 C--N 1.4 3.283 0 C-N-CA 121.874 1.716 . . . . 74.140000000000001 112.245 176.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.8 mt -65.93 -30.88 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.429 0.692 . . . . 73.209999999999994 111.446 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.67 -54.64 24.71 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.416 0.686 . . . . 54.109999999999999 111.026 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 63.5 t -71.68 -53.52 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-N 115.93 -0.577 . . . . 71.120000000000005 111.626 -174.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 202' ' ' PRO . 15.5 m -90.3 -25.02 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 112.805 0.669 . . . . 53.520000000000003 112.805 -172.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 100.76 142.8 13.25 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 117.796 0.271 . . . . 54.299999999999997 112.639 -176.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -175.19 -141.49 3.73 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 111.149 -0.781 . . . . 74.329999999999998 111.149 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -133.27 143.14 48.89 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 117.737 0.768 . . . . 64.140000000000001 109.19 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 33.2 m -128.95 169.4 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.647 0.779 . . . . 74.430000000000007 110.234 173.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -99.3 112.47 24.63 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.129 0.972 . . . . 75.519999999999996 108.513 171.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.58 144.65 30.06 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.8 0.84 . . . . 65.239999999999995 109.692 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 21.1 mmt -91.77 103.57 16.12 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 109.039 -0.726 . . . . 74.519999999999996 109.039 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 61.7 m -117.88 164.14 15.49 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.639 1.176 . . . . 75.400000000000006 108.916 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.0 mt -59.3 -20.0 50.86 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 123.344 0.657 . . . . 75.010000000000005 112.048 173.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -81.87 4.72 21.32 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.62 1.168 . . . . 73.209999999999994 111.982 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 97.97 -163.74 21.4 Favored Glycine 0 C--N 1.344 1.011 0 C-N-CA 123.488 0.566 . . . . 72.450000000000003 111.822 -175.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.16 118.39 5.37 Favored 'Trans proline' 0 C--N 1.365 1.404 0 C-N-CA 122.026 1.818 . . . . 73.519999999999996 109.907 172.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 28.7 m -118.13 153.2 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.039 0.536 . . . . 72.140000000000001 111.113 -172.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -95.41 111.76 23.59 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.54 0.736 . . . . 73.430000000000007 109.37 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 48.7 t -112.58 116.23 52.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 123.837 0.855 . . . . 62.149999999999999 109.17 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.57 101.25 2.44 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 109.099 -0.704 . . . . 75.519999999999996 109.099 174.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 63.9 t -77.55 121.64 84.66 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.955 0.902 . . . . 62.299999999999997 109.472 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.66 169.83 21.42 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.657 2.238 . . . . 45.32 110.936 173.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.96 176.53 2.97 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.633 2.222 . . . . 74.239999999999995 113.778 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 55.5 mtm180 70.94 12.05 7.06 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 125.45 1.5 . . . . 72.510000000000005 113.081 174.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 12.5 m -72.37 93.35 1.51 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.072 0.949 . . . . 75.420000000000002 110.765 -174.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -91.83 140.09 30.03 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.61 1.164 . . . . 60.329999999999998 111.007 -173.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -64.23 139.19 58.74 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.259 1.024 . . . . 71.439999999999998 111.646 -176.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 93.14 -23.37 29.85 Favored Glycine 0 C--N 1.343 0.934 0 CA-C-N 115.129 -0.941 . . . . 35.100000000000001 112.812 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -72.84 145.19 47.12 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 122.909 0.484 . . . . 74.219999999999999 110.265 176.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.489 ' HG3' ' HG2' ' A' ' 252' ' ' GLU . 2.6 mppt? -104.44 139.49 39.3 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.827 -1.175 . . . . 71.209999999999994 107.827 173.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.531 HD13 HD13 ' A' ' 173' ' ' ILE . 42.6 mt -92.24 99.47 12.25 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.221 -1.399 . . . . 72.5 107.221 175.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 46.0 ttm180 -73.04 100.98 3.13 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.117 0.484 . . . . 70.109999999999999 109.704 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.591 HD22 ' HA ' ' A' ' 173' ' ' ILE . 17.9 mt -102.21 88.12 3.23 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.136 -1.061 . . . . 73.400000000000006 108.136 -178.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -68.38 129.94 41.41 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.07 -0.968 . . . . 63.420000000000002 110.519 -175.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 84.67 27.62 34.68 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 123.762 0.664 . . . . 73.439999999999998 113.452 -175.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -125.9 -6.86 6.69 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 123.278 0.631 . . . . 73.340000000000003 112.651 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -86.79 -155.28 27.11 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 112.363 -0.295 . . . . 50.200000000000003 112.363 175.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.505 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 12.8 m-85 -70.46 140.03 87.08 Favored Pre-proline 0 N--CA 1.481 1.116 0 CA-C-N 117.184 0.492 . . . . 74.400000000000006 110.358 177.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -66.75 152.9 79.66 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.702 2.268 . . . . 70.239999999999995 111.854 174.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -160.71 -170.89 25.92 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 115.477 -0.783 . . . . 63.43 111.619 177.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.549 ' HB2' ' HA3' ' A' ' 186' ' ' GLY . 24.6 Cg_exo -61.89 -32.86 85.29 Favored 'Trans proline' 0 CA--C 1.556 1.58 0 C-N-CA 123.299 2.666 . . . . 71.5 112.749 177.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -87.0 3.71 44.84 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.271 0.629 . . . . 64.430000000000007 111.811 177.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 99.29 -167.93 21.7 Favored Glycine 0 C--N 1.342 0.88 0 N-CA-C 111.527 -0.629 . . . . 61.549999999999997 111.527 -174.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 28.4 mtm-85 -71.46 139.71 49.75 Favored 'General case' 0 CA--C 1.546 0.788 0 N-CA-C 109.085 -0.709 . . . . 74.239999999999995 109.085 174.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.25 -165.18 19.34 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 123.373 0.42 . . . . 74.030000000000001 113.696 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -100.3 128.56 46.35 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.095 0.558 . . . . 73.310000000000002 109.633 -174.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 28.8 tp -99.04 107.78 20.28 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 107.847 -1.168 . . . . 73.230000000000004 107.847 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.428 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 47.8 m-85 -88.04 107.86 18.94 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.761 0.824 . . . . 73.310000000000002 109.011 -178.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 41.1 mt -87.08 105.43 17.16 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.441 -0.948 . . . . 74.209999999999994 108.441 175.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.489 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 33.3 mt-10 -77.6 94.17 4.33 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.297 -0.865 . . . . 63.219999999999999 108.79 -173.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 99.7 t -53.57 112.35 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 124.433 1.093 . . . . 64.209999999999994 111.323 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -117.32 100.88 7.98 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 108.094 -1.076 . . . . 73.299999999999997 108.094 175.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 43.0 mt -75.68 107.12 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 O-C-N 124.023 0.827 . . . . 61.210000000000001 108.965 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 16.2 p . . . . . 0 C--O 1.26 1.621 0 C-N-CA 124.897 1.279 . . . . 71.120000000000005 108.3 -179.066 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 25.1 mmt . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 109.835 -0.432 . . . . 75.5 109.835 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.9 m -81.74 70.77 8.7 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-O 121.696 0.76 . . . . 61.520000000000003 111.236 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -87.87 55.26 3.4 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.257 1.023 . . . . 64.430000000000007 109.714 175.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.464 HD22 HG22 ' A' ' 221' ' ' VAL . 6.6 mp 53.15 59.21 4.58 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.193 -1.367 . . . . 72.420000000000002 110.648 -177.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.554 HH11 ' HB1' ' A' ' 222' ' ' ALA . 30.3 mmm180 -68.62 99.91 1.06 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.231 -1.349 . . . . 73.349999999999994 108.975 176.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.71 HG23 HD21 ' A' ' 235' ' ' LEU . 69.1 mt -59.68 -69.87 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 123.488 0.715 . . . . 65.319999999999993 110.355 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . 52.42 29.21 6.65 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.204 1.002 . . . . 73.150000000000006 113.037 177.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.509 ' H ' HG22 ' A' ' 173' ' ' ILE . . . -64.99 -32.29 73.94 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.257 1.023 . . . . 50.200000000000003 112.583 -173.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -74.71 87.99 2.22 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.108 -1.071 . . . . 74.519999999999996 108.108 170.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -173.12 153.96 19.41 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 115.509 -0.769 . . . . 73.329999999999998 112.135 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.2 -16.66 56.22 Favored 'Trans proline' 0 CA--C 1.557 1.633 0 C-N-CA 123.212 2.608 . . . . 75.409999999999997 113.079 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -80.82 11.55 3.84 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.837 0.855 . . . . 53.149999999999999 112.824 -176.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -64.81 -28.5 73.47 Favored Glycine 0 N--CA 1.477 1.399 0 N-CA-C 113.773 0.269 . . . . 63.509999999999998 113.773 173.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 29.2 m -84.19 140.75 31.51 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.344 0.657 . . . . 55.229999999999997 109.775 174.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 163.97 -26.73 0.21 Allowed Glycine 0 C--N 1.347 1.172 0 N-CA-C 112.346 -0.302 . . . . 63.329999999999998 112.346 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -71.82 155.93 52.26 Favored Glycine 0 C--N 1.352 1.443 0 CA-C-O 119.843 -0.421 . . . . 55.439999999999998 112.625 -178.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 20.3 m -60.49 -43.53 96.91 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.695 0.798 . . . . 72.349999999999994 112.248 -176.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -167.71 149.96 15.67 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 111.78 -0.528 . . . . 63.240000000000002 111.78 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -101.21 67.47 0.46 Allowed Glycine 0 C--N 1.348 1.196 0 N-CA-C 111.705 -0.558 . . . . 70.299999999999997 111.705 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 39.5 m -137.89 119.52 15.04 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.514 0.726 . . . . 65.409999999999997 109.374 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -153.64 -68.82 0.01 OUTLIER Glycine 0 C--N 1.343 0.948 0 N-CA-C 111.279 -0.728 . . . . 54.340000000000003 111.279 176.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 75.56 9.23 84.67 Favored Glycine 0 C--N 1.346 1.127 0 C-N-CA 122.927 0.298 . . . . 61.25 113.108 -173.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 61.4 m -154.92 -50.05 0.09 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.685 0.794 . . . . 73.010000000000005 109.916 -175.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.645 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 23.0 mp0 -69.99 -40.2 75.46 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.695 -0.684 . . . . 54.210000000000001 110.863 -176.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -76.68 132.29 39.28 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.888 -0.782 . . . . 60.109999999999999 108.888 172.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 91.4 mt -133.05 167.92 19.43 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.234 0.614 . . . . 72.129999999999995 110.519 -171.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -121.21 125.87 48.23 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 107.553 -1.277 . . . . 75.219999999999999 107.553 168.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -124.08 127.27 47.59 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.606 0.762 . . . . 33.340000000000003 109.15 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 43.4 m -67.49 118.46 10.83 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.81 0.844 . . . . 64.140000000000001 110.919 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 21.9 tp -109.47 110.78 21.99 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.531 -0.915 . . . . 71.420000000000002 108.531 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -88.24 127.25 35.45 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.206 -1.035 . . . . 75.129999999999995 108.206 174.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 3.0 p -141.85 127.59 10.84 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 124.298 1.039 . . . . 75.120000000000005 108.367 -176.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -69.5 155.25 67.31 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 121.543 1.495 . . . . 74.420000000000002 111.346 175.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.446 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -47.21 -50.65 46.43 Favored Pre-proline 0 CA--C 1.559 1.32 0 O-C-N 124.341 1.025 . . . . 64.219999999999999 113.657 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.411 ' O ' HG12 ' A' ' 206' ' ' VAL . 30.5 Cg_endo -60.72 -48.79 10.0 Favored 'Trans proline' 0 C--N 1.395 2.988 0 C-N-CA 121.933 1.755 . . . . 74.409999999999997 112.622 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 44.0 mt -66.56 -27.38 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.645 0.778 . . . . 73.209999999999994 111.384 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.33 -47.91 58.9 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.169 0.588 . . . . 74.409999999999997 111.194 176.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 201' ' ' ALA . 81.2 t -67.9 -48.91 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.329 0.651 . . . . 65.120000000000005 111.841 -176.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 202' ' ' PRO . 7.9 p -83.95 -29.1 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 CA-C-N 116.44 -0.346 . . . . 72.329999999999998 110.895 -175.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.61 86.07 0.64 Allowed Glycine 0 C--N 1.349 1.265 0 N-CA-C 111.559 -0.616 . . . . 64.349999999999994 111.559 -174.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -111.29 -122.94 4.31 Favored Glycine 0 C--N 1.344 1.02 0 N-CA-C 111.953 -0.459 . . . . 63.229999999999997 111.953 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 221' ' ' VAL . 95.9 mttt -136.99 149.84 47.76 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.914 0.885 . . . . 73.099999999999994 109.601 176.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 23.3 m -136.3 162.84 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 123.247 0.619 . . . . 71.430000000000007 111.461 177.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -86.3 106.53 17.43 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.565 0.746 . . . . 74.150000000000006 109.171 174.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -109.8 151.55 26.84 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.036 0.534 . . . . 51.030000000000001 110.756 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 31.8 mmt -83.55 111.3 18.96 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 123.898 0.749 . . . . 72.239999999999995 108.979 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 215' ' ' LEU . 3.4 m -126.83 176.4 7.31 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 108.581 -0.896 . . . . 73.319999999999993 108.581 -177.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.428 ' H ' HG22 ' A' ' 214' ' ' THR . 73.8 mt -59.89 -40.88 90.21 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.587 0.755 . . . . 75.239999999999995 112.652 -175.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -81.1 -3.38 51.78 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.308 0.643 . . . . 65.400000000000006 112.012 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 110.49 -151.76 17.5 Favored Glycine 0 C--N 1.343 0.94 0 CA-C-O 119.544 -0.587 . . . . 74.420000000000002 112.251 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.63 126.99 17.06 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 122.627 2.218 . . . . 65.349999999999994 112.316 177.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 32.8 m -129.59 162.78 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.509 0.724 . . . . 53.43 110.058 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -95.42 105.55 17.53 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 121.584 0.707 . . . . 72.409999999999997 109.991 175.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.464 HG22 HD22 ' A' ' 171' ' ' LEU . 55.3 t -99.77 126.77 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.793 0.837 . . . . 71.099999999999994 109.838 -174.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.554 ' HB1' HH11 ' A' ' 172' ' ' ARG . . . -76.63 100.01 5.22 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 123.946 0.779 . . . . 64.439999999999998 110.893 -177.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.561 ' HA ' HD12 ' A' ' 173' ' ' ILE . 59.5 t -69.25 141.94 91.98 Favored Pre-proline 0 CA--C 1.56 1.363 0 C-N-CA 125.662 1.585 . . . . 72.439999999999998 110.492 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.61 ' HD3' ' HB ' ' A' ' 173' ' ' ILE . 90.0 Cg_endo -76.88 163.12 31.61 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 122.313 2.008 . . . . 60.109999999999999 110.855 173.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.55 160.99 45.32 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 121.471 1.447 . . . . 63.020000000000003 111.207 172.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 69.24 14.24 8.6 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.762 1.225 . . . . 52.420000000000002 112.651 177.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 85.2 m -62.16 113.18 2.71 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.843 0.857 . . . . 53.130000000000003 110.438 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -112.92 141.2 47.03 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.916 0.886 . . . . 74.219999999999999 110.602 -168.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.52 144.02 57.33 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.778 0.831 . . . . 75.450000000000003 111.377 -177.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.03 -22.65 13.56 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.303 -0.862 . . . . 44.130000000000003 113.035 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -79.58 150.32 31.1 Favored 'General case' 0 C--N 1.351 0.657 0 N-CA-C 109.438 -0.578 . . . . 61.140000000000001 109.438 173.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.662 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.4 mppt? -114.53 142.87 45.84 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.041 0.536 . . . . 62.420000000000002 109.852 177.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.634 HD13 HG21 ' A' ' 173' ' ' ILE . 46.2 mt -100.09 99.42 10.14 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.683 -0.858 . . . . 51.119999999999997 108.683 -176.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 27.3 ttm-85 -75.06 113.97 13.0 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 123.479 0.487 . . . . 74.120000000000005 109.936 -176.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.71 HD21 HG23 ' A' ' 173' ' ' ILE . 46.0 mt -120.54 102.06 8.17 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.509 0.724 . . . . 65.099999999999994 109.237 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -67.62 140.12 56.87 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.879 0.472 . . . . 74.239999999999995 111.581 -176.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.431 ' HA2' ' HB2' ' A' ' 246' ' ' ARG . . . 84.32 9.83 81.17 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 115.788 -0.642 . . . . 61.530000000000001 114.302 178.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -104.65 -16.47 14.98 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 117.682 0.741 . . . . 61.399999999999999 111.8 -176.802 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -81.15 -161.69 27.19 Favored Glycine 0 CA--C 1.535 1.293 0 O-C-N 123.535 0.522 . . . . 45.140000000000001 112.86 173.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.645 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 27.8 m-85 -65.98 151.28 95.54 Favored Pre-proline 0 N--CA 1.487 1.395 0 C-N-CA 123.373 0.669 . . . . 75.420000000000002 111.657 -178.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.458 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 37.9 Cg_endo -64.6 128.99 22.41 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.885 2.39 . . . . 64.0 112.708 176.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -98.32 -156.06 29.58 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 119.233 -0.759 . . . . 42.229999999999997 112.19 176.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -59.11 -61.32 0.25 Allowed 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 122.977 2.451 . . . . 73.430000000000007 112.497 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -122.22 -13.08 8.18 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.686 0.794 . . . . 61.310000000000002 111.941 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -142.15 146.39 17.35 Favored Glycine 0 C--N 1.344 0.984 0 N-CA-C 111.732 -0.547 . . . . 75.329999999999998 111.732 -178.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.458 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 86.8 mtt180 -74.87 162.72 28.38 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.597 0.759 . . . . 74.140000000000001 110.231 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.8 173.98 55.27 Favored Glycine 0 C--N 1.342 0.916 0 CA-C-N 115.94 -0.573 . . . . 60.219999999999999 112.969 177.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -103.44 130.95 50.89 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.742 0.817 . . . . 62.399999999999999 110.631 -175.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 53.5 tp -102.94 117.42 34.56 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 123.86 0.864 . . . . 62.549999999999997 109.118 -173.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.662 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 19.5 m-85 -89.12 111.74 22.56 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.473 -0.936 . . . . 75.129999999999995 108.473 177.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.489 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 60.0 mt -85.85 111.57 20.31 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.642 -0.873 . . . . 55.049999999999997 108.642 175.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.405 ' HA ' ' HG3' ' A' ' 232' ' ' LYS . 31.6 mt-10 -76.05 101.43 5.28 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.237 -0.892 . . . . 74.230000000000004 108.971 -175.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 44.9 t -61.58 111.39 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 O-C-N 123.577 0.548 . . . . 63.210000000000001 110.84 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -114.0 93.6 4.44 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 106.598 -1.63 . . . . 75.409999999999997 106.598 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 26.9 mt -76.25 118.07 21.96 Favored 'Isoleucine or valine' 0 C--N 1.349 0.586 0 N-CA-C 109.405 -0.591 . . . . 53.420000000000002 109.405 -177.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 19.6 p . . . . . 0 C--O 1.253 1.275 0 C-N-CA 125.232 1.413 . . . . 65.439999999999998 107.922 -176.751 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 28.5 mmt . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 110.473 -0.195 . . . . 75.219999999999999 110.473 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 32.9 m -95.8 -83.72 0.36 Allowed 'General case' 0 C--N 1.35 0.607 0 N-CA-C 108.379 -0.971 . . . . 61.420000000000002 108.379 167.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 58.03 18.99 5.56 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.582 1.153 . . . . 74.230000000000004 112.837 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 8.6 mp -61.24 87.3 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 123.196 0.598 . . . . 62.109999999999999 110.429 -176.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -78.94 135.32 36.92 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.272 0.629 . . . . 64.030000000000001 109.493 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.719 HD12 ' HA ' ' A' ' 223' ' ' VAL . 97.4 mt -84.8 -73.44 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-N 115.582 -0.735 . . . . 55.420000000000002 110.32 -176.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . 61.03 5.35 0.99 Allowed 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 113.925 1.083 . . . . 52.109999999999999 113.925 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.599 ' H ' HG22 ' A' ' 173' ' ' ILE . . . -70.56 -21.24 62.72 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.135 0.974 . . . . 62.420000000000002 112.108 -172.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.412 ' HE1' ' HA ' ' A' ' 227' ' ' THR . 12.3 m-30 -70.62 104.36 2.79 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.597 -0.52 . . . . 75.099999999999994 109.597 173.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 145.4 175.7 18.74 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.382 -1.087 . . . . 61.329999999999998 110.382 -176.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.3 -29.07 72.6 Favored 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 122.766 2.311 . . . . 75.200000000000003 112.867 175.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -143.74 129.36 19.18 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.544 0.738 . . . . 71.409999999999997 109.875 178.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -88.64 -91.51 1.11 Allowed Glycine 0 C--N 1.348 1.205 0 N-CA-C 110.543 -1.023 . . . . 52.25 110.543 172.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 36.7 t -86.23 123.61 31.69 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.705 -0.85 . . . . 71.540000000000006 108.705 171.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -94.14 31.9 6.32 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-O 119.694 -0.503 . . . . 71.010000000000005 113.901 -175.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -69.2 91.87 0.3 Allowed Glycine 0 C--N 1.351 1.395 0 N-CA-C 111.384 -0.687 . . . . 73.439999999999998 111.384 174.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 25.9 t -62.72 93.73 0.06 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.092 0.957 . . . . 44.119999999999997 111.362 -174.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.462 ' HA3' ' HB2' ' A' ' 244' ' ' ALA . . . -121.08 2.17 11.64 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 115.344 -0.844 . . . . 72.420000000000002 112.102 176.025 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 70.9 -85.28 0.38 Allowed Glycine 0 C--N 1.351 1.398 0 N-CA-C 111.885 -0.486 . . . . 72.049999999999997 111.885 -175.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.3 p -171.51 153.94 3.65 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.586 1.154 . . . . 74.310000000000002 109.528 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -111.78 -43.54 0.95 Allowed Glycine 0 C--N 1.344 1.0 0 N-CA-C 112.165 -0.374 . . . . 54.32 112.165 177.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 140.56 -131.47 5.01 Favored Glycine 0 C--N 1.354 1.545 0 C-N-CA 123.186 0.422 . . . . 54.119999999999997 112.238 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 27.5 m -81.92 25.32 0.57 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.949 0.9 . . . . 73.209999999999994 112.04 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -81.24 1.82 30.65 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.945 0.898 . . . . 63.43 112.154 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -80.1 159.43 26.1 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.623 0.769 . . . . 72.430000000000007 110.934 174.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 49.2 mt -139.35 150.68 45.63 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.79 0.836 . . . . 62.219999999999999 109.832 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -107.49 122.21 46.17 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.973 -0.751 . . . . 73.409999999999997 108.973 173.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -129.41 137.13 50.74 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.438 0.695 . . . . 74.129999999999995 109.248 178.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 96.2 m -71.73 131.67 43.45 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.862 0.465 . . . . 65.340000000000003 110.815 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.459 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 53.8 tp -108.25 123.88 49.44 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.255 -1.017 . . . . 61.130000000000003 108.255 175.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -88.65 117.53 27.68 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 108.488 -0.93 . . . . 61.420000000000002 108.488 176.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 4.4 p -140.48 125.84 11.3 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 109.057 -0.72 . . . . 72.409999999999997 109.057 178.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.61 154.41 54.76 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 122.136 1.891 . . . . 62.240000000000002 111.749 175.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.68 -45.34 91.56 Favored Pre-proline 0 CA--C 1.562 1.427 0 N-CA-C 114.629 1.344 . . . . 73.319999999999993 114.629 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -56.24 -52.69 6.64 Favored 'Trans proline' 0 C--N 1.392 2.827 0 C-N-CA 121.914 1.743 . . . . 55.420000000000002 113.099 174.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 32.8 mt -67.02 -27.66 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.218 0.607 . . . . 74.420000000000002 111.167 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.31 -48.83 69.08 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-O 121.26 0.553 . . . . 43.229999999999997 110.839 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 71.1 t -69.21 -46.29 77.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-N 115.798 -0.637 . . . . 71.129999999999995 111.764 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 14.4 m -86.6 -29.87 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 112.287 0.477 . . . . 61.219999999999999 112.287 -172.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.89 116.39 0.54 Allowed Glycine 0 CA--C 1.531 1.053 0 O-C-N 123.322 0.389 . . . . 64.230000000000004 113.298 -173.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -165.11 -177.68 37.78 Favored Glycine 0 N--CA 1.473 1.108 0 N-CA-C 111.687 -0.565 . . . . 72.239999999999995 111.687 176.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -80.86 136.01 36.01 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 118.113 0.957 . . . . 72.209999999999994 109.994 -176.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 27.6 m -124.91 168.56 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 123.644 0.778 . . . . 72.209999999999994 111.15 178.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 55.2 ttp85 -83.4 131.65 35.03 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.288 -0.869 . . . . 75.349999999999994 110.019 173.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -134.35 159.74 40.07 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.25 0.62 . . . . 63.119999999999997 110.457 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 15.9 tpt -88.0 123.4 32.67 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.13 0.572 . . . . 63.109999999999999 110.717 -177.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.434 HG22 ' H ' ' A' ' 216' ' ' GLU . 50.8 m -144.52 161.06 40.03 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.964 0.906 . . . . 64.140000000000001 108.652 178.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 68.2 mt -63.78 -19.15 64.77 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.8 0.84 . . . . 65.430000000000007 111.763 176.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.434 ' H ' HG22 ' A' ' 214' ' ' THR . 3.2 mp0 -93.51 15.06 16.88 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.828 1.251 . . . . 72.019999999999996 111.155 175.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 90.54 -164.85 30.71 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-O 119.746 -0.475 . . . . 73.019999999999996 113.297 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.31 118.93 5.92 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.575 2.184 . . . . 51.43 111.616 174.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.7 m -113.06 149.78 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 123.023 0.529 . . . . 70.519999999999996 110.882 -176.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -82.29 114.85 21.06 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.643 0.777 . . . . 74.409999999999997 110.227 177.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 98.4 t -109.16 116.36 51.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.96 0.904 . . . . 72.010000000000005 109.308 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.84 100.64 2.44 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.573 0.749 . . . . 72.430000000000007 110.563 -177.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.719 ' HA ' HD12 ' A' ' 173' ' ' ILE . 69.4 t -77.35 134.61 66.48 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 124.54 1.136 . . . . 74.25 110.273 178.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.88 171.54 17.8 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 122.958 2.439 . . . . 73.319999999999993 110.905 172.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -71.38 168.52 23.24 Favored 'Trans proline' 0 C--N 1.366 1.485 0 CA-C-N 120.614 1.255 . . . . 64.0 111.3 170.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 14.9 mtm180 66.92 20.21 10.54 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 124.042 0.937 . . . . 75.219999999999999 112.29 173.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.412 ' HA ' ' HE1' ' A' ' 176' ' ' TYR . 99.8 m -69.56 113.28 6.7 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.698 0.799 . . . . 73.510000000000005 111.011 -178.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -115.32 141.81 47.54 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.112 -0.949 . . . . 72.140000000000001 110.125 -169.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.45 133.81 54.57 Favored 'General case' 0 C--N 1.35 0.611 0 C-N-CA 123.58 0.752 . . . . 71.519999999999996 111.665 -176.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.71 -15.12 61.28 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-N 115.332 -0.849 . . . . 54.200000000000003 113.159 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -77.02 124.6 28.02 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.798 0.439 . . . . 71.329999999999998 110.143 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.4 mppt? -88.05 143.9 26.82 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.041 0.536 . . . . 75.099999999999994 110.022 173.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.714 HD13 HD13 ' A' ' 173' ' ' ILE . 33.9 mt -109.27 103.28 12.21 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.299 -0.864 . . . . 64.310000000000002 109.224 -173.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -69.91 103.48 2.24 Favored 'General case' 0 CA--C 1.551 1.006 0 O-C-N 124.096 0.872 . . . . 74.430000000000007 111.121 -176.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 32.4 mt -119.45 94.34 4.38 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.611 0.764 . . . . 64.409999999999997 110.223 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -71.26 154.62 41.5 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.703 0.401 . . . . 61.219999999999999 111.289 178.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 82.11 18.4 67.29 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-N 115.992 -0.549 . . . . 53.509999999999998 113.987 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.477 ' HA ' ' HE2' ' A' ' 238' ' ' LYS . 11.3 mmpt? -118.87 -41.34 2.78 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 123.461 0.704 . . . . 60.409999999999997 111.718 -177.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -71.91 -153.97 1.83 Allowed Glycine 0 N--CA 1.485 1.916 0 N-CA-C 114.625 0.61 . . . . 73.239999999999995 114.625 -176.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -64.05 136.9 96.94 Favored Pre-proline 0 N--CA 1.485 1.296 0 C-N-CA 123.517 0.727 . . . . 74.409999999999997 110.813 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.765 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 18.6 Cg_endo -56.96 125.93 20.59 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 123.204 2.603 . . . . 74.409999999999997 113.97 -174.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -126.18 -169.84 12.88 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.505 -0.77 . . . . 62.32 113.311 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -69.25 -12.8 34.72 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 123.098 2.532 . . . . 70.109999999999999 112.611 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.462 ' HB2' ' HA3' ' A' ' 185' ' ' GLY . . . -102.42 23.3 12.04 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.491 1.116 . . . . 74.219999999999999 110.992 177.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 98.39 -87.62 0.83 Allowed Glycine 0 C--N 1.345 1.061 0 N-CA-C 110.473 -1.051 . . . . 63.140000000000001 110.473 -174.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.765 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 28.8 mtm180 -125.57 172.82 9.41 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 123.238 0.615 . . . . 54.5 109.774 172.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -84.25 -158.73 28.4 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 114.922 -1.035 . . . . 74.519999999999996 113.565 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -99.77 162.09 13.21 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.836 0.454 . . . . 51.240000000000002 109.95 -170.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 40.6 tp -141.98 108.78 5.4 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 108.271 -1.011 . . . . 53.039999999999999 108.271 173.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.476 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 78.4 m-85 -88.74 108.13 19.32 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 108.732 -0.84 . . . . 73.010000000000005 108.732 175.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 38.9 mt -86.92 114.98 24.01 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.704 -0.85 . . . . 74.340000000000003 108.704 177.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -78.26 102.92 7.88 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.781 0.832 . . . . 63.450000000000003 109.365 -178.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 84.7 t -56.0 111.97 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 O-C-N 123.771 0.669 . . . . 74.040000000000006 110.68 175.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -113.4 101.8 9.72 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.288 -1.004 . . . . 71.400000000000006 108.288 172.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 37.1 mt -76.34 103.7 3.93 Favored 'Isoleucine or valine' 0 C--N 1.35 0.621 0 O-C-N 124.206 0.941 . . . . 65.340000000000003 109.004 177.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 46.7 p . . . . . 0 C--O 1.254 1.326 0 CA-C-N 115.506 -0.77 . . . . 73.319999999999993 109.07 176.09 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 87.9 mtp . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.72 0.295 . . . . 75.430000000000007 110.205 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 45.4 t -148.13 151.28 35.33 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 123.896 0.878 . . . . 74.150000000000006 108.962 176.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -67.05 -49.95 63.45 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 123.916 0.76 . . . . 62.439999999999998 109.179 174.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.479 ' HA ' ' HD2' ' A' ' 238' ' ' LYS . 6.5 mp -89.41 71.8 8.05 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.448 -0.945 . . . . 64.030000000000001 108.448 172.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.06 105.74 5.43 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 107.364 -1.347 . . . . 73.319999999999993 107.364 176.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.607 HD12 ' HA ' ' A' ' 223' ' ' VAL . 49.3 mt -72.85 100.12 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.207 0.527 . . . . 74.530000000000001 110.788 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -92.74 35.33 1.04 Allowed 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.144 -0.934 . . . . 62.5 109.625 171.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.403 ' H ' HG22 ' A' ' 173' ' ' ILE . . . -121.71 177.7 5.15 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.713 1.205 . . . . 43.299999999999997 108.789 176.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.498 ' CE2' HD21 ' A' ' 233' ' ' LEU . 24.2 m-85 66.83 19.64 10.66 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.543 1.137 . . . . 61.350000000000001 110.846 -164.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -110.57 -132.59 6.23 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-O 119.155 -0.803 . . . . 63.310000000000002 111.866 -178.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -86.14 171.28 7.92 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 122.876 2.384 . . . . 75.540000000000006 113.315 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -127.38 123.49 36.33 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.322 1.049 . . . . 73.340000000000003 109.715 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 153.15 -32.78 0.79 Allowed Glycine 0 C--N 1.343 0.94 0 N-CA-C 111.71 -0.556 . . . . 44.229999999999997 111.71 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 22.9 p -67.36 102.68 1.13 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.508 0.723 . . . . 75.140000000000001 109.314 175.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 148.72 59.63 0.01 OUTLIER Glycine 0 C--N 1.338 0.656 0 N-CA-C 109.711 -1.356 . . . . 61.340000000000003 109.711 -173.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -129.26 -7.55 3.96 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.329 -0.436 . . . . 72.010000000000005 113.195 -178.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 95.6 p -73.92 152.62 40.1 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 117.182 0.491 . . . . 74.430000000000007 110.06 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -82.73 79.34 1.91 Allowed Glycine 0 CA--C 1.528 0.855 0 CA-C-O 119.81 -0.439 . . . . 64.409999999999997 112.677 -177.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -68.78 111.13 3.76 Favored Glycine 0 C--N 1.356 1.679 0 N-CA-C 111.741 -0.544 . . . . 74.209999999999994 111.741 176.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 48.0 m -125.04 102.46 7.52 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.7 0.8 . . . . 51.140000000000001 110.594 -177.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -163.02 -45.04 0.02 OUTLIER Glycine 0 C--N 1.338 0.693 0 N-CA-C 111.901 -0.479 . . . . 54.549999999999997 111.901 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 124.92 -132.02 7.97 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 111.365 -0.694 . . . . 63.409999999999997 111.365 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 67.5 m -88.52 68.79 8.83 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.369 0.668 . . . . 65.310000000000002 112.063 -175.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 14.5 pm0 -88.59 -20.86 24.45 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 108.786 -0.82 . . . . 61.539999999999999 108.786 162.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -75.83 130.4 38.51 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.656 1.583 . . . . 74.540000000000006 108.943 176.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.467 HD12 ' HA2' ' A' ' 239' ' ' GLY . 92.8 mt -135.67 163.91 29.07 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.861 0.864 . . . . 63.520000000000003 110.697 -175.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -121.52 153.5 37.9 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.252 1.021 . . . . 41.119999999999997 108.962 171.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.444 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -152.78 171.29 18.47 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.551 1.14 . . . . 62.200000000000003 109.366 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 25.0 m -106.8 131.68 53.64 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.489 0.716 . . . . 52.409999999999997 109.485 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.722 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 42.8 tp -109.02 113.84 27.06 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.594 0.758 . . . . 71.219999999999999 109.008 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -83.66 116.85 22.83 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 107.75 -1.204 . . . . 64.409999999999997 107.75 172.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.455 HG11 HG13 ' A' ' 253' ' ' VAL . 2.4 p -138.15 120.54 10.85 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 123.794 0.837 . . . . 73.129999999999995 109.281 -178.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.1 158.42 56.58 Favored 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 122.218 1.946 . . . . 73.239999999999995 112.311 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.402 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -51.38 -48.56 85.8 Favored Pre-proline 0 CA--C 1.565 1.545 0 C-N-CA 124.459 1.103 . . . . 74.129999999999995 113.87 -177.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.474 ' O ' HG12 ' A' ' 206' ' ' VAL . 53.7 Cg_exo -54.24 -54.38 4.77 Favored 'Trans proline' 0 C--N 1.401 3.296 0 C-N-CA 122.377 2.051 . . . . 72.510000000000005 112.687 175.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 58.1 mt -67.62 -27.98 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.267 0.627 . . . . 51.009999999999998 111.041 -176.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.59 -41.59 96.15 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.199 -0.455 . . . . 52.409999999999997 110.416 176.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 201' ' ' ALA . 64.3 t -74.86 -57.57 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 CA-C-N 116.545 -0.298 . . . . 70.219999999999999 111.63 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 202' ' ' PRO . 12.4 p -93.14 -28.48 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 112.666 0.617 . . . . 74.129999999999995 112.666 -167.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 98.12 144.99 18.05 Favored Glycine 0 N--CA 1.477 1.388 0 C-N-CA 122.472 0.082 . . . . 71.340000000000003 113.183 -177.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 170.23 -167.76 40.84 Favored Glycine 0 N--CA 1.472 1.058 0 N-CA-C 110.664 -0.974 . . . . 74.129999999999995 110.664 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -96.88 138.28 34.68 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 118.336 1.068 . . . . 54.420000000000002 110.939 175.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 15.4 m -119.85 170.19 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.448 1.099 . . . . 63.119999999999997 109.764 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -102.03 112.24 24.82 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 110.021 -0.363 . . . . 74.230000000000004 110.021 174.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -105.34 166.44 10.42 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.983 0.913 . . . . 64.439999999999998 109.817 171.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 91.3 mmm -101.96 132.81 47.55 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 120.911 0.386 . . . . 62.420000000000002 110.276 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 88.1 m -132.79 167.51 20.03 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.869 1.268 . . . . 63.43 108.547 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 82.6 mt -54.83 -38.78 67.83 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.991 0.917 . . . . 63.32 112.665 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -78.25 -15.6 58.63 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.063 0.545 . . . . 65.230000000000004 111.799 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 132.78 -164.27 24.07 Favored Glycine 0 C--N 1.344 1.027 0 O-C-N 123.617 0.573 . . . . 71.540000000000006 111.727 -177.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.47 128.72 12.16 Favored 'Trans proline' 0 CA--C 1.555 1.538 0 C-N-CA 122.79 2.327 . . . . 53.140000000000001 112.007 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.32 159.89 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.322 1.049 . . . . 72.310000000000002 110.015 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 37.7 mt-10 -84.83 147.47 26.8 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 122.78 0.432 . . . . 74.450000000000003 110.599 169.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.438 HG22 ' HB2' ' A' ' 171' ' ' LEU . 96.9 t -130.75 124.23 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.163 1.385 . . . . 65.0 108.46 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -77.59 99.28 5.69 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 108.937 -0.764 . . . . 73.349999999999994 108.937 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.607 ' HA ' HD12 ' A' ' 173' ' ' ILE . 88.2 t -96.2 123.33 55.34 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.504 1.122 . . . . 74.019999999999996 110.566 -175.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.0 164.2 36.42 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.739 2.292 . . . . 70.349999999999994 111.384 175.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.87 177.0 0.37 Allowed 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 122.714 2.276 . . . . 65.219999999999999 113.418 174.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 24.0 mtp180 66.03 20.63 11.27 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.35 1.06 . . . . 63.329999999999998 112.324 174.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -68.86 88.69 0.38 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.686 0.794 . . . . 62.409999999999997 110.473 -173.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 -86.28 131.3 34.25 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.894 1.278 . . . . 73.030000000000001 110.573 -172.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.99 120.29 8.82 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.407 1.083 . . . . 62.340000000000003 111.97 -175.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.0 -4.51 41.72 Favored Glycine 0 N--CA 1.473 1.148 0 O-C-N 123.835 0.71 . . . . 73.420000000000002 114.386 176.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -84.62 157.32 21.2 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 117.552 0.676 . . . . 62.219999999999999 109.977 173.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.706 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.5 mppt? -127.3 131.55 50.47 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.943 -0.762 . . . . 74.209999999999994 108.943 -172.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.498 HD21 ' CE2' ' A' ' 176' ' ' TYR . 20.4 mt -108.56 102.43 11.5 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.601 -0.727 . . . . 72.450000000000003 109.791 -166.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -70.48 103.69 2.54 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.117 1.367 . . . . 75.129999999999995 110.939 -173.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.601 HD11 HG12 ' A' ' 173' ' ' ILE . 26.6 mt -118.19 100.16 7.33 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 122.944 0.498 . . . . 73.109999999999999 112.045 -175.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -56.52 142.06 40.51 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.162 0.801 . . . . 71.239999999999995 113.162 169.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 100.09 -14.12 60.04 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-N 113.649 -1.614 . . . . 74.439999999999998 112.665 174.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.479 ' HD2' ' HA ' ' A' ' 171' ' ' LEU . 11.4 mmpt? -99.89 -20.04 16.34 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.918 0.487 . . . . 70.219999999999999 111.967 -171.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' GLY . . . . . 0.467 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -77.92 -162.26 18.5 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.496 0.498 . . . . 70.510000000000005 113.656 177.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -80.77 154.64 73.34 Favored Pre-proline 0 N--CA 1.487 1.407 0 C-N-CA 123.2 0.6 . . . . 60.229999999999997 111.022 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -48.35 130.81 21.86 Favored 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 123.8 3.0 . . . . 74.329999999999998 114.302 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -138.89 -177.4 15.36 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 119.732 -0.482 . . . . 72.150000000000006 112.917 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -64.94 -35.31 44.36 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 124.138 3.225 . . . . 71.140000000000001 113.863 -172.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -106.87 7.98 30.42 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.634 0.774 . . . . 54.439999999999998 111.006 -177.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 127.37 175.09 13.97 Favored Glycine 0 C--N 1.341 0.82 0 N-CA-C 111.229 -0.748 . . . . 24.440000000000001 111.229 -174.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 30.2 mtm180 -59.03 129.14 40.72 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.892 -0.781 . . . . 74.310000000000002 108.892 175.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -67.29 -156.84 0.63 Allowed Glycine 0 C--N 1.341 0.858 0 O-C-N 123.865 0.728 . . . . 75.450000000000003 114.835 -170.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -96.23 160.85 14.22 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.263 0.554 . . . . 74.129999999999995 110.406 -170.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.444 HD11 ' HB2' ' A' ' 195' ' ' ALA . 31.1 tp -137.52 114.68 10.86 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.3 -1.37 . . . . 60.340000000000003 107.3 175.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.706 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 1.9 m-85 -91.18 108.84 20.14 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.994 -0.743 . . . . 74.430000000000007 108.994 -177.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.722 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 43.2 mt -86.36 107.49 18.03 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.548 -0.538 . . . . 75.319999999999993 109.548 -178.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -82.95 108.48 16.31 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.027 -0.988 . . . . 62.340000000000003 110.183 -174.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.455 HG13 HG11 ' A' ' 199' ' ' VAL . 61.1 t -56.3 120.16 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 C-N-CA 125.337 1.455 . . . . 63.409999999999997 112.581 -173.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 53.4 mmt-85 -114.8 96.91 5.95 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.724 1.21 . . . . 74.109999999999999 108.001 170.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 53.8 mt -74.89 103.85 2.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.936 -1.135 . . . . 63.329999999999998 107.936 175.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 25.3 p . . . . . 0 CA--C 1.555 1.166 0 N-CA-C 108.727 -0.842 . . . . 61.329999999999998 108.727 174.497 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 22.9 ptp . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 112.368 0.507 . . . . 74.120000000000005 112.368 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 49.5 m -63.99 132.45 50.68 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 123.036 0.534 . . . . 74.310000000000002 111.278 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -81.05 134.69 35.71 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.042 0.537 . . . . 74.540000000000006 109.599 176.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 6.3 mp -80.89 101.32 9.36 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.504 -0.925 . . . . 73.150000000000006 108.504 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.513 ' HA ' ' HB3' ' A' ' 222' ' ' ALA . 45.8 mtm180 -87.82 144.19 26.73 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 110.068 -0.345 . . . . 74.200000000000003 110.068 177.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.693 HG22 ' H ' ' A' ' 175' ' ' ALA . 75.8 mt -87.62 -74.1 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 115.558 -0.746 . . . . 61.399999999999999 110.189 177.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . 66.25 -7.75 0.39 Allowed 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 125.346 1.459 . . . . 64.109999999999999 113.382 -176.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.693 ' H ' HG22 ' A' ' 173' ' ' ILE . . . -70.54 -3.69 19.3 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.53 1.132 . . . . 41.520000000000003 112.897 -174.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.539 ' CZ ' ' HA ' ' A' ' 227' ' ' THR . 8.5 m-85 -84.99 7.69 20.39 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.07 0.548 . . . . 74.439999999999998 111.109 169.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -132.19 -172.13 12.97 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-O 119.404 -0.664 . . . . 72.219999999999999 112.682 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -57.98 -50.78 9.29 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 123.513 2.809 . . . . 63.539999999999999 112.359 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -83.64 111.31 19.01 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.515 -0.766 . . . . 73.129999999999995 109.723 175.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -85.72 -99.54 0.73 Allowed Glycine 0 C--N 1.341 0.84 0 N-CA-C 110.423 -1.071 . . . . 44.439999999999998 110.423 169.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.2 t -139.8 154.14 47.29 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 108.455 -0.943 . . . . 74.439999999999998 108.455 171.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -80.68 -147.66 5.26 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 123.531 0.519 . . . . 75.25 113.657 -173.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 175.23 -173.24 46.12 Favored Glycine 0 C--N 1.342 0.873 0 N-CA-C 112.018 -0.433 . . . . 75.319999999999993 112.018 -178.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 20.7 m -77.8 -17.1 57.84 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.71 0.804 . . . . 62.240000000000002 111.515 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 113.22 -6.69 25.08 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-O 119.431 -0.649 . . . . 53.409999999999997 114.102 172.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.419 ' HA3' ' HB1' ' A' ' 244' ' ' ALA . . . -112.91 141.6 16.96 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-N 117.6 0.7 . . . . 61.25 111.673 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 26.4 t -85.84 82.23 8.25 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.019 -0.734 . . . . 42.219999999999999 109.019 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -163.14 67.73 0.23 Allowed Glycine 0 C--N 1.343 0.968 0 CA-C-N 115.398 -0.819 . . . . 72.349999999999994 111.314 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -130.99 60.09 0.68 Allowed Glycine 0 C--N 1.341 0.834 0 CA-C-N 114.897 -0.652 . . . . 70.019999999999996 112.253 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 31.2 m -68.09 -4.42 13.54 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.934 0.894 . . . . 71.420000000000002 112.09 174.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.672 ' HB3' ' HB2' ' A' ' 240' ' ' PHE . 85.9 mm-40 -81.41 26.27 0.47 Allowed 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.527 1.131 . . . . 72.409999999999997 111.654 172.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -75.67 154.09 36.76 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.086 0.954 . . . . 55.130000000000003 110.739 -178.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 87.9 mt -131.93 158.56 41.09 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.767 0.827 . . . . 54.100000000000001 110.051 -173.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -115.0 124.2 51.04 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.994 -1.113 . . . . 74.329999999999998 107.994 173.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -124.94 129.31 50.11 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.374 -0.973 . . . . 74.439999999999998 108.374 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 42.3 m -68.39 126.29 29.13 Favored 'General case' 0 C--O 1.242 0.708 0 O-C-N 123.517 0.511 . . . . 70.040000000000006 110.22 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.484 HD12 ' HB2' ' A' ' 212' ' ' ALA . 46.0 tp -106.84 109.95 21.98 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.034 -1.469 . . . . 71.540000000000006 107.034 177.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -92.17 118.04 30.45 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.242 -1.021 . . . . 54.399999999999999 108.242 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.461 HG23 HG11 ' A' ' 210' ' ' VAL . 5.7 p -137.85 131.71 17.02 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 123.335 0.654 . . . . 74.120000000000005 109.784 -176.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -76.34 157.81 37.09 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.241 1.961 . . . . 73.299999999999997 111.701 172.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -55.0 -46.23 99.7 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 124.415 1.086 . . . . 71.310000000000002 113.543 -176.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.448 ' O ' HG12 ' A' ' 206' ' ' VAL . 71.2 Cg_exo -53.56 -54.99 3.98 Favored 'Trans proline' 0 C--N 1.402 3.381 0 C-N-CA 122.272 1.981 . . . . 73.099999999999994 112.78 174.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 48.7 mt -69.84 -21.03 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.3 0.64 . . . . 64.5 110.756 -176.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.2 -48.52 56.77 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.851 0.46 . . . . 65.129999999999995 110.342 176.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.0 -55.69 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 CA-C-N 115.959 -0.564 . . . . 63.299999999999997 111.431 -177.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 202' ' ' PRO . 14.6 p -87.15 -32.21 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 N-CA-C 112.611 0.597 . . . . 64.120000000000005 112.611 -172.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 101.53 166.68 27.48 Favored Glycine 0 N--CA 1.477 1.374 0 N-CA-C 112.076 -0.41 . . . . 74.010000000000005 112.076 -173.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 163.43 -131.94 2.6 Favored Glycine 0 C--N 1.345 1.032 0 N-CA-C 111.456 -0.658 . . . . 52.310000000000002 111.456 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -137.86 139.05 39.69 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.655 1.182 . . . . 72.120000000000005 108.594 174.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.461 HG11 HG23 ' A' ' 199' ' ' VAL . 32.3 m -136.53 168.02 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 122.956 0.502 . . . . 71.0 110.563 178.116 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 29.3 ttm-85 -87.51 113.19 22.98 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.763 -0.653 . . . . 70.239999999999995 109.887 178.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.484 ' HB2' HD12 ' A' ' 197' ' ' LEU . . . -105.79 158.42 16.75 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.842 0.857 . . . . 40.329999999999998 110.238 173.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 36.8 tpp -93.26 110.68 22.2 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.923 -0.769 . . . . 64.0 108.923 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 60.5 m -126.0 163.88 22.05 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.308 1.043 . . . . 64.239999999999995 109.815 -175.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 95.6 mt -61.81 -17.25 55.49 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.968 0.907 . . . . 62.310000000000002 112.965 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -96.59 8.39 44.26 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.471 0.708 . . . . 65.400000000000006 111.485 177.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 102.42 -164.01 16.66 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-O 119.708 -0.495 . . . . 61.299999999999997 112.129 -176.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.36 118.12 5.07 Favored 'Trans proline' 0 C--N 1.367 1.537 0 C-N-CA 122.124 1.883 . . . . 75.230000000000004 110.906 175.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.7 m -118.42 157.29 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 123.478 0.711 . . . . 73.049999999999997 110.51 -175.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -90.56 108.83 20.05 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.148 -0.686 . . . . 60.119999999999997 109.148 173.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 94.3 t -97.8 129.06 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.091 0.956 . . . . 73.340000000000003 109.942 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 172' ' ' ARG . . . -69.88 103.09 2.12 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.999 0.92 . . . . 65.25 110.142 176.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.543 ' HA ' HD12 ' A' ' 173' ' ' ILE . 97.2 t -89.97 125.96 58.93 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 124.088 0.955 . . . . 74.230000000000004 110.166 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -78.18 171.44 17.06 Favored 'Trans proline' 0 CA--C 1.561 1.846 0 C-N-CA 123.163 2.575 . . . . 61.140000000000001 111.617 173.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.21 174.25 8.33 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.095 1.863 . . . . 72.319999999999993 113.694 174.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 67.16 15.37 10.03 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 125.903 1.681 . . . . 64.349999999999994 112.505 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.539 ' HA ' ' CZ ' ' A' ' 176' ' ' TYR . 93.9 m -64.75 100.96 0.43 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.523 0.729 . . . . 73.340000000000003 110.139 -176.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -101.83 137.26 40.36 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 125.135 1.374 . . . . 75.25 110.323 -174.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.92 132.9 53.65 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.568 1.147 . . . . 54.43 110.993 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.03 -1.55 67.93 Favored Glycine 0 C--N 1.337 0.613 0 O-C-N 123.849 0.718 . . . . 61.140000000000001 113.281 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -86.86 151.2 23.54 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 109.605 -0.517 . . . . 74.230000000000004 109.605 170.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.501 ' HG3' ' HA ' ' A' ' 252' ' ' GLU . 3.8 mppt? -131.67 139.03 48.96 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.279 -1.008 . . . . 73.340000000000003 108.279 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.585 HD13 HG21 ' A' ' 173' ' ' ILE . 29.1 mt -118.05 109.24 16.2 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.287 0.635 . . . . 74.319999999999993 110.309 -161.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 45.1 ttm-85 -76.96 108.9 10.35 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 124.057 0.848 . . . . 73.209999999999994 110.16 -174.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.454 HD21 HG23 ' A' ' 173' ' ' ILE . 21.8 mt -107.03 89.79 3.11 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.591 -0.892 . . . . 70.209999999999994 108.591 176.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.517 ' HG2' ' HB3' ' A' ' 248' ' ' ASP . 10.6 mtmp? -67.1 136.08 54.61 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.416 -0.357 . . . . 71.129999999999995 111.147 -177.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 95.24 -0.83 64.16 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 115.319 -0.855 . . . . 54.130000000000003 113.456 -175.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.53 ' HA ' ' HE2' ' A' ' 238' ' ' LYS . 10.4 mmpt? -106.55 -9.26 16.67 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 113.277 0.844 . . . . 71.010000000000005 113.277 -175.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.11 179.53 50.93 Favored Glycine 0 N--CA 1.476 1.334 0 N-CA-C 111.571 -0.612 . . . . 62.399999999999999 111.571 167.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.672 ' HB2' ' HB3' ' A' ' 191' ' ' GLN . 33.3 m-85 -60.28 154.33 53.29 Favored Pre-proline 0 N--CA 1.489 1.477 0 C-N-CA 123.42 0.688 . . . . 73.219999999999999 111.812 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 36.6 Cg_endo -63.79 129.36 24.54 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.477 2.118 . . . . 62.439999999999998 112.83 177.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -119.33 -175.22 15.96 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-O 119.451 -0.638 . . . . 63.409999999999997 112.256 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -60.13 -46.57 18.26 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 123.462 2.775 . . . . 71.219999999999999 112.974 -177.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.419 ' HB1' ' HA3' ' A' ' 186' ' ' GLY . . . -98.6 22.34 10.03 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.362 0.665 . . . . 45.539999999999999 111.031 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 111.44 178.56 20.24 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 115.625 -0.716 . . . . 75.120000000000005 112.449 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.423 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 82.2 mtt180 -63.11 142.58 58.33 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.673 0.789 . . . . 75.420000000000002 110.659 -177.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -69.48 -175.46 13.39 Favored Glycine 0 C--N 1.343 0.967 0 O-C-N 123.998 0.811 . . . . 53.140000000000001 112.155 175.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.517 ' HB3' ' HG2' ' A' ' 236' ' ' LYS . 1.4 p30 -104.05 171.29 7.43 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.855 0.462 . . . . 72.010000000000005 111.547 -178.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 32.9 tp -129.36 112.87 14.28 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 108.737 -0.838 . . . . 73.540000000000006 108.737 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -86.76 109.47 19.26 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.684 0.794 . . . . 54.43 109.28 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 44.5 mt -87.16 111.39 20.91 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 109.077 -0.712 . . . . 74.209999999999994 109.077 175.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.501 ' HA ' ' HG3' ' A' ' 232' ' ' LYS . 31.5 mt-10 -78.77 101.08 7.4 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.092 -0.958 . . . . 72.129999999999995 109.566 -177.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.8 t -59.51 110.03 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 O-C-N 123.765 0.666 . . . . 72.25 111.072 176.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -115.12 93.44 4.3 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.003 -1.11 . . . . 74.439999999999998 108.003 176.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.492 HD11 ' O ' ' A' ' 227' ' ' THR . 54.9 mt -77.17 125.65 37.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 N-CA-C 109.473 -0.565 . . . . 72.239999999999995 109.473 178.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 24.4 p . . . . . 0 C--O 1.25 1.127 0 C-N-CA 124.157 0.983 . . . . 73.299999999999997 109.632 179.775 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.475 ' SD ' ' N ' ' A' ' 168' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 109.143 -0.688 . . . . 72.310000000000002 109.143 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.9 t -72.34 91.99 1.38 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 109.583 -0.525 . . . . 72.430000000000007 109.583 -177.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -74.26 155.72 37.97 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.284 -0.871 . . . . 51.229999999999997 109.482 177.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.2 tt -66.58 102.66 0.93 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 108.008 -1.108 . . . . 73.019999999999996 108.008 178.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -117.89 146.19 44.1 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.064 0.946 . . . . 73.340000000000003 109.273 -177.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.671 HD12 ' HA ' ' A' ' 223' ' ' VAL . 73.7 mt -87.54 96.2 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-O 121.222 0.534 . . . . 73.519999999999996 110.487 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -87.45 63.42 7.66 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 108.538 -0.912 . . . . 45.43 108.538 171.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -156.0 -168.39 2.75 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.584 1.154 . . . . 74.549999999999997 109.253 -175.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.431 ' CZ ' ' HA ' ' A' ' 227' ' ' THR . 4.5 m-85 77.79 -63.09 0.35 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 125.591 1.556 . . . . 70.040000000000006 111.974 -176.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -100.16 100.43 2.18 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 118.511 -1.161 . . . . 72.299999999999997 111.871 -176.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.63 -9.98 25.89 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 123.006 2.47 . . . . 64.510000000000005 113.125 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -77.36 87.33 3.75 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 109.096 -0.705 . . . . 72.310000000000002 109.096 176.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 177.05 134.42 1.99 Allowed Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.384 -0.825 . . . . 61.109999999999999 111.433 -178.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 13.6 t -80.26 167.85 19.78 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.209 0.604 . . . . 74.439999999999998 110.453 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 89.26 18.78 52.36 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-N 116.235 -0.439 . . . . 60.539999999999999 112.799 -173.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -92.26 54.68 2.83 Favored Glycine 0 C--N 1.353 1.502 0 C-N-CA 123.652 0.644 . . . . 40.039999999999999 112.315 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.6 t -86.74 164.81 16.5 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.634 0.774 . . . . 73.400000000000006 110.092 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 179.63 -170.9 42.47 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.325 -0.71 . . . . 74.540000000000006 111.325 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 145.17 45.44 0.04 OUTLIER Glycine 0 N--CA 1.473 1.149 0 N-CA-C 110.818 -0.913 . . . . 71.120000000000005 110.818 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 33.4 t -78.77 116.05 18.86 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.873 0.869 . . . . 43.329999999999998 109.777 -177.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -78.56 73.49 2.23 Favored Glycine 0 CA--C 1.533 1.162 0 N-CA-C 111.712 -0.555 . . . . 64.040000000000006 111.712 176.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 131.67 162.67 10.57 Favored Glycine 0 C--N 1.343 0.97 0 N-CA-C 110.817 -0.913 . . . . 73.219999999999999 110.817 -176.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 50.2 m -110.46 90.27 3.27 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.079 0.951 . . . . 72.219999999999999 109.729 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.61 ' HG3' ' HA3' ' A' ' 242' ' ' GLY . 0.0 OUTLIER -98.04 39.68 1.22 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.582 1.182 . . . . 64.219999999999999 109.832 176.574 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -87.43 163.48 16.72 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 114.689 -1.141 . . . . 71.5 111.087 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 83.2 mt -140.66 172.04 13.26 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.196 0.998 . . . . 73.409999999999997 109.994 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -118.01 145.06 45.03 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.052 0.941 . . . . 71.239999999999995 109.516 174.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -146.08 140.17 26.55 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.021 0.928 . . . . 70.200000000000003 109.282 178.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.9 m -77.36 129.19 35.49 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.058 0.543 . . . . 43.509999999999998 109.711 178.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.559 HD13 HD13 ' A' ' 251' ' ' LEU . 54.0 tp -107.45 111.3 23.53 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.451 -1.314 . . . . 54.539999999999999 107.451 177.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -92.04 100.5 13.13 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 108.291 -1.003 . . . . 72.519999999999996 108.291 -178.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.502 HG23 HG11 ' A' ' 210' ' ' VAL . 2.9 p -124.28 131.49 24.2 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 124.013 0.925 . . . . 73.049999999999997 108.799 -178.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.513 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 98.4 Cg_endo -80.68 163.9 21.01 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.513 2.142 . . . . 70.219999999999999 111.355 172.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.17 -48.46 85.32 Favored Pre-proline 0 CA--C 1.566 1.581 0 N-CA-C 114.045 1.128 . . . . 72.510000000000005 114.045 176.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.513 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 25.5 Cg_endo -58.8 -52.46 5.2 Favored 'Trans proline' 0 C--N 1.396 3.044 0 C-N-CA 122.002 1.801 . . . . 62.43 113.057 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.8 mt -70.77 -22.21 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.238 0 C-N-CA 123.081 0.552 . . . . 55.420000000000002 110.856 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.33 -44.2 72.15 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.771 0.429 . . . . 64.040000000000006 110.717 177.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 76.1 t -71.49 -57.17 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 C-N-CA 122.181 0.192 . . . . 73.049999999999997 110.975 -178.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 202' ' ' PRO . 12.6 p -85.38 -25.99 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 112.208 0.447 . . . . 64.409999999999997 112.208 -170.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 99.89 -178.63 29.75 Favored Glycine 0 N--CA 1.475 1.273 0 N-CA-C 112.156 -0.378 . . . . 52.350000000000001 112.156 -172.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 139.6 -139.17 9.76 Favored Glycine 0 C--N 1.343 0.932 0 N-CA-C 111.764 -0.535 . . . . 63.5 111.764 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -133.86 146.35 50.52 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.524 0.73 . . . . 60.399999999999999 109.751 175.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.502 HG11 HG23 ' A' ' 199' ' ' VAL . 22.2 m -138.67 169.2 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 123.711 0.632 . . . . 75.0 112.02 -177.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 -73.22 133.07 43.88 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.424 -0.807 . . . . 73.219999999999999 110.27 172.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.437 ' HB2' HD12 ' A' ' 197' ' ' LEU . . . -144.13 148.99 35.81 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.468 -0.938 . . . . 61.439999999999998 108.468 168.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 64.8 mtp -89.03 130.72 35.45 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.459 -0.571 . . . . 72.019999999999996 109.459 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 42.3 m -143.2 172.93 12.07 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 125.228 1.411 . . . . 73.0 108.082 -175.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 77.0 mt -60.08 -21.35 61.35 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.27 0.628 . . . . 65.530000000000001 111.708 173.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -86.65 16.83 4.33 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.641 1.176 . . . . 71.319999999999993 111.674 174.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 76.34 -155.82 46.05 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-O 118.87 -0.961 . . . . 55.140000000000001 111.757 -175.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.85 119.73 6.62 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 121.954 1.77 . . . . 74.420000000000002 110.423 171.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.55 166.09 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.284 1.034 . . . . 75.420000000000002 109.978 -176.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -102.46 107.51 18.51 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.898 -0.779 . . . . 54.039999999999999 108.898 175.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 95.5 t -95.15 131.64 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.145 0.978 . . . . 63.310000000000002 109.639 -175.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.45 98.72 2.32 Favored 'General case' 0 C--N 1.351 0.659 0 O-C-N 124.055 0.847 . . . . 74.400000000000006 109.39 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.671 ' HA ' HD12 ' A' ' 173' ' ' ILE . 55.9 t -91.84 127.71 48.84 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 124.83 1.252 . . . . 74.230000000000004 110.022 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.493 ' HD3' ' HB ' ' A' ' 173' ' ' ILE . 92.4 Cg_endo -73.2 170.25 20.31 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.692 2.262 . . . . 73.150000000000006 110.962 173.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.46 178.07 4.11 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 122.02 1.813 . . . . 75.219999999999999 111.789 170.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 50.2 mtp180 63.68 20.29 12.15 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 124.978 1.311 . . . . 61.119999999999997 112.222 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.493 ' O ' HD11 ' A' ' 255' ' ' ILE . 98.1 m -65.64 106.68 1.53 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.361 0.664 . . . . 62.420000000000002 110.278 -178.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -100.13 139.86 35.2 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.925 1.29 . . . . 73.439999999999998 110.285 -174.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -69.92 127.95 34.66 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.737 1.215 . . . . 72.209999999999994 111.542 -177.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.39 10.55 53.71 Favored Glycine 0 C--N 1.342 0.881 0 O-C-N 123.724 0.64 . . . . 62.32 113.126 178.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -91.47 158.28 16.57 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 117.176 0.488 . . . . 75.409999999999997 111.341 175.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.402 ' HB3' ' HD2' ' A' ' 250' ' ' TYR . 1.8 mppt? -130.07 117.65 20.32 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.84 1.256 . . . . 74.120000000000005 109.162 -177.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 12.9 mt -105.8 100.7 10.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.301 -0.863 . . . . 55.5 108.711 -165.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 46.2 ttm105 -69.98 102.45 2.01 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 124.544 1.153 . . . . 73.010000000000005 110.057 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.473 HD21 HG23 ' A' ' 173' ' ' ILE . 29.8 mt -111.69 99.78 8.44 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.727 0.811 . . . . 61.5 110.159 -176.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -66.74 142.86 57.25 Favored 'General case' 0 C--O 1.246 0.887 0 C-N-CA 123.407 0.683 . . . . 71.549999999999997 110.489 178.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 87.03 13.35 66.54 Favored Glycine 0 CA--C 1.532 1.117 0 O-C-N 123.745 0.653 . . . . 53.210000000000001 113.021 -174.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -130.83 -25.38 2.31 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.338 0.655 . . . . 73.420000000000002 112.292 -175.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -75.07 -159.51 7.41 Favored Glycine 0 N--CA 1.476 1.306 0 CA-C-O 120.295 -0.169 . . . . 63.530000000000001 112.823 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -69.45 134.38 88.81 Favored Pre-proline 0 CA--C 1.554 1.105 0 CA-C-O 118.24 -0.886 . . . . 71.420000000000002 109.408 -174.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.578 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 78.0 Cg_exo -51.69 128.35 25.95 Favored 'Trans proline' 0 C--N 1.386 2.524 0 C-N-CA 122.904 2.403 . . . . 64.109999999999999 111.838 179.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.61 ' HA3' ' HG3' ' A' ' 191' ' ' GLN . . . -152.82 -162.44 10.96 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 119.558 -0.579 . . . . 52.229999999999997 113.069 -172.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.28 -16.1 50.49 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 123.578 2.852 . . . . 73.409999999999997 112.868 -177.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -94.96 19.96 9.59 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.088 0.955 . . . . 70.349999999999994 111.156 176.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 85.1 -73.75 2.58 Favored Glycine 0 C--N 1.352 1.462 0 N-CA-C 109.39 -1.484 . . . . 73.239999999999995 109.39 -170.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.578 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 59.2 mtt-85 -126.11 161.33 27.89 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.744 1.218 . . . . 71.430000000000007 109.036 166.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -82.45 -158.04 22.93 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-N 115.449 -0.796 . . . . 55.5 112.471 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -114.55 132.54 56.29 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.767 0.827 . . . . 73.450000000000003 110.089 -176.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 41.6 tp -106.88 121.33 44.21 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 108.415 -0.958 . . . . 71.420000000000002 108.415 -176.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.402 ' HD2' ' HB3' ' A' ' 232' ' ' LYS . 8.7 m-85 -87.79 113.27 23.3 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.4 -0.963 . . . . 53.520000000000003 108.4 179.05 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.559 HD13 HD13 ' A' ' 197' ' ' LEU . 51.2 mt -86.48 107.77 18.23 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.175 -0.676 . . . . 72.25 109.175 176.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.434 ' HG3' ' HD3' ' A' ' 254' ' ' ARG . 8.4 tp10 -76.02 97.67 4.09 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 107.683 -1.229 . . . . 60.310000000000002 107.683 177.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 91.5 t -62.82 108.87 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.777 0 C-N-CA 124.952 1.301 . . . . 63.009999999999998 110.927 -177.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.434 ' HD3' ' HG3' ' A' ' 252' ' ' GLU . 22.1 mmm180 -109.3 93.82 4.71 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.243 -1.021 . . . . 53.350000000000001 108.243 174.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.493 HD11 ' O ' ' A' ' 227' ' ' THR . 58.9 mt -75.4 131.79 34.37 Favored 'Isoleucine or valine' 0 C--N 1.351 0.631 0 N-CA-C 109.324 -0.621 . . . . 74.450000000000003 109.324 174.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 16.4 p . . . . . 0 CA--C 1.558 1.273 0 C-N-CA 125.496 1.518 . . . . 60.119999999999997 107.56 178.084 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 15.8 tpt . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 109.402 -0.592 . . . . 72.319999999999993 109.402 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 40.3 m -148.15 112.74 5.34 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.098 0.959 . . . . 75.129999999999995 109.497 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -131.51 147.71 52.56 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.713 0.805 . . . . 73.129999999999995 110.346 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 6.6 mp -79.33 95.5 5.73 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.072 0.949 . . . . 71.120000000000005 109.526 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -74.46 88.08 2.1 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.771 0.828 . . . . 74.200000000000003 110.525 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.515 HG23 HD22 ' A' ' 235' ' ' LEU . 29.1 mt -76.66 131.31 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 115.111 -0.949 . . . . 51.229999999999997 111.243 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -137.56 93.42 2.8 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.117 0.967 . . . . 71.430000000000007 108.631 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -132.54 179.05 6.37 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.226 1.01 . . . . 61.340000000000003 110.617 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.628 ' CE2' HD22 ' A' ' 233' ' ' LEU . 49.1 m-85 59.42 36.78 23.26 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.43 1.092 . . . . 65.530000000000001 110.648 -172.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 147.68 154.28 6.2 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 114.947 -1.024 . . . . 65.450000000000003 111.115 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.45 166.36 28.7 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 122.766 2.31 . . . . 71.439999999999998 112.574 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -154.0 -54.5 0.1 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.716 0.406 . . . . 74.140000000000001 110.996 -177.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 155.07 125.86 0.98 Allowed Glycine 0 C--N 1.35 1.353 0 CA-C-O 119.667 -0.518 . . . . 71.549999999999997 113.959 177.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.496 ' HB3' ' HE3' ' A' ' 236' ' ' LYS . 33.5 t 178.54 114.35 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 126.023 1.729 . . . . 70.140000000000001 108.029 168.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 174.53 45.72 0.05 OUTLIER Glycine 0 C--N 1.341 0.854 0 C-N-CA 121.559 -0.353 . . . . 53.530000000000001 112.627 177.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -158.11 59.17 0.34 Allowed Glycine 0 C--N 1.343 0.951 0 N-CA-C 111.624 -0.591 . . . . 45.32 111.624 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 44.7 m -148.95 156.76 42.75 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.329 1.052 . . . . 72.049999999999997 109.439 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -96.03 -174.83 36.31 Favored Glycine 0 N--CA 1.472 1.04 0 O-C-N 123.441 0.463 . . . . 62.25 112.513 175.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 160.35 -157.44 28.81 Favored Glycine 0 N--CA 1.47 0.966 0 N-CA-C 112.211 -0.356 . . . . 65.109999999999999 112.211 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 54.8 m -140.16 101.75 4.22 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.274 0.63 . . . . 75.239999999999995 110.276 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 151.37 -157.54 27.26 Favored Glycine 0 C--N 1.343 0.93 0 N-CA-C 111.685 -0.566 . . . . 73.150000000000006 111.685 177.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -96.67 -112.51 2.88 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 111.558 -0.617 . . . . 61.030000000000001 111.558 174.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 7.0 p -81.83 -38.79 24.94 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.997 0.919 . . . . 71.349999999999994 109.958 175.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.64 ' HB3' ' HB2' ' A' ' 240' ' ' PHE . 12.0 mm100 65.96 35.08 6.68 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.723 1.209 . . . . 75.439999999999998 112.138 173.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -94.29 138.65 32.03 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 114.353 -1.294 . . . . 74.450000000000003 110.807 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 91.5 mt -122.93 166.95 14.22 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.872 0.869 . . . . 61.310000000000002 110.455 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -106.34 149.89 26.51 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 107.955 -1.128 . . . . 62.140000000000001 107.955 166.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.97 129.15 12.76 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.933 -0.765 . . . . 71.129999999999995 108.933 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.5 m -65.52 121.77 15.67 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.572 0.749 . . . . 75.329999999999998 110.425 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.479 HD22 ' HB3' ' A' ' 251' ' ' LEU . 57.0 tp -108.0 112.99 25.85 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.951 0.901 . . . . 75.239999999999995 109.164 -178.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -85.93 112.07 20.84 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.312 -0.996 . . . . 72.409999999999997 108.312 174.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 2.2 p -139.49 119.9 9.42 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 123.945 0.898 . . . . 73.5 108.971 -177.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.425 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 44.3 Cg_endo -71.3 158.02 55.53 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 121.879 1.72 . . . . 70.420000000000002 111.171 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -52.1 -47.28 92.3 Favored Pre-proline 0 CA--C 1.567 1.611 0 C-N-CA 124.781 1.233 . . . . 65.019999999999996 113.606 -177.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 37.2 Cg_endo -63.07 -43.62 18.56 Favored 'Trans proline' 0 C--N 1.404 3.491 0 C-N-CA 121.478 1.452 . . . . 63.030000000000001 112.186 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 40.1 mt -71.12 -28.26 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 O-C-N 123.616 0.572 . . . . 74.340000000000003 110.361 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.57 -46.56 82.22 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.207 0.603 . . . . 63.140000000000001 110.509 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 67.5 t -67.82 -57.07 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 122.727 0.411 . . . . 73.099999999999994 111.513 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 17.2 m -78.9 -20.83 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 112.285 0.476 . . . . 64.239999999999995 112.285 -170.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 77.52 132.97 0.62 Allowed Glycine 0 C--N 1.345 1.07 0 N-CA-C 111.675 -0.57 . . . . 71.140000000000001 111.675 -171.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 175.87 -175.01 47.25 Favored Glycine 0 N--CA 1.468 0.828 0 CA-C-N 117.265 0.532 . . . . 73.200000000000003 112.269 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -79.03 143.6 35.48 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 122.849 0.46 . . . . 72.519999999999996 111.0 -178.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 19.9 m -139.45 169.44 16.99 Favored 'Isoleucine or valine' 0 C--O 1.253 1.263 0 O-C-N 124.338 1.024 . . . . 65.239999999999995 110.351 177.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -72.48 118.46 15.41 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.502 -1.226 . . . . 74.319999999999993 109.979 169.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -110.66 137.33 48.47 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.407 -0.59 . . . . 32.049999999999997 109.407 169.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 63.0 mtt -84.95 103.68 14.21 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.521 -0.918 . . . . 73.109999999999999 108.521 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 43.4 m -122.35 168.56 11.92 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.688 1.195 . . . . 64.310000000000002 109.015 -176.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 80.1 mt -54.69 -27.29 39.23 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.023 0.929 . . . . 54.32 111.73 174.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -90.95 15.82 10.69 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.507 1.123 . . . . 51.420000000000002 111.837 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 83.07 -149.74 26.82 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-O 119.273 -0.737 . . . . 44.539999999999999 112.174 -177.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.05 120.3 5.99 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.376 2.051 . . . . 64.140000000000001 111.377 177.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 22.6 m -119.24 167.44 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 123.2 0.6 . . . . 70.209999999999994 111.522 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -76.67 116.36 17.28 Favored 'General case' 0 C--N 1.348 0.526 0 C-N-CA 124.38 1.072 . . . . 73.129999999999995 108.822 175.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.407 HG22 HD11 ' A' ' 173' ' ' ILE . 1.1 t -124.78 115.19 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 108.613 -0.884 . . . . 64.040000000000006 108.613 174.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -81.39 99.01 8.47 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 115.76 -0.655 . . . . 62.109999999999999 109.401 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 56.1 t -80.32 130.26 66.2 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 123.609 0.764 . . . . 60.210000000000001 109.904 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.37 167.68 7.53 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.168 2.579 . . . . 53.030000000000001 112.27 171.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.25 -179.51 3.19 Favored 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 121.837 1.691 . . . . 75.200000000000003 112.913 174.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 48.2 mtt85 60.66 18.23 8.28 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 124.974 1.31 . . . . 72.25 112.298 173.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.497 ' HA ' ' OH ' ' A' ' 176' ' ' TYR . 96.6 m -68.3 103.45 1.6 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.025 0.93 . . . . 71.299999999999997 110.245 -174.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.452 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 47.4 tp60 -103.78 142.2 34.78 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.419 1.088 . . . . 73.329999999999998 110.285 -174.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.82 130.96 49.47 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.716 1.206 . . . . 41.109999999999999 111.583 -176.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 95.01 -10.34 70.1 Favored Glycine 0 C--N 1.347 1.142 0 O-C-N 123.711 0.632 . . . . 72.430000000000007 113.144 177.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.452 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 68.3 mtt-85 -78.52 155.45 29.75 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.038 0.535 . . . . 75.200000000000003 109.626 174.018 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.585 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.7 mppt? -130.18 118.1 20.9 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.994 -0.743 . . . . 51.109999999999999 108.994 -176.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.628 HD22 ' CE2' ' A' ' 176' ' ' TYR . 5.0 mt -89.66 103.91 16.51 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.091 -0.959 . . . . 74.439999999999998 109.035 -164.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 16.8 ttm-85 -69.42 102.11 1.7 Allowed 'General case' 0 CA--C 1.541 0.598 0 O-C-N 123.92 0.763 . . . . 74.239999999999995 109.712 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.515 HD22 HG23 ' A' ' 173' ' ' ILE . 14.3 mt -96.05 91.32 5.91 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.282 -1.007 . . . . 61.109999999999999 108.282 175.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.496 ' HE3' ' HB3' ' A' ' 181' ' ' SER . 6.0 mtmt -62.78 140.94 58.79 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.283 -0.636 . . . . 74.400000000000006 109.283 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 72.9 34.59 58.87 Favored Glycine 0 C--N 1.343 0.949 0 O-C-N 123.424 0.453 . . . . 53.509999999999998 113.737 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.432 ' HA ' ' NZ ' ' A' ' 238' ' ' LYS . 0.4 OUTLIER -128.01 -27.05 2.8 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.601 0.761 . . . . 73.319999999999993 112.124 179.262 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -74.88 -165.21 13.54 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 112.455 -0.258 . . . . 75.329999999999998 112.455 169.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.64 ' HB2' ' HB3' ' A' ' 191' ' ' GLN . 90.9 m-85 -75.72 150.57 84.22 Favored Pre-proline 0 N--CA 1.487 1.395 0 CA-C-N 117.216 0.508 . . . . 73.439999999999998 110.046 -176.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -64.81 157.64 55.2 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 122.284 1.989 . . . . 70.450000000000003 112.659 177.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -163.02 175.0 39.4 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 115.557 -0.747 . . . . 71.150000000000006 111.585 -176.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.71 -11.63 29.88 Favored 'Trans proline' 0 C--N 1.366 1.475 0 C-N-CA 122.952 2.435 . . . . 65.329999999999998 113.021 -177.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -104.16 14.83 29.69 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.892 0.877 . . . . 74.230000000000004 111.337 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 119.45 -124.39 5.96 Favored Glycine 0 C--N 1.348 1.223 0 N-CA-C 110.973 -0.851 . . . . 61.450000000000003 110.973 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 48.8 mtm180 -126.55 162.56 25.38 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.731 -0.841 . . . . 52.340000000000003 108.731 169.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -69.97 171.0 42.99 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 115.3 -0.864 . . . . 33.420000000000002 113.963 -177.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -110.71 136.28 50.03 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.919 0.888 . . . . 72.450000000000003 108.863 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 31.9 tp -105.29 108.11 19.46 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 107.717 -1.216 . . . . 73.129999999999995 107.717 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.585 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 19.3 m-85 -88.54 108.99 19.7 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.716 -0.846 . . . . 75.239999999999995 108.716 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.479 ' HB3' HD22 ' A' ' 197' ' ' LEU . 43.0 mt -86.85 107.07 18.16 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.856 -0.794 . . . . 64.329999999999998 108.856 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -78.05 102.76 7.6 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 114.657 -1.156 . . . . 72.409999999999997 109.55 -177.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 63.2 t -59.57 115.26 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.695 0 CA-C-N 114.388 -1.278 . . . . 72.109999999999999 112.053 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 20.7 mmt85 -112.66 93.99 4.7 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.294 -1.373 . . . . 72.010000000000005 107.294 171.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 22.9 mt -74.99 109.36 7.83 Favored 'Isoleucine or valine' 0 C--N 1.352 0.689 0 N-CA-C 109.018 -0.734 . . . . 73.439999999999998 109.018 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 25.6 p . . . . . 0 CA--C 1.558 1.277 0 C-N-CA 124.524 1.13 . . . . 73.420000000000002 108.428 177.173 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 22.3 mmt . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 109.54 -0.541 . . . . 62.340000000000003 109.54 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.7 m -74.98 102.68 4.89 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 109.42 -0.585 . . . . 70.510000000000005 109.42 174.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -68.69 -18.92 64.34 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.037 0.535 . . . . 75.349999999999994 112.311 -177.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.531 HD13 HG22 ' A' ' 221' ' ' VAL . 86.9 mt 58.9 44.31 16.79 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.326 1.05 . . . . 71.530000000000001 110.748 174.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 27.5 tpt180 -59.11 115.96 3.52 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 114.435 -1.257 . . . . 70.049999999999997 110.888 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.709 ' HA ' HD22 ' A' ' 235' ' ' LEU . 57.5 mt -77.78 108.29 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 114.768 -1.106 . . . . 72.329999999999998 108.618 171.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -84.07 40.08 0.74 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.891 0.876 . . . . 44.119999999999997 110.78 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -153.83 163.67 39.65 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.896 1.278 . . . . 72.099999999999994 109.272 -174.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.592 ' CE2' HD21 ' A' ' 233' ' ' LEU . 66.6 m-85 63.42 15.42 8.73 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.23 1.412 . . . . 62.420000000000002 112.067 -166.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -162.9 177.09 39.09 Favored Glycine 0 C--N 1.344 0.994 0 C-N-CA 123.397 0.522 . . . . 51.109999999999999 111.818 -177.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.09 123.24 13.04 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 123.374 2.716 . . . . 74.040000000000006 111.986 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -129.81 115.62 17.53 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.865 0.866 . . . . 62.350000000000001 108.904 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.8 165.23 54.74 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 116.293 -0.412 . . . . 70.010000000000005 112.262 178.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 39.9 m -70.89 -35.31 72.28 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.349 0.66 . . . . 74.299999999999997 111.748 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 91.08 -56.98 3.26 Favored Glycine 0 C--N 1.342 0.877 0 N-CA-C 111.564 -0.615 . . . . 63.100000000000001 111.564 -176.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 135.72 -161.69 24.82 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 111.538 -0.625 . . . . 22.199999999999999 111.538 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 22.8 t -93.51 -165.69 1.38 Allowed 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 123.719 0.807 . . . . 74.299999999999997 109.732 175.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 147.12 -22.32 1.58 Allowed Glycine 0 C--N 1.351 1.389 0 O-C-N 122.209 -0.307 . . . . 74.209999999999994 113.057 176.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -175.37 80.03 0.07 OUTLIER Glycine 0 C--N 1.342 0.869 0 N-CA-C 111.609 -0.596 . . . . 32.340000000000003 111.609 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 40.9 m -67.18 147.9 52.48 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.279 1.031 . . . . 53.530000000000001 111.845 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 99.73 68.01 0.87 Allowed Glycine 0 C--N 1.346 1.106 0 CA-C-N 116.128 -0.487 . . . . 51.219999999999999 111.886 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 70.17 -168.56 47.69 Favored Glycine 0 C--N 1.352 1.448 0 N-CA-C 113.623 0.209 . . . . 62.130000000000003 113.623 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 52.5 p -155.51 164.27 38.9 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.24 0.616 . . . . 44.32 110.615 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -88.7 53.39 2.69 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-O 122.992 1.377 . . . . 53.420000000000002 109.745 176.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -88.7 166.84 13.8 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 113.693 -1.594 . . . . 64.340000000000003 110.362 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.6 mt -133.19 164.61 26.68 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.618 0.767 . . . . 53.149999999999999 110.785 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -114.85 154.87 27.85 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 114.526 -1.215 . . . . 74.219999999999999 108.357 168.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -160.66 150.88 17.91 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.656 0.782 . . . . 72.310000000000002 109.319 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 33.2 m -81.66 135.65 35.52 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.065 0.546 . . . . 61.539999999999999 110.18 177.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.578 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 42.1 tp -114.54 113.57 24.6 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.707 -1.22 . . . . 71.439999999999998 107.707 170.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -91.93 123.7 35.5 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 109.269 -0.641 . . . . 52.229999999999997 109.269 177.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 3.6 p -142.92 130.9 11.22 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.531 1.132 . . . . 75.219999999999999 108.487 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.21 156.26 37.63 Favored 'Trans proline' 0 C--N 1.37 1.683 0 C-N-CA 121.586 1.524 . . . . 73.430000000000007 110.999 170.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -54.62 -42.18 93.53 Favored Pre-proline 0 CA--C 1.565 1.528 0 CA-C-O 117.333 -1.318 . . . . 73.019999999999996 114.29 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.24 -51.23 9.04 Favored 'Trans proline' 0 C--N 1.4 3.282 0 CA-C-N 121.832 1.69 . . . . 44.219999999999999 112.144 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 46.0 mt -68.69 -26.45 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.813 0.845 . . . . 74.150000000000006 110.802 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.468 ' HB1' ' O ' ' A' ' 227' ' ' THR . . . -70.69 -50.96 30.9 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.51 0.724 . . . . 72.409999999999997 111.326 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 96.1 t -67.65 -50.14 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.612 0.765 . . . . 65.109999999999999 111.253 -176.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.7 p -75.97 -31.5 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 122.524 0.33 . . . . 74.019999999999996 110.793 -177.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 79.96 103.46 0.27 Allowed Glycine 0 C--N 1.347 1.177 0 N-CA-C 111.667 -0.573 . . . . 72.340000000000003 111.667 -173.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -131.75 -129.7 3.06 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 116.978 0.389 . . . . 55.009999999999998 112.35 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -132.93 141.75 48.52 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.129 0.972 . . . . 75.439999999999998 108.393 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 17.2 m -130.67 165.96 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.21 0.604 . . . . 71.120000000000005 110.924 -178.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -82.11 120.42 25.29 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.133 -0.692 . . . . 74.299999999999997 109.133 168.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -118.21 136.67 53.5 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.557 0.743 . . . . 41.32 109.285 173.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 87.1 mtp -76.83 116.63 17.67 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.026 0.53 . . . . 73.340000000000003 109.578 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 33.6 m -127.21 170.35 12.52 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.431 1.093 . . . . 63.030000000000001 108.848 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 81.4 mt -57.82 -34.29 69.5 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.012 0.925 . . . . 71.409999999999997 111.963 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -84.56 2.16 42.55 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.676 0.79 . . . . 74.120000000000005 111.93 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 108.79 -161.8 13.09 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-O 119.648 -0.529 . . . . 74.219999999999999 112.567 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.2 119.66 6.61 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 122.189 1.926 . . . . 62.140000000000001 111.312 176.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 32.7 m -114.9 163.94 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 123.306 0.642 . . . . 74.140000000000001 109.979 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -103.61 110.0 21.9 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.242 0.544 . . . . 72.340000000000003 109.703 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.531 HG22 HD13 ' A' ' 171' ' ' LEU . 62.0 t -104.29 126.25 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.151 0.98 . . . . 72.540000000000006 109.207 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.1 99.81 2.87 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.103 0.561 . . . . 70.140000000000001 109.899 176.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 78.1 t -88.52 121.28 70.24 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 124.112 0.965 . . . . 71.450000000000003 109.724 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -60.76 169.02 6.14 Favored 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 123.987 3.124 . . . . 63.119999999999997 113.359 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.98 169.35 20.69 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 122.073 1.849 . . . . 62.109999999999999 113.629 178.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 65.53 22.02 11.79 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 125.554 1.541 . . . . 71.519999999999996 112.186 176.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.503 ' HA ' ' CZ ' ' A' ' 176' ' ' TYR . 94.8 m -66.39 104.55 1.25 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.029 0.932 . . . . 63.43 110.811 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -102.06 141.63 34.6 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.987 0.915 . . . . 63.240000000000002 110.935 -172.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.4 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -64.77 143.31 58.02 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.295 1.038 . . . . 75.209999999999994 111.576 -179.021 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.76 -9.17 75.14 Favored Glycine 0 N--CA 1.47 0.909 0 O-C-N 123.831 0.707 . . . . 70.340000000000003 112.939 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.42 HH11 ' HE1' ' A' ' 176' ' ' TYR . 89.3 mtt180 -78.15 154.14 31.46 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.237 0.615 . . . . 70.5 109.989 171.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -131.23 136.31 48.11 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.592 1.157 . . . . 71.239999999999995 108.437 -178.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.592 HD21 ' CE2' ' A' ' 176' ' ' TYR . 30.2 mt -110.12 103.16 11.84 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.875 -0.602 . . . . 61.130000000000003 109.912 -169.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -70.5 100.65 1.83 Allowed 'General case' 0 C--O 1.239 0.501 0 O-C-N 124.038 0.836 . . . . 73.430000000000007 109.203 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.709 HD22 ' HA ' ' A' ' 173' ' ' ILE . 12.4 mt -97.79 98.59 9.97 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.305 -1.368 . . . . 63.530000000000001 107.305 177.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 36.3 mtmt -76.88 141.74 40.45 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.298 -0.41 . . . . 75.420000000000002 110.331 -176.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.98 33.07 42.37 Favored Glycine 0 C--N 1.344 1.015 0 O-C-N 123.478 0.486 . . . . 71.549999999999997 113.278 -179.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -125.0 -33.95 2.85 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.74 0.816 . . . . 73.109999999999999 111.619 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -65.61 -159.81 0.6 Allowed Glycine 0 C--N 1.359 1.856 0 O-C-N 123.488 0.493 . . . . 53.420000000000002 113.491 176.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -71.72 146.17 90.58 Favored Pre-proline 0 CA--C 1.554 1.112 0 O-C-N 122.049 -0.677 . . . . 75.530000000000001 110.078 -177.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 20.7 Cg_endo -59.24 155.59 39.53 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.778 2.319 . . . . 72.140000000000001 112.925 175.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -164.33 -173.66 33.23 Favored Glycine 0 CA--C 1.539 1.551 0 CA-C-O 119.782 -0.454 . . . . 64.329999999999998 113.248 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.55 -34.66 96.81 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.869 3.046 . . . . 65.150000000000006 113.574 -178.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -100.81 22.04 12.66 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.956 0.902 . . . . 43.119999999999997 111.108 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 91.52 -163.72 28.81 Favored Glycine 0 C--N 1.347 1.164 0 N-CA-C 111.472 -0.651 . . . . 44.109999999999999 111.472 -173.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 31.6 mtt180 -69.57 156.36 39.04 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.096 0.474 . . . . 63.439999999999998 110.778 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.29 -165.63 27.56 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 115.334 -0.848 . . . . 55.509999999999998 112.363 177.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -99.07 168.8 9.85 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.214 0.606 . . . . 74.450000000000003 110.13 -177.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 40.4 tp -142.48 107.81 5.01 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.943 -0.762 . . . . 62.25 108.943 174.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -89.33 108.2 19.49 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.907 0.483 . . . . 72.340000000000003 109.964 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.578 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 34.7 mt -87.62 107.97 18.85 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 109.311 -0.625 . . . . 72.109999999999999 109.311 174.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -78.66 103.5 8.65 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 109.075 -0.713 . . . . 75.540000000000006 109.075 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.8 t -56.8 112.99 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 124.548 1.139 . . . . 72.329999999999998 111.194 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -116.34 100.55 7.97 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.039 -1.097 . . . . 74.420000000000002 108.039 176.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 30.1 mt -79.38 126.92 39.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 123.285 0.634 . . . . 54.43 110.665 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 19.7 p . . . . . 0 CA--C 1.557 1.213 0 C-N-CA 124.714 1.205 . . . . 64.540000000000006 108.708 176.135 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 53.1 tpp . . . . . 0 N--CA 1.473 0.692 0 N-CA-C 109.472 -0.566 . . . . 75.219999999999999 109.472 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 28.5 p -152.52 121.2 6.46 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.244 0.618 . . . . 75.409999999999997 110.534 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -65.89 142.25 57.97 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.394 0.678 . . . . 72.319999999999993 109.7 174.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.577 ' HA ' ' HE2' ' A' ' 238' ' ' LYS . 58.1 mt -80.46 81.36 6.73 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.372 0.606 . . . . 63.030000000000001 110.254 -173.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -70.56 127.95 34.47 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 114.682 -1.144 . . . . 73.530000000000001 109.933 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.615 HG22 ' H ' ' A' ' 175' ' ' ALA . 41.5 mt -76.13 -70.87 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 122.607 0.363 . . . . 72.340000000000003 110.2 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . 60.14 33.76 21.15 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.078 0.951 . . . . 32.030000000000001 111.384 -177.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.615 ' H ' HG22 ' A' ' 173' ' ' ILE . . . -130.03 161.6 30.6 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.682 1.193 . . . . 73.329999999999998 108.966 175.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.673 ' CE2' HD21 ' A' ' 233' ' ' LEU . 40.6 m-85 66.54 -68.44 0.14 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.724 1.21 . . . . 75.430000000000007 109.337 -159.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -96.77 95.35 1.73 Allowed Glycine 0 CA--C 1.533 1.179 0 N-CA-C 109.819 -1.312 . . . . 54.149999999999999 109.819 165.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -84.23 173.17 9.04 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.465 2.11 . . . . 72.109999999999999 112.519 -175.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -138.14 -175.29 4.05 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.452 0.701 . . . . 71.540000000000006 110.6 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.65 125.93 40.69 Favored Glycine 0 C--N 1.356 1.694 0 O-C-N 123.775 0.672 . . . . 61.25 113.058 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 53.8 m -118.53 133.75 55.63 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.381 1.072 . . . . 64.540000000000006 110.584 -172.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -137.73 16.83 3.5 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 115.59 -0.732 . . . . 44.399999999999999 111.846 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -90.0 44.31 2.98 Favored Glycine 0 C--N 1.349 1.278 0 C-N-CA 122.879 0.276 . . . . 53.32 112.689 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 49.5 m -88.38 114.83 25.4 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.308 0.643 . . . . 70.25 109.539 177.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -148.19 150.54 22.75 Favored Glycine 0 C--N 1.337 0.635 0 N-CA-C 111.564 -0.615 . . . . 50.310000000000002 111.564 -178.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -98.15 -170.12 32.12 Favored Glycine 0 N--CA 1.469 0.893 0 CA-C-O 119.807 -0.441 . . . . 64.140000000000001 112.471 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 17.3 m 59.79 91.43 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.586 1.155 . . . . 71.219999999999999 111.985 176.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -67.88 88.09 0.18 Allowed Glycine 0 C--N 1.35 1.337 0 CA-C-N 115.945 -0.57 . . . . 72.329999999999998 112.831 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -105.5 34.73 5.55 Favored Glycine 0 C--N 1.342 0.892 0 C-N-CA 123.584 0.611 . . . . 54.240000000000002 112.314 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 21.5 m 65.07 35.19 8.18 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.734 1.214 . . . . 71.409999999999997 112.279 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -65.74 -65.93 0.61 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.111 0.565 . . . . 75.549999999999997 109.724 175.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -80.33 132.14 35.75 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.467 -0.788 . . . . 73.219999999999999 109.431 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 86.2 mt -136.94 175.11 9.92 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.838 0.855 . . . . 64.409999999999997 109.772 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -105.26 163.49 12.56 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.055 0.942 . . . . 73.209999999999994 110.205 178.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -165.33 129.7 2.4 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.771 1.228 . . . . 60.109999999999999 108.13 175.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' THR . . . . . 0.446 ' HA ' ' HB2' ' A' ' 252' ' ' GLU . 50.1 m -70.69 137.11 49.52 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 122.794 0.438 . . . . 54.340000000000003 111.163 -178.071 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 21.9 tp -122.46 112.44 18.05 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.182 -1.044 . . . . 62.340000000000003 108.182 175.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -91.23 128.43 37.05 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 108.913 -0.773 . . . . 65.049999999999997 108.913 175.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 3.3 p -139.6 124.87 11.64 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 123.799 0.84 . . . . 61.439999999999998 109.578 -177.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -67.5 153.51 76.31 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 121.467 1.444 . . . . 44.329999999999998 111.717 176.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.59 -45.17 85.24 Favored Pre-proline 0 CA--C 1.564 1.496 0 CA-C-O 117.648 -1.167 . . . . 53.329999999999998 113.887 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.457 ' O ' HG12 ' A' ' 206' ' ' VAL . 19.9 Cg_endo -59.36 -52.27 5.07 Favored 'Trans proline' 0 C--N 1.397 3.127 0 CA-C-N 121.426 1.545 . . . . 62.310000000000002 112.17 175.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 46.0 mt -63.8 -27.31 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 123.639 0.776 . . . . 75.420000000000002 110.896 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' A' ' 227' ' ' THR . . . -70.86 -49.33 47.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.386 0.675 . . . . 72.510000000000005 111.169 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 84.7 t -67.84 -54.0 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 122.988 0.515 . . . . 73.209999999999994 110.96 -177.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.457 HG12 ' O ' ' A' ' 202' ' ' PRO . 11.1 p -74.34 -38.66 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 122.701 0.4 . . . . 60.32 111.345 -175.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.79 79.16 1.3 Allowed Glycine 0 C--N 1.343 0.955 0 N-CA-C 112.07 -0.412 . . . . 65.019999999999996 112.07 -172.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -99.33 -125.54 5.45 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-O 119.546 -0.586 . . . . 64.219999999999999 112.064 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.54 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 33.7 mtmm -138.18 150.18 46.54 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.101 0.961 . . . . 63.210000000000001 109.4 174.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 24.3 m -138.51 170.18 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 124.031 0.932 . . . . 75.439999999999998 110.946 177.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 19.3 ttm180 -96.76 115.72 27.91 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.798 0.839 . . . . 62.109999999999999 110.303 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -107.67 156.14 19.39 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 109.181 -0.674 . . . . 41.310000000000002 109.181 168.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 83.6 mtp -98.08 120.93 39.35 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.034 0.445 . . . . 61.130000000000003 110.063 177.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 215' ' ' LEU . 5.5 m -111.26 174.41 5.88 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 125.083 1.353 . . . . 70.230000000000004 107.382 175.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.42 ' H ' HG22 ' A' ' 214' ' ' THR . 76.1 mt -59.44 -35.17 73.51 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 113.118 0.785 . . . . 74.340000000000003 113.118 -171.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -90.6 -19.11 24.07 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.207 0.603 . . . . 74.219999999999999 111.279 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 147.04 -158.88 27.87 Favored Glycine 0 C--N 1.353 1.502 0 CA-C-O 119.824 -0.431 . . . . 65.340000000000003 113.324 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.9 143.91 29.99 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.496 2.797 . . . . 70.219999999999999 113.498 -173.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 31.2 m -133.25 161.45 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.106 0.962 . . . . 71.329999999999998 110.084 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -95.57 110.92 22.94 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.747 0.819 . . . . 74.349999999999994 109.656 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 54.5 t -96.52 111.28 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.574 1.149 . . . . 72.049999999999997 108.159 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.54 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . . . -73.72 95.8 2.42 Favored 'General case' 0 C--N 1.349 0.568 0 N-CA-C 109.34 -0.615 . . . . 73.439999999999998 109.34 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 53.6 t -64.31 132.09 95.24 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 124.468 1.107 . . . . 72.420000000000002 110.279 -173.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.74 166.71 28.66 Favored 'Trans proline' 0 CA--C 1.559 1.729 0 C-N-CA 122.668 2.246 . . . . 74.329999999999998 112.213 170.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.29 167.03 28.12 Favored 'Trans proline' 0 C--N 1.372 1.798 0 C-N-CA 121.822 1.682 . . . . 74.040000000000006 112.057 173.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 65.37 19.18 11.57 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.718 1.207 . . . . 73.450000000000003 112.157 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.544 ' HA ' ' CZ ' ' A' ' 176' ' ' TYR . 79.1 m -66.87 101.19 0.8 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.187 0.595 . . . . 42.329999999999998 110.659 -176.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -101.96 143.09 32.26 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 125.605 1.562 . . . . 71.019999999999996 110.596 -174.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -68.87 145.04 54.05 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 123.927 0.891 . . . . 64.099999999999994 111.166 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.06 -12.73 68.71 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.247 -0.888 . . . . 41.340000000000003 112.446 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.543 HH11 ' HE1' ' A' ' 176' ' ' TYR . 87.6 mtt180 -85.13 154.67 21.87 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.329 0.652 . . . . 72.349999999999994 110.415 175.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.552 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.3 mppt? -130.29 139.48 50.73 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.25 -1.019 . . . . 74.099999999999994 108.25 -178.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.673 HD21 ' CE2' ' A' ' 176' ' ' TYR . 26.1 mt -110.77 100.63 9.35 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 122.9 0.48 . . . . 61.240000000000002 109.829 -172.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -71.12 101.86 2.36 Favored 'General case' 0 CA--C 1.552 1.038 0 O-C-N 124.003 0.814 . . . . 75.209999999999994 110.01 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 173' ' ' ILE . 11.8 mt -106.45 107.77 18.95 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.303 0.641 . . . . 64.0 109.283 -175.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -61.15 150.6 33.73 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.507 0.558 . . . . 70.549999999999997 112.507 176.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.78 24.78 61.6 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.483 -0.781 . . . . 72.519999999999996 114.004 171.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.577 ' HE2' ' HA ' ' A' ' 171' ' ' LEU . 11.1 mmtp -119.83 -44.26 2.53 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.18 0.592 . . . . 72.310000000000002 109.578 -176.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -77.53 -177.01 45.97 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-N 115.352 -0.84 . . . . 74.219999999999999 112.727 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -64.83 150.87 94.03 Favored Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 123.703 0.801 . . . . 75.319999999999993 112.512 -171.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.645 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 52.6 Cg_endo -66.09 151.96 82.45 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 122.642 2.228 . . . . 74.349999999999994 112.329 -177.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -168.22 -156.07 9.97 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 119.413 -0.659 . . . . 44.119999999999997 113.214 -177.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.56 -30.41 61.09 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 123.545 2.83 . . . . 62.240000000000002 112.345 -176.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -85.76 16.19 4.2 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.268 1.027 . . . . 65.219999999999999 111.509 178.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 87.63 -74.01 2.28 Favored Glycine 0 C--N 1.35 1.319 0 N-CA-C 110.94 -0.864 . . . . 62.409999999999997 110.94 -175.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.645 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 14.1 mtm180 -128.42 169.21 14.56 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.3 1.04 . . . . 72.239999999999995 110.076 174.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -93.3 175.66 36.39 Favored Glycine 0 C--N 1.339 0.747 0 CA-C-N 115.658 -0.701 . . . . 61.100000000000001 113.451 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -99.61 170.37 8.63 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.215 1.006 . . . . 65.319999999999993 109.619 -176.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 238' ' ' LYS . 32.0 tp -141.88 118.88 11.25 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.292 -0.633 . . . . 74.120000000000005 109.292 172.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.552 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 13.9 m-85 -88.69 109.41 20.1 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.748 -0.834 . . . . 74.439999999999998 108.748 -178.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 30.2 mt -85.97 108.57 18.27 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.93 -0.767 . . . . 74.310000000000002 108.93 176.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 196' ' ' THR . 30.4 mt-10 -77.31 97.16 4.78 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 114.421 -1.263 . . . . 75.129999999999995 109.405 -174.107 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 65.6 t -60.67 105.16 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 O-C-N 123.765 0.665 . . . . 64.340000000000003 110.752 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -116.02 102.22 9.45 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 106.988 -1.486 . . . . 74.120000000000005 106.988 174.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.525 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 51.3 mt -81.52 131.63 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 116.111 -0.495 . . . . 75.239999999999995 110.843 -174.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 21.3 p . . . . . 0 CA--C 1.563 1.452 0 C-N-CA 124.537 1.135 . . . . 73.340000000000003 108.422 177.267 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 N--CA 1.484 1.266 0 N-CA-C 110.556 -0.164 . . . . 70.310000000000002 110.556 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 33.5 t -153.02 105.38 2.92 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.156 -0.683 . . . . 72.140000000000001 109.156 176.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -104.27 155.58 18.62 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.26 0.624 . . . . 72.439999999999998 111.234 -177.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.415 HD12 HG21 ' A' ' 219' ' ' VAL . 86.2 mt -97.63 27.21 4.47 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.374 1.07 . . . . 74.010000000000005 110.626 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -45.66 148.0 0.81 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 126.678 1.991 . . . . 65.120000000000005 114.487 178.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.618 HG23 HD21 ' A' ' 235' ' ' LEU . 75.9 mt -93.44 107.93 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.996 0.918 . . . . 73.040000000000006 110.152 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -84.1 -5.71 59.28 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.387 0.675 . . . . 70.409999999999997 110.76 173.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -76.38 -179.52 5.2 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.821 0.849 . . . . 31.41 111.023 177.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.567 ' CE2' HD21 ' A' ' 233' ' ' LEU . 25.3 m-85 64.35 37.98 8.1 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.44 1.096 . . . . 74.299999999999997 110.15 -160.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -157.63 71.46 0.25 Allowed Glycine 0 CA--C 1.534 1.279 0 CA-C-N 114.064 -1.425 . . . . 75.140000000000001 111.34 175.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -60.43 -5.44 4.24 Favored 'Trans proline' 0 C--N 1.389 2.661 0 C-N-CA 123.703 2.935 . . . . 71.420000000000002 114.979 175.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -62.43 84.01 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.399 0.68 . . . . 54.219999999999999 111.183 170.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -163.68 108.47 0.34 Allowed Glycine 0 C--N 1.339 0.749 0 CA-C-N 116.011 -0.541 . . . . 65.430000000000007 112.678 -173.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 50.0 m -109.06 33.09 4.45 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.202 1.001 . . . . 62.039999999999999 109.71 176.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -151.94 167.43 31.11 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.745 -0.661 . . . . 74.299999999999997 113.013 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 79.21 8.4 87.84 Favored Glycine 0 C--N 1.352 1.444 0 CA-C-O 119.462 -0.632 . . . . 51.43 114.272 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.3 p -69.65 90.2 0.56 Allowed 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 117.683 0.741 . . . . 73.109999999999999 111.48 -174.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -174.75 162.23 32.14 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 114.958 -1.019 . . . . 71.129999999999995 110.677 179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 70.45 62.8 3.5 Favored Glycine 0 C--N 1.35 1.328 0 CA-C-N 117.63 0.715 . . . . 53.049999999999997 112.866 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 26.9 m -126.29 119.98 28.77 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.846 0.859 . . . . 74.430000000000007 110.115 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 103.91 155.33 23.9 Favored Glycine 0 C--N 1.351 1.396 0 C-N-CA 123.356 0.503 . . . . 65.109999999999999 112.853 -179.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 100.52 -177.42 28.28 Favored Glycine 0 C--N 1.349 1.281 0 C-N-CA 123.051 0.358 . . . . 73.120000000000005 112.553 178.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 23.4 t -69.44 -11.62 60.97 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.817 0.847 . . . . 74.099999999999994 112.155 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -63.01 -36.2 82.75 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.335 1.054 . . . . 71.140000000000001 109.809 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.43 131.64 41.25 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 114.563 -1.199 . . . . 71.400000000000006 110.204 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 96.4 mt -135.8 155.49 50.27 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.81 0.844 . . . . 73.040000000000006 110.239 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -116.4 145.34 43.32 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.091 0.957 . . . . 62.030000000000001 109.17 172.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -150.1 136.76 19.15 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.31 0.644 . . . . 65.299999999999997 109.504 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 86.6 m -69.19 138.77 54.34 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.216 0.606 . . . . 64.549999999999997 110.353 175.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.523 HD13 HD13 ' A' ' 251' ' ' LEU . 45.3 tp -120.14 112.45 19.11 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 107.657 -1.238 . . . . 71.150000000000006 107.657 174.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -95.68 117.0 29.67 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.743 -0.836 . . . . 54.409999999999997 108.743 -178.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.9 p -142.32 129.07 11.03 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.019 0.928 . . . . 72.040000000000006 109.364 -176.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.08 155.58 61.25 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 121.792 1.662 . . . . 41.420000000000002 111.791 175.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -48.63 -46.69 71.54 Favored Pre-proline 0 N--CA 1.487 1.402 0 N-CA-C 114.522 1.304 . . . . 64.510000000000005 114.522 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.441 ' O ' HG12 ' A' ' 206' ' ' VAL . 19.7 Cg_endo -57.74 -55.13 2.59 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 121.418 1.412 . . . . 73.230000000000004 112.802 176.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 58.9 mt -65.2 -29.52 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 123.426 0.69 . . . . 43.200000000000003 111.277 -177.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.8 -53.22 28.79 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.052 0.541 . . . . 61.240000000000002 111.03 -178.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 89.9 t -67.39 -55.17 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 115.642 -0.708 . . . . 71.319999999999993 110.956 -176.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.441 HG12 ' O ' ' A' ' 202' ' ' PRO . 7.7 p -77.12 -22.89 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 N-CA-C 112.268 0.47 . . . . 73.400000000000006 112.268 -173.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.41 139.01 8.19 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-O 120.1 -0.278 . . . . 43.039999999999999 112.622 -177.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -171.83 -145.48 4.9 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 116.753 0.276 . . . . 42.119999999999997 113.116 -178.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.515 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 96.4 mttt -133.76 132.7 40.85 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.963 0.905 . . . . 71.140000000000001 109.131 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.413 HG22 HG21 ' A' ' 223' ' ' VAL . 34.9 m -131.88 164.94 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-O 121.135 0.493 . . . . 61.409999999999997 110.716 177.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -75.45 141.34 43.16 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.082 -0.963 . . . . 64.519999999999996 110.645 174.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -141.47 157.55 45.0 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.727 0.811 . . . . 52.549999999999997 110.045 173.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 55.4 ttp -81.91 129.65 34.83 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.151 0.58 . . . . 72.319999999999993 110.72 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 89.5 m -143.61 166.96 23.38 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 124.418 1.087 . . . . 73.420000000000002 108.251 176.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 96.4 mt -56.6 -27.9 59.16 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.751 0.82 . . . . 75.219999999999999 112.458 174.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.46 14.56 3.61 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.826 0.85 . . . . 62.520000000000003 111.663 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 85.2 -148.75 23.34 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 111.192 -0.763 . . . . 41.009999999999998 111.192 -175.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.66 129.19 13.32 Favored 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 122.412 2.075 . . . . 62.049999999999997 111.327 174.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.415 HG21 HD12 ' A' ' 171' ' ' LEU . 29.2 m -122.21 155.87 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.726 0.811 . . . . 63.0 109.78 178.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -97.24 104.76 16.81 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.896 -0.779 . . . . 75.319999999999993 108.896 176.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.6 t -96.41 130.56 44.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 124.04 0.936 . . . . 73.140000000000001 109.829 -176.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.515 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . . . -77.48 101.93 6.67 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.322 0.649 . . . . 65.349999999999994 110.191 178.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.453 ' HA ' HD12 ' A' ' 173' ' ' ILE . 50.2 t -91.43 126.0 56.02 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 124.303 1.041 . . . . 64.409999999999997 109.959 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.44 ' HD3' ' HB ' ' A' ' 173' ' ' ILE . 57.2 Cg_endo -66.7 172.6 9.18 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 123.665 2.91 . . . . 74.200000000000003 112.452 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.63 -179.41 1.98 Allowed 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 121.853 1.702 . . . . 73.510000000000005 112.154 166.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 68.86 5.29 4.91 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 125.28 1.432 . . . . 74.420000000000002 112.473 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.451 ' HA ' ' CZ ' ' A' ' 176' ' ' TYR . 90.5 m -67.05 114.34 5.75 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.374 0.607 . . . . 72.450000000000003 110.933 -171.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.429 ' HA ' HD11 ' A' ' 255' ' ' ILE . 6.7 tp-100 -125.77 139.53 53.44 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 124.033 0.933 . . . . 51.130000000000003 110.464 -165.269 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.426 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -61.39 134.24 56.7 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.999 0.92 . . . . 75.310000000000002 112.826 -171.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.85 -2.35 85.74 Favored Glycine 0 N--CA 1.474 1.203 0 CA-C-N 115.883 -0.599 . . . . 64.010000000000005 113.663 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -89.67 146.91 24.19 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.327 -0.62 . . . . 51.439999999999998 109.327 173.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -126.73 138.69 53.42 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.791 0.836 . . . . 73.329999999999998 108.97 -172.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.567 HD21 ' CE2' ' A' ' 176' ' ' TYR . 40.6 mt -113.53 109.02 17.97 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.073 -0.512 . . . . 62.100000000000001 111.008 -163.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -70.64 102.61 2.32 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 124.62 1.2 . . . . 73.540000000000006 109.806 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.618 HD21 HG23 ' A' ' 173' ' ' ILE . 33.0 mt -109.4 91.7 3.75 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.322 -0.622 . . . . 63.350000000000001 109.322 178.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.556 ' HG2' ' HB3' ' A' ' 248' ' ' ASP . 45.4 mtmt -70.13 143.53 52.32 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 122.851 0.46 . . . . 63.119999999999997 110.721 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.36 34.34 45.8 Favored Glycine 0 C--N 1.346 1.111 0 O-C-N 123.875 0.734 . . . . 72.340000000000003 112.067 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -131.26 -34.12 1.44 Allowed 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.005 0.922 . . . . 74.030000000000001 110.386 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -74.03 -163.24 9.05 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-N 116.304 -0.407 . . . . 42.32 113.581 175.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -71.26 149.52 94.2 Favored Pre-proline 0 N--CA 1.484 1.242 0 C-N-CA 122.835 0.454 . . . . 73.299999999999997 111.438 -176.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -67.83 161.32 44.46 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.918 2.412 . . . . 73.409999999999997 112.512 173.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -170.36 -173.26 37.52 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 115.739 -0.664 . . . . 73.200000000000003 112.188 177.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.25 -2.63 12.36 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 123.388 2.725 . . . . 74.200000000000003 113.133 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -118.44 21.17 12.76 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.269 1.028 . . . . 62.229999999999997 110.558 174.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 86.41 -167.07 38.76 Favored Glycine 0 C--N 1.345 1.043 0 CA-C-N 115.982 -0.554 . . . . 55.109999999999999 112.506 -175.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -79.85 132.95 36.23 Favored 'General case' 0 C--O 1.244 0.811 0 N-CA-C 109.252 -0.648 . . . . 74.010000000000005 109.252 175.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.96 -164.95 22.02 Favored Glycine 0 C--N 1.341 0.84 0 O-C-N 123.775 0.672 . . . . 52.399999999999999 113.663 -177.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.556 ' HB3' ' HG2' ' A' ' 236' ' ' LYS . 1.2 p-10 -113.52 132.81 55.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.589 0.709 . . . . 73.0 111.957 -168.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 42.0 tp -98.57 117.83 33.88 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.014 -1.448 . . . . 70.549999999999997 108.502 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -88.5 109.7 20.26 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 122.848 0.459 . . . . 74.319999999999993 109.939 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.523 HD13 HD13 ' A' ' 197' ' ' LEU . 31.8 mt -86.96 106.12 17.59 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.174 -0.676 . . . . 73.200000000000003 109.174 175.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -78.16 105.34 9.32 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 115.635 -0.711 . . . . 74.400000000000006 109.411 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 65.2 t -56.44 118.04 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 123.762 0.825 . . . . 74.340000000000003 111.014 176.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -117.3 94.77 4.69 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 107.799 -1.186 . . . . 74.340000000000003 107.799 175.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.429 HD11 ' HA ' ' A' ' 228' ' ' GLN . 14.5 mt -76.03 123.96 33.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 O-C-N 124.006 0.816 . . . . 75.319999999999993 109.779 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 37.4 p . . . . . 0 CA--C 1.557 1.239 0 CA-C-O 117.489 -1.243 . . . . 71.540000000000006 108.167 174.543 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 23.0 mmt . . . . . 0 N--CA 1.473 0.676 0 N-CA-C 109.847 -0.427 . . . . 73.230000000000004 109.847 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.7 t -162.84 -167.53 1.55 Allowed 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 124.804 1.242 . . . . 54.450000000000003 108.234 -178.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -157.08 150.25 23.9 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.519 0.728 . . . . 72.030000000000001 109.248 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 6.0 mp -71.56 87.87 0.92 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.367 0.667 . . . . 63.420000000000002 109.287 176.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -94.63 139.64 30.94 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.847 0.859 . . . . 72.099999999999994 109.653 177.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.433 ' HA ' HD22 ' A' ' 235' ' ' LEU . 26.4 mm -82.99 110.7 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 122.788 0.435 . . . . 75.310000000000002 110.205 178.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -94.25 12.21 27.58 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.751 0.82 . . . . 32.219999999999999 110.729 172.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.414 ' H ' HG22 ' A' ' 173' ' ' ILE . . . -103.85 178.84 4.44 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.36 1.064 . . . . 74.120000000000005 111.383 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 59.18 29.46 19.02 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.043 1.337 . . . . 74.310000000000002 111.837 -164.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -86.2 152.41 25.57 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 115.244 -0.889 . . . . 13.24 111.224 169.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.92 -9.48 12.08 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 123.683 2.922 . . . . 73.109999999999999 113.876 177.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -128.32 141.56 51.4 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.988 0.915 . . . . 61.509999999999998 108.686 171.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -86.24 -106.79 0.77 Allowed Glycine 0 C--N 1.347 1.146 0 N-CA-C 111.167 -0.773 . . . . 42.509999999999998 111.167 173.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.8 m -155.32 172.84 17.53 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.183 0.993 . . . . 44.520000000000003 109.476 174.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -166.19 74.39 0.15 Allowed Glycine 0 C--N 1.34 0.798 0 N-CA-C 111.39 -0.684 . . . . 73.230000000000004 111.39 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -124.29 45.18 1.2 Allowed Glycine 0 C--N 1.346 1.116 0 C-N-CA 123.301 0.477 . . . . 74.120000000000005 112.364 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 40.1 t -71.49 98.16 1.79 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.334 0.654 . . . . 74.319999999999993 109.769 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 134.3 -7.35 4.68 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-O 119.656 -0.524 . . . . 63.119999999999997 112.886 -177.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -78.47 -87.16 0.47 Allowed Glycine 0 C--N 1.352 1.455 0 CA-C-N 116.731 0.265 . . . . 73.5 112.684 178.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 75.6 m -150.85 79.64 1.32 Allowed 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.033 0.933 . . . . 43.32 109.63 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -91.36 -116.28 2.02 Favored Glycine 0 C--N 1.341 0.849 0 CA-C-N 115.244 -0.889 . . . . 42.149999999999999 111.814 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 76.24 -76.55 1.45 Allowed Glycine 0 C--N 1.348 1.242 0 C-N-CA 123.4 0.524 . . . . 75.409999999999997 112.529 176.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 23.9 t -162.61 12.89 0.07 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.573 0.749 . . . . 75.219999999999999 111.246 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -63.78 -36.66 84.62 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.213 0.53 . . . . 75.219999999999999 110.477 177.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -75.53 138.31 41.44 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.055 -0.975 . . . . 73.329999999999998 108.909 173.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.7 mt -129.49 168.98 15.55 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.154 0.582 . . . . 73.420000000000002 111.033 -172.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -120.49 141.91 49.77 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 124.637 1.175 . . . . 74.400000000000006 108.258 172.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -153.83 128.22 9.19 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.172 0.989 . . . . 73.349999999999994 108.36 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' THR . . . . . 0.415 ' HA ' ' HB2' ' A' ' 252' ' ' GLU . 92.9 m -72.87 135.06 45.07 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.084 0.553 . . . . 73.150000000000006 111.595 -175.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 40.5 tp -114.35 113.73 24.94 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.768 1.227 . . . . 73.239999999999995 108.343 178.061 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -89.25 116.43 27.47 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.09 -0.707 . . . . 53.299999999999997 109.09 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 7.0 p -136.38 133.26 19.24 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 108.283 -1.006 . . . . 72.340000000000003 108.283 -174.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.479 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 72.2 Cg_endo -74.84 161.85 38.46 Favored 'Trans proline' 0 C--N 1.37 1.658 0 C-N-CA 121.899 1.732 . . . . 64.319999999999993 111.892 175.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.05 -51.66 59.92 Favored Pre-proline 0 CA--C 1.569 1.696 0 N-CA-C 113.893 1.071 . . . . 74.010000000000005 113.893 177.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 23.1 Cg_endo -60.5 -52.48 3.85 Favored 'Trans proline' 0 C--N 1.399 3.221 0 C-N-CA 122.068 1.845 . . . . 74.0 112.926 -178.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 61.0 mt -64.26 -28.63 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 123.476 0.71 . . . . 75.430000000000007 111.447 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.23 -48.51 75.53 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.937 0.398 . . . . 75.329999999999998 111.234 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 61.7 t -71.37 -52.41 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.192 0 CA-C-N 116.099 -0.501 . . . . 70.319999999999993 112.18 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 202' ' ' PRO . 11.4 p -85.11 -31.73 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 112.395 0.517 . . . . 63.399999999999999 112.395 -172.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 100.39 149.94 24.11 Favored Glycine 0 N--CA 1.471 0.974 0 CA-C-N 116.45 -0.341 . . . . 62.219999999999999 112.372 -173.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 162.42 173.78 31.51 Favored Glycine 0 C--N 1.34 0.782 0 N-CA-C 111.788 -0.525 . . . . 72.420000000000002 111.788 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -81.15 134.79 35.7 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 116.993 0.396 . . . . 75.230000000000004 110.094 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 25.7 m -123.28 167.84 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.488 0.715 . . . . 62.130000000000003 110.48 173.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 -81.5 105.31 12.56 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.705 -1.134 . . . . 70.439999999999998 108.975 172.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.69 144.0 32.32 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.6 0.76 . . . . 72.329999999999998 109.43 175.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 41.4 ttm -86.91 115.66 24.46 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.192 0.52 . . . . 74.299999999999997 110.512 -177.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 9.2 m -116.15 162.57 17.24 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.626 1.17 . . . . 72.030000000000001 107.901 176.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 96.0 mt -56.8 -35.63 68.96 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.227 0.611 . . . . 75.209999999999994 112.349 -177.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -78.55 -20.06 51.48 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.047 0.539 . . . . 73.349999999999994 111.537 -177.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 142.13 -171.8 24.42 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 116.16 -0.473 . . . . 60.509999999999998 112.337 -176.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.52 129.07 14.24 Favored 'Trans proline' 0 C--N 1.365 1.441 0 C-N-CA 123.022 2.482 . . . . 73.409999999999997 111.463 177.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.73 159.93 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 123.723 0.809 . . . . 54.100000000000001 109.549 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -91.18 111.18 22.54 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.36 0.664 . . . . 71.299999999999997 109.661 174.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 93.2 t -107.58 120.99 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.24 1.016 . . . . 74.129999999999995 108.903 177.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.48 98.87 2.86 Favored 'General case' 0 C--N 1.348 0.509 0 C-N-CA 122.989 0.515 . . . . 72.519999999999996 109.959 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 62.2 t -78.03 136.15 62.18 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 124.534 1.134 . . . . 64.299999999999997 109.173 177.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -76.77 173.22 14.83 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.998 2.465 . . . . 74.129999999999995 111.201 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.49 179.52 1.24 Allowed 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 121.972 1.781 . . . . 74.439999999999998 112.197 166.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 27.8 mtt-85 71.23 0.05 3.28 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 125.184 1.394 . . . . 71.430000000000007 112.355 176.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 95.4 m -65.76 106.33 1.48 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.185 0.594 . . . . 54.530000000000001 110.712 -170.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.483 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 60.5 tp60 -115.1 141.45 47.99 Favored 'General case' 0 C--N 1.35 0.596 0 CA-C-N 115.054 -0.975 . . . . 72.109999999999999 110.329 -170.001 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.99 139.83 58.81 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.344 1.057 . . . . 54.119999999999997 111.513 -175.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 91.7 -27.21 10.13 Favored Glycine 0 C--N 1.344 0.978 0 O-C-N 123.836 0.71 . . . . 42.219999999999999 112.791 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.483 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 78.5 mtt180 -77.2 160.64 28.79 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.013 0.525 . . . . 72.010000000000005 110.413 176.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 2.8 mppt? -130.1 144.93 51.62 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.205 0.602 . . . . 71.439999999999998 109.653 -176.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.429 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 12.8 mt -97.9 104.44 16.47 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 115.738 -0.664 . . . . 74.239999999999995 109.269 -176.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 54.0 ttm-85 -71.51 105.74 3.72 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 123.873 0.733 . . . . 75.019999999999996 110.292 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.433 HD22 ' HA ' ' A' ' 173' ' ' ILE . 27.8 mt -112.26 94.59 5.0 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.18 0.592 . . . . 74.409999999999997 109.43 -178.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -65.74 143.81 57.29 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.32 0.248 . . . . 73.430000000000007 111.346 178.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 85.07 12.83 73.02 Favored Glycine 0 C--N 1.346 1.125 0 O-C-N 123.956 0.785 . . . . 53.340000000000003 113.707 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -110.78 -27.23 8.96 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 117.28 0.54 . . . . 74.129999999999995 110.539 -178.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -75.33 -167.69 21.93 Favored Glycine 0 C--N 1.352 1.469 0 O-C-N 123.473 0.483 . . . . 24.0 113.076 171.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 241' ' ' PRO . 71.2 m-85 -70.44 144.37 91.64 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 123.414 0.685 . . . . 75.400000000000006 112.847 -171.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 240' ' ' PHE . 13.7 Cg_exo -72.18 132.59 19.77 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 123.443 2.762 . . . . 72.140000000000001 111.856 173.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -140.91 -174.69 14.2 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 119.775 -0.459 . . . . 53.229999999999997 113.695 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -52.01 -53.64 6.63 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 124.501 3.467 . . . . 72.409999999999997 114.751 -173.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -94.27 -24.57 17.39 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.674 0.79 . . . . 75.120000000000005 112.017 -173.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 175.67 -164.91 35.39 Favored Glycine 0 C--N 1.347 1.155 0 C-N-CA 121.836 -0.221 . . . . 63.420000000000002 112.773 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 -107.53 150.71 26.52 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.909 0.884 . . . . 53.520000000000003 110.447 -177.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.3 167.8 52.91 Favored Glycine 0 C--N 1.348 1.235 0 O-C-N 123.669 0.605 . . . . 22.420000000000002 113.877 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -112.67 133.08 54.87 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.38 1.072 . . . . 72.450000000000003 110.137 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 40.2 tp -99.24 122.42 42.39 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.339 1.055 . . . . 73.109999999999999 108.808 -174.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.474 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 3.8 m-85 -89.6 110.14 21.03 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.485 -0.932 . . . . 72.219999999999999 108.485 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.447 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 27.8 mt -86.86 104.99 16.73 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.646 -0.872 . . . . 74.439999999999998 108.646 173.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.415 ' HB2' ' HA ' ' A' ' 196' ' ' THR . 32.5 mt-10 -77.88 97.33 5.24 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.68 -1.146 . . . . 71.299999999999997 109.46 -171.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 59.0 t -58.95 114.93 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 114.94 -1.027 . . . . 73.239999999999995 111.459 -177.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -116.86 95.97 5.26 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.74 -1.208 . . . . 75.420000000000002 107.74 171.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.466 HD11 ' HA ' ' A' ' 228' ' ' GLN . 50.8 mt -75.53 126.88 36.79 Favored 'Isoleucine or valine' 0 C--N 1.35 0.594 0 CA-C-N 115.376 -0.829 . . . . 75.109999999999999 108.955 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 14.5 p . . . . . 0 C--O 1.252 1.192 0 C-N-CA 124.79 1.236 . . . . 74.439999999999998 108.159 177.995 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.802 0 CA-C-O 120.472 0.177 . . . . 75.3 111.451 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.4 ' HE1' ' HA ' ' A' ' 227' ' ' THR . 3.3 m-30 . . . . . 0 N--CA 1.483 1.209 0 C-N-CA 124.409 1.084 . . . . 74.34 112.33 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 . . . . . 0 C--O 1.244 0.805 0 N-CA-C 108.084 -1.08 . . . . 54.21 108.084 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -78.67 140.83 38.33 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 113.569 -1.651 . . . . 75.42 109.699 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 82.5 mt -136.66 140.66 42.9 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.901 0.48 . . . . 63.42 110.318 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -93.88 122.96 36.9 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.385 -0.825 . . . . 64.31 108.804 174.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -123.51 127.75 48.79 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 107.445 -1.316 . . . . 62.25 107.445 176.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . 0.402 ' HA ' ' HB2' ' A' ' 252' ' ' GLU . 25.1 m -68.48 123.61 21.29 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.19 0.596 . . . . 63.31 110.452 -175.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 29.8 tp -108.36 111.62 23.63 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.604 -0.887 . . . . 75.21 108.604 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -81.97 126.17 31.64 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.404 -0.962 . . . . 73.51 108.404 174.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.484 HG11 HG13 ' A' ' 253' ' ' VAL . 6.4 p -142.68 130.3 11.2 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 108.305 -0.998 . . . . 25.2 108.305 178.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . 0.41 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 57.6 Cg_endo -73.85 155.57 48.56 Favored 'Trans proline' 0 C--N 1.363 1.307 0 C-N-CA 121.678 1.585 . . . . 61.04 110.666 172.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.81 -48.27 88.12 Favored Pre-proline 0 CA--C 1.56 1.35 0 C-N-CA 123.917 0.887 . . . . 60.44 113.08 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.468 ' O ' HG12 ' A' ' 206' ' ' VAL . 78.0 Cg_exo -52.57 -56.12 3.15 Favored 'Trans proline' 0 C--N 1.396 3.03 0 C-N-CA 122.453 2.102 . . . . 64.02 113.57 175.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 59.8 mt -65.09 -28.97 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 123.406 0.683 . . . . 75.3 111.077 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.54 -49.27 71.9 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.091 0.472 . . . . 54.14 111.052 177.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 65.9 t -73.98 -47.57 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 115.955 -0.566 . . . . 74.3 112.496 -173.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 202' ' ' PRO . 13.6 p -88.49 -22.2 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 O-C-N 122.233 -0.292 . . . . 61.44 111.34 -175.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 87.72 166.38 42.36 Favored Glycine 0 C--N 1.342 0.882 0 N-CA-C 111.533 -0.627 . . . . 51.3 111.533 -171.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 162.71 -128.15 1.82 Allowed Glycine 0 C--O 1.226 -0.359 0 N-CA-C 111.213 -0.755 . . . . 63.35 111.213 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.404 ' HD2' ' HB3' ' A' ' 220' ' ' GLU . 48.6 mtmt -137.65 151.48 48.32 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 108.712 -0.847 . . . . 73.11 108.712 173.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 26.6 m -138.37 162.3 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.075 0.55 . . . . 73.14 110.109 172.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 -84.42 115.43 22.53 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.456 -0.793 . . . . 75.03 109.854 174.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -106.79 156.76 18.32 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.716 0.806 . . . . 71.54 109.594 173.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 43.2 tpp -93.08 125.53 37.72 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.883 0.473 . . . . 65.32 109.874 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.442 HG22 ' H ' ' A' ' 216' ' ' GLU . 61.1 m -137.8 160.78 38.32 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.692 1.197 . . . . 75.11 108.044 -178.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 92.5 mt -65.95 -20.85 66.35 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.143 0.577 . . . . 64.1 111.788 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.442 ' H ' HG22 ' A' ' 214' ' ' THR . 13.5 mm-40 -80.02 -17.49 52.67 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.004 0.922 . . . . 74.12 110.95 174.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 125.0 -156.78 19.07 Favored Glycine 0 C--N 1.343 0.95 0 N-CA-C 111.449 -0.66 . . . . 32.44 111.449 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.9 121.07 6.04 Favored 'Trans proline' 0 C--N 1.363 1.3 0 C-N-CA 122.382 2.055 . . . . 70.23 111.607 173.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 32.7 m -111.26 155.91 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.244 0.617 . . . . 75.34 109.837 177.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.404 ' HB3' ' HD2' ' A' ' 209' ' ' LYS . 49.8 mt-10 -94.14 113.85 25.87 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.19 -0.67 . . . . 73.03 109.19 175.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 92.2 t -97.26 117.56 42.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 108.647 -0.872 . . . . 74.54 108.647 175.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.25 100.35 0.79 Allowed 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.474 0.484 . . . . 74.23 109.956 176.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 91.4 t -72.75 131.72 83.93 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 123.495 0.718 . . . . 75.21 109.754 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.33 165.92 31.25 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.266 1.977 . . . . 72.23 110.979 171.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -67.4 174.58 7.05 Favored 'Trans proline' 0 CA--C 1.551 1.374 0 C-N-CA 121.688 1.592 . . . . 65.41 112.818 170.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 69.91 0.32 3.01 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 125.374 1.47 . . . . 75.31 113.514 173.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.454 HG22 HG11 ' A' ' 253' ' ' VAL . 47.4 m -62.24 126.83 28.69 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.119 0.968 . . . . 75.03 111.781 -170.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.415 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 57.9 tp60 -124.4 143.2 50.75 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.816 0.846 . . . . 72.25 111.03 -167.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.86 131.75 51.66 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.904 1.282 . . . . 71.51 111.813 -178.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 99.4 -18.04 56.94 Favored Glycine 0 N--CA 1.473 1.116 0 O-C-N 123.705 0.628 . . . . 52.22 112.951 177.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.415 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 80.5 mtt180 -83.12 135.87 34.66 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.074 -0.714 . . . . 64.44 109.074 174.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.2 mppt? -102.11 131.78 48.4 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.192 -0.67 . . . . 71.43 109.192 176.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.509 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 29.0 mt -77.46 97.78 5.09 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.88 -1.155 . . . . 74.01 107.88 174.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -74.17 103.91 4.77 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.151 0.581 . . . . 74.55 110.18 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 7.4 mt -102.23 91.09 4.14 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.054 -1.091 . . . . 72.34 108.054 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -66.6 129.44 39.85 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.843 -0.617 . . . . 71.43 112.221 -172.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 95.5 -16.66 60.81 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 115.639 -0.709 . . . . 64.03 113.113 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.542 ' HA ' ' HE2' ' A' ' 238' ' ' LYS . 11.3 mmpt? -81.57 -12.63 58.71 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.324 0.649 . . . . 73.55 112.06 -176.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -79.5 -172.68 43.58 Favored Glycine 0 CA--C 1.535 1.339 0 N-CA-C 112.106 -0.398 . . . . 72.13 112.106 168.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -86.31 153.06 56.19 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 123.005 0.522 . . . . 75.03 111.451 -174.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.46 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 48.0 Cg_endo . . . . . 0 C--N 1.382 2.312 0 C-N-CA 123.019 2.479 . . . . 72.22 112.708 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 77.9 mtt180 . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 110.079 -0.341 . . . . 75.24 110.079 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -84.35 173.0 49.58 Favored Glycine 0 C--N 1.349 1.257 0 N-CA-C 114.014 0.366 . . . . 71.42 114.014 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -106.83 134.11 50.47 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.62 1.168 . . . . 75.4 109.007 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 32.7 tp -98.91 106.69 18.98 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.892 -0.781 . . . . 63.32 108.892 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.458 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 72.6 m-85 -88.76 107.52 19.0 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.361 0.664 . . . . 74.33 109.68 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.509 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 43.3 mt -88.08 108.47 19.26 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 108.787 -0.82 . . . . 75.12 108.787 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.402 ' HB2' ' HA ' ' A' ' 196' ' ' THR . 34.8 mt-10 -76.79 99.89 5.29 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.263 -0.88 . . . . 62.02 109.813 -171.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.484 HG13 HG11 ' A' ' 199' ' ' VAL . 95.0 t -61.69 106.48 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 123.228 0.611 . . . . 54.25 111.071 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -109.38 95.09 5.39 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.198 0.999 . . . . 73.23 108.521 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 21.8 mt -76.18 113.9 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 123.264 0.625 . . . . 72.43 109.453 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 23.8 p . . . . . 0 C--O 1.249 1.044 0 C-N-CA 124.664 1.186 . . . . 72.41 110.256 -178.748 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 111.462 0.171 . . . . 54.43 111.462 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.675 ' HB3' HH21 ' A' ' 226' ' ' ARG . 34.7 m-85 . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 108.909 -0.774 . . . . 53.54 108.909 166.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.571 ' HB2' ' HB2' ' A' ' 240' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 121.515 0.674 . . . . 75.22 110.407 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -75.48 143.08 42.77 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.349 1.06 . . . . 73.22 110.397 177.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 82.5 mt -121.13 146.96 46.21 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.721 0.409 . . . . 72.41 110.678 -171.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -93.76 149.71 21.01 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 109.438 -0.578 . . . . 71.05 109.438 171.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.461 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -144.54 127.99 16.94 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.589 0.755 . . . . 72.34 109.003 -177.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 38.5 m -71.31 117.8 13.31 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 122.943 0.497 . . . . 43.51 109.946 -176.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 41.5 tp -108.0 109.91 21.49 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.604 -0.887 . . . . 53.0 108.604 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -92.3 112.53 24.51 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.44 0.696 . . . . 65.34 109.156 175.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.409 ' HA ' HG11 ' A' ' 210' ' ' VAL . 7.0 p -130.24 128.99 22.82 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 124.305 1.042 . . . . 53.35 108.956 -178.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . 0.406 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 41.7 Cg_endo -70.26 155.11 65.02 Favored 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.004 1.803 . . . . 75.31 111.836 176.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -48.41 -46.49 68.95 Favored Pre-proline 0 CA--C 1.566 1.566 0 N-CA-C 114.79 1.404 . . . . 61.5 114.79 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.48 ' O ' HG12 ' A' ' 206' ' ' VAL . 25.7 Cg_endo -61.86 -52.69 2.7 Favored 'Trans proline' 0 C--N 1.393 2.921 0 CA-C-N 121.114 1.433 . . . . 64.53 112.888 176.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 50.7 mt -64.93 -24.61 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 123.574 0.749 . . . . 73.04 110.952 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.47 ' HB1' ' O ' ' A' ' 227' ' ' THR . . . -68.66 -55.1 12.58 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.578 0.751 . . . . 71.24 111.34 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 76.6 t -66.76 -51.5 55.25 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-N 115.858 -0.61 . . . . 72.23 112.121 -175.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 202' ' ' PRO . 11.5 p -87.69 -25.96 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 N-CA-C 111.913 0.338 . . . . 60.31 111.913 -174.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 92.29 153.4 29.92 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 111.641 -0.584 . . . . 74.12 111.641 -171.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 178.76 -128.89 1.31 Allowed Glycine 0 C--N 1.33 0.235 0 CA-C-O 119.551 -0.583 . . . . 72.21 111.944 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -139.56 141.39 37.22 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.059 0.944 . . . . 73.42 110.144 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.409 HG11 ' HA ' ' A' ' 199' ' ' VAL . 30.8 m -135.14 167.57 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.963 0.905 . . . . 71.23 109.425 169.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -93.47 111.42 23.08 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.102 -0.703 . . . . 75.03 109.102 173.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.48 145.25 29.85 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.844 0.458 . . . . 64.32 110.065 175.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 87.4 mtp -88.02 104.47 16.68 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.653 -0.869 . . . . 72.24 108.653 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 215' ' ' LEU . 27.7 m -111.78 177.35 4.68 Favored 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 124.824 1.25 . . . . 70.31 108.315 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.414 ' H ' HG22 ' A' ' 214' ' ' THR . 82.6 mt -63.57 -19.32 64.72 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.461 0.704 . . . . 71.31 112.845 -177.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -87.48 6.48 33.88 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.375 0.67 . . . . 74.11 111.555 175.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 93.65 -153.32 21.21 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 119.406 -0.663 . . . . 61.3 111.641 -173.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -75.63 126.46 9.58 Favored 'Trans proline' 0 C--N 1.367 1.527 0 C-N-CA 122.339 2.026 . . . . 72.44 111.079 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.94 153.16 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 123.124 0.57 . . . . 54.45 111.217 -171.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -84.92 110.58 18.97 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.198 -0.667 . . . . 71.35 109.198 175.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 95.4 t -109.2 123.0 64.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 123.854 0.862 . . . . 70.3 110.18 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -77.37 101.24 6.26 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.512 0.725 . . . . 73.12 109.943 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 57.3 t -73.67 130.95 82.75 Favored Pre-proline 0 CA--C 1.561 1.38 0 C-N-CA 125.12 1.368 . . . . 63.52 110.142 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -85.09 171.25 9.26 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 123.205 2.603 . . . . 74.04 111.032 174.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.04 166.35 21.09 Favored 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 121.689 1.593 . . . . 73.22 112.639 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . 0.675 HH21 ' HB3' ' A' ' 176' ' ' TYR . 29.3 mtm180 71.72 11.59 6.35 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 125.636 1.574 . . . . 71.11 112.634 177.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.47 ' O ' ' HB1' ' A' ' 204' ' ' ALA . 94.1 m -65.54 91.62 0.13 Allowed 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 121.776 0.798 . . . . 73.23 110.16 -178.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.508 ' HA ' HD11 ' A' ' 255' ' ' ILE . 32.8 tt0 -107.75 144.3 35.08 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 114.771 -1.104 . . . . 74.24 110.396 -168.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -55.02 129.98 39.97 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.004 1.321 . . . . 74.43 111.986 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 88.93 -9.06 78.15 Favored Glycine 0 N--CA 1.475 1.251 0 CA-C-N 115.997 -0.547 . . . . 62.11 114.032 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -81.98 150.89 27.42 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.437 -0.579 . . . . 73.01 109.437 171.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.509 ' HG3' ' HA ' ' A' ' 252' ' ' GLU . 0.0 OUTLIER -129.85 141.81 50.77 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.796 0.808 . . . . 73.13 110.995 -176.047 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 14.9 mt -114.77 99.64 7.65 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 114.101 -1.409 . . . . 71.31 109.516 -162.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . 0.543 ' HG3' ' HB3' ' A' ' 248' ' ' ASP . 52.1 ttp180 -76.78 102.54 6.31 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 123.516 0.51 . . . . 71.1 110.405 -175.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 21.9 mt -99.12 95.35 7.05 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.153 0.981 . . . . 74.44 108.443 176.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -66.64 148.06 52.42 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.64 0.776 . . . . 53.22 111.765 -176.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 72.67 30.93 63.29 Favored Glycine 0 CA--C 1.529 0.932 0 O-C-N 123.706 0.629 . . . . 75.43 113.513 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -130.12 -17.47 3.45 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 113.346 0.869 . . . . 74.43 113.346 -176.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -77.55 -152.82 5.54 Favored Glycine 0 N--CA 1.484 1.842 0 CA-C-N 118.028 0.376 . . . . 61.04 113.505 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.571 ' HB2' ' HB2' ' A' ' 191' ' ' GLN . 15.0 m-85 -69.12 155.34 93.76 Favored Pre-proline 0 N--CA 1.488 1.436 0 CA-C-O 118.595 -0.717 . . . . 73.31 110.152 172.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo . . . . . 0 C--N 1.377 2.061 0 C-N-CA 123.024 2.482 . . . . 52.53 113.02 175.17 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 . . . . . 0 C--O 1.244 0.806 0 N-CA-C 109.512 -0.551 . . . . 73.25 109.512 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -89.25 -160.16 36.17 Favored Glycine 0 C--N 1.339 0.719 0 CA-C-N 115.291 -0.868 . . . . 72.35 111.89 172.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.543 ' HB3' ' HG3' ' A' ' 234' ' ' ARG . 3.4 m-20 -98.21 169.95 9.23 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.175 0.59 . . . . 74.35 109.61 -176.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 33.7 tp -139.67 106.19 5.33 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.62 -0.882 . . . . 64.22 108.62 174.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -88.7 113.38 24.2 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.197 0.599 . . . . 73.13 109.401 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.461 HD23 ' HB3' ' A' ' 195' ' ' ALA . 57.0 mt -85.14 112.74 20.96 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.364 -0.976 . . . . 73.05 108.364 175.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.509 ' HA ' ' HG3' ' A' ' 232' ' ' LYS . 13.8 tp10 -76.83 101.0 5.7 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.749 1.219 . . . . 70.25 108.088 -179.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.69 106.94 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.518 0.675 . . . . 63.15 110.476 -176.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -107.02 96.5 6.47 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 114.425 -1.261 . . . . 70.43 107.7 174.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.508 HD11 ' HA ' ' A' ' 228' ' ' GLN . 24.2 mt -76.13 123.54 32.52 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 N-CA-C 108.83 -0.804 . . . . 73.14 108.83 176.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 41.5 p . . . . . 0 CA--C 1.549 0.934 0 C-N-CA 124.785 1.234 . . . . 73.11 108.755 177.358 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 112.498 0.555 . . . . 64.43 112.498 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 . . . . . 0 CA--C 1.541 0.633 0 N-CA-C 108.02 -1.104 . . . . 73.53 108.02 169.556 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.631 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 72.8 mt-30 . . . . . 0 CA--C 1.55 0.972 0 CA-C-O 120.967 0.413 . . . . 70.43 111.849 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -73.98 143.1 45.77 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.579 1.152 . . . . 54.13 110.683 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 95.2 mt -139.16 149.78 44.85 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.255 1.022 . . . . 62.01 109.942 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -111.54 128.47 56.04 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.305 1.042 . . . . 74.24 108.245 168.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -125.29 128.41 48.19 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.901 -0.777 . . . . 65.41 108.901 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 73.6 m -67.49 131.93 46.62 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.355 0.662 . . . . 65.22 110.373 178.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 20.6 tp -121.36 112.52 18.67 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.888 0.875 . . . . 72.14 108.969 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -92.47 120.47 32.98 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 108.752 -0.833 . . . . 61.24 108.752 172.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 3.0 p -131.64 128.05 21.65 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.143 0.977 . . . . 75.02 108.432 -178.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -71.39 153.03 61.22 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 121.6 1.533 . . . . 75.52 111.395 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -47.1 -48.73 53.46 Favored Pre-proline 0 CA--C 1.565 1.545 0 O-C-N 124.495 1.122 . . . . 73.41 113.064 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.32 -55.42 3.65 Favored 'Trans proline' 0 C--N 1.407 3.611 0 C-N-CA 122.458 2.106 . . . . 72.32 113.291 175.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 57.4 mt -67.76 -27.01 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 123.558 0.743 . . . . 75.12 111.1 -175.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.17 -45.48 73.38 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.588 0.755 . . . . 73.34 110.857 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 81.0 t -71.63 -55.92 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 115.77 -0.65 . . . . 54.43 110.685 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 11.2 m -73.52 -28.58 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 O-C-N 123.816 0.698 . . . . 74.3 112.191 -172.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 77.77 84.01 0.54 Allowed Glycine 0 C--N 1.344 0.994 0 CA-C-N 116.013 -0.54 . . . . 73.23 112.371 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -115.28 -126.0 4.04 Favored Glycine 0 C--N 1.342 0.886 0 N-CA-C 112.14 -0.384 . . . . 44.31 112.14 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -137.56 147.96 45.54 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.654 1.182 . . . . 75.01 108.36 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 28.4 m -133.35 168.71 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 121.305 0.574 . . . . 54.33 110.703 173.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -77.37 135.47 38.35 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.967 -1.015 . . . . 74.31 108.87 169.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -138.17 158.26 44.65 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.756 0.423 . . . . 64.3 110.509 176.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 67.0 mtm -81.02 119.06 23.04 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.045 -0.979 . . . . 71.2 110.242 -176.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.432 HG22 ' H ' ' A' ' 216' ' ' GLU . 89.4 m -135.42 151.68 50.67 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.186 0.994 . . . . 42.24 109.63 176.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 62.6 mt -57.41 -25.56 59.77 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.564 1.146 . . . . 75.45 112.808 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.432 ' H ' HG22 ' A' ' 214' ' ' THR . 34.0 mt-10 -86.43 -18.86 30.65 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.155 0.982 . . . . 72.24 111.585 -178.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 135.07 -177.72 19.11 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.543 -0.623 . . . . 62.21 111.543 -175.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.66 120.83 7.17 Favored 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 122.404 2.069 . . . . 73.22 111.431 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.6 m -113.14 161.67 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 123.064 0.546 . . . . 73.3 111.484 -173.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -91.59 111.99 23.73 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.799 0.839 . . . . 64.4 109.482 174.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 54.4 t -109.88 126.22 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.023 0.929 . . . . 75.21 109.421 -176.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -77.36 100.94 6.11 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.353 0.661 . . . . 24.33 111.188 -173.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 59.9 t -77.29 134.81 66.48 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 124.93 1.292 . . . . 74.3 109.827 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.03 170.3 20.71 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.523 2.149 . . . . 74.33 111.349 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.68 165.73 31.91 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 121.228 1.285 . . . . 73.33 111.259 169.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 63.39 22.97 13.52 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.781 0.832 . . . . 72.14 112.299 175.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 93.9 m -68.83 105.7 2.43 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.816 0.846 . . . . 42.24 109.634 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -105.51 141.45 36.97 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.259 1.024 . . . . 64.23 110.223 -171.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.74 136.89 58.2 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.474 1.11 . . . . 73.54 111.371 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 92.22 -9.22 76.7 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.499 -0.773 . . . . 75.42 113.435 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -84.86 144.22 28.55 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.995 0.518 . . . . 73.13 109.7 173.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.654 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.2 mppt? -110.66 129.47 55.81 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.508 0.723 . . . . 74.15 109.196 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.554 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 53.9 mt -95.03 101.35 13.1 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.831 0.852 . . . . 64.11 109.751 -173.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -72.35 105.29 4.03 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.333 0.653 . . . . 72.41 110.676 -176.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 17.8 mt -105.12 98.15 7.9 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.826 -1.176 . . . . 72.23 107.826 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -75.78 148.43 38.48 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 122.544 0.338 . . . . 74.1 111.349 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 72.03 33.68 62.29 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-N 115.757 -0.656 . . . . 75.32 113.272 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.13 -37.3 3.4 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.606 0.762 . . . . 71.24 111.338 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -68.72 -154.09 0.63 Allowed Glycine 0 C--N 1.355 1.631 0 N-CA-C 114.455 0.542 . . . . 72.44 114.455 -177.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.631 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 81.5 m-85 -66.66 144.71 98.74 Favored Pre-proline 0 N--CA 1.481 1.117 0 C-N-CA 122.81 0.444 . . . . 75.53 111.003 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo . . . . . 0 C--N 1.374 1.913 0 C-N-CA 122.678 2.252 . . . . 72.11 113.317 178.577 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 . . . . . 0 C--O 1.24 0.554 0 N-CA-C 108.623 -0.88 . . . . 73.13 108.623 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.8 -170.11 16.19 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-N 115.534 -0.757 . . . . 74.15 113.738 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -98.34 165.82 11.67 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.448 0.699 . . . . 71.21 109.291 -172.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 41.1 tp -141.58 105.24 4.7 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.515 -0.92 . . . . 72.12 108.515 175.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.654 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 33.0 m-85 -91.07 111.32 22.74 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.357 0.663 . . . . 74.42 109.899 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.554 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 48.5 mt -86.02 109.18 18.62 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.885 -0.783 . . . . 72.31 108.885 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -77.81 100.01 6.14 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.05 -0.977 . . . . 61.54 109.642 -173.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 48.6 t -57.84 111.45 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 O-C-N 123.963 0.789 . . . . 73.44 111.404 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 21.2 mmm-85 -115.48 98.93 7.01 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 106.818 -1.549 . . . . 65.4 106.818 171.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 36.5 mt -75.82 119.53 23.94 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 N-CA-C 109.45 -0.574 . . . . 75.22 109.45 -176.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 7.5 p . . . . . 0 C--O 1.261 1.689 0 C-N-CA 124.647 1.179 . . . . 73.05 108.867 -174.294 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 111.885 0.328 . . . . 74.11 111.885 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.582 ' CE2' HD21 ' A' ' 233' ' ' LEU . 37.7 m-85 . . . . . 0 N--CA 1.482 1.157 0 C-N-CA 123.246 0.618 . . . . 73.21 110.843 167.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 . . . . . 0 N--CA 1.479 0.994 0 CA-C-O 121.088 0.471 . . . . 74.42 110.844 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -77.27 149.02 35.43 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.522 -0.763 . . . . 71.35 109.899 175.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 95.6 mt -134.94 156.5 48.89 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.29 0.636 . . . . 63.42 110.55 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -108.86 124.51 50.75 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.663 -0.866 . . . . 73.55 108.663 169.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -124.07 130.09 51.97 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.117 0.967 . . . . 62.52 108.829 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 14.7 m -68.92 121.25 16.22 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.365 0.666 . . . . 71.21 110.102 -177.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.426 HD22 ' HB3' ' A' ' 251' ' ' LEU . 35.0 tp -106.35 110.47 22.71 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.629 -1.248 . . . . 63.51 107.629 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -89.2 116.65 27.6 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.485 -0.931 . . . . 74.43 108.485 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.7 p -137.69 132.82 17.58 Favored Pre-proline 0 CA--C 1.546 0.794 0 N-CA-C 108.972 -0.751 . . . . 73.31 108.972 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -75.13 156.47 42.42 Favored 'Trans proline' 0 C--N 1.366 1.472 0 C-N-CA 121.924 1.75 . . . . 71.23 111.27 170.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.412 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -52.6 -45.27 96.23 Favored Pre-proline 0 CA--C 1.554 1.118 0 N-CA-C 114.347 1.24 . . . . 42.22 114.347 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.406 ' O ' HG12 ' A' ' 206' ' ' VAL . 24.6 Cg_endo -59.14 -50.79 7.88 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 121.658 1.572 . . . . 74.02 112.956 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 49.6 mt -65.94 -25.02 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.676 0.79 . . . . 74.32 111.077 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.95 -46.44 62.41 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 122.848 0.459 . . . . 73.22 111.275 177.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 201' ' ' ALA . 87.7 t -64.46 -52.7 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 122.991 0.516 . . . . 72.13 111.442 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 202' ' ' PRO . 11.8 p -84.17 -34.32 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 112.04 0.385 . . . . 73.2 112.04 -174.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 84.49 89.3 0.82 Allowed Glycine 0 C--N 1.335 0.483 0 CA-C-N 116.561 -0.291 . . . . 43.03 112.507 -171.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -106.39 -135.13 7.93 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 111.05 -0.82 . . . . 61.41 111.05 172.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -128.97 144.26 51.13 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 108.783 -0.821 . . . . 52.04 108.783 174.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.44 HG11 ' HA ' ' A' ' 199' ' ' VAL . 33.7 m -134.11 162.07 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.116 0.566 . . . . 64.33 110.333 176.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 69.0 ttt-85 -74.44 135.53 42.33 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.112 0.565 . . . . 73.11 109.979 172.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -140.7 151.26 44.39 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.702 0.801 . . . . 73.21 109.565 177.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -80.63 122.34 26.96 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.962 -0.755 . . . . 74.22 108.962 176.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.416 HG22 ' H ' ' A' ' 216' ' ' GLU . 95.9 m -131.84 164.35 26.26 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 107.909 -1.145 . . . . 74.23 107.909 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 73.0 mt -63.86 -11.31 26.44 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.296 0.639 . . . . 54.11 112.069 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.416 ' H ' HG22 ' A' ' 214' ' ' THR . 40.9 mt-10 -103.43 17.74 23.41 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.817 1.247 . . . . 75.44 110.886 176.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 87.12 -161.99 33.38 Favored Glycine 0 C--N 1.349 1.281 0 CA-C-O 119.463 -0.632 . . . . 72.2 113.182 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -74.04 121.94 7.28 Favored 'Trans proline' 0 C--N 1.372 1.805 0 C-N-CA 122.505 2.137 . . . . 73.32 111.715 177.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.91 158.92 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.882 0.873 . . . . 65.31 110.402 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -90.42 108.93 20.09 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.873 0.469 . . . . 63.21 109.814 173.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 25.1 t -97.49 129.69 47.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 108.819 -0.808 . . . . 74.52 108.819 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.02 100.44 2.99 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.267 0.627 . . . . 64.01 110.586 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 50.9 t -64.27 139.43 97.7 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 125.254 1.421 . . . . 73.25 109.94 178.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.37 168.64 24.24 Favored 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 122.684 2.256 . . . . 71.22 111.548 173.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -73.82 172.92 14.87 Favored 'Trans proline' 0 CA--C 1.55 1.319 0 C-N-CA 121.453 1.435 . . . . 75.45 110.716 164.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 44.8 mtt180 66.12 6.34 4.09 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 124.684 1.194 . . . . 65.33 112.722 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.447 ' O ' HD11 ' A' ' 255' ' ' ILE . 94.4 m -59.91 110.54 1.2 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.375 0.67 . . . . 74.54 110.823 -170.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.494 ' HB3' ' HD3' ' A' ' 231' ' ' ARG . 60.1 tt0 -117.47 134.44 54.85 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.974 1.31 . . . . 74.55 110.328 -164.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.6 128.23 35.6 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.369 1.068 . . . . 71.43 112.444 -173.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.41 -9.85 62.93 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-N 115.915 -0.584 . . . . 54.3 113.119 177.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.494 ' HD3' ' HB3' ' A' ' 228' ' ' GLN . 76.2 mtp180 -89.41 158.55 17.7 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.079 0.552 . . . . 70.44 110.728 176.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.428 ' HG3' ' HA ' ' A' ' 252' ' ' GLU . 0.0 OUTLIER -131.34 144.11 51.0 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.088 0.555 . . . . 54.13 110.734 -174.036 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.582 HD21 ' CE2' ' A' ' 176' ' ' TYR . 44.6 mt -117.46 102.27 9.07 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.723 -0.672 . . . . 62.01 110.726 -164.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . 0.419 ' HG3' ' HB3' ' A' ' 248' ' ' ASP . 51.1 ttp180 -79.78 113.92 18.3 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.833 0.853 . . . . 74.41 110.935 -173.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 43.0 mt -112.38 96.95 6.3 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.574 0.75 . . . . 74.55 109.304 177.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -62.86 140.84 58.83 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.859 -0.61 . . . . 75.1 111.379 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 81.17 25.36 55.37 Favored Glycine 0 C--N 1.339 0.741 0 O-C-N 124.259 0.975 . . . . 74.14 114.508 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.78 -28.25 6.02 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.152 0.581 . . . . 72.23 111.306 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -74.63 -169.66 23.2 Favored Glycine 0 CA--C 1.535 1.339 0 O-C-N 123.399 0.437 . . . . 51.3 112.848 173.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -65.43 143.33 98.68 Favored Pre-proline 0 N--CA 1.486 1.339 0 C-N-CA 123.693 0.797 . . . . 71.41 111.495 -175.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo . . . . . 0 C--N 1.379 2.137 0 C-N-CA 122.735 2.29 . . . . 72.11 112.076 175.083 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 57.6 mtt85 . . . . . 0 N--CA 1.484 1.228 0 N-CA-C 110.478 -0.193 . . . . 63.03 110.478 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -71.79 -173.11 17.9 Favored Glycine 0 C--N 1.344 1.021 0 O-C-N 123.545 0.528 . . . . 75.12 113.565 -176.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.419 ' HB3' ' HG3' ' A' ' 234' ' ' ARG . 3.3 m-20 -98.67 157.88 15.98 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.805 -0.813 . . . . 73.15 108.805 -176.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 32.9 tp -125.9 106.49 9.69 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.102 -1.073 . . . . 74.55 108.102 172.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -89.68 107.47 19.11 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.857 -0.794 . . . . 72.34 108.857 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.426 ' HB3' HD22 ' A' ' 197' ' ' LEU . 62.3 mt -87.77 106.71 18.25 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.453 -0.944 . . . . 75.04 108.453 176.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.428 ' HA ' ' HG3' ' A' ' 232' ' ' LYS . 22.7 mt-10 -79.07 105.9 10.73 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 114.894 -1.048 . . . . 73.13 110.153 -173.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 83.4 t -60.15 107.45 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.693 0 O-C-N 124.169 0.918 . . . . 75.3 111.48 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -115.27 93.92 4.5 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 107.91 -1.144 . . . . 73.31 107.91 173.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.464 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 54.5 mt -76.65 132.5 32.83 Favored 'Isoleucine or valine' 0 C--N 1.351 0.671 0 CA-C-N 115.464 -0.789 . . . . 54.53 109.93 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 32.4 p . . . . . 0 C--O 1.253 1.237 0 C-N-CA 124.671 1.188 . . . . 72.42 108.694 -179.165 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 120.436 0.16 . . . . 73.14 111.166 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.461 ' CE2' HD21 ' A' ' 233' ' ' LEU . 6.2 m-85 . . . . . 0 N--CA 1.483 1.209 0 C-N-CA 123.787 0.835 . . . . 75.13 111.323 169.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 121.509 0.671 . . . . 74.41 110.762 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -83.77 159.15 21.5 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.541 -1.209 . . . . 75.3 112.631 -169.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.5 mt -143.68 138.01 28.62 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.097 0.959 . . . . 72.43 109.614 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -93.04 125.72 37.77 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.483 -1.303 . . . . 72.23 107.483 164.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -124.24 133.06 53.61 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.369 -0.604 . . . . 74.44 109.369 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . 0.589 HG23 ' HG3' ' A' ' 254' ' ' ARG . 42.9 m -65.94 122.16 16.72 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 124.038 0.836 . . . . 63.32 109.77 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 40.3 tp -109.28 108.8 19.52 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.018 -1.475 . . . . 71.21 107.018 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -95.7 103.09 14.95 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 122.098 0.951 . . . . 62.14 109.225 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 2.8 p -120.12 117.41 32.05 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-N 114.569 -1.196 . . . . 73.03 109.02 -174.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.9 154.59 73.33 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 122.136 1.891 . . . . 72.24 111.579 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -48.04 -45.25 63.24 Favored Pre-proline 0 CA--C 1.565 1.554 0 N-CA-C 114.713 1.375 . . . . 34.34 114.713 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.438 ' O ' HG22 ' A' ' 206' ' ' VAL . 26.1 Cg_endo -59.72 -50.85 7.03 Favored 'Trans proline' 0 C--N 1.399 3.187 0 C-N-CA 121.425 1.416 . . . . 71.15 112.227 176.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.7 mt -70.0 -23.24 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 123.672 0.789 . . . . 65.33 111.263 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.59 -51.06 46.63 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 122.923 0.489 . . . . 65.4 110.166 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 84.5 t -67.0 -48.69 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 CA-C-N 115.606 -0.725 . . . . 71.21 111.866 -177.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 202' ' ' PRO . 33.9 m -89.9 -23.04 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 113.313 0.857 . . . . 74.53 113.313 -174.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.78 149.69 24.37 Favored Glycine 0 N--CA 1.477 1.385 0 N-CA-C 112.15 -0.38 . . . . 72.11 112.15 -173.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 163.97 175.61 35.02 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 116.927 0.363 . . . . 55.31 112.282 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 221' ' ' VAL . 50.2 mtmt -82.12 135.66 35.27 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.872 0.469 . . . . 72.35 110.226 -177.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.465 HG11 ' HA ' ' A' ' 199' ' ' VAL . 33.9 m -138.94 170.03 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 123.84 0.856 . . . . 65.33 110.686 176.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -68.55 130.58 43.26 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.532 -0.758 . . . . 65.41 111.067 175.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -135.68 118.14 15.8 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.768 -0.827 . . . . 74.24 108.768 168.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 55.8 mtt -73.0 105.93 4.67 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.211 0.605 . . . . 64.41 109.874 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 25.6 m -110.03 171.46 7.44 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.88 1.272 . . . . 53.21 108.61 -175.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 85.8 mt -57.45 -35.33 70.0 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.576 0.75 . . . . 63.12 112.212 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -79.4 -11.02 59.92 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.803 0.841 . . . . 70.42 112.464 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 125.08 -179.33 16.2 Favored Glycine 0 N--CA 1.47 0.956 0 N-CA-C 111.121 -0.791 . . . . 61.43 111.121 -174.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.64 129.41 21.07 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 122.5 2.134 . . . . 74.24 110.997 176.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.474 HG23 HG23 ' A' ' 221' ' ' VAL . 29.5 m -123.29 162.26 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.777 0.831 . . . . 74.41 110.61 -174.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -90.58 106.04 18.23 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.692 0.758 . . . . 71.33 109.7 174.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.474 HG23 HG23 ' A' ' 219' ' ' VAL . 94.8 t -101.71 121.72 53.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 115.214 -0.903 . . . . 65.03 109.569 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.02 99.69 3.38 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 123.489 0.715 . . . . 52.54 110.009 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 31.1 t -84.53 132.64 46.3 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 114.547 -1.206 . . . . 74.53 109.172 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.42 170.05 17.06 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.862 2.375 . . . . 74.14 111.23 171.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.27 -174.43 0.26 Allowed 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.536 2.157 . . . . 62.32 113.563 174.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 38.5 mtp85 62.39 19.5 11.16 Favored 'General case' 0 N--CA 1.502 2.172 0 C-N-CA 125.137 1.375 . . . . 74.31 112.172 172.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.448 ' HA ' ' CZ ' ' A' ' 176' ' ' TYR . 55.5 m -71.82 99.18 2.12 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.965 0.906 . . . . 73.43 111.088 -171.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -98.55 134.94 40.81 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.255 1.422 . . . . 75.44 110.1 -175.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.67 146.22 54.21 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.25 0.62 . . . . 53.2 111.217 -178.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 96.73 -26.74 20.81 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-N 115.182 -0.917 . . . . 64.11 112.78 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -69.85 154.28 42.17 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 117.2 0.5 . . . . 74.21 111.12 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -130.32 142.92 50.51 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 108.176 -1.046 . . . . 71.51 108.176 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.461 HD21 ' CE2' ' A' ' 176' ' ' TYR . 27.4 mt -120.38 105.82 11.26 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.781 -0.645 . . . . 71.2 110.101 -165.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -73.23 102.86 3.76 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.744 0.818 . . . . 74.11 110.463 -174.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 37.3 mt -112.49 92.88 4.18 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.097 -0.705 . . . . 74.43 109.097 177.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.41 ' HG2' ' HB3' ' A' ' 248' ' ' ASP . 47.0 mtmt -69.59 144.26 53.07 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 122.293 0.237 . . . . 75.23 110.735 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 80.81 29.75 41.6 Favored Glycine 0 C--N 1.342 0.912 0 O-C-N 123.73 0.644 . . . . 30.34 113.432 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 249' ' ' LEU . 72.0 mmtt -123.33 -28.33 3.98 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 117.577 0.689 . . . . 73.14 112.11 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -72.02 -145.83 0.53 Allowed Glycine 0 N--CA 1.481 1.667 0 C-N-CA 123.111 0.386 . . . . 51.22 113.867 -177.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -76.65 149.5 80.97 Favored Pre-proline 0 N--CA 1.486 1.36 0 O-C-N 122.272 -0.546 . . . . 63.34 110.874 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo . . . . . 0 C--N 1.375 1.968 0 C-N-CA 122.746 2.297 . . . . 75.23 112.361 174.78 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 108.43 -0.952 . . . . 71.05 108.43 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.84 -175.75 46.91 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.982 -0.553 . . . . 73.32 113.885 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.41 ' HB3' ' HG2' ' A' ' 236' ' ' LYS . 3.6 p-10 -100.54 127.2 46.98 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.404 0.621 . . . . 74.22 110.057 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 238' ' ' LYS . 35.1 tp -99.95 110.91 23.23 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 107.845 -1.168 . . . . 70.21 107.845 -178.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -86.03 108.2 18.14 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.474 -1.306 . . . . 73.34 107.474 174.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 27.1 mt -84.2 105.13 14.82 Favored 'General case' 0 C--N 1.34 0.189 0 N-CA-C 107.775 -1.194 . . . . 63.02 107.775 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -77.18 103.23 6.99 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.649 -1.614 . . . . 61.42 108.966 -177.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 63.7 t -59.65 115.61 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 123.72 0.808 . . . . 72.52 110.722 177.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.589 ' HG3' HG23 ' A' ' 196' ' ' THR . 54.5 mmm-85 -125.64 97.1 5.03 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.001 -1.481 . . . . 73.15 107.001 177.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 54.8 mt -76.71 119.31 24.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 CA-C-N 116.232 -0.44 . . . . 72.35 110.197 -174.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 44.2 p . . . . . 0 C--O 1.255 1.344 0 C-N-CA 124.425 1.09 . . . . 63.44 108.185 177.785 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 112.143 0.423 . . . . 71.55 112.143 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 . . . . . 0 N--CA 1.49 1.569 0 C-N-CA 124.682 1.193 . . . . 61.31 112.103 177.206 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.517 ' HB3' ' HB2' ' A' ' 240' ' ' PHE . 82.3 mm-40 . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 121.352 0.596 . . . . 62.45 110.186 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -91.55 142.35 27.73 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.485 -0.779 . . . . 72.45 110.657 -175.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 96.2 mt -133.52 153.64 51.48 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.583 0.753 . . . . 63.54 110.244 -178.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -104.14 121.66 43.71 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 108.748 -0.834 . . . . 75.31 108.748 174.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -125.69 133.22 52.22 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.553 1.141 . . . . 74.31 109.117 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 39.3 m -65.51 139.38 58.48 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.473 0.709 . . . . 52.43 111.322 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.487 HD13 HD13 ' A' ' 251' ' ' LEU . 26.3 tp -115.17 122.57 46.45 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 123.837 0.855 . . . . 74.25 109.199 176.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -89.52 106.08 18.22 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.273 -0.64 . . . . 70.51 109.273 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.618 HG11 HG13 ' A' ' 253' ' ' VAL . 6.4 p -129.56 131.36 23.54 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 122.86 0.464 . . . . 72.42 110.042 178.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . 0.414 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 55.8 Cg_endo -74.46 157.64 44.86 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 121.943 1.762 . . . . 43.31 111.404 169.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.448 ' HA ' HG23 ' A' ' 255' ' ' ILE . . . -50.95 -48.97 83.23 Favored Pre-proline 0 CA--C 1.57 1.732 0 CA-C-O 117.949 -1.024 . . . . 53.22 113.652 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.479 ' O ' HG12 ' A' ' 206' ' ' VAL . 28.7 Cg_endo -60.91 -51.52 4.65 Favored 'Trans proline' 0 C--N 1.402 3.371 0 C-N-CA 121.529 1.486 . . . . 75.41 111.945 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.4 mt -62.83 -26.47 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 123.599 0.76 . . . . 65.43 111.32 -176.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.3 -52.99 33.81 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-O 120.953 0.406 . . . . 73.2 110.8 174.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 90.0 t -67.94 -43.99 85.39 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 N-CA-C 112.675 0.62 . . . . 75.44 112.675 -175.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 202' ' ' PRO . 11.0 p -99.92 -21.66 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 122.857 0.463 . . . . 72.21 112.183 -173.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.66 144.67 11.41 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 112.229 -0.348 . . . . 62.43 112.229 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -177.25 -140.35 3.63 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-O 119.224 -0.765 . . . . 74.44 111.898 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -116.94 143.34 45.82 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 118.005 0.902 . . . . 73.24 109.208 176.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 34.4 m -139.83 169.87 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 123.457 0.703 . . . . 61.45 111.352 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -90.12 114.12 26.0 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.12 0.568 . . . . 72.3 110.343 173.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.44 127.12 52.06 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.111 -1.07 . . . . 72.24 108.111 165.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 89.8 mmm -81.58 104.97 12.37 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.215 -0.661 . . . . 60.04 109.215 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 87.4 m -113.4 162.03 16.59 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.572 1.149 . . . . 73.14 109.76 -176.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 87.3 mt -58.0 -16.67 13.39 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.035 0.934 . . . . 70.53 112.986 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -103.7 29.25 5.89 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.037 0.935 . . . . 73.52 110.924 175.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 86.9 -165.38 36.31 Favored Glycine 0 C--N 1.348 1.231 0 CA-C-N 116.237 -0.438 . . . . 74.44 113.442 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -72.54 121.65 7.6 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.78 2.32 . . . . 55.1 111.395 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.4 m -121.15 147.8 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.821 0.849 . . . . 73.21 109.96 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 9.8 pt-20 -90.49 113.93 26.0 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.285 0.564 . . . . 72.43 110.949 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 63.9 t -102.83 132.2 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.283 0.633 . . . . 71.54 109.452 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -78.94 99.99 7.06 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 123.657 0.783 . . . . 65.55 109.765 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 74.5 t -80.03 134.02 56.93 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.317 1.047 . . . . 55.24 110.201 178.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.42 170.96 18.96 Favored 'Trans proline' 0 C--N 1.383 2.36 0 C-N-CA 122.939 2.426 . . . . 72.24 111.372 172.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -65.01 175.22 3.98 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 121.869 1.713 . . . . 72.14 113.47 172.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 72.31 5.33 5.26 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 125.248 1.419 . . . . 71.04 112.844 174.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 87.6 m -69.42 127.63 33.72 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.156 0.583 . . . . 75.51 110.913 -172.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -127.14 142.34 51.53 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.817 0.847 . . . . 71.52 110.809 -167.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.421 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -65.05 132.37 49.03 Favored 'General case' 0 C--N 1.348 0.543 0 C-N-CA 124.108 0.963 . . . . 73.24 110.767 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.13 -14.7 63.46 Favored Glycine 0 N--CA 1.468 0.77 0 O-C-N 123.994 0.809 . . . . 75.31 112.223 -178.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 78.2 mtt-85 -84.12 142.31 30.47 Favored 'General case' 0 C--N 1.351 0.65 0 N-CA-C 109.233 -0.654 . . . . 73.22 109.233 173.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.58 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.0 mppt? -110.64 130.88 55.46 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.786 -0.82 . . . . 74.34 108.786 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.406 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 27.1 mt -84.18 99.4 10.5 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.193 -1.04 . . . . 64.32 108.193 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -72.97 102.0 3.36 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.069 0.548 . . . . 74.11 109.956 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 14.0 mt -105.1 95.34 5.77 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.977 -0.749 . . . . 75.44 108.977 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -62.64 145.26 55.01 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 120.827 0.346 . . . . 63.24 111.452 176.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 74.58 19.78 79.76 Favored Glycine 0 C--N 1.344 0.985 0 CA-C-N 115.096 -0.956 . . . . 73.23 113.644 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -122.16 -11.17 8.47 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.426 0.691 . . . . 63.43 112.115 -176.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -77.98 -169.36 33.88 Favored Glycine 0 C--N 1.343 0.971 0 N-CA-C 111.842 -0.503 . . . . 40.42 111.842 167.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.517 ' HB2' ' HB3' ' A' ' 191' ' ' GLN . 18.0 m-30 -72.57 155.75 90.77 Favored Pre-proline 0 N--CA 1.483 1.201 0 CA-C-N 116.855 0.327 . . . . 71.13 110.995 -179.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo . . . . . 0 C--N 1.378 2.087 0 C-N-CA 122.557 2.171 . . . . 72.42 112.987 175.522 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 42.8 mtt180 . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 108.598 -0.889 . . . . 61.13 108.598 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -83.25 -165.82 38.62 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 116.014 -0.539 . . . . 53.31 112.811 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.54 164.83 12.1 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.921 0.888 . . . . 74.23 109.516 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 33.7 tp -134.99 107.76 7.49 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 107.793 -1.188 . . . . 72.42 107.793 173.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.58 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 73.5 m-85 -88.92 111.16 21.77 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.466 0.706 . . . . 60.13 109.608 -178.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.487 HD13 HD13 ' A' ' 197' ' ' LEU . 63.9 mt -86.46 104.33 15.83 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 107.998 -1.112 . . . . 74.52 107.998 174.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -78.95 97.58 6.1 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.38 -0.97 . . . . 75.13 108.38 -173.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.618 HG13 HG11 ' A' ' 199' ' ' VAL . 81.8 t -57.91 109.63 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-N 114.256 -1.338 . . . . 63.22 112.084 -175.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -105.03 97.93 7.71 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 124.281 1.033 . . . . 74.42 108.756 172.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.448 HG23 ' HA ' ' A' ' 201' ' ' ALA . 32.9 mt -77.56 126.92 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 123.651 0.594 . . . . 74.45 109.623 177.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 9.5 p . . . . . 0 CA--C 1.556 1.199 0 C-N-CA 124.677 1.191 . . . . 71.15 109.006 -178.389 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.838 0 CA-C-O 120.327 0.108 . . . . 74.13 111.182 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.42 ' HE1' ' HA ' ' A' ' 227' ' ' THR . 2.7 m-85 . . . . . 0 N--CA 1.494 1.738 0 C-N-CA 125.035 1.334 . . . . 74.55 113.423 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 109.336 -0.616 . . . . 73.42 109.336 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -75.59 147.29 39.72 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 114.954 -1.021 . . . . 64.42 109.936 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 96.0 mt -129.09 166.6 18.96 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.492 0.717 . . . . 73.43 110.289 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -119.65 145.34 46.55 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.388 1.075 . . . . 72.12 108.809 173.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.15 158.03 43.84 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.291 1.036 . . . . 53.54 108.562 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 16.5 m -92.46 130.83 38.02 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 122.68 0.392 . . . . 70.52 109.943 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 57.1 tp -111.99 126.11 54.79 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.724 0.809 . . . . 74.44 109.684 176.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -93.57 125.43 38.17 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.219 0.608 . . . . 63.51 109.368 170.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 6.5 p -144.94 133.76 11.04 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 124.045 0.938 . . . . 72.13 108.65 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.91 157.81 38.85 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.075 1.85 . . . . 74.33 111.29 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.22 -48.29 92.84 Favored Pre-proline 0 CA--C 1.555 1.173 0 N-CA-C 113.309 0.855 . . . . 51.22 113.309 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.528 ' O ' HG12 ' A' ' 206' ' ' VAL . 52.4 Cg_exo -56.13 -56.12 2.36 Favored 'Trans proline' 0 C--N 1.395 2.995 0 C-N-CA 121.836 1.691 . . . . 51.42 113.028 176.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 57.7 mt -60.91 -30.22 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 C-N-CA 122.717 0.407 . . . . 64.43 110.829 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.449 ' HB1' ' O ' ' A' ' 227' ' ' THR . . . -63.61 -53.55 49.87 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 122.927 0.491 . . . . 53.01 111.038 178.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 32.3 t -78.91 -42.4 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 116.154 -0.476 . . . . 42.45 112.175 -172.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 202' ' ' PRO . 9.9 p -90.02 -19.57 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 122.654 0.381 . . . . 73.44 111.395 -176.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.31 159.04 34.31 Favored Glycine 0 C--N 1.348 1.226 0 N-CA-C 111.986 -0.446 . . . . 72.3 111.986 -174.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.79 -138.68 5.39 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-O 119.603 -0.554 . . . . 75.1 112.352 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -137.31 142.31 41.89 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.564 0.746 . . . . 64.42 109.312 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.77 162.04 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 122.846 0.458 . . . . 72.42 110.539 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -86.51 104.77 16.28 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.295 -1.002 . . . . 53.44 108.295 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -103.49 138.86 39.61 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.773 0.829 . . . . 61.21 110.199 -175.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 22.5 ptt? -72.54 118.46 15.49 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 121.438 0.637 . . . . 72.12 109.401 176.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 28.0 m -135.45 154.59 51.39 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.091 0.956 . . . . 72.52 109.061 -177.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 68.7 mt -63.19 -21.66 66.36 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.003 0.921 . . . . 74.3 112.789 -177.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -93.62 0.8 56.69 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.276 0.63 . . . . 73.53 111.353 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 117.97 167.98 14.3 Favored Glycine 0 C--N 1.345 1.069 0 CA-C-O 119.534 -0.592 . . . . 53.35 112.515 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.76 121.26 8.3 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.513 2.142 . . . . 62.41 111.174 176.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 27.7 m -127.7 160.04 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 123.804 0.842 . . . . 61.4 110.879 -171.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -86.68 103.95 15.63 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.062 0.545 . . . . 74.15 109.817 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 99.0 t -96.84 124.14 49.5 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 N-CA-C 108.672 -0.862 . . . . 74.4 108.672 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.04 98.7 2.58 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.069 0.548 . . . . 43.14 110.244 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 94.8 t -73.97 128.0 87.24 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.203 1.001 . . . . 63.42 109.737 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.16 170.34 14.76 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.601 2.201 . . . . 70.52 111.317 176.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.52 167.87 26.13 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 121.249 1.3 . . . . 73.25 111.489 168.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 48.2 mtt-85 65.63 23.04 11.69 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 124.622 1.169 . . . . 75.5 111.989 176.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.449 ' O ' ' HB1' ' A' ' 204' ' ' ALA . 30.0 m -75.15 93.53 2.81 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.771 0.796 . . . . 74.13 110.416 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -86.03 145.71 26.97 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.461 -1.245 . . . . 74.32 110.531 -178.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.3 138.42 58.52 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.114 0.966 . . . . 72.41 111.126 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 92.74 -14.83 64.05 Favored Glycine 0 N--CA 1.473 1.108 0 CA-C-N 116.206 -0.452 . . . . 75.24 113.034 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -75.71 145.11 41.15 Favored 'General case' 0 C--N 1.348 0.504 0 N-CA-C 109.457 -0.571 . . . . 62.41 109.457 173.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.579 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 0.2 OUTLIER -110.48 122.71 48.39 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.199 -0.667 . . . . 74.41 109.199 175.451 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 18.7 mt -76.19 103.07 6.05 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.447 -0.945 . . . . 72.23 108.447 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 21.4 ttm-85 -70.95 101.2 2.12 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 109.395 -0.595 . . . . 74.33 109.395 175.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 10.0 mt -104.27 103.13 12.83 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 108.011 -1.107 . . . . 62.15 108.011 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -80.85 142.7 33.39 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.735 0.414 . . . . 74.04 111.521 -170.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 84.99 21.15 56.32 Favored Glycine 0 C--N 1.346 1.111 0 CA-C-N 115.985 -0.552 . . . . 51.42 113.506 178.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -113.27 -26.92 8.17 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.285 0.634 . . . . 63.51 112.534 -173.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -72.91 -134.74 0.21 Allowed Glycine 0 CA--C 1.539 1.553 0 N-CA-C 114.262 0.465 . . . . 73.45 114.262 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -93.56 137.73 23.22 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 123.266 0.626 . . . . 72.42 110.114 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 56.3 Cg_endo . . . . . 0 C--N 1.379 2.137 0 C-N-CA 122.751 2.3 . . . . 52.34 112.487 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.524 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 0.8 OUTLIER . . . . . 0 CA--C 1.544 0.743 0 N-CA-C 109.894 -0.41 . . . . 73.41 109.894 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -68.33 -173.27 7.67 Favored Glycine 0 N--CA 1.477 1.369 0 N-CA-C 114.362 0.505 . . . . 71.34 114.362 -173.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -95.97 168.81 10.4 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.456 -0.942 . . . . 74.11 108.456 178.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 238' ' ' LYS . 34.6 tp -141.49 108.81 5.53 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.493 -0.928 . . . . 75.52 108.493 178.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.579 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 81.1 m-85 -90.39 109.28 20.4 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.902 0.881 . . . . 75.34 110.032 -176.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.505 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 46.8 mt -88.0 107.14 18.58 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.153 -0.684 . . . . 74.23 109.153 174.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -80.25 101.09 8.67 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.69 1.196 . . . . 73.13 108.801 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 89.4 t -63.39 120.23 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 125.218 1.407 . . . . 51.3 112.733 -171.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -113.83 100.11 8.2 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.039 -1.097 . . . . 72.2 108.039 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 18.6 mt -75.88 120.11 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 122.962 0.505 . . . . 73.33 109.75 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 CA--C 1.554 1.129 0 C-N-CA 124.296 1.038 . . . . 75.14 108.895 -179.997 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 112.423 0.527 . . . . 41.43 112.423 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.453 ' CE2' ' HA ' ' A' ' 227' ' ' THR . 43.6 m-85 . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 109.268 -0.642 . . . . 73.4 109.268 173.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 111.153 0.057 . . . . 35.32 111.153 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.73 142.61 42.39 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.143 0.977 . . . . 51.05 109.11 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 88.9 mt -127.51 160.61 30.98 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.794 0.838 . . . . 63.5 110.326 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -129.99 119.92 23.95 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.274 -1.01 . . . . 73.25 108.274 173.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -126.66 132.9 51.09 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.666 1.186 . . . . 60.45 109.07 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 51.9 m -66.13 129.67 40.62 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.442 0.697 . . . . 74.5 110.369 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 41.5 tp -116.12 110.85 19.41 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 107.571 -1.27 . . . . 74.15 107.571 176.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -93.63 106.77 18.71 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.496 -0.927 . . . . 42.34 108.496 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 2.8 p -125.27 122.53 25.18 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 124.576 1.151 . . . . 53.52 109.02 -176.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . 0.405 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 72.2 Cg_endo -71.51 158.38 54.05 Favored 'Trans proline' 0 C--N 1.372 1.764 0 C-N-CA 122.301 2.0 . . . . 62.24 111.277 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.98 -45.05 80.93 Favored Pre-proline 0 CA--C 1.571 1.759 0 N-CA-C 114.195 1.183 . . . . 74.03 114.195 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 75.8 Cg_exo -53.69 -54.65 4.5 Favored 'Trans proline' 0 C--N 1.399 3.198 0 C-N-CA 122.225 1.95 . . . . 72.32 113.572 173.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 49.3 mt -71.44 -25.29 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 122.999 0.52 . . . . 15.14 110.66 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.88 -40.53 83.55 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.241 0.616 . . . . 74.52 111.007 177.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 97.7 t -78.58 -56.3 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 CA-C-N 116.63 -0.259 . . . . 73.12 111.595 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.3 p -92.49 -25.77 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 112.675 0.62 . . . . 62.42 112.675 -170.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 96.18 156.81 31.39 Favored Glycine 0 N--CA 1.478 1.47 0 O-C-N 122.476 -0.14 . . . . 74.14 113.097 -176.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 169.65 -131.17 2.2 Favored Glycine 0 C--N 1.346 1.105 0 N-CA-C 111.7 -0.56 . . . . 50.45 111.7 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -134.55 141.71 46.76 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.187 0.995 . . . . 70.11 108.973 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.465 HG11 ' HA ' ' A' ' 199' ' ' VAL . 19.4 m -131.61 167.13 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 122.903 0.481 . . . . 73.34 110.732 176.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -82.03 107.28 14.61 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.526 -0.916 . . . . 75.52 108.526 170.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.02 133.54 48.79 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.317 0.647 . . . . 65.24 109.652 175.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 22.9 mmt -81.01 104.12 11.3 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 109.374 -0.602 . . . . 75.42 109.374 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 30.7 m -112.72 163.15 14.92 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 124.528 1.131 . . . . 63.43 109.039 -177.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 84.6 mt -67.98 -17.03 64.31 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.517 0.727 . . . . 75.35 112.037 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -80.37 -19.68 45.81 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.022 0.929 . . . . 75.04 111.028 173.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 126.24 177.32 14.83 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 110.678 -0.969 . . . . 74.43 110.678 -172.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.87 121.24 7.91 Favored 'Trans proline' 0 CA--C 1.554 1.504 0 C-N-CA 121.981 1.787 . . . . 70.04 110.819 174.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.45 HG23 HG23 ' A' ' 221' ' ' VAL . 35.0 m -124.81 161.0 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 123.324 0.65 . . . . 73.13 111.043 -173.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -85.47 105.75 16.31 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.013 -0.736 . . . . 74.22 109.013 177.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.45 HG23 HG23 ' A' ' 219' ' ' VAL . 49.7 t -102.76 129.16 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.599 0.759 . . . . 64.21 110.394 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.23 100.56 3.74 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 123.42 0.688 . . . . 73.31 110.278 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.434 ' HA ' ' HD3' ' A' ' 224' ' ' PRO . 58.6 t -88.14 131.56 42.36 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 124.599 1.16 . . . . 61.32 109.389 178.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 223' ' ' VAL . 3.4 Cg_exo -78.88 174.21 12.52 Favored 'Trans proline' 0 C--N 1.377 2.026 0 C-N-CA 123.677 2.918 . . . . 65.24 111.199 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -62.54 176.9 1.44 Allowed 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 121.993 1.795 . . . . 62.11 112.758 166.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 69.27 5.56 5.19 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 124.506 1.123 . . . . 70.2 112.947 172.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.453 ' HA ' ' CE2' ' A' ' 176' ' ' TYR . 87.8 m -66.05 97.57 0.38 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.896 0.878 . . . . 64.44 111.204 -171.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -101.83 141.7 34.27 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.049 1.34 . . . . 65.5 111.086 -171.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.04 141.98 57.78 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.159 0.984 . . . . 74.24 112.517 -174.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.71 -20.14 29.46 Favored Glycine 0 C--N 1.351 1.364 0 O-C-N 123.833 0.708 . . . . 74.44 113.659 178.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -77.23 160.61 28.79 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.067 0.547 . . . . 75.14 110.632 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 12.6 mptt -127.55 143.64 51.16 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.317 0.579 . . . . 63.42 109.985 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.453 HD21 ' CE2' ' A' ' 176' ' ' TYR . 23.3 mt -106.27 99.54 9.12 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.769 -1.105 . . . . 65.3 109.136 -170.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 42.8 ttm105 -73.74 102.03 3.86 Favored 'General case' 0 C--O 1.24 0.569 0 O-C-N 124.567 1.167 . . . . 74.55 110.437 -174.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 30.2 mt -105.82 94.6 5.28 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.476 -0.935 . . . . 44.14 108.476 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -70.21 140.21 52.42 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 122.845 0.458 . . . . 75.44 111.002 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 81.46 17.65 70.64 Favored Glycine 0 CA--C 1.528 0.892 0 O-C-N 123.918 0.762 . . . . 40.14 113.202 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -122.07 -11.81 8.42 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.437 0.695 . . . . 54.32 112.295 -175.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -77.88 -161.82 17.29 Favored Glycine 0 N--CA 1.48 1.61 0 CA-C-O 119.804 -0.442 . . . . 73.22 112.74 171.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -71.5 149.94 93.66 Favored Pre-proline 0 N--CA 1.484 1.257 0 CA-C-N 117.911 0.856 . . . . 63.44 111.6 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo . . . . . 0 C--N 1.376 1.975 0 C-N-CA 122.909 2.406 . . . . 72.33 112.31 172.618 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 107.651 -1.24 . . . . 64.21 107.651 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -80.91 -158.07 18.46 Favored Glycine 0 C--N 1.34 0.8 0 O-C-N 123.435 0.46 . . . . 72.42 113.045 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -100.06 159.15 15.32 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.507 -0.553 . . . . 63.41 109.507 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 40.7 tp -126.68 108.37 11.03 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.51 -1.292 . . . . 75.32 107.51 172.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.511 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 15.0 m-85 -90.19 108.15 19.57 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.514 -0.921 . . . . 74.43 108.514 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 57.2 mt -87.2 105.53 17.27 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.982 -1.118 . . . . 72.11 107.982 174.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -78.74 112.3 15.73 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.503 -0.771 . . . . 70.33 109.842 -175.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 58.0 t -63.3 119.37 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 124.636 1.174 . . . . 75.23 111.726 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 49.7 mmm-85 -120.39 95.6 4.8 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 125.167 1.387 . . . . 72.51 107.495 173.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 49.8 mt -77.87 113.12 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 122.741 0.417 . . . . 74.24 110.509 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 75.0 p . . . . . 0 CA--C 1.559 1.299 0 C-N-CA 124.379 1.071 . . . . 72.04 108.714 177.625 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 113.718 1.007 . . . . 64.33 113.718 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 . . . . . 0 N--CA 1.475 0.777 0 C-N-CA 123.021 0.529 . . . . 73.44 110.041 170.649 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 . . . . . 0 N--CA 1.477 0.88 0 CA-C-O 120.614 0.245 . . . . 75.43 111.018 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -76.48 155.92 33.43 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.452 0.701 . . . . 75.53 111.276 -176.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 93.7 mt -128.74 152.93 47.88 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.147 0.979 . . . . 72.12 109.19 176.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -108.25 149.12 29.02 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.864 0.866 . . . . 74.35 108.852 172.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -155.03 136.1 13.86 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.972 0.909 . . . . 73.32 108.763 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 28.1 m -78.01 128.48 33.93 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.115 0.566 . . . . 55.32 109.888 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 22.0 tp -108.27 117.41 34.08 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.438 -0.579 . . . . 51.22 109.438 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -82.47 105.77 13.8 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.431 -0.951 . . . . 53.42 108.431 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.502 HG11 HG13 ' A' ' 253' ' ' VAL . 2.7 p -136.5 122.7 13.69 Favored Pre-proline 0 CA--C 1.548 0.888 0 N-CA-C 109.507 -0.553 . . . . 65.11 109.507 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . 0.449 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 54.9 Cg_endo -72.11 160.65 46.86 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.194 1.93 . . . . 71.51 112.049 173.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.75 -51.72 63.4 Favored Pre-proline 0 CA--C 1.567 1.611 0 C-N-CA 124.46 1.104 . . . . 63.14 113.745 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 56.6 Cg_endo -65.62 -36.06 34.91 Favored 'Trans proline' 0 C--N 1.401 3.327 0 C-N-CA 121.624 1.549 . . . . 60.22 112.606 -176.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 23.0 mt -72.7 -31.7 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 122.766 0.426 . . . . 71.15 110.551 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.1 -42.15 89.69 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 122.691 0.397 . . . . 74.0 110.768 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 90.7 t -69.7 -53.02 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.096 0 C-N-CA 123.281 0.632 . . . . 73.15 111.695 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 28.0 m -79.58 -32.83 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 112.153 0.427 . . . . 51.53 112.153 -175.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.18 105.77 0.97 Allowed Glycine 0 C--N 1.343 0.934 0 CA-C-N 116.146 -0.479 . . . . 65.43 112.584 -173.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -148.46 -177.03 22.39 Favored Glycine 0 C--N 1.344 1.021 0 N-CA-C 112.074 -0.41 . . . . 51.35 112.074 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.645 ' HB3' ' HB2' ' A' ' 220' ' ' GLU . 50.2 mtmt -86.93 127.61 35.07 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 117.13 0.465 . . . . 75.11 110.497 -175.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 20.7 m -124.22 167.95 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 123.14 0.576 . . . . 63.53 111.555 -177.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -71.53 106.63 4.07 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 123.974 0.796 . . . . 62.42 110.232 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.83 115.76 30.86 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 107.95 -1.13 . . . . 53.13 107.95 166.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 63.3 mtt -72.97 104.93 4.25 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 109.255 -0.646 . . . . 63.21 109.255 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 38.1 m -110.99 162.23 15.06 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.715 1.206 . . . . 73.34 109.268 -173.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 96.4 mt -57.68 -23.25 50.51 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.967 0.907 . . . . 61.31 112.95 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -87.47 -20.83 26.03 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.26 0.624 . . . . 72.55 111.707 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 139.05 -171.93 23.39 Favored Glycine 0 C--N 1.345 1.036 0 CA-C-O 119.577 -0.568 . . . . 71.11 111.95 -176.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.6 117.79 4.66 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.21 1.94 . . . . 72.11 110.788 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.403 HG23 HG23 ' A' ' 221' ' ' VAL . 32.8 m -116.26 166.78 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.15 0.58 . . . . 71.44 109.687 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.645 ' HB2' ' HB3' ' A' ' 209' ' ' LYS . 8.5 pt-20 -107.52 105.12 14.86 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.721 0.772 . . . . 75.54 109.746 178.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.403 HG23 HG23 ' A' ' 219' ' ' VAL . 58.7 t -99.46 131.42 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.886 1.275 . . . . 75.53 109.841 -175.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.73 100.43 2.84 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.801 0.841 . . . . 43.54 110.553 -176.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 80.8 t -78.55 138.62 58.83 Favored Pre-proline 0 N--CA 1.478 0.973 0 C-N-CA 124.872 1.269 . . . . 72.31 109.321 175.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -75.11 168.83 23.9 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 122.51 2.14 . . . . 65.33 111.506 178.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -68.35 172.71 10.77 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 121.421 1.414 . . . . 63.33 111.424 168.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 63.85 17.12 10.32 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.888 0.875 . . . . 73.54 112.071 174.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 53.7 m -75.01 133.18 41.71 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.943 0.897 . . . . 72.4 110.153 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -139.35 143.13 37.63 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.201 0.6 . . . . 51.33 110.846 -164.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.19 127.73 33.27 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 124.323 1.049 . . . . 65.51 111.373 -177.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 103.58 -21.84 37.67 Favored Glycine 0 N--CA 1.473 1.134 0 CA-C-N 115.902 -0.59 . . . . 71.04 112.719 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -75.81 141.98 42.36 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.082 0.553 . . . . 74.41 110.024 176.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.497 ' HG3' ' HG2' ' A' ' 252' ' ' GLU . 0.0 OUTLIER -108.38 127.57 54.0 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.497 0.719 . . . . 73.4 109.746 178.306 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 56.6 mt -90.6 96.88 10.87 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.9 -1.148 . . . . 73.23 107.9 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 30.4 ttp-105 -87.15 105.25 17.06 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 124.233 1.013 . . . . 74.15 110.24 -172.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 31.2 mt -99.85 94.82 6.52 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.602 -0.888 . . . . 72.41 108.602 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm -67.55 140.97 56.99 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.52 0.328 . . . . 74.34 110.554 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.06 28.41 56.38 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-N 116.097 -0.501 . . . . 74.03 113.642 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.451 ' HA ' ' HE2' ' A' ' 238' ' ' LYS . 9.3 mmpt? -127.54 -14.95 5.15 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.843 0.857 . . . . 74.53 112.801 -178.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -78.2 -152.98 6.23 Favored Glycine 0 N--CA 1.476 1.366 0 C-N-CA 122.736 0.207 . . . . 65.52 113.162 174.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -73.58 147.94 87.44 Favored Pre-proline 0 N--CA 1.485 1.296 0 C-N-CA 123.022 0.529 . . . . 71.31 111.28 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo . . . . . 0 C--N 1.377 2.058 0 C-N-CA 122.94 2.427 . . . . 72.3 112.741 172.892 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 66.2 mtm-85 . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 109.701 -0.481 . . . . 75.33 109.701 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -74.97 -157.25 5.79 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 116.405 -0.362 . . . . 74.11 112.994 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -97.37 170.02 9.36 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.071 0.548 . . . . 61.31 110.173 -175.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 29.4 tp -136.35 105.63 6.03 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.746 -1.205 . . . . 73.03 107.746 172.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -89.66 107.07 18.87 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.752 -0.833 . . . . 75.21 108.752 -178.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 71.9 mt -89.53 104.28 16.85 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.559 -1.275 . . . . 74.33 107.559 173.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.497 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 12.8 mt-10 -78.29 105.56 9.61 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.508 -0.769 . . . . 63.24 108.962 -173.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.502 HG13 HG11 ' A' ' 199' ' ' VAL . 61.3 t -59.62 104.21 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.82 0 O-C-N 124.073 0.858 . . . . 42.02 111.545 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -103.46 97.66 7.68 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 107.785 -1.191 . . . . 72.24 107.785 173.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 12.5 mt -75.02 114.73 15.39 Favored 'Isoleucine or valine' 0 C--N 1.356 0.853 0 O-C-N 123.958 0.786 . . . . 71.15 108.941 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 12.5 p . . . . . 0 C--O 1.256 1.423 0 C-N-CA 125.537 1.535 . . . . 72.15 108.16 -177.033 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.794 0 CA-C-O 120.382 0.134 . . . . 54.21 111.324 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 . . . . . 0 N--CA 1.487 1.382 0 C-N-CA 125.143 1.377 . . . . 75.24 110.162 -174.173 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.505 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 80.8 mt-30 . . . . . 0 N--CA 1.483 1.198 0 CA-C-O 120.311 0.1 . . . . 72.22 111.136 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -89.97 135.2 33.79 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.371 -0.603 . . . . 54.34 109.371 174.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 95.9 mt -131.72 129.09 40.22 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.022 0.929 . . . . 64.33 110.282 -172.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -92.6 119.95 32.55 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.926 -0.768 . . . . 73.23 108.926 173.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -130.73 128.53 41.01 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.703 1.201 . . . . 61.23 109.043 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 88.5 m -69.2 131.11 44.41 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.588 0.755 . . . . 71.15 111.451 -177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 42.3 tp -110.13 116.35 31.37 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.532 1.133 . . . . 75.21 108.476 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -92.11 109.39 20.75 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.475 -0.935 . . . . 74.32 108.475 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 3.4 p -130.92 122.87 19.63 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 124.198 0.999 . . . . 73.43 108.911 -178.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.87 156.56 65.44 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.08 1.853 . . . . 73.05 112.109 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -48.28 -46.22 67.22 Favored Pre-proline 0 CA--C 1.565 1.552 0 N-CA-C 114.569 1.322 . . . . 52.55 114.569 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.5 ' O ' HG22 ' A' ' 206' ' ' VAL . 17.9 Cg_endo -58.12 -52.7 5.3 Favored 'Trans proline' 0 C--N 1.4 3.283 0 C-N-CA 121.874 1.716 . . . . 74.14 112.245 176.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.8 mt -65.93 -30.88 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.429 0.692 . . . . 73.21 111.446 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.67 -54.64 24.71 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.416 0.686 . . . . 54.11 111.026 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 63.5 t -71.68 -53.52 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-N 115.93 -0.577 . . . . 71.12 111.626 -174.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 202' ' ' PRO . 15.5 m -90.3 -25.02 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 112.805 0.669 . . . . 53.52 112.805 -172.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 100.76 142.8 13.25 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 117.796 0.271 . . . . 54.3 112.639 -176.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -175.19 -141.49 3.73 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 111.149 -0.781 . . . . 74.33 111.149 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -133.27 143.14 48.89 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 117.737 0.768 . . . . 64.14 109.19 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 33.2 m -128.95 169.4 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.647 0.779 . . . . 74.43 110.234 173.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -99.3 112.47 24.63 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.129 0.972 . . . . 75.52 108.513 171.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.58 144.65 30.06 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.8 0.84 . . . . 65.24 109.692 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 21.1 mmt -91.77 103.57 16.12 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 109.039 -0.726 . . . . 74.52 109.039 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 61.7 m -117.88 164.14 15.49 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.639 1.176 . . . . 75.4 108.916 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.0 mt -59.3 -20.0 50.86 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 123.344 0.657 . . . . 75.01 112.048 173.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -81.87 4.72 21.32 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.62 1.168 . . . . 73.21 111.982 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 97.97 -163.74 21.4 Favored Glycine 0 C--N 1.344 1.011 0 C-N-CA 123.488 0.566 . . . . 72.45 111.822 -175.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.16 118.39 5.37 Favored 'Trans proline' 0 C--N 1.365 1.404 0 C-N-CA 122.026 1.818 . . . . 73.52 109.907 172.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 28.7 m -118.13 153.2 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.039 0.536 . . . . 72.14 111.113 -172.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -95.41 111.76 23.59 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.54 0.736 . . . . 73.43 109.37 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 48.7 t -112.58 116.23 52.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 123.837 0.855 . . . . 62.15 109.17 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.57 101.25 2.44 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 109.099 -0.704 . . . . 75.52 109.099 174.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 63.9 t -77.55 121.64 84.66 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.955 0.902 . . . . 62.3 109.472 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.66 169.83 21.42 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.657 2.238 . . . . 45.32 110.936 173.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.96 176.53 2.97 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.633 2.222 . . . . 74.24 113.778 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 55.5 mtm180 70.94 12.05 7.06 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 125.45 1.5 . . . . 72.51 113.081 174.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 12.5 m -72.37 93.35 1.51 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.072 0.949 . . . . 75.42 110.765 -174.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -91.83 140.09 30.03 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.61 1.164 . . . . 60.33 111.007 -173.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -64.23 139.19 58.74 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.259 1.024 . . . . 71.44 111.646 -176.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 93.14 -23.37 29.85 Favored Glycine 0 C--N 1.343 0.934 0 CA-C-N 115.129 -0.941 . . . . 35.1 112.812 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -72.84 145.19 47.12 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 122.909 0.484 . . . . 74.22 110.265 176.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.489 ' HG3' ' HG2' ' A' ' 252' ' ' GLU . 2.6 mppt? -104.44 139.49 39.3 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.827 -1.175 . . . . 71.21 107.827 173.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 42.6 mt -92.24 99.47 12.25 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.221 -1.399 . . . . 72.5 107.221 175.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 46.0 ttm180 -73.04 100.98 3.13 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.117 0.484 . . . . 70.11 109.704 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 17.9 mt -102.21 88.12 3.23 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.136 -1.061 . . . . 73.4 108.136 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -68.38 129.94 41.41 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.07 -0.968 . . . . 63.42 110.519 -175.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 84.67 27.62 34.68 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 123.762 0.664 . . . . 73.44 113.452 -175.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -125.9 -6.86 6.69 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 123.278 0.631 . . . . 73.34 112.651 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -86.79 -155.28 27.11 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 112.363 -0.295 . . . . 50.2 112.363 175.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.505 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 12.8 m-85 -70.46 140.03 87.08 Favored Pre-proline 0 N--CA 1.481 1.116 0 CA-C-N 117.184 0.492 . . . . 74.4 110.358 177.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo . . . . . 0 C--N 1.377 2.046 0 C-N-CA 122.702 2.268 . . . . 70.24 111.854 174.553 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 28.4 mtm-85 . . . . . 0 CA--C 1.546 0.788 0 N-CA-C 109.085 -0.709 . . . . 74.24 109.085 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.25 -165.18 19.34 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 123.373 0.42 . . . . 74.03 113.696 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -100.3 128.56 46.35 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.095 0.558 . . . . 73.31 109.633 -174.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 28.8 tp -99.04 107.78 20.28 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 107.847 -1.168 . . . . 73.23 107.847 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.428 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 47.8 m-85 -88.04 107.86 18.94 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.761 0.824 . . . . 73.31 109.011 -178.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 41.1 mt -87.08 105.43 17.16 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.441 -0.948 . . . . 74.21 108.441 175.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.489 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 33.3 mt-10 -77.6 94.17 4.33 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.297 -0.865 . . . . 63.22 108.79 -173.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 99.7 t -53.57 112.35 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 124.433 1.093 . . . . 64.21 111.323 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -117.32 100.88 7.98 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 108.094 -1.076 . . . . 73.3 108.094 175.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 43.0 mt -75.68 107.12 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 O-C-N 124.023 0.827 . . . . 61.21 108.965 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 16.2 p . . . . . 0 C--O 1.26 1.621 0 C-N-CA 124.897 1.279 . . . . 71.12 108.3 -179.066 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 112.583 0.586 . . . . 50.2 112.583 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 . . . . . 0 C--O 1.237 0.421 0 N-CA-C 108.108 -1.071 . . . . 74.52 108.108 170.902 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.645 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 23.0 mp0 . . . . . 0 N--CA 1.473 0.706 0 CA-C-O 120.747 0.308 . . . . 54.21 110.863 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -76.68 132.29 39.28 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.888 -0.782 . . . . 60.11 108.888 172.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 91.4 mt -133.05 167.92 19.43 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.234 0.614 . . . . 72.13 110.519 -171.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -121.21 125.87 48.23 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 107.553 -1.277 . . . . 75.22 107.553 168.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -124.08 127.27 47.59 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.606 0.762 . . . . 33.34 109.15 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 43.4 m -67.49 118.46 10.83 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.81 0.844 . . . . 64.14 110.919 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 21.9 tp -109.47 110.78 21.99 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.531 -0.915 . . . . 71.42 108.531 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -88.24 127.25 35.45 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.206 -1.035 . . . . 75.13 108.206 174.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 3.0 p -141.85 127.59 10.84 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 124.298 1.039 . . . . 75.12 108.367 -176.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -69.5 155.25 67.31 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 121.543 1.495 . . . . 74.42 111.346 175.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.446 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -47.21 -50.65 46.43 Favored Pre-proline 0 CA--C 1.559 1.32 0 O-C-N 124.341 1.025 . . . . 64.22 113.657 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.411 ' O ' HG12 ' A' ' 206' ' ' VAL . 30.5 Cg_endo -60.72 -48.79 10.0 Favored 'Trans proline' 0 C--N 1.395 2.988 0 C-N-CA 121.933 1.755 . . . . 74.41 112.622 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 44.0 mt -66.56 -27.38 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.645 0.778 . . . . 73.21 111.384 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.33 -47.91 58.9 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.169 0.588 . . . . 74.41 111.194 176.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 201' ' ' ALA . 81.2 t -67.9 -48.91 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.329 0.651 . . . . 65.12 111.841 -176.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 202' ' ' PRO . 7.9 p -83.95 -29.1 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 CA-C-N 116.44 -0.346 . . . . 72.33 110.895 -175.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.61 86.07 0.64 Allowed Glycine 0 C--N 1.349 1.265 0 N-CA-C 111.559 -0.616 . . . . 64.35 111.559 -174.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -111.29 -122.94 4.31 Favored Glycine 0 C--N 1.344 1.02 0 N-CA-C 111.953 -0.459 . . . . 63.23 111.953 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 221' ' ' VAL . 95.9 mttt -136.99 149.84 47.76 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.914 0.885 . . . . 73.1 109.601 176.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 23.3 m -136.3 162.84 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 123.247 0.619 . . . . 71.43 111.461 177.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -86.3 106.53 17.43 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.565 0.746 . . . . 74.15 109.171 174.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -109.8 151.55 26.84 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.036 0.534 . . . . 51.03 110.756 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 31.8 mmt -83.55 111.3 18.96 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 123.898 0.749 . . . . 72.24 108.979 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 215' ' ' LEU . 3.4 m -126.83 176.4 7.31 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 108.581 -0.896 . . . . 73.32 108.581 -177.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.428 ' H ' HG22 ' A' ' 214' ' ' THR . 73.8 mt -59.89 -40.88 90.21 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.587 0.755 . . . . 75.24 112.652 -175.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -81.1 -3.38 51.78 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.308 0.643 . . . . 65.4 112.012 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 110.49 -151.76 17.5 Favored Glycine 0 C--N 1.343 0.94 0 CA-C-O 119.544 -0.587 . . . . 74.42 112.251 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.63 126.99 17.06 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 122.627 2.218 . . . . 65.35 112.316 177.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 32.8 m -129.59 162.78 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.509 0.724 . . . . 53.43 110.058 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -95.42 105.55 17.53 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 121.584 0.707 . . . . 72.41 109.991 175.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 55.3 t -99.77 126.77 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.793 0.837 . . . . 71.1 109.838 -174.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -76.63 100.01 5.22 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 123.946 0.779 . . . . 64.44 110.893 -177.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 59.5 t -69.25 141.94 91.98 Favored Pre-proline 0 CA--C 1.56 1.363 0 C-N-CA 125.662 1.585 . . . . 72.44 110.492 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -76.88 163.12 31.61 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 122.313 2.008 . . . . 60.11 110.855 173.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.55 160.99 45.32 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 121.471 1.447 . . . . 63.02 111.207 172.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 69.24 14.24 8.6 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.762 1.225 . . . . 52.42 112.651 177.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 85.2 m -62.16 113.18 2.71 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.843 0.857 . . . . 53.13 110.438 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -112.92 141.2 47.03 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.916 0.886 . . . . 74.22 110.602 -168.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.52 144.02 57.33 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.778 0.831 . . . . 75.45 111.377 -177.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.03 -22.65 13.56 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.303 -0.862 . . . . 44.13 113.035 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -79.58 150.32 31.1 Favored 'General case' 0 C--N 1.351 0.657 0 N-CA-C 109.438 -0.578 . . . . 61.14 109.438 173.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.662 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.4 mppt? -114.53 142.87 45.84 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.041 0.536 . . . . 62.42 109.852 177.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.489 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 46.2 mt -100.09 99.42 10.14 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.683 -0.858 . . . . 51.12 108.683 -176.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 27.3 ttm-85 -75.06 113.97 13.0 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 123.479 0.487 . . . . 74.12 109.936 -176.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 46.0 mt -120.54 102.06 8.17 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.509 0.724 . . . . 65.1 109.237 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -67.62 140.12 56.87 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.879 0.472 . . . . 74.24 111.581 -176.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.431 ' HA2' ' HB2' ' A' ' 246' ' ' ARG . . . 84.32 9.83 81.17 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 115.788 -0.642 . . . . 61.53 114.302 178.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -104.65 -16.47 14.98 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 117.682 0.741 . . . . 61.4 111.8 -176.802 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -81.15 -161.69 27.19 Favored Glycine 0 CA--C 1.535 1.293 0 O-C-N 123.535 0.522 . . . . 45.14 112.86 173.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.645 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 27.8 m-85 -65.98 151.28 95.54 Favored Pre-proline 0 N--CA 1.487 1.395 0 C-N-CA 123.373 0.669 . . . . 75.42 111.657 -178.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.458 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 37.9 Cg_endo . . . . . 0 C--N 1.377 2.054 0 C-N-CA 122.885 2.39 . . . . 64.0 112.708 176.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.458 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 86.8 mtt180 . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 110.231 -0.285 . . . . 74.14 110.231 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.8 173.98 55.27 Favored Glycine 0 C--N 1.342 0.916 0 CA-C-N 115.94 -0.573 . . . . 60.22 112.969 177.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -103.44 130.95 50.89 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.742 0.817 . . . . 62.4 110.631 -175.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 53.5 tp -102.94 117.42 34.56 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 123.86 0.864 . . . . 62.55 109.118 -173.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.662 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 19.5 m-85 -89.12 111.74 22.56 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.473 -0.936 . . . . 75.13 108.473 177.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.489 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 60.0 mt -85.85 111.57 20.31 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.642 -0.873 . . . . 55.05 108.642 175.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.405 ' HA ' ' HG3' ' A' ' 232' ' ' LYS . 31.6 mt-10 -76.05 101.43 5.28 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.237 -0.892 . . . . 74.23 108.971 -175.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 44.9 t -61.58 111.39 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 O-C-N 123.577 0.548 . . . . 63.21 110.84 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -114.0 93.6 4.44 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 106.598 -1.63 . . . . 75.41 106.598 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 26.9 mt -76.25 118.07 21.96 Favored 'Isoleucine or valine' 0 C--N 1.349 0.586 0 N-CA-C 109.405 -0.591 . . . . 53.42 109.405 -177.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 19.6 p . . . . . 0 C--O 1.253 1.275 0 C-N-CA 125.232 1.413 . . . . 65.44 107.922 -176.751 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 112.108 0.41 . . . . 62.42 112.108 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.412 ' HE1' ' HA ' ' A' ' 227' ' ' THR . 12.3 m-30 . . . . . 0 N--CA 1.471 0.596 0 N-CA-C 109.597 -0.52 . . . . 75.1 109.597 173.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 CA--C 1.548 0.872 0 N-CA-C 112.154 0.427 . . . . 63.43 112.154 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -80.1 159.43 26.1 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.623 0.769 . . . . 72.43 110.934 174.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 49.2 mt -139.35 150.68 45.63 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.79 0.836 . . . . 62.22 109.832 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -107.49 122.21 46.17 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.973 -0.751 . . . . 73.41 108.973 173.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -129.41 137.13 50.74 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.438 0.695 . . . . 74.13 109.248 178.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 96.2 m -71.73 131.67 43.45 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.862 0.465 . . . . 65.34 110.815 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.459 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 53.8 tp -108.25 123.88 49.44 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.255 -1.017 . . . . 61.13 108.255 175.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -88.65 117.53 27.68 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 108.488 -0.93 . . . . 61.42 108.488 176.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 4.4 p -140.48 125.84 11.3 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 109.057 -0.72 . . . . 72.41 109.057 178.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.61 154.41 54.76 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 122.136 1.891 . . . . 62.24 111.749 175.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.68 -45.34 91.56 Favored Pre-proline 0 CA--C 1.562 1.427 0 N-CA-C 114.629 1.344 . . . . 73.32 114.629 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -56.24 -52.69 6.64 Favored 'Trans proline' 0 C--N 1.392 2.827 0 C-N-CA 121.914 1.743 . . . . 55.42 113.099 174.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 32.8 mt -67.02 -27.66 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.218 0.607 . . . . 74.42 111.167 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.31 -48.83 69.08 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-O 121.26 0.553 . . . . 43.23 110.839 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 71.1 t -69.21 -46.29 77.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-N 115.798 -0.637 . . . . 71.13 111.764 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 14.4 m -86.6 -29.87 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 112.287 0.477 . . . . 61.22 112.287 -172.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.89 116.39 0.54 Allowed Glycine 0 CA--C 1.531 1.053 0 O-C-N 123.322 0.389 . . . . 64.23 113.298 -173.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -165.11 -177.68 37.78 Favored Glycine 0 N--CA 1.473 1.108 0 N-CA-C 111.687 -0.565 . . . . 72.24 111.687 176.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -80.86 136.01 36.01 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 118.113 0.957 . . . . 72.21 109.994 -176.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 27.6 m -124.91 168.56 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 123.644 0.778 . . . . 72.21 111.15 178.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 55.2 ttp85 -83.4 131.65 35.03 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.288 -0.869 . . . . 75.35 110.019 173.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -134.35 159.74 40.07 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.25 0.62 . . . . 63.12 110.457 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 15.9 tpt -88.0 123.4 32.67 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.13 0.572 . . . . 63.11 110.717 -177.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.434 HG22 ' H ' ' A' ' 216' ' ' GLU . 50.8 m -144.52 161.06 40.03 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.964 0.906 . . . . 64.14 108.652 178.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 68.2 mt -63.78 -19.15 64.77 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.8 0.84 . . . . 65.43 111.763 176.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.434 ' H ' HG22 ' A' ' 214' ' ' THR . 3.2 mp0 -93.51 15.06 16.88 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.828 1.251 . . . . 72.02 111.155 175.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 90.54 -164.85 30.71 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-O 119.746 -0.475 . . . . 73.02 113.297 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.31 118.93 5.92 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.575 2.184 . . . . 51.43 111.616 174.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.7 m -113.06 149.78 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 123.023 0.529 . . . . 70.52 110.882 -176.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -82.29 114.85 21.06 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.643 0.777 . . . . 74.41 110.227 177.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 98.4 t -109.16 116.36 51.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.96 0.904 . . . . 72.01 109.308 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.84 100.64 2.44 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.573 0.749 . . . . 72.43 110.563 -177.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 69.4 t -77.35 134.61 66.48 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 124.54 1.136 . . . . 74.25 110.273 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.88 171.54 17.8 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 122.958 2.439 . . . . 73.32 110.905 172.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -71.38 168.52 23.24 Favored 'Trans proline' 0 C--N 1.366 1.485 0 CA-C-N 120.614 1.255 . . . . 64.0 111.3 170.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 14.9 mtm180 66.92 20.21 10.54 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 124.042 0.937 . . . . 75.22 112.29 173.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.412 ' HA ' ' HE1' ' A' ' 176' ' ' TYR . 99.8 m -69.56 113.28 6.7 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.698 0.799 . . . . 73.51 111.011 -178.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -115.32 141.81 47.54 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.112 -0.949 . . . . 72.14 110.125 -169.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.45 133.81 54.57 Favored 'General case' 0 C--N 1.35 0.611 0 C-N-CA 123.58 0.752 . . . . 71.52 111.665 -176.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.71 -15.12 61.28 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-N 115.332 -0.849 . . . . 54.2 113.159 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -77.02 124.6 28.02 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.798 0.439 . . . . 71.33 110.143 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.4 mppt? -88.05 143.9 26.82 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.041 0.536 . . . . 75.1 110.022 173.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 33.9 mt -109.27 103.28 12.21 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.299 -0.864 . . . . 64.31 109.224 -173.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -69.91 103.48 2.24 Favored 'General case' 0 CA--C 1.551 1.006 0 O-C-N 124.096 0.872 . . . . 74.43 111.121 -176.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 32.4 mt -119.45 94.34 4.38 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.611 0.764 . . . . 64.41 110.223 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -71.26 154.62 41.5 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.703 0.401 . . . . 61.22 111.289 178.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 82.11 18.4 67.29 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-N 115.992 -0.549 . . . . 53.51 113.987 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.477 ' HA ' ' HE2' ' A' ' 238' ' ' LYS . 11.3 mmpt? -118.87 -41.34 2.78 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 123.461 0.704 . . . . 60.41 111.718 -177.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -71.91 -153.97 1.83 Allowed Glycine 0 N--CA 1.485 1.916 0 N-CA-C 114.625 0.61 . . . . 73.24 114.625 -176.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -64.05 136.9 96.94 Favored Pre-proline 0 N--CA 1.485 1.296 0 C-N-CA 123.517 0.727 . . . . 74.41 110.813 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.765 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 18.6 Cg_endo . . . . . 0 C--N 1.379 2.139 0 C-N-CA 123.204 2.603 . . . . 74.41 113.97 -174.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.765 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 28.8 mtm180 . . . . . 0 C--O 1.242 0.667 0 CA-C-O 121.102 0.477 . . . . 54.5 109.774 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -84.25 -158.73 28.4 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 114.922 -1.035 . . . . 74.52 113.565 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -99.77 162.09 13.21 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.836 0.454 . . . . 51.24 109.95 -170.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 40.6 tp -141.98 108.78 5.4 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 108.271 -1.011 . . . . 53.04 108.271 173.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.476 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 78.4 m-85 -88.74 108.13 19.32 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 108.732 -0.84 . . . . 73.01 108.732 175.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 38.9 mt -86.92 114.98 24.01 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.704 -0.85 . . . . 74.34 108.704 177.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -78.26 102.92 7.88 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.781 0.832 . . . . 63.45 109.365 -178.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 84.7 t -56.0 111.97 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 O-C-N 123.771 0.669 . . . . 74.04 110.68 175.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -113.4 101.8 9.72 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.288 -1.004 . . . . 71.4 108.288 172.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 37.1 mt -76.34 103.7 3.93 Favored 'Isoleucine or valine' 0 C--N 1.35 0.621 0 O-C-N 124.206 0.941 . . . . 65.34 109.004 177.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 46.7 p . . . . . 0 C--O 1.254 1.326 0 CA-C-N 115.506 -0.77 . . . . 73.32 109.07 176.09 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.622 0 N-CA-C 108.789 -0.819 . . . . 43.3 108.789 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.498 ' CE2' HD21 ' A' ' 233' ' ' LEU . 24.2 m-85 . . . . . 0 N--CA 1.49 1.552 0 C-N-CA 124.543 1.137 . . . . 61.35 110.846 -164.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 108.786 -0.82 . . . . 61.54 108.786 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -75.83 130.4 38.51 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.656 1.583 . . . . 74.54 108.943 176.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.467 HD12 ' HA2' ' A' ' 239' ' ' GLY . 92.8 mt -135.67 163.91 29.07 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.861 0.864 . . . . 63.52 110.697 -175.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -121.52 153.5 37.9 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.252 1.021 . . . . 41.12 108.962 171.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.444 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -152.78 171.29 18.47 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.551 1.14 . . . . 62.2 109.366 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 25.0 m -106.8 131.68 53.64 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.489 0.716 . . . . 52.41 109.485 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.722 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 42.8 tp -109.02 113.84 27.06 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.594 0.758 . . . . 71.22 109.008 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -83.66 116.85 22.83 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 107.75 -1.204 . . . . 64.41 107.75 172.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.455 HG11 HG13 ' A' ' 253' ' ' VAL . 2.4 p -138.15 120.54 10.85 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 123.794 0.837 . . . . 73.13 109.281 -178.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.1 158.42 56.58 Favored 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 122.218 1.946 . . . . 73.24 112.311 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.402 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -51.38 -48.56 85.8 Favored Pre-proline 0 CA--C 1.565 1.545 0 C-N-CA 124.459 1.103 . . . . 74.13 113.87 -177.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.474 ' O ' HG12 ' A' ' 206' ' ' VAL . 53.7 Cg_exo -54.24 -54.38 4.77 Favored 'Trans proline' 0 C--N 1.401 3.296 0 C-N-CA 122.377 2.051 . . . . 72.51 112.687 175.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 58.1 mt -67.62 -27.98 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.267 0.627 . . . . 51.01 111.041 -176.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.59 -41.59 96.15 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.199 -0.455 . . . . 52.41 110.416 176.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 201' ' ' ALA . 64.3 t -74.86 -57.57 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 CA-C-N 116.545 -0.298 . . . . 70.22 111.63 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 202' ' ' PRO . 12.4 p -93.14 -28.48 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 112.666 0.617 . . . . 74.13 112.666 -167.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 98.12 144.99 18.05 Favored Glycine 0 N--CA 1.477 1.388 0 C-N-CA 122.472 0.082 . . . . 71.34 113.183 -177.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 170.23 -167.76 40.84 Favored Glycine 0 N--CA 1.472 1.058 0 N-CA-C 110.664 -0.974 . . . . 74.13 110.664 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -96.88 138.28 34.68 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 118.336 1.068 . . . . 54.42 110.939 175.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 15.4 m -119.85 170.19 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.448 1.099 . . . . 63.12 109.764 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -102.03 112.24 24.82 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 110.021 -0.363 . . . . 74.23 110.021 174.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -105.34 166.44 10.42 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.983 0.913 . . . . 64.44 109.817 171.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 91.3 mmm -101.96 132.81 47.55 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 120.911 0.386 . . . . 62.42 110.276 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 88.1 m -132.79 167.51 20.03 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.869 1.268 . . . . 63.43 108.547 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 82.6 mt -54.83 -38.78 67.83 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.991 0.917 . . . . 63.32 112.665 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -78.25 -15.6 58.63 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.063 0.545 . . . . 65.23 111.799 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 132.78 -164.27 24.07 Favored Glycine 0 C--N 1.344 1.027 0 O-C-N 123.617 0.573 . . . . 71.54 111.727 -177.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.47 128.72 12.16 Favored 'Trans proline' 0 CA--C 1.555 1.538 0 C-N-CA 122.79 2.327 . . . . 53.14 112.007 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.32 159.89 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.322 1.049 . . . . 72.31 110.015 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 37.7 mt-10 -84.83 147.47 26.8 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 122.78 0.432 . . . . 74.45 110.599 169.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 96.9 t -130.75 124.23 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.163 1.385 . . . . 65.0 108.46 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -77.59 99.28 5.69 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 108.937 -0.764 . . . . 73.35 108.937 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 88.2 t -96.2 123.33 55.34 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.504 1.122 . . . . 74.02 110.566 -175.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.0 164.2 36.42 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.739 2.292 . . . . 70.35 111.384 175.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.87 177.0 0.37 Allowed 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 122.714 2.276 . . . . 65.22 113.418 174.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 24.0 mtp180 66.03 20.63 11.27 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.35 1.06 . . . . 63.33 112.324 174.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -68.86 88.69 0.38 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.686 0.794 . . . . 62.41 110.473 -173.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 -86.28 131.3 34.25 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.894 1.278 . . . . 73.03 110.573 -172.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.99 120.29 8.82 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.407 1.083 . . . . 62.34 111.97 -175.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.0 -4.51 41.72 Favored Glycine 0 N--CA 1.473 1.148 0 O-C-N 123.835 0.71 . . . . 73.42 114.386 176.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -84.62 157.32 21.2 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 117.552 0.676 . . . . 62.22 109.977 173.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.706 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.5 mppt? -127.3 131.55 50.47 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.943 -0.762 . . . . 74.21 108.943 -172.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.498 HD21 ' CE2' ' A' ' 176' ' ' TYR . 20.4 mt -108.56 102.43 11.5 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.601 -0.727 . . . . 72.45 109.791 -166.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -70.48 103.69 2.54 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.117 1.367 . . . . 75.13 110.939 -173.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 26.6 mt -118.19 100.16 7.33 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 122.944 0.498 . . . . 73.11 112.045 -175.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -56.52 142.06 40.51 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.162 0.801 . . . . 71.24 113.162 169.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 100.09 -14.12 60.04 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-N 113.649 -1.614 . . . . 74.44 112.665 174.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -99.89 -20.04 16.34 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.918 0.487 . . . . 70.22 111.967 -171.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . 0.467 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -77.92 -162.26 18.5 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.496 0.498 . . . . 70.51 113.656 177.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -80.77 154.64 73.34 Favored Pre-proline 0 N--CA 1.487 1.407 0 C-N-CA 123.2 0.6 . . . . 60.23 111.022 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo . . . . . 0 C--N 1.383 2.344 0 C-N-CA 123.8 3.0 . . . . 74.33 114.302 177.704 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 30.2 mtm180 . . . . . 0 N--CA 1.476 0.831 0 N-CA-C 108.892 -0.781 . . . . 74.31 108.892 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -67.29 -156.84 0.63 Allowed Glycine 0 C--N 1.341 0.858 0 O-C-N 123.865 0.728 . . . . 75.45 114.835 -170.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -96.23 160.85 14.22 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.263 0.554 . . . . 74.13 110.406 -170.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.444 HD11 ' HB2' ' A' ' 195' ' ' ALA . 31.1 tp -137.52 114.68 10.86 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.3 -1.37 . . . . 60.34 107.3 175.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.706 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 1.9 m-85 -91.18 108.84 20.14 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.994 -0.743 . . . . 74.43 108.994 -177.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.722 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 43.2 mt -86.36 107.49 18.03 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.548 -0.538 . . . . 75.32 109.548 -178.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -82.95 108.48 16.31 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.027 -0.988 . . . . 62.34 110.183 -174.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.455 HG13 HG11 ' A' ' 199' ' ' VAL . 61.1 t -56.3 120.16 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 C-N-CA 125.337 1.455 . . . . 63.41 112.581 -173.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 53.4 mmt-85 -114.8 96.91 5.95 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.724 1.21 . . . . 74.11 108.001 170.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 53.8 mt -74.89 103.85 2.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.936 -1.135 . . . . 63.33 107.936 175.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 25.3 p . . . . . 0 CA--C 1.555 1.166 0 N-CA-C 108.727 -0.842 . . . . 61.33 108.727 174.497 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 112.897 0.703 . . . . 41.52 112.897 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.539 ' CZ ' ' HA ' ' A' ' 227' ' ' THR . 8.5 m-85 . . . . . 0 N--CA 1.482 1.174 0 C-N-CA 123.07 0.548 . . . . 74.44 111.109 169.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.672 ' HB3' ' HB2' ' A' ' 240' ' ' PHE . 85.9 mm-40 . . . . . 0 CA--C 1.555 1.17 0 CA-C-O 120.794 0.33 . . . . 72.41 111.654 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -75.67 154.09 36.76 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.086 0.954 . . . . 55.13 110.739 -178.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 87.9 mt -131.93 158.56 41.09 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.767 0.827 . . . . 54.1 110.051 -173.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -115.0 124.2 51.04 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.994 -1.113 . . . . 74.33 107.994 173.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -124.94 129.31 50.11 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.374 -0.973 . . . . 74.44 108.374 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 42.3 m -68.39 126.29 29.13 Favored 'General case' 0 C--O 1.242 0.708 0 O-C-N 123.517 0.511 . . . . 70.04 110.22 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.484 HD12 ' HB2' ' A' ' 212' ' ' ALA . 46.0 tp -106.84 109.95 21.98 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.034 -1.469 . . . . 71.54 107.034 177.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -92.17 118.04 30.45 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.242 -1.021 . . . . 54.4 108.242 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.461 HG23 HG11 ' A' ' 210' ' ' VAL . 5.7 p -137.85 131.71 17.02 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 123.335 0.654 . . . . 74.12 109.784 -176.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -76.34 157.81 37.09 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.241 1.961 . . . . 73.3 111.701 172.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -55.0 -46.23 99.7 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 124.415 1.086 . . . . 71.31 113.543 -176.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.448 ' O ' HG12 ' A' ' 206' ' ' VAL . 71.2 Cg_exo -53.56 -54.99 3.98 Favored 'Trans proline' 0 C--N 1.402 3.381 0 C-N-CA 122.272 1.981 . . . . 73.1 112.78 174.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 48.7 mt -69.84 -21.03 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.3 0.64 . . . . 64.5 110.756 -176.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.2 -48.52 56.77 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.851 0.46 . . . . 65.13 110.342 176.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.0 -55.69 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 CA-C-N 115.959 -0.564 . . . . 63.3 111.431 -177.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 202' ' ' PRO . 14.6 p -87.15 -32.21 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 N-CA-C 112.611 0.597 . . . . 64.12 112.611 -172.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 101.53 166.68 27.48 Favored Glycine 0 N--CA 1.477 1.374 0 N-CA-C 112.076 -0.41 . . . . 74.01 112.076 -173.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 163.43 -131.94 2.6 Favored Glycine 0 C--N 1.345 1.032 0 N-CA-C 111.456 -0.658 . . . . 52.31 111.456 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -137.86 139.05 39.69 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.655 1.182 . . . . 72.12 108.594 174.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.461 HG11 HG23 ' A' ' 199' ' ' VAL . 32.3 m -136.53 168.02 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 122.956 0.502 . . . . 71.0 110.563 178.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 29.3 ttm-85 -87.51 113.19 22.98 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.763 -0.653 . . . . 70.24 109.887 178.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.484 ' HB2' HD12 ' A' ' 197' ' ' LEU . . . -105.79 158.42 16.75 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.842 0.857 . . . . 40.33 110.238 173.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 36.8 tpp -93.26 110.68 22.2 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.923 -0.769 . . . . 64.0 108.923 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 60.5 m -126.0 163.88 22.05 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.308 1.043 . . . . 64.24 109.815 -175.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 95.6 mt -61.81 -17.25 55.49 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.968 0.907 . . . . 62.31 112.965 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -96.59 8.39 44.26 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.471 0.708 . . . . 65.4 111.485 177.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 102.42 -164.01 16.66 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-O 119.708 -0.495 . . . . 61.3 112.129 -176.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.36 118.12 5.07 Favored 'Trans proline' 0 C--N 1.367 1.537 0 C-N-CA 122.124 1.883 . . . . 75.23 110.906 175.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.7 m -118.42 157.29 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 123.478 0.711 . . . . 73.05 110.51 -175.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -90.56 108.83 20.05 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.148 -0.686 . . . . 60.12 109.148 173.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 94.3 t -97.8 129.06 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.091 0.956 . . . . 73.34 109.942 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.88 103.09 2.12 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.999 0.92 . . . . 65.25 110.142 176.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 97.2 t -89.97 125.96 58.93 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 124.088 0.955 . . . . 74.23 110.166 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -78.18 171.44 17.06 Favored 'Trans proline' 0 CA--C 1.561 1.846 0 C-N-CA 123.163 2.575 . . . . 61.14 111.617 173.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.21 174.25 8.33 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.095 1.863 . . . . 72.32 113.694 174.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 67.16 15.37 10.03 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 125.903 1.681 . . . . 64.35 112.505 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.539 ' HA ' ' CZ ' ' A' ' 176' ' ' TYR . 93.9 m -64.75 100.96 0.43 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.523 0.729 . . . . 73.34 110.139 -176.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -101.83 137.26 40.36 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 125.135 1.374 . . . . 75.25 110.323 -174.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.92 132.9 53.65 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.568 1.147 . . . . 54.43 110.993 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.03 -1.55 67.93 Favored Glycine 0 C--N 1.337 0.613 0 O-C-N 123.849 0.718 . . . . 61.14 113.281 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -86.86 151.2 23.54 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 109.605 -0.517 . . . . 74.23 109.605 170.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.501 ' HG3' ' HA ' ' A' ' 252' ' ' GLU . 3.8 mppt? -131.67 139.03 48.96 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.279 -1.008 . . . . 73.34 108.279 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.43 HD21 ' CE2' ' A' ' 176' ' ' TYR . 29.1 mt -118.05 109.24 16.2 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.287 0.635 . . . . 74.32 110.309 -161.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 45.1 ttm-85 -76.96 108.9 10.35 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 124.057 0.848 . . . . 73.21 110.16 -174.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 21.8 mt -107.03 89.79 3.11 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.591 -0.892 . . . . 70.21 108.591 176.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.517 ' HG2' ' HB3' ' A' ' 248' ' ' ASP . 10.6 mtmp? -67.1 136.08 54.61 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.416 -0.357 . . . . 71.13 111.147 -177.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 95.24 -0.83 64.16 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 115.319 -0.855 . . . . 54.13 113.456 -175.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.53 ' HA ' ' HE2' ' A' ' 238' ' ' LYS . 10.4 mmpt? -106.55 -9.26 16.67 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 113.277 0.844 . . . . 71.01 113.277 -175.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.11 179.53 50.93 Favored Glycine 0 N--CA 1.476 1.334 0 N-CA-C 111.571 -0.612 . . . . 62.4 111.571 167.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.672 ' HB2' ' HB3' ' A' ' 191' ' ' GLN . 33.3 m-85 -60.28 154.33 53.29 Favored Pre-proline 0 N--CA 1.489 1.477 0 C-N-CA 123.42 0.688 . . . . 73.22 111.812 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 36.6 Cg_endo . . . . . 0 C--N 1.376 2.008 0 C-N-CA 122.477 2.118 . . . . 62.44 112.83 177.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.423 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 82.2 mtt180 . . . . . 0 C--O 1.242 0.671 0 CA-C-O 120.572 0.225 . . . . 75.42 110.659 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -69.48 -175.46 13.39 Favored Glycine 0 C--N 1.343 0.967 0 O-C-N 123.998 0.811 . . . . 53.14 112.155 175.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.517 ' HB3' ' HG2' ' A' ' 236' ' ' LYS . 1.4 p30 -104.05 171.29 7.43 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.855 0.462 . . . . 72.01 111.547 -178.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 32.9 tp -129.36 112.87 14.28 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 108.737 -0.838 . . . . 73.54 108.737 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -86.76 109.47 19.26 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.684 0.794 . . . . 54.43 109.28 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 44.5 mt -87.16 111.39 20.91 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 109.077 -0.712 . . . . 74.21 109.077 175.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.501 ' HA ' ' HG3' ' A' ' 232' ' ' LYS . 31.5 mt-10 -78.77 101.08 7.4 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.092 -0.958 . . . . 72.13 109.566 -177.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.8 t -59.51 110.03 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 O-C-N 123.765 0.666 . . . . 72.25 111.072 176.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -115.12 93.44 4.3 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.003 -1.11 . . . . 74.44 108.003 176.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.492 HD11 ' O ' ' A' ' 227' ' ' THR . 54.9 mt -77.17 125.65 37.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 N-CA-C 109.473 -0.565 . . . . 72.24 109.473 178.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 24.4 p . . . . . 0 C--O 1.25 1.127 0 C-N-CA 124.157 0.983 . . . . 73.3 109.632 179.775 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.048 0 N-CA-C 109.253 -0.647 . . . . 74.55 109.253 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.431 ' CZ ' ' HA ' ' A' ' 227' ' ' THR . 4.5 m-85 . . . . . 0 N--CA 1.487 1.408 0 C-N-CA 125.591 1.556 . . . . 70.04 111.974 -176.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.456 HE21 ' HA2' ' A' ' 247' ' ' GLY . 5.7 pm0 . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 122.582 1.182 . . . . 64.22 109.832 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -87.43 163.48 16.72 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 114.689 -1.141 . . . . 71.5 111.087 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 83.2 mt -140.66 172.04 13.26 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.196 0.998 . . . . 73.41 109.994 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -118.01 145.06 45.03 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.052 0.941 . . . . 71.24 109.516 174.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -146.08 140.17 26.55 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.021 0.928 . . . . 70.2 109.282 178.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.9 m -77.36 129.19 35.49 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.058 0.543 . . . . 43.51 109.711 178.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.559 HD13 HD13 ' A' ' 251' ' ' LEU . 54.0 tp -107.45 111.3 23.53 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.451 -1.314 . . . . 54.54 107.451 177.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -92.04 100.5 13.13 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 108.291 -1.003 . . . . 72.52 108.291 -178.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.502 HG23 HG11 ' A' ' 210' ' ' VAL . 2.9 p -124.28 131.49 24.2 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 124.013 0.925 . . . . 73.05 108.799 -178.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . 0.513 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 98.4 Cg_endo -80.68 163.9 21.01 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.513 2.142 . . . . 70.22 111.355 172.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.17 -48.46 85.32 Favored Pre-proline 0 CA--C 1.566 1.581 0 N-CA-C 114.045 1.128 . . . . 72.51 114.045 176.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.513 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 25.5 Cg_endo -58.8 -52.46 5.2 Favored 'Trans proline' 0 C--N 1.396 3.044 0 C-N-CA 122.002 1.801 . . . . 62.43 113.057 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.8 mt -70.77 -22.21 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.238 0 C-N-CA 123.081 0.552 . . . . 55.42 110.856 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.33 -44.2 72.15 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.771 0.429 . . . . 64.04 110.717 177.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 76.1 t -71.49 -57.17 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 C-N-CA 122.181 0.192 . . . . 73.05 110.975 -178.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 202' ' ' PRO . 12.6 p -85.38 -25.99 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 112.208 0.447 . . . . 64.41 112.208 -170.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 99.89 -178.63 29.75 Favored Glycine 0 N--CA 1.475 1.273 0 N-CA-C 112.156 -0.378 . . . . 52.35 112.156 -172.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 139.6 -139.17 9.76 Favored Glycine 0 C--N 1.343 0.932 0 N-CA-C 111.764 -0.535 . . . . 63.5 111.764 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -133.86 146.35 50.52 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.524 0.73 . . . . 60.4 109.751 175.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.502 HG11 HG23 ' A' ' 199' ' ' VAL . 22.2 m -138.67 169.2 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 123.711 0.632 . . . . 75.0 112.02 -177.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 -73.22 133.07 43.88 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.424 -0.807 . . . . 73.22 110.27 172.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.437 ' HB2' HD12 ' A' ' 197' ' ' LEU . . . -144.13 148.99 35.81 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.468 -0.938 . . . . 61.44 108.468 168.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 64.8 mtp -89.03 130.72 35.45 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.459 -0.571 . . . . 72.02 109.459 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 42.3 m -143.2 172.93 12.07 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 125.228 1.411 . . . . 73.0 108.082 -175.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 77.0 mt -60.08 -21.35 61.35 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.27 0.628 . . . . 65.53 111.708 173.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -86.65 16.83 4.33 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.641 1.176 . . . . 71.32 111.674 174.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 76.34 -155.82 46.05 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-O 118.87 -0.961 . . . . 55.14 111.757 -175.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.85 119.73 6.62 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 121.954 1.77 . . . . 74.42 110.423 171.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.55 166.09 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.284 1.034 . . . . 75.42 109.978 -176.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -102.46 107.51 18.51 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.898 -0.779 . . . . 54.04 108.898 175.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 95.5 t -95.15 131.64 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.145 0.978 . . . . 63.31 109.639 -175.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.45 98.72 2.32 Favored 'General case' 0 C--N 1.351 0.659 0 O-C-N 124.055 0.847 . . . . 74.4 109.39 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 55.9 t -91.84 127.71 48.84 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 124.83 1.252 . . . . 74.23 110.022 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -73.2 170.25 20.31 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.692 2.262 . . . . 73.15 110.962 173.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.46 178.07 4.11 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 122.02 1.813 . . . . 75.22 111.789 170.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 50.2 mtp180 63.68 20.29 12.15 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 124.978 1.311 . . . . 61.12 112.222 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.493 ' O ' HD11 ' A' ' 255' ' ' ILE . 98.1 m -65.64 106.68 1.53 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.361 0.664 . . . . 62.42 110.278 -178.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -100.13 139.86 35.2 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.925 1.29 . . . . 73.44 110.285 -174.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -69.92 127.95 34.66 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.737 1.215 . . . . 72.21 111.542 -177.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.39 10.55 53.71 Favored Glycine 0 C--N 1.342 0.881 0 O-C-N 123.724 0.64 . . . . 62.32 113.126 178.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -91.47 158.28 16.57 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 117.176 0.488 . . . . 75.41 111.341 175.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.402 ' HB3' ' HD2' ' A' ' 250' ' ' TYR . 1.8 mppt? -130.07 117.65 20.32 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.84 1.256 . . . . 74.12 109.162 -177.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 12.9 mt -105.8 100.7 10.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.301 -0.863 . . . . 55.5 108.711 -165.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 46.2 ttm105 -69.98 102.45 2.01 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 124.544 1.153 . . . . 73.01 110.057 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 29.8 mt -111.69 99.78 8.44 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.727 0.811 . . . . 61.5 110.159 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -66.74 142.86 57.25 Favored 'General case' 0 C--O 1.246 0.887 0 C-N-CA 123.407 0.683 . . . . 71.55 110.489 178.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 87.03 13.35 66.54 Favored Glycine 0 CA--C 1.532 1.117 0 O-C-N 123.745 0.653 . . . . 53.21 113.021 -174.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -130.83 -25.38 2.31 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.338 0.655 . . . . 73.42 112.292 -175.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -75.07 -159.51 7.41 Favored Glycine 0 N--CA 1.476 1.306 0 CA-C-O 120.295 -0.169 . . . . 63.53 112.823 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -69.45 134.38 88.81 Favored Pre-proline 0 CA--C 1.554 1.105 0 CA-C-O 118.24 -0.886 . . . . 71.42 109.408 -174.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.578 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 78.0 Cg_exo . . . . . 0 C--N 1.386 2.524 0 C-N-CA 122.904 2.403 . . . . 64.11 111.838 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.578 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 59.2 mtt-85 . . . . . 0 C--O 1.241 0.655 0 N-CA-C 109.036 -0.728 . . . . 71.43 109.036 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.456 ' HA2' HE21 ' A' ' 191' ' ' GLN . . . -82.45 -158.04 22.93 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-N 115.449 -0.796 . . . . 55.5 112.471 177.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -114.55 132.54 56.29 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.767 0.827 . . . . 73.45 110.089 -176.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 41.6 tp -106.88 121.33 44.21 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 108.415 -0.958 . . . . 71.42 108.415 -176.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.402 ' HD2' ' HB3' ' A' ' 232' ' ' LYS . 8.7 m-85 -87.79 113.27 23.3 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.4 -0.963 . . . . 53.52 108.4 179.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.559 HD13 HD13 ' A' ' 197' ' ' LEU . 51.2 mt -86.48 107.77 18.23 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.175 -0.676 . . . . 72.25 109.175 176.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.434 ' HG3' ' HD3' ' A' ' 254' ' ' ARG . 8.4 tp10 -76.02 97.67 4.09 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 107.683 -1.229 . . . . 60.31 107.683 177.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 91.5 t -62.82 108.87 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.777 0 C-N-CA 124.952 1.301 . . . . 63.01 110.927 -177.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.434 ' HD3' ' HG3' ' A' ' 252' ' ' GLU . 22.1 mmm180 -109.3 93.82 4.71 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.243 -1.021 . . . . 53.35 108.243 174.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.493 HD11 ' O ' ' A' ' 227' ' ' THR . 58.9 mt -75.4 131.79 34.37 Favored 'Isoleucine or valine' 0 C--N 1.351 0.631 0 N-CA-C 109.324 -0.621 . . . . 74.45 109.324 174.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 16.4 p . . . . . 0 CA--C 1.558 1.273 0 C-N-CA 125.496 1.518 . . . . 60.12 107.56 178.084 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.85 0 N-CA-C 110.617 -0.142 . . . . 61.34 110.617 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.628 ' CE2' HD22 ' A' ' 233' ' ' LEU . 49.1 m-85 . . . . . 0 N--CA 1.483 1.178 0 C-N-CA 124.43 1.092 . . . . 65.53 110.648 -172.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.64 ' HB3' ' HB2' ' A' ' 240' ' ' PHE . 25.2 mm-40 . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 121.468 0.651 . . . . 75.44 112.138 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -94.29 138.65 32.03 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 114.353 -1.294 . . . . 74.45 110.807 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 91.5 mt -122.93 166.95 14.22 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.872 0.869 . . . . 61.31 110.455 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -106.34 149.89 26.51 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 107.955 -1.128 . . . . 62.14 107.955 166.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.97 129.15 12.76 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.933 -0.765 . . . . 71.13 108.933 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.5 m -65.52 121.77 15.67 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.572 0.749 . . . . 75.33 110.425 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.479 HD22 ' HB3' ' A' ' 251' ' ' LEU . 57.0 tp -108.0 112.99 25.85 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.951 0.901 . . . . 75.24 109.164 -178.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -85.93 112.07 20.84 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.312 -0.996 . . . . 72.41 108.312 174.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 2.2 p -139.49 119.9 9.42 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 123.945 0.898 . . . . 73.5 108.971 -177.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . 0.425 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 44.3 Cg_endo -71.3 158.02 55.53 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 121.879 1.72 . . . . 70.42 111.171 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -52.1 -47.28 92.3 Favored Pre-proline 0 CA--C 1.567 1.611 0 C-N-CA 124.781 1.233 . . . . 65.02 113.606 -177.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 37.2 Cg_endo -63.07 -43.62 18.56 Favored 'Trans proline' 0 C--N 1.404 3.491 0 C-N-CA 121.478 1.452 . . . . 63.03 112.186 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 40.1 mt -71.12 -28.26 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 O-C-N 123.616 0.572 . . . . 74.34 110.361 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.57 -46.56 82.22 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.207 0.603 . . . . 63.14 110.509 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 67.5 t -67.82 -57.07 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 122.727 0.411 . . . . 73.1 111.513 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 17.2 m -78.9 -20.83 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 112.285 0.476 . . . . 64.24 112.285 -170.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 77.52 132.97 0.62 Allowed Glycine 0 C--N 1.345 1.07 0 N-CA-C 111.675 -0.57 . . . . 71.14 111.675 -171.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 175.87 -175.01 47.25 Favored Glycine 0 N--CA 1.468 0.828 0 CA-C-N 117.265 0.532 . . . . 73.2 112.269 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -79.03 143.6 35.48 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 122.849 0.46 . . . . 72.52 111.0 -178.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 19.9 m -139.45 169.44 16.99 Favored 'Isoleucine or valine' 0 C--O 1.253 1.263 0 O-C-N 124.338 1.024 . . . . 65.24 110.351 177.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -72.48 118.46 15.41 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.502 -1.226 . . . . 74.32 109.979 169.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -110.66 137.33 48.47 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.407 -0.59 . . . . 32.05 109.407 169.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 63.0 mtt -84.95 103.68 14.21 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.521 -0.918 . . . . 73.11 108.521 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 43.4 m -122.35 168.56 11.92 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.688 1.195 . . . . 64.31 109.015 -176.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 80.1 mt -54.69 -27.29 39.23 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.023 0.929 . . . . 54.32 111.73 174.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -90.95 15.82 10.69 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.507 1.123 . . . . 51.42 111.837 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 83.07 -149.74 26.82 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-O 119.273 -0.737 . . . . 44.54 112.174 -177.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.05 120.3 5.99 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.376 2.051 . . . . 64.14 111.377 177.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 22.6 m -119.24 167.44 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 123.2 0.6 . . . . 70.21 111.522 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -76.67 116.36 17.28 Favored 'General case' 0 C--N 1.348 0.526 0 C-N-CA 124.38 1.072 . . . . 73.13 108.822 175.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 1.1 t -124.78 115.19 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 108.613 -0.884 . . . . 64.04 108.613 174.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -81.39 99.01 8.47 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 115.76 -0.655 . . . . 62.11 109.401 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 56.1 t -80.32 130.26 66.2 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 123.609 0.764 . . . . 60.21 109.904 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.37 167.68 7.53 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.168 2.579 . . . . 53.03 112.27 171.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.25 -179.51 3.19 Favored 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 121.837 1.691 . . . . 75.2 112.913 174.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 48.2 mtt85 60.66 18.23 8.28 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 124.974 1.31 . . . . 72.25 112.298 173.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.497 ' HA ' ' OH ' ' A' ' 176' ' ' TYR . 96.6 m -68.3 103.45 1.6 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.025 0.93 . . . . 71.3 110.245 -174.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.452 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 47.4 tp60 -103.78 142.2 34.78 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.419 1.088 . . . . 73.33 110.285 -174.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.82 130.96 49.47 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.716 1.206 . . . . 41.11 111.583 -176.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 95.01 -10.34 70.1 Favored Glycine 0 C--N 1.347 1.142 0 O-C-N 123.711 0.632 . . . . 72.43 113.144 177.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.452 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 68.3 mtt-85 -78.52 155.45 29.75 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.038 0.535 . . . . 75.2 109.626 174.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.585 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.7 mppt? -130.18 118.1 20.9 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.994 -0.743 . . . . 51.11 108.994 -176.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.628 HD22 ' CE2' ' A' ' 176' ' ' TYR . 5.0 mt -89.66 103.91 16.51 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.091 -0.959 . . . . 74.44 109.035 -164.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 16.8 ttm-85 -69.42 102.11 1.7 Allowed 'General case' 0 CA--C 1.541 0.598 0 O-C-N 123.92 0.763 . . . . 74.24 109.712 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.414 ' HB3' ' HG3' ' A' ' 238' ' ' LYS . 14.3 mt -96.05 91.32 5.91 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.282 -1.007 . . . . 61.11 108.282 175.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -62.78 140.94 58.79 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.283 -0.636 . . . . 74.4 109.283 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 72.9 34.59 58.87 Favored Glycine 0 C--N 1.343 0.949 0 O-C-N 123.424 0.453 . . . . 53.51 113.737 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.432 ' HA ' ' NZ ' ' A' ' 238' ' ' LYS . 0.4 OUTLIER -128.01 -27.05 2.8 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.601 0.761 . . . . 73.32 112.124 179.262 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -74.88 -165.21 13.54 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 112.455 -0.258 . . . . 75.33 112.455 169.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.64 ' HB2' ' HB3' ' A' ' 191' ' ' GLN . 90.9 m-85 -75.72 150.57 84.22 Favored Pre-proline 0 N--CA 1.487 1.395 0 CA-C-N 117.216 0.508 . . . . 73.44 110.046 -176.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo . . . . . 0 C--N 1.375 1.939 0 C-N-CA 122.284 1.989 . . . . 70.45 112.659 177.704 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 48.8 mtm180 . . . . . 0 N--CA 1.473 0.679 0 N-CA-C 108.731 -0.841 . . . . 52.34 108.731 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -69.97 171.0 42.99 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 115.3 -0.864 . . . . 33.42 113.963 -177.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -110.71 136.28 50.03 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.919 0.888 . . . . 72.45 108.863 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 31.9 tp -105.29 108.11 19.46 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 107.717 -1.216 . . . . 73.13 107.717 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.585 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 19.3 m-85 -88.54 108.99 19.7 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.716 -0.846 . . . . 75.24 108.716 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.479 ' HB3' HD22 ' A' ' 197' ' ' LEU . 43.0 mt -86.85 107.07 18.16 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.856 -0.794 . . . . 64.33 108.856 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -78.05 102.76 7.6 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 114.657 -1.156 . . . . 72.41 109.55 -177.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 63.2 t -59.57 115.26 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.695 0 CA-C-N 114.388 -1.278 . . . . 72.11 112.053 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 20.7 mmt85 -112.66 93.99 4.7 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.294 -1.373 . . . . 72.01 107.294 171.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 22.9 mt -74.99 109.36 7.83 Favored 'Isoleucine or valine' 0 C--N 1.352 0.689 0 N-CA-C 109.018 -0.734 . . . . 73.44 109.018 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 25.6 p . . . . . 0 CA--C 1.558 1.277 0 C-N-CA 124.524 1.13 . . . . 73.42 108.428 177.173 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.688 0 N-CA-C 109.272 -0.64 . . . . 72.1 109.272 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.592 ' CE2' HD21 ' A' ' 233' ' ' LEU . 66.6 m-85 . . . . . 0 N--CA 1.488 1.43 0 C-N-CA 125.23 1.412 . . . . 62.42 112.067 -166.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 . . . . . 0 CA--C 1.555 1.166 0 CA-C-O 122.992 1.377 . . . . 53.42 109.745 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -88.7 166.84 13.8 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 113.693 -1.594 . . . . 64.34 110.362 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.6 mt -133.19 164.61 26.68 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.618 0.767 . . . . 53.15 110.785 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -114.85 154.87 27.85 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 114.526 -1.215 . . . . 74.22 108.357 168.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -160.66 150.88 17.91 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.656 0.782 . . . . 72.31 109.319 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 33.2 m -81.66 135.65 35.52 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.065 0.546 . . . . 61.54 110.18 177.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.578 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 42.1 tp -114.54 113.57 24.6 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.707 -1.22 . . . . 71.44 107.707 170.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -91.93 123.7 35.5 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 109.269 -0.641 . . . . 52.23 109.269 177.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 3.6 p -142.92 130.9 11.22 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.531 1.132 . . . . 75.22 108.487 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.21 156.26 37.63 Favored 'Trans proline' 0 C--N 1.37 1.683 0 C-N-CA 121.586 1.524 . . . . 73.43 110.999 170.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -54.62 -42.18 93.53 Favored Pre-proline 0 CA--C 1.565 1.528 0 CA-C-O 117.333 -1.318 . . . . 73.02 114.29 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.24 -51.23 9.04 Favored 'Trans proline' 0 C--N 1.4 3.282 0 CA-C-N 121.832 1.69 . . . . 44.22 112.144 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 46.0 mt -68.69 -26.45 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.813 0.845 . . . . 74.15 110.802 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.468 ' HB1' ' O ' ' A' ' 227' ' ' THR . . . -70.69 -50.96 30.9 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.51 0.724 . . . . 72.41 111.326 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 96.1 t -67.65 -50.14 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.612 0.765 . . . . 65.11 111.253 -176.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.7 p -75.97 -31.5 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 122.524 0.33 . . . . 74.02 110.793 -177.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 79.96 103.46 0.27 Allowed Glycine 0 C--N 1.347 1.177 0 N-CA-C 111.667 -0.573 . . . . 72.34 111.667 -173.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -131.75 -129.7 3.06 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 116.978 0.389 . . . . 55.01 112.35 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -132.93 141.75 48.52 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.129 0.972 . . . . 75.44 108.393 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 17.2 m -130.67 165.96 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.21 0.604 . . . . 71.12 110.924 -178.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -82.11 120.42 25.29 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.133 -0.692 . . . . 74.3 109.133 168.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -118.21 136.67 53.5 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.557 0.743 . . . . 41.32 109.285 173.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 87.1 mtp -76.83 116.63 17.67 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.026 0.53 . . . . 73.34 109.578 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 33.6 m -127.21 170.35 12.52 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.431 1.093 . . . . 63.03 108.848 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 81.4 mt -57.82 -34.29 69.5 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.012 0.925 . . . . 71.41 111.963 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -84.56 2.16 42.55 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.676 0.79 . . . . 74.12 111.93 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 108.79 -161.8 13.09 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-O 119.648 -0.529 . . . . 74.22 112.567 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.2 119.66 6.61 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 122.189 1.926 . . . . 62.14 111.312 176.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 32.7 m -114.9 163.94 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 123.306 0.642 . . . . 74.14 109.979 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -103.61 110.0 21.9 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.242 0.544 . . . . 72.34 109.703 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 62.0 t -104.29 126.25 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.151 0.98 . . . . 72.54 109.207 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.1 99.81 2.87 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.103 0.561 . . . . 70.14 109.899 176.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 78.1 t -88.52 121.28 70.24 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 124.112 0.965 . . . . 71.45 109.724 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -60.76 169.02 6.14 Favored 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 123.987 3.124 . . . . 63.12 113.359 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.98 169.35 20.69 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 122.073 1.849 . . . . 62.11 113.629 178.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 65.53 22.02 11.79 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 125.554 1.541 . . . . 71.52 112.186 176.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.503 ' HA ' ' CZ ' ' A' ' 176' ' ' TYR . 94.8 m -66.39 104.55 1.25 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.029 0.932 . . . . 63.43 110.811 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -102.06 141.63 34.6 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.987 0.915 . . . . 63.24 110.935 -172.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.4 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -64.77 143.31 58.02 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.295 1.038 . . . . 75.21 111.576 -179.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.76 -9.17 75.14 Favored Glycine 0 N--CA 1.47 0.909 0 O-C-N 123.831 0.707 . . . . 70.34 112.939 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.42 HH11 ' HE1' ' A' ' 176' ' ' TYR . 89.3 mtt180 -78.15 154.14 31.46 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.237 0.615 . . . . 70.5 109.989 171.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -131.23 136.31 48.11 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.592 1.157 . . . . 71.24 108.437 -178.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.592 HD21 ' CE2' ' A' ' 176' ' ' TYR . 30.2 mt -110.12 103.16 11.84 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.875 -0.602 . . . . 61.13 109.912 -169.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -70.5 100.65 1.83 Allowed 'General case' 0 C--O 1.239 0.501 0 O-C-N 124.038 0.836 . . . . 73.43 109.203 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 12.4 mt -97.79 98.59 9.97 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.305 -1.368 . . . . 63.53 107.305 177.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 36.3 mtmt -76.88 141.74 40.45 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.298 -0.41 . . . . 75.42 110.331 -176.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.98 33.07 42.37 Favored Glycine 0 C--N 1.344 1.015 0 O-C-N 123.478 0.486 . . . . 71.55 113.278 -179.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -125.0 -33.95 2.85 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.74 0.816 . . . . 73.11 111.619 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -65.61 -159.81 0.6 Allowed Glycine 0 C--N 1.359 1.856 0 O-C-N 123.488 0.493 . . . . 53.42 113.491 176.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -71.72 146.17 90.58 Favored Pre-proline 0 CA--C 1.554 1.112 0 O-C-N 122.049 -0.677 . . . . 75.53 110.078 -177.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 20.7 Cg_endo . . . . . 0 C--N 1.378 2.101 0 C-N-CA 122.778 2.319 . . . . 72.14 112.925 175.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 31.6 mtt180 . . . . . 0 N--CA 1.477 0.917 0 CA-C-O 121.096 0.474 . . . . 63.44 110.778 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.29 -165.63 27.56 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 115.334 -0.848 . . . . 55.51 112.363 177.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -99.07 168.8 9.85 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.214 0.606 . . . . 74.45 110.13 -177.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 40.4 tp -142.48 107.81 5.01 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.943 -0.762 . . . . 62.25 108.943 174.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -89.33 108.2 19.49 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.907 0.483 . . . . 72.34 109.964 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.578 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 34.7 mt -87.62 107.97 18.85 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 109.311 -0.625 . . . . 72.11 109.311 174.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -78.66 103.5 8.65 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 109.075 -0.713 . . . . 75.54 109.075 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.8 t -56.8 112.99 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 124.548 1.139 . . . . 72.33 111.194 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -116.34 100.55 7.97 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.039 -1.097 . . . . 74.42 108.039 176.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 30.1 mt -79.38 126.92 39.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 123.285 0.634 . . . . 54.43 110.665 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 19.7 p . . . . . 0 CA--C 1.557 1.213 0 C-N-CA 124.714 1.205 . . . . 64.54 108.708 176.135 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 108.966 -0.753 . . . . 73.33 108.966 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.673 ' CE2' HD21 ' A' ' 233' ' ' LEU . 40.6 m-85 . . . . . 0 N--CA 1.486 1.33 0 C-N-CA 124.724 1.21 . . . . 75.43 109.337 -159.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 109.724 -0.473 . . . . 75.55 109.724 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -80.33 132.14 35.75 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.467 -0.788 . . . . 73.22 109.431 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 86.2 mt -136.94 175.11 9.92 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.838 0.855 . . . . 64.41 109.772 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -105.26 163.49 12.56 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.055 0.942 . . . . 73.21 110.205 178.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -165.33 129.7 2.4 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.771 1.228 . . . . 60.11 108.13 175.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . 0.446 ' HA ' ' HB2' ' A' ' 252' ' ' GLU . 50.1 m -70.69 137.11 49.52 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 122.794 0.438 . . . . 54.34 111.163 -178.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 21.9 tp -122.46 112.44 18.05 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.182 -1.044 . . . . 62.34 108.182 175.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -91.23 128.43 37.05 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 108.913 -0.773 . . . . 65.05 108.913 175.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 3.3 p -139.6 124.87 11.64 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 123.799 0.84 . . . . 61.44 109.578 -177.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -67.5 153.51 76.31 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 121.467 1.444 . . . . 44.33 111.717 176.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.59 -45.17 85.24 Favored Pre-proline 0 CA--C 1.564 1.496 0 CA-C-O 117.648 -1.167 . . . . 53.33 113.887 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.457 ' O ' HG12 ' A' ' 206' ' ' VAL . 19.9 Cg_endo -59.36 -52.27 5.07 Favored 'Trans proline' 0 C--N 1.397 3.127 0 CA-C-N 121.426 1.545 . . . . 62.31 112.17 175.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 46.0 mt -63.8 -27.31 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 123.639 0.776 . . . . 75.42 110.896 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' A' ' 227' ' ' THR . . . -70.86 -49.33 47.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.386 0.675 . . . . 72.51 111.169 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 84.7 t -67.84 -54.0 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 122.988 0.515 . . . . 73.21 110.96 -177.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.457 HG12 ' O ' ' A' ' 202' ' ' PRO . 11.1 p -74.34 -38.66 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 122.701 0.4 . . . . 60.32 111.345 -175.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.79 79.16 1.3 Allowed Glycine 0 C--N 1.343 0.955 0 N-CA-C 112.07 -0.412 . . . . 65.02 112.07 -172.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -99.33 -125.54 5.45 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-O 119.546 -0.586 . . . . 64.22 112.064 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.54 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 33.7 mtmm -138.18 150.18 46.54 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.101 0.961 . . . . 63.21 109.4 174.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 24.3 m -138.51 170.18 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 124.031 0.932 . . . . 75.44 110.946 177.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 19.3 ttm180 -96.76 115.72 27.91 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.798 0.839 . . . . 62.11 110.303 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -107.67 156.14 19.39 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 109.181 -0.674 . . . . 41.31 109.181 168.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 83.6 mtp -98.08 120.93 39.35 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.034 0.445 . . . . 61.13 110.063 177.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 215' ' ' LEU . 5.5 m -111.26 174.41 5.88 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 125.083 1.353 . . . . 70.23 107.382 175.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.42 ' H ' HG22 ' A' ' 214' ' ' THR . 76.1 mt -59.44 -35.17 73.51 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 113.118 0.785 . . . . 74.34 113.118 -171.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -90.6 -19.11 24.07 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.207 0.603 . . . . 74.22 111.279 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 147.04 -158.88 27.87 Favored Glycine 0 C--N 1.353 1.502 0 CA-C-O 119.824 -0.431 . . . . 65.34 113.324 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.9 143.91 29.99 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.496 2.797 . . . . 70.22 113.498 -173.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 31.2 m -133.25 161.45 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.106 0.962 . . . . 71.33 110.084 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -95.57 110.92 22.94 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.747 0.819 . . . . 74.35 109.656 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 54.5 t -96.52 111.28 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.574 1.149 . . . . 72.05 108.159 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.54 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . . . -73.72 95.8 2.42 Favored 'General case' 0 C--N 1.349 0.568 0 N-CA-C 109.34 -0.615 . . . . 73.44 109.34 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 53.6 t -64.31 132.09 95.24 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 124.468 1.107 . . . . 72.42 110.279 -173.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.74 166.71 28.66 Favored 'Trans proline' 0 CA--C 1.559 1.729 0 C-N-CA 122.668 2.246 . . . . 74.33 112.213 170.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.29 167.03 28.12 Favored 'Trans proline' 0 C--N 1.372 1.798 0 C-N-CA 121.822 1.682 . . . . 74.04 112.057 173.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 65.37 19.18 11.57 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.718 1.207 . . . . 73.45 112.157 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.544 ' HA ' ' CZ ' ' A' ' 176' ' ' TYR . 79.1 m -66.87 101.19 0.8 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.187 0.595 . . . . 42.33 110.659 -176.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -101.96 143.09 32.26 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 125.605 1.562 . . . . 71.02 110.596 -174.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -68.87 145.04 54.05 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 123.927 0.891 . . . . 64.1 111.166 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.06 -12.73 68.71 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.247 -0.888 . . . . 41.34 112.446 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.543 HH11 ' HE1' ' A' ' 176' ' ' TYR . 87.6 mtt180 -85.13 154.67 21.87 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.329 0.652 . . . . 72.35 110.415 175.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.552 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.3 mppt? -130.29 139.48 50.73 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.25 -1.019 . . . . 74.1 108.25 -178.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.673 HD21 ' CE2' ' A' ' 176' ' ' TYR . 26.1 mt -110.77 100.63 9.35 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 122.9 0.48 . . . . 61.24 109.829 -172.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -71.12 101.86 2.36 Favored 'General case' 0 CA--C 1.552 1.038 0 O-C-N 124.003 0.814 . . . . 75.21 110.01 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 11.8 mt -106.45 107.77 18.95 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.303 0.641 . . . . 64.0 109.283 -175.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -61.15 150.6 33.73 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.507 0.558 . . . . 70.55 112.507 176.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.78 24.78 61.6 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.483 -0.781 . . . . 72.52 114.004 171.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 249' ' ' LEU . 11.1 mmtp -119.83 -44.26 2.53 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.18 0.592 . . . . 72.31 109.578 -176.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -77.53 -177.01 45.97 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-N 115.352 -0.84 . . . . 74.22 112.727 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -64.83 150.87 94.03 Favored Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 123.703 0.801 . . . . 75.32 112.512 -171.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.645 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 52.6 Cg_endo . . . . . 0 C--N 1.383 2.352 0 C-N-CA 122.642 2.228 . . . . 74.35 112.329 -177.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.645 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 14.1 mtm180 . . . . . 0 N--CA 1.473 0.697 0 CA-C-O 120.826 0.346 . . . . 72.24 110.076 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -93.3 175.66 36.39 Favored Glycine 0 C--N 1.339 0.747 0 CA-C-N 115.658 -0.701 . . . . 61.1 113.451 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -99.61 170.37 8.63 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.215 1.006 . . . . 65.32 109.619 -176.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 238' ' ' LYS . 32.0 tp -141.88 118.88 11.25 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.292 -0.633 . . . . 74.12 109.292 172.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.552 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 13.9 m-85 -88.69 109.41 20.1 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.748 -0.834 . . . . 74.44 108.748 -178.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 30.2 mt -85.97 108.57 18.27 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.93 -0.767 . . . . 74.31 108.93 176.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 196' ' ' THR . 30.4 mt-10 -77.31 97.16 4.78 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 114.421 -1.263 . . . . 75.13 109.405 -174.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 65.6 t -60.67 105.16 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 O-C-N 123.765 0.665 . . . . 64.34 110.752 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -116.02 102.22 9.45 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 106.988 -1.486 . . . . 74.12 106.988 174.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.525 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 51.3 mt -81.52 131.63 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 116.111 -0.495 . . . . 75.24 110.843 -174.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 21.3 p . . . . . 0 CA--C 1.563 1.452 0 C-N-CA 124.537 1.135 . . . . 73.34 108.422 177.267 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 111.023 0.009 . . . . 31.41 111.023 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.567 ' CE2' HD21 ' A' ' 233' ' ' LEU . 25.3 m-85 . . . . . 0 N--CA 1.491 1.589 0 C-N-CA 124.44 1.096 . . . . 74.3 110.15 -160.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 CA--C 1.541 0.63 0 CA-C-O 121.11 0.481 . . . . 71.14 109.809 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.43 131.64 41.25 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 114.563 -1.199 . . . . 71.4 110.204 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 96.4 mt -135.8 155.49 50.27 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.81 0.844 . . . . 73.04 110.239 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -116.4 145.34 43.32 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.091 0.957 . . . . 62.03 109.17 172.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -150.1 136.76 19.15 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.31 0.644 . . . . 65.3 109.504 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 86.6 m -69.19 138.77 54.34 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.216 0.606 . . . . 64.55 110.353 175.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.523 HD13 HD13 ' A' ' 251' ' ' LEU . 45.3 tp -120.14 112.45 19.11 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 107.657 -1.238 . . . . 71.15 107.657 174.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -95.68 117.0 29.67 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.743 -0.836 . . . . 54.41 108.743 -178.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.9 p -142.32 129.07 11.03 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.019 0.928 . . . . 72.04 109.364 -176.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.08 155.58 61.25 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 121.792 1.662 . . . . 41.42 111.791 175.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -48.63 -46.69 71.54 Favored Pre-proline 0 N--CA 1.487 1.402 0 N-CA-C 114.522 1.304 . . . . 64.51 114.522 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.441 ' O ' HG12 ' A' ' 206' ' ' VAL . 19.7 Cg_endo -57.74 -55.13 2.59 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 121.418 1.412 . . . . 73.23 112.802 176.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 58.9 mt -65.2 -29.52 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 123.426 0.69 . . . . 43.2 111.277 -177.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.8 -53.22 28.79 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.052 0.541 . . . . 61.24 111.03 -178.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 89.9 t -67.39 -55.17 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 115.642 -0.708 . . . . 71.32 110.956 -176.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.441 HG12 ' O ' ' A' ' 202' ' ' PRO . 7.7 p -77.12 -22.89 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 N-CA-C 112.268 0.47 . . . . 73.4 112.268 -173.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.41 139.01 8.19 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-O 120.1 -0.278 . . . . 43.04 112.622 -177.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -171.83 -145.48 4.9 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 116.753 0.276 . . . . 42.12 113.116 -178.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.515 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 96.4 mttt -133.76 132.7 40.85 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.963 0.905 . . . . 71.14 109.131 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.413 HG22 HG21 ' A' ' 223' ' ' VAL . 34.9 m -131.88 164.94 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-O 121.135 0.493 . . . . 61.41 110.716 177.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -75.45 141.34 43.16 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.082 -0.963 . . . . 64.52 110.645 174.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -141.47 157.55 45.0 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.727 0.811 . . . . 52.55 110.045 173.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 55.4 ttp -81.91 129.65 34.83 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.151 0.58 . . . . 72.32 110.72 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 89.5 m -143.61 166.96 23.38 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 124.418 1.087 . . . . 73.42 108.251 176.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 96.4 mt -56.6 -27.9 59.16 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.751 0.82 . . . . 75.22 112.458 174.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.46 14.56 3.61 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.826 0.85 . . . . 62.52 111.663 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 85.2 -148.75 23.34 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 111.192 -0.763 . . . . 41.01 111.192 -175.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.66 129.19 13.32 Favored 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 122.412 2.075 . . . . 62.05 111.327 174.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.2 m -122.21 155.87 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.726 0.811 . . . . 63.0 109.78 178.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -97.24 104.76 16.81 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.896 -0.779 . . . . 75.32 108.896 176.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.6 t -96.41 130.56 44.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 124.04 0.936 . . . . 73.14 109.829 -176.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.515 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . . . -77.48 101.93 6.67 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.322 0.649 . . . . 65.35 110.191 178.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.413 HG21 HG22 ' A' ' 210' ' ' VAL . 50.2 t -91.43 126.0 56.02 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 124.303 1.041 . . . . 64.41 109.959 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.7 172.6 9.18 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 123.665 2.91 . . . . 74.2 112.452 178.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.63 -179.41 1.98 Allowed 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 121.853 1.702 . . . . 73.51 112.154 166.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 68.86 5.29 4.91 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 125.28 1.432 . . . . 74.42 112.473 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.451 ' HA ' ' CZ ' ' A' ' 176' ' ' TYR . 90.5 m -67.05 114.34 5.75 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.374 0.607 . . . . 72.45 110.933 -171.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.429 ' HA ' HD11 ' A' ' 255' ' ' ILE . 6.7 tp-100 -125.77 139.53 53.44 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 124.033 0.933 . . . . 51.13 110.464 -165.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.426 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -61.39 134.24 56.7 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.999 0.92 . . . . 75.31 112.826 -171.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.85 -2.35 85.74 Favored Glycine 0 N--CA 1.474 1.203 0 CA-C-N 115.883 -0.599 . . . . 64.01 113.663 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -89.67 146.91 24.19 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.327 -0.62 . . . . 51.44 109.327 173.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -126.73 138.69 53.42 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.791 0.836 . . . . 73.33 108.97 -172.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.567 HD21 ' CE2' ' A' ' 176' ' ' TYR . 40.6 mt -113.53 109.02 17.97 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.073 -0.512 . . . . 62.1 111.008 -163.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -70.64 102.61 2.32 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 124.62 1.2 . . . . 73.54 109.806 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 33.0 mt -109.4 91.7 3.75 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.322 -0.622 . . . . 63.35 109.322 178.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.556 ' HG2' ' HB3' ' A' ' 248' ' ' ASP . 45.4 mtmt -70.13 143.53 52.32 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 122.851 0.46 . . . . 63.12 110.721 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.36 34.34 45.8 Favored Glycine 0 C--N 1.346 1.111 0 O-C-N 123.875 0.734 . . . . 72.34 112.067 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -131.26 -34.12 1.44 Allowed 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.005 0.922 . . . . 74.03 110.386 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -74.03 -163.24 9.05 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-N 116.304 -0.407 . . . . 42.32 113.581 175.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -71.26 149.52 94.2 Favored Pre-proline 0 N--CA 1.484 1.242 0 C-N-CA 122.835 0.454 . . . . 73.3 111.438 -176.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo . . . . . 0 C--N 1.377 2.031 0 C-N-CA 122.918 2.412 . . . . 73.41 112.512 173.422 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 . . . . . 0 C--O 1.244 0.811 0 N-CA-C 109.252 -0.648 . . . . 74.01 109.252 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.96 -164.95 22.02 Favored Glycine 0 C--N 1.341 0.84 0 O-C-N 123.775 0.672 . . . . 52.4 113.663 -177.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.556 ' HB3' ' HG2' ' A' ' 236' ' ' LYS . 1.2 p-10 -113.52 132.81 55.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.589 0.709 . . . . 73.0 111.957 -168.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 42.0 tp -98.57 117.83 33.88 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.014 -1.448 . . . . 70.55 108.502 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -88.5 109.7 20.26 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 122.848 0.459 . . . . 74.32 109.939 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.523 HD13 HD13 ' A' ' 197' ' ' LEU . 31.8 mt -86.96 106.12 17.59 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.174 -0.676 . . . . 73.2 109.174 175.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -78.16 105.34 9.32 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 115.635 -0.711 . . . . 74.4 109.411 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 65.2 t -56.44 118.04 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 123.762 0.825 . . . . 74.34 111.014 176.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -117.3 94.77 4.69 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 107.799 -1.186 . . . . 74.34 107.799 175.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.429 HD11 ' HA ' ' A' ' 228' ' ' GLN . 14.5 mt -76.03 123.96 33.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 O-C-N 124.006 0.816 . . . . 75.32 109.779 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 37.4 p . . . . . 0 CA--C 1.557 1.239 0 CA-C-O 117.489 -1.243 . . . . 71.54 108.167 174.543 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.864 0 CA-C-O 120.533 0.206 . . . . 74.12 111.383 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 . . . . . 0 N--CA 1.486 1.368 0 C-N-CA 125.043 1.337 . . . . 74.31 111.837 -164.915 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.213 0.53 . . . . 75.22 110.477 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -75.53 138.31 41.44 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.055 -0.975 . . . . 73.33 108.909 173.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.7 mt -129.49 168.98 15.55 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.154 0.582 . . . . 73.42 111.033 -172.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -120.49 141.91 49.77 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 124.637 1.175 . . . . 74.4 108.258 172.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -153.83 128.22 9.19 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.172 0.989 . . . . 73.35 108.36 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . 0.415 ' HA ' ' HB2' ' A' ' 252' ' ' GLU . 92.9 m -72.87 135.06 45.07 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.084 0.553 . . . . 73.15 111.595 -175.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 40.5 tp -114.35 113.73 24.94 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.768 1.227 . . . . 73.24 108.343 178.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -89.25 116.43 27.47 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.09 -0.707 . . . . 53.3 109.09 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 7.0 p -136.38 133.26 19.24 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 108.283 -1.006 . . . . 72.34 108.283 -174.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . 0.479 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 72.2 Cg_endo -74.84 161.85 38.46 Favored 'Trans proline' 0 C--N 1.37 1.658 0 C-N-CA 121.899 1.732 . . . . 64.32 111.892 175.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.05 -51.66 59.92 Favored Pre-proline 0 CA--C 1.569 1.696 0 N-CA-C 113.893 1.071 . . . . 74.01 113.893 177.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 23.1 Cg_endo -60.5 -52.48 3.85 Favored 'Trans proline' 0 C--N 1.399 3.221 0 C-N-CA 122.068 1.845 . . . . 74.0 112.926 -178.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 61.0 mt -64.26 -28.63 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 123.476 0.71 . . . . 75.43 111.447 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.23 -48.51 75.53 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.937 0.398 . . . . 75.33 111.234 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 61.7 t -71.37 -52.41 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.192 0 CA-C-N 116.099 -0.501 . . . . 70.32 112.18 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 202' ' ' PRO . 11.4 p -85.11 -31.73 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 112.395 0.517 . . . . 63.4 112.395 -172.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 100.39 149.94 24.11 Favored Glycine 0 N--CA 1.471 0.974 0 CA-C-N 116.45 -0.341 . . . . 62.22 112.372 -173.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 162.42 173.78 31.51 Favored Glycine 0 C--N 1.34 0.782 0 N-CA-C 111.788 -0.525 . . . . 72.42 111.788 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -81.15 134.79 35.7 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 116.993 0.396 . . . . 75.23 110.094 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 25.7 m -123.28 167.84 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.488 0.715 . . . . 62.13 110.48 173.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 -81.5 105.31 12.56 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.705 -1.134 . . . . 70.44 108.975 172.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.69 144.0 32.32 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.6 0.76 . . . . 72.33 109.43 175.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 41.4 ttm -86.91 115.66 24.46 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.192 0.52 . . . . 74.3 110.512 -177.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 9.2 m -116.15 162.57 17.24 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.626 1.17 . . . . 72.03 107.901 176.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 96.0 mt -56.8 -35.63 68.96 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.227 0.611 . . . . 75.21 112.349 -177.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -78.55 -20.06 51.48 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.047 0.539 . . . . 73.35 111.537 -177.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 142.13 -171.8 24.42 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 116.16 -0.473 . . . . 60.51 112.337 -176.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.52 129.07 14.24 Favored 'Trans proline' 0 C--N 1.365 1.441 0 C-N-CA 123.022 2.482 . . . . 73.41 111.463 177.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.73 159.93 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 123.723 0.809 . . . . 54.1 109.549 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -91.18 111.18 22.54 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.36 0.664 . . . . 71.3 109.661 174.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 93.2 t -107.58 120.99 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.24 1.016 . . . . 74.13 108.903 177.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.48 98.87 2.86 Favored 'General case' 0 C--N 1.348 0.509 0 C-N-CA 122.989 0.515 . . . . 72.52 109.959 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 62.2 t -78.03 136.15 62.18 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 124.534 1.134 . . . . 64.3 109.173 177.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -76.77 173.22 14.83 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.998 2.465 . . . . 74.13 111.201 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.49 179.52 1.24 Allowed 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 121.972 1.781 . . . . 74.44 112.197 166.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 27.8 mtt-85 71.23 0.05 3.28 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 125.184 1.394 . . . . 71.43 112.355 176.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 95.4 m -65.76 106.33 1.48 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.185 0.594 . . . . 54.53 110.712 -170.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.483 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 60.5 tp60 -115.1 141.45 47.99 Favored 'General case' 0 C--N 1.35 0.596 0 CA-C-N 115.054 -0.975 . . . . 72.11 110.329 -170.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.99 139.83 58.81 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.344 1.057 . . . . 54.12 111.513 -175.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 91.7 -27.21 10.13 Favored Glycine 0 C--N 1.344 0.978 0 O-C-N 123.836 0.71 . . . . 42.22 112.791 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.483 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 78.5 mtt180 -77.2 160.64 28.79 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.013 0.525 . . . . 72.01 110.413 176.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 2.8 mppt? -130.1 144.93 51.62 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.205 0.602 . . . . 71.44 109.653 -176.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.429 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 12.8 mt -97.9 104.44 16.47 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 115.738 -0.664 . . . . 74.24 109.269 -176.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 54.0 ttm-85 -71.51 105.74 3.72 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 123.873 0.733 . . . . 75.02 110.292 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 27.8 mt -112.26 94.59 5.0 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.18 0.592 . . . . 74.41 109.43 -178.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -65.74 143.81 57.29 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.32 0.248 . . . . 73.43 111.346 178.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 85.07 12.83 73.02 Favored Glycine 0 C--N 1.346 1.125 0 O-C-N 123.956 0.785 . . . . 53.34 113.707 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -110.78 -27.23 8.96 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 117.28 0.54 . . . . 74.13 110.539 -178.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -75.33 -167.69 21.93 Favored Glycine 0 C--N 1.352 1.469 0 O-C-N 123.473 0.483 . . . . 24.0 113.076 171.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 241' ' ' PRO . 71.2 m-85 -70.44 144.37 91.64 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 123.414 0.685 . . . . 75.4 112.847 -171.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 240' ' ' PHE . 13.7 Cg_exo . . . . . 0 C--N 1.379 2.14 0 C-N-CA 123.443 2.762 . . . . 72.14 111.856 173.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 110.447 -0.205 . . . . 53.52 110.447 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.3 167.8 52.91 Favored Glycine 0 C--N 1.348 1.235 0 O-C-N 123.669 0.605 . . . . 22.42 113.877 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -112.67 133.08 54.87 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.38 1.072 . . . . 72.45 110.137 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 40.2 tp -99.24 122.42 42.39 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.339 1.055 . . . . 73.11 108.808 -174.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.474 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 3.8 m-85 -89.6 110.14 21.03 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.485 -0.932 . . . . 72.22 108.485 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.447 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 27.8 mt -86.86 104.99 16.73 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.646 -0.872 . . . . 74.44 108.646 173.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.415 ' HB2' ' HA ' ' A' ' 196' ' ' THR . 32.5 mt-10 -77.88 97.33 5.24 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.68 -1.146 . . . . 71.3 109.46 -171.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 59.0 t -58.95 114.93 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 114.94 -1.027 . . . . 73.24 111.459 -177.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -116.86 95.97 5.26 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.74 -1.208 . . . . 75.42 107.74 171.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.466 HD11 ' HA ' ' A' ' 228' ' ' GLN . 50.8 mt -75.53 126.88 36.79 Favored 'Isoleucine or valine' 0 C--N 1.35 0.594 0 CA-C-N 115.376 -0.829 . . . . 75.11 108.955 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 14.5 p . . . . . 0 C--O 1.252 1.192 0 C-N-CA 124.79 1.236 . . . . 74.44 108.159 177.995 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 121.042 0.449 . . . . 73.41 109.888 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 28.6 p -154.39 109.8 3.14 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.504 0.721 . . . . 64.33 109.499 -177.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -91.25 -178.02 5.03 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.457 0.703 . . . . 65.22 109.73 172.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 79.8 mt -68.59 102.44 1.48 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.307 -0.627 . . . . 72.24 109.307 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 4.1 tpm_? -62.98 117.17 6.06 Favored 'General case' 0 C--O 1.242 0.658 0 O-C-N 124.062 0.851 . . . . 65.52 110.756 -177.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.918 ' HA ' HD22 ' A' ' 235' ' ' LEU . 29.8 mt -86.5 97.02 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 121.356 0.598 . . . . 63.11 110.498 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -83.98 -2.95 57.56 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.907 -1.042 . . . . 75.45 111.344 176.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -83.11 171.67 13.48 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.625 0.77 . . . . 75.3 111.451 177.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.4 ' HE1' ' HA ' ' A' ' 227' ' ' THR . 3.3 m-30 67.65 22.5 9.02 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.409 1.084 . . . . 74.34 112.33 176.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -137.91 68.73 0.51 Allowed Glycine 0 C--N 1.339 0.739 0 N-CA-C 110.096 -1.202 . . . . 72.25 110.096 168.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -66.97 98.37 0.43 Allowed 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.705 2.27 . . . . 72.34 111.274 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 41.6 t60 -147.12 98.24 3.0 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.805 -0.634 . . . . 72.12 109.382 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -77.39 133.7 13.61 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 115.827 -0.624 . . . . 63.44 111.927 175.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 13.6 t -160.25 -171.56 3.24 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.579 0.752 . . . . 54.15 109.164 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -78.73 69.07 2.91 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-N 118.236 0.471 . . . . 72.41 113.222 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -147.59 166.19 28.72 Favored Glycine 0 N--CA 1.472 1.039 0 N-CA-C 111.362 -0.695 . . . . 61.1 111.362 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 37.7 m -78.79 83.96 4.89 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.381 0.673 . . . . 75.34 111.594 -175.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.612 ' HA2' ' HE2' ' A' ' 236' ' ' LYS . . . -106.26 -64.67 0.63 Allowed Glycine 0 C--N 1.337 0.623 0 N-CA-C 110.7 -0.96 . . . . 75.1 110.7 173.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 72.39 -175.48 43.15 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.487 -0.356 . . . . 72.44 112.312 -176.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 57.2 p -78.72 -13.45 59.81 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.359 0.663 . . . . 61.41 111.115 175.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 176.56 170.91 39.71 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 111.368 -0.693 . . . . 44.42 111.368 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -84.53 -173.5 49.86 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 122.809 0.242 . . . . 54.25 112.686 175.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 32.7 m -71.8 -80.35 0.06 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.173 0.589 . . . . 72.43 111.144 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 -106.5 74.26 1.01 Allowed 'General case' 0 C--O 1.244 0.805 0 N-CA-C 108.084 -1.08 . . . . 54.21 108.084 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -78.67 140.83 38.33 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 113.569 -1.651 . . . . 75.42 109.699 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 82.5 mt -136.66 140.66 42.9 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.901 0.48 . . . . 63.42 110.318 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -93.88 122.96 36.9 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.385 -0.825 . . . . 64.31 108.804 174.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -123.51 127.75 48.79 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 107.445 -1.316 . . . . 62.25 107.445 176.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . 0.402 ' HA ' ' HB2' ' A' ' 252' ' ' GLU . 25.1 m -68.48 123.61 21.29 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.19 0.596 . . . . 63.31 110.452 -175.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 29.8 tp -108.36 111.62 23.63 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.604 -0.887 . . . . 75.21 108.604 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -81.97 126.17 31.64 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.404 -0.962 . . . . 73.51 108.404 174.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.484 HG11 HG13 ' A' ' 253' ' ' VAL . 6.4 p -142.68 130.3 11.2 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 108.305 -0.998 . . . . 25.2 108.305 178.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.41 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 57.6 Cg_endo -73.85 155.57 48.56 Favored 'Trans proline' 0 C--N 1.363 1.307 0 C-N-CA 121.678 1.585 . . . . 61.04 110.666 172.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.81 -48.27 88.12 Favored Pre-proline 0 CA--C 1.56 1.35 0 C-N-CA 123.917 0.887 . . . . 60.44 113.08 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.468 ' O ' HG12 ' A' ' 206' ' ' VAL . 78.0 Cg_exo -52.57 -56.12 3.15 Favored 'Trans proline' 0 C--N 1.396 3.03 0 C-N-CA 122.453 2.102 . . . . 64.02 113.57 175.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 59.8 mt -65.09 -28.97 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 123.406 0.683 . . . . 75.3 111.077 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.54 -49.27 71.9 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.091 0.472 . . . . 54.14 111.052 177.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 65.9 t -73.98 -47.57 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 115.955 -0.566 . . . . 74.3 112.496 -173.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 202' ' ' PRO . 13.6 p -88.49 -22.2 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 O-C-N 122.233 -0.292 . . . . 61.44 111.34 -175.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 87.72 166.38 42.36 Favored Glycine 0 C--N 1.342 0.882 0 N-CA-C 111.533 -0.627 . . . . 51.3 111.533 -171.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 162.71 -128.15 1.82 Allowed Glycine 0 C--O 1.226 -0.359 0 N-CA-C 111.213 -0.755 . . . . 63.35 111.213 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.404 ' HD2' ' HB3' ' A' ' 220' ' ' GLU . 48.6 mtmt -137.65 151.48 48.32 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 108.712 -0.847 . . . . 73.11 108.712 173.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 26.6 m -138.37 162.3 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.075 0.55 . . . . 73.14 110.109 172.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 -84.42 115.43 22.53 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.456 -0.793 . . . . 75.03 109.854 174.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -106.79 156.76 18.32 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.716 0.806 . . . . 71.54 109.594 173.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 43.2 tpp -93.08 125.53 37.72 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.883 0.473 . . . . 65.32 109.874 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.442 HG22 ' H ' ' A' ' 216' ' ' GLU . 61.1 m -137.8 160.78 38.32 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.692 1.197 . . . . 75.11 108.044 -178.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 92.5 mt -65.95 -20.85 66.35 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.143 0.577 . . . . 64.1 111.788 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.442 ' H ' HG22 ' A' ' 214' ' ' THR . 13.5 mm-40 -80.02 -17.49 52.67 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.004 0.922 . . . . 74.12 110.95 174.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 125.0 -156.78 19.07 Favored Glycine 0 C--N 1.343 0.95 0 N-CA-C 111.449 -0.66 . . . . 32.44 111.449 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.9 121.07 6.04 Favored 'Trans proline' 0 C--N 1.363 1.3 0 C-N-CA 122.382 2.055 . . . . 70.23 111.607 173.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 32.7 m -111.26 155.91 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.244 0.617 . . . . 75.34 109.837 177.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.404 ' HB3' ' HD2' ' A' ' 209' ' ' LYS . 49.8 mt-10 -94.14 113.85 25.87 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.19 -0.67 . . . . 73.03 109.19 175.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 92.2 t -97.26 117.56 42.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 N-CA-C 108.647 -0.872 . . . . 74.54 108.647 175.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.25 100.35 0.79 Allowed 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.474 0.484 . . . . 74.23 109.956 176.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 91.4 t -72.75 131.72 83.93 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 123.495 0.718 . . . . 75.21 109.754 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.33 165.92 31.25 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.266 1.977 . . . . 72.23 110.979 171.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -67.4 174.58 7.05 Favored 'Trans proline' 0 CA--C 1.551 1.374 0 C-N-CA 121.688 1.592 . . . . 65.41 112.818 170.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 69.91 0.32 3.01 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 125.374 1.47 . . . . 75.31 113.514 173.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.454 HG22 HG11 ' A' ' 253' ' ' VAL . 47.4 m -62.24 126.83 28.69 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.119 0.968 . . . . 75.03 111.781 -170.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.415 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 57.9 tp60 -124.4 143.2 50.75 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.816 0.846 . . . . 72.25 111.03 -167.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.86 131.75 51.66 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.904 1.282 . . . . 71.51 111.813 -178.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 99.4 -18.04 56.94 Favored Glycine 0 N--CA 1.473 1.116 0 O-C-N 123.705 0.628 . . . . 52.22 112.951 177.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.415 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 80.5 mtt180 -83.12 135.87 34.66 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.074 -0.714 . . . . 64.44 109.074 174.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.2 mppt? -102.11 131.78 48.4 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.192 -0.67 . . . . 71.43 109.192 176.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.509 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 29.0 mt -77.46 97.78 5.09 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.88 -1.155 . . . . 74.01 107.88 174.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -74.17 103.91 4.77 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.151 0.581 . . . . 74.55 110.18 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.918 HD22 ' HA ' ' A' ' 173' ' ' ILE . 7.4 mt -102.23 91.09 4.14 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.054 -1.091 . . . . 72.34 108.054 -177.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.612 ' HE2' ' HA2' ' A' ' 185' ' ' GLY . 26.0 mtpp -66.6 129.44 39.85 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.843 -0.617 . . . . 71.43 112.221 -172.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 95.5 -16.66 60.81 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 115.639 -0.709 . . . . 64.03 113.113 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.542 ' HA ' ' HE2' ' A' ' 238' ' ' LYS . 11.3 mmpt? -81.57 -12.63 58.71 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.324 0.649 . . . . 73.55 112.06 -176.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -79.5 -172.68 43.58 Favored Glycine 0 CA--C 1.535 1.339 0 N-CA-C 112.106 -0.398 . . . . 72.13 112.106 168.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -86.31 153.06 56.19 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 123.005 0.522 . . . . 75.03 111.451 -174.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.46 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 48.0 Cg_endo -66.17 154.89 72.35 Favored 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 123.019 2.479 . . . . 72.22 112.708 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -177.89 -155.75 14.86 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-O 119.061 -0.855 . . . . 44.31 112.904 -178.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -48.98 -53.97 6.17 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 124.551 3.501 . . . . 71.01 114.992 -175.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -83.82 -3.11 57.6 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.398 0.679 . . . . 63.12 112.324 -173.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 127.61 -93.88 0.39 Allowed Glycine 0 C--N 1.343 0.947 0 N-CA-C 111.043 -0.823 . . . . 72.02 111.043 -178.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 77.9 mtt180 -127.44 159.29 34.94 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.926 0.89 . . . . 75.24 110.079 172.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -84.35 173.0 49.58 Favored Glycine 0 C--N 1.349 1.257 0 N-CA-C 114.014 0.366 . . . . 71.42 114.014 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -106.83 134.11 50.47 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.62 1.168 . . . . 75.4 109.007 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 32.7 tp -98.91 106.69 18.98 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.892 -0.781 . . . . 63.32 108.892 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.458 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 72.6 m-85 -88.76 107.52 19.0 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.361 0.664 . . . . 74.33 109.68 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.509 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 43.3 mt -88.08 108.47 19.26 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 108.787 -0.82 . . . . 75.12 108.787 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.402 ' HB2' ' HA ' ' A' ' 196' ' ' THR . 34.8 mt-10 -76.79 99.89 5.29 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.263 -0.88 . . . . 62.02 109.813 -171.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.484 HG13 HG11 ' A' ' 199' ' ' VAL . 95.0 t -61.69 106.48 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 123.228 0.611 . . . . 54.25 111.071 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -109.38 95.09 5.39 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.198 0.999 . . . . 73.23 108.521 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 21.8 mt -76.18 113.9 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 123.264 0.625 . . . . 72.43 109.453 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 23.8 p . . . . . 0 C--O 1.249 1.044 0 C-N-CA 124.664 1.186 . . . . 72.41 110.256 -178.748 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 92.9 mtp . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.404 0.145 . . . . 71.21 110.789 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.5 m -62.14 105.29 0.57 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.748 1.219 . . . . 75.44 112.524 -173.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 56.68 20.61 5.17 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.29 1.436 . . . . 74.11 113.559 171.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 86.6 mt -85.32 76.52 10.12 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-O 122.109 0.957 . . . . 75.11 108.479 174.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 33.5 mtm105 -119.98 155.17 33.37 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 113.895 -1.502 . . . . 73.42 108.047 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.724 HG22 ' H ' ' A' ' 175' ' ' ALA . 77.1 mt -87.32 -74.78 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 109.845 -0.428 . . . . 64.53 109.845 177.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . 55.93 19.36 3.55 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.124 0.97 . . . . 55.03 113.019 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.724 ' H ' HG22 ' A' ' 173' ' ' ILE . . . -87.04 12.19 11.94 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.837 0.855 . . . . 54.43 111.462 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.675 ' HB3' HH21 ' A' ' 226' ' ' ARG . 34.7 m-85 -92.76 65.94 4.29 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.909 -0.774 . . . . 53.54 108.909 166.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 145.74 162.35 9.65 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-N 114.485 -1.234 . . . . 51.42 111.233 -174.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -71.79 142.71 39.93 Favored 'Trans proline' 0 C--N 1.364 1.367 0 C-N-CA 122.905 2.403 . . . . 73.05 112.825 -173.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -79.65 -38.23 34.19 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.518 -0.549 . . . . 72.42 109.518 173.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 131.25 73.43 0.11 Allowed Glycine 0 C--N 1.344 0.983 0 CA-C-N 115.339 -0.846 . . . . 71.52 111.134 -175.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 56.9 p -61.32 92.3 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.328 1.051 . . . . 55.11 111.399 -176.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -161.75 -71.91 0.02 OUTLIER Glycine 0 C--N 1.34 0.801 0 N-CA-C 110.807 -0.917 . . . . 72.02 110.807 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -89.83 150.54 21.14 Favored Glycine 0 C--N 1.345 1.039 0 N-CA-C 111.002 -0.839 . . . . 75.2 111.002 174.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.419 ' HB2' ' HB1' ' A' ' 244' ' ' ALA . 90.7 p 49.81 89.28 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.276 1.43 . . . . 42.03 111.922 -175.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -95.23 -132.32 6.85 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 112.116 -0.394 . . . . 60.13 112.116 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -150.57 34.53 0.97 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 112.048 -0.421 . . . . 70.03 112.048 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 22.5 p -79.43 107.51 12.26 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 108.893 -0.781 . . . . 64.41 108.893 175.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.39 17.83 70.36 Favored Glycine 0 N--CA 1.473 1.13 0 N-CA-C 111.504 -0.638 . . . . 43.23 111.504 -166.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.441 ' HA2' HE22 ' A' ' 191' ' ' GLN . . . -91.76 67.39 2.15 Favored Glycine 0 C--N 1.348 1.198 0 N-CA-C 111.847 -0.501 . . . . 74.01 111.847 -177.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 16.3 m -110.95 16.18 21.36 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.574 0.75 . . . . 54.14 110.86 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.571 ' HB2' ' HB2' ' A' ' 240' ' ' PHE . 0.0 OUTLIER -112.7 13.55 19.87 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.585 1.154 . . . . 75.22 110.407 -172.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -75.48 143.08 42.77 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.349 1.06 . . . . 73.22 110.397 177.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 82.5 mt -121.13 146.96 46.21 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.721 0.409 . . . . 72.41 110.678 -171.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -93.76 149.71 21.01 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 109.438 -0.578 . . . . 71.05 109.438 171.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.461 ' HB3' HD23 ' A' ' 251' ' ' LEU . . . -144.54 127.99 16.94 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.589 0.755 . . . . 72.34 109.003 -177.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 38.5 m -71.31 117.8 13.31 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 122.943 0.497 . . . . 43.51 109.946 -176.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 41.5 tp -108.0 109.91 21.49 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.604 -0.887 . . . . 53.0 108.604 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -92.3 112.53 24.51 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.44 0.696 . . . . 65.34 109.156 175.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.409 ' HA ' HG11 ' A' ' 210' ' ' VAL . 7.0 p -130.24 128.99 22.82 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 124.305 1.042 . . . . 53.35 108.956 -178.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.406 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 41.7 Cg_endo -70.26 155.11 65.02 Favored 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.004 1.803 . . . . 75.31 111.836 176.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -48.41 -46.49 68.95 Favored Pre-proline 0 CA--C 1.566 1.566 0 N-CA-C 114.79 1.404 . . . . 61.5 114.79 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.48 ' O ' HG12 ' A' ' 206' ' ' VAL . 25.7 Cg_endo -61.86 -52.69 2.7 Favored 'Trans proline' 0 C--N 1.393 2.921 0 CA-C-N 121.114 1.433 . . . . 64.53 112.888 176.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 50.7 mt -64.93 -24.61 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 123.574 0.749 . . . . 73.04 110.952 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.47 ' HB1' ' O ' ' A' ' 227' ' ' THR . . . -68.66 -55.1 12.58 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.578 0.751 . . . . 71.24 111.34 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 76.6 t -66.76 -51.5 55.25 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-N 115.858 -0.61 . . . . 72.23 112.121 -175.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 202' ' ' PRO . 11.5 p -87.69 -25.96 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 N-CA-C 111.913 0.338 . . . . 60.31 111.913 -174.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 92.29 153.4 29.92 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 111.641 -0.584 . . . . 74.12 111.641 -171.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 178.76 -128.89 1.31 Allowed Glycine 0 C--N 1.33 0.235 0 CA-C-O 119.551 -0.583 . . . . 72.21 111.944 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -139.56 141.39 37.22 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.059 0.944 . . . . 73.42 110.144 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.409 HG11 ' HA ' ' A' ' 199' ' ' VAL . 30.8 m -135.14 167.57 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.963 0.905 . . . . 71.23 109.425 169.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -93.47 111.42 23.08 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.102 -0.703 . . . . 75.03 109.102 173.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -102.48 145.25 29.85 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.844 0.458 . . . . 64.32 110.065 175.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 87.4 mtp -88.02 104.47 16.68 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.653 -0.869 . . . . 72.24 108.653 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 215' ' ' LEU . 27.7 m -111.78 177.35 4.68 Favored 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 124.824 1.25 . . . . 70.31 108.315 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.414 ' H ' HG22 ' A' ' 214' ' ' THR . 82.6 mt -63.57 -19.32 64.72 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.461 0.704 . . . . 71.31 112.845 -177.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -87.48 6.48 33.88 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.375 0.67 . . . . 74.11 111.555 175.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 93.65 -153.32 21.21 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 119.406 -0.663 . . . . 61.3 111.641 -173.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -75.63 126.46 9.58 Favored 'Trans proline' 0 C--N 1.367 1.527 0 C-N-CA 122.339 2.026 . . . . 72.44 111.079 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.94 153.16 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 123.124 0.57 . . . . 54.45 111.217 -171.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -84.92 110.58 18.97 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.198 -0.667 . . . . 71.35 109.198 175.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 95.4 t -109.2 123.0 64.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 123.854 0.862 . . . . 70.3 110.18 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -77.37 101.24 6.26 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.512 0.725 . . . . 73.12 109.943 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.57 ' HA ' HD12 ' A' ' 173' ' ' ILE . 57.3 t -73.67 130.95 82.75 Favored Pre-proline 0 CA--C 1.561 1.38 0 C-N-CA 125.12 1.368 . . . . 63.52 110.142 177.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.709 ' HD3' ' HB ' ' A' ' 173' ' ' ILE . 63.8 Cg_endo -85.09 171.25 9.26 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 123.205 2.603 . . . . 74.04 111.032 174.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.04 166.35 21.09 Favored 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 121.689 1.593 . . . . 73.22 112.639 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.675 HH21 ' HB3' ' A' ' 176' ' ' TYR . 29.3 mtm180 71.72 11.59 6.35 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 125.636 1.574 . . . . 71.11 112.634 177.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.47 ' O ' ' HB1' ' A' ' 204' ' ' ALA . 94.1 m -65.54 91.62 0.13 Allowed 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 121.776 0.798 . . . . 73.23 110.16 -178.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.508 ' HA ' HD11 ' A' ' 255' ' ' ILE . 32.8 tt0 -107.75 144.3 35.08 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 114.771 -1.104 . . . . 74.24 110.396 -168.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -55.02 129.98 39.97 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.004 1.321 . . . . 74.43 111.986 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 88.93 -9.06 78.15 Favored Glycine 0 N--CA 1.475 1.251 0 CA-C-N 115.997 -0.547 . . . . 62.11 114.032 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -81.98 150.89 27.42 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.437 -0.579 . . . . 73.01 109.437 171.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.509 ' HG3' ' HA ' ' A' ' 252' ' ' GLU . 0.0 OUTLIER -129.85 141.81 50.77 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.796 0.808 . . . . 73.13 110.995 -176.047 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.659 HD13 HG21 ' A' ' 173' ' ' ILE . 14.9 mt -114.77 99.64 7.65 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 114.101 -1.409 . . . . 71.31 109.516 -162.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.543 ' HG3' ' HB3' ' A' ' 248' ' ' ASP . 52.1 ttp180 -76.78 102.54 6.31 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 123.516 0.51 . . . . 71.1 110.405 -175.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.53 HD21 HG23 ' A' ' 173' ' ' ILE . 21.9 mt -99.12 95.35 7.05 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.153 0.981 . . . . 74.44 108.443 176.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -66.64 148.06 52.42 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.64 0.776 . . . . 53.22 111.765 -176.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 72.67 30.93 63.29 Favored Glycine 0 CA--C 1.529 0.932 0 O-C-N 123.706 0.629 . . . . 75.43 113.513 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -130.12 -17.47 3.45 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 113.346 0.869 . . . . 74.43 113.346 -176.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -77.55 -152.82 5.54 Favored Glycine 0 N--CA 1.484 1.842 0 CA-C-N 118.028 0.376 . . . . 61.04 113.505 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.571 ' HB2' ' HB2' ' A' ' 191' ' ' GLN . 15.0 m-85 -69.12 155.34 93.76 Favored Pre-proline 0 N--CA 1.488 1.436 0 CA-C-O 118.595 -0.717 . . . . 73.31 110.152 172.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -50.49 129.41 26.35 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 123.024 2.482 . . . . 52.53 113.02 175.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -146.26 -163.84 10.59 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 119.389 -0.673 . . . . 73.24 112.961 -174.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -64.98 -31.18 56.34 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 123.521 2.814 . . . . 71.3 112.293 -177.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.419 ' HB1' ' HB2' ' A' ' 184' ' ' SER . . . -91.88 23.97 3.42 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.717 1.207 . . . . 74.35 110.793 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 89.58 -62.85 3.36 Favored Glycine 0 C--N 1.352 1.466 0 N-CA-C 110.413 -1.075 . . . . 64.25 110.413 -171.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -126.36 175.69 7.67 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 125.148 1.379 . . . . 73.25 109.512 169.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -89.25 -160.16 36.17 Favored Glycine 0 C--N 1.339 0.719 0 CA-C-N 115.291 -0.868 . . . . 72.35 111.89 172.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.543 ' HB3' ' HG3' ' A' ' 234' ' ' ARG . 3.4 m-20 -98.21 169.95 9.23 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.175 0.59 . . . . 74.35 109.61 -176.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 33.7 tp -139.67 106.19 5.33 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.62 -0.882 . . . . 64.22 108.62 174.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -88.7 113.38 24.2 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.197 0.599 . . . . 73.13 109.401 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.461 HD23 ' HB3' ' A' ' 195' ' ' ALA . 57.0 mt -85.14 112.74 20.96 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.364 -0.976 . . . . 73.05 108.364 175.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.509 ' HA ' ' HG3' ' A' ' 232' ' ' LYS . 13.8 tp10 -76.83 101.0 5.7 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.749 1.219 . . . . 70.25 108.088 -179.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.69 106.94 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.518 0.675 . . . . 63.15 110.476 -176.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -107.02 96.5 6.47 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 114.425 -1.261 . . . . 70.43 107.7 174.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.508 HD11 ' HA ' ' A' ' 228' ' ' GLN . 24.2 mt -76.13 123.54 32.52 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 N-CA-C 108.83 -0.804 . . . . 73.14 108.83 176.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 41.5 p . . . . . 0 CA--C 1.549 0.934 0 C-N-CA 124.785 1.234 . . . . 73.11 108.755 177.358 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 23.2 ptp . . . . . 0 N--CA 1.477 0.91 0 CA-C-O 120.935 0.398 . . . . 73.41 110.038 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 65.9 m -76.7 84.93 3.33 Favored 'General case' 0 C--N 1.35 0.601 0 CA-C-O 121.398 0.618 . . . . 65.34 109.965 176.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -109.57 86.5 2.3 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.952 0.901 . . . . 72.23 108.588 -177.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 5.4 mp -75.6 84.26 2.64 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.476 -0.784 . . . . 54.24 109.352 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -72.75 114.07 10.48 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 114.93 -1.032 . . . . 74.15 109.721 177.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.636 HG22 ' H ' ' A' ' 175' ' ' ALA . 73.3 mt -77.41 -83.91 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 109.509 -0.552 . . . . 63.01 109.509 176.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.468 ' HA ' ' HB3' ' A' ' 224' ' ' PRO . . . 48.31 26.63 1.14 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.429 1.092 . . . . 70.13 112.794 -176.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.636 ' H ' HG22 ' A' ' 173' ' ' ILE . . . -66.12 -17.36 64.66 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.325 1.05 . . . . 64.43 112.498 -167.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.18 92.72 0.78 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.02 -1.104 . . . . 73.53 108.02 169.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 150.6 -172.52 30.33 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-N 114.75 -1.113 . . . . 74.11 111.316 -174.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -87.48 39.91 0.6 Allowed 'Trans proline' 0 CA--C 1.552 1.377 0 C-N-CA 123.491 2.794 . . . . 74.51 112.64 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 30.2 m-70 -76.46 137.53 39.74 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.563 0.745 . . . . 73.25 111.324 -171.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 87.83 -75.95 2.03 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 115.232 -0.895 . . . . 70.02 111.665 -174.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 67.0 m -147.17 150.73 35.51 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.368 0.667 . . . . 35.21 110.517 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -114.86 42.61 1.88 Allowed Glycine 0 C--N 1.343 0.942 0 N-CA-C 110.918 -0.873 . . . . 74.4 110.918 175.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -90.3 141.77 16.07 Favored Glycine 0 C--N 1.346 1.103 0 N-CA-C 112.037 -0.425 . . . . 73.44 112.037 -177.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 41.8 m -76.98 107.57 9.42 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.412 0.685 . . . . 71.33 109.997 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 110.4 -145.66 17.25 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 115.845 -0.616 . . . . 63.22 111.696 -176.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -151.03 125.67 1.95 Allowed Glycine 0 C--N 1.346 1.114 0 N-CA-C 112.47 -0.252 . . . . 72.42 112.47 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 26.6 t -98.24 -178.31 4.0 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.516 0.726 . . . . 53.15 109.842 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 78.01 -91.51 1.11 Allowed Glycine 0 C--N 1.347 1.145 0 N-CA-C 111.011 -0.836 . . . . 73.15 111.011 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 77.73 127.9 0.4 Allowed Glycine 0 C--N 1.356 1.692 0 CA-C-O 119.54 -0.589 . . . . 52.54 112.621 177.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 40.5 m 75.2 -37.81 0.35 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 125.806 1.642 . . . . 72.33 111.253 -174.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.631 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 72.8 mt-30 -57.23 -22.73 43.11 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.686 1.195 . . . . 70.43 111.849 167.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -73.98 143.1 45.77 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.579 1.152 . . . . 54.13 110.683 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 95.2 mt -139.16 149.78 44.85 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.255 1.022 . . . . 62.01 109.942 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -111.54 128.47 56.04 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.305 1.042 . . . . 74.24 108.245 168.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -125.29 128.41 48.19 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.901 -0.777 . . . . 65.41 108.901 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 73.6 m -67.49 131.93 46.62 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.355 0.662 . . . . 65.22 110.373 178.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 20.6 tp -121.36 112.52 18.67 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.888 0.875 . . . . 72.14 108.969 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -92.47 120.47 32.98 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 108.752 -0.833 . . . . 61.24 108.752 172.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 3.0 p -131.64 128.05 21.65 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.143 0.977 . . . . 75.02 108.432 -178.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -71.39 153.03 61.22 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 121.6 1.533 . . . . 75.52 111.395 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -47.1 -48.73 53.46 Favored Pre-proline 0 CA--C 1.565 1.545 0 O-C-N 124.495 1.122 . . . . 73.41 113.064 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.32 -55.42 3.65 Favored 'Trans proline' 0 C--N 1.407 3.611 0 C-N-CA 122.458 2.106 . . . . 72.32 113.291 175.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 57.4 mt -67.76 -27.01 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 123.558 0.743 . . . . 75.12 111.1 -175.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.17 -45.48 73.38 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.588 0.755 . . . . 73.34 110.857 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 81.0 t -71.63 -55.92 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 115.77 -0.65 . . . . 54.43 110.685 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 11.2 m -73.52 -28.58 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 O-C-N 123.816 0.698 . . . . 74.3 112.191 -172.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 77.77 84.01 0.54 Allowed Glycine 0 C--N 1.344 0.994 0 CA-C-N 116.013 -0.54 . . . . 73.23 112.371 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -115.28 -126.0 4.04 Favored Glycine 0 C--N 1.342 0.886 0 N-CA-C 112.14 -0.384 . . . . 44.31 112.14 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -137.56 147.96 45.54 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.654 1.182 . . . . 75.01 108.36 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 28.4 m -133.35 168.71 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 121.305 0.574 . . . . 54.33 110.703 173.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -77.37 135.47 38.35 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.967 -1.015 . . . . 74.31 108.87 169.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -138.17 158.26 44.65 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.756 0.423 . . . . 64.3 110.509 176.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 67.0 mtm -81.02 119.06 23.04 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.045 -0.979 . . . . 71.2 110.242 -176.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.432 HG22 ' H ' ' A' ' 216' ' ' GLU . 89.4 m -135.42 151.68 50.67 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.186 0.994 . . . . 42.24 109.63 176.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 62.6 mt -57.41 -25.56 59.77 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.564 1.146 . . . . 75.45 112.808 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.432 ' H ' HG22 ' A' ' 214' ' ' THR . 34.0 mt-10 -86.43 -18.86 30.65 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.155 0.982 . . . . 72.24 111.585 -178.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 135.07 -177.72 19.11 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.543 -0.623 . . . . 62.21 111.543 -175.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.66 120.83 7.17 Favored 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 122.404 2.069 . . . . 73.22 111.431 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.6 m -113.14 161.67 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 123.064 0.546 . . . . 73.3 111.484 -173.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -91.59 111.99 23.73 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.799 0.839 . . . . 64.4 109.482 174.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 54.4 t -109.88 126.22 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.023 0.929 . . . . 75.21 109.421 -176.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -77.36 100.94 6.11 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.353 0.661 . . . . 24.33 111.188 -173.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.528 ' HA ' HD12 ' A' ' 173' ' ' ILE . 59.9 t -77.29 134.81 66.48 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 124.93 1.292 . . . . 74.3 109.827 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.566 ' HD3' ' HB ' ' A' ' 173' ' ' ILE . 87.6 Cg_endo -75.03 170.3 20.71 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.523 2.149 . . . . 74.33 111.349 176.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.68 165.73 31.91 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 121.228 1.285 . . . . 73.33 111.259 169.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 63.39 22.97 13.52 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.781 0.832 . . . . 72.14 112.299 175.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 93.9 m -68.83 105.7 2.43 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.816 0.846 . . . . 42.24 109.634 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -105.51 141.45 36.97 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.259 1.024 . . . . 64.23 110.223 -171.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.74 136.89 58.2 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.474 1.11 . . . . 73.54 111.371 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 92.22 -9.22 76.7 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.499 -0.773 . . . . 75.42 113.435 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -84.86 144.22 28.55 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.995 0.518 . . . . 73.13 109.7 173.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.654 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.2 mppt? -110.66 129.47 55.81 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.508 0.723 . . . . 74.15 109.196 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.617 HD13 HG21 ' A' ' 173' ' ' ILE . 53.9 mt -95.03 101.35 13.1 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.831 0.852 . . . . 64.11 109.751 -173.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -72.35 105.29 4.03 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.333 0.653 . . . . 72.41 110.676 -176.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.484 HD21 HG23 ' A' ' 173' ' ' ILE . 17.8 mt -105.12 98.15 7.9 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.826 -1.176 . . . . 72.23 107.826 174.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -75.78 148.43 38.48 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 122.544 0.338 . . . . 74.1 111.349 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 72.03 33.68 62.29 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-N 115.757 -0.656 . . . . 75.32 113.272 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.13 -37.3 3.4 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.606 0.762 . . . . 71.24 111.338 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -68.72 -154.09 0.63 Allowed Glycine 0 C--N 1.355 1.631 0 N-CA-C 114.455 0.542 . . . . 72.44 114.455 -177.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.631 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 81.5 m-85 -66.66 144.71 98.74 Favored Pre-proline 0 N--CA 1.481 1.117 0 C-N-CA 122.81 0.444 . . . . 75.53 111.003 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.48 164.04 34.35 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.678 2.252 . . . . 72.11 113.317 178.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 172.75 -161.13 32.4 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 115.356 -0.838 . . . . 51.22 112.509 175.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.404 ' HD2' HE22 ' A' ' 191' ' ' GLN . 67.8 Cg_endo -71.76 -10.54 26.61 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 123.125 2.55 . . . . 63.42 113.759 -177.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -99.72 19.33 16.12 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.638 0.775 . . . . 72.13 110.735 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 85.32 -100.8 2.47 Favored Glycine 0 C--N 1.347 1.168 0 N-CA-C 109.916 -1.274 . . . . 32.45 109.916 -171.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -127.42 159.85 33.24 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.623 -0.88 . . . . 73.13 108.623 165.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.8 -170.11 16.19 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-N 115.534 -0.757 . . . . 74.15 113.738 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -98.34 165.82 11.67 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.448 0.699 . . . . 71.21 109.291 -172.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 41.1 tp -141.58 105.24 4.7 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.515 -0.92 . . . . 72.12 108.515 175.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.654 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 33.0 m-85 -91.07 111.32 22.74 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.357 0.663 . . . . 74.42 109.899 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.554 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 48.5 mt -86.02 109.18 18.62 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.885 -0.783 . . . . 72.31 108.885 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -77.81 100.01 6.14 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.05 -0.977 . . . . 61.54 109.642 -173.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 48.6 t -57.84 111.45 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 O-C-N 123.963 0.789 . . . . 73.44 111.404 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 21.2 mmm-85 -115.48 98.93 7.01 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 106.818 -1.549 . . . . 65.4 106.818 171.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 36.5 mt -75.82 119.53 23.94 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 N-CA-C 109.45 -0.574 . . . . 75.22 109.45 -176.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 7.5 p . . . . . 0 C--O 1.261 1.689 0 C-N-CA 124.647 1.179 . . . . 73.05 108.867 -174.294 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 N--CA 1.483 1.21 0 N-CA-C 109.815 -0.439 . . . . 70.25 109.815 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 49.7 m -76.83 82.99 3.41 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.474 0.654 . . . . 75.14 109.778 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -144.84 118.57 9.23 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.104 -0.953 . . . . 74.3 108.542 -178.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 91.1 mt -80.33 71.18 7.12 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.488 0.661 . . . . 75.45 109.505 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.562 ' HA ' ' HB3' ' A' ' 222' ' ' ALA . 79.9 ttt180 -79.32 102.34 8.57 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.433 -0.803 . . . . 72.55 109.164 -178.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.599 HG23 HD21 ' A' ' 235' ' ' LEU . 68.3 mt -59.06 -64.68 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.343 0.657 . . . . 75.14 109.872 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . 54.43 24.14 5.01 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.703 1.201 . . . . 71.42 113.397 175.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.41 ' H ' HG22 ' A' ' 173' ' ' ILE . . . -80.09 -3.29 48.07 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.555 0.742 . . . . 74.11 111.885 -176.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.582 ' CE2' HD21 ' A' ' 233' ' ' LEU . 37.7 m-85 -87.14 4.89 40.46 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.246 0.618 . . . . 73.21 110.843 167.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -137.21 176.72 20.33 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 110.92 -0.872 . . . . 51.34 110.92 171.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.88 83.9 0.53 Allowed 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.657 2.238 . . . . 73.1 111.538 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -145.71 146.11 31.13 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.633 -0.712 . . . . 75.12 110.268 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 156.46 -85.43 0.13 Allowed Glycine 0 C--N 1.343 0.954 0 N-CA-C 109.05 -1.62 . . . . 72.33 109.05 -176.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 48.7 p -170.24 -49.45 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.998 0.919 . . . . 72.14 108.906 176.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 160.8 -155.85 27.09 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.028 -0.987 . . . . 51.24 111.136 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -87.06 -10.54 71.56 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-O 120.003 -0.332 . . . . 42.22 112.595 175.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 51.8 m -68.49 101.35 1.24 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.51 0.724 . . . . 73.44 110.847 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 160.5 -157.51 28.92 Favored Glycine 0 C--O 1.241 0.577 0 CA-C-N 114.853 -1.067 . . . . 63.04 111.19 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -160.82 87.37 0.11 Allowed Glycine 0 C--O 1.239 0.435 0 N-CA-C 109.827 -1.309 . . . . 65.24 109.827 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 53.7 m -63.52 92.75 0.07 Allowed 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.514 0.726 . . . . 73.23 111.213 -178.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 149.74 -167.2 29.85 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 115.393 -0.822 . . . . 55.12 111.85 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 91.91 -90.51 1.51 Allowed Glycine 0 C--N 1.339 0.713 0 N-CA-C 111.723 -0.551 . . . . 73.42 111.723 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 26.5 p -170.47 -22.11 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.556 0.742 . . . . 74.12 111.951 -172.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -72.93 -28.34 62.38 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.635 0.774 . . . . 74.42 110.844 -176.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -77.27 149.02 35.43 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.522 -0.763 . . . . 71.35 109.899 175.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 95.6 mt -134.94 156.5 48.89 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.29 0.636 . . . . 63.42 110.55 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -108.86 124.51 50.75 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.663 -0.866 . . . . 73.55 108.663 169.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -124.07 130.09 51.97 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.117 0.967 . . . . 62.52 108.829 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 14.7 m -68.92 121.25 16.22 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.365 0.666 . . . . 71.21 110.102 -177.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.426 HD22 ' HB3' ' A' ' 251' ' ' LEU . 35.0 tp -106.35 110.47 22.71 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.629 -1.248 . . . . 63.51 107.629 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -89.2 116.65 27.6 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.485 -0.931 . . . . 74.43 108.485 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 7.7 p -137.69 132.82 17.58 Favored Pre-proline 0 CA--C 1.546 0.794 0 N-CA-C 108.972 -0.751 . . . . 73.31 108.972 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -75.13 156.47 42.42 Favored 'Trans proline' 0 C--N 1.366 1.472 0 C-N-CA 121.924 1.75 . . . . 71.23 111.27 170.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.412 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -52.6 -45.27 96.23 Favored Pre-proline 0 CA--C 1.554 1.118 0 N-CA-C 114.347 1.24 . . . . 42.22 114.347 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.406 ' O ' HG12 ' A' ' 206' ' ' VAL . 24.6 Cg_endo -59.14 -50.79 7.88 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 121.658 1.572 . . . . 74.02 112.956 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 49.6 mt -65.94 -25.02 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.676 0.79 . . . . 74.32 111.077 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.95 -46.44 62.41 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 122.848 0.459 . . . . 73.22 111.275 177.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 201' ' ' ALA . 87.7 t -64.46 -52.7 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 122.991 0.516 . . . . 72.13 111.442 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 202' ' ' PRO . 11.8 p -84.17 -34.32 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 112.04 0.385 . . . . 73.2 112.04 -174.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 84.49 89.3 0.82 Allowed Glycine 0 C--N 1.335 0.483 0 CA-C-N 116.561 -0.291 . . . . 43.03 112.507 -171.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -106.39 -135.13 7.93 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 111.05 -0.82 . . . . 61.41 111.05 172.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -128.97 144.26 51.13 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 108.783 -0.821 . . . . 52.04 108.783 174.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.44 HG11 ' HA ' ' A' ' 199' ' ' VAL . 33.7 m -134.11 162.07 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.116 0.566 . . . . 64.33 110.333 176.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 69.0 ttt-85 -74.44 135.53 42.33 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.112 0.565 . . . . 73.11 109.979 172.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -140.7 151.26 44.39 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.702 0.801 . . . . 73.21 109.565 177.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -80.63 122.34 26.96 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.962 -0.755 . . . . 74.22 108.962 176.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.416 HG22 ' H ' ' A' ' 216' ' ' GLU . 95.9 m -131.84 164.35 26.26 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 107.909 -1.145 . . . . 74.23 107.909 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 73.0 mt -63.86 -11.31 26.44 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.296 0.639 . . . . 54.11 112.069 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.416 ' H ' HG22 ' A' ' 214' ' ' THR . 40.9 mt-10 -103.43 17.74 23.41 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.817 1.247 . . . . 75.44 110.886 176.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 87.12 -161.99 33.38 Favored Glycine 0 C--N 1.349 1.281 0 CA-C-O 119.463 -0.632 . . . . 72.2 113.182 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -74.04 121.94 7.28 Favored 'Trans proline' 0 C--N 1.372 1.805 0 C-N-CA 122.505 2.137 . . . . 73.32 111.715 177.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.91 158.92 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.882 0.873 . . . . 65.31 110.402 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -90.42 108.93 20.09 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.873 0.469 . . . . 63.21 109.814 173.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 25.1 t -97.49 129.69 47.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 108.819 -0.808 . . . . 74.52 108.819 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.562 ' HB3' ' HA ' ' A' ' 172' ' ' ARG . . . -73.02 100.44 2.99 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.267 0.627 . . . . 64.01 110.586 -178.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.529 ' HA ' HD12 ' A' ' 173' ' ' ILE . 50.9 t -64.27 139.43 97.7 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 125.254 1.421 . . . . 73.25 109.94 178.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.454 ' HD3' HD12 ' A' ' 173' ' ' ILE . 6.3 Cg_exo -73.37 168.64 24.24 Favored 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 122.684 2.256 . . . . 71.22 111.548 173.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -73.82 172.92 14.87 Favored 'Trans proline' 0 CA--C 1.55 1.319 0 C-N-CA 121.453 1.435 . . . . 75.45 110.716 164.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 44.8 mtt180 66.12 6.34 4.09 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 124.684 1.194 . . . . 65.33 112.722 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.447 ' O ' HD11 ' A' ' 255' ' ' ILE . 94.4 m -59.91 110.54 1.2 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.375 0.67 . . . . 74.54 110.823 -170.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.494 ' HB3' ' HD3' ' A' ' 231' ' ' ARG . 60.1 tt0 -117.47 134.44 54.85 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.974 1.31 . . . . 74.55 110.328 -164.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.6 128.23 35.6 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.369 1.068 . . . . 71.43 112.444 -173.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.41 -9.85 62.93 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-N 115.915 -0.584 . . . . 54.3 113.119 177.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.494 ' HD3' ' HB3' ' A' ' 228' ' ' GLN . 76.2 mtp180 -89.41 158.55 17.7 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.079 0.552 . . . . 70.44 110.728 176.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.428 ' HG3' ' HA ' ' A' ' 252' ' ' GLU . 0.0 OUTLIER -131.34 144.11 51.0 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.088 0.555 . . . . 54.13 110.734 -174.036 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.582 HD21 ' CE2' ' A' ' 176' ' ' TYR . 44.6 mt -117.46 102.27 9.07 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.723 -0.672 . . . . 62.01 110.726 -164.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.419 ' HG3' ' HB3' ' A' ' 248' ' ' ASP . 51.1 ttp180 -79.78 113.92 18.3 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.833 0.853 . . . . 74.41 110.935 -173.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.599 HD21 HG23 ' A' ' 173' ' ' ILE . 43.0 mt -112.38 96.95 6.3 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.574 0.75 . . . . 74.55 109.304 177.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -62.86 140.84 58.83 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.859 -0.61 . . . . 75.1 111.379 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 81.17 25.36 55.37 Favored Glycine 0 C--N 1.339 0.741 0 O-C-N 124.259 0.975 . . . . 74.14 114.508 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.78 -28.25 6.02 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.152 0.581 . . . . 72.23 111.306 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -74.63 -169.66 23.2 Favored Glycine 0 CA--C 1.535 1.339 0 O-C-N 123.399 0.437 . . . . 51.3 112.848 173.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -65.43 143.33 98.68 Favored Pre-proline 0 N--CA 1.486 1.339 0 C-N-CA 123.693 0.797 . . . . 71.41 111.495 -175.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.5 128.74 30.59 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.735 2.29 . . . . 72.11 112.076 175.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.59 -179.06 16.02 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-O 119.739 -0.479 . . . . 54.3 112.748 -176.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.17 -44.86 42.58 Favored 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 123.78 2.987 . . . . 62.25 113.289 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -94.0 20.15 8.2 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.106 0.563 . . . . 63.42 111.608 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 102.66 -176.74 25.3 Favored Glycine 0 C--N 1.348 1.246 0 C-N-CA 123.451 0.548 . . . . 75.11 111.948 -176.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 57.6 mtt85 -63.35 148.89 47.14 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.048 0.539 . . . . 63.03 110.478 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -71.79 -173.11 17.9 Favored Glycine 0 C--N 1.344 1.021 0 O-C-N 123.545 0.528 . . . . 75.12 113.565 -176.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.419 ' HB3' ' HG3' ' A' ' 234' ' ' ARG . 3.3 m-20 -98.67 157.88 15.98 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.805 -0.813 . . . . 73.15 108.805 -176.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 32.9 tp -125.9 106.49 9.69 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.102 -1.073 . . . . 74.55 108.102 172.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -89.68 107.47 19.11 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.857 -0.794 . . . . 72.34 108.857 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.426 ' HB3' HD22 ' A' ' 197' ' ' LEU . 62.3 mt -87.77 106.71 18.25 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.453 -0.944 . . . . 75.04 108.453 176.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.428 ' HA ' ' HG3' ' A' ' 232' ' ' LYS . 22.7 mt-10 -79.07 105.9 10.73 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 114.894 -1.048 . . . . 73.13 110.153 -173.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 83.4 t -60.15 107.45 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.693 0 O-C-N 124.169 0.918 . . . . 75.3 111.48 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -115.27 93.92 4.5 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 107.91 -1.144 . . . . 73.31 107.91 173.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.464 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 54.5 mt -76.65 132.5 32.83 Favored 'Isoleucine or valine' 0 C--N 1.351 0.671 0 CA-C-N 115.464 -0.789 . . . . 54.53 109.93 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 32.4 p . . . . . 0 C--O 1.253 1.237 0 C-N-CA 124.671 1.188 . . . . 72.42 108.694 -179.165 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 54.0 ttm . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 109.255 -0.646 . . . . 72.23 109.255 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.5 m -70.11 110.42 5.13 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 115.344 -0.843 . . . . 73.04 110.325 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -79.24 -65.06 1.05 Allowed 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 109.451 -0.574 . . . . 61.34 109.451 172.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.6 mt -106.88 97.68 7.44 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.259 -0.645 . . . . 73.33 109.259 173.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -77.7 122.08 24.88 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 108.144 -1.058 . . . . 73.11 108.144 173.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.686 HG22 ' H ' ' A' ' 175' ' ' ALA . 63.8 mt -72.46 -75.49 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 109.793 -0.447 . . . . 64.32 109.793 177.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . 59.56 11.23 2.24 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 124.596 1.159 . . . . 71.31 113.659 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.686 ' H ' HG22 ' A' ' 173' ' ' ILE . . . -75.57 -14.1 60.38 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.79 0.836 . . . . 73.14 111.166 177.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.461 ' CE2' HD21 ' A' ' 233' ' ' LEU . 6.2 m-85 -66.1 -17.73 64.89 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.787 0.835 . . . . 75.13 111.323 169.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -131.17 179.76 16.76 Favored Glycine 0 C--N 1.346 1.098 0 N-CA-C 111.411 -0.675 . . . . 74.32 111.411 174.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -72.53 81.8 1.5 Allowed 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 122.397 2.065 . . . . 63.4 112.358 177.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -76.25 99.0 4.61 Favored 'General case' 0 C--N 1.351 0.672 0 CA-C-N 115.743 -0.662 . . . . 74.32 109.698 175.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 163.65 -164.28 36.22 Favored Glycine 0 C--O 1.243 0.659 0 CA-C-N 115.189 -0.914 . . . . 43.33 111.646 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 22.7 t -174.24 -178.93 1.52 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.226 1.01 . . . . 72.22 109.136 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 93.83 -72.9 1.2 Allowed Glycine 0 C--N 1.347 1.155 0 N-CA-C 111.43 -0.668 . . . . 40.13 111.43 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -178.53 -67.0 0.06 OUTLIER Glycine 0 C--N 1.343 0.936 0 N-CA-C 111.226 -0.75 . . . . 45.31 111.226 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 20.9 t -168.35 159.47 10.61 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.026 0.93 . . . . 64.22 109.754 176.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -116.99 -178.22 17.81 Favored Glycine 0 C--N 1.345 1.07 0 CA-C-N 116.12 -0.491 . . . . 75.11 112.235 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -88.26 148.91 20.98 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-O 119.905 -0.386 . . . . 62.51 112.4 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 46.7 t -62.48 134.9 57.07 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.885 0.874 . . . . 63.21 111.157 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -170.21 98.68 0.14 Allowed Glycine 0 C--N 1.352 1.469 0 N-CA-C 111.994 -0.442 . . . . 43.13 111.994 -177.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -138.34 92.66 0.2 Allowed Glycine 0 C--N 1.343 0.968 0 C-N-CA 123.146 0.403 . . . . 73.22 112.126 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 66.6 m -155.43 167.15 31.32 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.569 1.148 . . . . 63.54 109.532 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 60.96 26.02 15.98 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 124.365 1.066 . . . . 74.41 110.762 -174.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -83.77 159.15 21.5 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.541 -1.209 . . . . 75.3 112.631 -169.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.5 mt -143.68 138.01 28.62 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.097 0.959 . . . . 72.43 109.614 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -93.04 125.72 37.77 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.483 -1.303 . . . . 72.23 107.483 164.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -124.24 133.06 53.61 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.369 -0.604 . . . . 74.44 109.369 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . 0.589 HG23 ' HG3' ' A' ' 254' ' ' ARG . 42.9 m -65.94 122.16 16.72 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 124.038 0.836 . . . . 63.32 109.77 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 40.3 tp -109.28 108.8 19.52 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.018 -1.475 . . . . 71.21 107.018 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -95.7 103.09 14.95 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 122.098 0.951 . . . . 62.14 109.225 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 2.8 p -120.12 117.41 32.05 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-N 114.569 -1.196 . . . . 73.03 109.02 -174.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.9 154.59 73.33 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 122.136 1.891 . . . . 72.24 111.579 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -48.04 -45.25 63.24 Favored Pre-proline 0 CA--C 1.565 1.554 0 N-CA-C 114.713 1.375 . . . . 34.34 114.713 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.438 ' O ' HG22 ' A' ' 206' ' ' VAL . 26.1 Cg_endo -59.72 -50.85 7.03 Favored 'Trans proline' 0 C--N 1.399 3.187 0 C-N-CA 121.425 1.416 . . . . 71.15 112.227 176.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 36.7 mt -70.0 -23.24 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 123.672 0.789 . . . . 65.33 111.263 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.59 -51.06 46.63 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 122.923 0.489 . . . . 65.4 110.166 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 84.5 t -67.0 -48.69 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 CA-C-N 115.606 -0.725 . . . . 71.21 111.866 -177.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 202' ' ' PRO . 33.9 m -89.9 -23.04 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 113.313 0.857 . . . . 74.53 113.313 -174.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.78 149.69 24.37 Favored Glycine 0 N--CA 1.477 1.385 0 N-CA-C 112.15 -0.38 . . . . 72.11 112.15 -173.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 163.97 175.61 35.02 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 116.927 0.363 . . . . 55.31 112.282 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 221' ' ' VAL . 50.2 mtmt -82.12 135.66 35.27 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.872 0.469 . . . . 72.35 110.226 -177.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.465 HG11 ' HA ' ' A' ' 199' ' ' VAL . 33.9 m -138.94 170.03 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 123.84 0.856 . . . . 65.33 110.686 176.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -68.55 130.58 43.26 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.532 -0.758 . . . . 65.41 111.067 175.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -135.68 118.14 15.8 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.768 -0.827 . . . . 74.24 108.768 168.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 55.8 mtt -73.0 105.93 4.67 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.211 0.605 . . . . 64.41 109.874 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 25.6 m -110.03 171.46 7.44 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.88 1.272 . . . . 53.21 108.61 -175.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 85.8 mt -57.45 -35.33 70.0 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.576 0.75 . . . . 63.12 112.212 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -79.4 -11.02 59.92 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.803 0.841 . . . . 70.42 112.464 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 125.08 -179.33 16.2 Favored Glycine 0 N--CA 1.47 0.956 0 N-CA-C 111.121 -0.791 . . . . 61.43 111.121 -174.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.64 129.41 21.07 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 122.5 2.134 . . . . 74.24 110.997 176.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.474 HG23 HG23 ' A' ' 221' ' ' VAL . 29.5 m -123.29 162.26 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.777 0.831 . . . . 74.41 110.61 -174.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -90.58 106.04 18.23 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.692 0.758 . . . . 71.33 109.7 174.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.474 HG23 HG23 ' A' ' 219' ' ' VAL . 94.8 t -101.71 121.72 53.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 115.214 -0.903 . . . . 65.03 109.569 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.02 99.69 3.38 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 123.489 0.715 . . . . 52.54 110.009 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.401 ' HA ' HD12 ' A' ' 173' ' ' ILE . 31.1 t -84.53 132.64 46.3 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 114.547 -1.206 . . . . 74.53 109.172 178.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.443 ' HD3' ' HB ' ' A' ' 173' ' ' ILE . 60.3 Cg_endo -69.42 170.05 17.06 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.862 2.375 . . . . 74.14 111.23 171.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.27 -174.43 0.26 Allowed 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.536 2.157 . . . . 62.32 113.563 174.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 38.5 mtp85 62.39 19.5 11.16 Favored 'General case' 0 N--CA 1.502 2.172 0 C-N-CA 125.137 1.375 . . . . 74.31 112.172 172.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.448 ' HA ' ' CZ ' ' A' ' 176' ' ' TYR . 55.5 m -71.82 99.18 2.12 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.965 0.906 . . . . 73.43 111.088 -171.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -98.55 134.94 40.81 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.255 1.422 . . . . 75.44 110.1 -175.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.67 146.22 54.21 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.25 0.62 . . . . 53.2 111.217 -178.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 96.73 -26.74 20.81 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-N 115.182 -0.917 . . . . 64.11 112.78 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -69.85 154.28 42.17 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 117.2 0.5 . . . . 74.21 111.12 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -130.32 142.92 50.51 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 108.176 -1.046 . . . . 71.51 108.176 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.63 HD13 HG21 ' A' ' 173' ' ' ILE . 27.4 mt -120.38 105.82 11.26 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.781 -0.645 . . . . 71.2 110.101 -165.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -73.23 102.86 3.76 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.744 0.818 . . . . 74.11 110.463 -174.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.602 HD21 HG23 ' A' ' 173' ' ' ILE . 37.3 mt -112.49 92.88 4.18 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.097 -0.705 . . . . 74.43 109.097 177.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.41 ' HG2' ' HB3' ' A' ' 248' ' ' ASP . 47.0 mtmt -69.59 144.26 53.07 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 122.293 0.237 . . . . 75.23 110.735 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 80.81 29.75 41.6 Favored Glycine 0 C--N 1.342 0.912 0 O-C-N 123.73 0.644 . . . . 30.34 113.432 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 249' ' ' LEU . 72.0 mmtt -123.33 -28.33 3.98 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 117.577 0.689 . . . . 73.14 112.11 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -72.02 -145.83 0.53 Allowed Glycine 0 N--CA 1.481 1.667 0 C-N-CA 123.111 0.386 . . . . 51.22 113.867 -177.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -76.65 149.5 80.97 Favored Pre-proline 0 N--CA 1.486 1.36 0 O-C-N 122.272 -0.546 . . . . 63.34 110.874 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -60.6 145.15 99.33 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.746 2.297 . . . . 75.23 112.361 174.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -167.25 -155.39 9.1 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 115.866 -0.606 . . . . 62.53 112.375 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -80.47 1.03 9.59 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 123.543 2.829 . . . . 51.14 113.336 -174.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -120.48 22.16 11.36 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.947 0.899 . . . . 72.23 110.352 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 91.6 -92.32 1.71 Allowed Glycine 0 C--N 1.348 1.244 0 N-CA-C 110.945 -0.862 . . . . 54.1 110.945 -174.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -126.12 169.43 12.81 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.43 -0.952 . . . . 71.05 108.43 167.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.84 -175.75 46.91 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.982 -0.553 . . . . 73.32 113.885 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.41 ' HB3' ' HG2' ' A' ' 236' ' ' LYS . 3.6 p-10 -100.54 127.2 46.98 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.404 0.621 . . . . 74.22 110.057 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 238' ' ' LYS . 35.1 tp -99.95 110.91 23.23 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 107.845 -1.168 . . . . 70.21 107.845 -178.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -86.03 108.2 18.14 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.474 -1.306 . . . . 73.34 107.474 174.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 27.1 mt -84.2 105.13 14.82 Favored 'General case' 0 C--N 1.34 0.189 0 N-CA-C 107.775 -1.194 . . . . 63.02 107.775 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -77.18 103.23 6.99 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.649 -1.614 . . . . 61.42 108.966 -177.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 63.7 t -59.65 115.61 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 123.72 0.808 . . . . 72.52 110.722 177.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.589 ' HG3' HG23 ' A' ' 196' ' ' THR . 54.5 mmm-85 -125.64 97.1 5.03 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.001 -1.481 . . . . 73.15 107.001 177.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 54.8 mt -76.71 119.31 24.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 CA-C-N 116.232 -0.44 . . . . 72.35 110.197 -174.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 44.2 p . . . . . 0 C--O 1.255 1.344 0 C-N-CA 124.425 1.09 . . . . 63.44 108.185 177.785 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 24.9 mmt . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 109.696 -0.483 . . . . 71.53 109.696 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 15.2 m -69.45 -26.66 64.7 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.448 0.699 . . . . 71.51 112.207 -173.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.406 ' O ' ' HD3' ' A' ' 238' ' ' LYS . 79.7 mm-40 61.54 75.64 0.4 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.011 1.324 . . . . 63.12 111.923 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.9 mp -91.78 12.51 21.15 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.93 0.892 . . . . 70.44 110.557 175.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -63.21 124.2 20.6 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.929 0.891 . . . . 74.33 110.675 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.688 ' HA ' HD22 ' A' ' 235' ' ' LEU . 73.5 mt -78.53 105.99 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 115.583 -0.735 . . . . 71.42 110.678 -174.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -66.46 -28.92 68.97 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 114.749 -1.114 . . . . 74.31 111.119 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -74.79 170.48 15.8 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.959 0.904 . . . . 71.55 112.143 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 64.76 23.3 12.7 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.682 1.193 . . . . 61.31 112.103 177.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 174.15 145.48 5.24 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 118.791 -1.005 . . . . 70.5 110.727 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -65.41 97.54 0.31 Allowed 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.764 2.309 . . . . 74.32 111.424 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -75.1 -40.43 59.97 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.255 -0.884 . . . . 73.34 109.687 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 178.74 -171.44 43.62 Favored Glycine 0 C--N 1.34 0.773 0 CA-C-N 115.314 -0.857 . . . . 70.31 111.715 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 34.8 p -87.45 -7.42 57.67 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.486 0.714 . . . . 61.2 111.254 176.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 100.87 87.97 1.99 Allowed Glycine 0 C--N 1.347 1.179 0 N-CA-C 111.708 -0.557 . . . . 34.4 111.708 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -74.88 73.91 1.43 Allowed Glycine 0 C--N 1.35 1.319 0 N-CA-C 111.395 -0.682 . . . . 62.13 111.395 173.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 40.6 t -158.82 165.17 34.87 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.559 1.144 . . . . 62.35 109.454 -172.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 161.68 -107.21 0.3 Allowed Glycine 0 C--N 1.348 1.208 0 N-CA-C 111.908 -0.477 . . . . 74.33 111.908 177.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.01 -11.55 28.15 Favored Glycine 0 CA--C 1.54 1.632 0 CA-C-O 119.72 -0.489 . . . . 75.1 114.3 176.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 37.8 m 57.01 82.94 0.11 Allowed 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.879 1.272 . . . . 71.43 111.472 -173.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -165.92 -105.83 0.19 Allowed Glycine 0 C--N 1.342 0.912 0 N-CA-C 110.823 -0.911 . . . . 64.35 110.823 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -151.47 158.68 27.86 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 111.761 -0.535 . . . . 53.42 111.761 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 18.9 m -92.59 121.44 34.02 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.775 0.83 . . . . 65.2 108.987 174.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.517 ' HB3' ' HB2' ' A' ' 240' ' ' PHE . 82.3 mm-40 -82.54 56.96 3.5 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.233 0.613 . . . . 62.45 110.186 175.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -91.55 142.35 27.73 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.485 -0.779 . . . . 72.45 110.657 -175.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 96.2 mt -133.52 153.64 51.48 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.583 0.753 . . . . 63.54 110.244 -178.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -104.14 121.66 43.71 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 108.748 -0.834 . . . . 75.31 108.748 174.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -125.69 133.22 52.22 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.553 1.141 . . . . 74.31 109.117 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 39.3 m -65.51 139.38 58.48 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.473 0.709 . . . . 52.43 111.322 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.487 HD13 HD13 ' A' ' 251' ' ' LEU . 26.3 tp -115.17 122.57 46.45 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 123.837 0.855 . . . . 74.25 109.199 176.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -89.52 106.08 18.22 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.273 -0.64 . . . . 70.51 109.273 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.618 HG11 HG13 ' A' ' 253' ' ' VAL . 6.4 p -129.56 131.36 23.54 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 122.86 0.464 . . . . 72.42 110.042 178.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.414 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 55.8 Cg_endo -74.46 157.64 44.86 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 121.943 1.762 . . . . 43.31 111.404 169.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.448 ' HA ' HG23 ' A' ' 255' ' ' ILE . . . -50.95 -48.97 83.23 Favored Pre-proline 0 CA--C 1.57 1.732 0 CA-C-O 117.949 -1.024 . . . . 53.22 113.652 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.479 ' O ' HG12 ' A' ' 206' ' ' VAL . 28.7 Cg_endo -60.91 -51.52 4.65 Favored 'Trans proline' 0 C--N 1.402 3.371 0 C-N-CA 121.529 1.486 . . . . 75.41 111.945 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 38.4 mt -62.83 -26.47 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 123.599 0.76 . . . . 65.43 111.32 -176.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.3 -52.99 33.81 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-O 120.953 0.406 . . . . 73.2 110.8 174.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 90.0 t -67.94 -43.99 85.39 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 N-CA-C 112.675 0.62 . . . . 75.44 112.675 -175.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 202' ' ' PRO . 11.0 p -99.92 -21.66 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 122.857 0.463 . . . . 72.21 112.183 -173.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.66 144.67 11.41 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 112.229 -0.348 . . . . 62.43 112.229 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -177.25 -140.35 3.63 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-O 119.224 -0.765 . . . . 74.44 111.898 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -116.94 143.34 45.82 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 118.005 0.902 . . . . 73.24 109.208 176.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 34.4 m -139.83 169.87 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 123.457 0.703 . . . . 61.45 111.352 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -90.12 114.12 26.0 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.12 0.568 . . . . 72.3 110.343 173.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.44 127.12 52.06 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.111 -1.07 . . . . 72.24 108.111 165.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 89.8 mmm -81.58 104.97 12.37 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.215 -0.661 . . . . 60.04 109.215 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 87.4 m -113.4 162.03 16.59 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.572 1.149 . . . . 73.14 109.76 -176.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 87.3 mt -58.0 -16.67 13.39 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.035 0.934 . . . . 70.53 112.986 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -103.7 29.25 5.89 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.037 0.935 . . . . 73.52 110.924 175.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 86.9 -165.38 36.31 Favored Glycine 0 C--N 1.348 1.231 0 CA-C-N 116.237 -0.438 . . . . 74.44 113.442 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -72.54 121.65 7.6 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.78 2.32 . . . . 55.1 111.395 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.4 m -121.15 147.8 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.821 0.849 . . . . 73.21 109.96 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 9.8 pt-20 -90.49 113.93 26.0 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.285 0.564 . . . . 72.43 110.949 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 63.9 t -102.83 132.2 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.283 0.633 . . . . 71.54 109.452 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -78.94 99.99 7.06 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 123.657 0.783 . . . . 65.55 109.765 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 74.5 t -80.03 134.02 56.93 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.317 1.047 . . . . 55.24 110.201 178.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.42 170.96 18.96 Favored 'Trans proline' 0 C--N 1.383 2.36 0 C-N-CA 122.939 2.426 . . . . 72.24 111.372 172.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -65.01 175.22 3.98 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 121.869 1.713 . . . . 72.14 113.47 172.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 72.31 5.33 5.26 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 125.248 1.419 . . . . 71.04 112.844 174.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 87.6 m -69.42 127.63 33.72 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.156 0.583 . . . . 75.51 110.913 -172.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -127.14 142.34 51.53 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.817 0.847 . . . . 71.52 110.809 -167.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.421 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -65.05 132.37 49.03 Favored 'General case' 0 C--N 1.348 0.543 0 C-N-CA 124.108 0.963 . . . . 73.24 110.767 -179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.13 -14.7 63.46 Favored Glycine 0 N--CA 1.468 0.77 0 O-C-N 123.994 0.809 . . . . 75.31 112.223 -178.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 78.2 mtt-85 -84.12 142.31 30.47 Favored 'General case' 0 C--N 1.351 0.65 0 N-CA-C 109.233 -0.654 . . . . 73.22 109.233 173.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.58 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.0 mppt? -110.64 130.88 55.46 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.786 -0.82 . . . . 74.34 108.786 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.577 HD13 HD13 ' A' ' 173' ' ' ILE . 27.1 mt -84.18 99.4 10.5 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.193 -1.04 . . . . 64.32 108.193 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -72.97 102.0 3.36 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.069 0.548 . . . . 74.11 109.956 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.688 HD22 ' HA ' ' A' ' 173' ' ' ILE . 14.0 mt -105.1 95.34 5.77 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.977 -0.749 . . . . 75.44 108.977 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -62.64 145.26 55.01 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 120.827 0.346 . . . . 63.24 111.452 176.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 74.58 19.78 79.76 Favored Glycine 0 C--N 1.344 0.985 0 CA-C-N 115.096 -0.956 . . . . 73.23 113.644 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.406 ' HD3' ' O ' ' A' ' 170' ' ' GLN . 31.1 mmmt -122.16 -11.17 8.47 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.426 0.691 . . . . 63.43 112.115 -176.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -77.98 -169.36 33.88 Favored Glycine 0 C--N 1.343 0.971 0 N-CA-C 111.842 -0.503 . . . . 40.42 111.842 167.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.517 ' HB2' ' HB3' ' A' ' 191' ' ' GLN . 18.0 m-30 -72.57 155.75 90.77 Favored Pre-proline 0 N--CA 1.483 1.201 0 CA-C-N 116.855 0.327 . . . . 71.13 110.995 -179.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.26 155.13 70.45 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.557 2.171 . . . . 72.42 112.987 175.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -173.04 -168.23 34.01 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-N 115.384 -0.825 . . . . 62.05 111.929 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -60.94 -23.83 78.08 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.452 2.768 . . . . 73.0 112.661 174.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -87.27 20.14 2.91 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.131 0.972 . . . . 63.02 111.94 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 79.22 -94.36 1.36 Allowed Glycine 0 C--N 1.349 1.302 0 N-CA-C 110.321 -1.112 . . . . 51.25 110.321 -173.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 42.8 mtt180 -128.48 159.46 35.36 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.598 -0.889 . . . . 61.13 108.598 164.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -83.25 -165.82 38.62 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 116.014 -0.539 . . . . 53.31 112.811 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.54 164.83 12.1 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.921 0.888 . . . . 74.23 109.516 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 33.7 tp -134.99 107.76 7.49 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 107.793 -1.188 . . . . 72.42 107.793 173.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.58 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 73.5 m-85 -88.92 111.16 21.77 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.466 0.706 . . . . 60.13 109.608 -178.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.487 HD13 HD13 ' A' ' 197' ' ' LEU . 63.9 mt -86.46 104.33 15.83 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 107.998 -1.112 . . . . 74.52 107.998 174.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -78.95 97.58 6.1 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.38 -0.97 . . . . 75.13 108.38 -173.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.618 HG13 HG11 ' A' ' 199' ' ' VAL . 81.8 t -57.91 109.63 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-N 114.256 -1.338 . . . . 63.22 112.084 -175.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -105.03 97.93 7.71 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 124.281 1.033 . . . . 74.42 108.756 172.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.448 HG23 ' HA ' ' A' ' 201' ' ' ALA . 32.9 mt -77.56 126.92 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 123.651 0.594 . . . . 74.45 109.623 177.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 9.5 p . . . . . 0 CA--C 1.556 1.199 0 C-N-CA 124.677 1.191 . . . . 71.15 109.006 -178.389 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 121.17 0.509 . . . . 62.55 109.992 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 33.4 t -173.55 118.24 0.28 Allowed 'General case' 0 C--O 1.246 0.875 0 C-N-CA 124.844 1.258 . . . . 65.31 108.073 177.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -68.95 -58.66 3.82 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.271 -0.64 . . . . 63.2 109.271 175.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.564 HD13 HG22 ' A' ' 221' ' ' VAL . 3.2 pp -74.35 123.69 25.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.535 -0.757 . . . . 72.25 111.436 -176.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -143.81 150.18 38.14 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.718 1.207 . . . . 65.44 108.613 175.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.854 ' HA ' HD22 ' A' ' 235' ' ' LEU . 22.6 mt -92.61 106.43 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 120.993 0.425 . . . . 63.54 111.092 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -86.82 -21.37 26.49 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.25 1.02 . . . . 71.41 111.257 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -72.87 165.1 25.57 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.51 0.724 . . . . 74.13 111.182 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.42 ' HE1' ' HA ' ' A' ' 227' ' ' THR . 2.7 m-85 70.84 5.04 5.29 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 125.035 1.334 . . . . 74.55 113.423 176.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -163.09 55.0 0.29 Allowed Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.201 -0.777 . . . . 73.44 111.807 171.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -83.69 174.33 8.75 Favored 'Trans proline' 0 C--N 1.383 2.374 0 C-N-CA 122.082 1.855 . . . . 75.1 111.49 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -98.77 41.96 1.12 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.463 0.705 . . . . 62.42 109.763 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 83.65 -56.2 5.04 Favored Glycine 0 C--N 1.351 1.404 0 CA-C-N 115.382 -0.826 . . . . 62.23 112.642 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 21.9 t -162.04 -171.08 2.72 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.012 0.925 . . . . 64.33 109.376 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -170.06 -15.24 0.02 OUTLIER Glycine 0 CA--C 1.525 0.698 0 N-CA-C 112.038 -0.425 . . . . 73.32 112.038 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 158.58 -148.96 18.86 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 111.244 -0.742 . . . . 54.13 111.244 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 39.8 t -73.16 -28.61 62.33 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.64 0.776 . . . . 54.12 110.617 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 98.28 -26.92 21.72 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-N 116.214 -0.448 . . . . 62.1 112.45 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 78.63 4.28 87.57 Favored Glycine 0 C--N 1.354 1.572 0 C-N-CA 122.774 0.226 . . . . 63.41 113.276 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 50.4 p -92.1 123.41 35.43 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.188 0.995 . . . . 71.34 110.237 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -165.24 35.89 0.27 Allowed Glycine 0 C--N 1.342 0.89 0 CA-C-N 116.3 -0.409 . . . . 74.51 112.877 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 67.97 43.71 81.23 Favored Glycine 0 C--N 1.346 1.12 0 C-N-CA 123.529 0.585 . . . . 44.3 113.646 177.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 35.8 m -143.49 -76.34 0.25 Allowed 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 117.468 0.634 . . . . 73.53 110.737 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -72.68 -41.4 65.38 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 109.336 -0.616 . . . . 73.42 109.336 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -75.59 147.29 39.72 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 114.954 -1.021 . . . . 64.42 109.936 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 96.0 mt -129.09 166.6 18.96 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.492 0.717 . . . . 73.43 110.289 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -119.65 145.34 46.55 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.388 1.075 . . . . 72.12 108.809 173.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.15 158.03 43.84 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.291 1.036 . . . . 53.54 108.562 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 16.5 m -92.46 130.83 38.02 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 122.68 0.392 . . . . 70.52 109.943 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 57.1 tp -111.99 126.11 54.79 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.724 0.809 . . . . 74.44 109.684 176.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -93.57 125.43 38.17 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.219 0.608 . . . . 63.51 109.368 170.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 6.5 p -144.94 133.76 11.04 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 124.045 0.938 . . . . 72.13 108.65 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.91 157.81 38.85 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.075 1.85 . . . . 74.33 111.29 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.22 -48.29 92.84 Favored Pre-proline 0 CA--C 1.555 1.173 0 N-CA-C 113.309 0.855 . . . . 51.22 113.309 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.528 ' O ' HG12 ' A' ' 206' ' ' VAL . 52.4 Cg_exo -56.13 -56.12 2.36 Favored 'Trans proline' 0 C--N 1.395 2.995 0 C-N-CA 121.836 1.691 . . . . 51.42 113.028 176.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 57.7 mt -60.91 -30.22 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 C-N-CA 122.717 0.407 . . . . 64.43 110.829 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.449 ' HB1' ' O ' ' A' ' 227' ' ' THR . . . -63.61 -53.55 49.87 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 122.927 0.491 . . . . 53.01 111.038 178.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 32.3 t -78.91 -42.4 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 116.154 -0.476 . . . . 42.45 112.175 -172.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 202' ' ' PRO . 9.9 p -90.02 -19.57 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 122.654 0.381 . . . . 73.44 111.395 -176.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.31 159.04 34.31 Favored Glycine 0 C--N 1.348 1.226 0 N-CA-C 111.986 -0.446 . . . . 72.3 111.986 -174.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.79 -138.68 5.39 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-O 119.603 -0.554 . . . . 75.1 112.352 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -137.31 142.31 41.89 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.564 0.746 . . . . 64.42 109.312 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.77 162.04 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 122.846 0.458 . . . . 72.42 110.539 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -86.51 104.77 16.28 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.295 -1.002 . . . . 53.44 108.295 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -103.49 138.86 39.61 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.773 0.829 . . . . 61.21 110.199 -175.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 22.5 ptt? -72.54 118.46 15.49 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 121.438 0.637 . . . . 72.12 109.401 176.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 28.0 m -135.45 154.59 51.39 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.091 0.956 . . . . 72.52 109.061 -177.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 68.7 mt -63.19 -21.66 66.36 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.003 0.921 . . . . 74.3 112.789 -177.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -93.62 0.8 56.69 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.276 0.63 . . . . 73.53 111.353 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 117.97 167.98 14.3 Favored Glycine 0 C--N 1.345 1.069 0 CA-C-O 119.534 -0.592 . . . . 53.35 112.515 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.76 121.26 8.3 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.513 2.142 . . . . 62.41 111.174 176.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.533 HG21 HD21 ' A' ' 171' ' ' LEU . 27.7 m -127.7 160.04 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 123.804 0.842 . . . . 61.4 110.879 -171.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -86.68 103.95 15.63 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.062 0.545 . . . . 74.15 109.817 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.564 HG22 HD13 ' A' ' 171' ' ' LEU . 99.0 t -96.84 124.14 49.5 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 N-CA-C 108.672 -0.862 . . . . 74.4 108.672 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.04 98.7 2.58 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.069 0.548 . . . . 43.14 110.244 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 94.8 t -73.97 128.0 87.24 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.203 1.001 . . . . 63.42 109.737 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.16 170.34 14.76 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.601 2.201 . . . . 70.52 111.317 176.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.52 167.87 26.13 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 121.249 1.3 . . . . 73.25 111.489 168.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 48.2 mtt-85 65.63 23.04 11.69 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 124.622 1.169 . . . . 75.5 111.989 176.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.449 ' O ' ' HB1' ' A' ' 204' ' ' ALA . 30.0 m -75.15 93.53 2.81 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.771 0.796 . . . . 74.13 110.416 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -86.03 145.71 26.97 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.461 -1.245 . . . . 74.32 110.531 -178.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.3 138.42 58.52 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.114 0.966 . . . . 72.41 111.126 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 92.74 -14.83 64.05 Favored Glycine 0 N--CA 1.473 1.108 0 CA-C-N 116.206 -0.452 . . . . 75.24 113.034 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -75.71 145.11 41.15 Favored 'General case' 0 C--N 1.348 0.504 0 N-CA-C 109.457 -0.571 . . . . 62.41 109.457 173.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.579 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 0.2 OUTLIER -110.48 122.71 48.39 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.199 -0.667 . . . . 74.41 109.199 175.451 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.445 HD13 HD13 ' A' ' 173' ' ' ILE . 18.7 mt -76.19 103.07 6.05 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.447 -0.945 . . . . 72.23 108.447 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 21.4 ttm-85 -70.95 101.2 2.12 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 109.395 -0.595 . . . . 74.33 109.395 175.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.854 HD22 ' HA ' ' A' ' 173' ' ' ILE . 10.0 mt -104.27 103.13 12.83 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 108.011 -1.107 . . . . 62.15 108.011 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -80.85 142.7 33.39 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.735 0.414 . . . . 74.04 111.521 -170.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 84.99 21.15 56.32 Favored Glycine 0 C--N 1.346 1.111 0 CA-C-N 115.985 -0.552 . . . . 51.42 113.506 178.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -113.27 -26.92 8.17 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.285 0.634 . . . . 63.51 112.534 -173.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -72.91 -134.74 0.21 Allowed Glycine 0 CA--C 1.539 1.553 0 N-CA-C 114.262 0.465 . . . . 73.45 114.262 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -93.56 137.73 23.22 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 123.266 0.626 . . . . 72.42 110.114 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 56.3 Cg_endo -69.17 128.88 17.24 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.751 2.3 . . . . 52.34 112.487 -178.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -137.55 -175.93 14.14 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-O 119.504 -0.609 . . . . 74.23 112.512 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.66 -28.95 69.27 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 123.998 3.132 . . . . 74.45 113.155 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -94.43 14.88 19.23 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.44 0.696 . . . . 71.34 110.725 177.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 97.68 175.19 33.86 Favored Glycine 0 C--N 1.349 1.3 0 N-CA-C 111.537 -0.625 . . . . 73.1 111.537 -176.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.524 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 0.8 OUTLIER -61.24 145.77 50.09 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.618 0.767 . . . . 73.41 109.894 172.421 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -68.33 -173.27 7.67 Favored Glycine 0 N--CA 1.477 1.369 0 N-CA-C 114.362 0.505 . . . . 71.34 114.362 -173.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -95.97 168.81 10.4 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.456 -0.942 . . . . 74.11 108.456 178.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 238' ' ' LYS . 34.6 tp -141.49 108.81 5.53 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.493 -0.928 . . . . 75.52 108.493 178.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.579 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 81.1 m-85 -90.39 109.28 20.4 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.902 0.881 . . . . 75.34 110.032 -176.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.505 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 46.8 mt -88.0 107.14 18.58 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.153 -0.684 . . . . 74.23 109.153 174.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -80.25 101.09 8.67 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.69 1.196 . . . . 73.13 108.801 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 89.4 t -63.39 120.23 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 125.218 1.407 . . . . 51.3 112.733 -171.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -113.83 100.11 8.2 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.039 -1.097 . . . . 72.2 108.039 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 18.6 mt -75.88 120.11 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 122.962 0.505 . . . . 73.33 109.75 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 CA--C 1.554 1.129 0 C-N-CA 124.296 1.038 . . . . 75.14 108.895 -179.997 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 121.061 0.458 . . . . 35.11 111.183 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 41.1 m -73.47 10.24 1.11 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.765 0.826 . . . . 64.12 112.696 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -58.73 137.2 57.77 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.16 0.984 . . . . 74.24 111.525 173.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.412 ' O ' HG13 ' A' ' 221' ' ' VAL . 62.5 mt -82.61 80.85 8.62 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.648 0.779 . . . . 63.24 109.35 176.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 55.1 mtm180 -79.15 105.24 10.34 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 107.366 -1.346 . . . . 63.11 107.366 175.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.621 HG21 HD13 ' A' ' 233' ' ' LEU . 50.9 mt -76.79 108.63 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 O-C-N 123.24 0.338 . . . . 74.54 110.195 -175.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -100.98 14.84 30.64 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.86 0.864 . . . . 75.04 110.432 174.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -73.03 -43.83 61.56 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.967 0.907 . . . . 41.43 112.423 -171.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.453 ' CE2' ' HA ' ' A' ' 227' ' ' THR . 43.6 m-85 -83.21 100.23 10.45 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.268 -0.642 . . . . 73.4 109.268 173.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 91.67 59.25 1.36 Allowed Glycine 0 CA--C 1.533 1.174 0 CA-C-N 114.586 -1.188 . . . . 70.12 112.196 -173.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.78 135.96 11.73 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 122.213 1.942 . . . . 63.4 111.999 -177.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -76.2 -42.87 44.85 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.069 0.462 . . . . 72.43 110.413 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -128.46 173.72 19.06 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 115.712 -0.676 . . . . 74.31 112.473 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 38.3 t -153.1 162.65 41.07 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.214 1.006 . . . . 42.05 109.063 175.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 98.63 -179.32 31.67 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 116.497 -0.32 . . . . 73.31 113.661 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -142.4 -97.51 0.28 Allowed Glycine 0 C--N 1.343 0.926 0 N-CA-C 110.547 -1.021 . . . . 74.12 110.547 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 35.8 p -158.96 -61.49 0.07 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.576 0.75 . . . . 64.31 110.903 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 174.48 66.84 0.05 OUTLIER Glycine 0 C--N 1.344 1.005 0 N-CA-C 110.993 -0.843 . . . . 72.55 110.993 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -75.93 80.92 1.05 Allowed Glycine 0 C--N 1.352 1.421 0 N-CA-C 112.024 -0.43 . . . . 34.13 112.024 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.8 m -68.19 120.77 14.9 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 123.733 0.813 . . . . 71.42 110.414 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 69.31 26.31 74.69 Favored Glycine 0 C--N 1.347 1.187 0 O-C-N 123.709 0.63 . . . . 51.33 112.727 -174.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -62.44 107.95 1.85 Allowed Glycine 0 C--N 1.352 1.46 0 C-N-CA 123.157 0.408 . . . . 63.31 112.868 -176.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 19.7 m -129.65 19.23 5.67 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.14 0.976 . . . . 73.24 110.349 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -85.42 2.43 44.49 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.043 0.937 . . . . 35.32 111.153 -175.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -75.73 142.61 42.39 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.143 0.977 . . . . 51.05 109.11 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 88.9 mt -127.51 160.61 30.98 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.794 0.838 . . . . 63.5 110.326 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -129.99 119.92 23.95 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.274 -1.01 . . . . 73.25 108.274 173.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -126.66 132.9 51.09 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.666 1.186 . . . . 60.45 109.07 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 51.9 m -66.13 129.67 40.62 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.442 0.697 . . . . 74.5 110.369 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 41.5 tp -116.12 110.85 19.41 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 107.571 -1.27 . . . . 74.15 107.571 176.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -93.63 106.77 18.71 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.496 -0.927 . . . . 42.34 108.496 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 2.8 p -125.27 122.53 25.18 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 124.576 1.151 . . . . 53.52 109.02 -176.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.405 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 72.2 Cg_endo -71.51 158.38 54.05 Favored 'Trans proline' 0 C--N 1.372 1.764 0 C-N-CA 122.301 2.0 . . . . 62.24 111.277 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.98 -45.05 80.93 Favored Pre-proline 0 CA--C 1.571 1.759 0 N-CA-C 114.195 1.183 . . . . 74.03 114.195 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 75.8 Cg_exo -53.69 -54.65 4.5 Favored 'Trans proline' 0 C--N 1.399 3.198 0 C-N-CA 122.225 1.95 . . . . 72.32 113.572 173.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 49.3 mt -71.44 -25.29 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 122.999 0.52 . . . . 15.14 110.66 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.88 -40.53 83.55 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.241 0.616 . . . . 74.52 111.007 177.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 97.7 t -78.58 -56.3 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 CA-C-N 116.63 -0.259 . . . . 73.12 111.595 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.3 p -92.49 -25.77 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 112.675 0.62 . . . . 62.42 112.675 -170.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 96.18 156.81 31.39 Favored Glycine 0 N--CA 1.478 1.47 0 O-C-N 122.476 -0.14 . . . . 74.14 113.097 -176.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 169.65 -131.17 2.2 Favored Glycine 0 C--N 1.346 1.105 0 N-CA-C 111.7 -0.56 . . . . 50.45 111.7 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -134.55 141.71 46.76 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.187 0.995 . . . . 70.11 108.973 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.465 HG11 ' HA ' ' A' ' 199' ' ' VAL . 19.4 m -131.61 167.13 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 122.903 0.481 . . . . 73.34 110.732 176.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -82.03 107.28 14.61 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.526 -0.916 . . . . 75.52 108.526 170.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.02 133.54 48.79 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.317 0.647 . . . . 65.24 109.652 175.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 22.9 mmt -81.01 104.12 11.3 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 109.374 -0.602 . . . . 75.42 109.374 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 30.7 m -112.72 163.15 14.92 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 124.528 1.131 . . . . 63.43 109.039 -177.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 84.6 mt -67.98 -17.03 64.31 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 123.517 0.727 . . . . 75.35 112.037 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -80.37 -19.68 45.81 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.022 0.929 . . . . 75.04 111.028 173.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 126.24 177.32 14.83 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 110.678 -0.969 . . . . 74.43 110.678 -172.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.87 121.24 7.91 Favored 'Trans proline' 0 CA--C 1.554 1.504 0 C-N-CA 121.981 1.787 . . . . 70.04 110.819 174.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.45 HG23 HG23 ' A' ' 221' ' ' VAL . 35.0 m -124.81 161.0 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 123.324 0.65 . . . . 73.13 111.043 -173.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -85.47 105.75 16.31 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.013 -0.736 . . . . 74.22 109.013 177.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.45 HG23 HG23 ' A' ' 219' ' ' VAL . 49.7 t -102.76 129.16 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.599 0.759 . . . . 64.21 110.394 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.23 100.56 3.74 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 123.42 0.688 . . . . 73.31 110.278 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.478 ' HA ' HD12 ' A' ' 173' ' ' ILE . 58.6 t -88.14 131.56 42.36 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 124.599 1.16 . . . . 61.32 109.389 178.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 223' ' ' VAL . 3.4 Cg_exo -78.88 174.21 12.52 Favored 'Trans proline' 0 C--N 1.377 2.026 0 C-N-CA 123.677 2.918 . . . . 65.24 111.199 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -62.54 176.9 1.44 Allowed 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 121.993 1.795 . . . . 62.11 112.758 166.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 69.27 5.56 5.19 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 124.506 1.123 . . . . 70.2 112.947 172.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.453 ' HA ' ' CE2' ' A' ' 176' ' ' TYR . 87.8 m -66.05 97.57 0.38 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.896 0.878 . . . . 64.44 111.204 -171.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -101.83 141.7 34.27 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.049 1.34 . . . . 65.5 111.086 -171.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.04 141.98 57.78 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.159 0.984 . . . . 74.24 112.517 -174.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.71 -20.14 29.46 Favored Glycine 0 C--N 1.351 1.364 0 O-C-N 123.833 0.708 . . . . 74.44 113.659 178.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -77.23 160.61 28.79 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.067 0.547 . . . . 75.14 110.632 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 12.6 mptt -127.55 143.64 51.16 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.317 0.579 . . . . 63.42 109.985 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.621 HD13 HG21 ' A' ' 173' ' ' ILE . 23.3 mt -106.27 99.54 9.12 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.769 -1.105 . . . . 65.3 109.136 -170.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 42.8 ttm105 -73.74 102.03 3.86 Favored 'General case' 0 C--O 1.24 0.569 0 O-C-N 124.567 1.167 . . . . 74.55 110.437 -174.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.502 HD21 HG23 ' A' ' 173' ' ' ILE . 30.2 mt -105.82 94.6 5.28 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.476 -0.935 . . . . 44.14 108.476 177.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -70.21 140.21 52.42 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 122.845 0.458 . . . . 75.44 111.002 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 81.46 17.65 70.64 Favored Glycine 0 CA--C 1.528 0.892 0 O-C-N 123.918 0.762 . . . . 40.14 113.202 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -122.07 -11.81 8.42 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.437 0.695 . . . . 54.32 112.295 -175.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -77.88 -161.82 17.29 Favored Glycine 0 N--CA 1.48 1.61 0 CA-C-O 119.804 -0.442 . . . . 73.22 112.74 171.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -71.5 149.94 93.66 Favored Pre-proline 0 N--CA 1.484 1.257 0 CA-C-N 117.911 0.856 . . . . 63.44 111.6 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -64.07 140.74 73.53 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.909 2.406 . . . . 72.33 112.31 172.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -163.43 -164.38 18.4 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-O 119.251 -0.75 . . . . 71.41 111.714 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -65.5 -22.28 59.12 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 123.163 2.575 . . . . 71.12 112.879 -174.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -97.0 22.66 8.12 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.846 0.858 . . . . 74.43 111.527 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.46 -97.63 2.35 Favored Glycine 0 C--N 1.346 1.111 0 N-CA-C 110.793 -0.923 . . . . 31.25 110.793 -177.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -128.08 152.83 47.5 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 107.651 -1.24 . . . . 64.21 107.651 166.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -80.91 -158.07 18.46 Favored Glycine 0 C--N 1.34 0.8 0 O-C-N 123.435 0.46 . . . . 72.42 113.045 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -100.06 159.15 15.32 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.507 -0.553 . . . . 63.41 109.507 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 40.7 tp -126.68 108.37 11.03 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.51 -1.292 . . . . 75.32 107.51 172.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.511 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 15.0 m-85 -90.19 108.15 19.57 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.514 -0.921 . . . . 74.43 108.514 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 57.2 mt -87.2 105.53 17.27 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.982 -1.118 . . . . 72.11 107.982 174.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -78.74 112.3 15.73 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.503 -0.771 . . . . 70.33 109.842 -175.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 58.0 t -63.3 119.37 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 124.636 1.174 . . . . 75.23 111.726 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 49.7 mmm-85 -120.39 95.6 4.8 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 125.167 1.387 . . . . 72.51 107.495 173.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 49.8 mt -77.87 113.12 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 122.741 0.417 . . . . 74.24 110.509 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 75.0 p . . . . . 0 CA--C 1.559 1.299 0 C-N-CA 124.379 1.071 . . . . 72.04 108.714 177.625 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 52.8 ttm . . . . . 0 N--CA 1.473 0.699 0 CA-C-O 120.764 0.316 . . . . 65.02 110.285 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 67.1 m -137.21 120.3 16.64 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.612 -1.255 . . . . 71.12 107.612 173.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -83.74 77.55 9.85 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.548 0.739 . . . . 61.33 110.357 -175.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 10.1 mp -69.06 93.85 0.61 Allowed 'General case' 0 C--N 1.353 0.744 0 N-CA-C 109.093 -0.706 . . . . 74.2 109.093 173.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -79.8 120.18 23.71 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 107.568 -1.271 . . . . 75.31 107.568 168.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.611 ' HB ' ' HD3' ' A' ' 224' ' ' PRO . 76.3 mt -77.46 -78.05 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 122.795 0.438 . . . . 73.23 110.419 -177.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . 51.51 27.21 3.69 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.439 1.096 . . . . 65.21 113.272 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.576 ' H ' HG22 ' A' ' 173' ' ' ILE . . . -73.96 -1.15 18.6 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 113.718 1.007 . . . . 64.33 113.718 -169.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -78.53 -29.48 46.49 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.021 0.529 . . . . 73.44 110.041 170.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -93.08 158.67 24.0 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 119.03 -0.872 . . . . 21.34 111.271 167.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.4 106.64 0.6 Allowed 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 122.726 2.284 . . . . 72.33 111.985 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -138.09 151.7 48.07 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.786 0.834 . . . . 72.42 110.591 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 174.82 -168.9 41.73 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-N 115.582 -0.735 . . . . 73.41 112.067 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 34.6 t -82.45 -25.36 33.66 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.052 0.541 . . . . 75.41 110.119 173.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 153.61 -149.73 21.28 Favored Glycine 0 C--N 1.351 1.393 0 N-CA-C 111.445 -0.662 . . . . 74.24 111.445 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.473 ' HA3' ' HB3' ' A' ' 187' ' ' SER . . . 102.4 111.39 3.5 Favored Glycine 0 C--N 1.346 1.105 0 C-N-CA 122.954 0.311 . . . . 74.51 112.678 174.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 22.6 t -86.48 104.71 16.21 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 109.162 -0.681 . . . . 65.51 109.162 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 91.25 -62.59 2.81 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 116.419 -0.355 . . . . 74.31 112.231 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -128.48 153.13 19.45 Favored Glycine 0 C--N 1.347 1.144 0 N-CA-C 111.847 -0.501 . . . . 74.1 111.847 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.473 ' HB3' ' HA3' ' A' ' 183' ' ' GLY . 44.3 p -152.71 149.94 28.91 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.128 0.971 . . . . 74.43 109.835 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 75.56 -96.15 1.02 Allowed Glycine 0 CA--C 1.532 1.129 0 CA-C-O 119.909 -0.384 . . . . 52.03 113.119 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 123.27 59.19 0.19 Allowed Glycine 0 C--N 1.347 1.169 0 C-N-CA 123.479 0.562 . . . . 74.25 112.014 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 19.2 m 61.33 18.38 9.19 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.702 1.201 . . . . 64.15 111.928 -177.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -90.59 21.73 3.84 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.329 1.052 . . . . 75.43 111.018 -176.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -76.48 155.92 33.43 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.452 0.701 . . . . 75.53 111.276 -176.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 93.7 mt -128.74 152.93 47.88 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.147 0.979 . . . . 72.12 109.19 176.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -108.25 149.12 29.02 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.864 0.866 . . . . 74.35 108.852 172.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -155.03 136.1 13.86 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.972 0.909 . . . . 73.32 108.763 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 28.1 m -78.01 128.48 33.93 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.115 0.566 . . . . 55.32 109.888 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 22.0 tp -108.27 117.41 34.08 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.438 -0.579 . . . . 51.22 109.438 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -82.47 105.77 13.8 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.431 -0.951 . . . . 53.42 108.431 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.502 HG11 HG13 ' A' ' 253' ' ' VAL . 2.7 p -136.5 122.7 13.69 Favored Pre-proline 0 CA--C 1.548 0.888 0 N-CA-C 109.507 -0.553 . . . . 65.11 109.507 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.449 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 54.9 Cg_endo -72.11 160.65 46.86 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.194 1.93 . . . . 71.51 112.049 173.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.75 -51.72 63.4 Favored Pre-proline 0 CA--C 1.567 1.611 0 C-N-CA 124.46 1.104 . . . . 63.14 113.745 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 56.6 Cg_endo -65.62 -36.06 34.91 Favored 'Trans proline' 0 C--N 1.401 3.327 0 C-N-CA 121.624 1.549 . . . . 60.22 112.606 -176.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 23.0 mt -72.7 -31.7 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 122.766 0.426 . . . . 71.15 110.551 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.1 -42.15 89.69 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 122.691 0.397 . . . . 74.0 110.768 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 90.7 t -69.7 -53.02 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.096 0 C-N-CA 123.281 0.632 . . . . 73.15 111.695 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 28.0 m -79.58 -32.83 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 112.153 0.427 . . . . 51.53 112.153 -175.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.18 105.77 0.97 Allowed Glycine 0 C--N 1.343 0.934 0 CA-C-N 116.146 -0.479 . . . . 65.43 112.584 -173.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -148.46 -177.03 22.39 Favored Glycine 0 C--N 1.344 1.021 0 N-CA-C 112.074 -0.41 . . . . 51.35 112.074 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.645 ' HB3' ' HB2' ' A' ' 220' ' ' GLU . 50.2 mtmt -86.93 127.61 35.07 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 117.13 0.465 . . . . 75.11 110.497 -175.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 20.7 m -124.22 167.95 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 123.14 0.576 . . . . 63.53 111.555 -177.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -71.53 106.63 4.07 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 123.974 0.796 . . . . 62.42 110.232 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.83 115.76 30.86 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 107.95 -1.13 . . . . 53.13 107.95 166.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 63.3 mtt -72.97 104.93 4.25 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 109.255 -0.646 . . . . 63.21 109.255 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 38.1 m -110.99 162.23 15.06 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.715 1.206 . . . . 73.34 109.268 -173.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 96.4 mt -57.68 -23.25 50.51 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.967 0.907 . . . . 61.31 112.95 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -87.47 -20.83 26.03 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.26 0.624 . . . . 72.55 111.707 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 139.05 -171.93 23.39 Favored Glycine 0 C--N 1.345 1.036 0 CA-C-O 119.577 -0.568 . . . . 71.11 111.95 -176.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.6 117.79 4.66 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.21 1.94 . . . . 72.11 110.788 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.403 HG23 HG23 ' A' ' 221' ' ' VAL . 32.8 m -116.26 166.78 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.15 0.58 . . . . 71.44 109.687 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.645 ' HB2' ' HB3' ' A' ' 209' ' ' LYS . 8.5 pt-20 -107.52 105.12 14.86 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.721 0.772 . . . . 75.54 109.746 178.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.403 HG23 HG23 ' A' ' 219' ' ' VAL . 58.7 t -99.46 131.42 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.886 1.275 . . . . 75.53 109.841 -175.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.73 100.43 2.84 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.801 0.841 . . . . 43.54 110.553 -176.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.518 ' HA ' HD12 ' A' ' 173' ' ' ILE . 80.8 t -78.55 138.62 58.83 Favored Pre-proline 0 N--CA 1.478 0.973 0 C-N-CA 124.872 1.269 . . . . 72.31 109.321 175.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.611 ' HD3' ' HB ' ' A' ' 173' ' ' ILE . 88.1 Cg_endo -75.11 168.83 23.9 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 122.51 2.14 . . . . 65.33 111.506 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -68.35 172.71 10.77 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 121.421 1.414 . . . . 63.33 111.424 168.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 63.85 17.12 10.32 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.888 0.875 . . . . 73.54 112.071 174.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 53.7 m -75.01 133.18 41.71 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.943 0.897 . . . . 72.4 110.153 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -139.35 143.13 37.63 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.201 0.6 . . . . 51.33 110.846 -164.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.19 127.73 33.27 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 124.323 1.049 . . . . 65.51 111.373 -177.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 103.58 -21.84 37.67 Favored Glycine 0 N--CA 1.473 1.134 0 CA-C-N 115.902 -0.59 . . . . 71.04 112.719 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -75.81 141.98 42.36 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.082 0.553 . . . . 74.41 110.024 176.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.497 ' HG3' ' HG2' ' A' ' 252' ' ' GLU . 0.0 OUTLIER -108.38 127.57 54.0 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.497 0.719 . . . . 73.4 109.746 178.306 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.568 HD13 HG21 ' A' ' 173' ' ' ILE . 56.6 mt -90.6 96.88 10.87 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.9 -1.148 . . . . 73.23 107.9 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 30.4 ttp-105 -87.15 105.25 17.06 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 124.233 1.013 . . . . 74.15 110.24 -172.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.555 HD21 HG23 ' A' ' 173' ' ' ILE . 31.2 mt -99.85 94.82 6.52 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.602 -0.888 . . . . 72.41 108.602 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm -67.55 140.97 56.99 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.52 0.328 . . . . 74.34 110.554 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.06 28.41 56.38 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-N 116.097 -0.501 . . . . 74.03 113.642 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.451 ' HA ' ' HE2' ' A' ' 238' ' ' LYS . 9.3 mmpt? -127.54 -14.95 5.15 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.843 0.857 . . . . 74.53 112.801 -178.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -78.2 -152.98 6.23 Favored Glycine 0 N--CA 1.476 1.366 0 C-N-CA 122.736 0.207 . . . . 65.52 113.162 174.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -73.58 147.94 87.44 Favored Pre-proline 0 N--CA 1.485 1.296 0 C-N-CA 123.022 0.529 . . . . 71.31 111.28 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -59.81 143.36 99.63 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.94 2.427 . . . . 72.3 112.741 172.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -154.4 -170.33 20.12 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-O 119.391 -0.672 . . . . 64.4 112.913 -176.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.64 -40.22 67.05 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 123.411 2.741 . . . . 73.31 113.285 -174.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -103.97 22.02 15.34 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.477 0.711 . . . . 51.55 111.501 -177.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 104.7 -161.85 15.01 Favored Glycine 0 N--CA 1.473 1.139 0 CA-C-O 119.642 -0.532 . . . . 24.32 111.864 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 66.2 mtm-85 -75.71 146.4 40.16 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.365 0.582 . . . . 75.33 109.701 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -74.97 -157.25 5.79 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 116.405 -0.362 . . . . 74.11 112.994 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -97.37 170.02 9.36 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.071 0.548 . . . . 61.31 110.173 -175.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 29.4 tp -136.35 105.63 6.03 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 107.746 -1.205 . . . . 73.03 107.746 172.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -89.66 107.07 18.87 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.752 -0.833 . . . . 75.21 108.752 -178.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 71.9 mt -89.53 104.28 16.85 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.559 -1.275 . . . . 74.33 107.559 173.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.497 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 12.8 mt-10 -78.29 105.56 9.61 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.508 -0.769 . . . . 63.24 108.962 -173.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.502 HG13 HG11 ' A' ' 199' ' ' VAL . 61.3 t -59.62 104.21 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.82 0 O-C-N 124.073 0.858 . . . . 42.02 111.545 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -103.46 97.66 7.68 Favored 'General case' 0 C--O 1.248 1.017 0 N-CA-C 107.785 -1.191 . . . . 72.24 107.785 173.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 12.5 mt -75.02 114.73 15.39 Favored 'Isoleucine or valine' 0 C--N 1.356 0.853 0 O-C-N 123.958 0.786 . . . . 71.15 108.941 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 12.5 p . . . . . 0 C--O 1.256 1.423 0 C-N-CA 125.537 1.535 . . . . 72.15 108.16 -177.033 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 65.3 mtm . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 121.201 0.525 . . . . 63.24 110.98 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 23.2 t -153.74 117.6 4.74 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.943 -1.026 . . . . 71.42 108.282 175.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -59.06 -40.87 86.5 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 121.496 0.665 . . . . 54.02 109.912 176.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 85.4 mt -103.47 91.82 4.21 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.862 -1.063 . . . . 54.13 109.095 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 -64.92 110.32 2.4 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.86 -0.792 . . . . 72.01 108.86 177.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.591 ' HA ' HD22 ' A' ' 235' ' ' LEU . 65.4 mt -81.59 -81.16 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 119.034 -0.508 . . . . 74.11 111.102 -172.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . 52.49 28.48 6.0 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.971 0.908 . . . . 74.43 112.472 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.522 ' H ' HG22 ' A' ' 173' ' ' ILE . . . -81.56 -178.94 7.17 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.441 -0.799 . . . . 54.21 111.324 -177.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 68.64 33.35 3.88 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 125.143 1.377 . . . . 75.24 110.162 -174.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 175.57 179.4 46.07 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 114.569 -1.196 . . . . 72.51 111.23 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -64.94 109.42 1.29 Allowed 'Trans proline' 0 C--N 1.367 1.539 0 C-N-CA 122.458 2.105 . . . . 62.31 110.746 173.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 51.8 t60 -67.3 -44.05 80.16 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.719 0.408 . . . . 64.03 109.994 178.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 119.69 15.08 5.46 Favored Glycine 0 N--CA 1.476 1.356 0 CA-C-N 115.61 -0.723 . . . . 73.33 112.908 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 9.4 m -79.26 157.48 27.76 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.027 0.931 . . . . 73.22 111.728 -173.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -164.86 101.26 0.18 Allowed Glycine 0 C--N 1.352 1.439 0 N-CA-C 111.766 -0.534 . . . . 64.01 111.766 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 176.99 96.57 0.1 Allowed Glycine 0 C--N 1.346 1.105 0 N-CA-C 110.975 -0.85 . . . . 62.2 110.975 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 61.4 p -138.31 144.09 40.26 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.462 1.105 . . . . 43.42 109.868 -175.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 161.49 -84.83 0.11 Allowed Glycine 0 C--N 1.346 1.104 0 N-CA-C 111.134 -0.786 . . . . 60.3 111.134 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.549 ' HA3' ' HB2' ' A' ' 243' ' ' PRO . . . -90.8 82.95 1.3 Allowed Glycine 0 C--N 1.344 0.987 0 C-N-CA 122.884 0.278 . . . . 73.33 112.852 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 64.4 m -119.34 141.13 49.3 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.209 0.603 . . . . 73.32 110.673 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 167.6 172.97 35.28 Favored Glycine 0 CA--C 1.528 0.876 0 O-C-N 123.71 0.631 . . . . 40.24 111.968 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 83.09 -98.29 2.05 Favored Glycine 0 C--N 1.346 1.089 0 N-CA-C 112.042 -0.423 . . . . 74.15 112.042 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 62.5 m -152.54 35.88 0.51 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.992 0.917 . . . . 53.24 110.623 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.505 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 80.8 mt-30 -59.78 -43.74 94.25 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.792 0.437 . . . . 72.22 111.136 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -89.97 135.2 33.79 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.371 -0.603 . . . . 54.34 109.371 174.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 95.9 mt -131.72 129.09 40.22 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.022 0.929 . . . . 64.33 110.282 -172.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -92.6 119.95 32.55 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.926 -0.768 . . . . 73.23 108.926 173.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -130.73 128.53 41.01 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.703 1.201 . . . . 61.23 109.043 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 88.5 m -69.2 131.11 44.41 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.588 0.755 . . . . 71.15 111.451 -177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 42.3 tp -110.13 116.35 31.37 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.532 1.133 . . . . 75.21 108.476 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -92.11 109.39 20.75 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.475 -0.935 . . . . 74.32 108.475 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 3.4 p -130.92 122.87 19.63 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 124.198 0.999 . . . . 73.43 108.911 -178.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.87 156.56 65.44 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.08 1.853 . . . . 73.05 112.109 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -48.28 -46.22 67.22 Favored Pre-proline 0 CA--C 1.565 1.552 0 N-CA-C 114.569 1.322 . . . . 52.55 114.569 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.5 ' O ' HG22 ' A' ' 206' ' ' VAL . 17.9 Cg_endo -58.12 -52.7 5.3 Favored 'Trans proline' 0 C--N 1.4 3.283 0 C-N-CA 121.874 1.716 . . . . 74.14 112.245 176.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.8 mt -65.93 -30.88 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.429 0.692 . . . . 73.21 111.446 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.67 -54.64 24.71 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.416 0.686 . . . . 54.11 111.026 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 63.5 t -71.68 -53.52 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-N 115.93 -0.577 . . . . 71.12 111.626 -174.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 202' ' ' PRO . 15.5 m -90.3 -25.02 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 112.805 0.669 . . . . 53.52 112.805 -172.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 100.76 142.8 13.25 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 117.796 0.271 . . . . 54.3 112.639 -176.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -175.19 -141.49 3.73 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 111.149 -0.781 . . . . 74.33 111.149 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -133.27 143.14 48.89 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 117.737 0.768 . . . . 64.14 109.19 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 33.2 m -128.95 169.4 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.647 0.779 . . . . 74.43 110.234 173.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -99.3 112.47 24.63 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.129 0.972 . . . . 75.52 108.513 171.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -101.58 144.65 30.06 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.8 0.84 . . . . 65.24 109.692 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 21.1 mmt -91.77 103.57 16.12 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 109.039 -0.726 . . . . 74.52 109.039 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 61.7 m -117.88 164.14 15.49 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.639 1.176 . . . . 75.4 108.916 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.0 mt -59.3 -20.0 50.86 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 123.344 0.657 . . . . 75.01 112.048 173.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -81.87 4.72 21.32 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.62 1.168 . . . . 73.21 111.982 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 97.97 -163.74 21.4 Favored Glycine 0 C--N 1.344 1.011 0 C-N-CA 123.488 0.566 . . . . 72.45 111.822 -175.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.16 118.39 5.37 Favored 'Trans proline' 0 C--N 1.365 1.404 0 C-N-CA 122.026 1.818 . . . . 73.52 109.907 172.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 28.7 m -118.13 153.2 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.039 0.536 . . . . 72.14 111.113 -172.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -95.41 111.76 23.59 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.54 0.736 . . . . 73.43 109.37 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 48.7 t -112.58 116.23 52.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 123.837 0.855 . . . . 62.15 109.17 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.57 101.25 2.44 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 109.099 -0.704 . . . . 75.52 109.099 174.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 63.9 t -77.55 121.64 84.66 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.955 0.902 . . . . 62.3 109.472 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.66 169.83 21.42 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.657 2.238 . . . . 45.32 110.936 173.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.96 176.53 2.97 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.633 2.222 . . . . 74.24 113.778 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 55.5 mtm180 70.94 12.05 7.06 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 125.45 1.5 . . . . 72.51 113.081 174.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 12.5 m -72.37 93.35 1.51 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.072 0.949 . . . . 75.42 110.765 -174.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -91.83 140.09 30.03 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.61 1.164 . . . . 60.33 111.007 -173.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -64.23 139.19 58.74 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.259 1.024 . . . . 71.44 111.646 -176.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 93.14 -23.37 29.85 Favored Glycine 0 C--N 1.343 0.934 0 CA-C-N 115.129 -0.941 . . . . 35.1 112.812 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -72.84 145.19 47.12 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 122.909 0.484 . . . . 74.22 110.265 176.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.489 ' HG3' ' HG2' ' A' ' 252' ' ' GLU . 2.6 mppt? -104.44 139.49 39.3 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.827 -1.175 . . . . 71.21 107.827 173.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.531 HD13 HD13 ' A' ' 173' ' ' ILE . 42.6 mt -92.24 99.47 12.25 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.221 -1.399 . . . . 72.5 107.221 175.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 46.0 ttm180 -73.04 100.98 3.13 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.117 0.484 . . . . 70.11 109.704 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.591 HD22 ' HA ' ' A' ' 173' ' ' ILE . 17.9 mt -102.21 88.12 3.23 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.136 -1.061 . . . . 73.4 108.136 -178.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -68.38 129.94 41.41 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.07 -0.968 . . . . 63.42 110.519 -175.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 84.67 27.62 34.68 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 123.762 0.664 . . . . 73.44 113.452 -175.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -125.9 -6.86 6.69 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 123.278 0.631 . . . . 73.34 112.651 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -86.79 -155.28 27.11 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 112.363 -0.295 . . . . 50.2 112.363 175.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.505 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 12.8 m-85 -70.46 140.03 87.08 Favored Pre-proline 0 N--CA 1.481 1.116 0 CA-C-N 117.184 0.492 . . . . 74.4 110.358 177.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -66.75 152.9 79.66 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.702 2.268 . . . . 70.24 111.854 174.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -160.71 -170.89 25.92 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 115.477 -0.783 . . . . 63.43 111.619 177.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.549 ' HB2' ' HA3' ' A' ' 186' ' ' GLY . 24.6 Cg_exo -61.89 -32.86 85.29 Favored 'Trans proline' 0 CA--C 1.556 1.58 0 C-N-CA 123.299 2.666 . . . . 71.5 112.749 177.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -87.0 3.71 44.84 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.271 0.629 . . . . 64.43 111.811 177.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 99.29 -167.93 21.7 Favored Glycine 0 C--N 1.342 0.88 0 N-CA-C 111.527 -0.629 . . . . 61.55 111.527 -174.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 28.4 mtm-85 -71.46 139.71 49.75 Favored 'General case' 0 CA--C 1.546 0.788 0 N-CA-C 109.085 -0.709 . . . . 74.24 109.085 174.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.25 -165.18 19.34 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 123.373 0.42 . . . . 74.03 113.696 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -100.3 128.56 46.35 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.095 0.558 . . . . 73.31 109.633 -174.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 28.8 tp -99.04 107.78 20.28 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 107.847 -1.168 . . . . 73.23 107.847 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.428 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 47.8 m-85 -88.04 107.86 18.94 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.761 0.824 . . . . 73.31 109.011 -178.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 41.1 mt -87.08 105.43 17.16 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.441 -0.948 . . . . 74.21 108.441 175.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.489 ' HG2' ' HG3' ' A' ' 232' ' ' LYS . 33.3 mt-10 -77.6 94.17 4.33 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.297 -0.865 . . . . 63.22 108.79 -173.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 99.7 t -53.57 112.35 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 124.433 1.093 . . . . 64.21 111.323 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -117.32 100.88 7.98 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 108.094 -1.076 . . . . 73.3 108.094 175.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 43.0 mt -75.68 107.12 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 O-C-N 124.023 0.827 . . . . 61.21 108.965 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 16.2 p . . . . . 0 C--O 1.26 1.621 0 C-N-CA 124.897 1.279 . . . . 71.12 108.3 -179.066 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 25.1 mmt . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 109.835 -0.432 . . . . 75.5 109.835 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.9 m -81.74 70.77 8.7 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-O 121.696 0.76 . . . . 61.52 111.236 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -87.87 55.26 3.4 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.257 1.023 . . . . 64.43 109.714 175.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.464 HD22 HG22 ' A' ' 221' ' ' VAL . 6.6 mp 53.15 59.21 4.58 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.193 -1.367 . . . . 72.42 110.648 -177.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.554 HH11 ' HB1' ' A' ' 222' ' ' ALA . 30.3 mmm180 -68.62 99.91 1.06 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.231 -1.349 . . . . 73.35 108.975 176.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.71 HG23 HD21 ' A' ' 235' ' ' LEU . 69.1 mt -59.68 -69.87 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 123.488 0.715 . . . . 65.32 110.355 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . 52.42 29.21 6.65 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.204 1.002 . . . . 73.15 113.037 177.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.509 ' H ' HG22 ' A' ' 173' ' ' ILE . . . -64.99 -32.29 73.94 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 124.257 1.023 . . . . 50.2 112.583 -173.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -74.71 87.99 2.22 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.108 -1.071 . . . . 74.52 108.108 170.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -173.12 153.96 19.41 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 115.509 -0.769 . . . . 73.33 112.135 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.2 -16.66 56.22 Favored 'Trans proline' 0 CA--C 1.557 1.633 0 C-N-CA 123.212 2.608 . . . . 75.41 113.079 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -80.82 11.55 3.84 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.837 0.855 . . . . 53.15 112.824 -176.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -64.81 -28.5 73.47 Favored Glycine 0 N--CA 1.477 1.399 0 N-CA-C 113.773 0.269 . . . . 63.51 113.773 173.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 29.2 m -84.19 140.75 31.51 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.344 0.657 . . . . 55.23 109.775 174.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 163.97 -26.73 0.21 Allowed Glycine 0 C--N 1.347 1.172 0 N-CA-C 112.346 -0.302 . . . . 63.33 112.346 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -71.82 155.93 52.26 Favored Glycine 0 C--N 1.352 1.443 0 CA-C-O 119.843 -0.421 . . . . 55.44 112.625 -178.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 20.3 m -60.49 -43.53 96.91 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.695 0.798 . . . . 72.35 112.248 -176.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -167.71 149.96 15.67 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 111.78 -0.528 . . . . 63.24 111.78 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -101.21 67.47 0.46 Allowed Glycine 0 C--N 1.348 1.196 0 N-CA-C 111.705 -0.558 . . . . 70.3 111.705 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 39.5 m -137.89 119.52 15.04 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.514 0.726 . . . . 65.41 109.374 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -153.64 -68.82 0.01 OUTLIER Glycine 0 C--N 1.343 0.948 0 N-CA-C 111.279 -0.728 . . . . 54.34 111.279 176.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 75.56 9.23 84.67 Favored Glycine 0 C--N 1.346 1.127 0 C-N-CA 122.927 0.298 . . . . 61.25 113.108 -173.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 61.4 m -154.92 -50.05 0.09 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.685 0.794 . . . . 73.01 109.916 -175.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.645 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 23.0 mp0 -69.99 -40.2 75.46 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.695 -0.684 . . . . 54.21 110.863 -176.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -76.68 132.29 39.28 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.888 -0.782 . . . . 60.11 108.888 172.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 91.4 mt -133.05 167.92 19.43 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.234 0.614 . . . . 72.13 110.519 -171.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -121.21 125.87 48.23 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 107.553 -1.277 . . . . 75.22 107.553 168.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -124.08 127.27 47.59 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.606 0.762 . . . . 33.34 109.15 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 43.4 m -67.49 118.46 10.83 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.81 0.844 . . . . 64.14 110.919 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 21.9 tp -109.47 110.78 21.99 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 108.531 -0.915 . . . . 71.42 108.531 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -88.24 127.25 35.45 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.206 -1.035 . . . . 75.13 108.206 174.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 3.0 p -141.85 127.59 10.84 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 124.298 1.039 . . . . 75.12 108.367 -176.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -69.5 155.25 67.31 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 121.543 1.495 . . . . 74.42 111.346 175.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.446 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -47.21 -50.65 46.43 Favored Pre-proline 0 CA--C 1.559 1.32 0 O-C-N 124.341 1.025 . . . . 64.22 113.657 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.411 ' O ' HG12 ' A' ' 206' ' ' VAL . 30.5 Cg_endo -60.72 -48.79 10.0 Favored 'Trans proline' 0 C--N 1.395 2.988 0 C-N-CA 121.933 1.755 . . . . 74.41 112.622 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 44.0 mt -66.56 -27.38 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.645 0.778 . . . . 73.21 111.384 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.33 -47.91 58.9 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.169 0.588 . . . . 74.41 111.194 176.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 201' ' ' ALA . 81.2 t -67.9 -48.91 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.329 0.651 . . . . 65.12 111.841 -176.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 202' ' ' PRO . 7.9 p -83.95 -29.1 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 CA-C-N 116.44 -0.346 . . . . 72.33 110.895 -175.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.61 86.07 0.64 Allowed Glycine 0 C--N 1.349 1.265 0 N-CA-C 111.559 -0.616 . . . . 64.35 111.559 -174.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -111.29 -122.94 4.31 Favored Glycine 0 C--N 1.344 1.02 0 N-CA-C 111.953 -0.459 . . . . 63.23 111.953 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 221' ' ' VAL . 95.9 mttt -136.99 149.84 47.76 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.914 0.885 . . . . 73.1 109.601 176.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 23.3 m -136.3 162.84 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 123.247 0.619 . . . . 71.43 111.461 177.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -86.3 106.53 17.43 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.565 0.746 . . . . 74.15 109.171 174.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -109.8 151.55 26.84 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.036 0.534 . . . . 51.03 110.756 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 31.8 mmt -83.55 111.3 18.96 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 123.898 0.749 . . . . 72.24 108.979 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 215' ' ' LEU . 3.4 m -126.83 176.4 7.31 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 108.581 -0.896 . . . . 73.32 108.581 -177.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.428 ' H ' HG22 ' A' ' 214' ' ' THR . 73.8 mt -59.89 -40.88 90.21 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.587 0.755 . . . . 75.24 112.652 -175.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -81.1 -3.38 51.78 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.308 0.643 . . . . 65.4 112.012 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 110.49 -151.76 17.5 Favored Glycine 0 C--N 1.343 0.94 0 CA-C-O 119.544 -0.587 . . . . 74.42 112.251 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.63 126.99 17.06 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 122.627 2.218 . . . . 65.35 112.316 177.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 32.8 m -129.59 162.78 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.509 0.724 . . . . 53.43 110.058 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -95.42 105.55 17.53 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 121.584 0.707 . . . . 72.41 109.991 175.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.464 HG22 HD22 ' A' ' 171' ' ' LEU . 55.3 t -99.77 126.77 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.793 0.837 . . . . 71.1 109.838 -174.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.554 ' HB1' HH11 ' A' ' 172' ' ' ARG . . . -76.63 100.01 5.22 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 123.946 0.779 . . . . 64.44 110.893 -177.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.561 ' HA ' HD12 ' A' ' 173' ' ' ILE . 59.5 t -69.25 141.94 91.98 Favored Pre-proline 0 CA--C 1.56 1.363 0 C-N-CA 125.662 1.585 . . . . 72.44 110.492 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.61 ' HD3' ' HB ' ' A' ' 173' ' ' ILE . 90.0 Cg_endo -76.88 163.12 31.61 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 122.313 2.008 . . . . 60.11 110.855 173.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.55 160.99 45.32 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 121.471 1.447 . . . . 63.02 111.207 172.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 69.24 14.24 8.6 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.762 1.225 . . . . 52.42 112.651 177.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 85.2 m -62.16 113.18 2.71 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.843 0.857 . . . . 53.13 110.438 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -112.92 141.2 47.03 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.916 0.886 . . . . 74.22 110.602 -168.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.52 144.02 57.33 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.778 0.831 . . . . 75.45 111.377 -177.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.03 -22.65 13.56 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.303 -0.862 . . . . 44.13 113.035 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -79.58 150.32 31.1 Favored 'General case' 0 C--N 1.351 0.657 0 N-CA-C 109.438 -0.578 . . . . 61.14 109.438 173.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.662 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.4 mppt? -114.53 142.87 45.84 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.041 0.536 . . . . 62.42 109.852 177.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.634 HD13 HG21 ' A' ' 173' ' ' ILE . 46.2 mt -100.09 99.42 10.14 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.683 -0.858 . . . . 51.12 108.683 -176.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 27.3 ttm-85 -75.06 113.97 13.0 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 123.479 0.487 . . . . 74.12 109.936 -176.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.71 HD21 HG23 ' A' ' 173' ' ' ILE . 46.0 mt -120.54 102.06 8.17 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.509 0.724 . . . . 65.1 109.237 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -67.62 140.12 56.87 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.879 0.472 . . . . 74.24 111.581 -176.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.431 ' HA2' ' HB2' ' A' ' 246' ' ' ARG . . . 84.32 9.83 81.17 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 115.788 -0.642 . . . . 61.53 114.302 178.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -104.65 -16.47 14.98 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 117.682 0.741 . . . . 61.4 111.8 -176.802 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -81.15 -161.69 27.19 Favored Glycine 0 CA--C 1.535 1.293 0 O-C-N 123.535 0.522 . . . . 45.14 112.86 173.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.645 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 27.8 m-85 -65.98 151.28 95.54 Favored Pre-proline 0 N--CA 1.487 1.395 0 C-N-CA 123.373 0.669 . . . . 75.42 111.657 -178.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.458 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 37.9 Cg_endo -64.6 128.99 22.41 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.885 2.39 . . . . 64.0 112.708 176.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -98.32 -156.06 29.58 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 119.233 -0.759 . . . . 42.23 112.19 176.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -59.11 -61.32 0.25 Allowed 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 122.977 2.451 . . . . 73.43 112.497 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -122.22 -13.08 8.18 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.686 0.794 . . . . 61.31 111.941 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -142.15 146.39 17.35 Favored Glycine 0 C--N 1.344 0.984 0 N-CA-C 111.732 -0.547 . . . . 75.33 111.732 -178.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.458 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 86.8 mtt180 -74.87 162.72 28.38 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.597 0.759 . . . . 74.14 110.231 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.8 173.98 55.27 Favored Glycine 0 C--N 1.342 0.916 0 CA-C-N 115.94 -0.573 . . . . 60.22 112.969 177.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -103.44 130.95 50.89 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.742 0.817 . . . . 62.4 110.631 -175.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 53.5 tp -102.94 117.42 34.56 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 123.86 0.864 . . . . 62.55 109.118 -173.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.662 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 19.5 m-85 -89.12 111.74 22.56 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.473 -0.936 . . . . 75.13 108.473 177.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.489 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 60.0 mt -85.85 111.57 20.31 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.642 -0.873 . . . . 55.05 108.642 175.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.405 ' HA ' ' HG3' ' A' ' 232' ' ' LYS . 31.6 mt-10 -76.05 101.43 5.28 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.237 -0.892 . . . . 74.23 108.971 -175.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 44.9 t -61.58 111.39 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 O-C-N 123.577 0.548 . . . . 63.21 110.84 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -114.0 93.6 4.44 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 106.598 -1.63 . . . . 75.41 106.598 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 26.9 mt -76.25 118.07 21.96 Favored 'Isoleucine or valine' 0 C--N 1.349 0.586 0 N-CA-C 109.405 -0.591 . . . . 53.42 109.405 -177.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 19.6 p . . . . . 0 C--O 1.253 1.275 0 C-N-CA 125.232 1.413 . . . . 65.44 107.922 -176.751 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 28.5 mmt . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 110.473 -0.195 . . . . 75.22 110.473 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 32.9 m -95.8 -83.72 0.36 Allowed 'General case' 0 C--N 1.35 0.607 0 N-CA-C 108.379 -0.971 . . . . 61.42 108.379 167.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 58.03 18.99 5.56 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.582 1.153 . . . . 74.23 112.837 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 8.6 mp -61.24 87.3 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 123.196 0.598 . . . . 62.11 110.429 -176.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -78.94 135.32 36.92 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.272 0.629 . . . . 64.03 109.493 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.719 HD12 ' HA ' ' A' ' 223' ' ' VAL . 97.4 mt -84.8 -73.44 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-N 115.582 -0.735 . . . . 55.42 110.32 -176.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . 61.03 5.35 0.99 Allowed 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 113.925 1.083 . . . . 52.11 113.925 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.599 ' H ' HG22 ' A' ' 173' ' ' ILE . . . -70.56 -21.24 62.72 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.135 0.974 . . . . 62.42 112.108 -172.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.412 ' HE1' ' HA ' ' A' ' 227' ' ' THR . 12.3 m-30 -70.62 104.36 2.79 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.597 -0.52 . . . . 75.1 109.597 173.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 145.4 175.7 18.74 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.382 -1.087 . . . . 61.33 110.382 -176.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.3 -29.07 72.6 Favored 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 122.766 2.311 . . . . 75.2 112.867 175.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -143.74 129.36 19.18 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.544 0.738 . . . . 71.41 109.875 178.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -88.64 -91.51 1.11 Allowed Glycine 0 C--N 1.348 1.205 0 N-CA-C 110.543 -1.023 . . . . 52.25 110.543 172.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 36.7 t -86.23 123.61 31.69 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.705 -0.85 . . . . 71.54 108.705 171.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -94.14 31.9 6.32 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-O 119.694 -0.503 . . . . 71.01 113.901 -175.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -69.2 91.87 0.3 Allowed Glycine 0 C--N 1.351 1.395 0 N-CA-C 111.384 -0.687 . . . . 73.44 111.384 174.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 25.9 t -62.72 93.73 0.06 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.092 0.957 . . . . 44.12 111.362 -174.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.462 ' HA3' ' HB2' ' A' ' 244' ' ' ALA . . . -121.08 2.17 11.64 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 115.344 -0.844 . . . . 72.42 112.102 176.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 70.9 -85.28 0.38 Allowed Glycine 0 C--N 1.351 1.398 0 N-CA-C 111.885 -0.486 . . . . 72.05 111.885 -175.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.3 p -171.51 153.94 3.65 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.586 1.154 . . . . 74.31 109.528 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -111.78 -43.54 0.95 Allowed Glycine 0 C--N 1.344 1.0 0 N-CA-C 112.165 -0.374 . . . . 54.32 112.165 177.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 140.56 -131.47 5.01 Favored Glycine 0 C--N 1.354 1.545 0 C-N-CA 123.186 0.422 . . . . 54.12 112.238 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 27.5 m -81.92 25.32 0.57 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.949 0.9 . . . . 73.21 112.04 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -81.24 1.82 30.65 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.945 0.898 . . . . 63.43 112.154 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -80.1 159.43 26.1 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.623 0.769 . . . . 72.43 110.934 174.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 49.2 mt -139.35 150.68 45.63 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.79 0.836 . . . . 62.22 109.832 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -107.49 122.21 46.17 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.973 -0.751 . . . . 73.41 108.973 173.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -129.41 137.13 50.74 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.438 0.695 . . . . 74.13 109.248 178.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 96.2 m -71.73 131.67 43.45 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.862 0.465 . . . . 65.34 110.815 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.459 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 53.8 tp -108.25 123.88 49.44 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.255 -1.017 . . . . 61.13 108.255 175.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -88.65 117.53 27.68 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 108.488 -0.93 . . . . 61.42 108.488 176.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 4.4 p -140.48 125.84 11.3 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 109.057 -0.72 . . . . 72.41 109.057 178.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.61 154.41 54.76 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 122.136 1.891 . . . . 62.24 111.749 175.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.68 -45.34 91.56 Favored Pre-proline 0 CA--C 1.562 1.427 0 N-CA-C 114.629 1.344 . . . . 73.32 114.629 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -56.24 -52.69 6.64 Favored 'Trans proline' 0 C--N 1.392 2.827 0 C-N-CA 121.914 1.743 . . . . 55.42 113.099 174.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 32.8 mt -67.02 -27.66 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.218 0.607 . . . . 74.42 111.167 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -66.31 -48.83 69.08 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-O 121.26 0.553 . . . . 43.23 110.839 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 71.1 t -69.21 -46.29 77.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-N 115.798 -0.637 . . . . 71.13 111.764 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 14.4 m -86.6 -29.87 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 112.287 0.477 . . . . 61.22 112.287 -172.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.89 116.39 0.54 Allowed Glycine 0 CA--C 1.531 1.053 0 O-C-N 123.322 0.389 . . . . 64.23 113.298 -173.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -165.11 -177.68 37.78 Favored Glycine 0 N--CA 1.473 1.108 0 N-CA-C 111.687 -0.565 . . . . 72.24 111.687 176.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -80.86 136.01 36.01 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 118.113 0.957 . . . . 72.21 109.994 -176.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 27.6 m -124.91 168.56 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 123.644 0.778 . . . . 72.21 111.15 178.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 55.2 ttp85 -83.4 131.65 35.03 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.288 -0.869 . . . . 75.35 110.019 173.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -134.35 159.74 40.07 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.25 0.62 . . . . 63.12 110.457 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 15.9 tpt -88.0 123.4 32.67 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.13 0.572 . . . . 63.11 110.717 -177.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.434 HG22 ' H ' ' A' ' 216' ' ' GLU . 50.8 m -144.52 161.06 40.03 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.964 0.906 . . . . 64.14 108.652 178.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 68.2 mt -63.78 -19.15 64.77 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.8 0.84 . . . . 65.43 111.763 176.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.434 ' H ' HG22 ' A' ' 214' ' ' THR . 3.2 mp0 -93.51 15.06 16.88 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.828 1.251 . . . . 72.02 111.155 175.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 90.54 -164.85 30.71 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-O 119.746 -0.475 . . . . 73.02 113.297 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.31 118.93 5.92 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.575 2.184 . . . . 51.43 111.616 174.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.7 m -113.06 149.78 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 123.023 0.529 . . . . 70.52 110.882 -176.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -82.29 114.85 21.06 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.643 0.777 . . . . 74.41 110.227 177.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 98.4 t -109.16 116.36 51.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.96 0.904 . . . . 72.01 109.308 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.84 100.64 2.44 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.573 0.749 . . . . 72.43 110.563 -177.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.719 ' HA ' HD12 ' A' ' 173' ' ' ILE . 69.4 t -77.35 134.61 66.48 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 124.54 1.136 . . . . 74.25 110.273 178.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.88 171.54 17.8 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 122.958 2.439 . . . . 73.32 110.905 172.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -71.38 168.52 23.24 Favored 'Trans proline' 0 C--N 1.366 1.485 0 CA-C-N 120.614 1.255 . . . . 64.0 111.3 170.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 14.9 mtm180 66.92 20.21 10.54 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 124.042 0.937 . . . . 75.22 112.29 173.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.412 ' HA ' ' HE1' ' A' ' 176' ' ' TYR . 99.8 m -69.56 113.28 6.7 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.698 0.799 . . . . 73.51 111.011 -178.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -115.32 141.81 47.54 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.112 -0.949 . . . . 72.14 110.125 -169.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.45 133.81 54.57 Favored 'General case' 0 C--N 1.35 0.611 0 C-N-CA 123.58 0.752 . . . . 71.52 111.665 -176.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.71 -15.12 61.28 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-N 115.332 -0.849 . . . . 54.2 113.159 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -77.02 124.6 28.02 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.798 0.439 . . . . 71.33 110.143 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.4 mppt? -88.05 143.9 26.82 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.041 0.536 . . . . 75.1 110.022 173.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.714 HD13 HD13 ' A' ' 173' ' ' ILE . 33.9 mt -109.27 103.28 12.21 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.299 -0.864 . . . . 64.31 109.224 -173.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -69.91 103.48 2.24 Favored 'General case' 0 CA--C 1.551 1.006 0 O-C-N 124.096 0.872 . . . . 74.43 111.121 -176.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 32.4 mt -119.45 94.34 4.38 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.611 0.764 . . . . 64.41 110.223 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -71.26 154.62 41.5 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.703 0.401 . . . . 61.22 111.289 178.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 82.11 18.4 67.29 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-N 115.992 -0.549 . . . . 53.51 113.987 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.477 ' HA ' ' HE2' ' A' ' 238' ' ' LYS . 11.3 mmpt? -118.87 -41.34 2.78 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 123.461 0.704 . . . . 60.41 111.718 -177.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -71.91 -153.97 1.83 Allowed Glycine 0 N--CA 1.485 1.916 0 N-CA-C 114.625 0.61 . . . . 73.24 114.625 -176.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -64.05 136.9 96.94 Favored Pre-proline 0 N--CA 1.485 1.296 0 C-N-CA 123.517 0.727 . . . . 74.41 110.813 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.765 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 18.6 Cg_endo -56.96 125.93 20.59 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 123.204 2.603 . . . . 74.41 113.97 -174.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -126.18 -169.84 12.88 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.505 -0.77 . . . . 62.32 113.311 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -69.25 -12.8 34.72 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 123.098 2.532 . . . . 70.11 112.611 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.462 ' HB2' ' HA3' ' A' ' 185' ' ' GLY . . . -102.42 23.3 12.04 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.491 1.116 . . . . 74.22 110.992 177.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 98.39 -87.62 0.83 Allowed Glycine 0 C--N 1.345 1.061 0 N-CA-C 110.473 -1.051 . . . . 63.14 110.473 -174.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.765 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 28.8 mtm180 -125.57 172.82 9.41 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 123.238 0.615 . . . . 54.5 109.774 172.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -84.25 -158.73 28.4 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 114.922 -1.035 . . . . 74.52 113.565 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -99.77 162.09 13.21 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.836 0.454 . . . . 51.24 109.95 -170.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 40.6 tp -141.98 108.78 5.4 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 108.271 -1.011 . . . . 53.04 108.271 173.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.476 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 78.4 m-85 -88.74 108.13 19.32 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 108.732 -0.84 . . . . 73.01 108.732 175.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 38.9 mt -86.92 114.98 24.01 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.704 -0.85 . . . . 74.34 108.704 177.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -78.26 102.92 7.88 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.781 0.832 . . . . 63.45 109.365 -178.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 84.7 t -56.0 111.97 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 O-C-N 123.771 0.669 . . . . 74.04 110.68 175.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -113.4 101.8 9.72 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.288 -1.004 . . . . 71.4 108.288 172.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 37.1 mt -76.34 103.7 3.93 Favored 'Isoleucine or valine' 0 C--N 1.35 0.621 0 O-C-N 124.206 0.941 . . . . 65.34 109.004 177.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 46.7 p . . . . . 0 C--O 1.254 1.326 0 CA-C-N 115.506 -0.77 . . . . 73.32 109.07 176.09 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 87.9 mtp . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.72 0.295 . . . . 75.43 110.205 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 45.4 t -148.13 151.28 35.33 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 123.896 0.878 . . . . 74.15 108.962 176.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -67.05 -49.95 63.45 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 123.916 0.76 . . . . 62.44 109.179 174.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.479 ' HA ' ' HD2' ' A' ' 238' ' ' LYS . 6.5 mp -89.41 71.8 8.05 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.448 -0.945 . . . . 64.03 108.448 172.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.06 105.74 5.43 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 107.364 -1.347 . . . . 73.32 107.364 176.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.607 HD12 ' HA ' ' A' ' 223' ' ' VAL . 49.3 mt -72.85 100.12 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.207 0.527 . . . . 74.53 110.788 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -92.74 35.33 1.04 Allowed 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.144 -0.934 . . . . 62.5 109.625 171.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.403 ' H ' HG22 ' A' ' 173' ' ' ILE . . . -121.71 177.7 5.15 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.713 1.205 . . . . 43.3 108.789 176.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.498 ' CE2' HD21 ' A' ' 233' ' ' LEU . 24.2 m-85 66.83 19.64 10.66 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.543 1.137 . . . . 61.35 110.846 -164.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -110.57 -132.59 6.23 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-O 119.155 -0.803 . . . . 63.31 111.866 -178.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -86.14 171.28 7.92 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 122.876 2.384 . . . . 75.54 113.315 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -127.38 123.49 36.33 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.322 1.049 . . . . 73.34 109.715 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 153.15 -32.78 0.79 Allowed Glycine 0 C--N 1.343 0.94 0 N-CA-C 111.71 -0.556 . . . . 44.23 111.71 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 22.9 p -67.36 102.68 1.13 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.508 0.723 . . . . 75.14 109.314 175.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 148.72 59.63 0.01 OUTLIER Glycine 0 C--N 1.338 0.656 0 N-CA-C 109.711 -1.356 . . . . 61.34 109.711 -173.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -129.26 -7.55 3.96 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.329 -0.436 . . . . 72.01 113.195 -178.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 95.6 p -73.92 152.62 40.1 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 117.182 0.491 . . . . 74.43 110.06 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -82.73 79.34 1.91 Allowed Glycine 0 CA--C 1.528 0.855 0 CA-C-O 119.81 -0.439 . . . . 64.41 112.677 -177.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -68.78 111.13 3.76 Favored Glycine 0 C--N 1.356 1.679 0 N-CA-C 111.741 -0.544 . . . . 74.21 111.741 176.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 48.0 m -125.04 102.46 7.52 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.7 0.8 . . . . 51.14 110.594 -177.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -163.02 -45.04 0.02 OUTLIER Glycine 0 C--N 1.338 0.693 0 N-CA-C 111.901 -0.479 . . . . 54.55 111.901 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 124.92 -132.02 7.97 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 111.365 -0.694 . . . . 63.41 111.365 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 67.5 m -88.52 68.79 8.83 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.369 0.668 . . . . 65.31 112.063 -175.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.59 -20.86 24.45 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 108.786 -0.82 . . . . 61.54 108.786 162.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -75.83 130.4 38.51 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.656 1.583 . . . . 74.54 108.943 176.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.467 HD12 ' HA2' ' A' ' 239' ' ' GLY . 92.8 mt -135.67 163.91 29.07 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.861 0.864 . . . . 63.52 110.697 -175.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -121.52 153.5 37.9 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.252 1.021 . . . . 41.12 108.962 171.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.444 ' HB2' HD11 ' A' ' 249' ' ' LEU . . . -152.78 171.29 18.47 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.551 1.14 . . . . 62.2 109.366 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 25.0 m -106.8 131.68 53.64 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.489 0.716 . . . . 52.41 109.485 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.722 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 42.8 tp -109.02 113.84 27.06 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.594 0.758 . . . . 71.22 109.008 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -83.66 116.85 22.83 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 107.75 -1.204 . . . . 64.41 107.75 172.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.455 HG11 HG13 ' A' ' 253' ' ' VAL . 2.4 p -138.15 120.54 10.85 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 123.794 0.837 . . . . 73.13 109.281 -178.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.1 158.42 56.58 Favored 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 122.218 1.946 . . . . 73.24 112.311 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.402 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -51.38 -48.56 85.8 Favored Pre-proline 0 CA--C 1.565 1.545 0 C-N-CA 124.459 1.103 . . . . 74.13 113.87 -177.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.474 ' O ' HG12 ' A' ' 206' ' ' VAL . 53.7 Cg_exo -54.24 -54.38 4.77 Favored 'Trans proline' 0 C--N 1.401 3.296 0 C-N-CA 122.377 2.051 . . . . 72.51 112.687 175.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 58.1 mt -67.62 -27.98 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.267 0.627 . . . . 51.01 111.041 -176.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.59 -41.59 96.15 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.199 -0.455 . . . . 52.41 110.416 176.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 201' ' ' ALA . 64.3 t -74.86 -57.57 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 CA-C-N 116.545 -0.298 . . . . 70.22 111.63 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 202' ' ' PRO . 12.4 p -93.14 -28.48 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 112.666 0.617 . . . . 74.13 112.666 -167.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 98.12 144.99 18.05 Favored Glycine 0 N--CA 1.477 1.388 0 C-N-CA 122.472 0.082 . . . . 71.34 113.183 -177.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 170.23 -167.76 40.84 Favored Glycine 0 N--CA 1.472 1.058 0 N-CA-C 110.664 -0.974 . . . . 74.13 110.664 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -96.88 138.28 34.68 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 118.336 1.068 . . . . 54.42 110.939 175.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 220' ' ' GLU . 15.4 m -119.85 170.19 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.448 1.099 . . . . 63.12 109.764 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -102.03 112.24 24.82 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 110.021 -0.363 . . . . 74.23 110.021 174.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -105.34 166.44 10.42 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.983 0.913 . . . . 64.44 109.817 171.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 91.3 mmm -101.96 132.81 47.55 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 120.911 0.386 . . . . 62.42 110.276 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 88.1 m -132.79 167.51 20.03 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.869 1.268 . . . . 63.43 108.547 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 82.6 mt -54.83 -38.78 67.83 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.991 0.917 . . . . 63.32 112.665 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -78.25 -15.6 58.63 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.063 0.545 . . . . 65.23 111.799 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 132.78 -164.27 24.07 Favored Glycine 0 C--N 1.344 1.027 0 O-C-N 123.617 0.573 . . . . 71.54 111.727 -177.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.47 128.72 12.16 Favored 'Trans proline' 0 CA--C 1.555 1.538 0 C-N-CA 122.79 2.327 . . . . 53.14 112.007 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.32 159.89 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.322 1.049 . . . . 72.31 110.015 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 210' ' ' VAL . 37.7 mt-10 -84.83 147.47 26.8 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 122.78 0.432 . . . . 74.45 110.599 169.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.438 HG22 ' HB2' ' A' ' 171' ' ' LEU . 96.9 t -130.75 124.23 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.163 1.385 . . . . 65.0 108.46 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -77.59 99.28 5.69 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 108.937 -0.764 . . . . 73.35 108.937 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.607 ' HA ' HD12 ' A' ' 173' ' ' ILE . 88.2 t -96.2 123.33 55.34 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.504 1.122 . . . . 74.02 110.566 -175.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.0 164.2 36.42 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.739 2.292 . . . . 70.35 111.384 175.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.87 177.0 0.37 Allowed 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 122.714 2.276 . . . . 65.22 113.418 174.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 24.0 mtp180 66.03 20.63 11.27 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.35 1.06 . . . . 63.33 112.324 174.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -68.86 88.69 0.38 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.686 0.794 . . . . 62.41 110.473 -173.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 -86.28 131.3 34.25 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.894 1.278 . . . . 73.03 110.573 -172.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.99 120.29 8.82 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.407 1.083 . . . . 62.34 111.97 -175.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.0 -4.51 41.72 Favored Glycine 0 N--CA 1.473 1.148 0 O-C-N 123.835 0.71 . . . . 73.42 114.386 176.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -84.62 157.32 21.2 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 117.552 0.676 . . . . 62.22 109.977 173.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.706 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.5 mppt? -127.3 131.55 50.47 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.943 -0.762 . . . . 74.21 108.943 -172.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.498 HD21 ' CE2' ' A' ' 176' ' ' TYR . 20.4 mt -108.56 102.43 11.5 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.601 -0.727 . . . . 72.45 109.791 -166.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -70.48 103.69 2.54 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.117 1.367 . . . . 75.13 110.939 -173.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.601 HD11 HG12 ' A' ' 173' ' ' ILE . 26.6 mt -118.19 100.16 7.33 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 122.944 0.498 . . . . 73.11 112.045 -175.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -56.52 142.06 40.51 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.162 0.801 . . . . 71.24 113.162 169.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 100.09 -14.12 60.04 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-N 113.649 -1.614 . . . . 74.44 112.665 174.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.479 ' HD2' ' HA ' ' A' ' 171' ' ' LEU . 11.4 mmpt? -99.89 -20.04 16.34 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.918 0.487 . . . . 70.22 111.967 -171.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . 0.467 ' HA2' HD12 ' A' ' 193' ' ' LEU . . . -77.92 -162.26 18.5 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.496 0.498 . . . . 70.51 113.656 177.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -80.77 154.64 73.34 Favored Pre-proline 0 N--CA 1.487 1.407 0 C-N-CA 123.2 0.6 . . . . 60.23 111.022 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -48.35 130.81 21.86 Favored 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 123.8 3.0 . . . . 74.33 114.302 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -138.89 -177.4 15.36 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-O 119.732 -0.482 . . . . 72.15 112.917 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -64.94 -35.31 44.36 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 124.138 3.225 . . . . 71.14 113.863 -172.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -106.87 7.98 30.42 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.634 0.774 . . . . 54.44 111.006 -177.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 127.37 175.09 13.97 Favored Glycine 0 C--N 1.341 0.82 0 N-CA-C 111.229 -0.748 . . . . 24.44 111.229 -174.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 30.2 mtm180 -59.03 129.14 40.72 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.892 -0.781 . . . . 74.31 108.892 175.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -67.29 -156.84 0.63 Allowed Glycine 0 C--N 1.341 0.858 0 O-C-N 123.865 0.728 . . . . 75.45 114.835 -170.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -96.23 160.85 14.22 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.263 0.554 . . . . 74.13 110.406 -170.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.444 HD11 ' HB2' ' A' ' 195' ' ' ALA . 31.1 tp -137.52 114.68 10.86 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.3 -1.37 . . . . 60.34 107.3 175.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.706 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 1.9 m-85 -91.18 108.84 20.14 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.994 -0.743 . . . . 74.43 108.994 -177.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.722 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 43.2 mt -86.36 107.49 18.03 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.548 -0.538 . . . . 75.32 109.548 -178.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -82.95 108.48 16.31 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.027 -0.988 . . . . 62.34 110.183 -174.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.455 HG13 HG11 ' A' ' 199' ' ' VAL . 61.1 t -56.3 120.16 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 C-N-CA 125.337 1.455 . . . . 63.41 112.581 -173.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 53.4 mmt-85 -114.8 96.91 5.95 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.724 1.21 . . . . 74.11 108.001 170.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 53.8 mt -74.89 103.85 2.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.936 -1.135 . . . . 63.33 107.936 175.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 25.3 p . . . . . 0 CA--C 1.555 1.166 0 N-CA-C 108.727 -0.842 . . . . 61.33 108.727 174.497 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 22.9 ptp . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 112.368 0.507 . . . . 74.12 112.368 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 49.5 m -63.99 132.45 50.68 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 123.036 0.534 . . . . 74.31 111.278 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -81.05 134.69 35.71 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.042 0.537 . . . . 74.54 109.599 176.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 6.3 mp -80.89 101.32 9.36 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.504 -0.925 . . . . 73.15 108.504 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.513 ' HA ' ' HB3' ' A' ' 222' ' ' ALA . 45.8 mtm180 -87.82 144.19 26.73 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 110.068 -0.345 . . . . 74.2 110.068 177.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.693 HG22 ' H ' ' A' ' 175' ' ' ALA . 75.8 mt -87.62 -74.1 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 115.558 -0.746 . . . . 61.4 110.189 177.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . 66.25 -7.75 0.39 Allowed 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 125.346 1.459 . . . . 64.11 113.382 -176.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.693 ' H ' HG22 ' A' ' 173' ' ' ILE . . . -70.54 -3.69 19.3 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.53 1.132 . . . . 41.52 112.897 -174.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.539 ' CZ ' ' HA ' ' A' ' 227' ' ' THR . 8.5 m-85 -84.99 7.69 20.39 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.07 0.548 . . . . 74.44 111.109 169.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -132.19 -172.13 12.97 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-O 119.404 -0.664 . . . . 72.22 112.682 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -57.98 -50.78 9.29 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 123.513 2.809 . . . . 63.54 112.359 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -83.64 111.31 19.01 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.515 -0.766 . . . . 73.13 109.723 175.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -85.72 -99.54 0.73 Allowed Glycine 0 C--N 1.341 0.84 0 N-CA-C 110.423 -1.071 . . . . 44.44 110.423 169.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.2 t -139.8 154.14 47.29 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 108.455 -0.943 . . . . 74.44 108.455 171.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -80.68 -147.66 5.26 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 123.531 0.519 . . . . 75.25 113.657 -173.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 175.23 -173.24 46.12 Favored Glycine 0 C--N 1.342 0.873 0 N-CA-C 112.018 -0.433 . . . . 75.32 112.018 -178.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 20.7 m -77.8 -17.1 57.84 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.71 0.804 . . . . 62.24 111.515 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 113.22 -6.69 25.08 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-O 119.431 -0.649 . . . . 53.41 114.102 172.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.419 ' HA3' ' HB1' ' A' ' 244' ' ' ALA . . . -112.91 141.6 16.96 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-N 117.6 0.7 . . . . 61.25 111.673 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 26.4 t -85.84 82.23 8.25 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.019 -0.734 . . . . 42.22 109.019 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -163.14 67.73 0.23 Allowed Glycine 0 C--N 1.343 0.968 0 CA-C-N 115.398 -0.819 . . . . 72.35 111.314 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -130.99 60.09 0.68 Allowed Glycine 0 C--N 1.341 0.834 0 CA-C-N 114.897 -0.652 . . . . 70.02 112.253 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 31.2 m -68.09 -4.42 13.54 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.934 0.894 . . . . 71.42 112.09 174.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.672 ' HB3' ' HB2' ' A' ' 240' ' ' PHE . 85.9 mm-40 -81.41 26.27 0.47 Allowed 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.527 1.131 . . . . 72.41 111.654 172.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -75.67 154.09 36.76 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.086 0.954 . . . . 55.13 110.739 -178.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 87.9 mt -131.93 158.56 41.09 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.767 0.827 . . . . 54.1 110.051 -173.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -115.0 124.2 51.04 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.994 -1.113 . . . . 74.33 107.994 173.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -124.94 129.31 50.11 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.374 -0.973 . . . . 74.44 108.374 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 42.3 m -68.39 126.29 29.13 Favored 'General case' 0 C--O 1.242 0.708 0 O-C-N 123.517 0.511 . . . . 70.04 110.22 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.484 HD12 ' HB2' ' A' ' 212' ' ' ALA . 46.0 tp -106.84 109.95 21.98 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.034 -1.469 . . . . 71.54 107.034 177.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -92.17 118.04 30.45 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.242 -1.021 . . . . 54.4 108.242 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.461 HG23 HG11 ' A' ' 210' ' ' VAL . 5.7 p -137.85 131.71 17.02 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 123.335 0.654 . . . . 74.12 109.784 -176.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -76.34 157.81 37.09 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.241 1.961 . . . . 73.3 111.701 172.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -55.0 -46.23 99.7 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 124.415 1.086 . . . . 71.31 113.543 -176.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.448 ' O ' HG12 ' A' ' 206' ' ' VAL . 71.2 Cg_exo -53.56 -54.99 3.98 Favored 'Trans proline' 0 C--N 1.402 3.381 0 C-N-CA 122.272 1.981 . . . . 73.1 112.78 174.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 48.7 mt -69.84 -21.03 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.3 0.64 . . . . 64.5 110.756 -176.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.2 -48.52 56.77 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.851 0.46 . . . . 65.13 110.342 176.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.0 -55.69 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 CA-C-N 115.959 -0.564 . . . . 63.3 111.431 -177.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 202' ' ' PRO . 14.6 p -87.15 -32.21 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 N-CA-C 112.611 0.597 . . . . 64.12 112.611 -172.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 101.53 166.68 27.48 Favored Glycine 0 N--CA 1.477 1.374 0 N-CA-C 112.076 -0.41 . . . . 74.01 112.076 -173.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 163.43 -131.94 2.6 Favored Glycine 0 C--N 1.345 1.032 0 N-CA-C 111.456 -0.658 . . . . 52.31 111.456 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -137.86 139.05 39.69 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.655 1.182 . . . . 72.12 108.594 174.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.461 HG11 HG23 ' A' ' 199' ' ' VAL . 32.3 m -136.53 168.02 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 122.956 0.502 . . . . 71.0 110.563 178.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 29.3 ttm-85 -87.51 113.19 22.98 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.763 -0.653 . . . . 70.24 109.887 178.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.484 ' HB2' HD12 ' A' ' 197' ' ' LEU . . . -105.79 158.42 16.75 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.842 0.857 . . . . 40.33 110.238 173.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 36.8 tpp -93.26 110.68 22.2 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.923 -0.769 . . . . 64.0 108.923 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 60.5 m -126.0 163.88 22.05 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.308 1.043 . . . . 64.24 109.815 -175.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 95.6 mt -61.81 -17.25 55.49 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.968 0.907 . . . . 62.31 112.965 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -96.59 8.39 44.26 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.471 0.708 . . . . 65.4 111.485 177.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 102.42 -164.01 16.66 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-O 119.708 -0.495 . . . . 61.3 112.129 -176.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.36 118.12 5.07 Favored 'Trans proline' 0 C--N 1.367 1.537 0 C-N-CA 122.124 1.883 . . . . 75.23 110.906 175.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.7 m -118.42 157.29 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 123.478 0.711 . . . . 73.05 110.51 -175.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -90.56 108.83 20.05 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.148 -0.686 . . . . 60.12 109.148 173.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 94.3 t -97.8 129.06 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.091 0.956 . . . . 73.34 109.942 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 172' ' ' ARG . . . -69.88 103.09 2.12 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.999 0.92 . . . . 65.25 110.142 176.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.543 ' HA ' HD12 ' A' ' 173' ' ' ILE . 97.2 t -89.97 125.96 58.93 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 124.088 0.955 . . . . 74.23 110.166 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -78.18 171.44 17.06 Favored 'Trans proline' 0 CA--C 1.561 1.846 0 C-N-CA 123.163 2.575 . . . . 61.14 111.617 173.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.21 174.25 8.33 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.095 1.863 . . . . 72.32 113.694 174.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 67.16 15.37 10.03 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 125.903 1.681 . . . . 64.35 112.505 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.539 ' HA ' ' CZ ' ' A' ' 176' ' ' TYR . 93.9 m -64.75 100.96 0.43 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.523 0.729 . . . . 73.34 110.139 -176.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -101.83 137.26 40.36 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 125.135 1.374 . . . . 75.25 110.323 -174.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.92 132.9 53.65 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.568 1.147 . . . . 54.43 110.993 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.03 -1.55 67.93 Favored Glycine 0 C--N 1.337 0.613 0 O-C-N 123.849 0.718 . . . . 61.14 113.281 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -86.86 151.2 23.54 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 109.605 -0.517 . . . . 74.23 109.605 170.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.501 ' HG3' ' HA ' ' A' ' 252' ' ' GLU . 3.8 mppt? -131.67 139.03 48.96 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.279 -1.008 . . . . 73.34 108.279 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.585 HD13 HG21 ' A' ' 173' ' ' ILE . 29.1 mt -118.05 109.24 16.2 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.287 0.635 . . . . 74.32 110.309 -161.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 45.1 ttm-85 -76.96 108.9 10.35 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 124.057 0.848 . . . . 73.21 110.16 -174.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.454 HD21 HG23 ' A' ' 173' ' ' ILE . 21.8 mt -107.03 89.79 3.11 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.591 -0.892 . . . . 70.21 108.591 176.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.517 ' HG2' ' HB3' ' A' ' 248' ' ' ASP . 10.6 mtmp? -67.1 136.08 54.61 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.416 -0.357 . . . . 71.13 111.147 -177.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 95.24 -0.83 64.16 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 115.319 -0.855 . . . . 54.13 113.456 -175.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.53 ' HA ' ' HE2' ' A' ' 238' ' ' LYS . 10.4 mmpt? -106.55 -9.26 16.67 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 113.277 0.844 . . . . 71.01 113.277 -175.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.11 179.53 50.93 Favored Glycine 0 N--CA 1.476 1.334 0 N-CA-C 111.571 -0.612 . . . . 62.4 111.571 167.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.672 ' HB2' ' HB3' ' A' ' 191' ' ' GLN . 33.3 m-85 -60.28 154.33 53.29 Favored Pre-proline 0 N--CA 1.489 1.477 0 C-N-CA 123.42 0.688 . . . . 73.22 111.812 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 36.6 Cg_endo -63.79 129.36 24.54 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.477 2.118 . . . . 62.44 112.83 177.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -119.33 -175.22 15.96 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-O 119.451 -0.638 . . . . 63.41 112.256 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -60.13 -46.57 18.26 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 123.462 2.775 . . . . 71.22 112.974 -177.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.419 ' HB1' ' HA3' ' A' ' 186' ' ' GLY . . . -98.6 22.34 10.03 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.362 0.665 . . . . 45.54 111.031 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 111.44 178.56 20.24 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 115.625 -0.716 . . . . 75.12 112.449 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.423 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 82.2 mtt180 -63.11 142.58 58.33 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.673 0.789 . . . . 75.42 110.659 -177.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -69.48 -175.46 13.39 Favored Glycine 0 C--N 1.343 0.967 0 O-C-N 123.998 0.811 . . . . 53.14 112.155 175.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.517 ' HB3' ' HG2' ' A' ' 236' ' ' LYS . 1.4 p30 -104.05 171.29 7.43 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.855 0.462 . . . . 72.01 111.547 -178.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 32.9 tp -129.36 112.87 14.28 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 108.737 -0.838 . . . . 73.54 108.737 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -86.76 109.47 19.26 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.684 0.794 . . . . 54.43 109.28 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 44.5 mt -87.16 111.39 20.91 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 109.077 -0.712 . . . . 74.21 109.077 175.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.501 ' HA ' ' HG3' ' A' ' 232' ' ' LYS . 31.5 mt-10 -78.77 101.08 7.4 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.092 -0.958 . . . . 72.13 109.566 -177.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.8 t -59.51 110.03 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 O-C-N 123.765 0.666 . . . . 72.25 111.072 176.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -115.12 93.44 4.3 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.003 -1.11 . . . . 74.44 108.003 176.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.492 HD11 ' O ' ' A' ' 227' ' ' THR . 54.9 mt -77.17 125.65 37.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 N-CA-C 109.473 -0.565 . . . . 72.24 109.473 178.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 24.4 p . . . . . 0 C--O 1.25 1.127 0 C-N-CA 124.157 0.983 . . . . 73.3 109.632 179.775 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.475 ' SD ' ' N ' ' A' ' 168' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 109.143 -0.688 . . . . 72.31 109.143 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.9 t -72.34 91.99 1.38 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 109.583 -0.525 . . . . 72.43 109.583 -177.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -74.26 155.72 37.97 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.284 -0.871 . . . . 51.23 109.482 177.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.2 tt -66.58 102.66 0.93 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 108.008 -1.108 . . . . 73.02 108.008 178.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -117.89 146.19 44.1 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.064 0.946 . . . . 73.34 109.273 -177.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.671 HD12 ' HA ' ' A' ' 223' ' ' VAL . 73.7 mt -87.54 96.2 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-O 121.222 0.534 . . . . 73.52 110.487 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -87.45 63.42 7.66 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 108.538 -0.912 . . . . 45.43 108.538 171.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -156.0 -168.39 2.75 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.584 1.154 . . . . 74.55 109.253 -175.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.431 ' CZ ' ' HA ' ' A' ' 227' ' ' THR . 4.5 m-85 77.79 -63.09 0.35 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 125.591 1.556 . . . . 70.04 111.974 -176.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -100.16 100.43 2.18 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 118.511 -1.161 . . . . 72.3 111.871 -176.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.63 -9.98 25.89 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 123.006 2.47 . . . . 64.51 113.125 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -77.36 87.33 3.75 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 109.096 -0.705 . . . . 72.31 109.096 176.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 177.05 134.42 1.99 Allowed Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.384 -0.825 . . . . 61.11 111.433 -178.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 13.6 t -80.26 167.85 19.78 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.209 0.604 . . . . 74.44 110.453 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 89.26 18.78 52.36 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-N 116.235 -0.439 . . . . 60.54 112.799 -173.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -92.26 54.68 2.83 Favored Glycine 0 C--N 1.353 1.502 0 C-N-CA 123.652 0.644 . . . . 40.04 112.315 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.6 t -86.74 164.81 16.5 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.634 0.774 . . . . 73.4 110.092 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 179.63 -170.9 42.47 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.325 -0.71 . . . . 74.54 111.325 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 145.17 45.44 0.04 OUTLIER Glycine 0 N--CA 1.473 1.149 0 N-CA-C 110.818 -0.913 . . . . 71.12 110.818 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 33.4 t -78.77 116.05 18.86 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.873 0.869 . . . . 43.33 109.777 -177.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -78.56 73.49 2.23 Favored Glycine 0 CA--C 1.533 1.162 0 N-CA-C 111.712 -0.555 . . . . 64.04 111.712 176.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 131.67 162.67 10.57 Favored Glycine 0 C--N 1.343 0.97 0 N-CA-C 110.817 -0.913 . . . . 73.22 110.817 -176.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 50.2 m -110.46 90.27 3.27 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.079 0.951 . . . . 72.22 109.729 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.61 ' HG3' ' HA3' ' A' ' 242' ' ' GLY . 5.7 pm0 -98.04 39.68 1.22 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.582 1.182 . . . . 64.22 109.832 176.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -87.43 163.48 16.72 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 114.689 -1.141 . . . . 71.5 111.087 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 83.2 mt -140.66 172.04 13.26 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.196 0.998 . . . . 73.41 109.994 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -118.01 145.06 45.03 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.052 0.941 . . . . 71.24 109.516 174.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -146.08 140.17 26.55 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.021 0.928 . . . . 70.2 109.282 178.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.9 m -77.36 129.19 35.49 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.058 0.543 . . . . 43.51 109.711 178.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.559 HD13 HD13 ' A' ' 251' ' ' LEU . 54.0 tp -107.45 111.3 23.53 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.451 -1.314 . . . . 54.54 107.451 177.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -92.04 100.5 13.13 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 108.291 -1.003 . . . . 72.52 108.291 -178.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.502 HG23 HG11 ' A' ' 210' ' ' VAL . 2.9 p -124.28 131.49 24.2 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 124.013 0.925 . . . . 73.05 108.799 -178.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.513 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 98.4 Cg_endo -80.68 163.9 21.01 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.513 2.142 . . . . 70.22 111.355 172.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -51.17 -48.46 85.32 Favored Pre-proline 0 CA--C 1.566 1.581 0 N-CA-C 114.045 1.128 . . . . 72.51 114.045 176.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.513 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 25.5 Cg_endo -58.8 -52.46 5.2 Favored 'Trans proline' 0 C--N 1.396 3.044 0 C-N-CA 122.002 1.801 . . . . 62.43 113.057 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 45.8 mt -70.77 -22.21 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.238 0 C-N-CA 123.081 0.552 . . . . 55.42 110.856 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -69.33 -44.2 72.15 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.771 0.429 . . . . 64.04 110.717 177.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 76.1 t -71.49 -57.17 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 C-N-CA 122.181 0.192 . . . . 73.05 110.975 -178.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 202' ' ' PRO . 12.6 p -85.38 -25.99 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 112.208 0.447 . . . . 64.41 112.208 -170.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 99.89 -178.63 29.75 Favored Glycine 0 N--CA 1.475 1.273 0 N-CA-C 112.156 -0.378 . . . . 52.35 112.156 -172.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 139.6 -139.17 9.76 Favored Glycine 0 C--N 1.343 0.932 0 N-CA-C 111.764 -0.535 . . . . 63.5 111.764 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -133.86 146.35 50.52 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.524 0.73 . . . . 60.4 109.751 175.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.502 HG11 HG23 ' A' ' 199' ' ' VAL . 22.2 m -138.67 169.2 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 123.711 0.632 . . . . 75.0 112.02 -177.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 -73.22 133.07 43.88 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.424 -0.807 . . . . 73.22 110.27 172.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.437 ' HB2' HD12 ' A' ' 197' ' ' LEU . . . -144.13 148.99 35.81 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.468 -0.938 . . . . 61.44 108.468 168.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 64.8 mtp -89.03 130.72 35.45 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.459 -0.571 . . . . 72.02 109.459 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 42.3 m -143.2 172.93 12.07 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 125.228 1.411 . . . . 73.0 108.082 -175.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 77.0 mt -60.08 -21.35 61.35 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.27 0.628 . . . . 65.53 111.708 173.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -86.65 16.83 4.33 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.641 1.176 . . . . 71.32 111.674 174.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 76.34 -155.82 46.05 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-O 118.87 -0.961 . . . . 55.14 111.757 -175.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.85 119.73 6.62 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 121.954 1.77 . . . . 74.42 110.423 171.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.55 166.09 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.284 1.034 . . . . 75.42 109.978 -176.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -102.46 107.51 18.51 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.898 -0.779 . . . . 54.04 108.898 175.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 95.5 t -95.15 131.64 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.145 0.978 . . . . 63.31 109.639 -175.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.45 98.72 2.32 Favored 'General case' 0 C--N 1.351 0.659 0 O-C-N 124.055 0.847 . . . . 74.4 109.39 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.671 ' HA ' HD12 ' A' ' 173' ' ' ILE . 55.9 t -91.84 127.71 48.84 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 124.83 1.252 . . . . 74.23 110.022 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.493 ' HD3' ' HB ' ' A' ' 173' ' ' ILE . 92.4 Cg_endo -73.2 170.25 20.31 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.692 2.262 . . . . 73.15 110.962 173.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.46 178.07 4.11 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 122.02 1.813 . . . . 75.22 111.789 170.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 50.2 mtp180 63.68 20.29 12.15 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 124.978 1.311 . . . . 61.12 112.222 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.493 ' O ' HD11 ' A' ' 255' ' ' ILE . 98.1 m -65.64 106.68 1.53 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.361 0.664 . . . . 62.42 110.278 -178.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -100.13 139.86 35.2 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.925 1.29 . . . . 73.44 110.285 -174.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -69.92 127.95 34.66 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.737 1.215 . . . . 72.21 111.542 -177.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 97.39 10.55 53.71 Favored Glycine 0 C--N 1.342 0.881 0 O-C-N 123.724 0.64 . . . . 62.32 113.126 178.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -91.47 158.28 16.57 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 117.176 0.488 . . . . 75.41 111.341 175.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.402 ' HB3' ' HD2' ' A' ' 250' ' ' TYR . 1.8 mppt? -130.07 117.65 20.32 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.84 1.256 . . . . 74.12 109.162 -177.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 12.9 mt -105.8 100.7 10.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.301 -0.863 . . . . 55.5 108.711 -165.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 46.2 ttm105 -69.98 102.45 2.01 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 124.544 1.153 . . . . 73.01 110.057 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.473 HD21 HG23 ' A' ' 173' ' ' ILE . 29.8 mt -111.69 99.78 8.44 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.727 0.811 . . . . 61.5 110.159 -176.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -66.74 142.86 57.25 Favored 'General case' 0 C--O 1.246 0.887 0 C-N-CA 123.407 0.683 . . . . 71.55 110.489 178.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 87.03 13.35 66.54 Favored Glycine 0 CA--C 1.532 1.117 0 O-C-N 123.745 0.653 . . . . 53.21 113.021 -174.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -130.83 -25.38 2.31 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.338 0.655 . . . . 73.42 112.292 -175.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -75.07 -159.51 7.41 Favored Glycine 0 N--CA 1.476 1.306 0 CA-C-O 120.295 -0.169 . . . . 63.53 112.823 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -69.45 134.38 88.81 Favored Pre-proline 0 CA--C 1.554 1.105 0 CA-C-O 118.24 -0.886 . . . . 71.42 109.408 -174.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.578 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 78.0 Cg_exo -51.69 128.35 25.95 Favored 'Trans proline' 0 C--N 1.386 2.524 0 C-N-CA 122.904 2.403 . . . . 64.11 111.838 179.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.61 ' HA3' ' HG3' ' A' ' 191' ' ' GLN . . . -152.82 -162.44 10.96 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 119.558 -0.579 . . . . 52.23 113.069 -172.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.28 -16.1 50.49 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 123.578 2.852 . . . . 73.41 112.868 -177.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -94.96 19.96 9.59 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.088 0.955 . . . . 70.35 111.156 176.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 85.1 -73.75 2.58 Favored Glycine 0 C--N 1.352 1.462 0 N-CA-C 109.39 -1.484 . . . . 73.24 109.39 -170.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.578 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 59.2 mtt-85 -126.11 161.33 27.89 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.744 1.218 . . . . 71.43 109.036 166.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.456 ' HA2' HE21 ' A' ' 191' ' ' GLN . . . -82.45 -158.04 22.93 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-N 115.449 -0.796 . . . . 55.5 112.471 177.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -114.55 132.54 56.29 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.767 0.827 . . . . 73.45 110.089 -176.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 41.6 tp -106.88 121.33 44.21 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 108.415 -0.958 . . . . 71.42 108.415 -176.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.402 ' HD2' ' HB3' ' A' ' 232' ' ' LYS . 8.7 m-85 -87.79 113.27 23.3 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.4 -0.963 . . . . 53.52 108.4 179.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.559 HD13 HD13 ' A' ' 197' ' ' LEU . 51.2 mt -86.48 107.77 18.23 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.175 -0.676 . . . . 72.25 109.175 176.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.434 ' HG3' ' HD3' ' A' ' 254' ' ' ARG . 8.4 tp10 -76.02 97.67 4.09 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 107.683 -1.229 . . . . 60.31 107.683 177.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 91.5 t -62.82 108.87 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.777 0 C-N-CA 124.952 1.301 . . . . 63.01 110.927 -177.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.434 ' HD3' ' HG3' ' A' ' 252' ' ' GLU . 22.1 mmm180 -109.3 93.82 4.71 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.243 -1.021 . . . . 53.35 108.243 174.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.493 HD11 ' O ' ' A' ' 227' ' ' THR . 58.9 mt -75.4 131.79 34.37 Favored 'Isoleucine or valine' 0 C--N 1.351 0.631 0 N-CA-C 109.324 -0.621 . . . . 74.45 109.324 174.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 16.4 p . . . . . 0 CA--C 1.558 1.273 0 C-N-CA 125.496 1.518 . . . . 60.12 107.56 178.084 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 15.8 tpt . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 109.402 -0.592 . . . . 72.32 109.402 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 40.3 m -148.15 112.74 5.34 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.098 0.959 . . . . 75.13 109.497 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -131.51 147.71 52.56 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.713 0.805 . . . . 73.13 110.346 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 6.6 mp -79.33 95.5 5.73 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.072 0.949 . . . . 71.12 109.526 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -74.46 88.08 2.1 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.771 0.828 . . . . 74.2 110.525 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.515 HG23 HD22 ' A' ' 235' ' ' LEU . 29.1 mt -76.66 131.31 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 115.111 -0.949 . . . . 51.23 111.243 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -137.56 93.42 2.8 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.117 0.967 . . . . 71.43 108.631 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -132.54 179.05 6.37 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.226 1.01 . . . . 61.34 110.617 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.628 ' CE2' HD22 ' A' ' 233' ' ' LEU . 49.1 m-85 59.42 36.78 23.26 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.43 1.092 . . . . 65.53 110.648 -172.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 147.68 154.28 6.2 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 114.947 -1.024 . . . . 65.45 111.115 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.45 166.36 28.7 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 122.766 2.31 . . . . 71.44 112.574 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -154.0 -54.5 0.1 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.716 0.406 . . . . 74.14 110.996 -177.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 155.07 125.86 0.98 Allowed Glycine 0 C--N 1.35 1.353 0 CA-C-O 119.667 -0.518 . . . . 71.55 113.959 177.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.496 ' HB3' ' HE3' ' A' ' 236' ' ' LYS . 33.5 t 178.54 114.35 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 126.023 1.729 . . . . 70.14 108.029 168.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 174.53 45.72 0.05 OUTLIER Glycine 0 C--N 1.341 0.854 0 C-N-CA 121.559 -0.353 . . . . 53.53 112.627 177.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -158.11 59.17 0.34 Allowed Glycine 0 C--N 1.343 0.951 0 N-CA-C 111.624 -0.591 . . . . 45.32 111.624 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 44.7 m -148.95 156.76 42.75 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.329 1.052 . . . . 72.05 109.439 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -96.03 -174.83 36.31 Favored Glycine 0 N--CA 1.472 1.04 0 O-C-N 123.441 0.463 . . . . 62.25 112.513 175.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 160.35 -157.44 28.81 Favored Glycine 0 N--CA 1.47 0.966 0 N-CA-C 112.211 -0.356 . . . . 65.11 112.211 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 54.8 m -140.16 101.75 4.22 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.274 0.63 . . . . 75.24 110.276 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 151.37 -157.54 27.26 Favored Glycine 0 C--N 1.343 0.93 0 N-CA-C 111.685 -0.566 . . . . 73.15 111.685 177.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.448 ' H ' ' NE2' ' A' ' 191' ' ' GLN . . . -96.67 -112.51 2.88 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 111.558 -0.617 . . . . 61.03 111.558 174.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 7.0 p -81.83 -38.79 24.94 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.997 0.919 . . . . 71.35 109.958 175.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.64 ' HB3' ' HB2' ' A' ' 240' ' ' PHE . 25.2 mm-40 65.96 35.08 6.68 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.723 1.209 . . . . 75.44 112.138 173.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -94.29 138.65 32.03 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 114.353 -1.294 . . . . 74.45 110.807 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 91.5 mt -122.93 166.95 14.22 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.872 0.869 . . . . 61.31 110.455 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -106.34 149.89 26.51 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 107.955 -1.128 . . . . 62.14 107.955 166.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.97 129.15 12.76 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.933 -0.765 . . . . 71.13 108.933 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.5 m -65.52 121.77 15.67 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.572 0.749 . . . . 75.33 110.425 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.479 HD22 ' HB3' ' A' ' 251' ' ' LEU . 57.0 tp -108.0 112.99 25.85 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.951 0.901 . . . . 75.24 109.164 -178.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -85.93 112.07 20.84 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.312 -0.996 . . . . 72.41 108.312 174.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 2.2 p -139.49 119.9 9.42 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 123.945 0.898 . . . . 73.5 108.971 -177.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.425 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 44.3 Cg_endo -71.3 158.02 55.53 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 121.879 1.72 . . . . 70.42 111.171 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -52.1 -47.28 92.3 Favored Pre-proline 0 CA--C 1.567 1.611 0 C-N-CA 124.781 1.233 . . . . 65.02 113.606 -177.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 37.2 Cg_endo -63.07 -43.62 18.56 Favored 'Trans proline' 0 C--N 1.404 3.491 0 C-N-CA 121.478 1.452 . . . . 63.03 112.186 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 40.1 mt -71.12 -28.26 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 O-C-N 123.616 0.572 . . . . 74.34 110.361 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.57 -46.56 82.22 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.207 0.603 . . . . 63.14 110.509 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 67.5 t -67.82 -57.07 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 122.727 0.411 . . . . 73.1 111.513 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 17.2 m -78.9 -20.83 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 112.285 0.476 . . . . 64.24 112.285 -170.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 77.52 132.97 0.62 Allowed Glycine 0 C--N 1.345 1.07 0 N-CA-C 111.675 -0.57 . . . . 71.14 111.675 -171.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 175.87 -175.01 47.25 Favored Glycine 0 N--CA 1.468 0.828 0 CA-C-N 117.265 0.532 . . . . 73.2 112.269 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -79.03 143.6 35.48 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 122.849 0.46 . . . . 72.52 111.0 -178.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 19.9 m -139.45 169.44 16.99 Favored 'Isoleucine or valine' 0 C--O 1.253 1.263 0 O-C-N 124.338 1.024 . . . . 65.24 110.351 177.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -72.48 118.46 15.41 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.502 -1.226 . . . . 74.32 109.979 169.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -110.66 137.33 48.47 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.407 -0.59 . . . . 32.05 109.407 169.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 63.0 mtt -84.95 103.68 14.21 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.521 -0.918 . . . . 73.11 108.521 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 43.4 m -122.35 168.56 11.92 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.688 1.195 . . . . 64.31 109.015 -176.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 80.1 mt -54.69 -27.29 39.23 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.023 0.929 . . . . 54.32 111.73 174.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -90.95 15.82 10.69 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.507 1.123 . . . . 51.42 111.837 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 83.07 -149.74 26.82 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-O 119.273 -0.737 . . . . 44.54 112.174 -177.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.05 120.3 5.99 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.376 2.051 . . . . 64.14 111.377 177.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 22.6 m -119.24 167.44 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 123.2 0.6 . . . . 70.21 111.522 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -76.67 116.36 17.28 Favored 'General case' 0 C--N 1.348 0.526 0 C-N-CA 124.38 1.072 . . . . 73.13 108.822 175.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.407 HG22 HD11 ' A' ' 173' ' ' ILE . 1.1 t -124.78 115.19 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 108.613 -0.884 . . . . 64.04 108.613 174.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -81.39 99.01 8.47 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 115.76 -0.655 . . . . 62.11 109.401 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 56.1 t -80.32 130.26 66.2 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 123.609 0.764 . . . . 60.21 109.904 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.37 167.68 7.53 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.168 2.579 . . . . 53.03 112.27 171.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.25 -179.51 3.19 Favored 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 121.837 1.691 . . . . 75.2 112.913 174.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 48.2 mtt85 60.66 18.23 8.28 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 124.974 1.31 . . . . 72.25 112.298 173.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.497 ' HA ' ' OH ' ' A' ' 176' ' ' TYR . 96.6 m -68.3 103.45 1.6 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.025 0.93 . . . . 71.3 110.245 -174.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.452 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 47.4 tp60 -103.78 142.2 34.78 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.419 1.088 . . . . 73.33 110.285 -174.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.82 130.96 49.47 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.716 1.206 . . . . 41.11 111.583 -176.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 95.01 -10.34 70.1 Favored Glycine 0 C--N 1.347 1.142 0 O-C-N 123.711 0.632 . . . . 72.43 113.144 177.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.452 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 68.3 mtt-85 -78.52 155.45 29.75 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.038 0.535 . . . . 75.2 109.626 174.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.585 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.7 mppt? -130.18 118.1 20.9 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.994 -0.743 . . . . 51.11 108.994 -176.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.628 HD22 ' CE2' ' A' ' 176' ' ' TYR . 5.0 mt -89.66 103.91 16.51 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.091 -0.959 . . . . 74.44 109.035 -164.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 16.8 ttm-85 -69.42 102.11 1.7 Allowed 'General case' 0 CA--C 1.541 0.598 0 O-C-N 123.92 0.763 . . . . 74.24 109.712 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.515 HD22 HG23 ' A' ' 173' ' ' ILE . 14.3 mt -96.05 91.32 5.91 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.282 -1.007 . . . . 61.11 108.282 175.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.496 ' HE3' ' HB3' ' A' ' 181' ' ' SER . 6.0 mtmt -62.78 140.94 58.79 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.283 -0.636 . . . . 74.4 109.283 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 72.9 34.59 58.87 Favored Glycine 0 C--N 1.343 0.949 0 O-C-N 123.424 0.453 . . . . 53.51 113.737 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.432 ' HA ' ' NZ ' ' A' ' 238' ' ' LYS . 0.4 OUTLIER -128.01 -27.05 2.8 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.601 0.761 . . . . 73.32 112.124 179.262 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -74.88 -165.21 13.54 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 112.455 -0.258 . . . . 75.33 112.455 169.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.64 ' HB2' ' HB3' ' A' ' 191' ' ' GLN . 90.9 m-85 -75.72 150.57 84.22 Favored Pre-proline 0 N--CA 1.487 1.395 0 CA-C-N 117.216 0.508 . . . . 73.44 110.046 -176.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -64.81 157.64 55.2 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 122.284 1.989 . . . . 70.45 112.659 177.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -163.02 175.0 39.4 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 115.557 -0.747 . . . . 71.15 111.585 -176.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.71 -11.63 29.88 Favored 'Trans proline' 0 C--N 1.366 1.475 0 C-N-CA 122.952 2.435 . . . . 65.33 113.021 -177.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -104.16 14.83 29.69 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.892 0.877 . . . . 74.23 111.337 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 119.45 -124.39 5.96 Favored Glycine 0 C--N 1.348 1.223 0 N-CA-C 110.973 -0.851 . . . . 61.45 110.973 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 48.8 mtm180 -126.55 162.56 25.38 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.731 -0.841 . . . . 52.34 108.731 169.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -69.97 171.0 42.99 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 115.3 -0.864 . . . . 33.42 113.963 -177.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -110.71 136.28 50.03 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.919 0.888 . . . . 72.45 108.863 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 31.9 tp -105.29 108.11 19.46 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 107.717 -1.216 . . . . 73.13 107.717 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.585 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 19.3 m-85 -88.54 108.99 19.7 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.716 -0.846 . . . . 75.24 108.716 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.479 ' HB3' HD22 ' A' ' 197' ' ' LEU . 43.0 mt -86.85 107.07 18.16 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.856 -0.794 . . . . 64.33 108.856 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -78.05 102.76 7.6 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 114.657 -1.156 . . . . 72.41 109.55 -177.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 63.2 t -59.57 115.26 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.695 0 CA-C-N 114.388 -1.278 . . . . 72.11 112.053 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 20.7 mmt85 -112.66 93.99 4.7 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.294 -1.373 . . . . 72.01 107.294 171.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 22.9 mt -74.99 109.36 7.83 Favored 'Isoleucine or valine' 0 C--N 1.352 0.689 0 N-CA-C 109.018 -0.734 . . . . 73.44 109.018 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 25.6 p . . . . . 0 CA--C 1.558 1.277 0 C-N-CA 124.524 1.13 . . . . 73.42 108.428 177.173 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 22.3 mmt . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 109.54 -0.541 . . . . 62.34 109.54 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.7 m -74.98 102.68 4.89 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 109.42 -0.585 . . . . 70.51 109.42 174.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -68.69 -18.92 64.34 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.037 0.535 . . . . 75.35 112.311 -177.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.531 HD13 HG22 ' A' ' 221' ' ' VAL . 86.9 mt 58.9 44.31 16.79 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.326 1.05 . . . . 71.53 110.748 174.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 27.5 tpt180 -59.11 115.96 3.52 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 114.435 -1.257 . . . . 70.05 110.888 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.709 ' HA ' HD22 ' A' ' 235' ' ' LEU . 57.5 mt -77.78 108.29 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 114.768 -1.106 . . . . 72.33 108.618 171.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -84.07 40.08 0.74 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.891 0.876 . . . . 44.12 110.78 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -153.83 163.67 39.65 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.896 1.278 . . . . 72.1 109.272 -174.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.592 ' CE2' HD21 ' A' ' 233' ' ' LEU . 66.6 m-85 63.42 15.42 8.73 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.23 1.412 . . . . 62.42 112.067 -166.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -162.9 177.09 39.09 Favored Glycine 0 C--N 1.344 0.994 0 C-N-CA 123.397 0.522 . . . . 51.11 111.818 -177.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.09 123.24 13.04 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 123.374 2.716 . . . . 74.04 111.986 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -129.81 115.62 17.53 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.865 0.866 . . . . 62.35 108.904 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.8 165.23 54.74 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 116.293 -0.412 . . . . 70.01 112.262 178.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 39.9 m -70.89 -35.31 72.28 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.349 0.66 . . . . 74.3 111.748 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 91.08 -56.98 3.26 Favored Glycine 0 C--N 1.342 0.877 0 N-CA-C 111.564 -0.615 . . . . 63.1 111.564 -176.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 135.72 -161.69 24.82 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 111.538 -0.625 . . . . 22.2 111.538 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 22.8 t -93.51 -165.69 1.38 Allowed 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 123.719 0.807 . . . . 74.3 109.732 175.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 147.12 -22.32 1.58 Allowed Glycine 0 C--N 1.351 1.389 0 O-C-N 122.209 -0.307 . . . . 74.21 113.057 176.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -175.37 80.03 0.07 OUTLIER Glycine 0 C--N 1.342 0.869 0 N-CA-C 111.609 -0.596 . . . . 32.34 111.609 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 40.9 m -67.18 147.9 52.48 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.279 1.031 . . . . 53.53 111.845 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 99.73 68.01 0.87 Allowed Glycine 0 C--N 1.346 1.106 0 CA-C-N 116.128 -0.487 . . . . 51.22 111.886 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 70.17 -168.56 47.69 Favored Glycine 0 C--N 1.352 1.448 0 N-CA-C 113.623 0.209 . . . . 62.13 113.623 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 52.5 p -155.51 164.27 38.9 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.24 0.616 . . . . 44.32 110.615 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -88.7 53.39 2.69 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-O 122.992 1.377 . . . . 53.42 109.745 176.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -88.7 166.84 13.8 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 113.693 -1.594 . . . . 64.34 110.362 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.6 mt -133.19 164.61 26.68 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.618 0.767 . . . . 53.15 110.785 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -114.85 154.87 27.85 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 114.526 -1.215 . . . . 74.22 108.357 168.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -160.66 150.88 17.91 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.656 0.782 . . . . 72.31 109.319 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 33.2 m -81.66 135.65 35.52 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.065 0.546 . . . . 61.54 110.18 177.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.578 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 42.1 tp -114.54 113.57 24.6 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.707 -1.22 . . . . 71.44 107.707 170.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -91.93 123.7 35.5 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 109.269 -0.641 . . . . 52.23 109.269 177.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 3.6 p -142.92 130.9 11.22 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.531 1.132 . . . . 75.22 108.487 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.21 156.26 37.63 Favored 'Trans proline' 0 C--N 1.37 1.683 0 C-N-CA 121.586 1.524 . . . . 73.43 110.999 170.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -54.62 -42.18 93.53 Favored Pre-proline 0 CA--C 1.565 1.528 0 CA-C-O 117.333 -1.318 . . . . 73.02 114.29 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.24 -51.23 9.04 Favored 'Trans proline' 0 C--N 1.4 3.282 0 CA-C-N 121.832 1.69 . . . . 44.22 112.144 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 46.0 mt -68.69 -26.45 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.813 0.845 . . . . 74.15 110.802 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.468 ' HB1' ' O ' ' A' ' 227' ' ' THR . . . -70.69 -50.96 30.9 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.51 0.724 . . . . 72.41 111.326 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 96.1 t -67.65 -50.14 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.612 0.765 . . . . 65.11 111.253 -176.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.7 p -75.97 -31.5 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 122.524 0.33 . . . . 74.02 110.793 -177.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 79.96 103.46 0.27 Allowed Glycine 0 C--N 1.347 1.177 0 N-CA-C 111.667 -0.573 . . . . 72.34 111.667 -173.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -131.75 -129.7 3.06 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 116.978 0.389 . . . . 55.01 112.35 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -132.93 141.75 48.52 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.129 0.972 . . . . 75.44 108.393 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 17.2 m -130.67 165.96 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.21 0.604 . . . . 71.12 110.924 -178.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -82.11 120.42 25.29 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.133 -0.692 . . . . 74.3 109.133 168.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -118.21 136.67 53.5 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.557 0.743 . . . . 41.32 109.285 173.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 87.1 mtp -76.83 116.63 17.67 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.026 0.53 . . . . 73.34 109.578 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 33.6 m -127.21 170.35 12.52 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.431 1.093 . . . . 63.03 108.848 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 81.4 mt -57.82 -34.29 69.5 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.012 0.925 . . . . 71.41 111.963 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -84.56 2.16 42.55 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.676 0.79 . . . . 74.12 111.93 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 108.79 -161.8 13.09 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-O 119.648 -0.529 . . . . 74.22 112.567 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.2 119.66 6.61 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 122.189 1.926 . . . . 62.14 111.312 176.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 32.7 m -114.9 163.94 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 123.306 0.642 . . . . 74.14 109.979 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -103.61 110.0 21.9 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.242 0.544 . . . . 72.34 109.703 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.531 HG22 HD13 ' A' ' 171' ' ' LEU . 62.0 t -104.29 126.25 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.151 0.98 . . . . 72.54 109.207 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.1 99.81 2.87 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.103 0.561 . . . . 70.14 109.899 176.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 78.1 t -88.52 121.28 70.24 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 124.112 0.965 . . . . 71.45 109.724 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -60.76 169.02 6.14 Favored 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 123.987 3.124 . . . . 63.12 113.359 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.98 169.35 20.69 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 122.073 1.849 . . . . 62.11 113.629 178.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 65.53 22.02 11.79 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 125.554 1.541 . . . . 71.52 112.186 176.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.503 ' HA ' ' CZ ' ' A' ' 176' ' ' TYR . 94.8 m -66.39 104.55 1.25 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.029 0.932 . . . . 63.43 110.811 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -102.06 141.63 34.6 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.987 0.915 . . . . 63.24 110.935 -172.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.4 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -64.77 143.31 58.02 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.295 1.038 . . . . 75.21 111.576 -179.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.76 -9.17 75.14 Favored Glycine 0 N--CA 1.47 0.909 0 O-C-N 123.831 0.707 . . . . 70.34 112.939 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.42 HH11 ' HE1' ' A' ' 176' ' ' TYR . 89.3 mtt180 -78.15 154.14 31.46 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.237 0.615 . . . . 70.5 109.989 171.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -131.23 136.31 48.11 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.592 1.157 . . . . 71.24 108.437 -178.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.592 HD21 ' CE2' ' A' ' 176' ' ' TYR . 30.2 mt -110.12 103.16 11.84 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.875 -0.602 . . . . 61.13 109.912 -169.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -70.5 100.65 1.83 Allowed 'General case' 0 C--O 1.239 0.501 0 O-C-N 124.038 0.836 . . . . 73.43 109.203 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.709 HD22 ' HA ' ' A' ' 173' ' ' ILE . 12.4 mt -97.79 98.59 9.97 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.305 -1.368 . . . . 63.53 107.305 177.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 36.3 mtmt -76.88 141.74 40.45 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.298 -0.41 . . . . 75.42 110.331 -176.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.98 33.07 42.37 Favored Glycine 0 C--N 1.344 1.015 0 O-C-N 123.478 0.486 . . . . 71.55 113.278 -179.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -125.0 -33.95 2.85 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.74 0.816 . . . . 73.11 111.619 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -65.61 -159.81 0.6 Allowed Glycine 0 C--N 1.359 1.856 0 O-C-N 123.488 0.493 . . . . 53.42 113.491 176.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -71.72 146.17 90.58 Favored Pre-proline 0 CA--C 1.554 1.112 0 O-C-N 122.049 -0.677 . . . . 75.53 110.078 -177.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 20.7 Cg_endo -59.24 155.59 39.53 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.778 2.319 . . . . 72.14 112.925 175.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -164.33 -173.66 33.23 Favored Glycine 0 CA--C 1.539 1.551 0 CA-C-O 119.782 -0.454 . . . . 64.33 113.248 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.55 -34.66 96.81 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.869 3.046 . . . . 65.15 113.574 -178.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -100.81 22.04 12.66 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.956 0.902 . . . . 43.12 111.108 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 91.52 -163.72 28.81 Favored Glycine 0 C--N 1.347 1.164 0 N-CA-C 111.472 -0.651 . . . . 44.11 111.472 -173.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 31.6 mtt180 -69.57 156.36 39.04 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.096 0.474 . . . . 63.44 110.778 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -78.29 -165.63 27.56 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 115.334 -0.848 . . . . 55.51 112.363 177.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -99.07 168.8 9.85 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.214 0.606 . . . . 74.45 110.13 -177.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 40.4 tp -142.48 107.81 5.01 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.943 -0.762 . . . . 62.25 108.943 174.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -89.33 108.2 19.49 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.907 0.483 . . . . 72.34 109.964 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.578 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 34.7 mt -87.62 107.97 18.85 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 109.311 -0.625 . . . . 72.11 109.311 174.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -78.66 103.5 8.65 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 109.075 -0.713 . . . . 75.54 109.075 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 94.8 t -56.8 112.99 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 124.548 1.139 . . . . 72.33 111.194 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -116.34 100.55 7.97 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.039 -1.097 . . . . 74.42 108.039 176.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 30.1 mt -79.38 126.92 39.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 123.285 0.634 . . . . 54.43 110.665 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 19.7 p . . . . . 0 CA--C 1.557 1.213 0 C-N-CA 124.714 1.205 . . . . 64.54 108.708 176.135 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 53.1 tpp . . . . . 0 N--CA 1.473 0.692 0 N-CA-C 109.472 -0.566 . . . . 75.22 109.472 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 28.5 p -152.52 121.2 6.46 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.244 0.618 . . . . 75.41 110.534 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -65.89 142.25 57.97 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.394 0.678 . . . . 72.32 109.7 174.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.577 ' HA ' ' HE2' ' A' ' 238' ' ' LYS . 58.1 mt -80.46 81.36 6.73 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.372 0.606 . . . . 63.03 110.254 -173.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -70.56 127.95 34.47 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 114.682 -1.144 . . . . 73.53 109.933 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.615 HG22 ' H ' ' A' ' 175' ' ' ALA . 41.5 mt -76.13 -70.87 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 122.607 0.363 . . . . 72.34 110.2 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . 60.14 33.76 21.15 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.078 0.951 . . . . 32.03 111.384 -177.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.615 ' H ' HG22 ' A' ' 173' ' ' ILE . . . -130.03 161.6 30.6 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.682 1.193 . . . . 73.33 108.966 175.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.673 ' CE2' HD21 ' A' ' 233' ' ' LEU . 40.6 m-85 66.54 -68.44 0.14 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.724 1.21 . . . . 75.43 109.337 -159.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -96.77 95.35 1.73 Allowed Glycine 0 CA--C 1.533 1.179 0 N-CA-C 109.819 -1.312 . . . . 54.15 109.819 165.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -84.23 173.17 9.04 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.465 2.11 . . . . 72.11 112.519 -175.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -138.14 -175.29 4.05 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.452 0.701 . . . . 71.54 110.6 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.65 125.93 40.69 Favored Glycine 0 C--N 1.356 1.694 0 O-C-N 123.775 0.672 . . . . 61.25 113.058 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 53.8 m -118.53 133.75 55.63 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.381 1.072 . . . . 64.54 110.584 -172.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -137.73 16.83 3.5 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 115.59 -0.732 . . . . 44.4 111.846 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -90.0 44.31 2.98 Favored Glycine 0 C--N 1.349 1.278 0 C-N-CA 122.879 0.276 . . . . 53.32 112.689 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 49.5 m -88.38 114.83 25.4 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.308 0.643 . . . . 70.25 109.539 177.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -148.19 150.54 22.75 Favored Glycine 0 C--N 1.337 0.635 0 N-CA-C 111.564 -0.615 . . . . 50.31 111.564 -178.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -98.15 -170.12 32.12 Favored Glycine 0 N--CA 1.469 0.893 0 CA-C-O 119.807 -0.441 . . . . 64.14 112.471 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 17.3 m 59.79 91.43 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.586 1.155 . . . . 71.22 111.985 176.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -67.88 88.09 0.18 Allowed Glycine 0 C--N 1.35 1.337 0 CA-C-N 115.945 -0.57 . . . . 72.33 112.831 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -105.5 34.73 5.55 Favored Glycine 0 C--N 1.342 0.892 0 C-N-CA 123.584 0.611 . . . . 54.24 112.314 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 21.5 m 65.07 35.19 8.18 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.734 1.214 . . . . 71.41 112.279 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -65.74 -65.93 0.61 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.111 0.565 . . . . 75.55 109.724 175.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -80.33 132.14 35.75 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.467 -0.788 . . . . 73.22 109.431 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 86.2 mt -136.94 175.11 9.92 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.838 0.855 . . . . 64.41 109.772 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -105.26 163.49 12.56 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.055 0.942 . . . . 73.21 110.205 178.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -165.33 129.7 2.4 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.771 1.228 . . . . 60.11 108.13 175.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . 0.446 ' HA ' ' HB2' ' A' ' 252' ' ' GLU . 50.1 m -70.69 137.11 49.52 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 122.794 0.438 . . . . 54.34 111.163 -178.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 21.9 tp -122.46 112.44 18.05 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.182 -1.044 . . . . 62.34 108.182 175.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -91.23 128.43 37.05 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 108.913 -0.773 . . . . 65.05 108.913 175.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 3.3 p -139.6 124.87 11.64 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 123.799 0.84 . . . . 61.44 109.578 -177.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -67.5 153.51 76.31 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 121.467 1.444 . . . . 44.33 111.717 176.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.59 -45.17 85.24 Favored Pre-proline 0 CA--C 1.564 1.496 0 CA-C-O 117.648 -1.167 . . . . 53.33 113.887 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.457 ' O ' HG12 ' A' ' 206' ' ' VAL . 19.9 Cg_endo -59.36 -52.27 5.07 Favored 'Trans proline' 0 C--N 1.397 3.127 0 CA-C-N 121.426 1.545 . . . . 62.31 112.17 175.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 46.0 mt -63.8 -27.31 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 123.639 0.776 . . . . 75.42 110.896 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' A' ' 227' ' ' THR . . . -70.86 -49.33 47.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.386 0.675 . . . . 72.51 111.169 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 84.7 t -67.84 -54.0 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 122.988 0.515 . . . . 73.21 110.96 -177.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.457 HG12 ' O ' ' A' ' 202' ' ' PRO . 11.1 p -74.34 -38.66 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 122.701 0.4 . . . . 60.32 111.345 -175.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 88.79 79.16 1.3 Allowed Glycine 0 C--N 1.343 0.955 0 N-CA-C 112.07 -0.412 . . . . 65.02 112.07 -172.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -99.33 -125.54 5.45 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-O 119.546 -0.586 . . . . 64.22 112.064 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.54 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 33.7 mtmm -138.18 150.18 46.54 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.101 0.961 . . . . 63.21 109.4 174.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 24.3 m -138.51 170.18 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 124.031 0.932 . . . . 75.44 110.946 177.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 19.3 ttm180 -96.76 115.72 27.91 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.798 0.839 . . . . 62.11 110.303 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -107.67 156.14 19.39 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 109.181 -0.674 . . . . 41.31 109.181 168.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 83.6 mtp -98.08 120.93 39.35 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.034 0.445 . . . . 61.13 110.063 177.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 215' ' ' LEU . 5.5 m -111.26 174.41 5.88 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 125.083 1.353 . . . . 70.23 107.382 175.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.42 ' H ' HG22 ' A' ' 214' ' ' THR . 76.1 mt -59.44 -35.17 73.51 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 113.118 0.785 . . . . 74.34 113.118 -171.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -90.6 -19.11 24.07 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.207 0.603 . . . . 74.22 111.279 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 147.04 -158.88 27.87 Favored Glycine 0 C--N 1.353 1.502 0 CA-C-O 119.824 -0.431 . . . . 65.34 113.324 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.9 143.91 29.99 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.496 2.797 . . . . 70.22 113.498 -173.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 31.2 m -133.25 161.45 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.106 0.962 . . . . 71.33 110.084 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -95.57 110.92 22.94 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.747 0.819 . . . . 74.35 109.656 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 54.5 t -96.52 111.28 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.574 1.149 . . . . 72.05 108.159 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.54 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . . . -73.72 95.8 2.42 Favored 'General case' 0 C--N 1.349 0.568 0 N-CA-C 109.34 -0.615 . . . . 73.44 109.34 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 53.6 t -64.31 132.09 95.24 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 124.468 1.107 . . . . 72.42 110.279 -173.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.74 166.71 28.66 Favored 'Trans proline' 0 CA--C 1.559 1.729 0 C-N-CA 122.668 2.246 . . . . 74.33 112.213 170.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.29 167.03 28.12 Favored 'Trans proline' 0 C--N 1.372 1.798 0 C-N-CA 121.822 1.682 . . . . 74.04 112.057 173.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 65.37 19.18 11.57 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.718 1.207 . . . . 73.45 112.157 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.544 ' HA ' ' CZ ' ' A' ' 176' ' ' TYR . 79.1 m -66.87 101.19 0.8 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.187 0.595 . . . . 42.33 110.659 -176.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -101.96 143.09 32.26 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 125.605 1.562 . . . . 71.02 110.596 -174.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -68.87 145.04 54.05 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 123.927 0.891 . . . . 64.1 111.166 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.06 -12.73 68.71 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.247 -0.888 . . . . 41.34 112.446 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.543 HH11 ' HE1' ' A' ' 176' ' ' TYR . 87.6 mtt180 -85.13 154.67 21.87 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.329 0.652 . . . . 72.35 110.415 175.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.552 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 3.3 mppt? -130.29 139.48 50.73 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.25 -1.019 . . . . 74.1 108.25 -178.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.673 HD21 ' CE2' ' A' ' 176' ' ' TYR . 26.1 mt -110.77 100.63 9.35 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 122.9 0.48 . . . . 61.24 109.829 -172.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -71.12 101.86 2.36 Favored 'General case' 0 CA--C 1.552 1.038 0 O-C-N 124.003 0.814 . . . . 75.21 110.01 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 173' ' ' ILE . 11.8 mt -106.45 107.77 18.95 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.303 0.641 . . . . 64.0 109.283 -175.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -61.15 150.6 33.73 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.507 0.558 . . . . 70.55 112.507 176.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.78 24.78 61.6 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.483 -0.781 . . . . 72.52 114.004 171.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.577 ' HE2' ' HA ' ' A' ' 171' ' ' LEU . 11.1 mmtp -119.83 -44.26 2.53 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.18 0.592 . . . . 72.31 109.578 -176.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -77.53 -177.01 45.97 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-N 115.352 -0.84 . . . . 74.22 112.727 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -64.83 150.87 94.03 Favored Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 123.703 0.801 . . . . 75.32 112.512 -171.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.645 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 52.6 Cg_endo -66.09 151.96 82.45 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 122.642 2.228 . . . . 74.35 112.329 -177.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -168.22 -156.07 9.97 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 119.413 -0.659 . . . . 44.12 113.214 -177.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.56 -30.41 61.09 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 123.545 2.83 . . . . 62.24 112.345 -176.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -85.76 16.19 4.2 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.268 1.027 . . . . 65.22 111.509 178.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 87.63 -74.01 2.28 Favored Glycine 0 C--N 1.35 1.319 0 N-CA-C 110.94 -0.864 . . . . 62.41 110.94 -175.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.645 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 14.1 mtm180 -128.42 169.21 14.56 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.3 1.04 . . . . 72.24 110.076 174.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -93.3 175.66 36.39 Favored Glycine 0 C--N 1.339 0.747 0 CA-C-N 115.658 -0.701 . . . . 61.1 113.451 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -99.61 170.37 8.63 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.215 1.006 . . . . 65.32 109.619 -176.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 238' ' ' LYS . 32.0 tp -141.88 118.88 11.25 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.292 -0.633 . . . . 74.12 109.292 172.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.552 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 13.9 m-85 -88.69 109.41 20.1 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.748 -0.834 . . . . 74.44 108.748 -178.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 30.2 mt -85.97 108.57 18.27 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.93 -0.767 . . . . 74.31 108.93 176.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 196' ' ' THR . 30.4 mt-10 -77.31 97.16 4.78 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 114.421 -1.263 . . . . 75.13 109.405 -174.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 65.6 t -60.67 105.16 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 O-C-N 123.765 0.665 . . . . 64.34 110.752 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -116.02 102.22 9.45 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 106.988 -1.486 . . . . 74.12 106.988 174.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.525 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 51.3 mt -81.52 131.63 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 116.111 -0.495 . . . . 75.24 110.843 -174.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 21.3 p . . . . . 0 CA--C 1.563 1.452 0 C-N-CA 124.537 1.135 . . . . 73.34 108.422 177.267 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 N--CA 1.484 1.266 0 N-CA-C 110.556 -0.164 . . . . 70.31 110.556 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 33.5 t -153.02 105.38 2.92 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.156 -0.683 . . . . 72.14 109.156 176.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -104.27 155.58 18.62 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.26 0.624 . . . . 72.44 111.234 -177.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.415 HD12 HG21 ' A' ' 219' ' ' VAL . 86.2 mt -97.63 27.21 4.47 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.374 1.07 . . . . 74.01 110.626 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -45.66 148.0 0.81 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 126.678 1.991 . . . . 65.12 114.487 178.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.618 HG23 HD21 ' A' ' 235' ' ' LEU . 75.9 mt -93.44 107.93 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.996 0.918 . . . . 73.04 110.152 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -84.1 -5.71 59.28 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.387 0.675 . . . . 70.41 110.76 173.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -76.38 -179.52 5.2 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.821 0.849 . . . . 31.41 111.023 177.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.567 ' CE2' HD21 ' A' ' 233' ' ' LEU . 25.3 m-85 64.35 37.98 8.1 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.44 1.096 . . . . 74.3 110.15 -160.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -157.63 71.46 0.25 Allowed Glycine 0 CA--C 1.534 1.279 0 CA-C-N 114.064 -1.425 . . . . 75.14 111.34 175.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -60.43 -5.44 4.24 Favored 'Trans proline' 0 C--N 1.389 2.661 0 C-N-CA 123.703 2.935 . . . . 71.42 114.979 175.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -62.43 84.01 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.399 0.68 . . . . 54.22 111.183 170.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -163.68 108.47 0.34 Allowed Glycine 0 C--N 1.339 0.749 0 CA-C-N 116.011 -0.541 . . . . 65.43 112.678 -173.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 50.0 m -109.06 33.09 4.45 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.202 1.001 . . . . 62.04 109.71 176.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -151.94 167.43 31.11 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.745 -0.661 . . . . 74.3 113.013 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 79.21 8.4 87.84 Favored Glycine 0 C--N 1.352 1.444 0 CA-C-O 119.462 -0.632 . . . . 51.43 114.272 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.3 p -69.65 90.2 0.56 Allowed 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 117.683 0.741 . . . . 73.11 111.48 -174.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -174.75 162.23 32.14 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 114.958 -1.019 . . . . 71.13 110.677 179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 70.45 62.8 3.5 Favored Glycine 0 C--N 1.35 1.328 0 CA-C-N 117.63 0.715 . . . . 53.05 112.866 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 26.9 m -126.29 119.98 28.77 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.846 0.859 . . . . 74.43 110.115 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 103.91 155.33 23.9 Favored Glycine 0 C--N 1.351 1.396 0 C-N-CA 123.356 0.503 . . . . 65.11 112.853 -179.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 100.52 -177.42 28.28 Favored Glycine 0 C--N 1.349 1.281 0 C-N-CA 123.051 0.358 . . . . 73.12 112.553 178.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 23.4 t -69.44 -11.62 60.97 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.817 0.847 . . . . 74.1 112.155 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -63.01 -36.2 82.75 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.335 1.054 . . . . 71.14 109.809 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.43 131.64 41.25 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 114.563 -1.199 . . . . 71.4 110.204 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 96.4 mt -135.8 155.49 50.27 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.81 0.844 . . . . 73.04 110.239 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -116.4 145.34 43.32 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.091 0.957 . . . . 62.03 109.17 172.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -150.1 136.76 19.15 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.31 0.644 . . . . 65.3 109.504 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 86.6 m -69.19 138.77 54.34 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.216 0.606 . . . . 64.55 110.353 175.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.523 HD13 HD13 ' A' ' 251' ' ' LEU . 45.3 tp -120.14 112.45 19.11 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 107.657 -1.238 . . . . 71.15 107.657 174.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -95.68 117.0 29.67 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.743 -0.836 . . . . 54.41 108.743 -178.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 255' ' ' ILE . 6.9 p -142.32 129.07 11.03 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.019 0.928 . . . . 72.04 109.364 -176.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.08 155.58 61.25 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 121.792 1.662 . . . . 41.42 111.791 175.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -48.63 -46.69 71.54 Favored Pre-proline 0 N--CA 1.487 1.402 0 N-CA-C 114.522 1.304 . . . . 64.51 114.522 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.441 ' O ' HG12 ' A' ' 206' ' ' VAL . 19.7 Cg_endo -57.74 -55.13 2.59 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 121.418 1.412 . . . . 73.23 112.802 176.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 58.9 mt -65.2 -29.52 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 123.426 0.69 . . . . 43.2 111.277 -177.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.8 -53.22 28.79 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.052 0.541 . . . . 61.24 111.03 -178.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 89.9 t -67.39 -55.17 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 115.642 -0.708 . . . . 71.32 110.956 -176.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.441 HG12 ' O ' ' A' ' 202' ' ' PRO . 7.7 p -77.12 -22.89 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 N-CA-C 112.268 0.47 . . . . 73.4 112.268 -173.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 91.41 139.01 8.19 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-O 120.1 -0.278 . . . . 43.04 112.622 -177.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -171.83 -145.48 4.9 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 116.753 0.276 . . . . 42.12 113.116 -178.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.515 ' HG2' ' HA ' ' A' ' 222' ' ' ALA . 96.4 mttt -133.76 132.7 40.85 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.963 0.905 . . . . 71.14 109.131 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.413 HG22 HG21 ' A' ' 223' ' ' VAL . 34.9 m -131.88 164.94 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-O 121.135 0.493 . . . . 61.41 110.716 177.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -75.45 141.34 43.16 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.082 -0.963 . . . . 64.52 110.645 174.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -141.47 157.55 45.0 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.727 0.811 . . . . 52.55 110.045 173.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 55.4 ttp -81.91 129.65 34.83 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.151 0.58 . . . . 72.32 110.72 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 89.5 m -143.61 166.96 23.38 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 124.418 1.087 . . . . 73.42 108.251 176.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 96.4 mt -56.6 -27.9 59.16 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.751 0.82 . . . . 75.22 112.458 174.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.46 14.56 3.61 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.826 0.85 . . . . 62.52 111.663 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 85.2 -148.75 23.34 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 111.192 -0.763 . . . . 41.01 111.192 -175.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.66 129.19 13.32 Favored 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 122.412 2.075 . . . . 62.05 111.327 174.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.415 HG21 HD12 ' A' ' 171' ' ' LEU . 29.2 m -122.21 155.87 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.726 0.811 . . . . 63.0 109.78 178.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -97.24 104.76 16.81 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.896 -0.779 . . . . 75.32 108.896 176.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.6 t -96.41 130.56 44.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 124.04 0.936 . . . . 73.14 109.829 -176.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.515 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . . . -77.48 101.93 6.67 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.322 0.649 . . . . 65.35 110.191 178.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.453 ' HA ' HD12 ' A' ' 173' ' ' ILE . 50.2 t -91.43 126.0 56.02 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 124.303 1.041 . . . . 64.41 109.959 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.44 ' HD3' ' HB ' ' A' ' 173' ' ' ILE . 57.2 Cg_endo -66.7 172.6 9.18 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 123.665 2.91 . . . . 74.2 112.452 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.63 -179.41 1.98 Allowed 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 121.853 1.702 . . . . 73.51 112.154 166.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 68.86 5.29 4.91 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 125.28 1.432 . . . . 74.42 112.473 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.451 ' HA ' ' CZ ' ' A' ' 176' ' ' TYR . 90.5 m -67.05 114.34 5.75 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.374 0.607 . . . . 72.45 110.933 -171.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.429 ' HA ' HD11 ' A' ' 255' ' ' ILE . 6.7 tp-100 -125.77 139.53 53.44 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 124.033 0.933 . . . . 51.13 110.464 -165.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.426 ' HB2' ' HB ' ' A' ' 255' ' ' ILE . . . -61.39 134.24 56.7 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.999 0.92 . . . . 75.31 112.826 -171.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.85 -2.35 85.74 Favored Glycine 0 N--CA 1.474 1.203 0 CA-C-N 115.883 -0.599 . . . . 64.01 113.663 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -89.67 146.91 24.19 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.327 -0.62 . . . . 51.44 109.327 173.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -126.73 138.69 53.42 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.791 0.836 . . . . 73.33 108.97 -172.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.567 HD21 ' CE2' ' A' ' 176' ' ' TYR . 40.6 mt -113.53 109.02 17.97 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.073 -0.512 . . . . 62.1 111.008 -163.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -70.64 102.61 2.32 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 124.62 1.2 . . . . 73.54 109.806 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.618 HD21 HG23 ' A' ' 173' ' ' ILE . 33.0 mt -109.4 91.7 3.75 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.322 -0.622 . . . . 63.35 109.322 178.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.556 ' HG2' ' HB3' ' A' ' 248' ' ' ASP . 45.4 mtmt -70.13 143.53 52.32 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 122.851 0.46 . . . . 63.12 110.721 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.36 34.34 45.8 Favored Glycine 0 C--N 1.346 1.111 0 O-C-N 123.875 0.734 . . . . 72.34 112.067 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -131.26 -34.12 1.44 Allowed 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.005 0.922 . . . . 74.03 110.386 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -74.03 -163.24 9.05 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-N 116.304 -0.407 . . . . 42.32 113.581 175.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -71.26 149.52 94.2 Favored Pre-proline 0 N--CA 1.484 1.242 0 C-N-CA 122.835 0.454 . . . . 73.3 111.438 -176.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -67.83 161.32 44.46 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.918 2.412 . . . . 73.41 112.512 173.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -170.36 -173.26 37.52 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 115.739 -0.664 . . . . 73.2 112.188 177.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.25 -2.63 12.36 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 123.388 2.725 . . . . 74.2 113.133 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -118.44 21.17 12.76 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.269 1.028 . . . . 62.23 110.558 174.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 86.41 -167.07 38.76 Favored Glycine 0 C--N 1.345 1.043 0 CA-C-N 115.982 -0.554 . . . . 55.11 112.506 -175.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -79.85 132.95 36.23 Favored 'General case' 0 C--O 1.244 0.811 0 N-CA-C 109.252 -0.648 . . . . 74.01 109.252 175.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.96 -164.95 22.02 Favored Glycine 0 C--N 1.341 0.84 0 O-C-N 123.775 0.672 . . . . 52.4 113.663 -177.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.556 ' HB3' ' HG2' ' A' ' 236' ' ' LYS . 1.2 p-10 -113.52 132.81 55.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.589 0.709 . . . . 73.0 111.957 -168.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 42.0 tp -98.57 117.83 33.88 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.014 -1.448 . . . . 70.55 108.502 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -88.5 109.7 20.26 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 122.848 0.459 . . . . 74.32 109.939 178.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.523 HD13 HD13 ' A' ' 197' ' ' LEU . 31.8 mt -86.96 106.12 17.59 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.174 -0.676 . . . . 73.2 109.174 175.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -78.16 105.34 9.32 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 115.635 -0.711 . . . . 74.4 109.411 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 65.2 t -56.44 118.04 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 123.762 0.825 . . . . 74.34 111.014 176.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -117.3 94.77 4.69 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 107.799 -1.186 . . . . 74.34 107.799 175.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.429 HD11 ' HA ' ' A' ' 228' ' ' GLN . 14.5 mt -76.03 123.96 33.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 O-C-N 124.006 0.816 . . . . 75.32 109.779 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 37.4 p . . . . . 0 CA--C 1.557 1.239 0 CA-C-O 117.489 -1.243 . . . . 71.54 108.167 174.543 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 23.0 mmt . . . . . 0 N--CA 1.473 0.676 0 N-CA-C 109.847 -0.427 . . . . 73.23 109.847 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.7 t -162.84 -167.53 1.55 Allowed 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 124.804 1.242 . . . . 54.45 108.234 -178.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -157.08 150.25 23.9 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.519 0.728 . . . . 72.03 109.248 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 6.0 mp -71.56 87.87 0.92 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.367 0.667 . . . . 63.42 109.287 176.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -94.63 139.64 30.94 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.847 0.859 . . . . 72.1 109.653 177.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.433 ' HA ' HD22 ' A' ' 235' ' ' LEU . 26.4 mm -82.99 110.7 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 122.788 0.435 . . . . 75.31 110.205 178.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -94.25 12.21 27.58 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.751 0.82 . . . . 32.22 110.729 172.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.414 ' H ' HG22 ' A' ' 173' ' ' ILE . . . -103.85 178.84 4.44 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.36 1.064 . . . . 74.12 111.383 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 59.18 29.46 19.02 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.043 1.337 . . . . 74.31 111.837 -164.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -86.2 152.41 25.57 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 115.244 -0.889 . . . . 13.24 111.224 169.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.92 -9.48 12.08 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 123.683 2.922 . . . . 73.11 113.876 177.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -128.32 141.56 51.4 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.988 0.915 . . . . 61.51 108.686 171.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -86.24 -106.79 0.77 Allowed Glycine 0 C--N 1.347 1.146 0 N-CA-C 111.167 -0.773 . . . . 42.51 111.167 173.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.8 m -155.32 172.84 17.53 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.183 0.993 . . . . 44.52 109.476 174.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -166.19 74.39 0.15 Allowed Glycine 0 C--N 1.34 0.798 0 N-CA-C 111.39 -0.684 . . . . 73.23 111.39 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -124.29 45.18 1.2 Allowed Glycine 0 C--N 1.346 1.116 0 C-N-CA 123.301 0.477 . . . . 74.12 112.364 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 40.1 t -71.49 98.16 1.79 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.334 0.654 . . . . 74.32 109.769 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 134.3 -7.35 4.68 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-O 119.656 -0.524 . . . . 63.12 112.886 -177.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -78.47 -87.16 0.47 Allowed Glycine 0 C--N 1.352 1.455 0 CA-C-N 116.731 0.265 . . . . 73.5 112.684 178.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.535 ' HB3' ' NE2' ' A' ' 191' ' ' GLN . 75.6 m -150.85 79.64 1.32 Allowed 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.033 0.933 . . . . 43.32 109.63 -179.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -91.36 -116.28 2.02 Favored Glycine 0 C--N 1.341 0.849 0 CA-C-N 115.244 -0.889 . . . . 42.15 111.814 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 76.24 -76.55 1.45 Allowed Glycine 0 C--N 1.348 1.242 0 C-N-CA 123.4 0.524 . . . . 75.41 112.529 176.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 23.9 t -162.61 12.89 0.07 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.573 0.749 . . . . 75.22 111.246 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.535 ' NE2' ' HB3' ' A' ' 187' ' ' SER . 78.3 mt-30 -63.78 -36.66 84.62 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.213 0.53 . . . . 75.22 110.477 177.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -75.53 138.31 41.44 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.055 -0.975 . . . . 73.33 108.909 173.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.7 mt -129.49 168.98 15.55 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.154 0.582 . . . . 73.42 111.033 -172.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -120.49 141.91 49.77 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 124.637 1.175 . . . . 74.4 108.258 172.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -153.83 128.22 9.19 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.172 0.989 . . . . 73.35 108.36 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . 0.415 ' HA ' ' HB2' ' A' ' 252' ' ' GLU . 92.9 m -72.87 135.06 45.07 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.084 0.553 . . . . 73.15 111.595 -175.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 40.5 tp -114.35 113.73 24.94 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.768 1.227 . . . . 73.24 108.343 178.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -89.25 116.43 27.47 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.09 -0.707 . . . . 53.3 109.09 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 7.0 p -136.38 133.26 19.24 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 108.283 -1.006 . . . . 72.34 108.283 -174.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.479 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 72.2 Cg_endo -74.84 161.85 38.46 Favored 'Trans proline' 0 C--N 1.37 1.658 0 C-N-CA 121.899 1.732 . . . . 64.32 111.892 175.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.05 -51.66 59.92 Favored Pre-proline 0 CA--C 1.569 1.696 0 N-CA-C 113.893 1.071 . . . . 74.01 113.893 177.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 23.1 Cg_endo -60.5 -52.48 3.85 Favored 'Trans proline' 0 C--N 1.399 3.221 0 C-N-CA 122.068 1.845 . . . . 74.0 112.926 -178.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 61.0 mt -64.26 -28.63 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 123.476 0.71 . . . . 75.43 111.447 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.23 -48.51 75.53 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.937 0.398 . . . . 75.33 111.234 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 61.7 t -71.37 -52.41 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.192 0 CA-C-N 116.099 -0.501 . . . . 70.32 112.18 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 202' ' ' PRO . 11.4 p -85.11 -31.73 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 112.395 0.517 . . . . 63.4 112.395 -172.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 100.39 149.94 24.11 Favored Glycine 0 N--CA 1.471 0.974 0 CA-C-N 116.45 -0.341 . . . . 62.22 112.372 -173.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 162.42 173.78 31.51 Favored Glycine 0 C--N 1.34 0.782 0 N-CA-C 111.788 -0.525 . . . . 72.42 111.788 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -81.15 134.79 35.7 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 116.993 0.396 . . . . 75.23 110.094 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 25.7 m -123.28 167.84 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.488 0.715 . . . . 62.13 110.48 173.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 -81.5 105.31 12.56 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.705 -1.134 . . . . 70.44 108.975 172.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -104.69 144.0 32.32 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.6 0.76 . . . . 72.33 109.43 175.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 41.4 ttm -86.91 115.66 24.46 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.192 0.52 . . . . 74.3 110.512 -177.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 9.2 m -116.15 162.57 17.24 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.626 1.17 . . . . 72.03 107.901 176.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 96.0 mt -56.8 -35.63 68.96 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.227 0.611 . . . . 75.21 112.349 -177.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -78.55 -20.06 51.48 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.047 0.539 . . . . 73.35 111.537 -177.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 142.13 -171.8 24.42 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 116.16 -0.473 . . . . 60.51 112.337 -176.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.52 129.07 14.24 Favored 'Trans proline' 0 C--N 1.365 1.441 0 C-N-CA 123.022 2.482 . . . . 73.41 111.463 177.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.73 159.93 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 123.723 0.809 . . . . 54.1 109.549 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -91.18 111.18 22.54 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.36 0.664 . . . . 71.3 109.661 174.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 93.2 t -107.58 120.99 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.24 1.016 . . . . 74.13 108.903 177.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.48 98.87 2.86 Favored 'General case' 0 C--N 1.348 0.509 0 C-N-CA 122.989 0.515 . . . . 72.52 109.959 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 62.2 t -78.03 136.15 62.18 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 124.534 1.134 . . . . 64.3 109.173 177.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -76.77 173.22 14.83 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.998 2.465 . . . . 74.13 111.201 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.49 179.52 1.24 Allowed 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 121.972 1.781 . . . . 74.44 112.197 166.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 27.8 mtt-85 71.23 0.05 3.28 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 125.184 1.394 . . . . 71.43 112.355 176.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 95.4 m -65.76 106.33 1.48 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.185 0.594 . . . . 54.53 110.712 -170.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.483 ' HB3' ' HD2' ' A' ' 231' ' ' ARG . 60.5 tp60 -115.1 141.45 47.99 Favored 'General case' 0 C--N 1.35 0.596 0 CA-C-N 115.054 -0.975 . . . . 72.11 110.329 -170.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.99 139.83 58.81 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.344 1.057 . . . . 54.12 111.513 -175.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 91.7 -27.21 10.13 Favored Glycine 0 C--N 1.344 0.978 0 O-C-N 123.836 0.71 . . . . 42.22 112.791 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.483 ' HD2' ' HB3' ' A' ' 228' ' ' GLN . 78.5 mtt180 -77.2 160.64 28.79 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.013 0.525 . . . . 72.01 110.413 176.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 250' ' ' TYR . 2.8 mppt? -130.1 144.93 51.62 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.205 0.602 . . . . 71.44 109.653 -176.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.429 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 12.8 mt -97.9 104.44 16.47 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 115.738 -0.664 . . . . 74.24 109.269 -176.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 54.0 ttm-85 -71.51 105.74 3.72 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 123.873 0.733 . . . . 75.02 110.292 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.433 HD22 ' HA ' ' A' ' 173' ' ' ILE . 27.8 mt -112.26 94.59 5.0 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.18 0.592 . . . . 74.41 109.43 -178.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -65.74 143.81 57.29 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.32 0.248 . . . . 73.43 111.346 178.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 85.07 12.83 73.02 Favored Glycine 0 C--N 1.346 1.125 0 O-C-N 123.956 0.785 . . . . 53.34 113.707 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -110.78 -27.23 8.96 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 117.28 0.54 . . . . 74.13 110.539 -178.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -75.33 -167.69 21.93 Favored Glycine 0 C--N 1.352 1.469 0 O-C-N 123.473 0.483 . . . . 24.0 113.076 171.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 241' ' ' PRO . 71.2 m-85 -70.44 144.37 91.64 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 123.414 0.685 . . . . 75.4 112.847 -171.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 240' ' ' PHE . 13.7 Cg_exo -72.18 132.59 19.77 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 123.443 2.762 . . . . 72.14 111.856 173.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.47 ' HA3' HE22 ' A' ' 191' ' ' GLN . . . -140.91 -174.69 14.2 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 119.775 -0.459 . . . . 53.23 113.695 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -52.01 -53.64 6.63 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 124.501 3.467 . . . . 72.41 114.751 -173.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -94.27 -24.57 17.39 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.674 0.79 . . . . 75.12 112.017 -173.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 175.67 -164.91 35.39 Favored Glycine 0 C--N 1.347 1.155 0 C-N-CA 121.836 -0.221 . . . . 63.42 112.773 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 -107.53 150.71 26.52 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.909 0.884 . . . . 53.52 110.447 -177.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.3 167.8 52.91 Favored Glycine 0 C--N 1.348 1.235 0 O-C-N 123.669 0.605 . . . . 22.42 113.877 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -112.67 133.08 54.87 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.38 1.072 . . . . 72.45 110.137 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 40.2 tp -99.24 122.42 42.39 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.339 1.055 . . . . 73.11 108.808 -174.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.474 ' HB3' ' HB3' ' A' ' 232' ' ' LYS . 3.8 m-85 -89.6 110.14 21.03 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.485 -0.932 . . . . 72.22 108.485 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.447 ' HB3' ' HB2' ' A' ' 197' ' ' LEU . 27.8 mt -86.86 104.99 16.73 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.646 -0.872 . . . . 74.44 108.646 173.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.415 ' HB2' ' HA ' ' A' ' 196' ' ' THR . 32.5 mt-10 -77.88 97.33 5.24 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.68 -1.146 . . . . 71.3 109.46 -171.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 59.0 t -58.95 114.93 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 114.94 -1.027 . . . . 73.24 111.459 -177.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -116.86 95.97 5.26 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.74 -1.208 . . . . 75.42 107.74 171.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.466 HD11 ' HA ' ' A' ' 228' ' ' GLN . 50.8 mt -75.53 126.88 36.79 Favored 'Isoleucine or valine' 0 C--N 1.35 0.594 0 CA-C-N 115.376 -0.829 . . . . 75.11 108.955 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 14.5 p . . . . . 0 C--O 1.252 1.192 0 C-N-CA 124.79 1.236 . . . . 74.44 108.159 177.995 . . . . . . . . 0 0 . 1 stop_ save_